<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003823.pub2" GROUP_ID="HTN" ID="541902030612423385" MERGED_FROM="" MODIFIED="2009-08-12 18:39:11 +0200" MODIFIED_BY="Ciprian Jauca" REVIEW_NO="A022" REVMAN_SUB_VERSION="5.0.21" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2009-08-12 18:39:11 +0200" MODIFIED_BY="Ciprian Jauca">
<TITLE MODIFIED="2008-08-13 05:22:32 -0700" MODIFIED_BY="Ciprian D Jauca">Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension</TITLE>
<CONTACT MODIFIED="2009-08-12 18:39:11 +0200" MODIFIED_BY="Ciprian Jauca"><PERSON ID="14170" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Balraj</FIRST_NAME><MIDDLE_INITIALS>S</MIDDLE_INITIALS><LAST_NAME>Heran</LAST_NAME><POSITION>Cochrane Heart Research Fellow</POSITION><EMAIL_1>benji.heran@pms.ac.uk</EMAIL_1><EMAIL_2>bsheran@ti.ubc.ca</EMAIL_2><ADDRESS><DEPARTMENT>Peninsula Technology Assessment Group (PenTAG)</DEPARTMENT><ORGANISATION>Peninsula College of Medicine &amp; Dentistry, University of Exeter</ORGANISATION><ADDRESS_1>Noy Scott House</ADDRESS_1><ADDRESS_2>Barrack Road</ADDRESS_2><CITY>Exeter</CITY><ZIP>EX2 5DW</ZIP><REGION>Devon</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0)1392 406965</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-08-12 18:39:11 +0200" MODIFIED_BY="Ciprian Jauca"><PERSON ID="14170" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Balraj</FIRST_NAME><MIDDLE_INITIALS>S</MIDDLE_INITIALS><LAST_NAME>Heran</LAST_NAME><POSITION>Cochrane Heart Research Fellow</POSITION><EMAIL_1>benji.heran@pms.ac.uk</EMAIL_1><EMAIL_2>bsheran@ti.ubc.ca</EMAIL_2><ADDRESS><DEPARTMENT>Peninsula Technology Assessment Group (PenTAG)</DEPARTMENT><ORGANISATION>Peninsula College of Medicine &amp; Dentistry, University of Exeter</ORGANISATION><ADDRESS_1>Noy Scott House</ADDRESS_1><ADDRESS_2>Barrack Road</ADDRESS_2><CITY>Exeter</CITY><ZIP>EX2 5DW</ZIP><REGION>Devon</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0)1392 406965</PHONE_1></ADDRESS></PERSON><PERSON ID="14192" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Michelle</FIRST_NAME><MIDDLE_INITIALS>MY</MIDDLE_INITIALS><LAST_NAME>Wong</LAST_NAME><POSITION>Resident</POSITION><EMAIL_1>email_mwong@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medicine</DEPARTMENT><ORGANISATION>University of Alberta</ORGANISATION><ADDRESS_1>2F1.19 Walter C Mackenzie Health Sciences Centre</ADDRESS_1><ADDRESS_2>8440 - 112 Street</ADDRESS_2><CITY>Edmonton</CITY><ZIP>T6G 2R7</ZIP><REGION>Alberta</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 (780) 407-7482</PHONE_1><FAX_1>+1 (780) 407-3340</FAX_1></ADDRESS></PERSON><PERSON ID="AB5FCEC682E26AA201B8424ED7FAC62B" ROLE="AUTHOR"><FIRST_NAME>Inderjit</FIRST_NAME><MIDDLE_INITIALS>K</MIDDLE_INITIALS><LAST_NAME>Heran</LAST_NAME><POSITION>Public Health Nurse</POSITION><EMAIL_1>indyheran@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Public Health</DEPARTMENT><ORGANISATION>Vancouver Coastal Health Authority</ORGANISATION><CITY>Vancouver</CITY><REGION>BC</REGION><COUNTRY CODE="CA">Canada</COUNTRY></ADDRESS></PERSON><PERSON ID="5489" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>James</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Wright</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>jim.wright@ti.ubc.ca</EMAIL_1><ADDRESS><DEPARTMENT>Department of Anesthesiology, Pharmacology and Therapeutics</DEPARTMENT><ORGANISATION>University of British Columbia</ORGANISATION><ADDRESS_1>2176 Health Sciences Mall</ADDRESS_1><CITY>Vancouver</CITY><ZIP>V6T 1Z3</ZIP><REGION>BC</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1-604-822-4270</PHONE_1><PHONE_2>+1-604-822-0700</PHONE_2><FAX_1>+1-604-822-0701</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-08-12 09:35:12 -0700" MODIFIED_BY="Ciprian D Jauca">
<UP_TO_DATE>
<DATE DAY="18" MONTH="7" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="14" MONTH="2" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="12" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2008"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2009-08-12 09:34:30 -0700" MODIFIED_BY="Ciprian D Jauca">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-06-17 23:26:28 -0700" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="6" YEAR="2009"/>
<DESCRIPTION>
<P>In the plain language summary, the correct brand name for lisinopril was entered.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-08-12 09:34:30 -0700" MODIFIED_BY="Ciprian D Jauca">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-08-12 09:34:30 -0700" MODIFIED_BY="Ciprian D Jauca">
<DATE DAY="18" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>Plain language summary was edited to improve readability.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-08-13 06:00:45 -0700" MODIFIED_BY="Ciprian D Jauca">
<INTERNAL_SOURCES MODIFIED="2008-08-13 06:00:33 -0700" MODIFIED_BY="Ciprian D Jauca">
<SOURCE MODIFIED="2008-08-13 06:00:33 -0700" MODIFIED_BY="Ciprian D Jauca">
<NAME>Department of Anesthesiology, Pharmacology &amp; Therapeutics, University of British Columbia</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-08-13 06:00:45 -0700" MODIFIED_BY="Ciprian D Jauca">
<SOURCE MODIFIED="2008-05-02 14:13:08 -0700" MODIFIED_BY="Ciprian D Jauca">
<NAME>Canadian Institutes of Health Research (CIHR)</NAME>
<COUNTRY CODE="CA">Canada</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-06-17 23:18:05 -0700" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-06-17 23:18:05 -0700" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2009-02-18 14:33:55 -0800" MODIFIED_BY="Ciprian D Jauca">ACE inhibitors for the treatment of high blood pressure</TITLE>
<SUMMARY_BODY MODIFIED="2009-06-17 23:18:05 -0700" MODIFIED_BY="[Empty name]">
<P>The class of drugs called ACE inhibitors is commonly used for the treatment of elevated blood pressure. This class includes drugs such as ramipril (brand name: Altace), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril) and quinapril (Accupril). We asked how much this class of drugs lowers blood pressure and whether there is a difference between individual drugs within the class. The available scientific literature was searched to find all the trials that had assessed this question.</P>
<P>We found 92 trials that randomly assigned participants to take either an ACE inhibitor or an inert substance (placebo). These trials evaluated the blood pressure lowering ability of 14 different ACE inhibitors in 12 954 participants. The trials followed participants for approximately 6 weeks (though people are typically expected to take anti-hypertension drugs for the rest of their lives). The blood pressure lowering effect was modest.  There was an 8-point reduction in the upper number that signifies the systolic pressure and a 5-point reduction in the lower number that signifies the diastolic pressure.  Most of the blood pressure lowering effect (about 70%) can be achieved with the lowest recommended dose of the drugs.  No ACE inhibitor drug appears to be any better or worse than others in terms of blood pressure lowering ability.</P>
<P>Most of the trials in this review were funded by companies that make ACE inhibitors and serious adverse effects were not reported by the authors of many of these trials.  This could mean that the drug companies are withholding unfavorable findings related to their drugs.  Due to incomplete reporting of  the number of participants who dropped out of the trials due to adverse drug reactions, as well as the short duration of these trials, this review could not provide a good estimate of the harms associated with this class of drugs.  Prescribing the least expensive ACE inhibitor in lower doses will lead to substantial cost savings, and possibly a reduction in dose-related adverse events. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-08-12 20:15:16 -0700" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2008-08-12 19:45:04 -0700" MODIFIED_BY="[Empty name]">
<P>ACE inhibitors are widely prescribed for hypertension so it is essential to determine and compare their effects on blood pressure (BP), heart rate and withdrawals due to adverse effects (WDAE).</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-06-02 11:06:56 -0700" MODIFIED_BY="[Empty name]">
<P>To quantify the dose-related systolic and/or diastolic BP lowering efficacy of ACE inhibitors versus placebo in the treatment of primary hypertension.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-08-12 19:45:39 -0700" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL (The Cochrane Library 2007, Issue 1), MEDLINE (1966 to February 2007), EMBASE (1988 to February 2007) and reference lists of articles.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-08-12 20:00:31 -0700" MODIFIED_BY="[Empty name]">
<P>Double-blind, randomized, controlled trials evaluating the BP lowering efficacy of fixed-dose monotherapy with an ACE inhibitor compared with placebo for a duration of 3 to 12 weeks in patients with primary hypertension.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-08-12 19:47:36 -0700" MODIFIED_BY="[Empty name]">
<P>Two authors independently assessed the risk of bias and extracted data. Study authors were contacted for additional information. WDAE information was collected from the trials.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-08-12 19:50:08 -0700" MODIFIED_BY="[Empty name]">
<P>Ninety two trials evaluated the dose-related trough BP lowering efficacy of 14 different ACE inhibitors in 12 954 participants with a baseline BP of 157/101 mm Hg. The data do not suggest that any one ACE inhibitor is better or worse at lowering BP. A dose of 1/8 or 1/4 of the manufacturer's maximum recommended daily dose (Max)<I> </I>achieved a BP lowering effect that was 60 to 70% of the BP lowering effect of Max. A dose of 1/2 Max achieved a BP lowering effect that was 90% of Max. ACE inhibitor doses above Max did not significantly lower BP more than Max. Combining the effects of 1/2 Max and higher doses gives an estimate of the average trough BP lowering efficacy for ACE inhibitors as a class of drugs of -8 mm Hg for SBP and -5 mm Hg for DBP. ACE inhibitors reduced BP measured 1 to 12 hours after the dose by about 11/6 mm Hg.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-08-12 20:15:16 -0700" MODIFIED_BY="[Empty name]">
<P>There are no clinically meaningful BP lowering differences between different ACE inhibitors. The BP lowering effect of ACE inhibitors is modest; the magnitude of trough BP lowering at one-half the manufacturers' maximum recommended dose and above is -8/-5 mm Hg. Furthermore, 60 to 70% of this trough BP lowering effect occurs with recommended starting doses. The review did not provide a good estimate of the incidence of harms associated with ACE inhibitors because of the short duration of the trials and the lack of reporting of adverse effects in many of the trials. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-08-13 05:55:34 -0700" MODIFIED_BY="Ciprian D Jauca">
<BACKGROUND>
<P>ACE inhibitors are widely used as pharmacological agents for the treatment of hypertension. Hypertension is an important health problem and it is associated with an increased risk of death, stroke, and heart disease. Considerable scientific evidence shows that blood pressure reduction with different drug treatments reduces death, stroke, and heart disease. However, evidence also suggests the blood pressure lowering effect of antihypertensive agents may not always parallel with reductions in mortality or cardiovascular morbidity. In other words, blood pressure lowering does not always explain better health outcomes. Other factors may contribute to the reductions in mortality and vascular morbidity with antihypertensive drugs. Such factors may be independent of the blood pressure lowering effect of the drug, or the mechanism by which these drugs lower blood pressure. Nevertheless, blood pressure reduction remains an important factor. One of the main difficulties of managing a patient with hypertension using ACE inhibitors is deciding which dose of ACE inhibitor should be prescribed. This decision should be made primarily on the basis of the best available evidence of effectiveness. Despite over 20 years of research evidence and clinical use of ACE inhibitors, the dose-related blood pressure lowering effect of this anti-hypertensive drug class is still not known. </P>
<P>A systematic review of the dose-related blood pressure lowering efficacy of ACE inhibitors has not been previously performed. The aims of this systematic review are: 1) to quantify the dose-related blood pressure lowering efficacy of ACE inhibitors in patients with primary hypertension; and 2) to establish dose equivalencies of different drugs within the ACE inhibitor class. The information derived from this review should facilitate future reviews of head-to-head comparisons with other drug classes and assist clinicians in choosing optimal doses of ACE inhibitors.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-06-05 16:50:12 -0700" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="2">Primary objective</HEADING>
<UL>
<LI>To quantify the dose-related systolic and/or diastolic blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors versus placebo in the treatment of primary hypertension.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Secondary objectives</HEADING>
<UL>
<LI>To determine the effects of ACE inhibitors on variability of blood pressure.</LI>
<LI>To determine the effects of ACE inhibitors on pulse pressure.</LI>
<LI>To quantify the dose-related effects of ACE inhibitors on heart rate.</LI>
<LI>To quantify the dose-related effect of ACE inhibitors on withdrawals due to adverse effects.</LI>
</UL>
</SUBSECTION>
</OBJECTIVES>
<METHODS MODIFIED="2008-08-13 05:35:13 -0700" MODIFIED_BY="Ciprian D Jauca">
<SELECTION_CRITERIA MODIFIED="2008-08-13 05:34:14 -0700" MODIFIED_BY="Ciprian D Jauca">
<CRIT_STUDIES>
<P>Included studies must be randomized controlled trials (RCTs) and their design must meet the following criteria:</P>
<UL>
<LI>double-blind</LI>
<LI>random allocation to ACE inhibitor group(s) and parallel placebo group</LI>
<LI>duration of follow-up of at least three weeks</LI>
<LI>office blood pressure measurements at baseline (following washout) and at one or more time points between 3 and 12 weeks post-treatment</LI>
</UL>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Participants must have an office baseline blood pressure of at least 140 mm Hg systolic and/or a diastolic blood pressure of at least 90 mm Hg. Patients must not have creatinine levels greater than 1.5 times the normal level, thereby excluding patients with secondary hypertension due to renal failure. Participants who were taking medications that affect blood pressure other than the study medications were excluded. Participants were not restricted by age, gender, baseline risk or any other co-morbid conditions.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-12 16:31:05 -0700" MODIFIED_BY="[Empty name]">
<P>Monotherapy with any ACE inhibitor, including alacepril, altiopril, benazepril, captopril, ceronapril, cilazapril, delapril, derapril, enalapril, fosinopril, idapril, imidapril, lisinopril, moexipril, moveltipril, pentopril, perindopril, quinapril, ramipril, spirapril, temocapril, trandolapril, and zofenopril.</P>
<P>Trials in which titration to a higher dose was based on blood pressure response were not eligible if the titration occurred before 3 weeks of treatment because dose-response relationships cannot be analyzed if patients within each randomized group are taking different doses. However, trials in which a response-dependent titration took place during or after the 3-12 week interval were eligible if pre-titration data were given. For forced titration trials, data from the lowest dose were extracted, provided this dose was given for a 3 to 12 week period.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-08-13 05:34:14 -0700" MODIFIED_BY="Ciprian D Jauca">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-08-13 05:34:08 -0700" MODIFIED_BY="Ciprian D Jauca">
<P>Change from baseline of trough and/or peak systolic and diastolic blood pressure at 3 to 12 weeks, compared with placebo. If blood pressure measurements were available at more than one time within the accepted window, the weighted means of blood pressures taken in the 3 to 12 week range were used.</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-08-13 05:34:00 -0700" MODIFIED_BY="Ciprian D Jauca">
<UL>
<LI>Standard deviation of the change in blood pressure compared with placebo.</LI>
<LI>Change in standard deviation of blood pressure compared with placebo.</LI>
<LI>Change in pulse pressure compared with placebo.</LI>
<LI>Change in heart rate compared with placebo.</LI>
<LI>Number of patient withdrawals due to adverse effects compared with placebo.</LI>
</UL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-12 13:59:03 -0700" MODIFIED_BY="[Empty name]">
<P>To identify randomized, double-blind, placebo-controlled trials of ACE inhibitors, Cochrane Central Register of Controlled Trials (The Cochrane Library 2007, Issue 1), Medline (1966 to February 2007), EMBASE (1988 to February 2007), and bibliographic citations were searched. Previously published meta-analyses on dose-response of ACE inhibitors, as well as narrative reviews, were used to help identify references to trials. No language restrictions were applied.</P>
<P>A modified, expanded version of the standard search strategy of the Cochrane Hypertension Group, with additional terms related to ACE inhibitors, was used to identify relevant articles (<LINK REF="REF-Heran-2002" TYPE="REFERENCE">Heran 2002</LINK>).</P>
<P>
<B>MEDLINE</B>
</P>
<OL>
<LI>randomized controlled trial.pt</LI>
<LI>randomized controlled trial$.mp</LI>
<LI>controlled clinical trial.pt</LI>
<LI>controlled clinical trial$.mp</LI>
<LI>random allocation.mp</LI>
<LI>exp double-blind method/</LI>
<LI>double-blind.mp</LI>
<LI>exp single-blind method/</LI>
<LI>single-blind.mp</LI>
<LI>10. or/1-9</LI>
<LI>ANIMALS.sh. not HUMAN.sh.</LI>
<LI>10 not 11</LI>
<LI>clinical trial.pt</LI>
<LI>clinical trial$.mp</LI>
<LI>exp clinical trials/</LI>
<LI>(clin$ adj25 trial$).mp</LI>
<LI>((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$)).mp</LI>
<LI>random$.mp</LI>
<LI>exp research design/</LI>
<LI>research design.mp</LI>
<LI>or/13-20</LI>
<LI>21 not 11</LI>
<LI>22 not 12</LI>
<LI>comparative stud$.mp</LI>
<LI>exp evaluation studies/</LI>
<LI>evaluation stud$.mp</LI>
<LI>follow-up stud$.mp</LI>
<LI>prospective stud$.mp</LI>
<LI>(control$ or prospectiv$ or volunteer$).mp</LI>
<LI>or/24-29</LI>
<LI>30 not 11</LI>
<LI>31 not (12 or 23)</LI>
<LI>12 and 23 and 32</LI>
<LI>exp angiotensin-converting enzyme inhibitors/</LI>
<LI>angiotensin-converting enzyme inhibitor$.mp</LI>
<LI>alacepril.mp</LI>
<LI>altiopril.mp</LI>
<LI>benazepril.mp</LI>
<LI>captopril.mp</LI>
<LI>ceronapril.mp</LI>
<LI>cilazapril.mp</LI>
<LI>delapril.mp</LI>
<LI>derapril.mp</LI>
<LI>exp enalapril/</LI>
<LI>enalapril.mp</LI>
<LI>fosinopril.mp</LI>
<LI>idapril.mp</LI>
<LI>imidapril.mp</LI>
<LI>lisinopril.mp</LI>
<LI>moexipril.mp</LI>
<LI>moveltipril.mp</LI>
<LI>pentopril.mp</LI>
<LI>perindopril.mp</LI>
<LI>quinapril.mp</LI>
<LI>ramipril.mp</LI>
<LI>spirapril.mp</LI>
<LI>temocapril.mp</LI>
<LI>trandolapril.mp</LI>
<LI>zofenopril.mp</LI>
<LI>or/34-59</LI>
<LI>exp hypertension/</LI>
<LI>hypertension.mp</LI>
<LI>exp blood pressure/</LI>
<LI>blood presure.mp</LI>
<LI>or/61-64</LI>
<LI>60 and 65</LI>
<LI>33 and 66</LI>
<LI>placebo$.mp</LI>
<LI>67 and 68</LI>
</OL>
<P>
<B>EMBASE</B>
</P>
<P>1. randomized controlled trial$.mp.<BR/>2. exp controlled clinical trials/<BR/>3. controlled clinical trial$.mp.<BR/>4. exp random allocation/<BR/>5. random allocation.mp.<BR/>6. double-blind.mp.<BR/>7. single-blind.mp.<BR/>8. or/1-7<BR/>9. exp animal/<BR/>10. 8 not 9<BR/>11. exp clinical trials/<BR/>12. clinical trial$.mp.<BR/>13. (clin$ adj25 trial$).mp.<BR/>14. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).mp.<BR/>15. random$.mp.<BR/>16. exp research design/<BR/>17. research design.mp.<BR/>18. or/11-17<BR/>19. 18 not 9<BR/>20. 19 not 10<BR/>21. exp comparative study/<BR/>22. comparative stud$.mp.<BR/>23. exp evaluation studies/<BR/>24. evaluation stud$.mp.<BR/>25. exp follow up studies/<BR/>26. follow up stud$.mp.<BR/>27. prospective stud$.mp.<BR/>28. (control$ or prospectiv$ or volunteer$).mp.<BR/>29. or/21-28<BR/>30. 29 not 9<BR/>31. 30 not (10 or 20)<BR/>32. 10 and 20 and 31<BR/>33. exp angiotensin-converting enzyme inhibitors/<BR/>34. angiotensin-converting enzyme inhibitor$.mp.<BR/>35. alacepril.mp.<BR/>36. altiopril.mp.<BR/>37. benazepril.mp.<BR/>38. captopril.mp.<BR/>39. exp ceronapril/<BR/>40. ceronapril.mp.<BR/>41. cilazapril.mp.<BR/>42. delapril.mp.<BR/>43. derapril.mp.<BR/>44. enalapril.mp.<BR/>45. fosinopril.mp.<BR/>46. idapril.mp.<BR/>47. imidapril.mp.<BR/>48. lisinopril.mp.<BR/>49. moexipril.mp.<BR/>50. exp moveltipril/<BR/>51. pentopril.mp.<BR/>52. perindopril.mp.<BR/>53. quinapril.mp.<BR/>54. ramipril.mp.<BR/>55. spirapril.mp.<BR/>56. temocapril.mp.<BR/>57. trandolapril.mp.<BR/>58. zofenopril.mp.<BR/>59. or/33-58<BR/>60. exp hypertension/<BR/>61. hypertension.mp.<BR/>62. exp blood pressure/<BR/>63. blood pressure.mp.<BR/>64. or/60-63<BR/>65. 59 and 64<BR/>66. 32 and 65<BR/>67. placebo$.mp.<BR/>68. 66 and 67</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-08-13 05:35:13 -0700" MODIFIED_BY="Ciprian D Jauca">
<SUBSECTION>
<HEADING LEVEL="3">Study Selection</HEADING>
<P>The databases listed above were searched using the updated search strategy to identify citations with potential relevance. The initial screen of these abstracts excluded articles whose titles and/or abstracts were clearly irrelevant. The full text of remaining articles was then retrieved (and translated into English where required) to assess whether the trials met the prespecified inclusion criteria. The bibliographies of pertinent articles, reviews and texts were searched for additional citations. Two independent reviewers assessed the eligibility of the trials using a trial selection form. A third reviewer resolved discrepancies. Trials with more than one publication were counted only once.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data Extraction</HEADING>
<P>Data were extracted independently by two reviewers using a standard form and then cross-checked. If data were presented numerically (in tables or text) and graphically (in figures), the numeric data were preferred because of possible measurement error when estimating from graphs. All numeric calculations and extractions from graphs or figures were confirmed by a second reviewer.</P>
<P>The position of the patient during blood pressure measurement may affect the blood pressure lowering effect. However, in order not to lose valuable data, if only one position was reported, data from that position were extracted. When blood pressure measurement data were available in more than one position, data were extracted in accordance with the following order of preference: 1) sitting; 2) standing; and 3) supine.</P>
<P>In the case of missing information in the included studies, investigators were contacted (by email, letter and/or fax) to obtain the missing information.<BR/>
<BR/>In the case of missing values for standard deviation of the change in blood pressure or heart rate, the standard deviation was imputed based on the information in the same trial or from other trials using the same dose. The following hierarchy (listed from high to low preference) was used to impute standard deviation values:</P>
<OL>
<LI>Pooled standard deviation calculated either from the t-statistic corresponding to an exact p-value reported or from the 95% confidence interval of the mean difference between treatment group and placebo.</LI>
<LI>Standard deviation of change in blood pressure/heart rate from a different position than that of the blood pressure data/heart rate used.</LI>
<LI>Standard deviation of blood pressure/heart rate at the end of treatment.</LI>
<LI>Standard deviation of blood pressure/heart rate at the end of treatment measured from a different position than that of the blood pressure/heart rate data used.</LI>
<LI>Standard deviation of blood pressure/heart rate at baseline (except if this measure was used for entry criteria).</LI>
<LI>Weighted mean standard deviation of change in blood pressure/heart rate from other trials using the same class of drug (at any dose).</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality Assessment</HEADING>
<P>The quality of all included trials was assessed by two independent reviewers using the following two approaches:</P>
<P>1. The Cochrane approach to assessment of allocation concealment:</P>
<P>
<B>Grade A: Adequate</B>
<BR/>
</P>
<UL>
<LI>Centralized (central office unaware of subject characteristics) or pharmacy-controlled randomization; pre-numbered or coded identical containers that are administered serially to patients; on-site computer system with allocations kept in a locked computer file that can be accessed only after patients enter; sequentially numbered, sealed, opaque envelopes.</LI>
</UL>
<P>
<B>Grade B: Unclear</B>
<BR/>
</P>
<UL>
<LI>Allocation concealment is not reported, or despite a description that reports adequate concealment (the use of a list, table or sealed envelopes), there are other features that lead the reviewer to be suspicious.</LI>
</UL>
<P>
<B>Grade C: Inadequate</B>
<BR/>
</P>
<UL>
<LI>Consists of the following methods: alternation; use of case record numbers, dates of birth or date at which the patient is invited to participate in the study; any procedure that is transparent before allocation, such as an open list of random numbers.</LI>
</UL>
<P>
<B>Grade D: Allocation concealment not used</B>
<BR/>
</P>
<UL>
<LI>Allocation concealment was not used to assess validity.</LI>
</UL>
<P>2. A 5-point scoring system described by <LINK REF="REF-Jadad-1996" TYPE="REFERENCE">Jadad 1996</LINK> and summarised as follows:</P>
<UL>
<LI>Was the study described as randomised? (1=yes; 0=no)</LI>
<LI>Was the study described as double-blind? (1=yes; 0=no)</LI>
<LI>Was there a description of withdrawals and dropouts? (1=yes; 0=no)</LI>
<LI>Was the method of randomisation well described and appropriate? (1=yes; 0=no)</LI>
<LI>Was the method of double blinding well described and appropriate? (1=yes; 0=no)</LI>
<LI>Deduct 1 point if methods for randomisation were inappropriate.</LI>
<LI>Deduct 1 point if methods for blinding were inappropriate.</LI>
</UL>
<P>A score of 0-2 reflects low quality, a score of 3-4 indicates moderate quality and a score of 5 represents a high quality study.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Data Analysis and Statistical Considerations</HEADING>
<P>Data synthesis and analyses were done using the Cochrane Review Manager software, RevMan 4.2.8.</P>
<P>Data for changes from baseline in blood pressure and heart rate were combined using a weighted mean difference method. The withdrawals due to adverse effects was analyzed using relative risk, risk difference, and number needed to harm.</P>
<P>When possible, subgroup analyses were used to examine the results for specific categories of participants. Possible subgroup analyses included:<BR/>
</P>
<UL>
<LI>Race: Black, white, other.</LI>
<LI>Age: Adults (18-69 years), older people (70 years and older).</LI>
<LI>Baseline severity of hypertension: Mild, moderate, severe.</LI>
</UL>
<P>The robustness of the results was tested using several sensitivity analyses, including:<BR/>
</P>
<UL>
<LI>Trials of high quality versus poor quality.</LI>
<LI>Trials that are industry-sponsored versus non-industry sponsored.</LI>
<LI>Trials that assess drug as primary drug of investigation versus trials that assess drug as comparator.</LI>
<LI>Trials with blood pressure data measured in the sitting position versus other measurement positions.</LI>
<LI>Trials with published standard deviations of blood pressure change versus imputed standard deviations.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Direct and indirect comparisons</HEADING>
<P>When possible, direct and indirect comparisons of effect sizes between doses were performed for each ACE inhibitor drug. In the direct method, only trials that randomized participants to different doses were included in the analysis. In the indirect method, an "adjusted indirect comparison" and the associated standard error were calculated using the method described by <LINK REF="REF-Bucher-1997" TYPE="REFERENCE">Bucher 1997</LINK> and <LINK REF="REF-Song-2003" TYPE="REFERENCE">Song 2003</LINK>.</P>
<P>A p value less than 0.05 (p &lt; 0.05) was considered statistically significant for all comparisons. If there was statistically significant heterogeneity associated with an effect estimate, a random effects model was applied. This model provides a more conservative statistical comparison of the difference between ACE inhibitor treatment and placebo because a confidence interval around the effect estimate is wider than a confidence interval around a fixed effect estimate. If a statistically significant difference was still present using the random effects model, the fixed effect pooled estimate and confidence interval were reported because of the tendency of smaller trials, which are more susceptible to publication bias, to be overweighted with a random effects analysis.</P>
</SUBSECTION>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-08-12 18:34:44 -0700" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2008-08-12 18:34:44 -0700" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Search findings</HEADING>
<P>The search strategy identified 4156 citations, of which only 92 (2.2%) trials met the inclusion criteria and had extractable data to evaluate the dose-related blood pressure lowering efficacy of 14 ACE inhibitors (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>).</P>
<P>Each included study is summarized in the "Characteristics of included studies". One hundred fifty eight studies were excluded because they did not meet the pre-specified inclusion criteria. An additional 48 trials met the inclusion criteria but did not have extractable data and therefore were excluded. The reasons for exclusion are detailed in the "Characteristic of excluded studies". Of the 92 included studies, 87 (95%) were published in English, 3 (3%) in German, and 2 (2%) in Portuguese. Seventy (76%) of the included studies were industry-sponsored while the remaining 22 (24%) did not report the source of funding. Twenty four duplicate publications of 17 included trials were also identified. Seventy six (82%) of the included studies randomized patients to fixed-dose monotherapy during double-blind treatment, 8 (9%) were forced-titration studies and 8 (9%) were titration to BP response at pre-specified intervals during the double-blind treatment phase. Only the pre-titration BP data were used in the analysis of these latter 16 studies.</P>
<P>Trials evaluating the antihypertensive efficacy of ACE inhibitor monotherapy using office blood pressure measurements were first published in 1983 (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>). There was a steady increase in the number of published studies through the 1980s and early 90s, peaking at 11 trials published in 1994. After 1994 the number of trials published annually steadily declined.</P>
<P>
<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> and <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> demonstrate that there is sufficient RCT evidence for the various ACE inhibitors to generate dose-response curves for systolic and diastolic BP reduction as well as accomplish the secondary goals of this review. These studies investigate most ACE inhibitors over a dose range that is wider than what is recommended by the manufacturers. Enalapril is the most extensively studied ACE inhibitor with 19 published studies investigating the antihypertensive efficacy of daily doses ranging from 5 to 40 mg daily (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Characteristics of excluded studies</HEADING>
<P>Forty eight studies that met the inclusion criteria were excluded from this review. Some of the reasons for exclusion were: failure to report adequate blood pressure data or the number of patients studied in each arm; crossover trials that did not report pre-crossover data, as well as parallel group trials with a forced titration schedule and trials in which patients were titrated to a pre-specified blood pressure response were also excluded if pre-titration data was not reported. Reasons for excluding each trial are listed in the "Characteristics of excluded studies" table.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Overview of included studies</HEADING>
<P>Baseline characteristics of the 92 included studies are provided in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. A total of 12 954 participants with a mean age of 54.4 years and baseline BP of 157.1/101.2 mm Hg were treated for a mean duration of 6.2 weeks. In most cases, the number of patients treated with an ACE inhibitor was larger than the number of placebo-treated patients because many of the included studies have multiple treatment arms comparing different doses of an ACE inhibitor with a single placebo arm.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Imputation of missing variance data</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Standard deviation of blood pressure change</HEADING>
<P>Forty (44%) of the included trials reported the standard deviation of the change in blood pressure. These values were pooled for the ACE inhibitor and placebo groups and weighted mean estimates of the standard deviation of the change in SBP and DBP were determined. Three trials (<LINK REF="STD-Chan-1997" TYPE="STUDY">Chan 1997</LINK>; <LINK REF="STD-Guitard-1994" TYPE="STUDY">Guitard 1994</LINK>; <LINK REF="STD-Messerli-1998" TYPE="STUDY">Messerli 1998</LINK>) were excluded from the calculation, and the weighted mean estimates were adjusted, because they reported standard deviation values that were so low they were more than 3 standard deviations away from the weighted mean SD of BP change. The weighted mean standard deviations of the change in SBP and DBP were 13.90 (SD 2.2) mm Hg and 8.1 (SD 1.4) mm Hg for the ACE inhibitor group, respectively. For the placebo group, the standard deviation of the change was 13.40 (SD 3.8) mm Hg for SBP and 7.7 (SD 2.2) mm Hg for DBP. There was no statistically significant difference between the ACE inhibitor and placebo groups for SD of SBP change, or SD of DBP change. These values were used according to the imputation hierarchy for trials that did not report SD of BP change or reported an outlier SD value.</P>
<P>The SD of BP change was imputed for 55 (60%) of the included studies. Of these studies, 29 (32%) were imputed using endpoint SD, 13 (14%) were imputed using baseline SD for SBP, 11 (12%) were imputed using the weighted mean SD of SBP change from other trials, and 7 (8%), were imputed using the weighted mean SD of DBP change from other trials.</P>
</SUBSECTION>
</SUBSECTION>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-08-12 16:44:26 -0700" MODIFIED_BY="[Empty name]">
<P>The Jadad and Cochrane scales were used in this review to assess the quality of the included studies. Eighty seven (94.6%) of the included trials did not report allocation concealment, while the remaining five (5.4%) trials reported an adequate method of concealment. The Jadad score for each included study is provided in the 'Notes' section of the "Characteristics of included studies" table. Using the Jadad quality score, 75 (81.5%) of the included studies were of good quality, 2 (2.2%) were of excellent quality, and 15 (16.3%) studies were of poor quality. Removing the studies that were considered poor according to the Jadad method did not alter the results of the meta-analysis. Rather, the Jadad score was not very useful for assessing the quality of trials included in this review because its scoring criteria were similar to two of the criteria for inclusion of studies in our systematic review; the studies had to be randomized and double-blind. Thus all included studies would score at least 2 on the Jadad scale. Furthermore, it was clear to us that the Jadad and Cochrane quality assessment scales were not evaluating the methodological quality of the trials but instead the quality of reporting in the published studies.</P>
<P>The most crucial factor in the included studies, which is not considered in the Jadad and Cochrane quality assessment scales, is the accuracy of blood pressure measurement (and the reporting of this outcome). The quality of the blood pressure results in the included trials appeared to be independent of the quality of reporting of the methodology.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-08-12 16:57:39 -0700" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of individual ACE inhibitor drugs</HEADING>
<P>Summarized below are the dose-related trough blood pressure lowering efficacy estimates of 13 of the 14 ACE inhibitors that were administered once daily in the included studies. Captopril was administered twice or three times daily in nearly all the trials evaluating this drug. The weighted mean placebo effect across all trials was -3.2 (95% CI -3.6, -2.9; range -14.7 to 3.7) mm Hg and -3.7 (95% CI -3.9, -3.5; range -10.1 to 3.0) mm Hg for SBP and DBP, respectively. Therefore, to determine the magnitude of the BP lowering efficacy of each ACE inhibitor, a weighted mean difference from placebo (ACEI effect size minus placebo effect size) with a 95% confidence interval (in parentheses) was calculated.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of benazepril</HEADING>
<P>Seven of the included trials assessed benazepril at doses ranging from 2 mg/day to 80 mg/day. The log dose-response curve for benazepril is presented in <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>. Benazepril doses of 2 to 10 mg/day did not significantly reduce BP compared with placebo. Benazepril at 20 mg/day was the lowest dose that demonstrated a significantly greater reduction in SBP and DBP as compared to placebo.</P>
<P>Only two trials (<LINK REF="STD-Moser-1991" TYPE="STUDY">Moser 1991</LINK>; <LINK REF="STD-Weinberger-1990" TYPE="STUDY">Weinberger 1990</LINK>) allowed a direct comparison analysis of the effect size for each dose and there was no statistically significant difference in the effect sizes between doses.</P>
<P>An indirect comparison demonstrated a statistically significant difference between the 10 and 20 mg/day groups, which is evidence of a dose-response effect for benazepril. Due to a paucity of data at 40 and 80 mg/day, reflected in the wide confidence intervals, the 20 mg/day group did not show a statistically significant difference between the 40 and 80 mg/day groups.</P>
<P>Based on the available evidence, the best estimate of the near maximal BP lowering efficacy of benazepril occurs between 20 and 80 mg/day. The best estimate of the blood pressure lowering effect across this dosage range is -8.70 (95% CI: -11.43, -5.97) mm Hg for SBP and - 4.92 (95% CI: -6.47, -3.36) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of captopril</HEADING>
<P>Captopril was the only ACE inhibitor that was usually prescribed as twice or three times daily dosing in the included trials. Three of the five trials assessed captopril at twice daily dosing (<LINK REF="STD-Drayer-1983" TYPE="STUDY">Drayer 1983</LINK>; <LINK REF="STD-Dupui-1993" TYPE="STUDY">Dupui 1993</LINK>; <LINK REF="STD-Muiesan-1987" TYPE="STUDY">Muiesan 1987</LINK>), one trial at three times daily dosing (<LINK REF="STD-VA-Study-Group-1984" TYPE="STUDY">VA Study Group 1984</LINK>), and one trial assessed captopril 50 mg once daily (<LINK REF="STD-Kayanakis-1987" TYPE="STUDY">Kayanakis 1987</LINK>). Sensitivity analyses were performed to assess the robustness of the results, which were unchanged whether the dosing was once, twice or three times daily.</P>
<P>All doses tested significantly lowered BP compared with placebo and there was no statistically significant difference between any of the doses using indirect comparisons (<LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). However, the paucity of data at doses other than 50 mg/day - the manufacturer's recommended starting dose - makes it difficult to adequately assess a dose-response relationship. The lowest effective dose appears to be 37.5 mg/day, the lowest dosage studied. The lowest effective dose could be lower but there are no data available below 37.5 mg/day. Based on the available evidence, the best estimate of the near maximal blood pressure lowering effect of captopril is -9.68 (95% CI -11.73, -7.63) mm Hg and -5.43 (95% CI -6.47, -4.40) mm Hg for SBP and DBP, respectively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of cilazapril</HEADING>
<P>Nine of the included trials assessed the SBP lowering efficacy of cilazapril at doses ranging from 2.5 to 10 mg/day, whereas 14 trials assessed the effect on DBP at a wider dosage range of 0.5 to 10 mg/day (<LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). There was no statistically significant difference compared with placebo for change in DBP at 0.5 and 1 mg/day. The three doses encompassing the manufacturer's recommended range did result in a statistically significant reduction in SBP and DBP and there was no statistically significant difference between all three doses. This suggests that the lowest effective dose of 2.5 mg/day - which is the manufacturer's recommended starting dose - is at the plateau of the dose-response curve and thus also the lowest dose with near maximal BP lowering efficacy.</P>
<P>The best estimate of the near maximal trough blood pressure lowering effect for doses of 2.5 to 10 mg/day is -5.58 (95% CI -7.84, -3.52) mm Hg and -3.50 (95% CI -4.40, -2.60) mm Hg for SBP and DBP, respectively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of enalapril</HEADING>
<P>Nineteen of the included studies assessed the BP lowering efficacy of enalapril from 5 to 20 mg/day but there was no data available at 40 mg/day, the manufacturer's maximum recommended daily dosage (<LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>). Compared with placebo, all doses demonstrated a statistically significant reduction in SBP and DBP. Based on the available evidence, the lowest effective dose is 5 mg/day. It is possible the lowest effective dose may be lower than 5 mg/day but there are no available data. Indirect comparisons showed a statistically significant difference in effect sizes between the 10 and 20 mg/day doses.</P>
<P>There was statistically significant heterogeneity in the effect estimate of DBP in the 10 mg/day group (Chi<SUP>2</SUP> = 23.73, p = 0.001, I<SUP>2</SUP> = 70.5%) as well as the SBP effect estimate at 20 mg/day (Chi<SUP>2</SUP> = 17.34, p = 0.02, I<SUP>2</SUP> = 59.6%). The random effects model still demonstrated a statistically significant difference from placebo for both groups. The heterogeneity in the two groups can be partly explained by two trials (<LINK REF="STD-Kuppers-1997" TYPE="STUDY">Kuppers 1997</LINK>; <LINK REF="STD-Prichard-2002" TYPE="STUDY">Prichard 2002</LINK>) that report large reductions in BP with enalapril (-14.10/-7.60 mm Hg for 10 mg/day group in <LINK REF="STD-Kuppers-1997" TYPE="STUDY">Kuppers 1997</LINK>; -20.70/-9.60 mm Hg for 20 mg/day group in <LINK REF="STD-Prichard-2002" TYPE="STUDY">Prichard 2002</LINK>). Both studies were funded by the same company and used enalapril as an active comparator against their centrally acting antihypertensive drug, moxonidine. When these trials are removed from the analysis, the heterogeneity at 20 mg/day is no longer statistically significant and the SBP effect size is reduced from -9.61 (95% CI -11.35, -7.86) mm Hg to -8.66 (95% CI -10.48, -6.84) mm Hg. The heterogeneity in the 10 mg/day dose for DBP is reduced but is still statistically significant (Chi<SUP>2</SUP> = 14.42, p = 0.03, I<SUP>2</SUP> = 58.4%) and a random effects model still yielded a significant reduction in DBP for 10 mg/day compared with placebo. The remaining heterogeneity is explained by one large trial (<LINK REF="STD-Waeber-1999" TYPE="STUDY">Waeber 1999</LINK>), which contributes 66% by weight to the estimate of the DBP lowering efficacy at 10 mg/day with enalapril. <LINK REF="STD-Waeber-1999" TYPE="STUDY">Waeber 1999</LINK> was designed to compare a fixed dose felodipine-metoprolol combination with the active comparator enalapril as well as placebo; 318 patients were randomized to enalapril 10 mg/day and 300 patients to placebo. This trial reported a SBP reduction of -3.80 (95% CI -5.76, -1.84) and DBP reduction of -1.60 (95% CI -2.75, -0.45) compared with placebo.</P>
<P>From the data that are available, it appears that the lowest dose with near maximal BP lowering efficacy is 20 mg/day. Further increases in BP may be achieved at doses higher than 20 mg/day but there are no available data. The best estimate of the near maximal blood pressure lowering efficacy of enalapril at 20 mg/day is -8.66 (95% CI -10.48, -6.84) mm Hg for SBP and -4.80 (95% CI -5.81, -3.79) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of fosinopril</HEADING>
<P>Six of the included trials evaluated fosinopril from 2.5 to 40 mg/day but there were few studies at each dose and therefore insufficient data to demonstrate a statistically significant difference between any of the doses using indirect comparisons (<LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>). The 2.5 and 5 mg/day groups did not have a statistically significant difference from placebo. The manufacturer's recommended starting dose of 10 mg/day significantly reduced DBP, but not SBP, as compared to placebo. The lowest effective dose appears to be between the 10 and 20 mg/day. Compared with placebo, the 20 and 40 mg/day groups had a statistically significant reduction in SBP and DBP.</P>
<P>The best estimate of the lowest dose at which near maximal BP lowering efficacy occurs is 20 mg/day (-9.26/-7.79 mm Hg). However, there was statistically significant heterogeneity in this group. One trial (<LINK REF="STD-Zamboulis-1996" TYPE="STUDY">Zamboulis 1996</LINK>) accounted for the heterogeneity in the 20 mg/day effect estimate because of its remarkably large reduction in BP (-26.40/-19.60 mm Hg). This small trial did not report the time of the BP measurement. The baseline BP differed between the treatment and placebo groups by 8 mm Hg for SBP and 13 mm Hg for DBP, which brings into question the quality of randomization in this trial. Furthermore, the baseline DBP in the benazepril group was 108 mm Hg whereas the weighted mean DBP in the other trials was 100 mm Hg. Thus, <LINK REF="STD-Zamboulis-1996" TYPE="STUDY">Zamboulis 1996</LINK> has been excluded from this analysis. Removal of this trial eliminated the heterogeneity and reduced the change in SBP to -7.46 (95% CI -12.15, -2.77) mm Hg and the change in DBP to -5.20 (95% CI -7.77, -2.63) mm Hg.</P>
<P>Based on the available data, the best estimate of the near maximal BP lowering occurs at doses of 20 mg/day and above and has a magnitude of -7.62 (95% CI -11.07, -4.17) mm Hg for SBP and -5.00 (95% CI -6.94, -3.05) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of imidapril</HEADING>
<P>Only one included multi-arm trial assessed imidapril at doses of 5, 10, 20 and 40 mg/day (<LINK REF="STD-Vandenburg-1994" TYPE="STUDY">Vandenburg 1994</LINK>). Compared with placebo, there was no statistically significant difference in change in DBP for any of the doses studied (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>). Only the 20 mg/day group had a significantly greater reduction in SBP compared with placebo. When all doses were combined to establish an overall effect with imidapril, there was a statistically significant reduction in SBP and DBP compared with placebo.</P>
<P>Due to a lack of data for each dose, a dose-response relationship with imidapril could not be statistically established. A visual inspection of the log dose-response curve (<LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>) indicates that the BP lowering efficacy is approaching near maximal at 10 mg/day with a magnitude of -8.90 (95% CI -20.02, 2.22) mm Hg for SBP and -7.40 (95% CI -15.16, 0.36) mm Hg for DBP.</P>
<P>Based on the results of this one trial, the best estimate of the near maximal BP lowering efficacy for imidapril for 10 to 40 mg/day is -9.30 (95% CI -14.83, -3.78) mm Hg and -5.76 (95% CI -9.44, -2.07) mm Hg for SBP and DBP, respectively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of lisinopril</HEADING>
<P>Although it appears in <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK> that lisinopril has been studied over a wide dosage range (1.25 - 80 mg/day), 4 of the 5 included studies assessed lisinopril at 10 mg/day only, while only one small trial investigated lisinopril at all other doses (<LINK REF="STD-Gomez-1989" TYPE="STUDY">Gomez 1989</LINK>). None of the included trials assessed the BP lowering efficacy at the manufacturer's recommended maintenance dosage of 40 mg/day.</P>
<P>Only the 10 and 80 mg/day groups significantly decreased BP compared with placebo. There is insufficient data below 10 mg/day to determine whether or not there is a lower effective dose and 10 mg/day does appear to be the lowest dose with near maximal BP lowering.</P>
<P>Indirect comparisons showed that there was no statistically significant difference between the effect sizes of 20 and 80 mg/day doses compared with the 10 mg/day dose. Based on the available evidence, the near maximal blood pressure lowering efficacy of lisinopril for doses 10 to 80 mg/day is -8.00 (95% CI -10.14, -5.85) mm Hg for SBP and -4.76 (95% CI -5.92, -3.60) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of moexipril</HEADING>
<P>Four of the included trials assessed moexipril at 7.5 and 15 mg/day (<LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>). Compared with placebo, only the 15 mg/day group had a statistically significant reduction in BP. An estimate of the near maximal BP lowering efficacy cannot be determined because there were no data for doses above 15 mg/day, including the manufacturer's maximum recommended dose of 30 mg/day.</P>
<P>The lowest effective dose is 15 mg/day and, based on the available data, BP lowering at this dosage has a magnitude of -8.45 (95% CI -11.99, -4.91) mm Hg for SBP and -4.38 (95% CI -6.29, -2.46) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of perindopril</HEADING>
<P>Six of the included trials assessed perindopril at a dose range of 2 to 16 mg/day (<LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>). All 6 trials studied perindopril at 4 mg/day, the manufacturer's recommended starting dose, but there was limited trial evidence at the other doses. Only 2 trials (<LINK REF="STD-Luccioni-1988" TYPE="STUDY">Luccioni 1988</LINK>; <LINK REF="STD-Myers-1996" TYPE="STUDY">Myers 1996</LINK>) provided data at 2 and 8 mg/day, and one trial assessed perindopril at 16 mg/day.</P>
<P>Perindopril 2 mg/day did not demonstrate a statistically significant reduction in BP compared with placebo. The lowest effective dose is 4 mg/day. Due to the wide confidence intervals for the 8 and 16 mg/day doses, indirect comparisons with 4 mg/day did not show a statistically significant difference. Because of the lack of data above and below 4 mg/day, there is very limited information regarding the dose-response of perindopril.</P>
<P>Based on the available data, the best estimate of the near maximal blood pressure lowering efficacy for perindopril 4 to 16 mg/day is -7.09 (95% CI -9.56, -4.61) mm Hg for SBP and -5.02 (95% CI -6.22, -3.82) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of quinapril</HEADING>
<P>Two of the included trials assessed the BP lowering efficacy of quinapril at 20 mg/day (<LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>). There were no data available for 10 and 40 mg/day, the manufacturer's recommended starting and maximum dose, respectively. At 20 mg/day, quinapril had a statistically significant reduction in BP compared with placebo. However, it cannot be established if the lowest effective dose is 20 mg/day. Furthermore, because there were no data for doses above 20 mg/day, the near maximal blood pressure lowering efficacy cannot be estimated. The magnitude of the BP lowering efficacy of quinapril at 20 mg/day is -7.05 (95% CI -11.26, -2.84) mm Hg for SBP and -3.35 (95% CI -5.98, -0.72) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of ramipril</HEADING>
<P>Six of the included studies assessed ramipril at doses ranging from 1.25 to 10 mg/day (<LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>). Compared with placebo, the manufacturer's recommended starting dose did not significantly reduce BP. A significant decrease in SBP and DBP was seen at 5 and 10 mg/day but there was no statistically significant difference between the two doses based on an indirect comparison. No included trials assessed the manufacturer's maximum recommended dose of 20 mg/day.</P>
<P>The lowest effective dose is 5 mg/day. Due to a lack of data, it cannot be determined if doses above 10 mg/day have greater efficacy. Thus, an estimate of the near maximal BP lowering efficacy of ramipril cannot be made. Based on the results of the two doses that were effective, the best estimate of the BP lowering effect of ramipril at 5 to 10 mg/day is -6.29 (95% CI -9.26, -3.32) mm Hg for SBP and -4.14 (95% CI -5.81, -2.48) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of spirapril</HEADING>
<P>The patent for spirapril expired in 2003 and it is no longer marketed in North America. The recommended starting dose and the maximum daily dose for the treatment of primary hypertension could not be found, explaining the lack of a shaded region in <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>.</P>
<P>All doses significantly reduced BP compared with placebo except for change in SBP at 3 mg/day. The lowest effective dose appears to be 3 and 6 mg/day. For SBP and DBP, there was no statistically significant difference in effect sizes between 6 and 24 mg/day using indirect comparisons. Thus, the estimate of the lowest dose at which near maximal BP lowering occurs is 6 mg/day. The best estimate of the near maximal BP lowering efficacy for spirapril is -8.54 (95% CI -11.18, -5.89) mm Hg and -6.08 (95% CI -7.50, -4.66) mm Hg for SBP and DBP, respectively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of temocapril</HEADING>
<P>There were no included trials that assessed the BP lowering efficacy of temocapril within the manufacturer's recommended dose range of 1 to 4 mg/day (<LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>). One included trial assessed temocapril at 20 mg/day (<LINK REF="STD-Lerch-1999" TYPE="STUDY">Lerch 1999</LINK>). The 20 mg/day dose did not show a statistically significant difference compared with placebo but, as indicated by the extremely wide confidence intervals, this is likely due to the lack of data at this dose.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging BP lowering efficacy of trandolapril</HEADING>
<P>All doses of trandolapril above 0.5 mg/day resulted in a statistically significant reduction in BP compared with placebo (<LINK REF="FIG-17" TYPE="FIGURE">Figure 17</LINK>). The manufacturer's recommended starting dose of 1 mg/day is the lowest effective dose that showed a statistically significant difference from 0.5 mg/day. Indirect comparisons showed that increasing the daily dose beyond 1 mg/day does not significantly reduce BP further.</P>
<P>Two trandolapril trials (<LINK REF="STD-DeQuattro-1997" TYPE="STUDY">DeQuattro 1997</LINK>; <LINK REF="STD-Weir-1995" TYPE="STUDY">Weir 1995</LINK>) assessed the BP lowering efficacy of 8 mg/day in black patients, and only one trial (<LINK REF="STD-Weir-1995" TYPE="STUDY">Weir 1995</LINK>) assessed black patients after treatment with trandolapril at 0.5, 12 and 16 mg/day. However, very few black patients were studied at these doses to statistically assess whether there is a difference in efficacy between black and non-black patients.</P>
<P>The lowest dose with near maximal BP lowering efficacy is 1 mg/day. Based on the available trial evidence, the best estimate of the near maximal BP lowering effect of trandolapril for doses of 1 to 16 mg/day is -7.31 (95% CI -8.85, -5.77) mm Hg for SBP and -4.42 (95% CI -5.24, -3.60) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Summary of the blood pressure lowering efficacy of ACE inhibitors</HEADING>
<P>
<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> provides an overview of the lowest effective dose, the lowest dose with near maximal blood pressure lowering and the near maximal blood pressure lowering effect of each ACE inhibitor studied in this review. The lowest effective dose is defined as the lowest dose for which there is a statistically significant difference from placebo. The lowest dose with near maximal blood pressure lowering efficacy is defined as the dose that demonstrates a statistically significantly greater response than doses below it, but does not exhibit a statistically significant difference in effect size compared with higher doses. If there was any discrepancy between SBP and DBP, SBP was used to define the doses.</P>
<P>ACE inhibitors were analyzed as a class by pooling all trials reporting trough blood pressure and categorizing individual doses as proportions of the manufacturers' maximum recommended daily dose (Max). The pooled efficacy data ranged from 1/16 Max to 2 Max (<LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>, 1/8 Max to Max; <LINK REF="FIG-19" TYPE="FIGURE">Figure 19</LINK>, 1/16 Max; <LINK REF="FIG-20" TYPE="FIGURE">Figure 20</LINK>, 1/8 Max; <LINK REF="FIG-21" TYPE="FIGURE">Figure 21</LINK>, 1/4 Max; <LINK REF="FIG-22" TYPE="FIGURE">Figure 22</LINK>, 1/2 Max; <LINK REF="FIG-23" TYPE="FIGURE">Figure 23</LINK>, Max; <LINK REF="FIG-24" TYPE="FIGURE">Figure 24</LINK>, 2 Max).</P>
<P>The pooled efficacy data were evaluated for the presence of a dose-response relationship. As shown in <LINK REF="FIG-25" TYPE="FIGURE">Figure 25</LINK>, a dose-response is present with a statistically significant difference between 1/4 Max and 1/2 Max. Further increases in the dosage beyond 1/2 Max did not result in a statistically significantly greater reduction in blood pressure.</P>
<P>Thus, near maximal blood pressure lowering is achieved at half of the manufacturers' recommended maximum dose and above (<LINK REF="FIG-26" TYPE="FIGURE">Figure 26</LINK>). Using this definition the best estimate of the near maximal blood pressure lowering for the ACE inhibitor class of drugs is -7.68 (95% CI -8.45, -6.91) mm Hg for SBP and -4.59 (95% CI -4.99, -4.19) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Analysis of publication bias</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Funnel plots</HEADING>
<P>In order to test for the possibility of publication bias in the ACE inhibitor review funnel plots were created of the trough SBP (<LINK REF="FIG-27" TYPE="FIGURE">Figure 27</LINK>) and DBP (<LINK REF="FIG-28" TYPE="FIGURE">Figure 28</LINK>) lowering effects of all doses of 1/2 Max and higher. These plots were reasonably symmetrical and there did not appear to be a paucity of smaller trials with small or absent BP lowering effect.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Tertile analysis based on trial size</HEADING>
<P>To further test for possible publication bias, a post-hoc tertile analysis was performed to determine if the magnitude of BP lowering differed according to trial size. Once again all ACE inhibitor doses of 1/2 Max and above were divided into tertiles according to the sample size in the active treatment arms. The lowest, middle and highest tertiles represented the smallest, medium-sized and largest trials, respectively. The mean effect size of the largest trials (highest tertile) was compared with that of the smallest trials (lowest tertile) using an unpaired t test (the indirect method).</P>
<P>As shown in <LINK REF="FIG-29" TYPE="FIGURE">Figure 29</LINK>, this tertile analysis did not suggest the presence of publication bias in the ACE inhibitor systematic review; there were no statistically significant differences in effect size between the largest (n=82-253 patients) and smallest (n=10-41 patients) trials for both SBP (p=0.9) and DBP (p=1.0).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Tertile analysis based on publication year</HEADING>
<P>Another possible source of bias in the ACE inhibitor review is bias introduced because the patients chosen for the trial were already known to respond well to ACE inhibitors. If this were occurring, it was hypothesized that there would be little possibility for this to happen in the earliest published trials and that it would be more likely to occur in later published trials when use of the class was more common. A post-hoc tertile analysis was done to determine the effect of the year of publication of trials on the BP lowering effect. This analysis was done for all ACE inhibitor doses at 1/2 Max and above (<LINK REF="FIG-30" TYPE="FIGURE">Figure 30</LINK>). The mean effect size of the latest tertile (1997-2002) was compared with that of the earliest tertile (1987-1993) using the indirect method and there was no statistically significant difference for SBP (p=0.5) or DBP (p=0.8) between the tertiles.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blood pressure variability</HEADING>
<P>The variability of blood pressure at both baseline and endpoint was reported for 26 (28%) of the included trials. In <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>, the number of observations represents the number of active treatment arms in these 26 trials. Ninety (98%) of the studies had diastolic hypertension entry criteria, 2 (2.2%) trials had systo-diastolic hypertension entry criteria (<LINK REF="STD-Dupui-1993" TYPE="STUDY">Dupui 1993</LINK>; <LINK REF="STD-Kayanakis-1987" TYPE="STUDY">Kayanakis 1987</LINK>), and no trials had isolated systolic hypertension entry criteria.</P>
<SUBSECTION>
<HEADING LEVEL="4">Systolic versus diastolic blood pressure variability</HEADING>
<P>The weighted mean standard deviations for SBP and DBP were compared in order to determine whether SBP varies to the same degree as DBP. For both the ACE inhibitor group and placebo group, the absolute variability of SBP is statistically significantly greater than that of DBP (<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>). The coefficient of variation in SBP was also significantly greater than the coefficient of variation in DBP for both the ACE inhibitor and placebo groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">ACE inhibitors versus placebo</HEADING>
<P>
<LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK> shows the weighted mean endpoint SD of SBP was 16.6 mm Hg for the ACE inhibitor group and 16.8 mm Hg for the placebo group (p = 0.8). The weighted mean SD of DBP was 9.0 mm Hg for the ACE inhibitor group and 8.9 mm Hg for the placebo group (p = 0.8). Based on the available evidence, there was no statistically significant difference in the endpoint blood pressure variability between the ACE inhibitor and placebo groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">The effect of blood pressure entry criteria on variability</HEADING>
<P>The included trials were categorized according to blood pressure entry criteria used: 1) diastolic hypertension; 2) systolic hypertension; and 3) systo-diastolic hypertension. None of the included studies had isolated systolic hypertension entry criteria. Only 2 trials had systo-diastolic hypertension entry criteria (<LINK REF="STD-Dupui-1993" TYPE="STUDY">Dupui 1993</LINK>; <LINK REF="STD-Kayanakis-1987" TYPE="STUDY">Kayanakis 1987</LINK>) and therefore a comparison with this subgroup was not feasible. To determine the effect of diastolic blood pressure entry criteria on baseline BP variability, the weighted mean baseline standard deviations of these trials were compared.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Baseline versus endpoint variability</HEADING>
<P>As shown in <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>, the standard deviations of blood pressure at baseline and endpoint were compared for trials with DBP entry criteria. For the ACE inhibitor group and placebo group, there was no statistically significant difference between the variability of SBP at baseline and endpoint. DBP variability at endpoint was significantly higher than at baseline in both the ACE inhibitor and placebo groups.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging peak blood pressure lowering efficacy</HEADING>
<P>Nine of the included trials reported the peak blood pressure lowering efficacy of ACE inhibitors. Peak blood pressure data were pooled across trials by categorizing individual doses as proportions of Max, ranging from 1/4 to 2 Max (<LINK REF="FIG-31" TYPE="FIGURE">Figure 31</LINK>). All doses exhibited a statistically significant reduction in peak SBP and DBP compared with placebo. Indirect comparison analysis of the results for each proportion of Max showed evidence of a dose-response since there was a greater reduction in blood pressure with 2 Max compared with 1/4 Max. There was no statistically significant difference in the effect sizes between 1/2 Max and 2 Max. Pooling the effects of all doses from 1/2 Max to 2 Max provides an estimate of the peak blood pressure lowering effect of ACE inhibitors, -11.43 (95% CI -13.40, -9.45) mm Hg for SBP and -6.35 (95% CI -7.19, -5.50) mm Hg for DBP.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging effect on pulse pressure</HEADING>
<P>Pulse pressure was not reported as an outcome in any of the included trials so the change in pulse pressure was calculated by subtracting the change in DBP from the change in SBP for each trial that reported both SBP and DBP. Seventy four (80%) of the included studies provided data to calculate the change in trough pulse pressure. A weighted mean and weighted standard deviation of the change in pulse pressure from baseline was then computed for each proportion of the recommended maximum dose (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>Based on the available evidence, there was a marginal increase from baseline in pulse pressure in patients randomized to placebo. All doses of ACE inhibitors demonstrated statistically significant reductions from baseline in pulse pressure compared with placebo. At 1/2 Max and above, where near maximal BP lowering is achieved, the estimate of the average reduction in pulse pressure was 2.9 and when this was compared to placebo it became 3.5 (95% CI 2.7, 4.3) mm Hg.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging effect on heart rate</HEADING>
<P>Of the 92 included studies, 16 (17%) reported dose-related trough heart rate data. There were few trials to adequately assess the heart rate effect of individual ACE inhibitors. Thus the data were pooled across all trials that reported this outcome and categorized as proportions of the manufacturers' maximum recommended daily dose. Based on the available evidence, there was no statistically significant change in heart rate compared with placebo over the range of 1/8 Max to Max (<LINK REF="FIG-32" TYPE="FIGURE">Figure 32</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dose-ranging effect on withdrawals due to adverse effects</HEADING>
<P>Fifty five of the included studies (60%) reported dose-related withdrawals due to adverse effects (WDAE) during the 3 to 12 week treatment period. There were not enough data to construct a meaningful dose-response relationship for individual ACE inhibitors. The data are therefore categorized according to the proportions of Max over a dose range of 1/8 Max to Max (<LINK REF="FIG-33" TYPE="FIGURE">Figure 33</LINK>).</P>
<P>At 1/4 Max, there was a marginally non-significant [RR 0.65 (95% CI 0.42, 1.00)] reduction in WDAE and there was a trend towards an increased WDAE with higher doses, but none of the doses demonstrated a statistically significant difference compared with placebo. A pooled estimate for all doses resulted in a statistically non-significant relative risk of 0.85 (95% CI 0.67, 1.07). The doses at which near maximal BP lowering efficacy is achieved (1/2 Max and above) also showed no statistically significant difference in WDAE [0.96 (95% CI 0.70, 1.31)] compared with placebo.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-08-13 05:55:34 -0700" MODIFIED_BY="Ciprian D Jauca">
<P>Ninety two trials with a mean duration of 6 weeks met the pre-specified inclusion criteria and reported data on 12 954 participants (8210 treated with ACE inhibitors and 4744 treated placebo) with a mean age of 54 years, mean baseline blood pressure of 157/101 mm Hg and a mean pulse pressure of 56 mm Hg.</P>
<SUBSECTION>
<HEADING LEVEL="2">Is there a difference in the magnitude of BP lowering effect between individual drugs in the ACE inhibitor class?</HEADING>
<P>This review provides a reasonable amount of data to assess the trough BP lowering effect of 14 different ACE inhibitors. When the different ACE inhibitors are compared, there is a remarkable similarity in their BP lowering effects at trough. When the best estimate of the BP lowering efficacy of these 14 drugs is compared, they range from -6/-4 mm Hg to -9/-5 mm Hg. The data are most consistent with the near maximum BP lowering effect of the each of the drugs being the same. However, for most of the drugs there are insufficient data over a broad dose range. It is therefore impossible with this analysis to be certain that there are no blood pressure lowering differences between one or more of the drugs. It would require head-to-head trials of different ACE inhibitors at equivalent BP lowering doses to assess whether or not there are differences between different drugs. This review will provide useful information for estimating equivalent doses and thereby designing trials to compare different ACE inhibitors. However, at the present time given that all the drugs are working by the same mechanism and the similarities in the blood pressure lowering effect it is most likely that the near maximal BP lowering of the different ACE inhibitors is the same.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">What is the dose-related blood pressure lowering effect of ACE inhibitors as a class?</HEADING>
<P>Based on the assumption of no difference between the different ACE inhibitors and the fact that the trough BP lowering effects of the different ACE inhibitors were so similar, the data for 13 of the 14 drugs that had the manufacturers' dosage information available were pooled. Data were pooled for 13 ACE inhibitors by categorizing individual doses as proportions of the manufacturers' maximum recommended daily dose (Max). It is recognized that this approach has its limitations but it provided a non-arbitrary method for pooling the drugs. Using this method, as a class ACE inhibitors demonstrated a dose-response relationship. A dose of 1/16 Max had no measurable BP lowering effect. A dose of 1/8 or 1/4 Max achieved a BP lowering effect that was 60 to 70% of the BP lowering effect of the maximum recommended dose. A dose of 1/2 Max achieved a BP lowering effect that was 90% of the maximum recommended dose.</P>
<P>Combining the effects of half maximum recommended doses and above gives a reasonable estimate of the near maximal trough blood pressure lowering efficacy for the ACE inhibitors as a class, -8 mm Hg for SBP and -5 mm Hg for DBP. This was accompanied by an average reduction in pulse pressure of 3 mm Hg. This is quite a modest effect and is likely considerably less than most clinicians would estimate can be achieved with these drugs. However, this effect is at trough and is obtained after subtracting the placebo effect which on average reduced BP by 3/4 mm Hg. Furthermore, most doctors probably do not measure BP in their patients at trough. In this review, there were much less data for BP measured 1 to 12 hours after the doses. From these data, we were able to estimate the average effect of ACE inhibitors 1 to 12 hours after the dose and it was modestly higher, averaging -11.4/-6.4 mm Hg.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">For each ACE inhibitor, do the manufacturer's dosage recommendations coincide with the findings of this review?</HEADING>
<P>Assuming that the lowest effective dose should be the manufacturer's recommended starting dose, for 6 of the ACE inhibitors there is agreement between the manufacturer's recommended dose and the lowest effective dose determined by this systematic review (see <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). For benazepril, moexipril and ramipril, the lowest effective doses were determined to be higher than the manufacturer's recommended starting doses. Three of the ACE inhibitors (imidapril, quinapril and temocapril) did not have data available at lower doses to determine the lowest effective dose and thus no comparison could be made with the manufacturer's recommendations. For one ACE inhibitor, captopril, the lowest effective dose from this review was less than that which the manufacturer's recommended. Spirapril is not shown in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK> as it has no manufacturer's recommended dose that we are aware of.</P>
<P>For 9 of the ACE inhibitors the lowest dose with near maximal BP lowering was achieved at 1/4 to 1/2 of the manufacturer's recommended maximum daily dose. For lisinopril, most of the blood pressure lowering effect was achieved at only 1/8 of the recommended maximum dose. Quinapril and three other ACE inhibitors (imidapril, moexipril and temocapril) did not have data at higher doses to determine the lowest dose with near maximal blood pressure lowering.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">What is the effect of ACE inhibitors on BP variability?</HEADING>
<P>The endpoint variabilities of the ACE inhibitor and placebo groups were compared in order to determine the effect of ACE inhibitors on blood pressure variability. Compared with placebo, ACE inhibitors did not change the variability in blood pressure. It appears that blood pressure criteria for entry into the trial does have an effect on the variability at baseline. In the trials with DBP entry criteria, the baseline standard deviations were substantively lower than the endpoint values in the ACE inhibitor and placebo groups. This effect is likely due to truncation of the distribution of blood pressures at the threshold and due to participants with slightly lower DBP than the threshold level for entry into the trial being entered as having a DBP at the threshold.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Is there evidence of a dose-response relationship for heart rate?</HEADING>
<P>There is a possibility of selective reporting bias of resting heart rate since less than 20% of the trials reported data for this outcome. Based on the few trials for which data were available, there were insufficient data at higher doses to determine a dose-related effect on heart rate. The available data demonstrate that for all doses ACE inhibitors did not have an effect on resting heart rate.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Is there evidence of a dose-response relationship for withdrawals due to adverse effects?</HEADING>
<P>There were not enough data to construct a meaningful dose-response relationship for individual ACE inhibitors and when combined there still were insufficient data at higher doses to determine a dose-related effect on WDAE. The available data demonstrate that for all doses ACE inhibitors did not change WDAE compared with placebo. However, only about half the trials reported the number of WDAE, so selective reporting bias is a distinct possibility. A description of the type and severity of the adverse effects that led to premature withdrawal was rarely reported. Short-term trials are not the best type of trial to assess adverse effects and longer trials and other types of data can assist, such as non-randomized trials or post-marketing surveillance studies. However, there is no justification for not reporting all withdrawals due to adverse effects in all completed trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Limitations of the review</HEADING>
<P>Many trials required imputation of the standard deviations of the blood pressure change because they did not report these values. However, our average estimates of the blood pressure lowering effect of these drugs were insensitive to the imputation strategy used.</P>
<P>One of the main limitations of this review is that not all the trials assessing the efficacy of ACE inhibitors have been published. We know that because many of the doses that have been approved by regulators are not included in this review. For example, quinapril has been approved for a dose range of 10 to 40 mg in Canada and 10 to 80 mg in the USA. We only found data for the effect of 20 mg of quinapril and we know that trials must have been completed and provided to the regulators for the other doses.</P>
<P>The use of maximum recommended dose by the manufacturer as a way of trying to compare equivalent doses of the drugs is imperfect but served our purposes in this review. Since this is planned to be published as a Cochrane review, it will be necessary to update it at least every 2 years. As more data for a wider range of doses become available, it may be possible to estimate the ED-50 for each drug and thus use that criteria to combine the equieffective doses of the different ACE inhibitors.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">What are the potential sources of bias?</HEADING>
<SUBSECTION>
<HEADING LEVEL="3">Sequence generation, allocation concealment</HEADING>
<P>Nearly all the trial publications simply reported that the trial was "randomized" but did not provide any details about the randomization method or the method of allocation concealment. Details of the methods for generation of the sequence of allocations or allocation concealment were reported in only 5 of the 92 (5.4%) included studies. Such vague reporting is insufficient to be confident that the allocation sequence was properly randomized and adequately concealed given the fact that many investigators use the term "randomized" when it is not justified. Authors should report their methods of sequence generation and allocation concealment clearly.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blinding bias</HEADING>
<P>Nearly all the trial publications simply reported that the trial was "double-blind" but did not provide any details about the blinding methods. There was a potential for loss of blinding in the trials studying ACE inhibitors since these drugs have a well known side effect that is unique to this class of drugs, namely a refractory cough. However, none of the included studies reported a significantly higher rate of cough or withdrawals due to cough over placebo in patients treated with ACE inhibitors. The success of blinding in patients or investigators was not assessed in any of the included trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Attrition bias</HEADING>
<P>It is unlikely that attrition bias would have had an impact on the systematic review since 89 to 100 percent of patients randomized to fixed-dose monotherapy in each trial completed the double-blind treatment period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Selective reporting bias</HEADING>
<P>This would not affect the blood pressure measurements as these were the primary outcome of most of these trials. As mentioned above, there is a potential for selective reporting bias for heart rate and withdrawals due to adverse effects.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other potential sources of bias</HEADING>
<P>Another potential source of bias that we became aware of in working on this review is selection bias. One of the exclusion criteria reported in nearly all trials was participants with a known hypersensitivity to ACE inhibitors. Although hypersensitivity to an ACE inhibitor may not have any connection to cough, it suggests that investigators have knowledge of each participant's prior experience with this drug class and thus may select for patients who have responded favorably to ACE inhibitors in terms of BP lowering or have been found to tolerate ACE inhibitor treatment. However, it was not possible to prove selection bias as none of the included trials described in detail these details of patient recruitment.</P>
<P>One could hypothesize that those patients who are known responders in previous trials tend to be recruited to participate in subsequent trials, so more recent trials may show a greater magnitude of blood pressure lowering efficacy. This hypothesis was tested by performing a post-hoc tertile analysis according to the year of trial publication. The trials were divided into three groups and the oldest group of trials was compared with the group of most recent trials for mean blood pressure lowering efficacy. This analysis did not show a statistically significant difference in blood pressure lowering between the oldest and most recent group of trials. This finding does not support the hypothesis, however, it does not rule out the possibility of some selection bias occurring during both the older and newer trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Publication Bias</HEADING>
<P>Yet another source of bias that may skew the results of systematic reviews is publication bias, which results from the selective publication of trials with positive results. This review was evaluated for the existence of publication bias since it only included and appraised published trial evidence. In the absence of bias, the funnel plot should resemble a symmetrical inverted funnel since the precision in the estimation of the true blood pressure lowering decreases as the study size decreases. Thus small studies will scatter more widely at the bottom of the graph (<LINK REF="REF-Cochrane-Handbook" TYPE="REFERENCE">Cochrane Handbook</LINK>). The most common way to investigate whether or not a review is subject to publication bias is to examine for funnel plot asymmetry as smaller studies with null results remained unpublished. The funnel plots generated from the results of the ACE inhibitor review did not demonstrate any signs of asymmetry.</P>
<P>A post-hoc tertile analysis was conducted for the class of ACE inhibitors to corroborate the reasonable symmetry observed in the funnel plots. The studies were divided into three groups according to sample size in order to compare the mean effect estimates between the largest trials (highest tertile) and smallest trials (lowest tertile). The results of this analysis demonstrated no statistically significant difference in the estimate of the blood pressure lowering efficacy of ACE inhibitors between the smallest and largest trials. In this case, publication bias did not impact our estimate of the true effect size.</P>
<P>Visual examination of the funnel plots also showed little resemblance to a characteristic inverted funnel as there was an absence of smaller sized studies that scattered more widely at the bottom of the graph. One explanation for this is that smaller studies included in this systematic review were conducted and analyzed with similar methodological rigor as larger trials so the reported treatment effects are of similar precision. Another possibility is that smaller studies are of lower methodological quality than larger studies and have less precise estimates of the effect size, but those trials with little or no reduction in blood pressure and those trials with exaggerated effect estimates remain unpublished.</P>
<P>The results of this review underscore the need for all studies, regardless of the findings, to be published and accessible for secondary analysis. Trial registration has been recognized in order to improve transparency in research and knowledge sharing. In recent years, regulatory bodies around the world, led by the World Health Organization (WHO), have set standards for trial registration and reporting and are urging research institutions and companies to register all medical studies that test treatments on humans (<LINK REF="REF-WHO_x002d_ICTRP" TYPE="REFERENCE">WHO-ICTRP</LINK>). Initiatives such as the WHO's International Clinical Trials Registry Platform will help improve transparency and reduce the risk of publication bias skewing the results of future systematic reviews.</P>
</SUBSECTION>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-08-12 15:52:13 -0700" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2008-08-12 15:50:31 -0700" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Specific findings of the review</HEADING>
<OL>
<LI>The review provides data on the dose-related blood pressure lowering efficacy of 14 different ACE inhibitors at trough. The best estimate of the blood pressure lowering efficacy of these 14 drugs ranges from -6/-4 to -9/-5 mm Hg. The data do not suggest that any one ACE inhibitor is better or worse at lowering blood pressure when used at doses of one-half the manufacturer's maximal recommended dose and above.</LI>
<LI>A dose-response relationship for the blood pressure lowering effect of the ACE inhibitors was evident. A dose of 1/16 of the maximum recommended dose had no measurable blood pressure lowering effect. A dose of 1/8 or 1/4 of the maximum recommended daily achieved a blood pressure lowering effect that was 60 to 70% of the blood pressure lowering effect of the maximum recommended dose. A dose of 1/2 of the maximum recommended dose achieved a blood pressure lowering effect that was 90% of the maximum recommended dose.</LI>
<LI>ACE inhibitor doses above the maximum recommended dose did not significantly lower blood pressure more than the maximum recommended dose.</LI>
<LI>Combining the effects of half maximum recommended doses and higher gives an estimate of the average trough blood pressure lowering efficacy for ACE inhibitors as a class of drugs of -8 mm Hg for SBP and -5 mm Hg for DBP.</LI>
<LI>ACE inhibitors reduced blood pressure measured 1 to 12 hours after the dose by about 11/6 mm Hg.</LI>
<LI>ACE inhibitors reduced trough pulse pressure by about 3 mm Hg.</LI>
<LI>ACE inhibitors did not significantly affect resting blood pressure variability or heart rate.</LI>
<LI>All doses of ACE inhibitors, whether analyzed individually or combined, did not change WDAE as compared to placebo; however, this outcome was not reported for about half the trials so there is judged to be a high risk of selective reporting bias.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Implications of these findings</HEADING>
<P>This systematic review provides the best available published evidence about the dose-related blood pressure lowering efficacy of ACE inhibitors for the treatment of primary hypertension. These findings have the potential to change prescribing behavior and drug funding policies around the world. The evidence from this review suggests that there are no clinically meaningful differences between ACE inhibitors for lowering blood pressure. Thus, substantial cost savings can be achieved by prescribing the least expensive ACE inhibitor.</P>
<P>The major limitation of this review is that it is limited to published trials and it is evident that a lot of trials that manufacturers would have needed to gain marketing approval have not been published. Thus even though there was no evidence of publication bias using standard methods to asses this, there remains a high risk for publication bias. It is also estimated that there is a high risk of patient selection bias that could have led to overestimation of the blood pressure lowering effect. For these reasons the magnitude of blood pressure lowering found is this review is probably an overestimate of the true effect. This observation makes even more surprising that the estimates of trough and peak blood pressure lowering effects of the ACE inhibitors are modest at best and lower than commonly believed can be achieved by this class of drugs. In addition, the review demonstrates that 60 to 70% of the blood pressure lowering effect occurs with recommended starting doses and that there is no evidence for using doses higher than half the manufacturer&#8217;s maximum recommended daily dose. If physicians prescribing ACE inhibitors were aware of this evidence they would prescribe lower doses leading to substantial cost savings, and possibly leading to a reduction in dose-related adverse events. </P>
<P>This review did not provide any evidence of an increase in withdrawals due to adverse effects overall and the trend towards higher withdrawals with higher doses was not statistically significant. However, this finding is severely limited by the short duration of the included trials and a high risk of both selective reporting bias and patient selection bias. Therefore, this systematic review is not a good measure of the incidence of adverse effects of this class of drugs.</P>
</SUBSECTION>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-08-12 15:52:13 -0700" MODIFIED_BY="[Empty name]">
<OL>
<LI>It is evident that for some of the ACE inhibitors studied (eg. quinapril and others) trials reporting data on doses recommended for use are not published. It should be mandatory that all clinical trials be registered and the results of these trials be published or otherwise made available in full detail.</LI>
<LI>Full dose-response data for doses within the recommended and beyond the recommended dose range are needed to properly analyze the dose-response relationship for each ACE inhibitor.</LI>
<LI>Trials should measure and report blood pressure data for peak effects as well as trough effects.</LI>
<LI>All trials should report withdrawals due to adverse effects and serious adverse events.</LI>
</OL>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-13 06:19:57 -0700" MODIFIED_BY="Ciprian D Jauca">
<P>The authors would like to acknowledge the assistance provided by Mr. Stephen Adams who retrieved the papers for this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-08-13 06:20:28 -0700" MODIFIED_BY="Ciprian D Jauca">
<P>No conflicts of interest declared.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-13 06:20:04 -0700" MODIFIED_BY="Ciprian D Jauca">
<UL>
<LI>Dr. James M. Wright conceived, designed and secured funding for the review, assisted with the analysis and interpretation of data, as well as provided a clinical perspective.</LI>
<LI>Dr. Balraj S. Heran designed the search strategy, undertook the search, screened search results, collected data for the review, screened retrieved papers against eligibility criteria, appraised quality of papers, extracted data from papers, wrote to authors of papers for additional information, entered data into RevMan, analyzed and interpreted data, and wrote the review.</LI>
<LI>Dr. Michelle Wong and Inderjit K. Heran screened retrieved papers against eligibility criteria, appraised quality of papers and extracted data from papers.</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-08-13 05:59:23 -0700" MODIFIED_BY="Ciprian D Jauca"/>
<PUBLIC_NOTES MODIFIED="2008-08-13 05:59:16 -0700" MODIFIED_BY="Ciprian D Jauca"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-06-05 11:24:42 -0700" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2008-06-05 11:24:42 -0700" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Applegate-1996" NAME="Applegate 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Applegate WB, Cohen JD, Wolfson P, Davis A, Green S</AU>
<TI>Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension</TI>
<SO>American Journal of Cardiology</SO>
<YR>1996</YR>
<VL>78</VL>
<PG>51-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Belz-1986" NAME="Belz 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Belz GG, Lange H, Tschollar W, Neis W</AU>
<TI>Cilazapril in essential hypertension: A placebo-controlled double-blind study to establish the dosage</TI>
<TO>Cilazapril bei essentieller hypertonie: Eine placebokontrollierte doppelblindstudie zur dosisfindung</TO>
<SO>Medizinische Klinik</SO>
<YR>1986</YR>
<VL>81</VL>
<NO>15-16</NO>
<PG>524-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Black-1997" NAME="Black 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Black HR, Graff A, Shute D, Stoltz R, Ruff D, Levine J, Shi Y, Mallows S</AU>
<TI>Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>8</NO>
<PG>483-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boeijinga-1993" NAME="Boeijinga 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boeijinga JK, Kraaij CJ, Kleinbloesem H, Cohen AF, Breimer DD</AU>
<TI>The influence of cilazapril on anticoagulants in hypertensive patients treated with coumarins</TI>
<SO>Current Therapeutic Research</SO>
<YR>1993</YR>
<VL>54</VL>
<NO>4</NO>
<PG>443-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brown-1990" NAME="Brown 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brown CL, Backhouse CI, Grippat JC, Santoni JP</AU>
<TI>The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1990</YR>
<VL>39</VL>
<NO>4</NO>
<PG>327-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carlsen-1995" NAME="Carlsen 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carlsen JE, Buchmann M, Hoglund C, Pellinen T, Honkanen T, Soerensen OH, Leth A, Maltbaek N</AU>
<TI>24-hour antihypertensive effect of oral cilazapril? A placebo-controlled study evaluating 1, 2.5 and 5 mg once daily</TI>
<SO>Clinical Drug Investigation</SO>
<YR>1995</YR>
<VL>10</VL>
<NO>4</NO>
<PG>221-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chan-1997" NAME="Chan 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chan P, Lin CN, Tomlinson B, Lin TH, Lee YS</AU>
<TI>Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>7</NO>
<PG>743-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chrysant-1993" NAME="Chrysant 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chrysant SG, McDonald RH, Wright JT, Barden PL, Weiss RJ</AU>
<TI>Perindopril as monotherapy in hypertension: A multicenter comparison of two dosing regimens</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1993</YR>
<VL>53</VL>
<NO>4</NO>
<PG>479-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chrysant-1994" NAME="Chrysant 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chrysant S</AU>
<TI>Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1994</YR>
<VL>154</VL>
<NO>7</NO>
<PG>737-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chrysant-1996" NAME="Chrysant 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chrysant SG, Fagan T, Glazer R, Kriegman A</AU>
<TI>Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension</TI>
<SO>Archives of Family Medicine</SO>
<YR>1996</YR>
<VL>5</VL>
<NO>1</NO>
<PG>17-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fagan T, Head K, DeSilva J, Whalen J</AU>
<TI>Double-blind comparison of once daily benazepril, hydrochlorothiazide and placebo in mild to moderate hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1989</YR>
<VL>2</VL>
<NO>5, Part 2</NO>
<PG>78A</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomez HJ</AU>
<TI>Dose-response studies with benazepril in mild to moderate hypertension</TI>
<SO>Clinical Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>Suppl IV</NO>
<PG>IV-22-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cushman-1998" NAME="Cushman 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cushman WC, Cohen JD, Jones RP, Marbury TC, Rhoades RB, Smith LK</AU>
<TI>Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1998</YR>
<VL>11</VL>
<NO>1</NO>
<PG>23-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Bruijn-1994" NAME="De Bruijn 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Bruijn JHB, Orofiamma BA, Pauly NC</AU>
<TI>Efficacy and tolerability of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>Suppl 4</NO>
<PG>S60-S64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DeQuattro-1997" NAME="DeQuattro 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;duplicate publication of DeQuattro(2) and Levine (trandola)&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>DeQuattro V, Lee D, Messerli F</AU>
<TI>Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: A 4 X 4 trial design</TI>
<SO>Clinical and Experimental Hypertension</SO>
<YR>1997</YR>
<VL>19</VL>
<NO>3</NO>
<PG>373-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;duplicate publication of DeQuattro 1997&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>DeQuattro V, Lee D, and the Trandolapril Study Group</AU>
<TI>Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>7 Pt 2</NO>
<PG>138S-145S</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levine JH, Applegate WB</AU>
<TI>Trandolapril and verapamil slow release in the treatment of hypertension: A dose-response assessment with the use of a multifactorial trial design</TI>
<SO>Current Therapeutic Research</SO>
<YR>1997</YR>
<VL>58</VL>
<NO>6</NO>
<PG>361-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Drayer-1983" NAME="Drayer 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Drayer J, Weber MA</AU>
<TI>Monotherapy of essential hypertension with a converting-enzyme inhibitor</TI>
<SO>Hypertension</SO>
<YR>1983</YR>
<VL>5</VL>
<NO>Suppl III</NO>
<PG>III108-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dupui-1993" NAME="Dupui 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dupui P, Larrue V, Pavy-Le Traon A, Allavoine T, Geraud G, Bes A</AU>
<TI>Effects of a captopril-induced decrease of the arterial blood pressure on the cerebral blood flow of elderly subjects with moderate hypertension</TI>
<TO>Consequences d'une diminution de la pression sanguine arterielle induite par le captopril sur l'hemodynamique cerebrale du sujet age moderement hypertendu</TO>
<SO>Circulation et metabolisme du cerveau</SO>
<YR>1993</YR>
<VL>10</VL>
<NO>3-4</NO>
<PG>143-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larrue V, Dupui P, Pave-Le Traon A, Allavoine T, Geraud G, Bes A</AU>
<TI>Cerebral blood flow changes induced by a chronic treatment with captopril in previously untreated elderly hypertensive subjects</TI>
<TO>Effets du captopril sur le debit sanguin cerebral du sujet age hypertendu</TO>
<SO>Archives des Maladies du Coeur et des Vaisseaux</SO>
<YR>1994</YR>
<VL>87</VL>
<NO>8</NO>
<PG>997-1000</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fairhurst-1994" NAME="Fairhurst 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fairhurst GJ</AU>
<TI>A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension</TI>
<SO>Blood Pressure</SO>
<YR>1994</YR>
<VL>3</VL>
<NO>Suppl 2</NO>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-1990" NAME="Fernandez 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez PG, Bolli P, Lee C, Vasdev S</AU>
<TI>Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1990</YR>
<VL>6</VL>
<NO>1</NO>
<PG>9-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez PG, Bolli P, Lee C</AU>
<TI>The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1990</YR>
<VL>6</VL>
<NO>2</NO>
<PG>53-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernandez-1994" NAME="Fernandez 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernandez M, Madero R, Gonzalez D, Camacho P, Villalpando J, Arriaga J</AU>
<TI>Combined versus single effect of fosinopril and hydrochlorothiazide in hypertensive patients</TI>
<SO>Hypertension</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>Suppl 1</NO>
<PG>I207-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ford-1993" NAME="Ford 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ford NF, Fulmor IE, Nichola PS, Alpin PG, Herron JM</AU>
<TI>Fosinopril monotherapy: Relationship between blood pressure reduction and time of administration</TI>
<SO>Clinical Cardiology</SO>
<YR>1993</YR>
<VL>16</VL>
<NO>4</NO>
<PG>324-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gerritsen-1998" NAME="Gerritsen 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gerritsen TA, Bak AAA, Stolk RP, Jonker JJC, Grobbee DE</AU>
<TI>Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension</TI>
<SO>Journal of Hypertension</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>5</NO>
<PG>689-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gomez-1989" NAME="Gomez 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomez HJ, Cirillo VJ, Sromosky JA, Otterbein ES, Shaw WC, Rush JE, Chrysant SG, Gradman AH, Leon AS, MacCarthy P, Nelson EB, Pool J, Vedin A</AU>
<TI>Lisinopril dose-response relationship in essential hypertension</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1989</YR>
<VL>28</VL>
<NO>4</NO>
<PG>415-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gradman-1995" NAME="Gradman 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gradman AH, Arcuri KE, Goldberg AI, Ikeda LS, Nelson EB, Snavely DB, Sweet CS</AU>
<TI>A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension</TI>
<SO>Hypertension</SO>
<YR>1995</YR>
<VL>25</VL>
<NO>6</NO>
<PG>1345-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gradman-1997" NAME="Gradman 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC</AU>
<TI>Combined enalapril and felodipine extended release (ER) for systemic hypertension</TI>
<SO>American Journal of Cardiology</SO>
<YR>1997</YR>
<VL>79</VL>
<NO>4</NO>
<PG>431-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guitard-1994" NAME="Guitard 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, Mellein B, Waite R</AU>
<TI>Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension</TI>
<SO>Blood Pressure</SO>
<YR>1994</YR>
<VL>3</VL>
<NO>Suppl 2</NO>
<PG>81-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guitard-1997" NAME="Guitard 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guitard C, Lohmann FW, Alfiero R, Ruina M, Alvisi V</AU>
<TI>Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension</TI>
<SO>Cardiovascular Drugs and Therapy</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>3</NO>
<PG>449-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guntzel-1991" NAME="Guntzel 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guntzel P, Kobrin I, Pasquier C, Zimlichman R, Viskoper JR</AU>
<TI>The effect of cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1991</YR>
<VL>17</VL>
<NO>1</NO>
<PG>8-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Two independent RCTs reported in Kobrin 1991.  Study 2 is same RCT reported in Guntzel 1991.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobrin I, Guntzel P, Viskoper R, Paran E, Zimlichman R</AU>
<TI>Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension</TI>
<SO>Drugs</SO>
<YR>1991</YR>
<VL>41</VL>
<NO>Suppl. 1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holwerda-1996" NAME="Holwerda 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holwerda NJ, Fogari R, Angeli P, Porcellati C, Hereng C, Oddou-Stock P, Heath R, Bodin F</AU>
<TI>Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril</TI>
<SO>Journal of Hypertension</SO>
<YR>1996</YR>
<VL>14</VL>
<NO>9</NO>
<PG>1147-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Homuth-1993" NAME="Homuth 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Homuth V, Faulhaber H-D, Loose U, Loffler K, Luft FC</AU>
<TI>Usefulness of piretanide plus ramipril for systemic hypertension: A multicenter trial</TI>
<SO>American Journal of Cardiology</SO>
<YR>1993</YR>
<VL>72</VL>
<NO>9</NO>
<PG>666-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kayanakis-1987" NAME="Kayanakis 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kayanakis JG, Baulac L</AU>
<TI>Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1987</YR>
<VL>23</VL>
<NO>23 Suppl 1</NO>
<PG>89S-92S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobrin-1991" NAME="Kobrin 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobrin I, Guntzel P, Viskoper R, Paran E, Zimlichman R</AU>
<TI>Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension</TI>
<SO>Drugs</SO>
<YR>1991</YR>
<VL>41</VL>
<NO>Suppl 1</NO>
<PG>31-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koch-1999" NAME="Koch 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koch B, Oparil S, Stimpel M</AU>
<TI>Co-administration of an ACE-inhibitor (moexipril) and hormonal replacement therapy in postmenopausal women</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>5</NO>
<PG>337-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohlmann-Jr-1999" NAME="Kohlmann Jr 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohlmann Jr O, Jardim PCBV, Oigman W</AU>
<TI>Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension: EMBATHE substudy with ambulatory blood pressure monitoring</TI>
<TO>Estudo multicentrico brasileiro de avaliacao da eficacia e tolerabilidade de trandolapril na hipertensao arterial essencial leve a moderada: EMBATHE subestudo com monitorizacao arterial de pressao arterial</TO>
<SO>Arquivos Brasileiros de Cardiologia</SO>
<YR>1999</YR>
<VL>72</VL>
<NO>5</NO>
<PG>547-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kostis-1991" NAME="Kostis 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kostis JB</AU>
<TI>Double-blind study of ascending doses of ramipril in patients with mild to moderate hypertension</TI>
<SO>Advances in Therapy</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>1</NO>
<PG>6-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schnaper HW</AU>
<TI>Dose-response relationship of ramipril in patients with mild-to-moderate hypertension</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1991</YR>
<VL>18</VL>
<NO>Suppl 2</NO>
<PG>S128-S130</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krum-1992" NAME="Krum 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krum H, Jackson B, Conway EL, Howes LG, Johnston CI, Louis WJ</AU>
<TI>Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>3</NO>
<PG>451-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krum-1998" NAME="Krum 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V</AU>
<TI>The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension</TI>
<SO>New England Journal of Medicine</SO>
<YR>1998</YR>
<VL>338</VL>
<NO>12</NO>
<PG>784-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuppers-1997" NAME="Kuppers 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuppers HE, Jager BA, Luszick JH, Grave MA, Hughes PR, Kaan EC</AU>
<TI>Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension</TI>
<SO>Journal of Hypertension</SO>
<YR>1997</YR>
<VL>15</VL>
<PG>93-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuschnir-1996" NAME="Kuschnir 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuschnir E, Acuna E, Sevilla D, Vasquez J, Bendersky M, Resk J, Glazer R</AU>
<TI>Treatment of patients with essential hypertension: Amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo</TI>
<SO>Clinical Therapeutics</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>6</NO>
<PG>1213-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lacourciere-1994" NAME="Lacourciere 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacourciere Y, Leenen F, Rangno R, Spence JD, Lenis JH, Myers MG</AU>
<TI>Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1994</YR>
<VL>10</VL>
<NO>6</NO>
<PG>605-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lerch-1999" NAME="Lerch 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lerch M, Weidmann P, Ho MP, Gerber P, Eckenberger P, Kaemmereit A, Teuscher AU</AU>
<TI>Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1999</YR>
<VL>33</VL>
<NO>4</NO>
<PG>527-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levine-1995" NAME="Levine 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levine JH, Ferdinand KC, Cargo P, Laine H, Lefkowitz M</AU>
<TI>Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>5 Pt 1</NO>
<PG>494-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luccioni-1988" NAME="Luccioni 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luccioni R, Gass FR, Schwab C, Santoni JP, Perret L</AU>
<TI>Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder</TI>
<SO>European Heart Journal</SO>
<YR>1988</YR>
<VL>9</VL>
<PG>1131-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-MacLean-1989" NAME="MacLean 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maclean D</AU>
<TI>Quinapril: A double-blind, placebo-controlled trial in essential hypertension</TI>
<SO>Angiology</SO>
<YR>1989</YR>
<VL>40</VL>
<NO>4 Pt 2</NO>
<PG>370-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mancia-1992" NAME="Mancia 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;duplicate publication of Mancia 1992&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mancia G, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palomba C, Porcellati C, Ranieri G, Tettamanti F, Verdecchia P, Marelli C, Omboni S, Ravogli A, Zanchetti A</AU>
<TI>Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring</TI>
<SO>American Journal of Cardiology</SO>
<YR>1992</YR>
<VL>70</VL>
<NO>12</NO>
<PG>60D-66D</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ravogli A, Omboni S, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti F, Verdecchia P, Marelli C, Zanchetti A, Mancia G</AU>
<TI>Twenty-four hour ambulatory blood pressure monitoring and antihypertensive treatment: Focus on ACE inhibitors</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>Suppl 1</NO>
<PG>S15-S19</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mancia-1997" NAME="Mancia 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mancia G, Agabiti-Rosei E, Benetti G, Calcagnini G, Campa PP, Carretta R, Casati R, Coca A, De la Sierra A, Federighi G, Fogari R, Fontana S, Gomez B, Infelise V, Nami R, Pasotti C, Pirrelli A, Otero L, Vidal L</AU>
<TI>Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: The Veratran Study</TI>
<SO>American Journal of Hypertension</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>5 Pt 1</NO>
<PG>492-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCarron-1991" NAME="McCarron 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burris JF</AU>
<TI>The effect of ramipril on ambulatory blood pressure: A multicenter trial</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1991</YR>
<VL>18</VL>
<NO>Suppl 2</NO>
<PG>S131-S133</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McCarron D</AU>
<TI>24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: magnitude and duration of antihypertensive effects</TI>
<SO>Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>9</NO>
<PG>737-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McFate_x002d_Smith-1991" NAME="McFate-Smith 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Gomez HJ, Glazer R, Mallows S, De Silva J</AU>
<TI>Benazepril in the treatment of older and elderly hypertensive patients</TI>
<SO>Benazepril: Profile of a new ACE inhibitor. Royal Society of Medicine Services International Congress and Symposium Series</SO>
<YR>1990</YR>
<NO>166</NO>
<PG>111-21</PG>
<ED>Brunner HR, Salvetti A, Sever PS</ED>
<PB>Royal Society of Medicine Services Limited</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>McFate Smith W, Gomez HJ</AU>
<TI>The use of benazepril in hypertensive patients age 55 and over</TI>
<SO>Clinical Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>Suppl IV</NO>
<PG>IV79-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Messerli-1998" NAME="Messerli 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Messerli F, Frishman WH, Elliott WJ</AU>
<TI>Effects of verapamil and trandolapril in the treatment of hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1998</YR>
<VL>11</VL>
<NO>3 Pt 1</NO>
<PG>322-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moser-1991" NAME="Moser 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomez HJ</AU>
<TI>Dose-response studies with benazepril in mild to moderate hypertension</TI>
<SO>Clinical Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>Suppl IV</NO>
<PG>IV-22-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Moser M, Abraham PA, Bennett WM, Brachfeld N, Goodman RP, McKenney JM, Hollifield JW, Kirkendall WM, Lasseter KC, Leon AS, Lunn JA, Miller K, Morganroth J, Ruddy MC, Sambhi MP, Stein WJ, Weber MA, Williams RL, Zawada ET, DeSilva J, Gourley LA, Whalen JJ</AU>
<TI>The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: A multicenter study</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1991</YR>
<VL>49</VL>
<NO>3</NO>
<PG>322-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moser M, Whalen J, Gourley L, DeSilva J</AU>
<TI>Double-blind comparison of benazepril, hydrochlorothiazide, and placebo in mild to moderate hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1989</YR>
<VL>2</VL>
<NO>5 Pt 2</NO>
<PG>44A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mroczek-1991" NAME="Mroczek 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mroczek WJ, Klein J, Burris JF</AU>
<TI>Dose-finding study of cilazapril (Inhibace(TM)) in patients with uncomplicated essential hypertension</TI>
<SO>Clinical and Experimental Hypertension - Theory and Practice</SO>
<YR>1991</YR>
<VL>13</VL>
<NO>8</NO>
<PG>1415-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mroczek-1996" NAME="Mroczek 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mroczek WJ, Stimpel M</AU>
<TI>A double-blind evaluation of moexipril versus hydrochlorothiazide in hypertension</TI>
<SO>Advances in Therapy</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>2</NO>
<PG>79-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muiesan-1987" NAME="Muiesan 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muiesan G, Agabiti-Rosei E, Buoninconti R, Cagli V, Carotti A, Corea L, Innocenti P, Malerba M, Paciaroni E, Pirrelli A, Toso M, Botta G</AU>
<TI>Antihypertensive efficacy and tolerability of captopril in the elderly: Comparison with hydrochlorothiazide and placebo in multicentre, double-blind study</TI>
<SO>Journal of Hypertension</SO>
<YR>1987</YR>
<VL>5</VL>
<NO>Suppl 5</NO>
<PG>S599-S602</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myers-1996" NAME="Myers 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myers MG</AU>
<TI>A dose-response study of perindopril in hypertension: Effects on blood pressure 6 and 24 h after dosing</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>1996</YR>
<VL>12</VL>
<NO>11</NO>
<PG>1191-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-New-2000" NAME="New 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>New JP, Bilous RW, Walker M</AU>
<TI>Insulin sensitivity in hypertensive type 2 diabetic patients after 1 and 19 days' treatment with trandolapril</TI>
<SO>Diabetic Medicine</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>2</NO>
<PG>134-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oparil-1999" NAME="Oparil 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oparil S</AU>
<TI>Eprosartan versus enalapril in hypertensive patients with angiotensin-converting enzyme inhibitor-induced cough</TI>
<SO>Current Therapeutic Research</SO>
<YR>1999</YR>
<VL>60</VL>
<NO>1</NO>
<PG>1-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Overlack-1994" NAME="Overlack 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonner G, Lederle RM, Scholze J, Stumpe KO</AU>
<TI>Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant therapy</TI>
<SO>Arzneimittel-Forschung</SO>
<YR>1993</YR>
<VL>43</VL>
<NO>8</NO>
<PG>852-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Middeke M, Krone W</AU>
<TI>Effects of perindopril on serum lipids in hypertensive patients with hyperlipidemia</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1994</YR>
<VL>23</VL>
<NO>4</NO>
<PG>629-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Overlack A, Adamczak M, Bachmann W, Bonner G, Bretzel RG, Derichs R, Krone W, Lederle RM, Reimann HJ, Zschiedrich H, Stumpe KO</AU>
<TI>ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases</TI>
<SO>American Journal of Medicine</SO>
<YR>1994</YR>
<VL>97</VL>
<NO>2</NO>
<PG>126-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Overlack A, Kronig B, Stumpe KO</AU>
<TI>Clinical and functional course of COPD in hypertensive patients with concomitant chronic bronchitis and emphysema during treatment with an ACE inhibitor, perindopril</TI>
<SO>Journal of Drug Development</SO>
<YR>1993</YR>
<VL>6</VL>
<NO>1</NO>
<PG>5-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stumpe KO, Overlack A</AU>
<TI>A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies</TI>
<SO>American Journal of Cardiology</SO>
<YR>1993</YR>
<VL>71</VL>
<NO>17</NO>
<PG>32E-37E</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stumpe KO, Overlack A</AU>
<TI>Angiotensin-converting enzyme inhibition in mild hypertension with concomitant diseases and therapies: an efficacy, safety, and compatibility study of novel design, the Perindopril Therapeutic Safety Study</TI>
<SO>The American Journal of Medicine</SO>
<YR>1992</YR>
<VL>92</VL>
<NO>4B</NO>
<PG>98S-101S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Persson-1996" NAME="Persson 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Persson B, Stimpel M</AU>
<TI>Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1996</YR>
<VL>50</VL>
<PG>259-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pittrow-1997" NAME="Pittrow 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pittrow DB, Antlsperger A, Welzel D, Wambach G, Schardt W, Weldinger G</AU>
<TI>Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension</TI>
<SO>Cardiovascular Drugs and Therapy</SO>
<YR>1997</YR>
<VL>11</VL>
<NO>5</NO>
<PG>619-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pizarro-1996" NAME="Pizarro 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pizarro M, Lima J, Domingues J, Gouveia AC, Monteiro A, Carrageta M, de Freitas AF</AU>
<TI>Antihypertensive effect of fosinopril in mild hypertension</TI>
<TO>Efeito anti-hipertensor do fosinopril na hipertensao arterial ligeira</TO>
<SO>Revista Portuguesa de Cardiologia</SO>
<YR>1996</YR>
<VL>15</VL>
<NO>6</NO>
<PG>495-7,460</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poirier-1991" NAME="Poirier 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lacourciere Y, Poirier L, Pyzyk M</AU>
<TI>2.5 and 5 mg cilazapril once daily compared with placebo in hypertension: A comparative out-patient study of 24-hour blood pressure monitoring</TI>
<TO>2,5 und 5 mg cilazapril einmal taglich verglichen mit plazebo bei hypertonie: Eine vergleichsstudie mit ambulantem 24-studen-monitoring</TO>
<SO>Cardiology</SO>
<YR>1993</YR>
<VL>82</VL>
<NO>Suppl 2</NO>
<PG>78-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poirier L, Pyzyk M, Provencher P, Lacourciere Y</AU>
<TI>Comparative effects of 2.5 and 5 mg cilazapril versus placebo on daily blood pressure load</TI>
<SO>American Journal of Hypertension</SO>
<YR>1991</YR>
<VL>4</VL>
<NO>11</NO>
<PG>913-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pool-1990" NAME="Pool 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pool JL</AU>
<TI>Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: Findings of the fosinopril study group II</TI>
<SO>Clinical Therapeutics</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>6</NO>
<PG>520-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pool-1997" NAME="Pool 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pool JL, Cushman WC, Saini RK, Nwachuku CE, Battikha JP</AU>
<TI>Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1997</YR>
<VL>10</VL>
<NO>1</NO>
<PG>117-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pool-2001" NAME="Pool 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pool J, Kaihlanen P, Lewis G, Ginsberg D, Oparil S, Glazer R, Messerli FH</AU>
<TI>Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone</TI>
<SO>Journal of Human Hypertension</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>7</NO>
<PG>495-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pordy-1994" NAME="Pordy 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pordy RC</AU>
<TI>Cilazapril plus hydrochlorothiazide: Improved efficacy without reduced safety in mild to moderate hypertension</TI>
<SO>Cardiology</SO>
<YR>1994</YR>
<VL>85</VL>
<NO>5</NO>
<PG>311-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prager-1994" NAME="Prager 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prager G, Klein P, Schmitt M, Prager R</AU>
<TI>Antihypertensive efficacy of cilazapril 2.5 and 5.0 mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1994</YR>
<VL>24</VL>
<NO>Suppl 3</NO>
<PG>S93-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Prichard-2002" NAME="Prichard 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Prichard BN, Jager BA, Luszick JH, Kuster LJ, Verboom CN, Hughes PR, Sauermann W, Kuppers HE</AU>
<TI>Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension</TI>
<SO>Blood Pressure</SO>
<YR>2002</YR>
<VL>11</VL>
<NO>3</NO>
<PG>166-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reimann-1995" NAME="Reimann 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reimann HJ, Muller M, Trinczek-Gartner H, Kirchhoff R, Kirchhoff G</AU>
<TI>ACE inhibition in hypertensive patients with concomitant NSAID therapy</TI>
<TO>ACE-hemmung bei patienten mit hypertonie und gleichzeitiger NSAR-therapie</TO>
<SO>Munchener Medizinische Wochenschrift</SO>
<YR>1995</YR>
<VL>137</VL>
<NO>12</NO>
<PG>187-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roca_x002d_Cusachs-2001" NAME="Roca-Cusachs 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roca-Cusachs A, Torres F, Horas M, Rios J, Calvo G, Delgadillo J, Teran M</AU>
<TI>Nitrendipine and enalapril combination therapy in mild to moderate hypertension: Assessment of dose-response relationship by a clinical trial of factorial design</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>6</NO>
<PG>840-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sassano-1984" NAME="Sassano 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sassano P, Chatellier G, Alhenc-Gelas F, Corvol P, Menard J</AU>
<TI>Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension</TI>
<SO>American Journal of Medicine</SO>
<YR>1984</YR>
<VL>77</VL>
<NO>2A</NO>
<PG>18-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saynavalammi-1988" NAME="Saynavalammi 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saynavalammi P, Porsti I, Porsti P, Nurmi AK, Seppala E, Manninen V, Vapaatalo H</AU>
<TI>Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1988</YR>
<VL>12</VL>
<NO>1</NO>
<PG>88-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schoenberger-1986" NAME="Schoenberger 1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schoenberger JA, Wilson DJ</AU>
<TI>Once-daily treatment of essential hypertension with captopril</TI>
<SO>Journal of Clinical Hypertension</SO>
<YR>1986</YR>
<VL>2</VL>
<NO>4</NO>
<PG>379-87</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholze-1998" NAME="Scholze 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scholze J, Zilles P, Compagnone D</AU>
<TI>Verapamil SR and trandolapril combination therapy in hypertension - a clinical trial of factorial design</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>5</NO>
<PG>491-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholze-1999" NAME="Scholze 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scholze J, Bauer B, Massaro J</AU>
<TI>Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER</TI>
<SO>Clinical and Experimental Hypertension</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>8</NO>
<PG>1447-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Simon-1983" NAME="Simon 1983" YEAR="1983">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morioka S, Simon G, Cohn JN</AU>
<TI>Cardiac and hormonal effects of enalapril in hypertension</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1983</YR>
<VL>34</VL>
<NO>5</NO>
<PG>583-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Simon G, Morioka S, Snyder DK, Cohn JN</AU>
<TI>Increased renal plasma flow in long-term enalapril treatment of hypertension</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1983</YR>
<VL>34</VL>
<NO>4</NO>
<PG>459-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1998" NAME="Smith 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith DHG, Neutel JM, Morgenstern P</AU>
<TI>Once-daily telmisartan compared with enalapril in the treatment of hypertension</TI>
<SO>Advances in Therapy</SO>
<YR>1998</YR>
<VL>15</VL>
<NO>4</NO>
<PG>229-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2000" NAME="Smith 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith DHG, Matzek KM, Kempthorne-Rawson J</AU>
<TI>Dose response and safety of telmisartan in patients with mild to moderate hypertension</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>2000</YR>
<VL>40</VL>
<NO>12 Pt 1</NO>
<PG>1380-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trevisan-1995" NAME="Trevisan 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trevisan R, Tiengo A</AU>
<TI>Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients</TI>
<SO>American Journal of Hypertension</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>9</NO>
<PG>876-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Uusitupa-1996" NAME="Uusitupa 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uusitupa M, Korhonen M, Litmanen, Niskanen L, Vaisanen S, Rauramaa R</AU>
<TI>Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>5</NO>
<PG>319-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-VA-Study-Group-1984" NAME="VA Study Group 1984" YEAR="1984">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Veterans Administration Cooperation Study Group on Antihypertensive Agents</AU>
<TI>Low-dose captopril for the treatment of mild to moderate hypertension</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1984</YR>
<VL>144</VL>
<NO>10</NO>
<PG>1947-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veterans Administration Cooperative Study Group on Antihypertensive Agents</AU>
<TI>Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1982</YR>
<VL>14</VL>
<NO>Suppl 2</NO>
<PG>97S-101S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vandenburg-1994" NAME="Vandenburg 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vandenburg MJ, MacKay EM, Dews I, Pullan T, Brugier S</AU>
<TI>Dose finding studies with imidapril - a new ACE inhibitor</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1994</YR>
<VL>37</VL>
<NO>3</NO>
<PG>265-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaur-1998" NAME="Vaur 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaur L, Dubroca I, Dutrey-Dupagne C, Genes N, Chatellier G, Bouvier-d'Yvoire M, Elkik F, Menard J</AU>
<TI>Superiority of home blood pressure measurements over office measurements for testing antihypertensive drugs</TI>
<SO>Blood Pressure Monitoring</SO>
<YR>1998</YR>
<VL>3</VL>
<NO>2</NO>
<PG>107-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Villamil-1987" NAME="Villamil 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villamil AS, Cairns V, Witte PU, Bertolasi CA</AU>
<TI>A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo</TI>
<SO>American Journal of Cardiology</SO>
<YR>1987</YR>
<VL>59</VL>
<NO>10</NO>
<PG>110D-14D</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Waeber-1999" NAME="Waeber 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waeber B, Detry JM, Dahlof B, Puig JG, Gundersen T, Hosie J, Januszewicz W, Lindstrom CJ, Magometschnigg D, Safar M, Tanser P, Toutouzas P</AU>
<TI>Felodipine-metoprolol combination tablet: A valuable option to initiate antihypertensive therapy?</TI>
<SO>American Journal of Hypertension</SO>
<YR>1999</YR>
<VL>12</VL>
<NO>9 Pt 1</NO>
<PG>915-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinberger-1990" NAME="Weinberger 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomez HJ</AU>
<TI>Dose-response studies with benazepril in mild to moderate hypertension</TI>
<SO>Clinical Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>8 Suppl IV</NO>
<PG>IV22-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weinberger MH, Black HR, Lasseter KC, Lewis GP, MacLeod CM, Pascual AV, Zager PG, DeSilva J, Gourley LA, Bennett DA, Whalen JJ</AU>
<TI>Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1990</YR>
<VL>47</VL>
<NO>5</NO>
<PG>608-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weir-1995" NAME="Weir 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Weir MR, Gray JM, Paster R, Saunders E</AU>
<TI>Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients</TI>
<SO>Hypertension</SO>
<YR>1995</YR>
<VL>26</VL>
<NO>1</NO>
<PG>124-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weir MR, Saunders E</AU>
<TI>Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African-Americans</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1998</YR>
<VL>12</VL>
<NO>3</NO>
<PG>189-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whalen-1989" NAME="Whalen 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gomez HJ</AU>
<TI>Dose-response studies with benazepril in mild to moderate hypertension</TI>
<SO>Clinical Cardiology</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>8 Suppl IV</NO>
<PG>IV22-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Whalen J, Skalky C, DeSilva J, Weber M</AU>
<TI>Peak and trough effects of 3 once daily dose levels of benazepril in mild-moderate hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1989</YR>
<VL>2</VL>
<NO>5 Pt 2</NO>
<PG>45A</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whelton-1992" NAME="Whelton 1992" YEAR="1992">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Whelton A, Dunne Jr B, Glazer N, Kostis JB, Miller WE, Rector DJ, Tresznewsky ON</AU>
<TI>Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1992</YR>
<VL>6</VL>
<NO>4</NO>
<PG>325-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-White-1988" NAME="White 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White WB, McCabe EJ, Hager WD, Schulman P</AU>
<TI>The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure</TI>
<SO>Clinical Pharmacology and Therapeutics</SO>
<YR>1988</YR>
<VL>44</VL>
<NO>2</NO>
<PG>173-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-White-1995" NAME="White 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White WB, Whelton A, Fox A, Stimpel M, Kaihlanen PM</AU>
<TI>Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring</TI>
<SO>Journal of Clinical Pharmacology</SO>
<YR>1995</YR>
<VL>35</VL>
<NO>3</NO>
<PG>233-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-White-2002" NAME="White 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ</AU>
<TI>Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising</TI>
<SO>American Journal of Hypertension</SO>
<YR>2002</YR>
<VL>144</VL>
<NO>4</NO>
<PG>657-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yebes-1993" NAME="Yebes 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yebes RB</AU>
<TI>A placebo-controlled double blind study to evaluate the efficacy of once daily quinapril in patients with mild to moderate hypertension</TI>
<SO>Philippine Journal of Internal Medicine</SO>
<YR>1993</YR>
<VL>31</VL>
<NO>6</NO>
<PG>317-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yodfat-1993" NAME="Yodfat 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yodfat Y, Zimilchman R</AU>
<TI>Dose-finding and dose justification of once-daily cilazapril in combination with hydrochlorothiazide in non-obese patients with mild-to-moderate essential hypertension</TI>
<SO>Journal of Drug Development</SO>
<YR>1993</YR>
<VL>6</VL>
<NO>3</NO>
<PG>117-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zamboulis-1996" NAME="Zamboulis 1996" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zamboulis C, Karagiannis A, Gotzamani-Psarrakou A, Deligianni K, Spyridonidis T, Fragos S, Psarrakos K</AU>
<TI>Effects of fosinopril on renal function in patients with mild to moderate essential hypertension</TI>
<SO>Clinical Drug Investigation</SO>
<YR>1996</YR>
<VL>12</VL>
<NO>5</NO>
<PG>251-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-06-05 11:24:42 -0700" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bainbridge-1993" MODIFIED="2008-06-05 09:58:18 -0700" MODIFIED_BY="[Empty name]" NAME="Bainbridge 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1993303543" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bainbridge AD, MacFadyen RJ, Stark S, Lees KR, Reid JL</AU>
<TI>The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1993</YR>
<VL>36</VL>
<NO>4</NO>
<PG>323-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bakris-2002" MODIFIED="2008-06-05 09:57:56 -0700" MODIFIED_BY="[Empty name]" NAME="Bakris 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-06-04 16:24:17 -0700" MODIFIED_BY="[Empty name]" NOTES="2002044321" NOTES_MODIFIED="2008-06-04 16:24:17 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bakris G, Sica D, Ram V, Fagan T, Vaitkus PT, Anders RJ</AU>
<TI>A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes</TI>
<SO>American Journal of Hypertension</SO>
<YR>2002</YR>
<VL>15</VL>
<NO>1 I</NO>
<PG>53-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Beaulieu-1993" MODIFIED="2008-06-05 11:18:51 -0700" MODIFIED_BY="[Empty name]" NAME="Beaulieu 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-06-05 11:18:51 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Beaulieu M, Lacourciere Y, Cleroux J</AU>
<TI>Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril</TI>
<SO>American Journal of Hypertension</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>8</NO>
<PG>763-6</PG>
<IDENTIFIERS MODIFIED="2008-06-05 11:18:51 -0700" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE MODIFIED="2008-06-05 11:16:31 -0700" MODIFIED_BY="[Empty name]" NOTES="1993303544" NOTES_MODIFIED="2008-06-05 11:16:31 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Beaulieu M, Nadeau A, Lacourciere Y, Cleroux J</AU>
<TI>Post-exercise reduction in blood pressure in hypertensive subjects: Effects of angiotensin converting enzyme inhibition</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1993</YR>
<VL>36</VL>
<NO>4</NO>
<PG>331-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bergstrand-1985" MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NAME="Bergstrand 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="2988589" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bergstrand R, Herlitz H, Johansson S, Berglund G, Vedin A, Wilhelmsson C, et al</AU>
<TI>Effective dose range of enalapril in mild to moderate essential hypertension</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1985</YR>
<VL>19</VL>
<NO>5</NO>
<PG>605-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bohlen-1996" MODIFIED="2008-06-04 15:40:28 -0700" MODIFIED_BY="[Empty name]" NAME="Bohlen 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="96354181" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bohlen L, Bienz R, Doser M, Papiri M, Shaw S, Riesen W, et al</AU>
<TI>Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1996</YR>
<VL>27</VL>
<NO>6</NO>
<PG>770-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canter-1994" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Canter 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="94275776" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canter D, Frank GJ, Knapp LE, Phelps M, Quade M, Texter M</AU>
<TI>Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group [see comments]</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1994</YR>
<VL>8</VL>
<NO>3</NO>
<PG>155-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Canter-1994a" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Canter 1994a" YEAR="1994">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="95287280" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Canter DA, Texter MJ, McLain RW</AU>
<TI>Ambulatory blood pressure monitoring can play an integral role in patient selection, dosage adjustment and efficacy assessment in clinical trials of antihypertensive agents</TI>
<SO>Journal of Hypertension - Supplement</SO>
<YR>1994</YR>
<VL>12</VL>
<NO>7</NO>
<PG>S33-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cleroux-1994" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Cleroux 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="95000444" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cleroux J, Beaulieu M, Kouame N, Lacourciere Y</AU>
<TI>Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise</TI>
<SO>American Journal of Hypertension</SO>
<YR>1994</YR>
<VL>7</VL>
<NO>6</NO>
<PG>566-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cuspidi-1997" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Cuspidi 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="98024303" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cuspidi C, Lonati L, Sampieri L, Leonetti G, Muiesan ML, Agabiti-Rosei E, et al</AU>
<TI>Lack of effect of short-term lisinopril administration on left ventricular filling dynamics in hypertensive patients with diastolic dysfunction</TI>
<SO>Blood Pressure</SO>
<YR>1997</YR>
<VL>6</VL>
<NO>5</NO>
<PG>307-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duprez-1986" MODIFIED="2008-06-04 15:43:14 -0700" MODIFIED_BY="[Empty name]" NAME="Duprez 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="87044752" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duprez D, Clement DL</AU>
<TI>Vasodilator effects of enalapril in patients with arterial hypertension</TI>
<SO>Acta Cardiologica</SO>
<YR>1986</YR>
<VL>41</VL>
<NO>5</NO>
<PG>359-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fagard-2001" MODIFIED="2008-06-05 09:57:05 -0700" MODIFIED_BY="[Empty name]" NAME="Fagard 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="11317199" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fagard R, Lijnen P, Pardaens K, Thijs L, Vinck W</AU>
<TI>A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension</TI>
<SO>Journal of Human Hypertension</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>3</NO>
<PG>161-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gall-1992" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Gall 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="92255877" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gall MA, Rossing P, Skott P, Hommel E, Mathiesen ER, Gerdes LU, et al</AU>
<TI>Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1992</YR>
<VL>5</VL>
<NO>5 Pt 1</NO>
<PG>257-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gans-1993" MODIFIED="2008-06-04 15:44:53 -0700" MODIFIED_BY="[Empty name]" NAME="Gans 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="94134203" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gans RO, Stehouwer CD, Bilo HJ, Goggin T, Kraaij CJ, Donker AJ, et al</AU>
<TI>Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus</TI>
<SO>Netherlands Journal of Medicine</SO>
<YR>1993</YR>
<VL>43</VL>
<NO>3-4</NO>
<PG>163-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gleerup-1996" MODIFIED="2008-06-04 15:45:25 -0700" MODIFIED_BY="[Empty name]" NAME="Gleerup 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="97027441" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gleerup G, Petersen JR, Mehlsen J, Winther K</AU>
<TI>Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension</TI>
<SO>Angiology</SO>
<YR>1996</YR>
<VL>47</VL>
<NO>10</NO>
<PG>951-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guitard-1994a" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Guitard 1994a" YEAR="1994">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="94340122" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, et al</AU>
<TI>Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension</TI>
<SO>Blood Pressure</SO>
<YR>1994</YR>
<VL>Supplement. 2</VL>
<PG>81-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gupta-1990" MODIFIED="2008-06-05 11:22:21 -0700" MODIFIED_BY="[Empty name]" NAME="Gupta 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-06-05 11:22:21 -0700" MODIFIED_BY="[Empty name]" NOTES="90315777" NOTES_MODIFIED="2008-06-05 11:22:21 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gupta RK, Kjeldsen SE, Krause L, Kneisley J, Posvar E, Weder AB, et al</AU>
<TI>Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor</TI>
<SO>Clinical Pharmacology &amp; Therapeutics</SO>
<YR>1990</YR>
<VL>48</VL>
<NO>1</NO>
<PG>41-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-06-05 11:21:51 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gupta RK, Kjeldsen SE, Motley E, Weder AB, Zweifler AJ, Julius S</AU>
<TI>Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1991</YR>
<VL>17</VL>
<NO>1</NO>
<PG>13-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Homuth-1993a" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Homuth 1993a" YEAR="1993">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="94070649" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Homuth V, Faulhaber HD, Loose U, Loffler K, Luft FC</AU>
<TI>Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial</TI>
<SO>American Journal of Cardiology</SO>
<YR>1993</YR>
<VL>72</VL>
<NO>9</NO>
<PG>666-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hu-1999" MODIFIED="2008-06-05 09:55:25 -0700" MODIFIED_BY="[Empty name]" NAME="Hu 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1999141438" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hu Y, Zhu J</AU>
<TI>Quality of life of patients with mild hypertension treated with captopril: A randomized double-blind placebo-controlled clinical trial</TI>
<SO>Chinese Medical Journal</SO>
<YR>1999</YR>
<VL>112</VL>
<NO>4</NO>
<PG>302-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kahan-1999" MODIFIED="2008-06-05 09:54:39 -0700" MODIFIED_BY="[Empty name]" NAME="Kahan 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="2000020230" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kahan T, Eliasson K</AU>
<TI>The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>1999</YR>
<VL>12</VL>
<NO>12 I</NO>
<PG>1188-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karlberg-1987" MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NAME="Karlberg 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="3034016" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karlberg BE, Lindstrom T, Rosenqvist U, Ohman KP</AU>
<TI>Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension</TI>
<SO>American Journal of Cardiology</SO>
<YR>1987</YR>
<VL>59</VL>
<NO>10</NO>
<PG>104D-9D</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kjeldsen-1992" MODIFIED="2008-06-04 15:55:41 -0700" MODIFIED_BY="[Empty name]" NAME="Kjeldsen 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="92246105" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kjeldsen SE, Gupta RK, Krause L, Weder AB, Julius S</AU>
<TI>Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril</TI>
<SO>American Heart Journal</SO>
<YR>1992</YR>
<VL>123</VL>
<NO>5</NO>
<PG>1433-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lacourciere-1999" MODIFIED="2008-06-05 09:53:56 -0700" MODIFIED_BY="[Empty name]" NAME="Lacourciere 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1999100662" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lacourciere Y, Bittar N, Blanchard E, Kilpatrick FW, Schumacher D, Chappel C, et al</AU>
<TI>The incidence of cough: A comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist</TI>
<SO>International Journal of Clinical Practice</SO>
<YR>1999</YR>
<VL>53</VL>
<NO>2</NO>
<PG>99-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lavezzaro-1990" MODIFIED="2008-06-05 09:53:00 -0700" MODIFIED_BY="[Empty name]" NAME="Lavezzaro 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1990107310" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lavezzaro G, Ladetto PE, Valente M, Stramignoni D, Zanna C, Assogna G, et al</AU>
<TI>Ketanserin and captopril interaction in the treatment of essential hypertensives</TI>
<SO>Cardiovascular Drugs &amp; Therapy</SO>
<YR>1990</YR>
<VL>4</VL>
<NO>SUPPL. 1</NO>
<PG>119-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leonetti-1991" MODIFIED="2008-06-05 09:52:30 -0700" MODIFIED_BY="[Empty name]" NAME="Leonetti 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1991156606" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leonetti G, Mazzola C, Pasotti C, Angioni L, Vaccarella A, Capra A, et al</AU>
<TI>Treatment of hypertension in the elderly: Effects on blood pressure, heart rate, and physical fitness</TI>
<SO>American Journal of Medicine</SO>
<YR>1991</YR>
<VL>90</VL>
<NO>SUPPL.3A</NO>
<PG>12S-3S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Littler-1990" MODIFIED="2008-06-05 09:51:46 -0700" MODIFIED_BY="[Empty name]" NAME="Littler 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1990375306" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Littler WA, West JW</AU>
<TI>Twenty-four hour action of ACE inhibitors</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1990</YR>
<VL>4</VL>
<NO>SUPPL. 4</NO>
<PG>13-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Louis-1992" MODIFIED="2008-06-05 09:51:18 -0700" MODIFIED_BY="[Empty name]" NAME="Louis 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1992256391" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Louis WJ, Workman BS, Conway EL, Worland P, Rowley K, Drummer O, et al</AU>
<TI>Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>3</NO>
<PG>505-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miyajima-1999" MODIFIED="2008-06-05 09:50:47 -0700" MODIFIED_BY="[Empty name]" NAME="Miyajima 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-06-04 16:23:33 -0700" MODIFIED_BY="[Empty name]" NOTES="1999354332" NOTES_MODIFIED="2008-06-04 16:23:33 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miyajima E, Shigemasa T, Yamada Y, Tochikubo O, Ishii M</AU>
<TI>Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans</TI>
<SO>Clinical &amp; Experimental Pharmacology &amp; Physiology</SO>
<YR>1999</YR>
<VL>26</VL>
<NO>10</NO>
<PG>797-802</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morgan-2001" MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NAME="Morgan 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="11281235" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morgan TO, Anderson AI, MacInnis RJ</AU>
<TI>ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension</TI>
<SO>American Journal of Hypertension</SO>
<YR>2001</YR>
<VL>14</VL>
<NO>3</NO>
<PG>241-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petersen-1996" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Petersen 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="96208683" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petersen JR, Drabaek H, Gleerup G, Mehlsen J, Petersen LJ, Winther K</AU>
<TI>ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension</TI>
<SO>Angiology</SO>
<YR>1996</YR>
<VL>47</VL>
<NO>3</NO>
<PG>233-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrie-2000" MODIFIED="2008-06-04 16:00:51 -0700" MODIFIED_BY="[Empty name]" NAME="Petrie 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="20300155" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrie JR, Morris AD, Ueda S, Small M, Donnelly R, Connell JM, et al</AU>
<TI>Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial</TI>
<SO>Journal of Clinical Endocrinology &amp; Metabolism</SO>
<YR>2000</YR>
<VL>85</VL>
<NO>5</NO>
<PG>1882-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrov-2001" MODIFIED="2008-06-05 09:50:20 -0700" MODIFIED_BY="[Empty name]" NAME="Petrov 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="11588528" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrov VV, Fagard RH, Lijnen PJ</AU>
<TI>T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>4</NO>
<PG>578-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Plouin-1991" MODIFIED="2008-06-04 16:01:17 -0700" MODIFIED_BY="[Empty name]" NAME="Plouin 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="91283096" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Plouin PF, Battaglia C, Alhenc-Gelas F, Corvol P</AU>
<TI>Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?</TI>
<SO>American Journal of Hypertension</SO>
<YR>1991</YR>
<VL>4</VL>
<NO>4 Pt 1</NO>
<PG>356-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pritchard-1996" MODIFIED="2008-06-05 11:24:29 -0700" MODIFIED_BY="[Empty name]" NAME="Pritchard 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-06-05 11:24:29 -0700" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pritchard G, Lyons D, Webster J, Petrie JC, MacDonald TM</AU>
<TI>Do trandolapril and indomethacin influence renal function and renal functional reserve in hypertensive patients?</TI>
<SO>British Journal of Clinical Pharmacology</SO>
<YR>1997</YR>
<VL>44</VL>
<NO>2</NO>
<PG>145-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2008-06-05 11:23:50 -0700" MODIFIED_BY="[Empty name]" NOTES="97157828" NOTES_MODIFIED="2008-06-05 11:23:50 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Pritchard G, Lyons D, Webster J, Petrie JC, MacDonald TM</AU>
<TI>Indomethacin does not attenuate the hypotensive effect of trandolapril</TI>
<SO>Journal of Human Hypertension</SO>
<YR>1996</YR>
<VL>10</VL>
<NO>11</NO>
<PG>763-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reisin-1997" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Reisin 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="97375517" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reisin E, Weir MR, Falkner B, Hutchinson HG, Anzalone DA, Tuck ML</AU>
<TI>Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group</TI>
<SO>Hypertension</SO>
<YR>1997</YR>
<VL>30</VL>
<NO>1 Pt 1</NO>
<PG>140-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salvetti-1987" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Salvetti 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="88155093" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvetti A, Innocenti PF, Iardella M, Pambianco F, Saba GC, Rossetti M, et al</AU>
<TI>Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study</TI>
<SO>Journal of Hypertension - Supplement</SO>
<YR>1987</YR>
<VL>5</VL>
<NO>4</NO>
<PG>S139-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salvetti-1988" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Salvetti 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="89199337" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvetti A, Circo A, Raciti S, Gulizia M, Cardillo R, Miceli S, et al</AU>
<TI>Captopril at 50 mg as well as at 100 mg once a day reduces blood pressure for up to 24 h: a double-blind randomized crossover study in mild to moderate hypertensives</TI>
<SO>Journal of Hypertension - Supplement</SO>
<YR>1988</YR>
<VL>6</VL>
<NO>4</NO>
<PG>S666-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salvetti-1989" MODIFIED="2008-06-04 16:12:02 -0700" MODIFIED_BY="[Empty name]" NAME="Salvetti 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="89247030" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salvetti A, Arzilli F</AU>
<TI>Chronic dose-response curve of enalapril in essential hypertensives. An Italian multicenter study</TI>
<SO>American Journal of Hypertension</SO>
<YR>1989</YR>
<VL>2</VL>
<NO>5 Pt 1</NO>
<PG>352-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Samuelsson-1992" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Samuelsson 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="93130946" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Samuelsson O, Hedner T, Ljungman S, Herlitz H, Widgren B, Pennert K</AU>
<TI>A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1992</YR>
<VL>43</VL>
<NO>5</NO>
<PG>469-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sassano-1984a" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Sassano 1984a" YEAR="1984">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="87085900" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sassano P, Chatellier G, Amiot AM, Alhenc-Gelas F, Corvol P, Menard J</AU>
<TI>A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension</TI>
<SO>Journal of Hypertension - Supplement</SO>
<YR>1984</YR>
<VL>2</VL>
<NO>2</NO>
<PG>S75-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholze-1993" MODIFIED="2008-06-04 16:16:17 -0700" MODIFIED_BY="[Empty name]" NAME="Scholze 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="93217251" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scholze J, Breitstadt A, Cairns V, Bauer B, Bender N, Priestley C, et al</AU>
<TI>Short report: ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design. The East Germany Collaborative Trial Group</TI>
<SO>Journal of Hypertension</SO>
<YR>1993</YR>
<VL>11</VL>
<NO>2</NO>
<PG>217-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Thurig-1995" MODIFIED="2008-06-04 16:17:14 -0700" MODIFIED_BY="[Empty name]" NAME="Thurig 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="96287391" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thurig C, Bohlen L, Schneider M, de Courten M, Shaw SG, Riesen W, et al</AU>
<TI>Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients</TI>
<SO>European Journal of Clinical Pharmacology</SO>
<YR>1995</YR>
<VL>49</VL>
<NO>1-2</NO>
<PG>21-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tomei-1992" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Tomei 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="92301065" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tomei R, Rossi L, Carbonieri E, Franceschini L, Molon G, Zardini P</AU>
<TI>Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study</TI>
<SO>Journal of Cardiovascular Pharmacology</SO>
<YR>1992</YR>
<VL>19</VL>
<NO>6</NO>
<PG>911-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiggam-1998" MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NAME="Wiggam 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="99072186" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiggam MI, Hunter SJ, Atkinson AB, Ennis CN, Henry JS, Browne JN, et al</AU>
<TI>Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study</TI>
<SO>Journal of Hypertension</SO>
<YR>1998</YR>
<VL>16</VL>
<NO>11</NO>
<PG>1651-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilkins-1983" MODIFIED="2008-06-05 09:49:25 -0700" MODIFIED_BY="[Empty name]" NAME="Wilkins 1983" YEAR="1983">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="6309461" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilkins LH, Dustan HP, Walker JF, Oparil S</AU>
<TI>Enalapril in low-renin essential hypertension</TI>
<SO>Clinical Pharmacology &amp; Therapeutics</SO>
<YR>1983</YR>
<VL>34</VL>
<NO>3</NO>
<PG>297-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wing-1987" MODIFIED="2008-06-04 16:21:35 -0700" MODIFIED_BY="[Empty name]" NAME="Wing 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="88171833" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wing LM, Chalmers JP, West MJ, Bune AJ, Russell AE, Elliott JM, et al</AU>
<TI>Treatment of hypertension with enalapril and hydrochlorothiazide or enalapril and atenolol: contrasts in hypotensive interactions</TI>
<SO>Journal of Hypertension - Supplement</SO>
<YR>1987</YR>
<VL>5</VL>
<NO>5</NO>
<PG>S603-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wing-1988" MODIFIED="2008-06-04 16:22:04 -0700" MODIFIED_BY="[Empty name]" NAME="Wing 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-06-04 15:31:47 -0700" MODIFIED_BY="[Empty name]" NOTES="88165542" NOTES_MODIFIED="2008-06-04 15:31:47 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wing LM, Chalmers JP, West MJ, Russell AE, Morris MJ, Cain MD, et al</AU>
<TI>Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination</TI>
<SO>Clinical &amp; Experimental Hypertension - Part A, Theory &amp; Practice</SO>
<YR>1988</YR>
<VL>10</VL>
<NO>1</NO>
<PG>119-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Youssef-1993" NAME="Youssef 1993" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Youssef S, Osman L, Sabbour MS</AU>
<TI>Serum lipoprotein profile under different antihypertensive therapy</TI>
<SO>Cardiovascular Risk Factors</SO>
<YR>1993</YR>
<VL>3</VL>
<NO>2</NO>
<PG>107-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zanchetti-2001" MODIFIED="2008-06-05 09:48:46 -0700" MODIFIED_BY="[Empty name]" NAME="Zanchetti 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-06-04 16:23:57 -0700" MODIFIED_BY="[Empty name]" NOTES="11243303" NOTES_MODIFIED="2008-06-04 16:23:57 -0700" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zanchetti A, Omboni S</AU>
<TI>Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group</TI>
<SO>American Journal of Hypertension</SO>
<YR>2001</YR>
<VL>14</VL>
<NO>2</NO>
<PG>129-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Bucher-1997" NAME="Bucher 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bucher HC, Guyatt GH, Griffith LE, Walter D</AU>
<TI>The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1997</YR>
<VL>50</VL>
<NO>6</NO>
<PG>683-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cochrane-Handbook" NAME="Cochrane Handbook" TYPE="BOOK_SECTION">
<AU>Sterne JAC, Egger M, Moher D (editors)</AU>
<TI>Chapter 10: Addressing reporting biases</TI>
<SO>Cochrane Handbook for Systematic Reviews of Intervention</SO>
<YR>Version 5.0.0 (updated February 2008)</YR>
<ED>Higgins JPT, Green S</ED>
<PB>The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Heran-2002" NAME="Heran 2002" TYPE="OTHER">
<AU>Heran BS, Jauca CD, Wright JM</AU>
<TI>Development of an optimal search strategy for finding trials demonstrating ACE inhibitor blood pressure lowering efficacy</TI>
<SO>10th International Cochran Colloquium, Stavenger, Norway</SO>
<YR>2002</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" TYPE="JOURNAL_ARTICLE">
<AU>88.Jadad AR, Moore RA, Carrol D, et al</AU>
<TI>Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>17</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Song-2003" NAME="Song 2003" TYPE="JOURNAL_ARTICLE">
<AU>Song F, Altman DG, Glenny AM Deeks JJ</AU>
<TI>Validity of indirect comparison for estimating efficacy of competing interventions: emperical evidence from published meta-analyses</TI>
<SO>British Medical Journal</SO>
<YR>2003</YR>
<VL>326</VL>
<PG>472-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO_x002d_ICTRP" NAME="WHO-ICTRP" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>International Clinical Trials Registry Platform (ICTRP)</TI>
<SO>Available from: http://www.who.int/ictrp/en</SO>
<YR>2006 [cited 2008 Feb 29]</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-02-18 14:49:17 -0800" MODIFIED_BY="Ciprian D Jauca">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-02-18 14:49:17 -0800" MODIFIED_BY="Ciprian D Jauca" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Applegate-1996">
<CHAR_METHODS>
<P>7-day washout period; 4-week single-blind placebo baseline phase; inclusion criteria= average sitting DBP 95-115 mm Hg of week 2 and 4 of baseline phase recordings; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 5 mg: n=56(38 males,18 females); mean age=52.5(11.2) years; baseline SBP=152.8(17.3) mm Hg, DBP=100.5(5.2) mm Hg, HR=77.4(9.2) bpm;<BR/>Placebo: n=58(39 males,19 females); mean age=54.2(10.2) years; baseline SBP=152.5(13.0) mm Hg, DBP=100.4(4.8) mm Hg, HR=76.8(10.0) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 5 mg once daily;<BR/>Placebo;<BR/>administered in the morning (between 7:30 AM and 10:00 AM)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Adjusted BP change reported, SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; used endpoint BP and SD data to calculate change in BP instead of entering adjusted BP change data; BP data from Table II, p. 53; Jadad score=4; funding source= Merck</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Belz-1986">
<CHAR_METHODS>
<P>4-week placebo washout; inclusion criteria= DBP 95-114 mm Hg; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 1.25 mg: n=8(4 males,4 females); mean age=47.8(7.1) years; baseline sitting SBP=154.1(10.6) mm Hg, DBP=103.6(6.7) mm Hg;<BR/>Cilazapril 2.5 mg: n=6(3 males,3 females); mean age=47.2(9.1) years; baseline sitting SBP=149.8(13.2) mm Hg, DBP=100.2(4.4) mm Hg;<BR/>Cilazapril 5 mg: n=6(2 males,4 females); mean age=51.5(9.1) years; baseline sitting SBP=162.2(24.0) mm Hg, DBP=104.3(5.5) mm Hg;<BR/>Placebo: n=7(3 males,4 females); mean age=52.7(9.6) years; baseline sitting SBP=148.3(17.3) mm Hg, DBP=98.3(4.9) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 1.25 mg once daily;<BR/>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>administered in the morning at approximately 7 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peak sitting SBP/DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table 2, p. 526; lying and standing BP data also available; Jadad score=2; funding source= Hoffmann-La Roche AG</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Black-1997">
<CHAR_METHODS>
<P>2- to 4-week placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg after run-in; 12-week total double-blind treatment, 4-week double-blind treatment at initial fixed dose, non-responders were up-titrated after 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Lisinopril 10 mg: n=187(112 males,75 females); mean age=53.9(10.7) years; baseline sitting SBP=153.9(14.9) mm Hg, DBP=101.0(4.5) mm Hg;<BR/>Placebo: n=183(113 males,70 females); mean age=54.0(11.8) years; baseline sitting SBP=154.1(14.4) mm Hg, DBP=101.0(4.4) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Lisinopril 10 mg once daily;<BR/>Placebo;<BR/>administered at approximately 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Least mean square change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change reported, SD of change not reported, endpoint BP and SD not reported; imputed SBP SD of change from baseline SBP SD of change, imputed overall trial mean DBP SD of change; SBP data from Figure 1, p. 487, DBP data from text, p. 485; Jadad score=2; funding source= Ciba-Geigy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Boeijinga-1993">
<CHAR_METHODS>
<P>Inclusion criteria= sitting DBP 90-105 mm Hg before start of study; 3-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=14(11 males,3 females); mean age=63.7(4.2) years; baseline SBP=139 mm Hg, DBP=92 mm Hg;<BR/>Placebo: n=12(10 males,2 females); mean age=63.3(7.8) years; baseline SBP=135 mm Hg, DBP=92 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Placebo;<BR/>administered in the morning before breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peak (2-3 h after dosing) supine SBP/DBP using mercury sphygmomanometer;<BR/>Peak (2-3 h after dosing) HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used DBP only since patients did not have SBP &gt;/= 140 mm Hg at baseline; BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from text, p. 446; Jadad score=3; funding source= Hoffman-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Brown-1990">
<CHAR_METHODS>
<P>2-week single-blind placebo run-in; inclusion criteria= supine DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=40(19 males,21 females); mean age=58 years; baseline upright SBP=154(15) mm Hg, DBP=102(7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 4 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough erect SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SEM of change reported, endpoint BP and SD not reported; calculated SD of change from N and SEM of change; BP data from Table 2, p. 329; Jadad score=4; funding source= Servier</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Carlsen-1995">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= mean pre-dose sitting DBP 100-115 mm Hg after 3 and 4 weeks of run-in, mean baseline DBP &gt;/= 100 mm Hg at hourly measurements 21-24 h post-placebo and also during whole BP profile (i.e. hourly measurements 1-8 h and 21-24 h post-dose); 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 1 mg: n=42(26 males,16 females); mean age=53 years; baseline sitting BP not reported;<BR/>Cilazapril 2.5 mg: n=42(28 males,14 females); mean age=52 years; baseline sitting BP not reported;<BR/>Cilazapril 5 mg: n=42(27 males,15 females); mean age=48 years; baseline sitting BP not reported;<BR/>Placebo: n=43(22 males,21 females); mean age=56 years; baseline sitting BP not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 1 mg once daily;<BR/>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken at approximately 12 noon before meal</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>SBP change not reported; DBP change and SE of change reported, endpoint DBP and SD not reported; calculated DBP SD of change from N and SE of change; BP data from text, p. 224; Jadad score=2; funding source= Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chan-1997">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at last 2 visits of run-in; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Lisinopril 10 mg: n=26(18 males,8 females); mean age=70.5 years; baseline sitting SBP=163.8(13.0) mm Hg, DBP=104.9(5.0) mm Hg, HR=62.5 bpm;<BR/>Placebo: n=27(15 males,12 females); mean age=73.4 years; baseline sitting SBP=167.9(14.8) mm Hg, DBP=105.5(5.4) mm Hg, HR=61.9 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Lisinopril 10 mg once daily;<BR/>Placebo;<BR/>taken between 8 AM and 10 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD reported; SD of change values are too low; imputed endpoint SBP SD for SBP SD of change; imputed overall trial mean DBP SD of change; SBP data from Table 2, p. 745; DBP data from Table 3, p. 746; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-02-18 14:49:17 -0800" MODIFIED_BY="Ciprian D Jauca" STUDY_ID="STD-Chrysant-1993">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= supine DBP 95-114 mm Hg after run-in; 16-week double-blind treatment, forced-titration of dose by 4 mg every 4 weeks to maximum 16 mg daily</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Perindopril 4-16 mg once daily: n=117(65 males,52 females); mean age=55(10) years; baseline upright SBP=154(15) mm Hg, DBP=102(7) mm Hg; baseline supine SBP=157(16) mm Hg, DBP=100(5) mm Hg;<BR/>Perindopril 2-8 mg twice daily: n=113(73 males,40 females); mean age=53(12) years; baseline upright SBP=150(15) mm Hg, DBP=101(6) mm Hg; baseline supine SBP=152(15) mm Hg, DBP=100(4) mm Hg;<BR/>Placebo: n=59(45 males,15 females); mean age=51(12) years; baseline upright SBP=161(14) mm Hg, DBP=103(8) mm Hg; baseline supine SBP=153(10) mm Hg, DBP=101(5) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 4 mg once daily (wk 0-4), perindopril 8 mg once daily (wk 4-8), Perindopril 12 mg once daily (wk 8-12), perindopril 16 mg once daily (wk 12-16);<BR/>Perindopril 2 mg twice daily (wk 0-4), perindopril 4 mg twice daily (wk 4-8), perindopril 6 mg twice daily (wk 8-12), perindopril 8 mg twice daily (wk 12-16);<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Once daily dosing: upright and supine SBP/DBP 24 ± 2 h after last dose;<BR/>Twice daily dosing: upright and supine SBP/DBP 12 ± 2 h after last dose;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-02-18 14:49:17 -0800" MODIFIED_BY="Ciprian D Jauca">
<P>Used week 4 supine data only; BP change reported, SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Figure 1, p. 481; BP measurement device not reported; Jadad score=3; funding source= RW Johnson Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chrysant-1994">
<CHAR_METHODS>
<P>4-week single-blind placebo period; inclusion criteria= sitting DBP 100-114 mm Hg after placebo period; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Lisinopril 10 mg: n=85; mean age=54 years; baseline sitting SBP=154 mm Hg, DBP=104 mm Hg, HR=77 bpm; baseline upright SBP=154 mm Hg, DBP=103 mm Hg, HR=78 bpm;<BR/>Placebo: n=81; mean age=53 years; baseline sitting SBP=155 mm Hg, DBP=103 mm Hg, HR=77 bpm; baseline upright SBP=154 mm Hg, DBP=104 mm Hg, HR=79 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Lisinopril 10 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough upright SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported and SEM reported; calculated endpoint SD from N and endpoint SEM; imputed endpoint SD for SD of change; BP data from Figure 1, p. 739; Jadad score=2; funding source= ICI Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Chrysant-1996">
<CHAR_METHODS>
<P>1-week washout; 1- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at 2 consecutive visits during run-in, with a difference of 10 mm Hg or less between 2 visits; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Benazepril 20 mg: n=42(28 males,14 females); mean age=53.7 years; baseline sitting SBP=153 mm Hg, DBP=104 mm Hg;<BR/>Placebo: n=40(22 males,18 females); mean age=53.5 years; baseline sitting SBP=153 mm Hg, DBP=103 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in peak sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported and SE of change reported, endpoint BP reported; endpoint SD not reported, SD of change calculated from N and SE of change; BP data from Fagan abstract; SD of change data from Figure 1, p. 8; Jadad score=4; funding source= Ciba Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Cushman-1998">
<CHAR_METHODS>
<P>7-day washout; 4-week single-blind placebo baseline; inclusion criteria= mean sitting DBP 95-115 mm Hg of week 2 and week 4 baseline recordings with difference in these means &lt;/= 7 mm Hg, mean sitting SBP had to be &lt; 210 mm Hg at each baseline visit; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 5 mg: n=144(94 males,50 females); mean age=56.1(10.0) years; baseline sitting SBP=155.2 mm Hg, DBP=101.6(5.5) mm Hg;<BR/>Placebo: n=150(104 males,46 females); mean age=55.8(11.4) years; baseline sitting SBP=155.4 mm Hg, DBP=101.6(5.6) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 5 mg once daily;<BR/>Placebo;<BR/>administered between 6:30 AM and 10:00 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported; endpoint BP reported; endpoint SD not reported; imputed overall trial mean SD of change for SBP and DBP; BP data from Table 2, p. 26; Jadad score=4; funding source= Merck</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-De-Bruijn-1994">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= supine and standing DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 0.5 mg: n=41(17 males,24 females); mean age=49(13) years; baseline SBP=163.8(12.8) mm Hg, DBP=99.5(5.8) mm Hg;<BR/>Trandolapril 1 mg: n=42(8 males,38 females); mean age=48(13) years; baseline SBP=159.9(14.3) mm Hg, DBP=99.9(5.2) mm Hg;<BR/>Trandolapril 2 mg: n=43(23 males,20 females); mean age=46(13) years; baseline SBP=161.1(13.1) mm Hg, DBP=99.8(5.9) mm Hg;<BR/>Placebo: n=44(18 males,26 females); mean age=50(7) years; baseline SBP=157.3(16.6) mm Hg, DBP=99.2(6.0) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 0.5 mg once daily;<BR/>Trandolapril 1 mg once daily;<BR/>Trandolapril 2 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD not reported; BP data from Figures 1 and 2, pp. S61-S62; Jadad score=3; funding source= Roussel Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-DeQuattro-1997">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg during final 2 wks of run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 0.5 mg: n=41; baseline SBP=155.4(15.7) mm Hg, DBP=100.3(4.4) mm Hg;<BR/>Trandolapril 2 mg: n=67; baseline SBP=151.4(16.5) mm Hg, DBP=99.8(4.6) mm Hg;<BR/>Trandolapril 8 mg: n=43; baseline SBP=150.7(16.3) mm Hg, DBP=99.5(4.2) mm Hg;<BR/>Placebo: n=53; baseline SBP=154.8(15.1) mm Hg, DBP=100.3(4.6) mm Hg; <BR/>All patients (trandolapril monotherapy, verapamil monotherapy + verapamil/trandolapril combination treatment arms): n=726(456 males,270 females); mean age=54.7(10.9) years; baseline sitting SBP=151.8(16.2) mm Hg, DBP=100.4(6.1) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 0.5 mg once daily;<BR/>Trandolapril 2 mg once daily;<BR/>Trandolapril 8 mg once daily;<BR/>Placebo;<BR/>administered in the morning (8 AM ± 1 h)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Supine baseline BP reported in duplicate publication for each treatment arm; BP change reported, SD of change not reported, endpoint BP and SD not reported; imputed baseline SBP SD for SBP SD of change; imputed overall trial mean DBP SD of change; data from Table II, p. 367; duplicate publications=Levine 97, DeQuattro 97(NEJM); Jadad score=3; funding source= Knoll Pharma</P>
<P>Change in sitting SBP data is not the same as data reported in Levine 1997. Reviewers have decided to use data from DeQuattro 1997 (primary reference) because unadjusted endpoint data is provided. At this time, DBP data that is only available in Levine 1997 will not be used unless an explanation for the discrepancy in BP data is adequately explained by authors.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Drayer-1983">
<CHAR_METHODS>
<P>4- to 6-week placebo run-in; inclusion criteria= supine DBP 95-115 mm Hg on 2 consecutive visits after beginning of placebo run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Captopril 25 mg twice daily: n=77(60 males,17 females); mean age=52 years; baseline supine SBP=156 mm Hg, DBP=101 mm Hg;<BR/>Captopril 50 mg twice daily: n=71(50 males,21 females); mean age=52 years; baseline supine SBP=154 mm Hg, DBP=101 mm Hg;<BR/>Captopril 100 mg twice daily: n=69(44 males,25 females); mean age=55 years; baseline supine SBP=158 mm Hg, DBP=102 mm Hg;<BR/>Placebo: n=77(53 males,24 females); mean age=53 years; baseline supine SBP=157 mm Hg, DBP=102 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 25 mg twice daily;<BR/>Captopril 50 mg twice daily;<BR/>Captopril 100 mg twice daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Percent change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported, endpoint BP and SD not reported; baseline SD not reported; imputed overall trial mean SD of change for SBP and DBP; percent change in SBP data from text, p. III-110; percent change in DBP data from Figure 1, p. III-110; percent change in BP has been converted to absolute BP change data; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Dupui-1993">
<CHAR_METHODS>
<P>Inclusion criteria= SBP 160-210 mm Hg and DBP 95-115 mm Hg based on 3 separate measurements over a period of several days; approximately 8-week (60 days) double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=13(4 males,9 females);<BR/>Captopril 75 mg daily: n=8(3 males,5 females); mean age=63(9) years; baseline upright SBP=155.3(7.9) mm Hg, DBP=94.4(10.9) mm Hg; baseline lying SBP=164.3(10.4) mm Hg, DBP=96.5(10.7) mm Hg; baseline HR=64.5(10.7) bpm;<BR/>Placebo: n=5(1 male,4 females); mean age=63(4) years; baseline upright SBP=157.1(10.6) mm Hg, DBP=103.0(16.2) mm Hg; baseline lying SBP=168.1(7.0) mm Hg, DBP=100.4(11.1) mm Hg; baseline HR=66.2(4.9) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 75 mg daily (50 mg in the morning, 25 mg at bedtime);<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Upright SBP/DBP using Dynamap automated oscillometric device;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table III, p. 150; lying BP data also available; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fairhurst-1994">
<CHAR_METHODS>
<P>3- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-115 mm Hg, as determined by mean of 3 consecutive BP measurements using either mercury or random-zero sphygmomanometer; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=283(157 males,126 females); mean age=55 years;<BR/>Spirapril 3 mg: n=55;<BR/>Spirapril 6 mg: n=61;<BR/>Spirapril 12 mg: n=58;<BR/>Spirapril 24 mg: n=49;<BR/>Placebo: n=60</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Spirapril 3 mg once daily;<BR/>Spirapril 6 mg once daily;<BR/>Spirapril 12 mg once daily;<BR/>Spirapril 24 mg once daily;<BR/>Placebo;<BR/>administered in the morning before breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported; endpoint BP and SD of change not reported; imputed overall trial mean SBP/DBP SD of change; BP data from Figure 1, p. 78; baseline BP for all patients is not reported; Jadad score=3; funding source= Sandoz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fernandez-1990">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 94-114 mm Hg on 2 consecutive visits (one week apart) of run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 1.25 mg: n=6(5 males,1 female); age=41(5) years; baseline sitting SBP=133(7) mm Hg, DBP=97(3) mm Hg, HR=77(5) bpm;<BR/>Cilazapril 2.5 mg: n=6(5 males,1 female); age=44(13) years; baseline sitting SBP=146(17) mm Hg, DBP=100(10) mm Hg, HR=77(13) bpm;<BR/>Cilazapril 5 mg: n=6(4 males,2 females); age=42(9) years; baseline sitting SBP=144(8) mm Hg, DBP=98(4) mm Hg, HR=72(8) bpm;<BR/>Placebo: n=6(3 males,3 females); age=48(8) years; baseline sitting SBP=150(10) mm Hg, DBP=101(3) mm Hg, HR=65(9) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 1.25 mg once daily;<BR/>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken at 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>Trough erect SBP/DBP using mercury sphygmomanometer;<BR/>Trough supine HR;<BR/>Trough erect HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Only cilazapril 2.5 mg and placebo groups have BP &gt;/= 140/90 mm Hg after placebo run-in; used supine BP for cilazapril 2.5 mg and placebo groups only; BP change reported and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; data from Table 4, p. 55; Jadad score=3; funding source= Hoffman-La Roche<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Fernandez-1994">
<CHAR_METHODS>
<P>4- to 5-week single-blind placebo run-in; inclusion criteria= mean sitting DBP 95-110 mm Hg at 2 consecutive visits 1 week apart; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fosinopril 20 mg: n=16(7 males,9 females); mean age=48.8(11.6) years; baseline sitting SBP=149.7(12.0) mm Hg, DBP=101.9(4.4) mm Hg, HR=72.9 bpm;<BR/>Placebo: n=17(2 males,15 females); mean age=53.2(7.0) years; baseline sitting SBP=146.6(9.9) mm Hg, DBP=100.3(3.7) mm Hg, HR=73.4 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported; endpoint BP and SD not reported; BP data from Table 2, p. I-209; Jadad score=3; funding source= Bristol-Myers Squibb</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ford-1993">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= mean supine DBP 95-115 mm Hg at 2 separate visits following discontinuation or tapering of antihypertensive medication (all patients had received antihypertensive therapy that was discontinued during the first 2 weeks of placebo run-in); 4-week double-blind treatment; 1-week single-blind placebo washout period</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fosinopril 10 mg: n=17(4 males,13 females); mean age=49(9.1) years; baseline supine SBP=163.8 mm Hg, DBP=102.2 mm Hg; baseline HR=77.4 bpm;<BR/>Fosinopril 20 mg: n=15(6 males,9 females); mean age=55(8.1) years; baseline supine SBP=161.2 mm Hg, DBP=100.2 mm Hg; baseline HR=73.9 bpm;<BR/>Fosinopril 40 mg: n=16(9 males,7 females); mean age=51(9.6) years; baseline supine SBP=164.4 mm Hg, DBP=101.8 mm Hg; baseline HR=77.8 bpm;<BR/>Placebo: n=16(0 males,16 females); mean age=56(14) years; baseline supine SBP=154.7 mm Hg, DBP=99.8 mm Hg; baseline HR=74.2 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 10 mg once daily,<BR/>Fosinopril 20 mg once daily, <BR/>Fosinopril 40 mg once daily, <BR/>Placebo; <BR/>administered in morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>Trough HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported, endpoint SD not reported; imputed overall trial mean SBP and DBP SD of change; BP data from Table II, p. 327; trough and peak BP data also available in Figures 1 and 2, p.327; 2 sets of baseline BP are reported; Jadad score=3; funding source= Bristol-Myers Squibb</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gerritsen-1998">
<CHAR_METHODS>
<P>3-week washout period; 4-week placebo run-in; inclusion criteria= sitting DBP 90-115 mm Hg and SBP &lt;/= 200 mm Hg during run-in; 8-week double-blind treatment, dosage of enalapril doubled after 4 weeks of treatment if DBP &gt;/= 85 mm Hg</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg: n=40(28 males,12 females); mean age=58.8(9.5) years; baseline SBP=165(15) mm Hg, DBP=92(7.8) mm Hg, HR=81.2(13.3) bpm;<BR/>Placebo: n=41(26 males,15 females); mean age=61.9(7.8) years; baseline SBP=166(18) mm Hg, DBP=93(8.2) mm Hg, HR=81.2(14.3) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using automated device (Dinamap);<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD for SD of change; position of BP measurement not reported but likely sitting; BP data from Figure 1, p. 693; Jadad score=4; funding source= Bayer</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gomez-1989">
<CHAR_METHODS>
<P>4-week single-blind placebo washout; inclusion criteria= supine DBP 95-115 mm Hg after washout; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Lisinopril 1.25 mg: n=41(38 males,3 females); mean age=58 years; baseline BP not reported for all randomized patients;<BR/>Lisinopril 5 mg: n=41(37 males,4 females); mean age=56 years; baseline BP not reported for all randomized patients;<BR/>Lisinopril 20 mg: n=44(42 males,2 females); mean age=54 years; baseline BP not reported for all randomized patients;<BR/>Lisinopril 80 mg: n=43(37 males,6 females); mean age=57 years; baseline BP not reported for all randomized patients;<BR/>Placebo: n=47(40 males,7 females); mean age=56 years; baseline BP not reported for all randomized patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Lisinopril 1.25 mg once daily;<BR/>Lisinopril 5 mg once daily;<BR/>Lisinopril 20 mg once daily<BR/>Lisinopril 80 mg once daily (patients received 40 mg once daily for the first 2 weeks and then 80 mg once daily for the last 4 weeks);<BR/>Placebo;<BR/>administered at 9 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough erect SBP/DBP using mercury sphygmomanometer;<BR/>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and 95% CI reported, endpoint BP reported, endpoint SD not reported; calculated SD of change from 95% CI; erect BP data from Table 3, p. 418; supine BP data from Table 2, p. 417; Jadad score=3; funding source= Merck Sharp &amp; Dohme</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gradman-1995">
<CHAR_METHODS>
<P>7-day washout period; total 4-week single-blind placebo run-in, patients' supine DBP &gt;/= 95 mm Hg after initial 2-week single-blind placebo phase; additional 2-week single-blind placebo phase; inclusion criteria= mean supine DBP 100-115 mm Hg, and two BP readings during weeks 2 and 4 of single-blind placebo phase could not differ by &gt; 7 mm Hg; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=83(56 males,27 females); median age=53 years; baseline SBP=155.4 mm Hg, DBP=103.1 mm Hg;<BR/>Placebo: n=78(47 males,31 females); median age=53 years; baseline SBP=157.9 mm Hg, DBP=103.3 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP;<BR/>Mean change from baseline in peak supine SBP/DBP;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP reported; endpoint SD not reported, BP data from Table 2, p. 1348; BP measurement device not reported; Jadad score=3; funding source= Merck</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Gradman-1997">
<CHAR_METHODS>
<P>4-week single-blind placebo baseline; inclusion criteria= sitting DBP 95-115 mm Hg; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=707(457 males,250 females); mean age=53.5(10.5) years; baseline sitting SBP=155.5(17.7) mm Hg, DBP=101.9(5.7) mm Hg;<BR/>Enalapril 5 mg: n=85;<BR/>Enalapril 20 mg: n=48;<BR/>Placebo: n=79</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 5 mg once daily;<BR/>Enalapril 20 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported; SD of change not reported; endpoint BP and SD not reported; baseline SBP SD for all groups reported; imputed baseline SBP SD for SD of change; imputed systematic review overall mean SD of change for DBP; DBP data from Figure 1, p. 432; SBP data from Figure 2, p. 433; Jadad score=3; funding source= Astra Merck, Inc.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Guitard-1994">
<CHAR_METHODS>
<P>3- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-119 mm Hg; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Spirapril 6 mg: n=66(32 males,34 females); mean age=58(11) years; baseline sitting SBP=171(12) mm Hg, DBP=106(4) mm Hg, HR=76(10) bpm;<BR/>Spirapril 12 mg: n=64(23 males,41 females); mean age=58(9) years; baseline sitting SBP=168(14) mm Hg, DBP=105(4) mm Hg, HR=73(9) bpm;<BR/>Spirapril 24 mg: n=66(35 males,31 females); mean age=58(11) years; baseline sitting SBP=170(12) mm Hg, DBP=106(4) mm Hg, HR=74(9) bpm;<BR/>Placebo: n=64(24 males, 40 females); mean age=57(11) years; baseline sitting SBP=167(11) mm Hg, DBP=105(3) mm Hg, HR=73(9) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Spirapril 6 mg once daily;<BR/>Spirapril 12 mg once daily;<BR/>Spirapril 24 mg once daily;<BR/>Placebo;<BR/>administered in the morning before breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change reported but values are too low, endpoint SBP not reported, endpoint DBP reported, endpoint SD not reported; change in trough BP data from Table II, p. 83; SD of change data from Figure 2, p. 85; change in peak DBP data in subgroup of patients (from one study center) in Figure 3, p. 85; Table II provides data for both efficacy and intention-to-treat (ITT) analysis, ITT analysis BP data used instead of efficacy analysis BP data; imputed baseline SBP SD for SBP SD of change; imputed overall trial mean DBP SD of change; Jadad score=3; funding source= Sandoz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-12 14:46:30 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guitard-1997">
<CHAR_METHODS>
<P>4-week placebo washout; inclusion criteria= mean DBP &gt;/= 100 mm Hg at end of washout period and mean DBP 100-115 mm Hg 24 hours after capsule intake during placebo phase; 8-week double-blind treatment, titrated to response at 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 5 mg: n=101(54 males,47 females); mean age=56.2(9.7) years; baseline SBP=163.2(16.4) mm Hg, DBP=99.5(6.1) mm Hg;<BR/>Spirapril 6 mg: n=101(50 males,50 females); mean age=58.0(7.9) years; baseline SBP=161.8(16.3) mm Hg, DBP=99.7(6.6) mm Hg;<BR/>Placebo: n=50(32 males,18 females); mean age=56.5(8.2) years; baseline SBP=161.3(18.2) mm Hg, DBP=98.2(6.9) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 5 mg once daily;<BR/>Spirapril 6 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in trough sitting DBP;<BR/>Adjusted mean change from baseline in peak sitting DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-12 14:46:30 -0700" MODIFIED_BY="[Empty name]">
<P>Used week 4 BP data only; BP change reported, SD of change not reported, endpoint BP reported, endpoint SD not reported; imputed overall trial mean DBP SD of change; DBP data from Table 5, p. 455; BP measurement device not reported; Jadad score=2; funding source= Novartis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Guntzel-1991">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-115 mm Hg at end of 3rd and 4th week of run-in as well as during baseline BP profile (BP measured hourly during first 10 hours and last 4 hours after last placebo capsule); 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=29(17 males,12 females); mean age=56(7) years; baseline DBP=103.5 mm Hg;<BR/>Cilazapril 5 mg: n=29(22 males,7 females); mean age=49(8) years; baseline DBP=103.1 mm Hg;<BR/>Placebo: n=27(17 males,10 females); mean age=52(9) years; baseline DBP=104.3 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken at 10 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Endpoint (week 8) BP change and DBP SE of change reported, endpoint BP and SD reported; BP also reported at weeks 4,6,8; calculated DBP SD of change from N and SE of change; imputed overall trial mean SBP SD of change; BP data from Figure 1, p. 10; Jadad score=3; funding source= Hoffman-La Roche Ltd.</P>
<P>Duplication publication = Study 2 of Kobrin 1991.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Holwerda-1996">
<CHAR_METHODS>
<P>1-week washout; 2-week placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=69(40 males,29 females); mean age=52.5(10.3) years; baseline sitting SBP=161.5(10.4) mm Hg, DBP=102.2(4.2) mm Hg;<BR/>Valsartan 80 mg: n=137(65 males,72 females); mean age=53.1(12.4) years; baseline sitting SBP=161.7(11.6) mm Hg, DBP=101.2(4.5) mm Hg;<BR/>Placebo: n=142(76 males,66 females); mean age=53.1(12.9) years; baseline sitting SBP=161.0(11.5) mm Hg, DBP=101.8(4.4) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Valsartan 80 mg once daily;<BR/>Placebo;<BR/>taken in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer; <BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table 3, p. 1150; Jadad score=3; funding source= Ciba-Geigy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Homuth-1993">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= DBP 100-115 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Ramipril 2.5 mg: n=40(26 males,14 females); mean age=47(10) years; baseline SBP=159(15) mm Hg, DBP=107(5) mm Hg;<BR/>Ramipril 5 mg: n=40(23 males,17 females); mean age=48(8) years; baseline SBP=159(13) mm Hg, DBP=107(6) mm Hg;<BR/>Ramipril 10 mg: n=40(24 males,16 females); mean age=47(9) years; baseline SBP=160(14) mm Hg, DBP=109(5) mm Hg;<BR/>Placebo: n=40(22 males,18 females); mean age=46(10) years; baseline SBP=161(17) mm Hg, DBP=109(5) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipril 2.5 mg once daily;<BR/>Ramipril 5 mg once daily;<BR/>Ramipril 10 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer; <BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported, endpoint BP and SD not reported; imputed baseline SBP SD for SBP SD of change; imputed overall trial mean DBP SD of change; BP data from Figures 1 and 2, p. 669; Jadad score=3; funding source= Cassella AG</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kayanakis-1987">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= SBP 160-200 mm Hg and DBP 95-120 mm Hg at 2 consecutive measurements; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Captopril 50 mg: n=42(23 males,19 females); mean age=52.8(10.6) years; baseline supine SBP=175.5(8.9) mm Hg, DBP=104.5(4.4) mm Hg;<BR/>Placebo: n=83(47 males,36 females); mean age=52.8(9.0) years; baseline supine SBP=172.0(7.7) mm Hg, DBP=102.5(3.8) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 50 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change for SBP and DBP; SBP data from Figure 1, p. 91S; DBP data from Figure 2, p. 91S; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kobrin-1991">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-115 mm Hg at last 2 visits of run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=29(18 males,11 females); mean age=50(9) years;<BR/>Cilazapril 5 mg: n=29(16 males,13 females); mean age=48(9) years;<BR/>Placebo: n=28(13 males,15 females); mean age=52(8) years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>SBP change not reported; DBP change and SE of change reported, endpoint BP and SD not reported; calculated DBP SD of change from N and SE of change; BP data from Table II, p. 34; Jadad score=3; funding source= Hoffman-La Roche Ltd.</P>
<P>Kobrin 1991 reports results for 2 independent RCTs. Study 2 is same RCT as reported in Guntzel 1991. Data for Study 1 is entered as Kobrin 1991.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Koch-1999">
<CHAR_METHODS>
<P>1-week washout; 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at end of placebo run-in; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>95 postmenopausal women taking HRT regimens that were held constant throughout experimental period;<BR/>Moexipril 15 mg: n=47; mean age=56.1(8.0) years; baseline sitting SBP=154.6(11.8) mm Hg, DBP=99.5(3.8) mm Hg, HR=72.7(7.7) bpm;<BR/>Placebo: n=48; mean age=57.0(6.8) years; baseline sitting SBP=158.5(13.6) mm Hg, DBP=100.0(3.7) mm Hg, HR=72.4(6.3) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Moexipril 15 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported, endpoint BP and SD not reported; baseline SD reported; imputed baseline SBP SD for SBP SD of change; imputed overall trial mean SD of change for DBP; change in BP data from text and Figure 1, p. 339; Jadad score=3; funding source= Schwarz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kohlmann-Jr-1999">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= DBP 95-115 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 2 mg: n=135(55 males,80 females); mean age=53.1(11.3) years; baseline SBP=157.3(15) mm Hg, DBP=101.0(6.3) mm Hg, HR=75.6(9.1) bpm;<BR/>Placebo: n=135(55 males,80 females); mean age=53.1(11.3) years; baseline SBP=156.1(18) mm Hg, DBP=100.3(6.6) mm Hg, HR=75.6(9.1) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 2 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>SBP/DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; endpoint BP (week 8) data from text, p. 549; BP data for weeks 5 and 8 provided in Figures 1 and 2, p. 550; BP measurement device not reported; time of post-dose BP measurement not reported; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kostis-1991">
<CHAR_METHODS>
<P>2-to 4-week single-blind placebo washout; inclusion criteria= supine DBP 95-114 mm Hg after washout; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Ramipril 1.25 mg: n=44(18 males,26 females); mean age=52.3 years; baseline SBP=159(15) mm Hg, DBP=99.9(3.7) mm Hg;<BR/>Ramipril 2.5 mg: n=43(27 males,16 females); mean age=49.4 years; baseline supine DBP=99.8(3.7) mm Hg;<BR/>Ramipril 5 mg: n=43(23 males,20 females); mean age=53.4 years; baseline supine DBP=100.7(5.1) mm Hg;<BR/>Ramipril 10 mg: 44(29 males,15 females); mean age=52.1 years; baseline supine DBP=101.2(4.4) mm Hg;<BR/>Placebo: n=42(22 males,20 females); mean age=51.3 years; baseline supine DBP=99.3(3.6) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipril 1.25 mg once daily;<BR/>Ramipril 2.5 mg once daily;<BR/>Ramipril 5 mg once daily;<BR/>Ramipril 10 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough standing SBP/DBP using mercury sphygmomanometer; <BR/>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer; <BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD not reported; BP data from Table 3, p. 13, SD data from Figures II and III, p. 12; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Krum-1992">
<CHAR_METHODS>
<P>3-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=22; mean age=59(11) years;<BR/>Cilazapril 2.5 mg: n=6; baseline sitting SBP=173(22) mm Hg, DBP=110(7.4) mm Hg;<BR/>Placebo: n=5; baseline sitting SBP=159(27) mm Hg, DBP=101(13.4) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Placebo;<BR/>taken at approximately 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using oscillometric device (Dinamap);<BR/>Trough standing SBP/DBP using oscillometric device (Dinamap)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SE reported; calculated endpoint SD from N and SE; endpoint SD values are too low; imputed SBP SD of change from baseline SBP SD of change, imputed overall trial mean DBP SD of change; BP data from Table 2, p. 455; Jadad score=2; funding source= Roche Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Krum-1998">
<CHAR_METHODS>
<P>4- to 6-week placebo run-in; inclusion criteria= mean sitting DBP 95-115 mm Hg after run-in, DBP could not differ by more than 7 mm Hg on 3 consecutive visits; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=50(33 males,17 females); mean age=59(10) years; baseline SBP=161.9(14.3) mm Hg, DBP=102.2(5.0) mm Hg, HR=76.2(8.4) bpm;<BR/>Placebo: n=49(27 males,22 females); mean age=56(9) years; baseline SBP=158.3(14.1) mm Hg, DBP=101.7(4.5) mm Hg, HR=71.8(7.8) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough sitting HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported; endpoint BP and SD not reported; SBP/DBP data from Table 2, p. 788; Jadad score=3; funding source= Hoffman-La Roche</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kuppers-1997">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= 1) sitting DBP=95-114 mm Hg during last 2 weeks of run-in, and also on day 0, the first day of active treatment, and 2) mean daytime (0600-2159h) &gt;/= 85mm Hg by ambulatory BP monitoring; consecutive measurements; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg once daily: n=77(32 males,45 females); mean age=55.8(8.7) years; baseline sitting SBP=166.8(14.8) mm Hg, DBP=106.7(4.6) mm Hg;<BR/>Placebo: n=77(33 males,44 females); mean age=57.2(9.5) years; baseline sitting SBP=166.4(14.1) mm Hg, DBP=106.9(4.7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily,<BR/>Placebo;<BR/>administered at approximately 8AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Figure 1, p. 95; Jadad score=4; funding source= Solvay Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kuschnir-1996">
<CHAR_METHODS>
<P>2-to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-120 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Benazepril 20 mg: n=77(32 males,45 females); mean age=55.8(8.7) years; baseline sitting SBP=166.8(14.8) mm Hg, DBP=106.7(4.6) mm Hg;<BR/>Placebo: n=77(33 males,44 females); mean age=57.2(9.5) years; baseline sitting SBP=166.4(14.1) mm Hg, DBP=106.9(4.7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 20 mg once daily;<BR/>Placebo;<BR/>administered at approximately 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported, endpoint SD not reported, baseline SBP SD reported, imputed baseline SBP SD for SBP SD of change, imputed overall trial mean DBP SD of change; BP data from Table II, p. 1218; Jadad score=3; funding source= Ciba-Geigy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lacourciere-1994">
<CHAR_METHODS>
<P>2-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-109 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=130; 102(79%) caucasian, 25(19%) black, 3(2%) oriental;<BR/>Cilazapril 2.5 mg: n=44(22 males,22 females); mean age=52.5(9.0) years; baseline sitting SBP=153.6(16.4) mm Hg, DBP=102.0(4.7) mm Hg;<BR/>Cilazapril 5 mg: n=42(31 males,11 females); mean age=50.4(9.1) years; baseline sitting SBP=154.8(15.1) mm Hg, DBP=101.0(4.3) mm Hg;<BR/>Placebo: n=44(29 males,15 females); mean age=53.6(8.5) years; baseline sitting SBP=157.5(15.8) mm Hg, DBP=101.1(3.8) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Peak sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported, endpoint SD not reported; baseline SBP SD reported, imputed baseline SBP SD for SBP SD of change, imputed overall trial mean DBP SD of change; BP data from Table 3, p. 608; Jadad score=3; funding source= Hoffman-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lerch-1999">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= supine DBP 90-115 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Temocapril 20 mg: n=19(13 males,6 females); mean age=57.6(8.3) years; baseline SBP=162(22) mm Hg, DBP=98(9) mm Hg;<BR/>Placebo: n=11(8 males,3 females); mean age=56.1(5.6) years; baseline SBP=151(13) mm Hg, DBP=97(7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Temocapril 20 mg once daily;<BR/>Placebo;<BR/>administered between 7 AM and 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SE reported, calculated endpoint SD from N and endpoint SE, imputed endpoint SD for SD of change; BP data from Table 1, p. 529; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Levine-1995">
<CHAR_METHODS>
<P>2-week placebo run-in period; inclusion criteria= supine DBP &gt;/= 95 mm Hg after run-in; 12-week double-blind treatment, forced titration (dose doubled) every 4 weeks starting at 10 mg</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg: n=31(17 males,14 females); mean age=56 years; baseline SBP=152.5(13.4) mm Hg, DBP=102.5(5.0) mm Hg;<BR/>Placebo: n=29(17 males,12 females); mean age=53 years; baseline SBP=149.8(14.5) mm Hg, DBP=100.2(4.3) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Placebo;<BR/>average dosing time 9 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SE of change reported, endpoint BP and endpoint SE reported, calculated SD of change from N and SE of change; SBP data from Table 2, p. 496; DBP data from Table 3, p. 497; Jadad score=3; funding source= Lederle Laboratories</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Luccioni-1988">
<CHAR_METHODS>
<P>2-week placebo run-in period; inclusion criteria= supine DBP &gt;/= 95 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=40(31 males,9 females); mean age=56.6(9.5) years; baseline BP not reported for all patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 2 mg once daily;<BR/>Perindopril 4 mg once daily;<BR/>Perindopril 8 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Supine SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and endpoint SE reported, calculated endpoint SD from N and endpoint SE, imputed endpoint SD for SD of change; BP data from Figure 2, p. 1133; time of BP measurement not reported (but most likely measured during the first 8 h post-dose since ambulatory measurements were taken during that period); Jadad score=2; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-MacLean-1989">
<CHAR_METHODS>
<P>4-week single-blind placebo washout; inclusion criteria= sitting DBP &gt;/= 95 mm Hg after washout; 12-week double-blind treatment, forced titration (dose doubled) every 4 weeks starting at 20 mg daily</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Quinapril once daily: n=91(64 males,27 females); median age=49 years; baseline SBP=163 mm Hg, DBP=107 mm Hg;<BR/>Quinapril twice daily: n=90(61 males,29 females); median age=51 years; baseline SBP=164 mm Hg, DBP=106 mm Hg;<BR/>Placebo: n=89(56 males,33 females); median age=52 years; baseline SBP=162 mm Hg, DBP=105 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Quinapril 20, 40, 80 mg once daily (morning administration of active drug);<BR/>Quinapril 20, 40, 80 mg twice daily (2 capsules taken 12 h apart);<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SE of change reported, endpoint BP and SD not reported, calculated SD of change from N and change SE; BP data from Table III, p. 375; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mancia-1992">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= supine and standing clinic DBP &gt;/= 95 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 2 mg: n=42(31 males,11 females); mean age=51.4(9.7) years; baseline supine SBP=159.8(12.8) mm Hg, DBP=102.4(5.1) mm Hg, HR=72.1(8.3) bpm;<BR/>Placebo: n=20(15 males, 5 females); mean age=51.1(7.6) years; baseline supine SBP=158.0(13.5) mm Hg, DBP=102.3(4.8) mm Hg, HR=73.9(8.3) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 2 mg once daily;<BR/>Placebo;<BR/>administered at approximately 9 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>Trough supine HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SE reported, calculated endpoint SD from N and SE; imputed endpoint SD for SD of change; BP data from Table II, p. 62D; duplicate publication=Ravogli 94; Jadad score=3; funding source= Roussel Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mancia-1997">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= sitting DBP 100-110 mm Hg at end of run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 1 mg: n=50; mean age=51(10) years; baseline sitting SBP=159.3(12.4) mm Hg, DBP=103.6(3.1) mm Hg, HR=73.2(10.6) bpm;<BR/>Placebo: n=51; mean age=52(9) years; baseline sitting SBP=158.2(13.5) mm Hg, DBP=103.5(3.4) mm Hg, HR=75.4(8.2) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 1 mg once daily;<BR/>Placebo;<BR/>administered at approximately 9 AM after breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Peak sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD for SD of change; trough BP data from Table 1, p. 493; peak BP data (using 24h ambulatory BP monitoring) in Figure 3, p. 496; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-McCarron-1991">
<CHAR_METHODS>
<P>3- to 4-week single-blind placebo run-in; inclusion criteria= supine DBP 100-114 mm Hg; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Ramipril 10 mg: n=67(44 males,23 females); mean age=53.8(9.8) years; baseline supine SBP=152.7(11.4) mm Hg, DBP=102.9(3.0) mm Hg;<BR/>Placebo: n=33(23 males,10 females); mean age=52.3(11.7) years; baseline supine SBP=151.9(13.2) mm Hg, DBP=102.1(3.0) mm Hg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipril 10 mg once daily;<BR/>Placebo;<BR/>administered in the morning<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough standing SBP/DBP using mercury sphygmomanometer;<BR/>WDAE<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported, endpoint BP and SE reported, calculated SD of change from N and SE of change; BP data from Table III, p. 740; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-12 14:44:55 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McFate_x002d_Smith-1991">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=202; mean age=70 years; baseline sitting SBP=177 mm Hg, DBP=103 mm Hg;<BR/>Benazepril 2 mg BID: n=50;<BR/>Benazepril 10 mg BID: n=50;<BR/>Placebo: n=50</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 2 mg twice daily;<BR/>Benazepril 10 mg twice daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in sitting SBP/DBP;<BR/>BP measured 10-14 h post-dose</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-12 14:44:55 -0700" MODIFIED_BY="[Empty name]">
<P>BP change reported; SD of change not reported, endpoint BP and SD not reported; imputed overall trial mean SD of change; BP data from Table 1, p. IV-81; BP measurement device not reported; Jadad score=3; funding source= Ciba-Geigy Inc.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Messerli-1998">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 4 mg: n=159(106 males,53 females); mean age=54.3 years; baseline SBP=151.8(14.8) mm Hg, DBP=101.3(5.0) mm Hg;<BR/>Placebo: n=152(103 males,49 females); mean age=53.8 years; baseline SBP=153.6(13.4) mm Hg, DBP=100.5(4.5) mm Hg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 4 mg once daily;<BR/>Placebo;<BR/>administered in the morning<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD not reported; SD of change values reported are low; imputed baseline SBP SD for SBP SD of change, imputed overall trial mean DBP SD of change; BP data from Table 2, p. 325; Jadad score=3; funding source= Knoll Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Moser-1991">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg on 2 consecutive visits (weeks 2 and 4 of run-in) with &lt;/= 10 mm Hg difference between 2 visits; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Benazepril 2 mg once daily: n=34(24 males,10 females); mean age=50.4 years; baseline sitting SBP=151.6(15.9) mm Hg, DBP=102.1(5.6) mm Hg;<BR/>Benazepril 5 mg once daily: n=38(23 males,15 females); mean age=51.1 years; baseline sitting SBP=152.7(15.2) mm Hg, DBP=101.2(5.3) mm Hg;<BR/>Benazepril 10 mg once daily: n=34(23 males,11 females); mean age=51.9 years; baseline sitting SBP=153.1(13.7) mm Hg, DBP=101.8(5.7) mm Hg;<BR/>Benazepril 20 mg once daily: n=36(23 males,13 females); mean age=50.4 years; baseline sitting SBP=151.9(15.7) mm Hg, DBP=101.7(4.7) mm Hg;<BR/>Placebo: n=31(21 males,10 females); mean age=48.2 years; baseline sitting SBP=150.7(14.3) mm Hg, DBP=101.7(4.9) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 2 mg once daily;<BR/>Benazepril 5 mg once daily;<BR/>Benazepril 10 mg once daily;<BR/>Benazepril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SE reported, calculated endpoint SD from N and endpoint SE, imputed endpoint SD for SD of change; DBP data from Table III, p. 325; Jadad score=3; funding source= Ciba-Geigy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mroczek-1991">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at each of last 2 visits during run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=59(45 males,14 females); mean age=52.4 years; baseline sitting SBP=146.3 mm Hg, DBP=101.1 mm Hg, HR=75.5 bpm;<BR/>Cilazapril 5 mg: n=59(41 males,18 females); mean age=52.9 years; baseline sitting SBP=148.4 mm Hg, DBP=101.3 mm Hg, HR=76.2 bpm;<BR/>Cilazapril 10 mg: n=58(34 males,24 females); mean age=50.3 years; baseline sitting SBP=144.3 mm Hg, DBP=100.8 mm Hg, HR=75.1 bpm;<BR/>Placebo: n=59(36 males,23 females); mean age=54.0 years; baseline sitting SBP=149.8 mm Hg, DBP=100.7 mm Hg, HR=77.3 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Cilazapril 10 mg once daily;<BR/>Placebo;<BR/>taken in the morning after light breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough sitting HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported, endpoint BP and SE reported; calculated SD of change from N and SE of change; BP data from text and Table 2, p. 1424; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Mroczek-1996">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at last 2 consecutive visits of placebo run-in, with difference between visits of 10 mm Hg or less; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Moexipril 7.5 mg: n=51(31 males,20 females); mean age=54.9 years; baseline sitting SBP=152.2 mm Hg, DBP=101.8 mm Hg, HR=75.8 bpm; baseline standing SBP=148.4 mm Hg, DBP=100.9 mm Hg;<BR/>Moexipril 15 mg: n=47(30 males,17 females); mean age=56.0 years; baseline sitting SBP=154.0 mm Hg, DBP=100.9 mm Hg, HR=73.6 bpm; baseline standing SBP=150.4 mm Hg, DBP=100.2 mm Hg;<BR/>Placebo: n=51(37 males,14 females); mean age=55.3 years; baseline sitting SBP=154.2 mm Hg, DBP=101.2 mm Hg, HR=74.7 bpm; baseline standing SBP=150.9 mm Hg, DBP=101.1 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Moexipril 7.5 mg once daily;<BR/>Moexipril 15 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting DBP using mercury sphygmomanometer;<BR/>Trough standing SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported; endpoint SBP not reported, endpoint DBP reported, endpoint SD not reported; change in SBP data from Table 3, p. 85; change in DBP data from Table 2, p. 83; Jadad score=3; funding source= Schwarz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Muiesan-1987">
<CHAR_METHODS>
<P>3-week placebo run-in; inclusion criteria= supine DBP 100-110 mm Hg during run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=152(77 males,75 females); mean age=69(4) years;<BR/>Captopril 25 mg: n=52; baseline standing SBP=173(13) mm Hg, DBP=106(5) mm Hg; baseline supine SBP=176(14) mm Hg, DBP=105(5) mm Hg;<BR/>Placebo: n=50; baseline standing SBP=172(14) mm Hg, DBP=106(5) mm Hg; baseline supine SBP=176(14) mm Hg, DBP=104(5) mm Hg;<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 25 mg twice daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Standing SBP/DBP using mercury sphygmomanometer;<BR/>Supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change in captopril group; imputed baseline SBP SD for SBP SD of change in placebo group; in placebo group, imputed systematic review overall mean SD of change for DBP; BP data from text and Figure 1, p. S600; baseline supine SBP/DBP and SD for placebo group from Table 1, p. S601; supine BP data also available; Jadad score=3; funding source= Squibb Italia SpA</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Myers-1996">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= supine DBP 95-114 mm Hg after run-in; 12-week double-blind treatment; 293 patients included in safety analysis; 260 patients included in efficacy analyses</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Perindopril 2 mg: n=62(39 males,23 females); mean age=51(16) years; baseline SBP/DBP not reported for all 62 patients;<BR/>Perindopril 4 mg: n=57(32 males,25 females); mean age=51(15) years; baseline SBP/DBP not reported for all 57 patients;<BR/>Perindopril 8 mg: n=59(32 males,27 females); mean age=51(15) years; baseline SBP/DBP not reported for all 59 patients;<BR/>Perindopril 16 mg: n=57(35 males,22 females); mean age=51(15) years; baseline SBP/DBP not reported for all 57 patients;<BR/>Placebo: n=58(30 males,28 females); mean age=53(15) years; baseline SBP/DBP not reported for all 58 patients</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 2 mg once daily;<BR/>Perindopril 4 mg once daily;<BR/>Perindopril 8 mg once daily;<BR/>Perindopril 16 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in peak supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported, endpoint BP and SD not reported, baseline SEM reported, calculated baseline SD from N and baseline SEM, imputed baseline SBP SD for SBP SD of change; imputed overall trial mean DBP SD of change; BP data from Table 2, p. 1193; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-New-2000">
<CHAR_METHODS>
<P>No placebo run-in; inclusion criteria= patients with established Type 2 DM and BP &gt; 75th centile for age and sex, taking no anti-hypertensive medication; 3-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 4 mg: n=12(10 males,2 females); mean age=58(11) years; baseline SBP=168(13) mm Hg, DBP=98(10) mm Hg;<BR/>Placebo: n=12(9 males,3 females); mean age=60(12) years; baseline SBP=165(14) mm Hg, DBP=93(6) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 4 mg once daily;<BR/>Placebo;<BR/>administered at 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD for SD of change; SBP/DBP data from Figure 1, p. 137; Jadad score=2; funding source= Hoechst Marion Rousell</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Oparil-1999">
<CHAR_METHODS>
<P>4- to 5-week single-blind placebo run-in during which previous antihypertensive medication withdrawn; patients qualified for 3- to 4-week enalapril challenge period if sitting DBP 95-114 mm Hg and difference between their average sitting DBP values for last 2 visits of placebo run-in period did not exceed 12 mm Hg; during enalapril challenge patients received enalapril 20 mg daily (10 mg for first 3 days); patients who developed persistent, nonproductive cough while receiving enalapril were then given placebo for 2-4 weeks to allow cough to clear; eligible patients (those meeting inclusion criteria for enalapril challenge and whose cough subsequently cleared during placebo washout period) then entered 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=45(23 males,22 females); baseline sitting SBP=154.6(14.1) mm Hg, DBP=100.9(4.7) mm Hg, HR=74.8(9.4) bpm;<BR/>Placebo:n=45(21 males,24 females); baseline sitting SBP=154.1(14.1) mm Hg, DBP=99.8(4.0) mm Hg, HR=74.4(8.1) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily (10 mg for first 3 days);<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in sitting DBP;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>DBP change and SD of change reported, endpoint BP and SD not reported, DBP data from text (p. 8) and Figure 3, p. 10; BP measurement device not reported; time of BP measurement not reported; Jadad score=4; funding source= SmithKline Beecham Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Overlack-1994">
<CHAR_METHODS>
<P>3-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-104 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Perindopril 4 mg: n=253(130 males,123 females); mean age=59.3(11.1) years; baseline SBP=161.7(17.5) mm Hg, DBP=99.4(4.8) mm Hg, HR=78.5(14.3) bpm;<BR/>Placebo: n=237(133 males,104 females); mean age=59.1(10.8) years; baseline SBP=160.3(16.9) mm Hg, DBP=99.5(4.6) mm Hg, HR=79.3(13.9) bpm<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 4 mg once daily;<BR/>Placebo;<BR/>administered in the morning<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using automatic device;<BR/>HR<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SEM reported, calculated endpoint SD from N and endpoint SEM, imputed endpoint SD for SD of change; BP data from Table III, p. 129; Jadad score=3; funding source= Servier</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Persson-1996">
<CHAR_METHODS>
<P>Washout phase; 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg, with a difference of 10 mm Hg or less at last 2 consecutive visits of run-in; subjects with DBP =/&gt; 110 mm Hg could be included directly following minimum of 7 days single-blind placebo; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Moexipril 7.5 mg: n=50(21 males,29 females); mean age=70.4 years; baseline sitting SBP=173 mm Hg, DBP=102 mm Hg, HR=76.7 bpm;<BR/>Moexipril 15 mg: n=53(31 males,22 females); mean age=69.2 years; baseline sitting SBP=169 mm Hg, DBP=102 mm Hg, HR=73.9 bpm;<BR/>Placebo: n=48(33 males,15 females); mean age=70.7 years; baseline sitting SBP=172 mm Hg, DBP=103 mm Hg, HR=72.7 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Moexipril 7.5 mg once daily;<BR/>Moexipril 15 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Placebo-corrected adjusted change from baseline in peak sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint SBP not reported, endpoint DBP reported, endpoint SD not reported; change in trough BP data from Table 2, p. 261; placebo-corrected change in peak DBP data from Table 4, p. 262; endpoint BP data used instead of weighted mean of BP change for 3 measurements (at weeks 4,6,8) because N values not reported for weeks 4 and 6; Jadad score=3; funding source= Schwarz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pittrow-1997">
<CHAR_METHODS>
<P>2-week washout; 2-week single-blind placebo run-in; inclusion criteria= mean sitting DBP 100-114 mm Hg; 6-week double-blind treatment phase at fixed dose, patients with inadequate BP response had their doses doubled and were treated for another 6 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Spirapril 3 mg: n= 52(32 males,20 females); mean age=55.8 years; baseline sitting SBP=159.0 mm Hg, DBP=104.6 mm Hg (trough data); baseline sitting SBP=156.7 mm Hg, DBP=103.4 mm Hg (peak data);<BR/>Spirapril 6 mg: n= 52(28 males,24 females); mean age=53.6 years; baseline sitting SBP=159.0 mm Hg, DBP=104.8 mm Hg (trough data); baseline sitting SBP=157.6 mm Hg, DBP=102.9 mm Hg (peak data);<BR/>Placebo: n= 26(18 males,8 females); mean age=54.2 years; baseline sitting SBP=154.2 mm Hg, DBP=104.1 mm Hg (trough data); baseline sitting SBP=151.6 mm Hg, DBP=102.8 mm Hg (peak data)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Spirapril 3 mg once daily;<BR/>Spirapril 6 mg once daily;<BR/>Placebo;<BR/>taken in the morning before breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in peak sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 6 BP data only; BP change and SD of change reported, endpoint BP reported, endpoint SD not reported; change in trough and peak BP data from Table 2A, p. 624; Jadad score=3; funding source= Novartis Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pizarro-1996">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= mean sitting DBP 95-110 mm Hg; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fosinopril 20 mg: n=16(4 males,12 females); mean age=56.4(8.1) years; baseline sitting SBP=151.8(14.0) mm Hg, DBP=100.8(4.8) mm Hg, HR=75.9(11.9) bpm;<BR/>Placebo: n=18(2 males,15 females); mean age=53.2(7.0) years; baseline sitting SBP=160.1(22.1) mm Hg, DBP=100.1(2.4) mm Hg, HR=72.3(6.1) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP;<BR/>Trough HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>SBP change not reported, DBP change reported; SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from text, p. 496 and p. 460; BP measurement device not reported; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Poirier-1991">
<CHAR_METHODS>
<P>2-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-109 mm Hg, within 10 mm Hg on 2 consecutive weekly visits during run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=42(27 males,15 females); all white;<BR/>Cilazapril 2.5 mg: n=14; mean age=53.6(8.0) years; baseline sitting SBP=153.6(16.4) mm Hg, DBP=102.0(4.7) mm Hg;<BR/>Cilazapril 5 mg: n=14; mean age=53.1(8.2) years; baseline sitting SBP=154.8(15.1) mm Hg, DBP=101.0(4.3) mm Hg;<BR/>Placebo: n=14; mean age=55.1(7.7) years; baseline sitting SBP=157.5(15.8) mm Hg, DBP=101.1(3.8) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported, endpoint SD not reported; baseline SBP SD reported, imputed baseline SBP SD for SBP SD of change, imputed overall trial mean DBP SD of change; BP data from Table 1, p. 914; Jadad score=3; funding source= Hoffman-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pool-1990">
<CHAR_METHODS>
<P>4- to 6-week placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg on 2 consecutive visits after beginning of placebo run-in; 4-week double-bind treatment at fixed dose; after 4 weeks, patients with inadequate BP response had their doses doubled during the second 4 weeks; hydrochlorothiazide 25 mg was added during final 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=418 patients randomized to double-blind treatment; n=380 who completed 4 weeks of double-blind treatment included in efficacy analysis;<BR/>Fosinopril 5 mg: n=83 randomized; for efficacy analysis n=74(53 males,21 females); mean age=53.2 years; baseline sitting SBP=151.7 mm Hg, DBP=101.4 mm Hg;<BR/>Fosinopril 10 mg: n=84 randomized; for efficacy analysis n=71(55 males,16 females); mean age=53.5 years; baseline sitting SBP=148.6 mm Hg, DBP=100.9 mm Hg;<BR/>Fosinopril 20 mg: n=84 randomized; for efficacy analysis n=79(51 males,28 females); mean age=54.2 years; baseline sitting SBP=153.2 mm Hg, DBP=102.4 mm Hg;<BR/>Fosinopril 40 mg: n=85 randomized; for efficacy analysis n=79(52 males, 27 females); mean age=50.9 years; baseline sitting SBP=153.0 mm Hg, DBP=102.2 mm Hg;<BR/>Placebo: n=82 randomized; for efficacy analysis n=77(52 males,25 females); mean age=53.2 years; baseline sitting SBP=151.7 mm Hg, DBP=101.4 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 5 mg once daily;<BR/>Fosinopril 10 mg once daily;<BR/>Fosinopril 20 mg once daily;<BR/>Fosinopril 40 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change in trough standing SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported, endpoint BP and SD not reported; baseline SD not reported; imputed overall trial mean SD of change for SBP and DBP; change in SBP data from Figure 2, p. 524; change in DBP data from Table II, p. 526; Jadad score=3; funding source= Bristol-Myers Squibb</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pool-1997">
<CHAR_METHODS>
<P>4- to 5-week single-blind placebo run-in; inclusion criteria= mean sitting DBP 95-110 mm Hg at consecutive visits (third and fourth weeks, or fourth and fifth weeks) during run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=548(335 males,213 females); mean age=51.5(11.0) years; baseline sitting SBP=149.5(15.7) mm Hg, DBP=100.1(4.0) mm Hg;<BR/>Fosinopril 2.5 mg: n=33 randomized; BP data reported for n=29; baseline sitting SBP=153.0 mm Hg, DBP=100.4 mm Hg;<BR/>Fosinopril 10 mg: n=30 randomized; BP data reported for n=29; baseline sitting SBP=147.4 mm Hg, DBP=99.6 mm Hg;<BR/>Fosinopril 40 mg: n=32 randomized; BP data reported for n=28; baseline sitting SBP=147.2 mm Hg, DBP=98.6 mm Hg;<BR/>Placebo: n=32 randomized; BP data reported for n=29; baseline sitting SBP=150.4 mm Hg, DBP=99.8 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 2.5 mg once daily;<BR/>Fosinopril 10 mg once daily;<BR/>Fosinopril 40 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Adjusted mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Adjusted BP change reported, SD of change not reported, endpoint BP reported; endpoint SD not reported; baseline SD not reported; imputed overall trial mean SD of change for SBP and DBP; used endpoint BP data to calculated change in BP instead of entering adjusted BP change data; BP data from Tables 3 and 4, p. 120; Jadad score=3; funding source= Bristol-Myers Squibb</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pool-2001">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-115 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=454(286 males,168 females); mean age=53.8 years; <BR/>Benazepril 10 mg: n=116; baseline SBP=155.3 mm Hg, DBP=104.2 mm Hg, HR=74.2 bpm;<BR/>Placebo: n=115; baseline SBP=156.1 mm Hg, DBP=105.1 mm Hg, HR=74.4 bpm<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 10 mg once daily;<BR/>Placebo;<BR/>administered at approximately 8 AM<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough sitting HR;<BR/>WDAE<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported, SD of change not reported; endpoint BP and SD not reported, baseline SD not reported, imputed overall trial mean SBP and DBP SD of change; BP and HR data from Table 1, p. 497; Jadad score=5; funding source= Novartis Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Pordy-1994">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 0.5-10 mg: n=288(166 males,122 females); mean age=53.9(12.1) years; baseline sitting DBP=100.4 mm Hg;<BR/>Placebo: n=97(57 males,40 females); mean age=53.0(11.9) years; baseline sitting DBP=100.3 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 0.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Cilazapril 10 mg once daily;<BR/>Placebo;<BR/>taken between 8 AM and 10 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>SBP not reported; DBP change and SD of change reported, endpoint BP and SD not reported; BP data from Table 3, p. 315; Jadad score=3; funding source= Hoffmann-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Prager-1994">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= DBP 95-115 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=54(36 males,18 females); mean age=55.6(10.1) years; baseline sitting SBP=162.5(15.1) mm Hg, DBP=102.4(5.4) mm Hg;<BR/>Cilazapril 5 mg: n=55(32 males,23 females); mean age=55.6(10.8) years; baseline sitting SBP=158.8(16.5) mm Hg, DBP=100.8(4.3) mm Hg;<BR/>Placebo: n=53(29 males,24 females); mean age=58.1(9.5) years; baseline sitting SBP=161.4(16.5) mm Hg, DBP=102.1(5.7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table 2, p. S95; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Prichard-2002">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= 1) sitting DBP=95-114 mm Hg and sitting SBP&lt;/=200mm Hg during 2 weeks immediately prior to randomization, and on day 0, the first day of active treatment, with variation in DBP of not more than 10 mm Hg between the last week of run-in phase and day 0, and 2) mean daytime (0600-2159h) DBP&gt;/=85 mm Hg by ambulatory BP monitoring on day immediately preceding randomization; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg once daily: n=53(35 males,18 females); mean age=52.2(10.3) years; baseline sitting SBP=165.2(14.5) mm Hg, DBP=101.1(4.4) mm Hg; baseline HR=78.0(7.3) bpm;<BR/>Placebo: n=50(29 males,21 females); mean age=53.7(8.7) years; baseline sitting SBP=162.8(14.5) mm Hg, DBP=99.9(3.9) mm Hg; baseline HR=76.6(8.8) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily,<BR/>Placebo;<BR/>administered in morning (8.00+/-2 h)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD reported, BP data from Table II, p. 169; Jadad score=4; funding source= Solvay Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Reimann-1995">
<CHAR_METHODS>
<P>3-week placebo run-in; inclusion criteria= DBP 95-104 mm Hg; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Perindopril 4 mg: n=27(20 males,7 females); mean age=54(9.8) years; baseline sitting SBP=161.3(12.5) mm Hg, DBP=100.4(3.8) mm Hg;<BR/>Placebo: n=26(14 males,12 females); mean age=55(8.5) years; baseline sitting SBP=159.6(17.3) mm Hg, DBP=100.7(3.2) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Perindopril 4 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table 3, p. 190; time and position of BP measurement not reported; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Roca_x002d_Cusachs-2001">
<CHAR_METHODS>
<P>1-week washout (only for patients previously treated with anti-hypertensive therapy); 2-week single-blind placebo run-in; inclusion criteria= DBP 90-109 mm Hg (which differed &lt; 10mm Hg from that observed in previous visit) after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients (per protocol population): n=342(137 males,205 females); mean age=55.6(9.9) years; baseline sitting SBP=158.3(10.6) mm Hg, DBP=98.6(5.3) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 5 mg once daily;<BR/>Enalapril 10 mg once daily;<BR/>Enalapril 20 mg once daily;<BR/>Placebo;<BR/>taken in the morning;<BR/>patients assigned to receive either 10 or 20 mg received 5 mg for the first week of treatment before titration to dose assigned</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP reported; endpoint SD not reported; baseline SD reported; imputed baseline SBP SD for SD of change; imputed overall trial mean DBP SD of change; BP data from Figure 1, p. 844; Jadad score=2; funding source= VITA INVEST</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Sassano-1984">
<CHAR_METHODS>
<P>15-day washout; 15-day placebo run-in; inclusion criteria= DBP 95-120 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=53(40 males,13 females); mean age=47.4 years; baseline supine SBP=161.4(13.0) mm Hg, DBP=103.3(6.3) mm Hg;<BR/>Placebo: n=47(31 males,16 females); mean age=46.8 years; baseline supine SBP=163.5(13.8) mm Hg, DBP=104.6(7.0) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peak supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table I, p. 19; Jadad score=3; funding source= Merck Sharpe and Dohme</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Saynavalammi-1988">
<CHAR_METHODS>
<P>4-week single-blind placebo phase; inclusion criteria= DBP 100-115 mm Hg after placebo phase; 12-week double-blind treatment, dosage doubled every 4 weeks (10-40 mg twice daily)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Quinapril: n=7(2 males,5 females); mean age=48(11) years; baseline SBP=159(8) mm Hg, DBP=105(3) mm Hg;<BR/>Placebo: n=7(3 males,4 females); mean age=47(13) years; baseline SBP=162(21) mm Hg, DBP=105(5) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Quinapril 10 mg twice daily;<BR/>Placebo<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough (12h after previous dose) sitting SBP/DBP using mercury sphygmomanometer<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SD of change not reported, endpoint BP and SEM reported, calculated endpoint SD from N and endpoint SEM, imputed endpoint SD for SD of change; BP data from Figure 2, p. 90; Jadad score=2; funding source= Warner-Lambert/Parke-Davis Co.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Schoenberger-1986">
<CHAR_METHODS>
<P>4- to 6-week single-blind placebo run-in; inclusion criteria= sitting DBP 92-109 mm Hg on last 2 visits of run-in; 4-week double-blind treatment at fixed dose, after 4-weeks captopril dosage doubled in all randomized patients for additional 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Captopril 50 mg once daily: n=88(58 males,30 females); mean age=52 years; baseline sitting SBP=149.3 mm Hg, DBP=98.2 mm Hg;<BR/>Captopril 50 mg twice daily: n=91(60 males,31 females); mean age=52 years; baseline sitting SBP=151.2 mm Hg, DBP=100.1 mm Hg;<BR/>Placebo: n=90(58 males,32 females); mean age=51 years; baseline sitting SBP=148.7 mm Hg, DBP=98.5 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 50 mg once daily;<BR/>Captopril 50 mg twice daily;<BR/>Placebo;<BR/>patients in daily schedule groups received their active medication in the morning and placebo in the evening</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Sitting DBP<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change not reported, SD of change not reported, endpoint SBP not reported; endpoint DBP reported; endpoint SD not reported; baseline SD not reported; imputed overall trial mean SD of change for DBP; DBP data from Table 3, p. 382; BP measurement device not reported; Jadad score=2; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Scholze-1998">
<CHAR_METHODS>
<P>1-week washout period (for patients previously treated with antihypertensive therapy); 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 100-115 mm Hg (which differed by less than 10 mm Hg from that observed on the previous visit) after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 0.5-2 mg: n=85; baseline SBP/DBP not reported;<BR/>Placebo: n=30; baseline SBP/DBP not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 0.5 mg once daily;<BR/>Trandolapril 1 mg once daily;<BR/>Trandolapril 2 mg once daily;<BR/>Placebo;<BR/>administered with or immediately after breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Adjusted and non-adjusted BP data reported; non-adjusted BP entered in Revman; BP change reported, SD of change not reported; 95% confidence interval of change reported; endpoint BP and SD not reported; calculated SD of change from 95% CI of change; BP data from Table 1, p. 493; Jadad score=3; funding source= Knoll AG</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Scholze-1999">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= supine DBP 100-115 mm Hg after run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=507(327 males,180 females); mean age=50.2 years; baseline SBP/DBP not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipril 2.5 mg once daily;<BR/>Ramipril 5 mg once daily;<BR/>Ramipril 10 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SEM of change reported, endpoint BP and SD not reported; calculated SD of change from N and change SE; BP data from Table 1, p. 1453; Jadad score=3; funding source= Hoechst AG</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Simon-1983">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= not reported but baseline DBP for all groups is at least 90 mm Hg; 12-week total double-blind treatment; increasing doses of enalapril 10, 20, and 40 mg daily every 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n= 34(33 male,1 female) white patients;<BR/>Enalapril once and twice daily: n=21; mean age=52(11) years; baseline SBP=143(15) mm Hg, DBP=93(5) mm Hg;<BR/>Placebo: n=12; mean age=50(17) years; baseline SBP=150(14) mm Hg, DBP=92(7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Enalapril 10 mg twice daily;<BR/>Placebo;<BR/>first dose taken in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 DBP only since patients treated with enalapril 10 mg once daily did not have SBP &gt;/= 140mm Hg at baseline; BP change and SD of change not reported; endpoint BP reported; endpoint SD not reported; imputed overall trial mean SD of change; BP data from Figure 1, p. 461; BP measurement device not reported; Jadad score=2; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Smith-1998">
<CHAR_METHODS>
<P>2- to 3-week screening/washout period; 4-week single-blind placebo run-in; inclusion criteria= supine DBP 95-114 mm Hg; 12-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=72(44 males,28 females); mean age=53.1(11.0) years; baseline supine SBP=153.8(13.8) mm Hg, DBP=100.4(4.2) mm Hg;<BR/>Placebo: n=76(49 males,27 females); mean age=55.6(9.6) years; baseline supine SBP=154.8(11.8) mm Hg, DBP=100.4(4.5) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported; endpoint BP and SD not reported; calculated SD of change from N and SE of change; change in BP data from Figures 1 and 2, p. 235; SE of change data from Table 2, p. 234; Jadad score=3; funding source= Boehringer Ingelheim Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Smith-2000">
<CHAR_METHODS>
<P>Minimum 7-day washout; 4-week single-blind placebo run-in; inclusion criteria= supine DBP 100-114 mm Hg during final 2 weeks of run-in, mean supine DBP could not vary by more than 7 mm Hg between weeks 2 and 3 or weeks 3 and 4 of run-in, or by more than 10 mm Hg between weeks 2 and 4 of run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 20 mg: n=42(31 males,11 females); mean age=52.0 years; baseline supine SBP=155.3 mm Hg, DBP=103.3 mm Hg, HR=72.7 bpm;<BR/>Placebo: n=43(24 males,19 females); mean age=52.0 years; baseline supine SBP=159.5 mm Hg, DBP=104.9 mm Hg, HR=72.5 bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 20 mg once daily;<BR/>Placebo;<BR/>taken with water (120 mL) between 6 AM and 9 AM and at least 1 h before breakfast</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough standing SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough standing HR;<BR/>Mean change from baseline in trough supine HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported; endpoint BP and SD not reported; calculated SD of change from N and SE of change; change in BP data from Table II, p. 1385; Jadad score=4; funding source= Boehringer Ingelheim Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Trevisan-1995">
<CHAR_METHODS>
<P>No minimal BP inclusion criteria; 24-week total double-blind treatment, report BP at week 4 of double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients (normotensive and hypertensive) with non-insulin-dependent diabetes mellitus: <BR/>Ramipril 1.25 mg: n=60(44 males,16 females); mean age=56(7) years; baseline SBP=147(15) mm Hg, DBP=90(6) mm Hg;<BR/>Placebo: n=62(50 males,12 females); mean age=58(7) years; baseline SBP=151(14) mm Hg, DBP=91(6) mm Hg;<BR/>Subgroup of patients with BP &gt;/= 160/95 mm Hg: <BR/>Ramipril 1.25 mg: n=19; baseline SBP=156(12) mm Hg, DBP=95(4) mm Hg;<BR/>Placebo: n=24; baseline SBP=161(9) mm Hg, DBP=95(3) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipil 1.25 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; no minimal BP inclusion criteria, trial included both hypertensive and non-hypertensive patients; Used BP data from subgroup with BP &gt;/= 160/95 mm Hg; BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD of change; BP data from Table 5, p. 881; time of BP measurement not reported; Jadad score=4; funding source= Hoechst</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Uusitupa-1996">
<CHAR_METHODS>
<P>4-week normal sodium, placebo run-in (week 0-4); inclusion criteria= mean supine DBP 95-114 mm Hg and mean daytime ambulatory DBP 90-105 mm Hg after run-in; 8-week low-sodium placebo period (week 4-12); 12-week double-blind treatment (week 12-24)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril 2.5 mg: n=19(10 males,9 females); mean age=53.7(5.7) years; baseline sitting SBP=157.3(17.1) mm Hg, DBP=104.0(8.0) mm Hg, HR=70(13) bpm;<BR/>Placebo: n=20(14 males,6 females); mean age=50.5(9.5) years; baseline sitting SBP=147.0(10.3) mm Hg, DBP=99.4(5.3) mm Hg, HR=70(10) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Placebo;<BR/>taken before breakfast in the morning between 7 AM and 9 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting HR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported; SD of change not reported; 95% confidence interval of change reported; calculated SD of change from 95% CI of change; endpoint BP and SD reported; BP change data from Table 6, p. 323; endpoint BP data from Table 4, p. 322; Jadad score=3; funding source= Hoffmann-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-VA-Study-Group-1984">
<CHAR_METHODS>
<P>2- to 5-week single-blind placebo run-in; inclusion criteria= sitting DBP 92-109 mm Hg on 2 consecutive clinic visits during run-in; 7-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Captopril 12.5 mg TID: n=83(all males); mean age=55.7(9.8) years; baseline sitting SBP=147.8(14.6) mm Hg, DBP=97.0(3.6) mm Hg;<BR/>Captopril 25 mg TID: n=84(all males); mean age=55.7(8.1) years; baseline sitting SBP=147.4(11.9) mm Hg, DBP=97.9(3.7) mm Hg;<BR/>Captopril 37.5 mg BID: n=88(all males); mean age=54.9(7.9) years; baseline sitting SBP=149.0(13.1) mm Hg, DBP=97.5(4.7) mm Hg;<BR/>Captopril 50 mg TID: n=89(all males); mean age=55.1(8.0) years; baseline sitting SBP=148.2(16.0) mm Hg, DBP=98.1(4.7) mm Hg;<BR/>Placebo: n=83(all males); mean age=54.4(8.0) years; baseline sitting SBP=146.3(14.6) mm Hg, DBP=97.8(4.6) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Captopril 12.5 mg three times daily,<BR/>Captopril 25 mg three times daily,<BR/>Captopril 37.5 mg twice daily,<BR/>Captopril 50 mg three times daily,<BR/>Placebo;<BR/>all patients were directed to take the capsules at least 1 h before breakfast, 2 h after lunch, and at bedtime, ie, at least 2 h after dinner</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in sitting SBP/DBP using mercury sphygmomanometer; WDAE; visits were scheduled approx 3 h from the time the patient took his last dose of medication</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported; endpoint BP and SD reported; calculated SD of change from N and change SE; BP data from Table 4, p. 1953; Jadad score=4; funding source= E.R. Squibb &amp; Sons Inc.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vandenburg-1994">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Imidapril 5 mg: n=33(21 males,12 females); mean age=53.2(12.1) years; baseline sitting DBP=102.3(5.7) mm Hg;<BR/>Imidapril 10 mg: n=31(18 males,13 females); mean age=52.3(11.7) years; baseline sitting DBP=100.8(4.5) mm Hg;<BR/>Imidapril 20 mg: n=31(16 males,15 females); mean age=52.5(10.0) years; baseline sitting DBP=101.0(5.6) mm Hg;<BR/>Imidapril 40 mg: n=32(21 males,11 females); mean age=49.8(13.6) years; baseline sitting DBP=102.2(5.1) mm Hg;<BR/>Placebo: n=35(20 males,15 females); mean age=51.9(11.8) years; baseline sitting DBP=101.3(5.3) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Imidapril 5 mg once daily;<BR/>Imidapril 10 mg once daily;<BR/>Imidapril 20 mg once daily;<BR/>Imidapril 40 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough standing SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported; endpoint BP and SD reported; change in BP data from Table 4, p. 271; Jadad score=3; funding source= Tanabe Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Vaur-1998">
<CHAR_METHODS>
<P>2-week washout; 2-week single-blind placebo run-in; inclusion criteria= mean supine DBP 95-114 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Trandolapril 2 mg: n=24(15 males,9 females); mean age=56(10) years; baseline sitting SBP=163(16) mm Hg, DBP=101(6) mm Hg;<BR/>Placebo: n=10(5 males,5 females); mean age=53(12) years; baseline SBP=157(14) mm Hg, DBP=100(7) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 2 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported; endpoint BP and SD not reported; SBP/DBP data from Table 3, p. 110; Jadad score=3; funding source= Roussel Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Villamil-1987">
<CHAR_METHODS>
<P>2-week placebo run-in; inclusion criteria= supine and standing DBP 95-120 mm Hg after run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Ramipril 2.5 mg: n=28(12 males,16 females); median age=54 years; baseline SBP=162.0 mm Hg, DBP=101.1 mm Hg;<BR/>Ramipril 5 mg: n=29(11 males,18 females); median age=53 years; baseline SBP=166.8 mm Hg, DBP=103.2 mm Hg;<BR/>Placebo: n=27(15 males,12 females); median age=52 years; baseline SBP=166.6 mm Hg, DBP=101.5 mm Hg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Ramipril 2.5 mg once daily;<BR/>Ramipril 5 mg once daily;<BR/>Placebo;<BR/>administered between 6 AM and 8 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough standing SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SEM of change reported, endpoint BP and SD not reported; calculated SD of change from N and change SE; BP data from Tables III and IV, p. 112D; Jadad score=3; funding source= Hoechst AG</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Waeber-1999">
<CHAR_METHODS>
<P>4-week placebo run-in; inclusion criteria= sitting DBP 95-110 mm Hg after run-in; 12-week total double-blind treatment, titrated to response at 4 weeks</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg: n=321(188 males,133 females); mean age=52.4(10.2) years; baseline sitting SBP=158.0(15.4) mm Hg, DBP=100.9(4.6) mm Hg;<BR/>Placebo: n=304(165 males,135 females); mean age=51.0(10.7) years; baseline SBP=157.2(15.3) mm Hg, DBP=101.0(4.4) mm Hg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SD of change reported, endpoint BP and SD not reported; BP data from Figure I, p. 917; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Weinberger-1990">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg, inclusive, on 2 consecutive visits (weeks 2 and 4 of run-in) with &lt;/= 10mm Hg difference between 2 visits; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Benazepril 5 mg: n=38(23 males,15 females); mean age=51.1 years; baseline sitting SBP=152.7(15.2) mm Hg, DBP=101.2(5.3) mm Hg;<BR/>Benazepril 10 mg: n=34(23 males,11 females); mean age=51.9 years; baseline sitting SBP=153.1(13.7) mm Hg, DBP=101.8(5.7) mm Hg;<BR/>Benazepril 20 mg: n=36(23 males,13 females); mean age=50.4 years; baseline sitting SBP=151.9(15.7) mm Hg, DBP=101.7(4.7) mm Hg;<BR/>Benazepril 40 mg: n=34(24 males,10 females); mean age=50.4 years; baseline sitting SBP=151.6(15.9) mm Hg, DBP=102.1(5.6) mm Hg;<BR/>Placebo: n=31(21 males,10 females); mean age=48.2 years; baseline sitting SBP=150.7(14.3) mm Hg, DBP=101.7(4.9) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 5 mg once daily;<BR/>Benazepril 10 mg once daily;<BR/>Benazepril 20 mg once daily;<BR/>Benazepril 40 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in peak sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported, endpoint BP reported, endpoint SE not reported; calculated SD of change from N and SE of change; DBP data from Table III, p. 325; Jadad score=2; funding source= Ciba-Geigy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Weir-1995">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= mean supine DBP 95-114 mm Hg during both of final 2 consecutive weeks of run-in; 6-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Black and white patients reported in Weir 1995:<BR/>Trandolapril 1 mg: n=51(33 males,18 females); mean age=58.3(11.4) years; baseline sitting SBP=154.8(15.0) mm Hg, DBP=100.3(4.3) mm Hg;<BR/>Trandolapril 2 mg: n=53(36 males,17 females); mean age=57.3(10.9) years; baseline sitting SBP=151.9(13.1) mm Hg, DBP=101.7(5.1) mm Hg;<BR/>Trandolapril 4 mg: n=53(28 males,25 females); mean age=53.0(12.4) years; baseline sitting SBP=147.6(13.8) mm Hg, DBP=99.9(4.4) mm Hg;<BR/>Placebo: n=50(35 males,15 females); mean age=60.6(9.9) years; baseline SBP=152.1(14.9) mm Hg, DBP=100.9(5.0) mm Hg<BR/>Only black patients reported in Weir 1998 (duplicate publication):<BR/>Trandolapril 0.25 mg: n=23(12 males,11 females); mean age=48.6(12.7) years; baseline supine SBP=159.1(13.5) mm Hg, DBP=101.7(5.3) mm Hg;<BR/>Trandolapril 0.5 mg: n=22(9 males,13 females); mean age=49.4(12.3) years; baseline supine SBP=152.1(11.7) mm Hg, DBP=101.6(4.9) mm Hg;<BR/>Trandolapril 1 mg: n=23(7 males,16 females); mean age=52.7(11.1) years; baseline supine SBP=150.7(13.1) mm Hg, DBP=99.7(3.5) mm Hg (same patients as Weir 1995);<BR/>Trandolapril 2 mg: n=22(10 males,12 females); mean age=53.0(10.2) years; baseline supine SBP=146.1(11.4) mm Hg, DBP=99.1(3.2) mm Hg (same patients as Weir 1995);<BR/>Trandolapril 4 mg: n=60(28 males,32 females); mean age=53.6(10.8) years; baseline supine SBP=156.2(16.1) mm Hg, DBP=101.7(4.9) mm Hg (same patients as Weir 1995);<BR/>Trandolapril 8 mg: n=38(19 males,19 females); mean age=55.3(11.9) years; baseline supine SBP=158.7(19.3) mm Hg, DBP=101.4(4.3) mm Hg;<BR/>Trandolapril 12 mg: n=38(19 males,19 females); mean age=53.1(13.5) years; baseline supine SBP=153.0(12.4) mm Hg, DBP=100.9(4.1) mm Hg;<BR/>Trandolapril 16 mg: n=36(15 males,21 females); mean age=54.4(12.2) years; baseline supine SBP=159.5(17.3) mm Hg, DBP=100.5(3.7) mm Hg;<BR/>Placebo: n=60(27 males,33 females); mean age=53.5(10.0) years; baseline supine SBP=155.7(15.5) mm Hg, DBP=100.6(4.2) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Trandolapril 0.25 mg once daily (black patients only);<BR/>Trandolapril 0.5 mg once daily (black patients only);<BR/>Trandolapril 1 mg once daily (black and white patients);<BR/>Trandolapril 2 mg once daily (black and white patients);<BR/>Trandolapril 4 mg once daily (black and white patients);<BR/>Trandolapril 8 mg once daily (black patients only);<BR/>Trandolapril 12 mg once daily (black patients only);<BR/>Trandolapril 16 mg once daily (black patients only);<BR/>Placebo;<BR/>administered between 8 AM and 10 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer (Trandolapril 1, 2, 4 mg treatment arms);<BR/>Mean change from baseline in trough supine SBP/DBP using mercury sphygmomanometer (Trandolapril 0.25, 0.5, 8, 12, 16 mg treatment arms);<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Weir 1995: BP change and SE of change reported; calculated SD of change from N and SE of change; endpoint BP and SD not reported; SBP/DBP data from Table 2, p. 126; Jadad score=3; funding source= Knoll Pharma</P>
<P>Weir 1998: BP change and SE of change reported for trandalopril groups; SBP SE of change in placebo group not reported; DBP SE of change in placebo group reported; imputed baseline SBP SE for SE of change; calculated SD of change from N and SE of change; endpoint BP and SD not reported; SBP/DBP data from Table 2, p. 191</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Whalen-1989">
<CHAR_METHODS>
<P>2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=165;<BR/>Benazepril 20 mg: n=50; baseline sitting SBP=156 mmHg, DBP=103 mm Hg;<BR/>Benazepril 40 mg: n=50; baseline sitting SBP=154 mmHg, DBP=102 mm Hg;<BR/>Benazepril 80 mg: n=37; baseline sitting SBP=161 mmHg, DBP=104 mm Hg;<BR/>Placebo: n=50; baseline sitting SBP=154 mmHg, DBP=103 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Benazepril 20 mg once daily;<BR/>Benazepril 40 mg once daily;<BR/>Benazepril 80 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP;<BR/>Mean change from baseline in peak sitting SBP/DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change reported; SD of change not reported, endpoint BP and SD not reported; imputed overall trial mean SD of change; BP data from abstract; BP measurement device not reported; Jadad score=2; funding source= Ciba-Geigy Inc.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Whelton-1992">
<CHAR_METHODS>
<P>2-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg during run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg: n=36(24 males,12 females); mean age=53 years; baseline sitting SBP=152.9 mm Hg, DBP=100.5 mm Hg;<BR/>Lisinopril 10 mg: n=37(22 males,15 females); mean age=51 years; baseline sitting SBP=146.9 mm Hg, DBP=99.1 mm Hg;<BR/>Placebo: n=37(23 males,14 females); mean age=50 years; baseline sitting SBP=149.9 mm Hg, DBP=99.5 mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Lisinopril 10 mg once daily;<BR/>Placebo;<BR/>administered between 8 AM and 9 AM</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Baseline adjusted mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SE of change reported, endpoint BP and SD not reported; calculated SD of change from N and change SE; BP data from Table II, p. 328; Jadad score=3; funding source= ICI Americas Inc.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-White-1988">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= DBP 95-114 mm Hg after run-in; 4-week double-bind treatment at fixed dose; after 4 weeks (week 0-4), patients with inadequate BP response had their doses doubled during the second 4 weeks (week 4-8); hydrochlorothiazide 12.5 mg (in a single morning dose) was added during final 4 weeks (week 8-12)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>All patients: n=18(10 males,8 females); mean age=52(12) years;<BR/>Cilazapril 2.5 mg: n=9; baseline sitting SBP=155(15) mm Hg, DBP=104(4) mm Hg, HR=77(8) bpm;<BR/>Placebo: n=9; baseline sitting SBP=152(15) mm Hg, DBP=100(4) mm Hg, HR=83(8) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Trough standing SBP/DBP using mercury sphygmomanometer;<BR/>Trough sitting HR;<BR/>Trough standing HR;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SD of change not reported; endpoint BP and SD reported; imputed endpoint SD for SD of change; BP data from Table 1, p. 174; Jadad score=3; funding source= Hoffmann-La Roche Ltd.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-White-1995">
<CHAR_METHODS>
<P>Minimum 1-week washout; 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg on 2 separate visits at end of placebo run-in, with difference between visits of 10 mm Hg or less; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Moexipril 7.5 mg: n=16(12 males,4 females); mean age=56(12) years; baseline sitting SBP=161(12) mm Hg, DBP=103(4) mm Hg, HR=76(8) bpm;<BR/>Moexipril 15 mg: n=18(16 males,2 females); mean age=58(9) years; baseline sitting SBP=157(13) mm Hg, DBP=104(4) mm Hg, HR=78(13) bpm;<BR/>Placebo: n=17(15 males,2 females); mean age=50(12) years; baseline sitting SBP=149(17) mm Hg, DBP=106(4) mm Hg, HR=77(8) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Moexipril 7.5 mg once daily;<BR/>Moexipril 15 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>Mean change from baseline in trough sitting HR</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change reported, endpoint BP and SD not reported; change in BP data from Table II, p. 235; Jadad score=2; funding source= Schwarz Pharma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-White-2002">
<CHAR_METHODS>
<P>1- to 2-week washout period for patients who were currently receiving antihypertensive therapy; 2- to 4-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-115 mm Hg during 2 consecutive weeks of run-in; also required that ambulatory awake DBP &gt;/= 85 mm Hg; total 8-week double-blind treatment: 4-week low-dose treatment (week 0-4), forced titration at week 4 to high-dose, 4-week high-dose treatment (week 4-8)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Enalapril 10 mg: n=99(58 males,41 females); mean age=54(10) years; baseline SBP=145(16) mm Hg, DBP=93(8) mm Hg; baseline HR=72(10) bpm;<BR/>Placebo: n=46(30 males,16 females); mean age=56(11) years; baseline SBP=148(12) mm Hg, DBP=95(6) mm Hg; baseline HR=71(9) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Enalapril 10 mg once daily;<BR/>Placebo;<BR/>administered in the morning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Used week 4 BP data only; BP change and SD of change reported, endpoint BP and SD not reported; BP data from Table IV, p. 663; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-08-12 14:54:36 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yebes-1993">
<CHAR_METHODS>
<P>4-week single-blind placebo washout; inclusion criteria= sitting DBP &gt; 100 and &lt; 115 mm Hg after washout; 8-week double-blind treatment, randomized to either placebo or quinapril 20 mg once daily for 4 weeks with optional titration to 40 mg once daily for subsequent 4 weeks based on diastolic response</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Quinapril: n=10; mean age=55(14.9) years; baseline SBP=161(22.2) mm Hg, DBP=105(5.6) mm Hg;<BR/>Placebo: n=11; mean age=50(9.9) years; baseline SBP=154(20.6) mm Hg, DBP=103(5.0) mm Hg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Quinapril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in sitting SBP/DBP</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-08-12 14:54:36 -0700" MODIFIED_BY="[Empty name]">
<P>Used week 4 BP data only; BP change and SD of change reported, endpoint BP and SD reported; time of dosing not reported; time of BP measurement not reported; SBP data from Table IA, p. 321, DBP data from Table IIA, p. 323; time of BP measurement not reported; BP measurement device not reported; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Yodfat-1993">
<CHAR_METHODS>
<P>4-week single-blind placebo run-in; inclusion criteria= sitting DBP &gt; 100 mm Hg after run-in; 8-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Cilazapril: n=94(67 males,27 females); mean age=52.4(8.1) years; baseline BP not reported;<BR/>Placebo: n=46(28 males,18 females); mean age=54.1(7.0) years; baseline BP not reported</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Cilazapril 2.5 mg once daily;<BR/>Cilazapril 5 mg once daily;<BR/>Placebo;<BR/>taken at approximately 12 PM before meal</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Mean change from baseline in trough sitting DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>SBP change not reported; DBP change reported; SD of change not reported, endpoint SBP/DBP and SD not reported; imputed overall trial mean SD of change for DBP; baseline BP not reported; BP data from Figure 1, p. 119; Jadad score=3; funding source= not reported</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Zamboulis-1996">
<CHAR_METHODS>
<P>4-week washout; 2-week single-blind placebo run-in; inclusion criteria= sitting DBP 95-114 mm Hg at end of placebo run-in; 4-week double-blind treatment</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Fosinopril 20 mg: n=12(8 males,4 females); mean age=51 years; baseline seated SBP=150.8(15.9) mm Hg, DBP=108.8(4.7) mm Hg; baseline HR=76.9(5.3) bpm;<BR/>Placebo: n=11(7 males,4 females); mean age=45 years; baseline seated SBP=143.0(20.0) mm Hg, DBP=95.5(12.6) mm Hg; baseline HR=79.0(9.8) bpm</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Fosinopril 20 mg once daily;<BR/>Placebo</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Sitting SBP/DBP using mercury sphygmomanometer;<BR/>WDAE</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>BP change and SD of change not reported, endpoint BP and SD reported; imputed endpoint SD for SD of change; time of BP measurement (peak and/or trough) not reported; BP data from Table 1, p. 254; Jadad score=3; funding source= Bristol-Myers Squibb</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BP=blood pressure, DBP=diastolic blood pressure; SBP=systolic blood pressure; SD=standard deviation; WDAE=withdrawal due to adverse effects; bpm=beats per minute</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-08-12 14:36:44 -0700" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:12:16 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bainbridge-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:12:16 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment (ramipril 2.5 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:12:22 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bakris-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:12:22 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, forced titration at 4 weeks. Pre-titration data not reported (enalapril 10 mg/day vs. losartan 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:12:37 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beaulieu-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:12:37 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment (fosinopril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-08-12 14:36:44 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bergstrand-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-08-12 14:36:44 -0700" MODIFIED_BY="[Empty name]">
<P>Balanced, two-period, incomplete-block design with 2 treatment periods of 3-weeks duration. First treatment period data not reported (enalapril 2.5, 5, 10, 20, 40 vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:25:54 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bohlen-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:25:54 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 6-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (perindopril 4 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:26:04 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Canter-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:26:04 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period. Number of patients per treatment arm not reported (quinapril 2.5, 10, 40 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:26:19 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Canter-1994a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:26:19 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment (quniapril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:27:23 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cleroux-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:27:23 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment. 8-week treatment periods but titration in non-responders after 4 weeks treatment (quinapril 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:27:43 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cuspidi-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:27:43 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment (lisinopril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:27:55 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Duprez-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:27:55 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 6 weeks of treatment (enalapril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:28:06 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fagard-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:28:06 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 6 weeks of treatment (enalapril 20 mg/day vs. losartan 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:28:21 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gall-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:28:21 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment. 8-week treatment periods but titration in non-responders after 4 weeks treatment (captopril 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:28:32 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gans-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:28:32 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (cilazapril 2.5 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:28:44 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gleerup-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:28:44 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (spirapril 6 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:28:56 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guitard-1994a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:28:56 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 3 weeks of treatment (spirapril 3, 6, 12, 24 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:29:07 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gupta-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:29:07 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment (quinapril 40 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:29:23 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Homuth-1993a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:29:23 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 6-week treatment period. BP data not extractable from figures (ramipril 2.5, 10, 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:29:32 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hu-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:29:32 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 12-week treatment period, titration in non-responders every 4 weeks. Pre-titration data not reported (captopril 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:29:46 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kahan-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:29:46 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 6 weeks of treatment (ramipril 5 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:29:55 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karlberg-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:29:55 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 4-week treatment period. BP data for placebo group not reported at week 4 (ramipril 5 mg/day vs. ramipril 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:30:05 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kjeldsen-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:30:05 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (quinapril 40 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:30:16 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lacourciere-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:30:16 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period. BP data for placebo group not reported (lisinopril 20 mg/day vs. telmisartan 80 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:30:26 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lavezzaro-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:30:26 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (captopril 100 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:30:43 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leonetti-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:30:43 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (captopril 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:30:51 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Littler-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:30:51 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 6 weeks of treatment (perindopril 8 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:31:00 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Louis-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:31:00 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 4-week treatment period. Only maximum BP reduction is reported (perindopril 2, 4, 8 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:31:18 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miyajima-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:31:18 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 12-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (imidapril 5 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:31:27 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morgan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:31:27 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data for first 4 weeks of treatment. 8-week treatment periods but titration in non-responders after 4 weeks treatment (enalapril 20 mg/day vs. perindopril 4 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:31:36 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petersen-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:31:36 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (spirapril 24 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:31:52 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petrie-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:31:52 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (trandolapril 2 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:32:02 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petrov-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:32:02 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 6 weeks of treatment (enalapril 20 mg/day vs. losartan 50 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:32:11 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Plouin-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:32:11 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (perindopril 4 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:32:22 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pritchard-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:32:22 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 3 weeks of treatment (trandolapril 2 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:32:33 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reisin-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:32:33 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 12-week treatment period, titration in non-responders every 4 weeks. Pre-titration data not reported (lisinopril 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:33:26 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salvetti-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:33:26 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no baseline data and no pre-crossover data reported for first 4 weeks of captopril 100 mg/day vs. placebo. Only mean arterial blood pressure values given.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:33:08 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salvetti-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:33:08 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (captopril 50, 100 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:32:59 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salvetti-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:32:59 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (enalapril 10, 20, 40 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:33:49 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Samuelsson-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:33:49 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, titration in non-responders at 2 or 4 weeks. Pre-titration data not reported (lisinopril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:34:03 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sassano-1984a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:34:03 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 6-month treatment period. Additional BP lowering drugs added to enalapril 20 mg in non-responders at 4 weeks. Data during first 4 weeks not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:36:54 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scholze-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:36:54 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 6-week treatment period. Number of patients per treatment arm not reported (ramipril 2.5, 5, 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:37:33 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Thurig-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:37:33 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 8 weeks of treatment (lisinopril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:37:59 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tomei-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:37:59 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (lisinopril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:38:13 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wiggam-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:38:13 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 8 weeks of treatment (captopril 100 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:38:30 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilkins-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:38:30 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 12-week treatment period, titration in non-responders every 4 weeks. Pre-titration data not reported (enalapril 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:38:45 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wing-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:38:45 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (enalapril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:38:54 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wing-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:38:54 -0700" MODIFIED_BY="[Empty name]">
<P>Crossover trial with no pre-crossover data reported for first 4 weeks of treatment (enalapril 20 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:39:10 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Youssef-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:39:10 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment. Highly suspicious data (enalapril 20 mg/day vs. benazepril 10 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-06-05 11:39:20 -0700" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zanchetti-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-06-05 11:39:20 -0700" MODIFIED_BY="[Empty name]">
<P>Parallel group trial with 8-week treatment period, titration in non-responders at 4 weeks. Pre-titration data not reported (enalapril 10 mg/day vs. candesartan 4 mg/day vs. placebo).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Applegate-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Belz-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Black-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Boeijinga-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Brown-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Carlsen-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chan-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chrysant-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chrysant-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Chrysant-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cushman-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-De-Bruijn-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-DeQuattro-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Drayer-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dupui-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fairhurst-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Fernandez-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ford-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gerritsen-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gomez-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gradman-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Gradman-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Guitard-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Guitard-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Guntzel-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Holwerda-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Homuth-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kayanakis-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kobrin-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Koch-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kohlmann-Jr-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kostis-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Krum-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Krum-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Kuppers-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kuschnir-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lacourciere-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lerch-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Levine-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Luccioni-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-MacLean-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mancia-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mancia-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-McCarron-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-McFate_x002d_Smith-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Messerli-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Moser-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mroczek-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Mroczek-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Muiesan-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Myers-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-New-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Oparil-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Overlack-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Persson-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pittrow-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pizarro-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Poirier-1991">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pool-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pool-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Pool-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Pordy-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Prager-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Prichard-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Reimann-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Roca_x002d_Cusachs-2001">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Sassano-1984">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Saynavalammi-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Schoenberger-1986">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Scholze-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Scholze-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Simon-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Smith-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Smith-2000">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Trevisan-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Uusitupa-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-VA-Study-Group-1984">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Vandenburg-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Vaur-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Villamil-1987">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Waeber-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weinberger-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Weir-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Whalen-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Whelton-1992">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-White-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-White-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-White-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yebes-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yodfat-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Zamboulis-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-12 15:44:57 -0700" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" NO="1">
<TITLE>Overview of the 92 included studies investigating ACE inhibitors as monotherapy</TITLE>
<TABLE COLS="9" ROWS="16">
<TR>
<TH>
<P>ACE inhibitor</P>
</TH>
<TH>
<P>Dose range (mg/day)</P>
</TH>
<TH>
<P>Number of studies</P>
</TH>
<TH>
<P>ACEI patients (n)</P>
</TH>
<TH>
<P>Placebo patients (n)</P>
</TH>
<TH>
<P>Mean duration (wks)</P>
</TH>
<TH>
<P>Mean age (yrs)</P>
</TH>
<TH>
<P>Baseline BP (mm Hg)</P>
</TH>
<TH>
<P>Baseline PP (mm Hg)</P>
</TH>
</TR>
<TR>
<TD>
<P>Benazepril</P>
</TD>
<TD>
<P>2 - 80</P>
</TD>
<TD>
<P>7</P>
</TD>
<TD>
<P>591</P>
</TD>
<TD>
<P>335</P>
</TD>
<TD>
<P>6.0</P>
</TD>
<TD>
<P>56.3</P>
</TD>
<TD>
<P>159.5/103.5</P>
</TD>
<TD>
<P>56.0</P>
</TD>
</TR>
<TR>
<TD>
<P>Captopril</P>
</TD>
<TD>
<P>37.5 - 200</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>660</P>
</TD>
<TD>
<P>383</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>54.9</P>
</TD>
<TD>
<P>155.0/100.1</P>
</TD>
<TD>
<P>54.9</P>
</TD>
</TR>
<TR>
<TD>
<P>Cilazapril</P>
</TD>
<TD>
<P>0.5 - 10</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>1054</P>
</TD>
<TD>
<P>448</P>
</TD>
<TD>
<P>4.9</P>
</TD>
<TD>
<P>53.3</P>
</TD>
<TD>
<P>153.5/101.0</P>
</TD>
<TD>
<P>52.5</P>
</TD>
</TR>
<TR>
<TD>
<P>Enalapril</P>
</TD>
<TD>
<P>5 - 20</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>1477</P>
</TD>
<TD>
<P>1331</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>54.2</P>
</TD>
<TD>
<P>157.5/100.5</P>
</TD>
<TD>
<P>57.0</P>
</TD>
</TR>
<TR>
<TD>
<P>Fosinopril</P>
</TD>
<TD>
<P>2.5 - 40</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>481</P>
</TD>
<TD>
<P>168</P>
</TD>
<TD>
<P>5.0</P>
</TD>
<TD>
<P>52.5</P>
</TD>
<TD>
<P>152.1/101.2</P>
</TD>
<TD>
<P>50.9</P>
</TD>
</TR>
<TR>
<TD>
<P>Imidapril</P>
</TD>
<TD>
<P>5 - 40</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>127</P>
</TD>
<TD>
<P>35</P>
</TD>
<TD>
<P>4.0</P>
</TD>
<TD>
<P>51.9</P>
</TD>
<TD>
<P>160.7/101.5</P>
</TD>
<TD>
<P>59.2</P>
</TD>
</TR>
<TR>
<TD>
<P>Lisinopril</P>
</TD>
<TD>
<P>1.25 - 80</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>484</P>
</TD>
<TD>
<P>357</P>
</TD>
<TD>
<P>5.7</P>
</TD>
<TD>
<P>55.2</P>
</TD>
<TD>
<P>154.5/101.8</P>
</TD>
<TD>
<P>52.7</P>
</TD>
</TR>
<TR>
<TD>
<P>Moexipril</P>
</TD>
<TD>
<P>7.5 - 15</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>274</P>
</TD>
<TD>
<P>159</P>
</TD>
<TD>
<P>10.7</P>
</TD>
<TD>
<P>60.5</P>
</TD>
<TD>
<P>160.4/101.7</P>
</TD>
<TD>
<P>58.7</P>
</TD>
</TR>
<TR>
<TD>
<P>Perindopril</P>
</TD>
<TD>
<P>2 - 16</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>658</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>7.1</P>
</TD>
<TD>
<P>55.9</P>
</TD>
<TD>
<P>159.4/99.9</P>
</TD>
<TD>
<P>59.5</P>
</TD>
</TR>
<TR>
<TD>
<P>Quinapril</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>99</P>
</TD>
<TD>
<P>97</P>
</TD>
<TD>
<P>4.0</P>
</TD>
<TD>
<P>52.6</P>
</TD>
<TD>
<P>161.7/105.6</P>
</TD>
<TD>
<P>56.1</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramipril</P>
</TD>
<TD>
<P>1.25 - 10</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>548</P>
</TD>
<TD>
<P>199</P>
</TD>
<TD>
<P>6.6</P>
</TD>
<TD>
<P>51.2</P>
</TD>
<TD>
<P>156.6/100.9</P>
</TD>
<TD>
<P>55.7</P>
</TD>
</TR>
<TR>
<TD>
<P>Spirapril</P>
</TD>
<TD>
<P>3 -24</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>586</P>
</TD>
<TD>
<P>189</P>
</TD>
<TD>
<P>5.6</P>
</TD>
<TD>
<P>52.3</P>
</TD>
<TD>
<P>164.3/103.5</P>
</TD>
<TD>
<P>60.8</P>
</TD>
</TR>
<TR>
<TD>
<P>Temocapril</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>19</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD>
<P>6.0</P>
</TD>
<TD>
<P>57.0</P>
</TD>
<TD>
<P>158.0/97.6</P>
</TD>
<TD>
<P>60.4</P>
</TD>
</TR>
<TR>
<TD>
<P>Trandolapril</P>
</TD>
<TD>
<P>0.25 - 16</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>1152</P>
</TD>
<TD>
<P>636</P>
</TD>
<TD>
<P>6.1</P>
</TD>
<TD>
<P>53.4</P>
</TD>
<TD>
<P>155.4/100.7</P>
</TD>
<TD>
<P>54.7</P>
</TD>
</TR>
<TR>
<TD>
<P>TOTAL</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>92</P>
</TD>
<TD>
<P>8210</P>
</TD>
<TD>
<P>4744</P>
</TD>
<TD>
<P>6.2</P>
</TD>
<TD>
<P>54.4</P>
</TD>
<TD>
<P>157.1/101.2</P>
</TD>
<TD>
<P>55.9</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2008-05-02 13:59:47 -0700" MODIFIED_BY="Ciprian D Jauca" NO="2">
<TITLE>Summary of the blood pressure lowering efficacy of ACE inhibitors</TITLE>
<TABLE COLS="5" ROWS="15">
<TR>
<TH>
<P>ACE Inhibitor</P>
</TH>
<TH>
<P>Lowest effective dose (mg/day)</P>
</TH>
<TH>
<P>Lowest dose with near maximal BP lowering (mg/day)</P>
</TH>
<TH>
<P>Near maximal trough SBP lowering (mm Hg), 95% CI</P>
</TH>
<TH>
<P>Near maximal trough DBP lowering (mm Hg), 95% CI</P>
</TH>
</TR>
<TR>
<TD>
<P>benazepril</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>-8.70 (-11.43, -5.97)</P>
</TD>
<TD>
<P>-4.92 (-6.47, -3.36)</P>
</TD>
</TR>
<TR>
<TD>
<P>captopril</P>
</TD>
<TD>
<P>37.5</P>
</TD>
<TD>
<P>37.5</P>
</TD>
<TD>
<P>-9.68 (-11.73, -7.63)</P>
</TD>
<TD>
<P>-5.43 (-6.47, -4.40)</P>
</TD>
</TR>
<TR>
<TD>
<P>cilazapril</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>-5.58 (-7.84, -3.32)</P>
</TD>
<TD>
<P>-3.50 (-4.40, -2.60)</P>
</TD>
</TR>
<TR>
<TD>
<P>enalapril</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>-8.66 (-10.48, -6.84)</P>
</TD>
<TD>
<P>-4.80 (-5.81, -3.79)</P>
</TD>
</TR>
<TR>
<TD>
<P>fosinopril</P>
</TD>
<TD>
<P>10-20</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>-7.62 (-11.07, -4.17)</P>
</TD>
<TD>
<P>-5.00 (-6.94, -3.05)</P>
</TD>
</TR>
<TR>
<TD>
<P>imidapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-9.30 (-14.83, -3.78)</P>
</TD>
<TD>
<P>-5.76 (-9.44, -2.07)</P>
</TD>
</TR>
<TR>
<TD>
<P>lisinopril</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>-8.00 (-10.14, -5.85)</P>
</TD>
<TD>
<P>-4.76 (-5.92, -3.60)</P>
</TD>
</TR>
<TR>
<TD>
<P>moexipril</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-8.45 (-11.99, -4.91)</P>
</TD>
<TD>
<P>-4.38 (-6.29, -2.46)</P>
</TD>
</TR>
<TR>
<TD>
<P>perindopril</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>-7.09 (-9.56, -4.61)</P>
</TD>
<TD>
<P>-5.02 (-6.22, -3.82)</P>
</TD>
</TR>
<TR>
<TD>
<P>quinapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-7.05 (-11.26, -2.84)</P>
</TD>
<TD>
<P>-3.35 (-5.98, -0.72)</P>
</TD>
</TR>
<TR>
<TD>
<P>ramipril</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>-6.29 (-9.26, -3.32)</P>
</TD>
<TD>
<P>-4.14 (-5.81, -2.48)</P>
</TD>
</TR>
<TR>
<TD>
<P>spirapril</P>
</TD>
<TD>
<P>3-6</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>-8.54 (-11.18, -5.89)</P>
</TD>
<TD>
<P>-6.08( -7.50, -4.66)</P>
</TD>
</TR>
<TR>
<TD>
<P>temocapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>-10.00 (-23.87, 3.87)</P>
</TD>
<TD>
<P>-5.00 (-13.34, 3.34)</P>
</TD>
</TR>
<TR>
<TD>
<P>trandolapril</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>-7.31 (-8.85, -5.77)</P>
</TD>
<TD>
<P>-4.42 (-5.24, -3.60)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" NO="3">
<TITLE>Variability of SBP and DBP at end of treatment</TITLE>
<TABLE COLS="4" ROWS="15">
<TR>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P>ACE Inhibitor</P>
</TH>
<TH>
<P>Placebo</P>
</TH>
</TR>
<TR>
<TD>
<P>SBP</P>
</TD>
<TD>
<P>Weighted mean SD</P>
</TD>
<TD>
<P>16.6</P>
</TD>
<TD>
<P>16.8</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>SD of weighted mean SD</P>
</TD>
<TD>
<P>3.1</P>
</TD>
<TD>
<P>3.0</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Weighted mean SBP</P>
</TD>
<TD>
<P>146.0</P>
</TD>
<TD>
<P>152.9</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Weighted mean coefficient of variation (CV)</P>
</TD>
<TD>
<P>11.2</P>
</TD>
<TD>
<P>11.0</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>SD of weighted mean CV</P>
</TD>
<TD>
<P>2.1</P>
</TD>
<TD>
<P>2.0</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Number of observations</P>
</TD>
<TD>
<P>22</P>
</TD>
<TD>
<P>19</P>
</TD>
</TR>
<TR>
<TD>
<P>DBP</P>
</TD>
<TD>
<P>Weighted mean SD</P>
</TD>
<TD>
<P>9.0</P>
</TD>
<TD>
<P>8.9</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>SD of weighted mean SD</P>
</TD>
<TD>
<P>1.7</P>
</TD>
<TD>
<P>1.8</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Weighted mean DBP</P>
</TD>
<TD>
<P>91.8</P>
</TD>
<TD>
<P>96.4</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Weighted mean coefficient of variation (CV)</P>
</TD>
<TD>
<P>9.8</P>
</TD>
<TD>
<P>9.2</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>SD of weighted mean CV</P>
</TD>
<TD>
<P>1.8</P>
</TD>
<TD>
<P>1.9</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Number of observations</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>18</P>
</TD>
</TR>
<TR>
<TD>
<P>t-test</P>
</TD>
<TD>
<P>SD of SBP vs SD of DBP</P>
</TD>
<TD>
<P>p &lt; 0.0001</P>
</TD>
<TD>
<P>p &lt; 0.0001</P>
</TD>
</TR>
<TR>
<TD>
<P>t-test</P>
</TD>
<TD>
<P>CV SBP vs CV DBP</P>
</TD>
<TD>
<P>p = 0.0227</P>
</TD>
<TD>
<P>p = 0.0045</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" NO="4">
<TITLE>SD of BP at baseline vs endpoint in trials with DBP entry criteria</TITLE>
<TABLE COLS="4" ROWS="7">
<TR>
<TH>
<P/>
</TH>
<TH>
<P/>
</TH>
<TH>
<P>ACE Inhibitor</P>
</TH>
<TH>
<P>Placebo</P>
</TH>
</TR>
<TR>
<TD>
<P>Weighted mean SD of SBP</P>
</TD>
<TD>
<P>At baseline (SD)</P>
</TD>
<TD>
<P>14.8 (3.0)</P>
</TD>
<TD>
<P>14.9 (2.8)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>At endpoint (SD)</P>
</TD>
<TD>
<P>16.6 (3.1)</P>
</TD>
<TD>
<P>16.8 (3.0)</P>
</TD>
</TR>
<TR>
<TD>
<P>t-test</P>
</TD>
<TD>
<P>baseline vs endpoint</P>
</TD>
<TD>
<P>p = 0.06</P>
</TD>
<TD>
<P>p = 0.05</P>
</TD>
</TR>
<TR>
<TD>
<P>Weighted mean SD of DBP</P>
</TD>
<TD>
<P>At baseline (SD)</P>
</TD>
<TD>
<P>5.1 (1.5)</P>
</TD>
<TD>
<P>5.1 (1.6)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>At endpoint (SD)</P>
</TD>
<TD>
<P>9.0 (1.7)</P>
</TD>
<TD>
<P>8.9 (1.8)</P>
</TD>
</TR>
<TR>
<TD>
<P>t-test</P>
</TD>
<TD>
<P>baseline vs endpoint</P>
</TD>
<TD>
<P>p &lt; 0.0001</P>
</TD>
<TD>
<P>p &lt; 0.0001</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2008-05-02 14:01:46 -0700" MODIFIED_BY="Ciprian D Jauca" NO="5">
<TITLE>Change in pulse pressure according to proportions of Max</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TH>
<P/>
</TH>
<TH>
<P>Proportion of recommended maximum dose (Max)</P>
</TH>
<TH>
<P>Number of studies</P>
</TH>
<TH>
<P>Weighted mean change from baseline in pulse pressure (95% CI)</P>
</TH>
</TR>
<TR>
<TD>
<P>ACE inhibitors</P>
</TD>
<TD>
<P>1/8 Max</P>
</TD>
<TD>
<P>18</P>
</TD>
<TD>
<P>-1.2 (-2.0, -0.4)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>1/4 Max</P>
</TD>
<TD>
<P>40</P>
</TD>
<TD>
<P>-1.8 (-2.6, -0.9)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>1/2 Max</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD>
<P>-2.5 (-3.2, -1.9)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Max</P>
</TD>
<TD>
<P>16</P>
</TD>
<TD>
<P>-3.7 (-5.5, -1.9)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>2 Max</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>-4.1 (-6.3, -1.9)</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>1/2 Max and above</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD>
<P>-2.9 (-3.5, -2.3)</P>
</TD>
</TR>
<TR>
<TD>
<P>Placebo</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>74</P>
</TD>
<TD>
<P>0.6 (0.1, 1.1)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2008-08-12 15:44:57 -0700" MODIFIED_BY="[Empty name]" NO="6">
<TITLE>Comparison of manufacturers' dosage recommendations and findings of this review</TITLE>
<TABLE COLS="5" ROWS="14">
<TR>
<TH>
<P>ACE Inhibitor</P>
</TH>
<TH>
<P>Lowest effective dose (mg/day)</P>
</TH>
<TH>
<P>Manufacturer's recommended starting dose (mg/day)</P>
</TH>
<TH>
<P>Lowest dose with near maximal BP lowering (mg/day)</P>
</TH>
<TH>
<P>Manufacturer's recommended maximum dose (mg/day)</P>
</TH>
</TR>
<TR>
<TD>
<P>benazepril</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>40</P>
</TD>
</TR>
<TR>
<TD>
<P>captopril</P>
</TD>
<TD>
<P>37.5</P>
</TD>
<TD>
<P>50</P>
</TD>
<TD>
<P>37.5</P>
</TD>
<TD>
<P>150</P>
</TD>
</TR>
<TR>
<TD>
<P>cilazapril</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>10</P>
</TD>
</TR>
<TR>
<TD>
<P>enalapril</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>40</P>
</TD>
</TR>
<TR>
<TD>
<P>fosinopril</P>
</TD>
<TD>
<P>10-20</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>20</P>
</TD>
<TD>
<P>40</P>
</TD>
</TR>
<TR>
<TD>
<P>imidapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>30</P>
</TD>
</TR>
<TR>
<TD>
<P>lisinopril</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>80</P>
</TD>
</TR>
<TR>
<TD>
<P>moexipril</P>
</TD>
<TD>
<P>15</P>
</TD>
<TD>
<P>7.5</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>30</P>
</TD>
</TR>
<TR>
<TD>
<P>perindopril</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>8</P>
</TD>
</TR>
<TR>
<TD>
<P>quinapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>10</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>40</P>
</TD>
</TR>
<TR>
<TD>
<P>ramipril</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>2.5</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>20</P>
</TD>
</TR>
<TR>
<TD>
<P>temocapril</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>Not estimable</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>trandolapril</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-07-07 22:38:36 -0700" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" NO="1">
<NAME>Benazepril vs Placebo</NAME>
<CONT_OUTCOME CHI2="17.40175864145502" CI_END="-4.327758215180719" CI_START="-8.049019304054138" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.188388759617428" ESTIMABLE="YES" I2="13.801815614965925" I2_Q="36.600235839223494" ID="CMP-001.01" NO="1" P_CHI2="0.2954199063863333" P_Q="0.14912729717275364" P_Z="7.088713338304112E-11" Q="9.463757601344543" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="638" TOTAL_2="359" UNITS="" WEIGHT="700.0" Z="6.518768128067367">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Benazepril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Benazepril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="12.270966662978992" CI_START="-11.870966662978994" DF="0.0" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.01" NO="1" P_CHI2="1.0" P_Z="0.9740940351857844" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="7" WEIGHT="100.0" Z="0.03247401868072688">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="12.270966662978992" CI_START="-11.870966662978994" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="-2.3" MEAN_2="-2.5" ORDER="1" SD_1="15.9" SD_2="14.3" SE="6.158769629540766" STUDY_ID="STD-Moser-1991" TOTAL_1="29" TOTAL_2="7" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.1732435509179986" CI_START="-12.173243550917999" DF="0.0" EFFECT_SIZE="-5.5" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" NO="2" P_CHI2="1.0" P_Z="0.10622915032951986" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="24" WEIGHT="100.0" Z="1.6153766654429067">
<NAME>4 mg</NAME>
<CONT_DATA CI_END="1.1732435509179986" CI_START="-12.173243550917999" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="-3.9" ORDER="2" SD_1="13.9" SD_2="13.4" SE="3.4047786610140247" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="24" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.074045125495581" CI_END="3.060476964118684" CI_START="-16.091857509824827" DF="1.0" EFFECT_SIZE="-6.515690272853072" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.03" NO="3" P_CHI2="0.785535648308288" P_Z="0.18234382972570198" STUDIES="2" TAU2="0.0" TOTAL_1="50" TOTAL_2="10" WEIGHT="100.0" Z="1.3335730207285272">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="7.101253436990113" CI_START="-17.901253436990114" EFFECT_SIZE="-5.4" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-2.5" ORDER="3" SD_1="15.2" SD_2="14.3" SE="6.378307731977936" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="6" WEIGHT="58.67813804247885"/>
<CONT_DATA CI_END="6.7971016323326054" CI_START="-22.99710163233261" EFFECT_SIZE="-8.100000000000001" ESTIMABLE="YES" MEAN_1="-5.9" MEAN_2="2.2" ORDER="4" SD_1="13.9" SD_2="13.4" SE="7.6007017219903235" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="4" WEIGHT="41.32186195752115"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0978770209351747" CI_END="0.6084685885859886" CI_START="-5.975460382454385" DF="2.0" EFFECT_SIZE="-2.683495896934198" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.04" NO="4" P_CHI2="0.9522396829168613" P_Z="0.1101108644965944" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="126" WEIGHT="100.0" Z="1.597695034009742">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="7.272764651856988" CI_START="-16.07276465185699" EFFECT_SIZE="-4.4" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-2.5" ORDER="5" SD_1="13.7" SD_2="14.3" SE="5.955601604891858" STUDY_ID="STD-Moser-1991" TOTAL_1="30" TOTAL_2="7" WEIGHT="7.953583118353934"/>
<CONT_DATA CI_END="1.0208475480770147" CI_START="-6.020847548077015" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="-5.5" MEAN_2="-3.0" ORDER="6" SD_1="13.9" SD_2="13.4" SE="1.7963837988090652" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" WEIGHT="87.42101435514986"/>
<CONT_DATA CI_END="12.106657854992992" CI_START="-18.50665785499299" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="2.2" ORDER="7" SD_1="13.9" SD_2="13.4" SE="7.809662818158882" STUDY_ID="STD-Weinberger-1990" TOTAL_1="12" TOTAL_2="4" WEIGHT="4.6254025264962015"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.765949017271581" CI_END="-5.457017571887835" CI_START="-11.136114365575867" DF="5.0" EFFECT_SIZE="-8.296565968731851" ESTIMABLE="YES" I2="35.61636847113046" ID="CMP-001.01.05" NO="5" P_CHI2="0.16961518736998993" P_Z="1.0246068613211315E-8" STUDIES="6" TAU2="0.0" TOTAL_1="260" TOTAL_2="162" WEIGHT="100.0" Z="5.726604453070131">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="2.8946171675547934" CI_START="-8.894617167554793" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-6.5" ORDER="8" SD_1="13.8" SD_2="13.1" SE="3.0075130023055427" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="23.205308210423684"/>
<CONT_DATA CI_END="-8.21997203940238" CI_START="-17.380027960597623" EFFECT_SIZE="-12.8" ESTIMABLE="YES" MEAN_1="-14.9" MEAN_2="-2.1" ORDER="9" SD_1="14.8" SD_2="14.1" SE="2.3367918985880842" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="38.438133570713156"/>
<CONT_DATA CI_END="-1.426756449082001" CI_START="-14.773243550917998" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-3.9" ORDER="10" SD_1="13.9" SD_2="13.4" SE="3.4047786610140247" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="24" WEIGHT="18.106086857603305"/>
<CONT_DATA CI_END="5.068892838085532" CI_START="-20.06889283808553" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.5" ORDER="11" SD_1="15.7" SD_2="14.3" SE="6.412818264635144" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="6" WEIGHT="5.103927577711878"/>
<CONT_DATA CI_END="6.615402055121692" CI_START="-26.815402055121695" EFFECT_SIZE="-10.100000000000001" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="2.2" ORDER="12" SD_1="13.9" SD_2="13.4" SE="8.528423066429104" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="3" WEIGHT="2.8857911420611426"/>
<CONT_DATA CI_END="3.709437103497934" CI_START="-12.509437103497934" EFFECT_SIZE="-4.3999999999999995" ESTIMABLE="YES" MEAN_1="-9.7" MEAN_2="-5.3" ORDER="13" SD_1="13.9" SD_2="13.4" SE="4.137543938288733" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="14" WEIGHT="12.260752641486837"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.2987640814296313E-4" CI_END="-1.3549039583100244" CI_START="-15.997546824945452" DF="1.0" EFFECT_SIZE="-8.676225391627739" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.06" NO="6" P_CHI2="0.9909072386023378" P_Z="0.020196331681393367" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="17" WEIGHT="100.00000000000001" Z="2.322680330897083">
<NAME>40 mg (Max Dose)</NAME>
<CONT_DATA CI_END="6.415257643000865" CI_START="-23.615257643000866" EFFECT_SIZE="-8.600000000000001" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="2.2" ORDER="14" SD_1="13.9" SD_2="13.4" SE="7.660986508649803" STUDY_ID="STD-Weinberger-1990" TOTAL_1="14" TOTAL_2="4" WEIGHT="23.774608372262097"/>
<CONT_DATA CI_END="-0.31429380440123467" CI_START="-17.085706195598764" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-5.3" ORDER="15" SD_1="13.9" SD_2="13.4" SE="4.278500146810933" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="76.22539162773792"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.8490296522806275" CI_START="-19.95097034771937" DF="0.0" EFFECT_SIZE="-11.399999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.07" NO="7" P_CHI2="1.0" P_Z="0.008975425343652466" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="13" WEIGHT="100.0" Z="2.612988762113515">
<NAME>80 mg</NAME>
<CONT_DATA CI_END="-2.8490296522806275" CI_START="-19.95097034771937" EFFECT_SIZE="-11.399999999999999" ESTIMABLE="YES" MEAN_1="-16.7" MEAN_2="-5.3" ORDER="16" SD_1="13.9" SD_2="13.4" SE="4.36282014117011" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="13" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.134103502804926" CI_END="-2.1819751475905202" CI_START="-4.348124640625061" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.2650498941077903" ESTIMABLE="YES" I2="17.282924972387814" I2_Q="53.92302406241357" ID="CMP-001.02" NO="2" P_CHI2="0.2556810579388791" P_Q="0.04269285920973265" P_Z="3.4517286105978392E-9" Q="13.02168789923909" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="638" TOTAL_2="359" UNITS="" WEIGHT="700.0" Z="5.908530524560196">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Benazepril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Benazepril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.743909052340715" CI_START="-6.543909052340714" DF="0.0" EFFECT_SIZE="1.1" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" NO="1" P_CHI2="1.0" P_Z="0.7779055896549777" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="7" WEIGHT="100.0" Z="0.28204945509311924">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="8.743909052340715" CI_START="-6.543909052340714" EFFECT_SIZE="1.1" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-4.7" ORDER="17" SD_1="7.7" SD_2="9.6" SE="3.900025262012411" STUDY_ID="STD-Moser-1991" TOTAL_1="29" TOTAL_2="7" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.24610366741493062" CI_START="-7.953896332585071" DF="0.0" EFFECT_SIZE="-4.1000000000000005" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.02" NO="2" P_CHI2="1.0" P_Z="0.03705803212605706" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="24" WEIGHT="100.0" Z="2.0851241556941496">
<NAME>4 mg</NAME>
<CONT_DATA CI_END="-0.24610366741493062" CI_START="-7.953896332585071" EFFECT_SIZE="-4.1000000000000005" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="-5.3" ORDER="18" SD_1="8.1" SD_2="7.7" SE="1.9663097704774741" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="24" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.08292426497264248" CI_END="4.5297396497637745" CI_START="-8.603990925094546" DF="1.0" EFFECT_SIZE="-2.0371256376653855" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.03" NO="3" P_CHI2="0.7733729782065929" P_Z="0.5431835597964789" STUDIES="2" TAU2="0.0" TOTAL_1="50" TOTAL_2="10" WEIGHT="99.99999999999999" Z="0.6080059064787718">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="6.9640518194142045" CI_START="-9.564051819414203" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.7" ORDER="19" SD_1="9.2" SD_2="9.6" SE="4.216430446987797" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="6" WEIGHT="63.1437181167307"/>
<CONT_DATA CI_END="7.5168883460130065" CI_START="-14.116888346013008" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-5.0" ORDER="20" SD_1="10.2" SD_2="9.7" SE="5.518921996187299" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="4" WEIGHT="36.85628188326928"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2594828736172116" CI_END="1.2247197321699703" CI_START="-2.667675418533603" DF="2.0" EFFECT_SIZE="-0.7214778431818162" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.04" NO="4" P_CHI2="0.8783225093604417" P_Z="0.4674825480514837" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="125" WEIGHT="100.0" Z="0.7265812095282235">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="6.448937072455834" CI_START="-9.048937072455834" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.7" ORDER="21" SD_1="8.6" SD_2="9.6" SE="3.9536119712292983" STUDY_ID="STD-Moser-1991" TOTAL_1="30" TOTAL_2="7" WEIGHT="6.30796951973708"/>
<CONT_DATA CI_END="1.437956061200838" CI_START="-2.637956061200839" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-4.1" ORDER="22" SD_1="8.1" SD_2="7.7" SE="1.0397926070458314" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" WEIGHT="91.19777059175789"/>
<CONT_DATA CI_END="8.622989426179133" CI_START="-16.02298942617913" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-5.0" ORDER="23" SD_1="9.9" SD_2="9.7" SE="6.287355034776812" STUDY_ID="STD-Weinberger-1990" TOTAL_1="12" TOTAL_2="3" WEIGHT="2.494259888505038"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.661594194251479" CI_END="-2.925393521175762" CI_START="-6.143312727918561" DF="5.0" EFFECT_SIZE="-4.534353124547161" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.05" NO="5" P_CHI2="0.45855802272908386" P_Z="3.3221769130821744E-8" STUDIES="6" TAU2="0.0" TOTAL_1="260" TOTAL_2="162" WEIGHT="100.0" Z="5.52355000006029">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="0.9893751520552083" CI_START="-5.58937515205521" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-7.0" ORDER="24" SD_1="7.4" SD_2="7.6" SE="1.6782834674521472" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="23.925634595099762"/>
<CONT_DATA CI_END="-3.9959900988745347" CI_START="-9.004009901125466" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-3.5" ORDER="25" SD_1="8.1" SD_2="7.7" SE="1.2775795478267844" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="41.28746294937126"/>
<CONT_DATA CI_END="0.053896332585070095" CI_START="-7.65389633258507" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-5.3" ORDER="26" SD_1="8.1" SD_2="7.7" SE="1.9663097704774741" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="24" WEIGHT="17.429712521694412"/>
<CONT_DATA CI_END="5.3587925580107045" CI_START="-10.958792558010703" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-4.7" ORDER="27" SD_1="8.3" SD_2="9.6" SE="4.162725755353781" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="6" WEIGHT="3.8890049720057553"/>
<CONT_DATA CI_END="8.575328477574931" CI_START="-12.77532847757493" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-5.0" ORDER="28" SD_1="9.6" SD_2="9.7" SE="5.446696246349708" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="4" WEIGHT="2.271578693111538"/>
<CONT_DATA CI_END="0.5084149312700594" CI_START="-9.108414931270062" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-4.5" ORDER="29" SD_1="8.1" SD_2="7.7" SE="2.4533180044114196" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="13" WEIGHT="11.196606268717277"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.10841427072450183" CI_END="-0.31131881944855433" CI_START="-9.14855365767675" DF="1.0" EFFECT_SIZE="-4.729936238562653" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.06" NO="6" P_CHI2="0.7419567753829068" P_Z="0.035900240977933685" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="17" WEIGHT="100.0" Z="2.098055522220868">
<NAME>40 mg (Max Dose)</NAME>
<CONT_DATA CI_END="4.478935169254827" CI_START="-17.27893516925483" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-11.4" MEAN_2="-5.0" ORDER="30" SD_1="10.1" SD_2="9.7" SE="5.5505791203647" STUDY_ID="STD-Weinberger-1990" TOTAL_1="14" TOTAL_2="4" WEIGHT="16.496811928132605"/>
<CONT_DATA CI_END="0.4354274538095293" CI_START="-9.23542745380953" EFFECT_SIZE="-4.4" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-4.5" ORDER="31" SD_1="8.1" SD_2="7.7" SE="2.4671001569165374" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="83.5031880718674"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.9957915320385364" CI_START="-11.604208467961465" DF="0.0" EFFECT_SIZE="-6.800000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.07" NO="7" P_CHI2="1.0" P_Z="0.005534048047773559" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="14" WEIGHT="100.0" Z="2.774183340242861">
<NAME>80 mg</NAME>
<CONT_DATA CI_END="-1.9957915320385364" CI_START="-11.604208467961465" EFFECT_SIZE="-6.800000000000001" ESTIMABLE="YES" MEAN_1="-11.3" MEAN_2="-4.5" ORDER="32" SD_1="8.1" SD_2="7.7" SE="2.451171810225314" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Captopril vs Placebo</NAME>
<CONT_OUTCOME CHI2="3.9478057501090613" CI_END="-7.630648964667673" CI_START="-11.727102508424851" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.678875736546262" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="0.8618016443485852" P_Q="0.7426703513451343" P_Z="2.010317794427559E-20" Q="2.722531290530927" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="573" TOTAL_2="293" UNITS="" WEIGHT="600.0" Z="9.261790791392773">
<NAME>Change in SBP</NAME>
<GROUP_LABEL_1>Captopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Captopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.2467425193253368" CI_START="-14.953257480674662" DF="0.0" EFFECT_SIZE="-8.6" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.01" NO="1" P_CHI2="1.0" P_Z="0.007976133956894811" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="28" WEIGHT="100.00000000000001" Z="2.6530784118723507">
<NAME>37.5 mg</NAME>
<CONT_DATA CI_END="-2.2467425193253368" CI_START="-14.953257480674662" EFFECT_SIZE="-8.6" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-1.6" ORDER="33" SD_1="15.5" SD_2="14.6" SE="3.241517461947437" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="83" TOTAL_2="28" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1815796797415248" CI_END="-5.1625396620902695" CI_START="-11.336944700597355" DF="2.0" EFFECT_SIZE="-8.249742181343812" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.02" NO="2" P_CHI2="0.5538898459005577" P_Z="1.6277362206971876E-7" STUDIES="3" TAU2="0.0" TOTAL_1="170" TOTAL_2="154" WEIGHT="100.0" Z="5.237491695583464">
<NAME>50 mg</NAME>
<CONT_DATA CI_END="0.614048046431372" CI_START="-11.414048046431372" EFFECT_SIZE="-5.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-2.2" ORDER="34" SD_1="13.9" SD_2="13.4" SE="3.0684482438807117" STUDY_ID="STD-Drayer-1983" TOTAL_1="77" TOTAL_2="26" WEIGHT="26.35096069326399"/>
<CONT_DATA CI_END="-5.016210296082976" CI_START="-13.783789703917021" EFFECT_SIZE="-9.399999999999999" ESTIMABLE="YES" MEAN_1="-20.4" MEAN_2="-11.0" ORDER="35" SD_1="10.3" SD_2="13.9" SE="2.236668499266209" STUDY_ID="STD-Kayanakis-1987" TOTAL_1="41" TOTAL_2="80" WEIGHT="49.59419157532899"/>
<CONT_DATA CI_END="-2.7054626641495165" CI_START="-15.294537335850483" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-5.0" ORDER="36" SD_1="18.0" SD_2="14.0" SE="3.2115576538655763" STUDY_ID="STD-Muiesan-1987" TOTAL_1="52" TOTAL_2="48" WEIGHT="24.054847731407015"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.04369477983660969" CI_END="-3.233455261417693" CI_START="-15.085105774041448" DF="1.0" EFFECT_SIZE="-9.15928051772957" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.03" NO="3" P_CHI2="0.8344226361054967" P_Z="0.0024501743709684108" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="32" WEIGHT="100.0" Z="3.0294278286265635">
<NAME>75 mg</NAME>
<CONT_DATA CI_END="9.148304890787141" CI_START="-24.14830489078714" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-8.0" ORDER="37" SD_1="11.9" SD_2="16.5" SE="8.49418919026413" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="12.669446435285764"/>
<CONT_DATA CI_END="-3.058883471788847" CI_START="-15.741116528211155" EFFECT_SIZE="-9.4" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-1.6" ORDER="38" SD_1="14.7" SD_2="14.6" SE="3.235322984620672" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="84" TOTAL_2="27" WEIGHT="87.33055356471424"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-5.831975090769765" CI_START="-18.168024909230233" DF="0.0" EFFECT_SIZE="-12.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.04" NO="4" P_CHI2="1.0" P_Z="1.3721005562283256E-4" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="25" WEIGHT="100.0" Z="3.813144103760741">
<NAME>100 mg</NAME>
<CONT_DATA CI_END="-5.831975090769765" CI_START="-18.168024909230233" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-2.2" ORDER="39" SD_1="13.9" SD_2="13.4" SE="3.147009311335733" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="25" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-5.936576542996404" CI_START="-18.063423457003594" DF="0.0" EFFECT_SIZE="-12.0" ESTIMABLE="YES" I2="0.0" ID="CMP-002.01.05" NO="5" P_CHI2="1.0" P_Z="1.0491888196426188E-4" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="28" WEIGHT="100.0" Z="3.8789254917227036">
<NAME>150 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-5.936576542996404" CI_START="-18.063423457003594" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="-13.6" MEAN_2="-1.6" ORDER="40" SD_1="13.2" SD_2="14.6" SE="3.0936402427958405" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="89" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.237189992144966E-31" CI_END="-6.080806185134926" CI_START="-18.31919381486507" DF="0.0" EFFECT_SIZE="-12.199999999999998" ESTIMABLE="YES" I2="100.0" ID="CMP-002.01.06" NO="6" P_CHI2="0.0" P_Z="9.320493086377643E-5" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="26" WEIGHT="100.0" Z="3.907632497813915">
<NAME>200 mg</NAME>
<CONT_DATA CI_END="-6.080806185134928" CI_START="-18.31919381486507" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-14.4" MEAN_2="-2.2" ORDER="41" SD_1="13.9" SD_2="13.4" SE="3.1220950298742687" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="26" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.041800901301533" CI_END="-4.400354333325694" CI_START="-6.468329050437221" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.434341691881458" ESTIMABLE="YES" I2="0.46230725225896274" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="0.43342473558901873" P_Q="0.6102939615272395" P_Z="6.972543004673458E-25" Q="3.5868166441512397" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="660" TOTAL_2="383" UNITS="" WEIGHT="600.0" Z="10.301009879510728">
<NAME>Change in DBP</NAME>
<GROUP_LABEL_1>Captopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Captopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.061769267215416" CI_START="-8.738230732784583" DF="0.0" EFFECT_SIZE="-5.3999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.01" NO="1" P_CHI2="1.0" P_Z="0.0015218546636619904" STUDIES="1" TAU2="0.0" TOTAL_1="83" TOTAL_2="28" WEIGHT="100.00000000000001" Z="3.170483517682978">
<NAME>37.5 mg</NAME>
<CONT_DATA CI_END="-2.061769267215416" CI_START="-8.738230732784583" EFFECT_SIZE="-5.3999999999999995" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-3.2" ORDER="42" SD_1="9.1" SD_2="7.3" SE="1.7032102421861428" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="83" TOTAL_2="28" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.362721003511114" CI_END="-3.150968429715985" CI_START="-6.017721221344839" DF="3.0" EFFECT_SIZE="-4.584344825530412" ESTIMABLE="YES" I2="44.0582495707716" ID="CMP-002.02.02" NO="2" P_CHI2="0.1470839745646242" P_Z="3.644923092484771E-10" STUDIES="4" TAU2="0.0" TOTAL_1="257" TOTAL_2="243" WEIGHT="100.0" Z="6.268521497207238">
<NAME>50 mg</NAME>
<CONT_DATA CI_END="0.6251517276075917" CI_START="-6.4251517276075925" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.1" ORDER="43" SD_1="8.1" SD_2="7.7" SE="1.7985798491265854" STUDY_ID="STD-Drayer-1983" TOTAL_1="76" TOTAL_2="25" WEIGHT="16.533502602578846"/>
<CONT_DATA CI_END="-3.112554334235936" CI_START="-8.487445665764065" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-14.9" MEAN_2="-9.1" ORDER="44" SD_1="7.4" SD_2="6.6" SE="1.3711709434266615" STUDY_ID="STD-Kayanakis-1987" TOTAL_1="41" TOTAL_2="80" WEIGHT="28.44730386550766"/>
<CONT_DATA CI_END="-3.8168372480595467" CI_START="-10.783162751940452" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-3.3" ORDER="45" SD_1="10.0" SD_2="7.7" SE="1.7771565086987293" STUDY_ID="STD-Muiesan-1987" TOTAL_1="52" TOTAL_2="48" WEIGHT="16.934522752071928"/>
<CONT_DATA CI_END="-0.877342648216044" CI_START="-5.5226573517839554" EFFECT_SIZE="-3.1999999999999997" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-3.4" ORDER="46" SD_1="8.1" SD_2="7.7" SE="1.1850510367051539" STUDY_ID="STD-Schoenberger-1986" TOTAL_1="88" TOTAL_2="90" WEIGHT="38.08467077984157"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.09226325363917974" CI_END="-2.684865511700478" CI_START="-9.158911956706673" DF="1.0" EFFECT_SIZE="-5.921888734203575" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.03" NO="3" P_CHI2="0.761319394434423" P_Z="3.3629686635845165E-4" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="32" WEIGHT="100.00000000000001" Z="3.5856056140732218">
<NAME>75 mg</NAME>
<CONT_DATA CI_END="18.340010256156003" CI_START="-23.740010256156" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-6.4" ORDER="47" SD_1="14.0" SD_2="21.3" SE="10.734896366523527" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="2.3670080544371173"/>
<CONT_DATA CI_END="-2.7239726723476925" CI_START="-9.276027327652306" EFFECT_SIZE="-5.999999999999999" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-3.2" ORDER="48" SD_1="8.3" SD_2="7.3" SE="1.6714732278211193" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="84" TOTAL_2="27" WEIGHT="97.63299194556289"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.8914623878332644" CI_START="-9.908537612166736" DF="0.0" EFFECT_SIZE="-6.4" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.04" NO="4" P_CHI2="1.0" P_Z="3.499427916198094E-4" STUDIES="1" TAU2="0.0" TOTAL_1="71" TOTAL_2="26" WEIGHT="100.0" Z="3.575213062433099">
<NAME>100 mg</NAME>
<CONT_DATA CI_END="-2.8914623878332644" CI_START="-9.908537612166736" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-4.1" ORDER="49" SD_1="8.1" SD_2="7.7" SE="1.790103103853761" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="26" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-4.168836810752266" CI_START="-10.431163189247734" DF="0.0" EFFECT_SIZE="-7.3" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.05" NO="5" P_CHI2="1.0" P_Z="4.889734320007611E-6" STUDIES="1" TAU2="0.0" TOTAL_1="89" TOTAL_2="28" WEIGHT="100.0" Z="4.569463877281927">
<NAME>150 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-4.168836810752266" CI_START="-10.431163189247734" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-3.2" ORDER="50" SD_1="7.6" SD_2="7.3" SE="1.5975615949813107" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="89" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.1692144731094993" CI_START="-10.230785526890504" DF="0.0" EFFECT_SIZE="-6.700000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-002.02.06" NO="6" P_CHI2="1.0" P_Z="1.9984105688034237E-4" STUDIES="1" TAU2="0.0" TOTAL_1="68" TOTAL_2="26" WEIGHT="100.0" Z="3.719217323285922">
<NAME>200 mg</NAME>
<CONT_DATA CI_END="-3.1692144731094993" CI_START="-10.230785526890504" EFFECT_SIZE="-6.700000000000001" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-4.1" ORDER="51" SD_1="8.1" SD_2="7.7" SE="1.8014542893343384" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="26" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Cilazapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="14.158312735573581" CI_END="-3.3171503107202054" CI_START="-7.836164491906429" CI_STUDY="95" CI_TOTAL="95" DF="14.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.576657401313317" ESTIMABLE="YES" I2="1.1181610304158012" I2_Q="0.0" ID="CMP-003.01" NO="1" P_CHI2="0.43798459171311255" P_Q="0.8909572370589547" P_Z="1.3157545297377618E-6" Q="0.23091770066116268" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="479" TOTAL_2="226" UNITS="" WEIGHT="300.0" Z="4.837359310000545">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Cilazapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Cilazapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.758854822690505" CI_END="-1.9954750682242945" CI_START="-8.324756378189095" DF="8.0" EFFECT_SIZE="-5.160115723206695" ESTIMABLE="YES" I2="8.663858895396142" ID="CMP-003.01.01" NO="1" P_CHI2="0.3630456125752609" P_Z="0.00139431156162304" STUDIES="9" TAU2="0.0" TOTAL_1="236" TOTAL_2="125" WEIGHT="100.00000000000001" Z="3.1958260277106323">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="6.996942518114464" CI_START="-20.996942518114466" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="0.0" ORDER="52" SD_1="15.0" SD_2="9.0" SE="7.14142842854285" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" WEIGHT="5.111901158138056"/>
<CONT_DATA CI_END="0.26452217154217195" CI_START="-18.064522171542173" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-11.3" MEAN_2="-2.4" ORDER="53" SD_1="13.9" SD_2="13.4" SE="4.675862538205168" STUDY_ID="STD-Guntzel-1991" TOTAL_1="28" TOTAL_2="12" WEIGHT="11.924197305525812"/>
<CONT_DATA CI_END="26.402704418317366" CI_START="-32.40270441831737" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-2.0" ORDER="54" SD_1="22.1" SD_2="26.8" SE="15.001655464203498" STUDY_ID="STD-Krum-1992" TOTAL_1="6" TOTAL_2="5" WEIGHT="1.1584418805258136"/>
<CONT_DATA CI_END="10.089741815791232" CI_START="-6.289741815791231" EFFECT_SIZE="1.9" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-5.5" ORDER="55" SD_1="16.4" SD_2="15.8" SE="4.178516483155236" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="22" WEIGHT="14.931670049544149"/>
<CONT_DATA CI_END="1.7906748188240762" CI_START="-11.990674818824075" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-7.7" MEAN_2="-2.6" ORDER="56" SD_1="12.0" SD_2="12.9" SE="3.515715019855895" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="21.09236583025003"/>
<CONT_DATA CI_END="4.6670456279008485" CI_START="-18.26704562790085" EFFECT_SIZE="-6.8" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-2.8" ORDER="57" SD_1="11.2" SD_2="13.3" SE="5.85064099052403" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="7" WEIGHT="7.616329508181152"/>
<CONT_DATA CI_END="6.451605923932528" CI_START="-7.85160592393253" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-11.6" ORDER="58" SD_1="16.4" SD_2="15.0" SE="3.648845581012449" STUDY_ID="STD-Prager-1994" TOTAL_1="54" TOTAL_2="27" WEIGHT="19.581306038600488"/>
<CONT_DATA CI_END="-4.388604820771427" CI_START="-21.41139517922857" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-0.3" ORDER="59" SD_1="15.6" SD_2="11.0" SE="4.342628357646044" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" WEIGHT="13.824431978554259"/>
<CONT_DATA CI_END="4.506087605638783" CI_START="-24.506087605638783" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-4.0" ORDER="60" SD_1="18.0" SD_2="13.0" SE="7.401201103724839" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="4.759356250680259"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.168540212221913" CI_END="-2.1223585312291293" CI_START="-9.376193409718134" DF="4.0" EFFECT_SIZE="-5.749275970473631" ESTIMABLE="YES" I2="22.60870892440183" ID="CMP-003.01.02" NO="2" P_CHI2="0.2704373378524091" P_Z="0.0018907726060822388" STUDIES="5" TAU2="0.0" TOTAL_1="193" TOTAL_2="84" WEIGHT="100.0" Z="3.1068735442892033">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="-2.124898905641915" CI_START="-20.675101094358084" EFFECT_SIZE="-11.4" ESTIMABLE="YES" MEAN_1="-13.8" MEAN_2="-2.4" ORDER="61" SD_1="13.9" SD_2="13.4" SE="4.732281392678079" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="12" WEIGHT="15.291075602112743"/>
<CONT_DATA CI_END="4.727741222791757" CI_START="-11.327741222791758" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-5.5" ORDER="62" SD_1="15.1" SD_2="15.8" SE="4.0958616005771304" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="22" WEIGHT="20.41214339599414"/>
<CONT_DATA CI_END="-2.0093251811759245" CI_START="-15.790674818824076" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-2.6" ORDER="63" SD_1="12.0" SD_2="12.9" SE="3.515715019855895" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="27.70459645469544"/>
<CONT_DATA CI_END="4.154259185694928" CI_START="-24.154259185694926" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-2.8" ORDER="64" SD_1="19.4" SD_2="13.3" SE="7.221693509340946" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="7" WEIGHT="6.566002617921443"/>
<CONT_DATA CI_END="5.918927344046337" CI_START="-7.318927344046339" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-11.6" ORDER="65" SD_1="12.3" SD_2="15.0" SE="3.3770658013390005" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="26" WEIGHT="30.02618192927624"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.07072417472723558" CI_START="-14.070724174727236" DF="0.0" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.03" NO="3" P_CHI2="1.0" P_Z="0.05233599662455083" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="17" WEIGHT="100.0" Z="1.9403596509702121">
<NAME>10 mg (Max Dose)</NAME>
<CONT_DATA CI_END="0.07072417472723558" CI_START="-14.070724174727236" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-2.6" ORDER="66" SD_1="12.7" SD_2="12.9" SE="3.6075786241483034" STUDY_ID="STD-Mroczek-1991" TOTAL_1="50" TOTAL_2="17" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="29.99725218476204" CI_END="-2.2544817831033366" CI_START="-3.9515701500579916" CI_STUDY="95" CI_TOTAL="95" DF="25.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.103025966580664" ESTIMABLE="YES" I2="16.659033147377865" I2_Q="42.86538849841822" ID="CMP-003.02" NO="2" P_CHI2="0.22439201641199846" P_Q="0.13583503551796883" P_Z="7.645943469630546E-13" Q="7.001010236832116" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1054" TOTAL_2="448" UNITS="" WEIGHT="500.0" Z="7.167357052248528">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Cilazapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Cilazapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.446883539979026" CI_START="-3.446883539979026" DF="0.0" EFFECT_SIZE="-0.5" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" NO="1" P_CHI2="1.0" P_Z="0.7394750495810558" STUDIES="1" TAU2="0.0" TOTAL_1="97" TOTAL_2="32" WEIGHT="100.0" Z="0.3325485988757472">
<NAME>0.5 mg</NAME>
<CONT_DATA CI_END="2.446883539979026" CI_START="-3.446883539979026" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-5.4" MEAN_2="-4.9" ORDER="67" SD_1="7.3" SD_2="7.4" SE="1.5035396380870605" STUDY_ID="STD-Pordy-1994" TOTAL_1="97" TOTAL_2="32" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.86332889212094" CI_START="-3.6633288921209393" DF="0.0" EFFECT_SIZE="1.1" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.02" NO="2" P_CHI2="1.0" P_Z="0.6508250480943114" STUDIES="1" TAU2="0.0" TOTAL_1="42" TOTAL_2="14" WEIGHT="100.0" Z="0.4526163176681441">
<NAME>1 mg</NAME>
<CONT_DATA CI_END="5.86332889212094" CI_START="-3.6633288921209393" EFFECT_SIZE="1.1" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-4.5" ORDER="68" SD_1="7.8" SD_2="7.9" SE="2.430314500518106" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="12.504414166931845" CI_END="-1.9409554927914552" CI_START="-4.69598457991264" DF="12.0" EFFECT_SIZE="-3.3184700363520476" ESTIMABLE="YES" I2="4.033888834758669" ID="CMP-003.02.03" NO="3" P_CHI2="0.4060657050740626" P_Z="2.339889429001304E-6" STUDIES="13" TAU2="0.0" TOTAL_1="369" TOTAL_2="189" WEIGHT="99.99999999999999" Z="4.721606596046254">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="3.5837273836744172" CI_START="-7.583727383674417" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-6.0" ORDER="69" SD_1="6.8" SD_2="7.6" SE="2.848892850949378" STUDY_ID="STD-Boeijinga-1993" TOTAL_1="14" TOTAL_2="12" WEIGHT="6.0861685101801735"/>
<CONT_DATA CI_END="4.6419454066507395" CI_START="-4.6419454066507395" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-4.5" ORDER="70" SD_1="7.8" SD_2="7.9" SE="2.3683830127827923" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="15" WEIGHT="8.806276727805393"/>
<CONT_DATA CI_END="6.365538411601468" CI_START="-12.365538411601468" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.0" ORDER="71" SD_1="11.0" SD_2="4.0" SE="4.778423728943817" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" WEIGHT="2.1633504919188917"/>
<CONT_DATA CI_END="-1.248719734235153" CI_START="-10.351280265764846" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.4" ORDER="72" SD_1="6.8" SD_2="6.7" SE="2.3221244378288395" STUDY_ID="STD-Guntzel-1991" TOTAL_1="28" TOTAL_2="12" WEIGHT="9.160627538360604"/>
<CONT_DATA CI_END="-1.8590404707060344" CI_START="-11.340959529293967" EFFECT_SIZE="-6.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-4.3" ORDER="73" SD_1="7.5" SD_2="7.4" SE="2.4189013505809545" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="14" WEIGHT="8.442282671274222"/>
<CONT_DATA CI_END="3.357263002613596" CI_START="-15.357263002613596" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-2.0" ORDER="74" SD_1="8.1" SD_2="7.7" SE="4.774201503916649" STUDY_ID="STD-Krum-1992" TOTAL_1="6" TOTAL_2="5" WEIGHT="2.167178646901009"/>
<CONT_DATA CI_END="4.1100960660212795" CI_START="-3.91009606602128" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-3.1" ORDER="75" SD_1="8.1" SD_2="7.7" SE="2.046004976444672" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="22" WEIGHT="11.800022409185333"/>
<CONT_DATA CI_END="0.7039973808939042" CI_START="-6.903997380893905" EFFECT_SIZE="-3.1000000000000005" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-3.3" ORDER="76" SD_1="6.7" SD_2="7.1" SE="1.9408506538382084" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="13.113299097254"/>
<CONT_DATA CI_END="3.9091404954851257" CI_START="-10.309140495485126" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-4.4" MEAN_2="-1.2" ORDER="77" SD_1="8.1" SD_2="7.7" SE="3.627179147964513" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.754552584740788"/>
<CONT_DATA CI_END="1.8658428144384018" CI_START="-6.265842814438402" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-7.7" ORDER="78" SD_1="9.0" SD_2="8.7" SE="2.074447717666881" STUDY_ID="STD-Prager-1994" TOTAL_1="54" TOTAL_2="27" WEIGHT="11.478660627145166"/>
<CONT_DATA CI_END="-2.3772746546627985" CI_START="-12.4227253453372" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-1.7" ORDER="79" SD_1="9.8" SD_2="5.5" SE="2.5626620616275693" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" WEIGHT="7.521656990062144"/>
<CONT_DATA CI_END="-0.025196872625598665" CI_START="-15.9748031273744" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.0" ORDER="80" SD_1="7.0" SD_2="10.0" SE="4.068851871911234" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="2.983681383149881"/>
<CONT_DATA CI_END="1.0927376980077708" CI_START="-6.69273769800777" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-3.7" ORDER="81" SD_1="8.1" SD_2="7.7" SE="1.986127157801464" STUDY_ID="STD-Yodfat-1993" TOTAL_1="48" TOTAL_2="23" WEIGHT="12.522242322022391"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.13666723394948" CI_END="-2.1114311060974926" CI_START="-4.866780257892277" DF="8.0" EFFECT_SIZE="-3.4891056819948845" ESTIMABLE="YES" I2="21.07859698494793" ID="CMP-003.02.04" NO="4" P_CHI2="0.2555645404220145" P_Z="6.912185252240558E-7" STUDIES="9" TAU2="0.0" TOTAL_1="404" TOTAL_2="165" WEIGHT="100.0" Z="4.963814818539095">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="2.9633288921209395" CI_START="-6.563328892120939" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-4.5" ORDER="82" SD_1="7.8" SD_2="7.9" SE="2.430314500518106" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="14" WEIGHT="8.36511949914455"/>
<CONT_DATA CI_END="-0.9513518526429028" CI_START="-10.248648147357097" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.4" ORDER="83" SD_1="7.0" SD_2="6.7" SE="2.371802841289452" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="12" WEIGHT="8.782940400028732"/>
<CONT_DATA CI_END="-3.459040470706033" CI_START="-12.940959529293966" EFFECT_SIZE="-8.2" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.3" ORDER="84" SD_1="7.5" SD_2="7.4" SE="2.4189013505809545" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="14" WEIGHT="8.444244344504249"/>
<CONT_DATA CI_END="2.1439632762336536" CI_START="-5.943963276233653" EFFECT_SIZE="-1.9" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-3.1" ORDER="85" SD_1="8.1" SD_2="7.7" SE="2.0632844828435215" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="22" WEIGHT="11.605901533293"/>
<CONT_DATA CI_END="-2.0960026191060948" CI_START="-9.703997380893904" EFFECT_SIZE="-5.8999999999999995" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-3.3" ORDER="86" SD_1="6.7" SD_2="7.1" SE="1.9408506538382084" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="13.116346141376786"/>
<CONT_DATA CI_END="1.4091404954851257" CI_START="-12.809140495485126" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-1.2" ORDER="87" SD_1="8.1" SD_2="7.7" SE="3.627179147964513" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="7" WEIGHT="3.755425003443525"/>
<CONT_DATA CI_END="1.8039316279980127" CI_START="-4.203931627998012" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="-6.1" MEAN_2="-4.9" ORDER="88" SD_1="7.4" SD_2="7.4" SE="1.5326463402861692" STUDY_ID="STD-Pordy-1994" TOTAL_1="94" TOTAL_2="31" WEIGHT="21.033580144565807"/>
<CONT_DATA CI_END="1.4345728890759224" CI_START="-6.234572889075921" EFFECT_SIZE="-2.3999999999999995" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-7.7" ORDER="89" SD_1="7.1" SD_2="8.7" SE="1.9564506895649836" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="26" WEIGHT="12.908009990266232"/>
<CONT_DATA CI_END="0.7789220826401686" CI_START="-7.1789220826401685" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-3.7" ORDER="90" SD_1="8.1" SD_2="7.7" SE="2.030099590617684" STUDY_ID="STD-Yodfat-1993" TOTAL_1="46" TOTAL_2="22" WEIGHT="11.988432943377122"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3551605470485992" CI_END="-1.6737603567091877" CI_START="-6.444601850600254" DF="1.0" EFFECT_SIZE="-4.059181103654721" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.05" NO="5" P_CHI2="0.5512065289428068" P_Z="8.523890641500373E-4" STUDIES="2" TAU2="0.0" TOTAL_1="142" TOTAL_2="48" WEIGHT="100.0" Z="3.3351972728819645">
<NAME>10 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-1.0930812617599135" CI_START="-8.906918738240089" EFFECT_SIZE="-5.000000000000001" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-3.3" ORDER="91" SD_1="7.1" SD_2="7.1" SE="1.993362515361182" STUDY_ID="STD-Mroczek-1991" TOTAL_1="50" TOTAL_2="17" WEIGHT="37.27874024364806"/>
<CONT_DATA CI_END="-0.48798170195247703" CI_START="-6.512018298047523" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.9" ORDER="92" SD_1="7.4" SD_2="7.4" SE="1.5367722681671392" STUDY_ID="STD-Pordy-1994" TOTAL_1="92" TOTAL_2="31" WEIGHT="62.721259756351934"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" NO="4">
<NAME>Enalapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="46.34838581640413" CI_END="-5.917158027072436" CI_START="-8.018544506471173" CI_STUDY="95" CI_TOTAL="95" DF="19.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.967851266771805" ESTIMABLE="YES" I2="59.006123589151386" I2_Q="85.54857662554102" ID="CMP-004.01" NO="1" P_CHI2="4.423471452450478E-4" P_Q="9.88098906728685E-4" P_Z="1.2585571617520472E-38" Q="13.83946721493706" RANDOM="NO" SCALE="100.0" SORT_BY="USER" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1340" TOTAL_2="1245" UNITS="" WEIGHT="300.0" Z="12.99783515920602">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Enalapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Enalapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.4351985157777216" CI_END="-3.1764491812585134" CI_START="-7.947088215978374" DF="3.0" EFFECT_SIZE="-5.561768698618444" ESTIMABLE="YES" I2="0.0" ID="CMP-004.01.01" NO="1" P_CHI2="0.4871162836982469" P_Z="4.877670034801112E-6" STUDIES="4" TAU2="0.0" TOTAL_1="299" TOTAL_2="253" WEIGHT="99.99999999999999" Z="4.569981614747959">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="0.20652410484025285" CI_START="-12.60652410484025" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-2.0" ORDER="93" SD_1="17.1" SD_2="17.8" SE="3.268694810401669" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" WEIGHT="13.86271179415668"/>
<CONT_DATA CI_END="-3.7387001967916635" CI_START="-10.061299803208337" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="0.4" ORDER="94" SD_1="13.9" SD_2="13.4" SE="1.6129377009701535" STUDY_ID="STD-Cushman-1998" TOTAL_1="140" TOTAL_2="147" WEIGHT="56.932696640724"/>
<CONT_DATA CI_END="2.196682304568296" CI_START="-7.996682304568297" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-4.0" ORDER="95" SD_1="13.9" SD_2="13.4" SE="2.600395897460502" STUDY_ID="STD-Gradman-1997" TOTAL_1="85" TOTAL_2="40" WEIGHT="21.903725943350615"/>
<CONT_DATA CI_END="6.92794023274611" CI_START="-10.72794023274611" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="-7.5" ORDER="96" SD_1="10.6" SD_2="10.6" SE="4.504133903673627" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="18" TOTAL_2="8" WEIGHT="7.300865621768693"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="12.728877334602277" CI_END="-3.8399926822803674" CI_START="-6.997818433154533" DF="7.0" EFFECT_SIZE="-5.4189055577174505" ESTIMABLE="YES" I2="45.00693332183235" ID="CMP-004.01.02" NO="2" P_CHI2="0.07899635455486331" P_Z="1.7356424660739423E-11" STUDIES="8" TAU2="0.0" TOTAL_1="607" TOTAL_2="515" WEIGHT="100.0" Z="6.726691443193163">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="-3.188455044245875" CI_START="-12.211544955754125" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-0.4" ORDER="1" SD_1="12.9" SD_2="12.9" SE="2.3018509479462965" STUDY_ID="STD-White-2002" TOTAL_1="99" TOTAL_2="46" WEIGHT="12.248016250949503"/>
<CONT_DATA CI_END="0.6484103815978219" CI_START="-13.44841038159782" EFFECT_SIZE="-6.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-1.2" ORDER="1" SD_1="15.3" SD_2="15.2" SE="3.5961938266186433" STUDY_ID="STD-Whelton-1992" TOTAL_1="35" TOTAL_2="37" WEIGHT="5.018038258479975"/>
<CONT_DATA CI_END="-0.1779622441004447" CI_START="-15.622037755899555" EFFECT_SIZE="-7.9" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="3.7" ORDER="1" SD_1="17.8" SD_2="12.4" SE="3.939887577940209" STUDY_ID="STD-Levine-1995" TOTAL_1="31" TOTAL_2="29" WEIGHT="4.180733564091866"/>
<CONT_DATA CI_END="0.28605417447190007" CI_START="-18.2860541744719" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-1.2" ORDER="1" SD_1="21.8" SD_2="20.3" SE="4.737869801546921" STUDY_ID="STD-Gerritsen-1998" TOTAL_1="40" TOTAL_2="39" WEIGHT="2.8910387084503455"/>
<CONT_DATA CI_END="-1.84214009992886" CI_START="-5.757859900071139" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-4.8" ORDER="1" SD_1="13.4" SD_2="11.4" SE="0.9989264677894537" STUDY_ID="STD-Waeber-1999" TOTAL_1="318" TOTAL_2="300" WEIGHT="65.03589325624439"/>
<CONT_DATA CI_END="-7.680909953630103" CI_START="-20.519090046369897" EFFECT_SIZE="-14.1" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-3.9" ORDER="98" SD_1="15.3" SD_2="15.9" SE="3.275106122869022" STUDY_ID="STD-Kuppers-1997" TOTAL_1="47" TOTAL_2="44" WEIGHT="6.050195337599197"/>
<CONT_DATA CI_END="5.339096021516564" CI_START="-11.539096021516563" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-7.5" ORDER="100" SD_1="10.6" SD_2="10.6" SE="4.305740354457059" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="25" TOTAL_2="8" WEIGHT="3.500454812763485"/>
<CONT_DATA CI_END="3.0239290432927426" CI_START="-27.42392904329274" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="2.1" ORDER="101" SD_1="18.0" SD_2="20.0" SE="7.767453465154029" STUDY_ID="STD-Simon-1983" TOTAL_1="12" TOTAL_2="12" WEIGHT="1.0756298114212268"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.344842751087075" CI_END="-7.8643736192127465" CI_START="-11.35148061398317" DF="7.0" EFFECT_SIZE="-9.607927116597958" ESTIMABLE="YES" I2="59.64218240282819" ID="CMP-004.01.03" NO="3" P_CHI2="0.015302928288597584" P_Z="3.424592296407745E-27" STUDIES="8" TAU2="0.0" TOTAL_1="434" TOTAL_2="477" WEIGHT="100.00000000000001" Z="10.800466485748045">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="-3.4881047514761963" CI_START="-11.311895248523802" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-13.1" MEAN_2="-5.7" ORDER="1" SD_1="13.3" SD_2="14.2" SE="1.9959015978764578" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="19.86534541860038"/>
<CONT_DATA CI_END="-5.751280081616442" CI_START="-16.84871991838356" EFFECT_SIZE="-11.3" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="2.5" ORDER="1" SD_1="13.0" SD_2="13.1" SE="2.831031571065159" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="9.873814130066323"/>
<CONT_DATA CI_END="-2.756274958550298" CI_START="-11.643725041449702" EFFECT_SIZE="-7.2" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-1.8" ORDER="1" SD_1="13.5" SD_2="13.8" SE="2.2672483150207032" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="15.394876066733628"/>
<CONT_DATA CI_END="-3.3948616190742857" CI_START="-12.805138380925714" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-0.9" ORDER="1" SD_1="11.5" SD_2="11.4" SE="2.4006249186409776" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="13.731745732296954"/>
<CONT_DATA CI_END="-6.988197773693704" CI_START="-14.811802226306293" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-3.8" ORDER="105" SD_1="13.6" SD_2="11.7" SE="1.995854136689292" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="19.866290221198856"/>
<CONT_DATA CI_END="-0.2424708022045543" CI_START="-11.757529197795446" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.0" ORDER="106" SD_1="13.9" SD_2="13.4" SE="2.9375688753518436" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="39" WEIGHT="9.170610677469247"/>
<CONT_DATA CI_END="-14.485483185481645" CI_START="-26.914516814518354" EFFECT_SIZE="-20.7" ESTIMABLE="YES" MEAN_1="-21.9" MEAN_2="-1.2" ORDER="109" SD_1="17.1" SD_2="14.4" SE="3.170730107051798" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="7.871469552038294"/>
<CONT_DATA CI_END="-2.3183893717722857" CI_START="-19.281610628227718" EFFECT_SIZE="-10.8" ESTIMABLE="YES" MEAN_1="-18.3" MEAN_2="-7.5" ORDER="110" SD_1="10.6" SD_2="10.6" SE="4.327431878916948" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="8" WEIGHT="4.225848201596334"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="55.68696616062933" CI_END="-3.1939467671923247" CI_START="-4.341800964170222" CI_STUDY="95" CI_TOTAL="95" DF="21.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.7678738656812736" ESTIMABLE="YES" I2="62.289200780977374" I2_Q="88.2715850831559" ID="CMP-004.02" NO="2" P_CHI2="5.610039219394736E-5" P_Q="1.981872539719154E-4" P_Z="6.875649457462031E-38" Q="17.052602710428005" RANDOM="NO" SCALE="100.0" SORT_BY="USER" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1477" TOTAL_2="1331" UNITS="" WEIGHT="300.0" Z="12.867308573629243">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Enalapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Enalapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.2745758453692646" CI_END="-1.2523097771672915" CI_START="-3.672056237152715" DF="4.0" EFFECT_SIZE="-2.4621830071600033" ESTIMABLE="YES" I2="0.0" ID="CMP-004.02.01" NO="1" P_CHI2="0.8656741389042345" P_Z="6.644362964162597E-5" STUDIES="5" TAU2="0.0" TOTAL_1="400" TOTAL_2="302" WEIGHT="99.99999999999999" Z="3.9886741005164676">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="-1.0446979958580411" CI_START="-6.355302004141958" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-5.0" ORDER="1" SD_1="8.1" SD_2="7.7" SE="1.3547708147122302" STUDY_ID="STD-Guitard-1997" TOTAL_1="101" TOTAL_2="50" WEIGHT="20.76117305340764"/>
<CONT_DATA CI_END="0.676225633097292" CI_START="-5.476225633097291" EFFECT_SIZE="-2.3999999999999995" ESTIMABLE="YES" MEAN_1="-5.6" MEAN_2="-3.2" ORDER="113" SD_1="8.9" SD_2="7.8" SE="1.5695317145428012" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" WEIGHT="15.468327613383881"/>
<CONT_DATA CI_END="-0.4697921898483701" CI_START="-4.13020781015163" EFFECT_SIZE="-2.3" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-3.5" ORDER="114" SD_1="8.1" SD_2="7.7" SE="0.9337966537079636" STUDY_ID="STD-Cushman-1998" TOTAL_1="140" TOTAL_2="147" WEIGHT="43.69974737943535"/>
<CONT_DATA CI_END="1.3673484241221652" CI_START="-4.567348424122164" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.4" ORDER="115" SD_1="8.1" SD_2="7.7" SE="1.5139810973712937" STUDY_ID="STD-Gradman-1997" TOTAL_1="85" TOTAL_2="39" WEIGHT="16.62427242909778"/>
<CONT_DATA CI_END="5.017064453133744" CI_START="-8.017064453133745" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-5.4" ORDER="117" SD_1="8.1" SD_2="7.7" SE="3.325093983634147" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="18" TOTAL_2="8" WEIGHT="3.446479524675358"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="23.7256108458562" CI_END="-2.2028181530802033" CI_START="-3.991946093593131" DF="7.0" EFFECT_SIZE="-3.097382123336667" ESTIMABLE="YES" I2="70.4960178033832" ID="CMP-004.02.02" NO="2" P_CHI2="0.0012729988555362226" P_Z="1.1506545959215747E-11" STUDIES="8" TAU2="0.0" TOTAL_1="607" TOTAL_2="515" WEIGHT="99.99999999999999" Z="6.786275336304494">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="-0.5259731763340678" CI_START="-6.074026823665932" EFFECT_SIZE="-3.3" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-2.7" ORDER="1" SD_1="8.0" SD_2="7.9" SE="1.4153458153043126" STUDY_ID="STD-White-2002" TOTAL_1="99" TOTAL_2="46" WEIGHT="10.399237394152092"/>
<CONT_DATA CI_END="-2.3363992805054816" CI_START="-8.263600719494518" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-1.5" ORDER="1" SD_1="7.7" SD_2="5.6" SE="1.5120689680376898" STUDY_ID="STD-Gerritsen-1998" TOTAL_1="40" TOTAL_2="39" WEIGHT="9.111364516529022"/>
<CONT_DATA CI_END="-3.5335500093847623" CI_START="-13.066449990615236" EFFECT_SIZE="-8.299999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="0.1" ORDER="1" SD_1="11.1" SD_2="7.5" SE="2.431906926970284" STUDY_ID="STD-Levine-1995" TOTAL_1="31" TOTAL_2="29" WEIGHT="3.522351748544339"/>
<CONT_DATA CI_END="-0.44802445612516384" CI_START="-2.7519755438748374" EFFECT_SIZE="-1.6000000000000005" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="-5.8" ORDER="1" SD_1="7.8" SD_2="6.8" SE="0.5877534245330387" STUDY_ID="STD-Waeber-1999" TOTAL_1="318" TOTAL_2="300" WEIGHT="60.302634548082565"/>
<CONT_DATA CI_END="0.8280596235304598" CI_START="-7.6280596235304605" EFFECT_SIZE="-3.4000000000000004" ESTIMABLE="YES" MEAN_1="-8.5" MEAN_2="-5.1" ORDER="1" SD_1="9.1" SD_2="9.2" SE="2.157212916605027" STUDY_ID="STD-Whelton-1992" TOTAL_1="35" TOTAL_2="37" WEIGHT="4.47652071714263"/>
<CONT_DATA CI_END="-4.572532860650113" CI_START="-10.627467139349886" EFFECT_SIZE="-7.6" ESTIMABLE="YES" MEAN_1="-12.1" MEAN_2="-4.5" ORDER="119" SD_1="8.1" SD_2="6.6" SE="1.5446544748934987" STUDY_ID="STD-Kuppers-1997" TOTAL_1="47" TOTAL_2="44" WEIGHT="8.730998808341758"/>
<CONT_DATA CI_END="2.3089883406154827" CI_START="-10.108988340615483" EFFECT_SIZE="-3.9000000000000004" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-5.4" ORDER="121" SD_1="8.1" SD_2="7.7" SE="3.167909405270296" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="25" TOTAL_2="8" WEIGHT="2.0757790103121616"/>
<CONT_DATA CI_END="-0.8880354783536291" CI_START="-16.11196452164637" EFFECT_SIZE="-8.5" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="1.1" ORDER="122" SD_1="10.0" SD_2="9.0" SE="3.8837267325770144" STUDY_ID="STD-Simon-1983" TOTAL_1="12" TOTAL_2="12" WEIGHT="1.3811132568954196"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.634176758975869" CI_END="-4.383904245238912" CI_START="-6.288131513420086" DF="8.0" EFFECT_SIZE="-5.336017879329499" ESTIMABLE="YES" I2="41.32392339175658" ID="CMP-004.02.03" NO="3" P_CHI2="0.09181309127966253" P_Z="4.542158969784603E-28" STUDIES="9" TAU2="0.0" TOTAL_1="470" TOTAL_2="514" WEIGHT="100.0" Z="10.984406156873254">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="-1.80942837700211" CI_START="-6.790571622997891" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="-2.9" ORDER="1" SD_1="7.6" SD_2="7.7" SE="1.2707231574881996" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="14.614349773819281"/>
<CONT_DATA CI_END="-3.8072023435700277" CI_START="-10.992797656429973" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-1.4" ORDER="1" SD_1="8.4" SD_2="8.5" SE="1.8330937123179314" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="7.0228283057217835"/>
<CONT_DATA CI_END="-0.7419618771852332" CI_START="-6.658038122814766" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-3.4" ORDER="1" SD_1="6.6" SD_2="6.2" SE="1.509230856356236" STUDY_ID="STD-Oparil-1999" TOTAL_1="36" TOTAL_2="36" WEIGHT="10.360245215024012"/>
<CONT_DATA CI_END="-1.2262714980440963" CI_START="-6.773728501955904" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-1.8" ORDER="1" SD_1="6.8" SD_2="6.7" SE="1.4151936075533633" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="11.782831578641744"/>
<CONT_DATA CI_END="-2.665473531417828" CI_START="-7.3345264685821725" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-4.5" ORDER="1" SD_1="8.4" SD_2="7.5" SE="1.1911068198174144" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="16.633359108440338"/>
<CONT_DATA CI_END="-3.347453568100355" CI_START="-7.852546431899644" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.6" ORDER="126" SD_1="6.7" SD_2="7.8" SE="1.1492795019028121" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="17.86611251316383"/>
<CONT_DATA CI_END="-0.39170793875296495" CI_START="-7.008292061247033" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.4" ORDER="127" SD_1="8.1" SD_2="7.7" SE="1.6879351290852382" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="40" WEIGHT="8.28266093032431"/>
<CONT_DATA CI_END="-6.743710042056022" CI_START="-12.45628995794398" EFFECT_SIZE="-9.600000000000001" ESTIMABLE="YES" MEAN_1="-11.9" MEAN_2="-2.3" ORDER="131" SD_1="7.5" SD_2="7.0" SE="1.457317573421772" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="11.111507466623175"/>
<CONT_DATA CI_END="0.7427237433625011" CI_START="-11.7427237433625" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.4" ORDER="132" SD_1="8.1" SD_2="7.7" SE="3.1851216617265976" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="8" WEIGHT="2.3261051082415225"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" NO="5">
<NAME>Fosinopril vs Placebo</NAME>
<CONT_OUTCOME CHI2="11.269060171373626" CI_END="-3.9373559215334413" CI_START="-8.961767838715856" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.449561880124649" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.01" NO="1" P_CHI2="0.5060119556373417" P_Q="0.42200538345434246" P_Z="4.859050432529291E-7" Q="3.8834763761132463" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="481" TOTAL_2="168" UNITS="" WEIGHT="500.0" Z="5.031796440844168">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Fosinopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Fosinopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.211120610152854" CI_START="-13.011120610152854" DF="0.0" EFFECT_SIZE="-2.9" ESTIMABLE="YES" I2="0.0" ID="CMP-005.01.01" NO="1" P_CHI2="1.0" P_Z="0.5740186038767108" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="9" WEIGHT="100.0" Z="0.5621429883309671">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="7.211120610152852" CI_START="-13.011120610152853" EFFECT_SIZE="-2.9" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-3.4" ORDER="135" SD_1="13.9" SD_2="13.4" SE="5.158829799888203" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7017529223547973E-32" CI_END="2.972215421177697" CI_START="-10.372215421177698" DF="0.0" EFFECT_SIZE="-3.7000000000000006" ESTIMABLE="YES" I2="100.0" ID="CMP-005.01.02" NO="2" P_CHI2="0.0" P_Z="0.27709190032859976" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="20" WEIGHT="99.99999999999999" Z="1.08687539071066">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="2.9722154211776974" CI_START="-10.372215421177698" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-4.1" ORDER="136" SD_1="13.9" SD_2="13.4" SE="3.404254095385059" STUDY_ID="STD-Pool-1990" TOTAL_1="74" TOTAL_2="20" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3725829775031504" CI_END="1.303856912730886" CI_START="-9.028609197597563" DF="2.0" EFFECT_SIZE="-3.8623761424333383" ESTIMABLE="YES" I2="0.0" ID="CMP-005.01.03" NO="3" P_CHI2="0.8300316643360183" P_Z="0.1428371419567692" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="34" WEIGHT="99.99999999999999" Z="1.4653071305695191">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="6.576415640176203" CI_START="-20.376415640176205" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-5.6" ORDER="137" SD_1="13.9" SD_2="13.4" SE="6.875848610727774" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="5" WEIGHT="14.69600170191615"/>
<CONT_DATA CI_END="2.7379415852376656" CI_START="-10.937941585237665" EFFECT_SIZE="-4.1" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-4.1" ORDER="138" SD_1="13.9" SD_2="13.4" SE="3.488809814452957" STUDY_ID="STD-Pool-1990" TOTAL_1="71" TOTAL_2="19" WEIGHT="57.08174154937455"/>
<CONT_DATA CI_END="7.92474281495481" CI_START="-11.524742814954811" EFFECT_SIZE="-1.8000000000000003" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-3.4" ORDER="139" SD_1="13.9" SD_2="13.4" SE="4.9616946493212835" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="10" WEIGHT="28.22225674870929"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.321363828374704" CI_END="-4.793001301195525" CI_START="-13.72079355050683" DF="4.0" EFFECT_SIZE="-9.256897425851177" ESTIMABLE="YES" I2="36.72251576400014" ID="CMP-005.01.04" NO="4" P_CHI2="0.17639992937288385" P_Z="4.815034541376711E-5" STUDIES="5" TAU2="0.0" TOTAL_1="138" TOTAL_2="70" WEIGHT="100.0" Z="4.0644282610069515">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="3.1400828585161253" CI_START="-14.740082858516123" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="140" SD_1="12.9" SD_2="13.3" SE="4.561350580436353" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="24.931308462217906"/>
<CONT_DATA CI_END="7.290690988838177" CI_START="-20.090690988838176" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-5.6" ORDER="141" SD_1="13.9" SD_2="13.4" SE="6.985174777102335" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="5" WEIGHT="10.63108091438636"/>
<CONT_DATA CI_END="7.046251042870823" CI_START="-19.446251042870827" EFFECT_SIZE="-6.200000000000001" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-4.1" ORDER="142" SD_1="14.5" SD_2="24.2" SE="6.758415535874925" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="11.356439637747341"/>
<CONT_DATA CI_END="-2.239907624451811" CI_START="-15.76009237554819" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-13.1" MEAN_2="-4.1" ORDER="143" SD_1="13.9" SD_2="13.4" SE="3.449090100058437" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="19" WEIGHT="43.603655409366084"/>
<CONT_DATA CI_END="-11.900039253544783" CI_START="-40.899960746455214" EFFECT_SIZE="-26.4" ESTIMABLE="YES" MEAN_1="-22.9" MEAN_2="3.5" ORDER="144" SD_1="20.2" SD_2="15.1" SE="7.3980750977207" STUDY_ID="STD-Zamboulis-1996" TOTAL_1="12" TOTAL_2="11" WEIGHT="9.477515576282299"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6916369893825257" CI_END="-2.7191679216585944" CI_START="-12.905105927008773" DF="2.0" EFFECT_SIZE="-7.812136924333683" ESTIMABLE="YES" I2="0.0" ID="CMP-005.01.05" NO="5" P_CHI2="0.7076410028127786" P_Z="0.002643601358509269" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="35" WEIGHT="100.0" Z="3.0064009825991755">
<NAME>40 mg (Max Dose)</NAME>
<CONT_DATA CI_END="0.6023648905345205" CI_START="-24.80236489053452" EFFECT_SIZE="-12.1" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-5.6" ORDER="145" SD_1="13.9" SD_2="13.4" SE="6.48091750191797" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="6" WEIGHT="16.075811215547475"/>
<CONT_DATA CI_END="-1.0399076244518115" CI_START="-14.56009237554819" EFFECT_SIZE="-7.800000000000001" ESTIMABLE="YES" MEAN_1="-11.9" MEAN_2="-4.1" ORDER="146" SD_1="13.9" SD_2="13.4" SE="3.449090100058437" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="19" WEIGHT="56.759270467058165"/>
<CONT_DATA CI_END="4.471625882971166" CI_START="-15.071625882971164" EFFECT_SIZE="-5.299999999999999" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-3.4" ORDER="147" SD_1="13.9" SD_2="13.4" SE="4.985615021525142" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="10" WEIGHT="27.164918317394367"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="32.695640130033354" CI_END="-3.7008384935834613" CI_START="-6.508250385693405" CI_STUDY="95" CI_TOTAL="95" DF="12.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.104544439638433" ESTIMABLE="YES" I2="63.29785882070216" I2_Q="58.40760299597878" ID="CMP-005.02" NO="2" P_CHI2="0.0010796902394031305" P_Q="0.04739513796587469" P_Z="1.0230925969634472E-12" Q="9.617142285916518" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="481" TOTAL_2="168" UNITS="" WEIGHT="500.0" Z="7.127364023279359">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Fosinopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Fosinopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.909543543771878" CI_START="-6.309543543771879" DF="0.0" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.01" NO="1" P_CHI2="1.0" P_Z="0.8067826692118879" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="10" WEIGHT="100.0" Z="0.24457868603253896">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="4.909543543771878" CI_START="-6.309543543771879" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-4.2" ORDER="148" SD_1="8.1" SD_2="7.7" SE="2.862064603237224" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.72342883075431" CI_START="-7.1234288307543085" DF="0.0" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.02" NO="2" P_CHI2="1.0" P_Z="0.109915662958061" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="19" WEIGHT="100.0" Z="1.5985723256568807">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="0.72342883075431" CI_START="-7.1234288307543085" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.9" ORDER="149" SD_1="8.1" SD_2="7.7" SE="2.001786186737009" STUDY_ID="STD-Pool-1990" TOTAL_1="74" TOTAL_2="19" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.09520947890435684" CI_END="-0.4693299536150888" CI_START="-6.421070996648929" DF="2.0" EFFECT_SIZE="-3.4452004751320087" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.03" NO="3" P_CHI2="0.9535105996827896" P_Z="0.02326385839524153" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="34" WEIGHT="100.0" Z="2.26907347008398">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="4.270314669433346" CI_START="-11.270314669433347" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="-0.7" ORDER="150" SD_1="8.1" SD_2="7.7" SE="3.9645191088839367" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="5" WEIGHT="14.66732278829355"/>
<CONT_DATA CI_END="0.7649498385609079" CI_START="-6.964949838560907" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-4.9" ORDER="151" SD_1="8.1" SD_2="7.7" SE="1.9719494179725436" STUDY_ID="STD-Pool-1990" TOTAL_1="71" TOTAL_2="20" WEIGHT="59.2843877590851"/>
<CONT_DATA CI_END="1.6307500782313147" CI_START="-10.030750078231314" EFFECT_SIZE="-4.2" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.2" ORDER="152" SD_1="8.1" SD_2="7.7" SE="2.9749271538780953" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="9" WEIGHT="26.048289452621347"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="22.662582090790643" CI_END="-5.455896662942185" CI_START="-10.116095259848176" DF="4.0" EFFECT_SIZE="-7.78599596139518" ESTIMABLE="YES" I2="82.3497605701979" ID="CMP-005.02.04" NO="4" P_CHI2="1.478742198098848E-4" P_Z="5.784855569166443E-11" STUDIES="5" TAU2="0.0" TOTAL_1="138" TOTAL_2="71" WEIGHT="100.0" Z="6.5491937095730215">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="1.3569551483579216" CI_START="-9.356955148357923" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-6.5" ORDER="153" SD_1="7.7" SD_2="8.0" SE="2.7331906048340175" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="18.91963866473113"/>
<CONT_DATA CI_END="4.700172731872" CI_START="-10.100172731872" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-0.7" ORDER="154" SD_1="8.1" SD_2="7.7" SE="3.775667711367973" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="6" WEIGHT="9.914370495950129"/>
<CONT_DATA CI_END="-1.3202189406903013" CI_START="-12.479781059309698" EFFECT_SIZE="-6.8999999999999995" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.7" ORDER="155" SD_1="9.0" SD_2="7.4" SE="2.8468793831531083" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="17.438717469251774"/>
<CONT_DATA CI_END="-1.8041394782905016" CI_START="-9.595860521709497" EFFECT_SIZE="-5.699999999999999" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-4.9" ORDER="156" SD_1="8.1" SD_2="7.7" SE="1.9877204644776885" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="19" WEIGHT="35.7719041330663"/>
<CONT_DATA CI_END="-14.101081805389779" CI_START="-25.098918194610224" EFFECT_SIZE="-19.6" ESTIMABLE="YES" MEAN_1="-16.6" MEAN_2="3.0" ORDER="157" SD_1="7.6" SD_2="5.8" SE="2.805622061417958" STUDY_ID="STD-Zamboulis-1996" TOTAL_1="12" TOTAL_2="11" WEIGHT="17.95536923700066"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.32070627442183464" CI_END="-1.761865547091809" CI_START="-7.694025095511634" DF="2.0" EFFECT_SIZE="-4.727945321301721" ESTIMABLE="YES" I2="0.0" ID="CMP-005.02.05" NO="5" P_CHI2="0.8518429389965465" P_Z="0.0017829410470511905" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="34" WEIGHT="100.0" Z="3.1241919489823617">
<NAME>40 mg (Max Dose)</NAME>
<CONT_DATA CI_END="2.229712687729979" CI_START="-13.429712687729978" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-0.7" ORDER="158" SD_1="8.1" SD_2="7.7" SE="3.9948247771335357" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="5" WEIGHT="14.350730316473387"/>
<CONT_DATA CI_END="-0.1041394782905023" CI_START="-7.895860521709498" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-4.9" ORDER="159" SD_1="8.1" SD_2="7.7" SE="1.9877204644776885" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="19" WEIGHT="57.96406767029625"/>
<CONT_DATA CI_END="-0.1628579462169748" CI_START="-11.437142053783024" EFFECT_SIZE="-5.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.2" ORDER="160" SD_1="8.1" SD_2="7.7" SE="2.8761457344359806" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="10" WEIGHT="27.685202013230363"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" NO="6">
<NAME>Imidapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="1.0583579335878732" CI_END="-3.775347762092892" CI_START="-14.831680416371938" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-9.303514089232415" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.01" NO="1" P_CHI2="0.7871349624305719" P_Q="0.7871349624305719" P_Z="9.720939905065398E-4" Q="1.0583579335878732" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="127" TOTAL_2="35" UNITS="" WEIGHT="400.0" Z="3.298481171783362">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Imidapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Imidapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.1554246780370905" CI_START="-15.95542467803709" DF="0.0" EFFECT_SIZE="-4.8999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.01" NO="1" P_CHI2="1.0" P_Z="0.3850124329583373" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="8" WEIGHT="100.0" Z="0.8686978387474701">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="6.1554246780370905" CI_START="-15.95542467803709" EFFECT_SIZE="-4.8999999999999995" ESTIMABLE="YES" MEAN_1="-10.7" MEAN_2="-5.8" ORDER="161" SD_1="12.1" SD_2="14.8" SE="5.640626442751432" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="33" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="2.219768974365053" CI_START="-20.01976897436505" DF="0.0" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.02" NO="2" P_CHI2="1.0" P_Z="0.11671580678020947" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0" Z="1.5687088016504884">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="2.219768974365053" CI_START="-20.01976897436505" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-5.8" ORDER="162" SD_1="15.6" SD_2="14.8" SE="5.673455768614306" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.5839905654036794" CI_START="-24.216009434596316" DF="0.0" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.03" NO="3" P_CHI2="1.0" P_Z="0.025462320466459427" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0" Z="2.2343155108432136">
<NAME>20 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-1.5839905654036794" CI_START="-24.216009434596316" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" MEAN_1="-18.7" MEAN_2="-5.8" ORDER="163" SD_1="16.7" SD_2="14.8" SE="5.773580292217386" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.1562169513333096" CI_START="-21.356216951333305" DF="0.0" EFFECT_SIZE="-10.599999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-006.01.04" NO="4" P_CHI2="1.0" P_Z="0.053421419376367005" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="9" WEIGHT="100.0" Z="1.9314986235517766">
<NAME>40 mg</NAME>
<CONT_DATA CI_END="0.1562169513333096" CI_START="-21.356216951333305" EFFECT_SIZE="-10.599999999999998" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-5.8" ORDER="164" SD_1="13.6" SD_2="14.8" SE="5.487966634171329" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="32" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.7338540807435671" CI_END="-2.0725322815962595" CI_START="-9.442602992298093" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.757567636947177" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-006.02" NO="2" P_CHI2="0.8652137250901476" P_Q="0.8652137250901476" P_Z="0.002196548612371206" Q="0.7338540807435671" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="127" TOTAL_2="35" UNITS="" WEIGHT="400.0" Z="3.0622841082335412">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Imidapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Imidapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.877340090769721" CI_START="-10.277340090769721" DF="0.0" EFFECT_SIZE="-3.2" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.01" NO="1" P_CHI2="1.0" P_Z="0.3755138869788348" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="9" WEIGHT="100.0" Z="0.8861923646580128">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="3.877340090769721" CI_START="-10.277340090769721" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-4.7" ORDER="165" SD_1="7.5" SD_2="10.1" SE="3.610954153543063" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="33" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.3567392425332203" CI_START="-15.15673924253322" DF="0.0" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.02" NO="2" P_CHI2="1.0" P_Z="0.06150832888251965" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="8" WEIGHT="100.0" Z="1.8698235214697931">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="0.3567392425332203" CI_START="-15.15673924253322" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-12.1" MEAN_2="-4.7" ORDER="166" SD_1="9.5" SD_2="10.1" SE="3.9575927433959954" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="8" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.00454300184375" CI_START="-13.60454300184375" DF="0.0" EFFECT_SIZE="-6.3" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.03" NO="3" P_CHI2="1.0" P_Z="0.09094691114419118" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0" Z="1.690423767713548">
<NAME>20 mg (Max Dose)</NAME>
<CONT_DATA CI_END="1.00454300184375" CI_START="-13.60454300184375" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-4.7" ORDER="167" SD_1="8.9" SD_2="10.1" SE="3.726876136225488" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.8894656770552585" CI_START="-13.889465677055256" DF="0.0" EFFECT_SIZE="-6.499999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-006.02.04" NO="4" P_CHI2="1.0" P_Z="0.08469985302287004" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="9" WEIGHT="99.99999999999999" Z="1.7240442619644478">
<NAME>40 mg</NAME>
<CONT_DATA CI_END="0.8894656770552585" CI_START="-13.889465677055256" EFFECT_SIZE="-6.499999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-4.7" ORDER="168" SD_1="9.6" SD_2="10.1" SE="3.7702048279164413" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="32" TOTAL_2="9" WEIGHT="99.99999999999999"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" NO="7">
<NAME>Lisinopril vs Placebo</NAME>
<CONT_OUTCOME CHI2="8.998886988713506" CI_END="-5.2714582674013295" CI_START="-9.397322688367101" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.334390477884215" ESTIMABLE="YES" I2="22.212602416504733" I2_Q="38.63656927751695" ID="CMP-007.01" NO="1" P_CHI2="0.2527361092034882" P_Q="0.16362600216645362" P_Z="3.2078181996224766E-12" Q="6.518540363380357" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="484" TOTAL_2="357" UNITS="" WEIGHT="500.0" Z="6.968305168807117">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Lisinopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Lisinopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="13.397862522244022" CI_START="-6.997862522244023" DF="0.0" EFFECT_SIZE="3.2" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.01" NO="1" P_CHI2="1.0" P_Z="0.5385418174674115" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="10" WEIGHT="100.0" Z="0.6150195432471918">
<NAME>1.25 mg</NAME>
<CONT_DATA CI_END="13.397862522244026" CI_START="-6.9978625222440245" EFFECT_SIZE="3.2" ESTIMABLE="YES" MEAN_1="-2.5" MEAN_2="-5.7" ORDER="169" SD_1="12.4" SD_2="15.1" SE="5.203086690716494" STUDY_ID="STD-Gomez-1989" TOTAL_1="36" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="9.218845359934535" CI_START="-13.218845359934535" DF="0.0" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.02" NO="2" P_CHI2="1.0" P_Z="0.7267847919445758" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="10" WEIGHT="100.0" Z="0.349405651233879">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="9.218845359934535" CI_START="-13.218845359934535" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-7.7" MEAN_2="-5.7" ORDER="170" SD_1="19.2" SD_2="15.1" SE="5.724005873795313" STUDY_ID="STD-Gomez-1989" TOTAL_1="37" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.48034662533315" CI_END="-5.513330060501948" CI_START="-9.983672731483566" DF="3.0" EFFECT_SIZE="-7.748501395992757" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.03" NO="3" P_CHI2="0.4788536220629068" P_Z="1.0871848970764062E-11" STUDIES="4" TAU2="0.0" TOTAL_1="330" TOTAL_2="318" WEIGHT="100.0" Z="6.794460643425064">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="-4.414456911693317" CI_START="-10.385543088306683" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-0.9" ORDER="171" SD_1="14.9" SD_2="14.4" SE="1.5232642598824602" STUDY_ID="STD-Black-1997" TOTAL_1="187" TOTAL_2="183" WEIGHT="56.04991414382416"/>
<CONT_DATA CI_END="-5.150336766965391" CI_START="-19.24966323303461" EFFECT_SIZE="-12.200000000000001" ESTIMABLE="YES" MEAN_1="-13.3" MEAN_2="-1.1" ORDER="172" SD_1="11.2" SD_2="14.8" SE="3.5968330482812205" STUDY_ID="STD-Chan-1997" TOTAL_1="26" TOTAL_2="27" WEIGHT="10.052750332124553"/>
<CONT_DATA CI_END="-1.0935861059109016" CI_START="-10.5064138940891" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.1" ORDER="173" SD_1="15.3" SD_2="14.2" SE="2.401275702621421" STUDY_ID="STD-Chrysant-1994" TOTAL_1="80" TOTAL_2="71" WEIGHT="22.55492584528464"/>
<CONT_DATA CI_END="-2.763208800649985" CI_START="-16.036791199350017" EFFECT_SIZE="-9.4" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-1.2" ORDER="174" SD_1="13.9" SD_2="15.2" SE="3.386180180707491" STUDY_ID="STD-Whelton-1992" TOTAL_1="37" TOTAL_2="37" WEIGHT="11.342409678766648"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.5654578418591936E-32" CI_END="3.0684063285270664" CI_START="-18.66840632852707" DF="0.0" EFFECT_SIZE="-7.800000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-007.01.04" NO="4" P_CHI2="0.0" P_Z="0.15954006190659767" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="9" WEIGHT="100.0" Z="1.4066201260147662">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="3.0684063285270673" CI_START="-18.668406328527066" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-13.5" MEAN_2="-5.7" ORDER="175" SD_1="14.9" SD_2="15.1" SE="5.545207164139581" STUDY_ID="STD-Gomez-1989" TOTAL_1="41" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.1353372454167054" CI_START="-24.464662754583294" DF="0.0" EFFECT_SIZE="-13.8" ESTIMABLE="YES" I2="0.0" ID="CMP-007.01.05" NO="5" P_CHI2="1.0" P_Z="0.011206915579042449" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="10" WEIGHT="100.0" Z="2.5361798688879014">
<NAME>80 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-3.1353372454167054" CI_START="-24.464662754583294" EFFECT_SIZE="-13.8" ESTIMABLE="YES" MEAN_1="-19.5" MEAN_2="-5.7" ORDER="176" SD_1="16.5" SD_2="15.1" SE="5.441254450951545" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="13.416113983071154" CI_END="-3.0986010220385367" CI_START="-5.309664204306197" CI_STUDY="95" CI_TOTAL="95" DF="7.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.204132613172367" ESTIMABLE="YES" I2="47.823937625807254" I2_Q="62.28615451390012" ID="CMP-007.02" NO="2" P_CHI2="0.0625960264776888" P_Q="0.03136538838861769" P_Z="9.097784008151771E-14" Q="10.606184409050178" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="484" TOTAL_2="357" UNITS="" WEIGHT="500.0" Z="7.453381318210215">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Lisinopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Lisinopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.938695158642068" CI_START="-2.338695158642069" DF="0.0" EFFECT_SIZE="2.8" ESTIMABLE="YES" I2="0.0" ID="CMP-007.02.01" NO="1" P_CHI2="1.0" P_Z="0.2855404786560424" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="10" WEIGHT="100.0" Z="1.0679557722903263">
<NAME>1.25 mg</NAME>
<CONT_DATA CI_END="7.9386951586420675" CI_START="-2.338695158642068" EFFECT_SIZE="2.8" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-5.0" ORDER="177" SD_1="7.8" SD_2="7.2" SE="2.621831420972752" STUDY_ID="STD-Gomez-1989" TOTAL_1="36" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.322011146874589" CI_START="-5.322011146874589" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-007.02.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="10" WEIGHT="100.0" Z="0.0">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="5.322011146874589" CI_START="-5.322011146874589" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-5.0" ORDER="178" SD_1="9.0" SD_2="7.2" SE="2.715361705038426" STUDY_ID="STD-Gomez-1989" TOTAL_1="37" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8099295740209773" CI_END="-3.5006462047059284" CI_START="-5.922011933749552" DF="3.0" EFFECT_SIZE="-4.71132906922774" ESTIMABLE="YES" I2="0.0" ID="CMP-007.02.03" NO="3" P_CHI2="0.421868040520997" P_Z="2.4003797028186994E-14" STUDIES="4" TAU2="0.0" TOTAL_1="330" TOTAL_2="318" WEIGHT="99.99999999999999" Z="7.6271297509857705">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="-2.689910539231597" CI_START="-5.910089460768402" EFFECT_SIZE="-4.3" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-3.2" ORDER="179" SD_1="8.1" SD_2="7.7" SE="0.8214893097365987" STUDY_ID="STD-Black-1997" TOTAL_1="187" TOTAL_2="183" WEIGHT="56.540647384566874"/>
<CONT_DATA CI_END="-3.842144600465568" CI_START="-12.357855399534431" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-1.4" ORDER="180" SD_1="8.1" SD_2="7.7" SE="2.1724151224817656" STUDY_ID="STD-Chan-1997" TOTAL_1="26" TOTAL_2="27" WEIGHT="8.08498045965761"/>
<CONT_DATA CI_END="-2.4382422531885766" CI_START="-7.161757746811423" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-5.3" ORDER="181" SD_1="6.9" SD_2="7.8" SE="1.2050005844192377" STUDY_ID="STD-Chrysant-1994" TOTAL_1="80" TOTAL_2="71" WEIGHT="26.277866028509706"/>
<CONT_DATA CI_END="0.014145289428536323" CI_START="-8.014145289428537" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-5.1" ORDER="182" SD_1="8.4" SD_2="9.2" SE="2.048070944717149" STUDY_ID="STD-Whelton-1992" TOTAL_1="37" TOTAL_2="37" WEIGHT="9.096506127265798"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.971886631645452" CI_START="-10.171886631645451" DF="0.0" EFFECT_SIZE="-4.6" ESTIMABLE="YES" I2="0.0" ID="CMP-007.02.04" NO="4" P_CHI2="1.0" P_Z="0.1056424186558881" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="10" WEIGHT="100.0" Z="1.6180936413312763">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="0.971886631645452" CI_START="-10.171886631645451" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-5.0" ORDER="183" SD_1="10.9" SD_2="7.2" SE="2.8428515399240917" STUDY_ID="STD-Gomez-1989" TOTAL_1="41" TOTAL_2="10" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.263007840552023E-32" CI_END="-0.28031262377598587" CI_START="-11.719687376224016" DF="0.0" EFFECT_SIZE="-6.000000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-007.02.05" NO="5" P_CHI2="0.0" P_Z="0.03978071875200618" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="9" WEIGHT="100.0" Z="2.056018648173709">
<NAME>80 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-0.280312623775985" CI_START="-11.719687376224016" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.0" ORDER="184" SD_1="10.5" SD_2="7.2" SE="2.9182614687515582" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="9" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" NO="8">
<NAME>Moexipril vs Placebo</NAME>
<CONT_OUTCOME CHI2="8.307037311541851" CI_END="-3.3012849678523843" CI_START="-9.029411423932304" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.165348195892344" ESTIMABLE="YES" I2="27.772083175026054" I2_Q="78.41037681691355" ID="CMP-008.01" NO="1" P_CHI2="0.21646094071622857" P_Q="0.03138368533432012" P_Z="2.4524481628735426E-5" Q="4.631854810617589" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="274" TOTAL_2="159" UNITS="" WEIGHT="200.0" Z="4.2191318605656845">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Moexipril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Moexipril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.293319203293703" CI_END="3.047452391149738" CI_START="-6.70760272871965" DF="2.0" EFFECT_SIZE="-1.830075168784956" ESTIMABLE="YES" I2="12.790160343681473" ID="CMP-008.01.01" NO="1" P_CHI2="0.3176966144948252" P_Z="0.46210246191164217" STUDIES="3" TAU2="0.0" TOTAL_1="112" TOTAL_2="56" WEIGHT="99.99999999999999" Z="0.735389267563175">
<NAME>7.5 mg</NAME>
<CONT_DATA CI_END="1.940941782233491" CI_START="-12.14094178223349" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-2.9" ORDER="185" SD_1="14.2" SD_2="14.0" SE="3.592383246718583" STUDY_ID="STD-Mroczek-1996" TOTAL_1="46" TOTAL_2="23" WEIGHT="47.98858641511569"/>
<CONT_DATA CI_END="7.483773027409619" CI_START="-9.483773027409619" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-7.6" ORDER="186" SD_1="17.7" SD_2="17.3" SE="4.328535164078798" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="24" WEIGHT="33.053799014304516"/>
<CONT_DATA CI_END="16.20231775557719" CI_START="-6.202317755577191" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="-4.4" ORDER="187" SD_1="13.2" SD_2="14.0" SE="5.715573267641469" STUDY_ID="STD-White-1995" TOTAL_1="16" TOTAL_2="9" WEIGHT="18.957614570579786"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.3818632976305592" CI_END="-4.9084751395814115" CI_START="-11.985084998247814" DF="3.0" EFFECT_SIZE="-8.446780068914613" ESTIMABLE="YES" I2="0.0" ID="CMP-008.01.02" NO="2" P_CHI2="0.709791723234526" P_Z="2.884141666048695E-6" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="103" WEIGHT="100.0" Z="4.678902765885495">
<NAME>15 mg</NAME>
<CONT_DATA CI_END="-5.483072463711219" CI_START="-15.71692753628878" EFFECT_SIZE="-10.6" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-1.6" ORDER="188" SD_1="11.8" SD_2="13.6" SE="2.6107252871228512" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="47.815861125636566"/>
<CONT_DATA CI_END="-0.1396981028563964" CI_START="-14.260301897143602" EFFECT_SIZE="-7.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-2.9" ORDER="189" SD_1="14.0" SD_2="14.0" SE="3.6022610378733297" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="23" WEIGHT="25.115623920289963"/>
<CONT_DATA CI_END="2.572675847872654" CI_START="-14.172675847872656" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.6" ORDER="190" SD_1="17.5" SD_2="17.3" SE="4.271851888052665" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="24" WEIGHT="17.859198308324093"/>
<CONT_DATA CI_END="5.859543703626938" CI_START="-17.459543703626935" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="191" SD_1="14.0" SD_2="14.0" SE="5.948856099191582" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="8" WEIGHT="9.209316645749377"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="17.4110579094758" CI_END="-2.0443718913802433" CI_START="-5.035090053720949" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.539730972550596" ESTIMABLE="YES" I2="65.53914166964802" I2_Q="46.78602851791096" ID="CMP-008.02" NO="2" P_CHI2="0.007885553038092796" P_Q="0.17042465880870383" P_Z="3.4922289151272677E-6" Q="1.8792057276472658" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="274" TOTAL_2="159" UNITS="" WEIGHT="200.0" Z="4.639517898089225">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Moexipril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Moexipril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="9.281094418846124" CI_END="0.1646309064886582" CI_START="-4.62629512799861" DF="2.0" EFFECT_SIZE="-2.230832110754976" ESTIMABLE="YES" I2="78.45081722324886" ID="CMP-008.02.01" NO="1" P_CHI2="0.009652438050106849" P_Z="0.06796131433095856" STUDIES="3" TAU2="0.0" TOTAL_1="112" TOTAL_2="55" WEIGHT="100.0" Z="1.8252632418705907">
<NAME>7.5 mg</NAME>
<CONT_DATA CI_END="0.4536545337157376" CI_START="-6.453654533715736" EFFECT_SIZE="-2.999999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-5.2" ORDER="192" SD_1="6.9" SD_2="6.9" SE="1.7621010186706096" STUDY_ID="STD-Mroczek-1996" TOTAL_1="46" TOTAL_2="23" WEIGHT="48.10842667474594"/>
<CONT_DATA CI_END="-0.8375670963087938" CI_START="-8.762432903691204" EFFECT_SIZE="-4.799999999999999" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-3.9" ORDER="193" SD_1="7.8" SD_2="8.3" SE="2.021686589624284" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="24" WEIGHT="36.547283153185624"/>
<CONT_DATA CI_END="12.415276086936494" CI_START="0.18472391306350566" EFFECT_SIZE="6.3" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-7.3" ORDER="194" SD_1="6.8" SD_2="7.4" SE="3.120096152364539" STUDY_ID="STD-White-1995" TOTAL_1="16" TOTAL_2="8" WEIGHT="15.344290172068433"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.250757762982412" CI_END="-2.461340649898692" CI_START="-6.28956993448234" DF="3.0" EFFECT_SIZE="-4.375455292190516" ESTIMABLE="YES" I2="52.00581891420768" ID="CMP-008.02.02" NO="2" P_CHI2="0.10002772392218895" P_Z="7.455152493051263E-6" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="104" WEIGHT="100.0" Z="4.480261839693478">
<NAME>15 mg</NAME>
<CONT_DATA CI_END="-2.420768175355181" CI_START="-8.779231824644821" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-4.3" ORDER="195" SD_1="8.1" SD_2="7.7" SE="1.6220868596169085" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="36.24862160193091"/>
<CONT_DATA CI_END="-0.2375090244367115" CI_START="-7.162490975563289" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-5.2" ORDER="196" SD_1="6.8" SD_2="6.9" SE="1.7666094902125629" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="23" WEIGHT="30.560368776563394"/>
<CONT_DATA CI_END="-2.2420548070861277" CI_START="-10.157945192913871" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-3.9" ORDER="197" SD_1="8.0" SD_2="8.3" SE="2.0193968991949025" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="24" WEIGHT="23.388175217042747"/>
<CONT_DATA CI_END="8.513530909512486" CI_START="-3.713530909512487" EFFECT_SIZE="2.3999999999999995" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-7.3" ORDER="198" SD_1="8.1" SD_2="7.4" SE="3.1192057393580894" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="9" WEIGHT="9.802834404462962"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2008-05-02 14:21:15 -0700" MODIFIED_BY="Ciprian D Jauca" NO="9">
<NAME>Perindopril vs Placebo</NAME>
<CONT_OUTCOME CHI2="1.761679140732626" CI_END="-4.457521334021081" CI_START="-9.265631910853129" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.861576622437105" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.01" MODIFIED="2008-05-02 14:21:09 -0700" MODIFIED_BY="Ciprian D Jauca" NO="1" P_CHI2="0.9978619009219913" P_Q="0.7959006185808599" P_Z="2.218130466422969E-8" Q="1.022116608349088" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="658" TOTAL_2="396" UNITS="" WEIGHT="400.0" Z="5.594065628165974">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Perindopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Perindopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1804085537282421" CI_END="6.722597342649278" CI_START="-13.201196356402052" DF="1.0" EFFECT_SIZE="-3.239299506876387" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.01" NO="1" P_CHI2="0.671022376574739" P_Z="0.523916804565644" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="16" WEIGHT="100.0" Z="0.6373194246553937">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="13.009622909759198" CI_START="-27.009622909759198" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.6" ORDER="199" SD_1="16.8" SD_2="15.1" SE="10.209178876546993" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="24.78599013752774"/>
<CONT_DATA CI_END="9.486630980893388" CI_START="-13.486630980893388" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-2.7" MEAN_2="-0.7" ORDER="200" SD_1="19.7" SD_2="19.0" SE="5.860633701179443" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="13" WEIGHT="75.21400986247227"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4887325096781632" CI_END="-4.1225604321429605" CI_START="-9.407320611914358" DF="5.0" EFFECT_SIZE="-6.76494052202866" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.02" NO="2" P_CHI2="0.9925300560023129" P_Z="5.225574288082885E-7" STUDIES="6" TAU2="0.0" TOTAL_1="472" TOTAL_2="348" WEIGHT="100.0" Z="5.0178397239230295">
<NAME>4 mg</NAME>
<CONT_DATA CI_END="8.132376199755992" CI_START="-17.33237619975599" EFFECT_SIZE="-4.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-3.7" ORDER="201" SD_1="17.1" SD_2="10.8" SE="6.4962296757426925" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.306968073216794"/>
<CONT_DATA CI_END="-1.1568497204055932" CI_START="-12.843150279594408" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="0.0" ORDER="202" SD_1="18.0" SD_2="19.0" SE="2.9812539034821204" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="20.450148431502043"/>
<CONT_DATA CI_END="13.266314216382124" CI_START="-32.86631421638212" EFFECT_SIZE="-9.8" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-5.6" ORDER="203" SD_1="25.0" SD_2="15.1" SE="11.768743914850614" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="1.3123031430614565"/>
<CONT_DATA CI_END="6.803342060299711" CI_START="-14.80334206029971" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-0.7" ORDER="204" SD_1="15.9" SD_2="19.0" SE="5.5120104989250285" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="14" WEIGHT="5.982384497127206"/>
<CONT_DATA CI_END="-3.432635657420326" CI_START="-10.367364342579675" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-5.4" ORDER="205" SD_1="19.1" SD_2="20.0" SE="1.7690959476448556" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="58.075321036461105"/>
<CONT_DATA CI_END="0.7095638646875297" CI_START="-16.10956386468753" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-14.1" MEAN_2="-6.4" ORDER="206" SD_1="10.5" SD_2="19.3" SE="4.290672650630877" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="9.872874818631386"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0704214689771327" CI_END="-0.31235729927293576" CI_START="-19.316579128106433" DF="1.0" EFFECT_SIZE="-9.814468213689684" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.03" NO="3" P_CHI2="0.790724112984184" P_Z="0.042929759499371986" STUDIES="2" TAU2="0.0" TOTAL_1="64" TOTAL_2="18" WEIGHT="100.0" Z="2.024392726994986">
<NAME>8 mg (Max Dose)</NAME>
<CONT_DATA CI_END="12.80631616464778" CI_START="-27.60631616464778" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.6" ORDER="207" SD_1="22.2" SD_2="15.1" SE="10.309534422077459" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="4" WEIGHT="22.113928590655405"/>
<CONT_DATA CI_END="0.2668880195827157" CI_START="-21.266888019582716" EFFECT_SIZE="-10.5" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-0.7" ORDER="208" SD_1="15.4" SD_2="19.0" SE="5.493411156791938" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="14" WEIGHT="77.8860714093446"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.8508606799084806" CI_START="-19.650860679908483" DF="0.0" EFFECT_SIZE="-8.9" ESTIMABLE="YES" I2="0.0" ID="CMP-009.01.04" MODIFIED="2008-05-02 14:21:09 -0700" MODIFIED_BY="Ciprian D Jauca" NO="4" P_CHI2="1.0" P_Z="0.10468821393005324" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="14" WEIGHT="100.0" Z="1.6225379513107945">
<NAME>16 mg</NAME>
<CONT_DATA CI_END="1.8508606799084788" CI_START="-19.65086067990848" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-0.7" ORDER="209" SD_1="15.1" SD_2="19.0" SE="5.4852337924114405" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="5.204952494190195" CI_END="-3.6575459955098304" CI_START="-5.967995714249083" CI_STUDY="95" CI_TOTAL="95" DF="10.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.8127708548794566" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-009.02" MODIFIED="2008-05-02 14:21:15 -0700" MODIFIED_BY="Ciprian D Jauca" NO="2" P_CHI2="0.8770730785659916" P_Q="0.6055055079988649" P_Z="3.204075119393231E-16" Q="1.8435444328594617" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="658" TOTAL_2="396" UNITS="" WEIGHT="400.0" Z="8.165386560807763">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Perindopril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Perindopril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.4228687065717077" CI_END="2.2037374409412402" CI_START="-6.404311980027445" DF="1.0" EFFECT_SIZE="-2.1002872695431023" ESTIMABLE="YES" I2="0.0" ID="CMP-009.02.01" NO="1" P_CHI2="0.5155090936029163" P_Z="0.33885633060849774" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="16" WEIGHT="100.00000000000001" Z="0.9564274562515723">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="12.415605314547918" CI_START="-9.815605314547916" EFFECT_SIZE="1.2999999999999998" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-6.3" ORDER="210" SD_1="12.2" SD_2="7.2" SE="5.6713314133455475" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="14.992818261422451"/>
<CONT_DATA CI_END="1.968173049303525" CI_START="-7.368173049303525" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-1.8" ORDER="211" SD_1="8.1" SD_2="7.7" SE="2.3817647090076544" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="13" WEIGHT="85.00718173857756"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8123204438353926" CI_END="-3.614943024174604" CI_START="-6.210967205042897" DF="5.0" EFFECT_SIZE="-4.91295511460875" ESTIMABLE="YES" I2="0.0" ID="CMP-009.02.02" NO="2" P_CHI2="0.7288932273301096" P_Z="1.1851454675341613E-13" STUDIES="6" TAU2="0.0" TOTAL_1="472" TOTAL_2="348" WEIGHT="99.99999999999999" Z="7.418432504025691">
<NAME>4 mg</NAME>
<CONT_DATA CI_END="2.384666608330236" CI_START="-11.784666608330237" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-1.7" ORDER="212" SD_1="10.4" SD_2="4.5" SE="3.614692241394833" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="3.356747233120877"/>
<CONT_DATA CI_END="-0.5653351193671332" CI_START="-6.434664880632867" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-3.0" ORDER="213" SD_1="8.0" SD_2="10.0" SE="1.4973055136630717" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="19.563224817714516"/>
<CONT_DATA CI_END="16.715592682973302" CI_START="-11.315592682973303" EFFECT_SIZE="2.6999999999999997" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-6.3" ORDER="214" SD_1="18.4" SD_2="7.2" SE="7.150943993627694" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="0.857698281992283"/>
<CONT_DATA CI_END="0.46629929540306847" CI_START="-8.66629929540307" EFFECT_SIZE="-4.1000000000000005" ESTIMABLE="YES" MEAN_1="-5.9" MEAN_2="-1.8" ORDER="215" SD_1="8.1" SD_2="7.7" SE="2.329787348860211" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="14" WEIGHT="8.08032312505286"/>
<CONT_DATA CI_END="-3.944033204009827" CI_START="-7.255966795990174" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-5.2" ORDER="216" SD_1="9.5" SD_2="9.2" SE="0.8448965435345895" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="61.440427187118914"/>
<CONT_DATA CI_END="0.21406726094507533" CI_START="-9.814067260945075" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-7.2" ORDER="217" SD_1="9.0" SD_2="9.6" SE="2.5582445904595175" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="6.701579355000541"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.12621891092363322" CI_END="-1.5197015783285828" CI_START="-10.107054201226584" DF="1.0" EFFECT_SIZE="-5.813377889777583" ESTIMABLE="YES" I2="0.0" ID="CMP-009.02.03" NO="3" P_CHI2="0.7223851462637811" P_Z="0.007962103259377885" STUDIES="2" TAU2="0.0" TOTAL_1="64" TOTAL_2="18" WEIGHT="100.00000000000001" Z="2.6536726259740693">
<NAME>8 mg (Max Dose)</NAME>
<CONT_DATA CI_END="8.72453309825337" CI_START="-16.12453309825337" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="218" SD_1="16.5" SD_2="7.2" SE="6.339163982734632" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="4" WEIGHT="11.942587925934044"/>
<CONT_DATA CI_END="-1.5244180072057514" CI_START="-10.67558199279425" EFFECT_SIZE="-6.1000000000000005" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-1.8" ORDER="219" SD_1="8.1" SD_2="7.7" SE="2.3345235059857505" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="14" WEIGHT="88.05741207406597"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.441388239763971E-31" CI_END="-0.9148048891853566" CI_START="-10.085195110814645" DF="0.0" EFFECT_SIZE="-5.500000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-009.02.04" MODIFIED="2008-05-02 14:21:15 -0700" MODIFIED_BY="Ciprian D Jauca" NO="4" P_CHI2="0.0" P_Z="0.018722943763825994" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="14" WEIGHT="100.0" Z="2.3510017904243705">
<NAME>16 mg</NAME>
<CONT_DATA CI_END="-0.9148048891853557" CI_START="-10.085195110814645" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-7.3" MEAN_2="-1.8" ORDER="220" SD_1="8.1" SD_2="7.7" SE="2.3394282481627613" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="14" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" NO="10">
<NAME>Quinapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="3.777542292447479" CI_END="-1.9943152086260945" CI_START="-9.747161036329757" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.870738122477926" ESTIMABLE="YES" I2="47.055523269755504" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="0.15125767726335626" P_Q="1.0" P_Z="0.002994395541400469" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="99" TOTAL_2="97" UNITS="" WEIGHT="99.99999999999997" Z="2.9683126785796423">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Quinapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Quinapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="3.777542292447479" CI_END="-1.9943152086260945" CI_START="-9.747161036329757" DF="2.0" EFFECT_SIZE="-5.870738122477926" ESTIMABLE="YES" I2="47.055523269755504" ID="CMP-010.01.01" NO="1" P_CHI2="0.15125767726335626" P_Z="0.002994395541400469" STUDIES="3" TAU2="0.0" TOTAL_1="99" TOTAL_2="97" WEIGHT="99.99999999999997" Z="2.9683126785796423">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="-1.0516865160939162" CI_START="-10.348313483906084" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.7" ORDER="221" SD_1="14.1" SD_2="15.9" SE="2.3716320914932045" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="69.54589258299104"/>
<CONT_DATA CI_END="10.641591807057086" CI_START="-9.241591807057087" EFFECT_SIZE="0.6999999999999993" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-14.7" ORDER="222" SD_1="10.7" SD_2="8.1" SE="5.072333923212413" STUDY_ID="STD-Saynavalammi-1988" TOTAL_1="7" TOTAL_2="7" WEIGHT="15.203740530919026"/>
<CONT_DATA CI_END="-3.273617500454904" CI_START="-23.126382499545095" EFFECT_SIZE="-13.2" ESTIMABLE="YES" MEAN_1="-19.7" MEAN_2="-6.5" ORDER="223" SD_1="13.7" SD_2="8.7" SE="5.06457392984929" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="15.250366886089914"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.18852402126497145" CI_END="-0.6814813848858061" CI_START="-5.846137444858533" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.2638094148721697" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-010.02" NO="2" P_CHI2="0.9100443470568628" P_Q="1.0" P_Z="0.01324168280273027" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="99" TOTAL_2="97" UNITS="" WEIGHT="100.0" Z="2.4772022885047567">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Quinapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Quinapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.18852402126497145" CI_END="-0.6814813848858061" CI_START="-5.846137444858533" DF="2.0" EFFECT_SIZE="-3.2638094148721697" ESTIMABLE="YES" I2="0.0" ID="CMP-010.02.01" NO="1" P_CHI2="0.9100443470568628" P_Z="0.01324168280273027" STUDIES="3" TAU2="0.0" TOTAL_1="99" TOTAL_2="97" WEIGHT="100.0" Z="2.4772022885047567">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="-0.31699911195857844" CI_START="-6.08300088804142" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.9" ORDER="224" SD_1="8.7" SD_2="9.9" SE="1.4709458494044605" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="80.2293486480483"/>
<CONT_DATA CI_END="13.085938268823757" CI_START="-14.685938268823755" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-5.5" ORDER="225" SD_1="14.4" SD_2="12.0" SE="7.084792566778912" STUDY_ID="STD-Saynavalammi-1988" TOTAL_1="7" TOTAL_2="7" WEIGHT="3.458377190769565"/>
<CONT_DATA CI_END="2.2937279500491288" CI_START="-10.493727950049127" EFFECT_SIZE="-4.1" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-10.1" ORDER="226" SD_1="7.7" SD_2="7.2" SE="3.2621660400303467" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="16.31227416118214"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-011" NO="11">
<NAME>Ramipril vs Placebo</NAME>
<CONT_OUTCOME CHI2="12.623149619966895" CI_END="-1.9110996265871165" CI_START="-6.674648175896509" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.292873901241813" ESTIMABLE="YES" I2="0.0" I2_Q="68.05442975313888" ID="CMP-011.01" NO="1" P_CHI2="0.4773236838735986" P_Q="0.02452002073134829" P_Z="4.114799064154513E-4" Q="9.39097338634852" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="548" TOTAL_2="199" UNITS="" WEIGHT="400.0" Z="3.5326094190121076">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Ramipril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ramipril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.102918342030969" CI_END="10.083746046997886" CI_START="-1.9714609926733075" DF="1.0" EFFECT_SIZE="4.056142527162289" ESTIMABLE="YES" I2="52.447036101543816" ID="CMP-011.01.01" NO="1" P_CHI2="0.14701835276628095" P_Z="0.1871977209294479" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="35" WEIGHT="100.0" Z="1.3189144314548744">
<NAME>1.25 mg</NAME>
<CONT_DATA CI_END="8.24138134761764" CI_START="-13.641381347617639" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="0.5" ORDER="227" SD_1="16.4" SD_2="16.6" SE="5.582440000898924" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="11" WEIGHT="30.349046111728967"/>
<CONT_DATA CI_END="14.222393449831042" CI_START="-0.22239344983104203" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-9.0" ORDER="228" SD_1="12.0" SD_2="12.0" SE="3.6849623293082727" STUDY_ID="STD-Trevisan-1995" TOTAL_1="19" TOTAL_2="24" WEIGHT="69.65095388827103"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.08326299271166117" CI_END="0.9456365180163946" CI_START="-9.711184980495386" DF="3.0" EFFECT_SIZE="-4.3827742312394955" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.02" NO="2" P_CHI2="0.9937673252053398" P_Z="0.10693411004679822" STUDIES="4" TAU2="0.0" TOTAL_1="149" TOTAL_2="48" WEIGHT="100.0" Z="1.6121279026394946">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="5.845242233125181" CI_START="-14.245242233125182" EFFECT_SIZE="-4.2" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-5.7" ORDER="229" SD_1="15.0" SD_2="17.0" SE="5.125217765408329" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="14" WEIGHT="28.1367909411322"/>
<CONT_DATA CI_END="5.205656695723091" CI_START="-16.205656695723093" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="0.5" ORDER="230" SD_1="9.9" SD_2="16.6" SE="5.462170111373446" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="10" WEIGHT="24.772438932733188"/>
<CONT_DATA CI_END="6.524649247948644" CI_START="-13.324649247948642" EFFECT_SIZE="-3.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-3.7" ORDER="231" SD_1="15.5" SD_2="16.7" SE="5.063689601560544" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="14" WEIGHT="28.824717347439083"/>
<CONT_DATA CI_END="7.7673841592963235" CI_START="-17.167384159296322" EFFECT_SIZE="-4.699999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-5.4" ORDER="232" SD_1="17.6" SD_2="16.6" SE="6.361027170722247" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="10" WEIGHT="18.266052778695528"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.5991830378044877" CI_END="-2.1893609770441333" CI_START="-12.757008332485947" DF="3.0" EFFECT_SIZE="-7.47318465476504" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.03" NO="3" P_CHI2="0.8966193791855013" P_Z="0.005569964272791379" STUDIES="4" TAU2="0.0" TOTAL_1="148" TOTAL_2="47" WEIGHT="99.99999999999999" Z="2.7720782650102933">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="3.7811084742595" CI_START="-16.3811084742595" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-5.7" ORDER="233" SD_1="13.0" SD_2="17.0" SE="5.143517204284363" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="27.471353517090204"/>
<CONT_DATA CI_END="5.403438003209226" CI_START="-16.603438003209227" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-5.1" MEAN_2="0.5" ORDER="234" SD_1="12.9" SD_2="16.6" SE="5.61410214167349" STUDY_ID="STD-Kostis-1991" TOTAL_1="42" TOTAL_2="10" WEIGHT="23.058966145282"/>
<CONT_DATA CI_END="2.5144713674483343" CI_START="-17.114471367448335" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-3.7" ORDER="235" SD_1="16.5" SD_2="16.7" SE="5.00747536427385" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="15" WEIGHT="28.984299498463457"/>
<CONT_DATA CI_END="0.2741775891525027" CI_START="-23.074177589152505" EFFECT_SIZE="-11.4" ESTIMABLE="YES" MEAN_1="-16.8" MEAN_2="-5.4" ORDER="236" SD_1="10.8" SD_2="16.6" SE="5.95632250451382" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="9" WEIGHT="20.485380839164325"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4468118610712575" CI_END="-2.1561489235107496" CI_START="-9.330419708271936" DF="3.0" EFFECT_SIZE="-5.7432843158913425" ESTIMABLE="YES" I2="0.0" ID="CMP-011.01.04" NO="4" P_CHI2="0.930411225335295" P_Z="0.0017007259578646875" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="69" WEIGHT="100.0" Z="3.1380556295786657">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="5.908904582459143" CI_START="-14.508904582459142" EFFECT_SIZE="-4.3" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-5.7" ORDER="237" SD_1="14.0" SD_2="17.0" SE="5.208720498430419" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="12.346312022275002"/>
<CONT_DATA CI_END="2.047922973340837" CI_START="-19.447922973340837" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="0.5" ORDER="238" SD_1="10.4" SD_2="16.6" SE="5.483734934988133" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="10" WEIGHT="11.139006239485346"/>
<CONT_DATA CI_END="-0.8153776513338435" CI_START="-9.784622348666156" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-1.3" ORDER="239" SD_1="10.3" SD_2="10.7" SE="2.28811467151452" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="32" WEIGHT="63.97993347346689"/>
<CONT_DATA CI_END="3.331878209823029" CI_START="-16.93187820982303" EFFECT_SIZE="-6.8" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-3.7" ORDER="240" SD_1="16.7" SD_2="16.7" SE="5.169420606573381" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="14" WEIGHT="12.534748264772762"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="10.909486138446628" CI_END="-1.6193799829623128" CI_START="-4.272861190576279" CI_STUDY="95" CI_TOTAL="95" DF="13.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.946120586769296" ESTIMABLE="YES" I2="0.0" I2_Q="66.28450831259242" ID="CMP-011.02" NO="2" P_CHI2="0.6184003062053922" P_Q="0.030678435615156152" P_Z="1.3475515198737915E-5" Q="8.897986800294753" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="548" TOTAL_2="199" UNITS="" WEIGHT="400.0" Z="4.3522375267712">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Ramipril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Ramipril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.2159315172213017" CI_END="5.389296723804539" CI_START="-1.832057695186388" DF="1.0" EFFECT_SIZE="1.7786195143090755" ESTIMABLE="YES" I2="17.75852621328194" ID="CMP-011.02.01" NO="1" P_CHI2="0.27016064460536604" P_Z="0.3343053540901184" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="34" WEIGHT="100.0" Z="0.9654782158533165">
<NAME>1.25 mg</NAME>
<CONT_DATA CI_END="5.407160934626826" CI_START="-8.607160934626826" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-4.3" MEAN_2="-2.7" ORDER="241" SD_1="9.3" SD_2="10.4" SE="3.5751478036833415" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="10" WEIGHT="26.55174968893314"/>
<CONT_DATA CI_END="7.2130628457347745" CI_START="-1.2130628457347745" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-5.0" ORDER="242" SD_1="7.0" SD_2="7.0" SE="2.149561358763159" STUDY_ID="STD-Trevisan-1995" TOTAL_1="19" TOTAL_2="24" WEIGHT="73.44825031106686"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1366345118034714" CI_END="0.3909624408267134" CI_START="-5.175379502300741" DF="3.0" EFFECT_SIZE="-2.3922085307370136" ESTIMABLE="YES" I2="0.0" ID="CMP-011.02.02" NO="2" P_CHI2="0.9871048283281668" P_Z="0.09205795066171334" STUDIES="4" TAU2="0.0" TOTAL_1="149" TOTAL_2="46" WEIGHT="100.0" Z="1.684640509569453">
<NAME>2.5 mg</NAME>
<CONT_DATA CI_END="2.6806720870523932" CI_START="-7.080672087052394" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.8" ORDER="243" SD_1="8.1" SD_2="7.7" SE="2.490184577650667" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="32.51775180353005"/>
<CONT_DATA CI_END="3.4846585448249128" CI_START="-10.484658544824914" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-6.2" MEAN_2="-2.7" ORDER="244" SD_1="9.0" SD_2="10.4" SE="3.5636667815934415" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="10" WEIGHT="15.877766557456011"/>
<CONT_DATA CI_END="2.5172389993889754" CI_START="-7.317238999388975" EFFECT_SIZE="-2.4" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-2.6" ORDER="245" SD_1="9.3" SD_2="7.7" SE="2.508841508402975" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="14" WEIGHT="32.03591534102348"/>
<CONT_DATA CI_END="4.491589545056456" CI_START="-8.091589545056456" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-6.8" ORDER="246" SD_1="10.8" SD_2="7.0" SE="3.210053651334265" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="9" WEIGHT="19.568566297990465"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.48286495120831413" CI_END="-1.0208327047566579" CI_START="-6.378207717606496" DF="3.0" EFFECT_SIZE="-3.699520211181577" ESTIMABLE="YES" I2="0.0" ID="CMP-011.02.03" NO="3" P_CHI2="0.9226394967606525" P_Z="0.006791569166210026" STUDIES="4" TAU2="0.0" TOTAL_1="148" TOTAL_2="49" WEIGHT="100.00000000000003" Z="2.7068952076725354">
<NAME>5 mg</NAME>
<CONT_DATA CI_END="1.1507400409076443" CI_START="-8.350740040907645" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.8" ORDER="247" SD_1="8.1" SD_2="7.7" SE="2.423891499221861" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="14" WEIGHT="31.792272410684916"/>
<CONT_DATA CI_END="3.22008069688047" CI_START="-11.02008069688047" EFFECT_SIZE="-3.8999999999999995" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-2.7" ORDER="248" SD_1="10.0" SD_2="10.4" SE="3.632760985937883" STUDY_ID="STD-Kostis-1991" TOTAL_1="42" TOTAL_2="10" WEIGHT="14.153839696388806"/>
<CONT_DATA CI_END="2.2056911577214966" CI_START="-7.405691157721497" EFFECT_SIZE="-2.6" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-2.6" ORDER="249" SD_1="9.3" SD_2="7.7" SE="2.451928298493327" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="15" WEIGHT="31.069365930554277"/>
<CONT_DATA CI_END="0.38732989445831745" CI_START="-10.787329894458317" EFFECT_SIZE="-5.2" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-6.8" ORDER="250" SD_1="8.8" SD_2="7.0" SE="2.85073090043004" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="10" WEIGHT="22.984521962372018"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.17606835791878872" CI_END="-2.303607031951552" CI_START="-6.539455987035499" DF="3.0" EFFECT_SIZE="-4.4215315094935255" ESTIMABLE="YES" I2="0.0" ID="CMP-011.02.04" NO="4" P_CHI2="0.9813569613717587" P_Z="4.28108236574113E-5" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="70" WEIGHT="100.0" Z="4.091761820125895">
<NAME>10 mg</NAME>
<CONT_DATA CI_END="1.0806720870523936" CI_START="-8.680672087052393" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-4.8" ORDER="251" SD_1="8.1" SD_2="7.7" SE="2.490184577650667" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="18.83049250976641"/>
<CONT_DATA CI_END="1.8626795802685336" CI_START="-11.262679580268534" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="-2.7" ORDER="252" SD_1="7.7" SD_2="10.4" SE="3.348367435337645" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="11" WEIGHT="10.41498234836707"/>
<CONT_DATA CI_END="-1.346406783150384" CI_START="-7.253593216849618" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-3.6" ORDER="253" SD_1="7.8" SD_2="6.5" SE="1.5069630055180518" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="32" WEIGHT="51.418520403101134"/>
<CONT_DATA CI_END="-0.38354953916252477" CI_START="-10.016450460837474" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-2.6" ORDER="254" SD_1="8.6" SD_2="7.7" SE="2.45741783973023" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="14" WEIGHT="19.33600473876539"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-012" NO="12">
<NAME>Spirapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="4.910126371386376" CI_END="-5.4423635001512265" CI_START="-10.325900375471758" CI_STUDY="95" CI_TOTAL="95" DF="8.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.884131937811492" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-012.01" NO="1" P_CHI2="0.7671374254335885" P_Q="0.5778609078669708" P_Z="2.4763266864721125E-10" Q="1.9738071996411573" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="486" TOTAL_2="139" UNITS="" WEIGHT="400.0" Z="6.328452120660307">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Spirapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Spirapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.026091431957774785" CI_END="2.292529124305812" CI_START="-10.470702631198833" DF="1.0" EFFECT_SIZE="-4.0890867534465105" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.01" NO="1" P_CHI2="0.8716772472772693" P_Z="0.2091641070025504" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="26" WEIGHT="100.0" Z="1.2558673100891435">
<NAME>3 mg</NAME>
<CONT_DATA CI_END="4.238138992153688" CI_START="-11.638138992153689" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.4" MEAN_2="-6.7" ORDER="255" SD_1="13.9" SD_2="13.4" SE="4.050145336735121" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="54" TOTAL_2="14" WEIGHT="64.62847695940818"/>
<CONT_DATA CI_END="5.930100248189583" CI_START="-15.530100248189584" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-2.2" ORDER="256" SD_1="13.9" SD_2="17.7" SE="5.474641540776894" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="12" WEIGHT="35.37152304059182"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4796963680652273" CI_END="-3.4006807990408605" CI_START="-11.929188997661377" DF="2.0" EFFECT_SIZE="-7.664934898351119" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.02" NO="2" P_CHI2="0.7867473001492525" P_Z="4.2668035404177016E-4" STUDIES="3" TAU2="0.0" TOTAL_1="164" TOTAL_2="46" WEIGHT="100.0" Z="3.523006836539675">
<NAME>6 mg</NAME>
<CONT_DATA CI_END="2.8018030224424075" CI_START="-13.401803022442408" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-6.7" ORDER="257" SD_1="13.9" SD_2="13.4" SE="4.13364892740295" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="59" TOTAL_2="13" WEIGHT="27.702744152495146"/>
<CONT_DATA CI_END="-3.088906429889753" CI_START="-14.511093570110248" EFFECT_SIZE="-8.8" ESTIMABLE="YES" MEAN_1="-14.8" MEAN_2="-6.0" ORDER="258" SD_1="12.0" SD_2="11.0" SE="2.913876793226113" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="20" WEIGHT="55.75035021634991"/>
<CONT_DATA CI_END="2.682978150043957" CI_START="-18.282978150043956" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.2" ORDER="259" SD_1="14.4" SD_2="17.7" SE="5.348556520799541" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="13" WEIGHT="16.546905631154942"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3035713050993949" CI_END="-3.6562722513674126" CI_START="-13.272937774561715" DF="1.0" EFFECT_SIZE="-8.464605012964563" ESTIMABLE="YES" I2="0.0" ID="CMP-012.01.03" NO="3" P_CHI2="0.5816522430761104" P_Z="5.599076346583298E-4" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="34" WEIGHT="100.0" Z="3.450327128203384">
<NAME>12 mg (Max Dose)</NAME>
<CONT_DATA CI_END="1.2071595519974139" CI_START="-14.607159551997414" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-6.7" ORDER="260" SD_1="13.9" SD_2="13.4" SE="4.034339209479398" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="56" TOTAL_2="14" WEIGHT="36.978392394122736"/>
<CONT_DATA CI_END="-3.4431087398213176" CI_START="-15.556891260178682" EFFECT_SIZE="-9.5" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-6.0" ORDER="261" SD_1="14.0" SD_2="11.0" SE="3.0903074280724887" STUDY_ID="STD-Guitard-1994" TOTAL_1="56" TOTAL_2="20" WEIGHT="63.02160760587727"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.1269600666228214" CI_END="-4.949847311495498" CI_START="-14.38620624640397" DF="1.0" EFFECT_SIZE="-9.668026778949734" ESTIMABLE="YES" I2="52.98454278985144" ID="CMP-012.01.04" NO="4" P_CHI2="0.1447275949343424" P_Z="5.9153005364137914E-5" STUDIES="2" TAU2="0.0" TOTAL_1="106" TOTAL_2="33" WEIGHT="100.0" Z="4.016164374208189">
<NAME>24 mg</NAME>
<CONT_DATA CI_END="3.266047257130878" CI_START="-12.866047257130877" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-6.7" ORDER="262" SD_1="13.9" SD_2="13.4" SE="4.115405854778368" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="47" TOTAL_2="14" WEIGHT="34.2158543385171"/>
<CONT_DATA CI_END="-6.382802124056556" CI_START="-18.01719787594344" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-18.2" MEAN_2="-6.0" ORDER="263" SD_1="12.0" SD_2="11.0" SE="2.968012637899858" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="19" WEIGHT="65.78414566148291"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.873451305802526" CI_END="-4.470389970728704" CI_START="-7.109960758778433" CI_STUDY="95" CI_TOTAL="95" DF="9.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.790175364753568" ESTIMABLE="YES" I2="30.08867796048308" I2_Q="0.0" ID="CMP-012.02" NO="2" P_CHI2="0.16841673632947118" P_Q="0.5602311784977494" P_Z="8.057278769112547E-18" Q="2.0591009176047645" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="586" TOTAL_2="189" UNITS="" WEIGHT="400.0" Z="8.59877312665142">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Spirapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Spirapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.3958008795268757" CI_END="-0.2941252837548709" CI_START="-7.524934808057809" DF="1.0" EFFECT_SIZE="-3.9095300459063402" ESTIMABLE="YES" I2="28.35654320987657" ID="CMP-012.02.01" NO="1" P_CHI2="0.23742811898020855" P_Z="0.03405552695925203" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="26" WEIGHT="100.0" Z="2.119413617714493">
<NAME>3 mg</NAME>
<CONT_DATA CI_END="-1.0244180072057514" CI_START="-10.17558199279425" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.3" ORDER="264" SD_1="8.1" SD_2="7.7" SE="2.3345235059857505" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="54" TOTAL_2="14" WEIGHT="62.43400102014088"/>
<CONT_DATA CI_END="4.798742722486145" CI_START="-6.998742722486145" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-4.7" ORDER="265" SD_1="8.3" SD_2="9.6" SE="3.0096179159488003" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="12" WEIGHT="37.56599897985911"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.712090046471834" CI_END="-4.6207398231988215" CI_START="-8.424712629331344" DF="3.0" EFFECT_SIZE="-6.522726226265083" ESTIMABLE="YES" I2="19.18299495855823" ID="CMP-012.02.02" NO="2" P_CHI2="0.2942786928183745" P_Z="1.7979387308259154E-11" STUDIES="4" TAU2="0.0" TOTAL_1="264" TOTAL_2="95" WEIGHT="100.00000000000003" Z="6.721556191928805">
<NAME>6 mg</NAME>
<CONT_DATA CI_END="1.1681730493035243" CI_START="-8.168173049303526" EFFECT_SIZE="-3.500000000000001" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-5.3" ORDER="266" SD_1="8.1" SD_2="7.7" SE="2.3817647090076544" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="59" TOTAL_2="13" WEIGHT="16.60049055436503"/>
<CONT_DATA CI_END="-2.6677294524607404" CI_START="-10.73227054753926" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-4.8" ORDER="267" SD_1="8.1" SD_2="7.7" SE="2.0573186953154727" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="19" WEIGHT="22.249255768973384"/>
<CONT_DATA CI_END="-5.340003195145432" CI_START="-10.659996804854568" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.0" ORDER="268" SD_1="8.1" SD_2="7.7" SE="1.3571661652133833" STUDY_ID="STD-Guitard-1997" TOTAL_1="100" TOTAL_2="50" WEIGHT="51.127267908665274"/>
<CONT_DATA CI_END="2.4077084858171567" CI_START="-9.607708485817158" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-4.7" ORDER="269" SD_1="10.3" SD_2="9.6" SE="3.06521371474435" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="13" WEIGHT="10.022985767996328"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9431278911360947" CI_END="-3.1993676375191105" CI_START="-9.200047024377028" DF="1.0" EFFECT_SIZE="-6.199707330948069" ESTIMABLE="YES" I2="0.0" ID="CMP-012.02.03" NO="3" P_CHI2="0.33147489178071554" P_Z="5.123023067564053E-5" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="34" WEIGHT="100.0" Z="4.049942448169953">
<NAME>12 mg (Max Dose)</NAME>
<CONT_DATA CI_END="0.05733021614151124" CI_START="-9.057330216141512" EFFECT_SIZE="-4.500000000000001" ESTIMABLE="YES" MEAN_1="-9.8" MEAN_2="-5.3" ORDER="270" SD_1="8.1" SD_2="7.7" SE="2.325211203924741" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="56" TOTAL_2="14" WEIGHT="43.34308896839773"/>
<CONT_DATA CI_END="-3.5139386272581623" CI_START="-11.48606137274184" EFFECT_SIZE="-7.500000000000001" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-4.8" ORDER="271" SD_1="8.1" SD_2="7.7" SE="2.033742152500445" STUDY_ID="STD-Guitard-1994" TOTAL_1="56" TOTAL_2="20" WEIGHT="56.65691103160227"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.763331571062956" CI_END="-1.8305123835638302" CI_START="-7.858345669875888" DF="1.0" EFFECT_SIZE="-4.844429026719859" ESTIMABLE="YES" I2="79.00629034361246" ID="CMP-012.02.04" NO="4" P_CHI2="0.029072318490739546" P_Z="0.0016307235675395873" STUDIES="2" TAU2="0.0" TOTAL_1="106" TOTAL_2="34" WEIGHT="100.0" Z="3.150354685353455">
<NAME>24 mg</NAME>
<CONT_DATA CI_END="3.7509236881501105" CI_START="-5.550923688150111" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="-6.2" MEAN_2="-5.3" ORDER="272" SD_1="8.1" SD_2="7.7" SE="2.372963852823829" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="47" TOTAL_2="14" WEIGHT="41.993690783531484"/>
<CONT_DATA CI_END="-3.7427487947436697" CI_START="-11.65725120525633" EFFECT_SIZE="-7.7" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.8" ORDER="273" SD_1="8.1" SD_2="7.7" SE="2.0190428173530854" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="20" WEIGHT="58.006309216468516"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-013" NO="13">
<NAME>Temocapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.8678415732730116" CI_START="-23.86784157327301" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-10.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.15756288532143883" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="1.4133158171617866">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Temocapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Temocapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.8678415732730116" CI_START="-23.86784157327301" DF="0.0" EFFECT_SIZE="-10.0" ESTIMABLE="YES" I2="0.0" ID="CMP-013.01.01" NO="1" P_CHI2="1.0" P_Z="0.15756288532143883" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="11" WEIGHT="100.0" Z="1.4133158171617866">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="3.8678415732730116" CI_START="-23.86784157327301" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="0.0" ORDER="274" SD_1="21.8" SD_2="16.6" SE="7.075559389183054" STUDY_ID="STD-Lerch-1999" TOTAL_1="19" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.343788908403477" CI_START="-13.343788908403477" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-013.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.24019292070353215" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="19" TOTAL_2="11" UNITS="" WEIGHT="100.0" Z="1.1745047759813707">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Temocapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Temocapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.343788908403477" CI_START="-13.343788908403477" DF="0.0" EFFECT_SIZE="-5.0" ESTIMABLE="YES" I2="0.0" ID="CMP-013.02.01" NO="1" P_CHI2="1.0" P_Z="0.24019292070353215" STUDIES="1" TAU2="0.0" TOTAL_1="19" TOTAL_2="11" WEIGHT="100.0" Z="1.1745047759813707">
<NAME>20 mg</NAME>
<CONT_DATA CI_END="3.343788908403477" CI_START="-13.343788908403477" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-1.0" ORDER="275" SD_1="13.1" SD_2="10.0" SE="4.257113382806122" STUDY_ID="STD-Lerch-1999" TOTAL_1="19" TOTAL_2="11" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-014" NO="14">
<NAME>Trandolapril vs Placebo</NAME>
<CONT_OUTCOME CHI2="11.569771102101555" CI_END="-5.388627382057026" CI_START="-8.284960989718185" CI_STUDY="95" CI_TOTAL="95" DF="22.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.836794185887605" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.01" NO="1" P_CHI2="0.9656389082555251" P_Q="0.6662581332912643" P_Z="2.183025015078195E-20" Q="4.9484189255838755" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1152" TOTAL_2="636" UNITS="" WEIGHT="800.0" Z="9.252988218351806">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>Trandolapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Trandolapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.861366548594398" CI_START="-13.261366548594399" DF="0.0" EFFECT_SIZE="-2.7" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.01" NO="1" P_CHI2="1.0" P_Z="0.6163272704761672" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="12" WEIGHT="100.0" Z="0.5010623136607678">
<NAME>0.25 mg</NAME>
<CONT_DATA CI_END="7.861366548594398" CI_START="-13.261366548594399" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-0.7" ORDER="276" SD_1="14.4" SD_2="15.5" SE="5.388551336606748" STUDY_ID="STD-Weir-1995" TOTAL_1="23" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.0982653811373646" CI_END="1.3256705337027266" CI_START="-7.9952173947051755" DF="3.0" EFFECT_SIZE="-3.3347734305012247" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.02" NO="2" P_CHI2="0.7774928754177737" P_Z="0.16078115585199265" STUDIES="4" TAU2="0.0" TOTAL_1="131" TOTAL_2="54" WEIGHT="100.0" Z="1.4024491809333242">
<NAME>0.5 mg</NAME>
<CONT_DATA CI_END="2.3830695248671265" CI_START="-15.983069524867124" EFFECT_SIZE="-6.799999999999999" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-9.6" ORDER="277" SD_1="15.6" SD_2="15.5" SE="4.685325647461895" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="41" TOTAL_2="15" WEIGHT="25.75602490094097"/>
<CONT_DATA CI_END="4.870848575026361" CI_START="-12.07084857502636" EFFECT_SIZE="-3.6" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="0.0" ORDER="278" SD_1="15.7" SD_2="15.1" SE="4.321940934549478" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="41" TOTAL_2="18" WEIGHT="30.269186157551704"/>
<CONT_DATA CI_END="6.716481314714873" CI_START="-11.31648131471487" EFFECT_SIZE="-2.299999999999999" ESTIMABLE="YES" MEAN_1="-13.6" MEAN_2="-11.3" ORDER="279" SD_1="12.5" SD_2="12.4" SE="4.600330100877223" STUDY_ID="STD-Scholze-1998" TOTAL_1="27" TOTAL_2="10" WEIGHT="26.716551938530976"/>
<CONT_DATA CI_END="11.918352344211554" CI_START="-10.518352344211555" EFFECT_SIZE="0.7" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="-0.7" ORDER="280" SD_1="15.5" SD_2="15.5" SE="5.723754330538972" STUDY_ID="STD-Weir-1995" TOTAL_1="22" TOTAL_2="11" WEIGHT="17.258237002976355"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.180791967693045" CI_END="-5.059774755111672" CI_START="-11.838212825034049" DF="3.0" EFFECT_SIZE="-8.44899379007286" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.03" NO="3" P_CHI2="0.5357417347781086" P_Z="1.0290530105963555E-6" STUDIES="4" TAU2="0.0" TOTAL_1="194" TOTAL_2="100" WEIGHT="100.0" Z="4.885999802115184">
<NAME>1 mg</NAME>
<CONT_DATA CI_END="0.6876836117107636" CI_START="-16.887683611710763" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-9.6" ORDER="281" SD_1="13.1" SD_2="15.5" SE="4.483594433891077" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="42" TOTAL_2="15" WEIGHT="14.874776501747855"/>
<CONT_DATA CI_END="-5.918970626968613" CI_START="-17.081029373031388" EFFECT_SIZE="-11.5" ESTIMABLE="YES" MEAN_1="-21.2" MEAN_2="-9.7" ORDER="282" SD_1="12.3" SD_2="16.1" SE="2.847516289612378" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" WEIGHT="36.87827999386918"/>
<CONT_DATA CI_END="4.534343624741025" CI_START="-13.334343624741022" EFFECT_SIZE="-4.399999999999999" ESTIMABLE="YES" MEAN_1="-15.7" MEAN_2="-11.3" ORDER="283" SD_1="12.3" SD_2="12.4" SE="4.55842234613186" STUDY_ID="STD-Scholze-1998" TOTAL_1="28" TOTAL_2="10" WEIGHT="14.390436583479977"/>
<CONT_DATA CI_END="-1.1752329327900757" CI_START="-12.824767067209923" EFFECT_SIZE="-6.999999999999999" ESTIMABLE="YES" MEAN_1="-9.7" MEAN_2="-2.7" ORDER="284" SD_1="10.4" SD_2="13.3" SE="2.971874541142053" STUDY_ID="STD-Weir-1995" TOTAL_1="74" TOTAL_2="24" WEIGHT="33.856506920902994"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.8470532342996318" CI_END="-3.659079830572081" CI_START="-8.75506157022417" DF="6.0" EFFECT_SIZE="-6.207070700398125" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.04" NO="4" P_CHI2="0.9332138655257409" P_Z="1.8006555932114655E-6" STUDIES="7" TAU2="0.0" TOTAL_1="407" TOTAL_2="229" WEIGHT="99.99999999999999" Z="4.7745991425411605">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="-1.1823488532753412" CI_START="-19.61765114672466" EFFECT_SIZE="-10.4" ESTIMABLE="YES" MEAN_1="-20.0" MEAN_2="-9.6" ORDER="285" SD_1="14.6" SD_2="15.5" SE="4.702969656295888" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="14" WEIGHT="7.641087968313254"/>
<CONT_DATA CI_END="2.5934431969476357" CI_START="-13.793443196947635" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-5.6" MEAN_2="0.0" ORDER="286" SD_1="16.5" SD_2="15.1" SE="4.180404977630441" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="67" TOTAL_2="17" WEIGHT="9.670809768971731"/>
<CONT_DATA CI_END="-2.7197541822017426" CI_START="-11.680245817798259" EFFECT_SIZE="-7.200000000000001" ESTIMABLE="YES" MEAN_1="-14.3" MEAN_2="-7.1" ORDER="287" SD_1="18.0" SD_2="19.0" SE="2.2858817065710726" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="32.343874912518224"/>
<CONT_DATA CI_END="1.0378318884243942" CI_START="-14.437831888424395" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-6.3" ORDER="288" SD_1="14.7" SD_2="14.0" SE="3.947945956894833" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="10.843192174252982"/>
<CONT_DATA CI_END="2.8565652292383295" CI_START="-14.85656522923833" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-17.3" MEAN_2="-11.3" ORDER="289" SD_1="12.3" SD_2="12.4" SE="4.518738762088378" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="10" WEIGHT="8.276849983478295"/>
<CONT_DATA CI_END="4.059658237431083" CI_START="-10.659658237431081" EFFECT_SIZE="-3.299999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-6.9" ORDER="290" SD_1="12.0" SD_2="9.0" SE="3.7549966711037173" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="11.986170199478252"/>
<CONT_DATA CI_END="1.009218851692271" CI_START="-10.60921885169227" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-2.7" ORDER="291" SD_1="10.3" SD_2="13.3" SE="2.963941632353782" STUDY_ID="STD-Weir-1995" TOTAL_1="75" TOTAL_2="24" WEIGHT="19.23801499298725"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4101661858678411" CI_END="-5.4922117125401115" CI_START="-10.816194261461508" DF="2.0" EFFECT_SIZE="-8.15420298700081" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.05" NO="5" P_CHI2="0.4940675820856859" P_Z="1.9280523357979298E-9" STUDIES="3" TAU2="0.0" TOTAL_1="243" TOTAL_2="187" WEIGHT="100.0" Z="6.003755282927574">
<NAME>4 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-5.843011424906308" CI_START="-12.156988575093692" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="0.0" ORDER="292" SD_1="14.8" SD_2="13.4" SE="1.61073805437019" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="71.0996126605744"/>
<CONT_DATA CI_END="4.783120214539968" CI_START="-12.183120214539967" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-26.8" MEAN_2="-23.1" ORDER="293" SD_1="10.4" SD_2="10.8" SE="4.328202090167848" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="9.8469563396932"/>
<CONT_DATA CI_END="-1.2015420753412105" CI_START="-13.39845792465879" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.7" ORDER="294" SD_1="12.3" SD_2="13.3" SE="3.1115152996497115" STUDY_ID="STD-Weir-1995" TOTAL_1="76" TOTAL_2="23" WEIGHT="19.053430999732413"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.08507540751979653" CI_END="1.0513752368134446" CI_START="-12.524388392737961" DF="1.0" EFFECT_SIZE="-5.736506577962259" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.06" NO="6" P_CHI2="0.7705336936637909" P_Z="0.09764385682068476" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="30" WEIGHT="100.0" Z="1.6563850987223858">
<NAME>8 mg</NAME>
<CONT_DATA CI_END="2.0086051288419586" CI_START="-15.008605128841959" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="0.0" ORDER="295" SD_1="16.3" SD_2="15.1" SE="4.341204836393296" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="43" TOTAL_2="18" WEIGHT="63.643170379155215"/>
<CONT_DATA CI_END="6.857482218060626" CI_START="-15.657482218060625" EFFECT_SIZE="-4.3999999999999995" ESTIMABLE="YES" MEAN_1="-5.1" MEAN_2="-0.7" ORDER="296" SD_1="22.2" SD_2="15.5" SE="5.743718918744532" STUDY_ID="STD-Weir-1995" TOTAL_1="38" TOTAL_2="12" WEIGHT="36.356829620844785"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.202055880962043" CI_START="-16.602055880962045" DF="0.0" EFFECT_SIZE="-5.7" ESTIMABLE="YES" I2="0.0" ID="CMP-014.01.07" NO="7" P_CHI2="1.0" P_Z="0.3054849470858044" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="12" WEIGHT="100.0" Z="1.0247420150714237">
<NAME>12 mg</NAME>
<CONT_DATA CI_END="5.202055880962043" CI_START="-16.602055880962045" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-0.7" ORDER="297" SD_1="20.1" SD_2="15.5" SE="5.562375618611397" STUDY_ID="STD-Weir-1995" TOTAL_1="37" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.878937653375413E-32" CI_END="3.159641318028501" CI_START="-17.3596413180285" DF="0.0" EFFECT_SIZE="-7.1000000000000005" ESTIMABLE="YES" I2="100.0" ID="CMP-014.01.08" NO="8" P_CHI2="0.0" P_Z="0.1749853606336461" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="12" WEIGHT="100.0" Z="1.3563577769313717">
<NAME>16 mg</NAME>
<CONT_DATA CI_END="3.159641318028502" CI_START="-17.3596413180285" EFFECT_SIZE="-7.1" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-0.7" ORDER="298" SD_1="16.3" SD_2="15.5" SE="5.234607063678334" STUDY_ID="STD-Weir-1995" TOTAL_1="36" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="20.827955544512964" CI_END="-3.3480627254170976" CI_START="-4.8863769854957635" CI_STUDY="95" CI_TOTAL="95" DF="22.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.1172198554564305" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-014.02" NO="2" P_CHI2="0.5313916215317198" P_Q="0.44271794410447685" P_Z="9.452804823043462E-26" Q="6.86832158460459" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1152" TOTAL_2="636" UNITS="" WEIGHT="800.0" Z="10.491487783146663">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>Trandolapril</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Trandolapril</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.658514565672638" CI_START="-4.458514565672639" DF="0.0" EFFECT_SIZE="0.6" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.01" NO="1" P_CHI2="1.0" P_Z="0.8161690693350492" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="12" WEIGHT="100.0" Z="0.2324750429116657">
<NAME>0.25 mg</NAME>
<CONT_DATA CI_END="5.658514565672638" CI_START="-4.458514565672639" EFFECT_SIZE="0.6" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.7" ORDER="299" SD_1="7.7" SD_2="7.0" SE="2.580922203455551" STUDY_ID="STD-Weir-1995" TOTAL_1="23" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.16236205782401852" CI_END="0.24353278343459683" CI_START="-4.895508859805766" DF="3.0" EFFECT_SIZE="-2.325988038185584" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.02" NO="2" P_CHI2="0.9834236074876741" P_Z="0.07602949882473423" STUDIES="4" TAU2="0.0" TOTAL_1="131" TOTAL_2="53" WEIGHT="99.99999999999999" Z="1.7742034798691342">
<NAME>0.5 mg</NAME>
<CONT_DATA CI_END="2.9662529898379546" CI_START="-8.166252989837956" EFFECT_SIZE="-2.6000000000000005" ESTIMABLE="YES" MEAN_1="-9.8" MEAN_2="-7.2" ORDER="300" SD_1="9.1" SD_2="9.2" SE="2.8399771800624136" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="41" TOTAL_2="14" WEIGHT="21.309752206198855"/>
<CONT_DATA CI_END="1.5209641043410373" CI_START="-7.320964104341038" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-1.8" ORDER="301" SD_1="8.1" SD_2="7.7" SE="2.255635378615647" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="41" TOTAL_2="17" WEIGHT="33.780829149566"/>
<CONT_DATA CI_END="4.098869680267687" CI_START="-7.2988696802676865" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-9.4" ORDER="302" SD_1="8.0" SD_2="7.8" SE="2.9076400001324734" STUDY_ID="STD-Scholze-1998" TOTAL_1="27" TOTAL_2="10" WEIGHT="20.32950625115588"/>
<CONT_DATA CI_END="3.2827704738002863" CI_START="-7.082770473800287" EFFECT_SIZE="-1.9000000000000001" ESTIMABLE="YES" MEAN_1="-2.6" MEAN_2="-0.7" ORDER="303" SD_1="8.0" SD_2="7.0" SE="2.6443192398846707" STUDY_ID="STD-Weir-1995" TOTAL_1="22" TOTAL_2="12" WEIGHT="24.57991239307926"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.570615635864496" CI_END="-2.2462314973361535" CI_START="-5.886780495731888" DF="3.0" EFFECT_SIZE="-4.066505996534021" ESTIMABLE="YES" I2="60.37310379636745" ID="CMP-014.02.03" NO="3" P_CHI2="0.05577157722414838" P_Z="1.194587707235535E-5" STUDIES="4" TAU2="0.0" TOTAL_1="194" TOTAL_2="100" WEIGHT="100.0" Z="4.378573286410946">
<NAME>1 mg</NAME>
<CONT_DATA CI_END="-1.4943366409793715" CI_START="-11.905663359020629" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.9" MEAN_2="-7.2" ORDER="304" SD_1="7.7" SD_2="9.2" SE="2.6559994979919206" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="42" TOTAL_2="15" WEIGHT="12.227047817934736"/>
<CONT_DATA CI_END="-3.757485661436923" CI_START="-10.042514338563077" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-6.1" ORDER="305" SD_1="8.3" SD_2="7.8" SE="1.60335310411356" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" WEIGHT="33.55206342037771"/>
<CONT_DATA CI_END="3.831907021839039" CI_START="-7.431907021839037" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-9.4" ORDER="306" SD_1="7.8" SD_2="7.8" SE="2.873474750690728" STUDY_ID="STD-Scholze-1998" TOTAL_1="28" TOTAL_2="10" WEIGHT="10.446307777643225"/>
<CONT_DATA CI_END="1.051223586867847" CI_START="-4.4512235868678465" EFFECT_SIZE="-1.6999999999999997" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.1" ORDER="307" SD_1="5.9" SD_2="6.0" SE="1.40371129702849" STUDY_ID="STD-Weir-1995" TOTAL_1="74" TOTAL_2="24" WEIGHT="43.77458098404432"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.89561971194613" CI_END="-2.937426001287082" CI_START="-5.547285053415282" DF="6.0" EFFECT_SIZE="-4.242355527351182" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.04" NO="4" P_CHI2="0.43498404850876937" P_Z="1.8671591995854698E-10" STUDIES="7" TAU2="0.0" TOTAL_1="407" TOTAL_2="230" WEIGHT="100.00000000000001" Z="6.371887429278925">
<NAME>2 mg</NAME>
<CONT_DATA CI_END="-0.3385324101112941" CI_START="-10.861467589888708" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-7.2" ORDER="308" SD_1="8.2" SD_2="9.2" SE="2.684471567534144" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="15" WEIGHT="6.151206638480724"/>
<CONT_DATA CI_END="0.3515554310134874" CI_START="-7.751555431013488" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-5.5" MEAN_2="-1.8" ORDER="309" SD_1="8.1" SD_2="7.7" SE="2.067158102379248" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="67" TOTAL_2="18" WEIGHT="10.373625026141342"/>
<CONT_DATA CI_END="-1.2540421710735012" CI_START="-6.145957828926499" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="310" SD_1="9.8" SD_2="10.4" SE="1.2479605993885103" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="28.46270591637532"/>
<CONT_DATA CI_END="-3.631209535139104" CI_START="-9.168790464860894" EFFECT_SIZE="-6.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-1.2" ORDER="311" SD_1="7.0" SD_2="3.9" SE="1.412674154576697" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="22.21232065706099"/>
<CONT_DATA CI_END="0.1822857283975301" CI_START="-10.982285728397532" EFFECT_SIZE="-5.4" ESTIMABLE="YES" MEAN_1="-14.8" MEAN_2="-9.4" ORDER="312" SD_1="7.8" SD_2="7.8" SE="2.8481572990268638" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="10" WEIGHT="5.464494480462482"/>
<CONT_DATA CI_END="4.355344260103939" CI_START="-4.95534426010394" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-8.0" ORDER="313" SD_1="7.0" SD_2="6.0" SE="2.375219288121976" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="7.8572489026017704"/>
<CONT_DATA CI_END="-0.7432783873248274" CI_START="-6.656721612675172" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-3.1" ORDER="314" SD_1="7.3" SD_2="6.0" SE="1.5085591551668371" STUDY_ID="STD-Weir-1995" TOTAL_1="75" TOTAL_2="23" WEIGHT="19.47839837887739"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.23706777144035407" CI_END="-3.1344947453378937" CI_START="-6.09962181831511" DF="2.0" EFFECT_SIZE="-4.617058281826502" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.05" NO="5" P_CHI2="0.8882217205948184" P_Z="1.035773524847422E-9" STUDIES="3" TAU2="0.0" TOTAL_1="243" TOTAL_2="188" WEIGHT="100.0" Z="6.103797728854949">
<NAME>4 mg (Max Dose)</NAME>
<CONT_DATA CI_END="-2.7323818254451604" CI_START="-6.26761817455484" EFFECT_SIZE="-4.5" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="0.0" ORDER="315" SD_1="8.1" SD_2="7.7" SE="0.901862579362471" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="70.3476691428925"/>
<CONT_DATA CI_END="5.083988207138917" CI_START="-11.483988207138916" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-10.0" ORDER="316" SD_1="10.6" SD_2="10.1" SE="4.226602260287413" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="3.202931753481216"/>
<CONT_DATA CI_END="-2.2172604296608815" CI_START="-7.982739570339118" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-3.1" ORDER="317" SD_1="7.1" SD_2="6.0" SE="1.470812521596213" STUDY_ID="STD-Weir-1995" TOTAL_1="76" TOTAL_2="24" WEIGHT="26.449399103626295"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.09396878283337251" CI_END="-1.0081037855008481" CI_START="-7.815353686711401" DF="1.0" EFFECT_SIZE="-4.411728736106125" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.06" NO="6" P_CHI2="0.7591910511528772" P_Z="0.011070151135417422" STUDIES="2" TAU2="0.0" TOTAL_1="81" TOTAL_2="29" WEIGHT="100.0" Z="2.540476567722518">
<NAME>8 mg</NAME>
<CONT_DATA CI_END="0.3028699721203152" CI_START="-8.302869972120316" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-1.8" ORDER="318" SD_1="8.1" SD_2="7.7" SE="2.195382163172795" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="43" TOTAL_2="18" WEIGHT="62.57011489944318"/>
<CONT_DATA CI_END="0.4632996391520354" CI_START="-10.663299639152035" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-0.7" ORDER="319" SD_1="11.7" SD_2="7.0" SE="2.8384703407994394" STUDY_ID="STD-Weir-1995" TOTAL_1="38" TOTAL_2="11" WEIGHT="37.42988510055681"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.619766704563772" CI_START="-11.78023329543623" DF="0.0" EFFECT_SIZE="-6.2" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.07" NO="7" P_CHI2="1.0" P_Z="0.02943234879680045" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="12" WEIGHT="100.0" Z="2.177646714893913">
<NAME>12 mg</NAME>
<CONT_DATA CI_END="-0.619766704563772" CI_START="-11.78023329543623" EFFECT_SIZE="-6.2" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-0.7" ORDER="320" SD_1="12.2" SD_2="7.0" SE="2.8471101201105715" STUDY_ID="STD-Weir-1995" TOTAL_1="37" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.0243094332278995" CI_START="-11.3756905667721" DF="0.0" EFFECT_SIZE="-6.2" ESTIMABLE="YES" I2="0.0" ID="CMP-014.02.08" NO="8" P_CHI2="1.0" P_Z="0.018881814172483934" STUDIES="1" TAU2="0.0" TOTAL_1="36" TOTAL_2="12" WEIGHT="100.00000000000001" Z="2.347856106808754">
<NAME>16 mg</NAME>
<CONT_DATA CI_END="-1.0243094332279004" CI_START="-11.3756905667721" EFFECT_SIZE="-6.2" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-0.7" ORDER="321" SD_1="10.2" SD_2="7.0" SE="2.6407069760451143" STUDY_ID="STD-Weir-1995" TOTAL_1="36" TOTAL_2="12" WEIGHT="100.00000000000001"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-015" NO="15">
<NAME>1/16 Max Dose vs Placebo</NAME>
<CONT_OUTCOME CHI2="5.0762897305811325" CI_END="3.462684618952058" CI_START="-3.783881254456678" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1605983177523099" ESTIMABLE="YES" I2="40.90171839627127" I2_Q="0.0" ID="CMP-015.01" NO="1" P_CHI2="0.1662955222749648" P_Q="0.46907597365524467" P_Z="0.9307721409025269" Q="1.5139815522574454" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="129" TOTAL_2="133" UNITS="" WEIGHT="100.00000000000003" Z="0.08687340300797756">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="4.12699377668654" CI_START="-9.92699377668654" DF="0.0" EFFECT_SIZE="-2.9" ESTIMABLE="YES" I2="0.0" ID="CMP-015.01.01" NO="1" P_CHI2="1.0" P_Z="0.4185923000457289" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="26.586756602890155" Z="0.8088658871484447">
<NAME>Fosinopril 2.5 mg</NAME>
<CONT_DATA CI_END="4.12699377668654" CI_START="-9.92699377668654" EFFECT_SIZE="-2.9" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-3.4" ORDER="322" SD_1="13.9" SD_2="13.4" SE="3.585266786591269" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="29" WEIGHT="26.586756602890155"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="5.793082374026448" CI_START="-9.793082374026447" DF="0.0" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" ID="CMP-015.01.02" NO="2" P_CHI2="1.0" P_Z="0.6149635942725781" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="39" WEIGHT="21.616529199699535" Z="0.5030009668760631">
<NAME>Lisinopril 5 mg</NAME>
<CONT_DATA CI_END="5.793082374026448" CI_START="-9.793082374026447" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-7.7" MEAN_2="-5.7" ORDER="323" SD_1="19.2" SD_2="15.1" SE="3.9761354981506227" STUDY_ID="STD-Gomez-1989" TOTAL_1="37" TOTAL_2="39" WEIGHT="21.616529199699535"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.562308178323687" CI_END="7.047594828062714" CI_START="-3.021284573125231" DF="1.0" EFFECT_SIZE="2.013155127468741" ESTIMABLE="YES" I2="71.9283130503726" ID="CMP-015.01.03" NO="3" P_CHI2="0.059105651837150996" P_Z="0.43319038814269606" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="65" WEIGHT="51.79671419741033" Z="0.783743927783136">
<NAME>Ramipril 1.25 mg</NAME>
<CONT_DATA CI_END="4.321405923323575" CI_START="-9.721405923323577" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="0.5" ORDER="324" SD_1="16.4" SD_2="16.6" SE="3.5824157886101626" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="41" WEIGHT="26.6290905782807"/>
<CONT_DATA CI_END="14.222393449831042" CI_START="-0.22239344983104203" EFFECT_SIZE="7.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-9.0" ORDER="325" SD_1="12.0" SD_2="12.0" SE="3.6849623293082727" STUDY_ID="STD-Trevisan-1995" TOTAL_1="19" TOTAL_2="24" WEIGHT="25.167623619129632"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.5972421666508825" CI_END="2.1573470079920245" CI_START="-1.8643278038362778" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.14650960207787336" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-015.02" NO="2" P_CHI2="0.457973280711261" P_Q="0.8592837255265913" P_Z="0.886445795482046" Q="0.30331226267016786" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="129" TOTAL_2="133" UNITS="" WEIGHT="100.0" Z="0.14280296488287328">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.3675257526459257" CI_START="-4.767525752645926" DF="0.0" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" I2="0.0" ID="CMP-015.02.01" NO="1" P_CHI2="1.0" P_Z="0.735891065530794" STUDIES="1" TAU2="0.0" TOTAL_1="29" TOTAL_2="29" WEIGHT="24.43955468759263" Z="0.33729959503896656">
<NAME>Fosinopril 2.5 mg</NAME>
<CONT_DATA CI_END="3.3675257526459257" CI_START="-4.767525752645926" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-4.2" ORDER="326" SD_1="8.1" SD_2="7.7" SE="2.0753063753875325" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="29" WEIGHT="24.43955468759263"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="3.6763929855469213" CI_START="-3.6763929855469213" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" ID="CMP-015.02.02" NO="2" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="39" WEIGHT="29.91644972845579" Z="0.0">
<NAME>Lisinopril 5 mg</NAME>
<CONT_DATA CI_END="3.6763929855469217" CI_START="-3.6763929855469217" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-5.0" ORDER="327" SD_1="9.0" SD_2="7.2" SE="1.8757451741694442" STUDY_ID="STD-Gomez-1989" TOTAL_1="37" TOTAL_2="39" WEIGHT="29.91644972845579"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.2939299039807146" CI_END="3.6721480105575925" CI_START="-2.2805674496187724" DF="1.0" EFFECT_SIZE="0.6957902804694102" ESTIMABLE="YES" I2="56.406688876383065" ID="CMP-015.02.03" NO="3" P_CHI2="0.12988082188511174" P_Z="0.6468191932929117" STUDIES="2" TAU2="0.0" TOTAL_1="63" TOTAL_2="65" WEIGHT="45.64399558395157" Z="0.458185478421192">
<NAME>Ramipril 1.25 mg</NAME>
<CONT_DATA CI_END="2.6053586667915587" CI_START="-5.805358666791558" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-4.3" MEAN_2="-2.7" ORDER="328" SD_1="9.3" SD_2="10.4" SE="2.1456305829917746" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="41" WEIGHT="22.8637691875549"/>
<CONT_DATA CI_END="7.2130628457347745" CI_START="-1.2130628457347745" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-5.0" ORDER="329" SD_1="7.0" SD_2="7.0" SE="2.149561358763159" STUDY_ID="STD-Trevisan-1995" TOTAL_1="19" TOTAL_2="24" WEIGHT="22.78022639639667"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-016" NO="16">
<NAME>1/8 Max Dose vs Placebo</NAME>
<CONT_OUTCOME CHI2="12.620082510517673" CI_END="-4.452075070168759" CI_START="-6.954502999363264" CI_STUDY="95" CI_TOTAL="95" DF="17.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.703289034766011" ESTIMABLE="YES" I2="0.0" I2_Q="7.68986188865659" ID="CMP-016.01" NO="1" P_CHI2="0.7612243988661316" P_Q="0.3671863422096747" P_Z="4.1118766612134534E-19" Q="5.4165231493523045" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1011" TOTAL_2="1014" UNITS="" WEIGHT="99.99999999999999" Z="8.933916514560083">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.18541373217047566" CI_END="-0.4668033725251819" CI_START="-12.32002739581121" DF="1.0" EFFECT_SIZE="-6.393415384168195" ESTIMABLE="YES" I2="0.0" ID="CMP-016.01.01" NO="1" P_CHI2="0.6667614669685179" P_Z="0.034486367156839955" STUDIES="2" TAU2="0.0" TOTAL_1="50" TOTAL_2="41" WEIGHT="4.457077358405703" Z="2.1143384899427713">
<NAME>Benazepril 5 mg</NAME>
<CONT_DATA CI_END="2.054602073886489" CI_START="-12.85460207388649" EFFECT_SIZE="-5.4" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-2.5" ORDER="330" SD_1="15.2" SD_2="14.3" SE="3.80343829411532" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="2.817177648676829"/>
<CONT_DATA CI_END="1.6706383434933905" CI_START="-17.870638343493393" EFFECT_SIZE="-8.100000000000001" ESTIMABLE="YES" MEAN_1="-5.9" MEAN_2="2.2" ORDER="331" SD_1="13.9" SD_2="13.4" SE="4.985111165594337" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="15" WEIGHT="1.6398997097288739"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.3603179410216564" CI_END="-2.916917370172066" CI_START="-7.328588944771417" DF="3.0" EFFECT_SIZE="-5.122753157471742" ESTIMABLE="YES" I2="10.72273360276459" ID="CMP-016.01.02" NO="2" P_CHI2="0.3393354373331833" P_Z="5.320168605030002E-6" STUDIES="4" TAU2="0.0" TOTAL_1="299" TOTAL_2="308" WEIGHT="32.174870593890276" Z="4.551749385943483">
<NAME>Enalapril 5 mg</NAME>
<CONT_DATA CI_END="0.20652410484025285" CI_START="-12.60652410484025" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-2.0" ORDER="332" SD_1="17.1" SD_2="17.8" SE="3.268694810401669" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" WEIGHT="3.814329761973644"/>
<CONT_DATA CI_END="-3.7387001967916635" CI_START="-10.061299803208337" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="0.4" ORDER="333" SD_1="13.9" SD_2="13.4" SE="1.6129377009701535" STUDY_ID="STD-Cushman-1998" TOTAL_1="140" TOTAL_2="147" WEIGHT="15.665050420918822"/>
<CONT_DATA CI_END="1.2788942777503074" CI_START="-7.078894277750308" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-4.0" ORDER="334" SD_1="13.9" SD_2="13.4" SE="2.1321280955736395" STUDY_ID="STD-Gradman-1997" TOTAL_1="85" TOTAL_2="79" WEIGHT="8.964795716623815"/>
<CONT_DATA CI_END="4.577937119832576" CI_START="-8.377937119832577" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="-7.5" ORDER="335" SD_1="10.6" SD_2="10.6" SE="3.305130691650315" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="18" TOTAL_2="24" WEIGHT="3.7306946943739954"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6575134822471806" CI_START="-8.057513482247181" DF="0.0" EFFECT_SIZE="-3.7" ESTIMABLE="YES" I2="0.0" ID="CMP-016.01.03" NO="3" P_CHI2="1.0" P_Z="0.09606821341976503" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="77" WEIGHT="8.244905583059763" Z="1.6642212978440158">
<NAME>Fosinopril 5 mg</NAME>
<CONT_DATA CI_END="0.6575134822471806" CI_START="-8.057513482247181" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-4.1" ORDER="336" SD_1="13.9" SD_2="13.4" SE="2.223262017373121" STUDY_ID="STD-Pool-1990" TOTAL_1="74" TOTAL_2="77" WEIGHT="8.244905583059763"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.48034662533315" CI_END="-5.51333006050195" CI_START="-9.983672731483566" DF="3.0" EFFECT_SIZE="-7.748501395992758" ESTIMABLE="YES" I2="0.0" ID="CMP-016.01.04" NO="4" P_CHI2="0.4788536220629068" P_Z="1.0871848970763983E-11" STUDIES="4" TAU2="0.0" TOTAL_1="330" TOTAL_2="318" WEIGHT="31.335853424324856" Z="6.794460643425065">
<NAME>Lisinopril 10 mg</NAME>
<CONT_DATA CI_END="-4.414456911693317" CI_START="-10.385543088306683" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-0.9" ORDER="337" SD_1="14.9" SD_2="14.4" SE="1.5232642598824602" STUDY_ID="STD-Black-1997" TOTAL_1="187" TOTAL_2="183" WEIGHT="17.563718940568666"/>
<CONT_DATA CI_END="-5.150336766965391" CI_START="-19.24966323303461" EFFECT_SIZE="-12.200000000000001" ESTIMABLE="YES" MEAN_1="-13.3" MEAN_2="-1.1" ORDER="338" SD_1="11.2" SD_2="14.8" SE="3.5968330482812205" STUDY_ID="STD-Chan-1997" TOTAL_1="26" TOTAL_2="27" WEIGHT="3.15011510918788"/>
<CONT_DATA CI_END="-1.0935861059109016" CI_START="-10.5064138940891" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.1" ORDER="339" SD_1="15.3" SD_2="14.2" SE="2.401275702621421" STUDY_ID="STD-Chrysant-1994" TOTAL_1="80" TOTAL_2="71" WEIGHT="7.0677785028435585"/>
<CONT_DATA CI_END="-2.763208800649985" CI_START="-16.036791199350017" EFFECT_SIZE="-9.4" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-1.2" ORDER="340" SD_1="13.9" SD_2="15.2" SE="3.386180180707491" STUDY_ID="STD-Whelton-1992" TOTAL_1="37" TOTAL_2="37" WEIGHT="3.5542408717247524"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.21862268918310673" CI_END="-0.9806612203026037" CI_START="-8.051477939979153" DF="3.0" EFFECT_SIZE="-4.516069580140878" ESTIMABLE="YES" I2="0.0" ID="CMP-016.01.05" NO="5" P_CHI2="0.9745284206542542" P_Z="0.012292854581403709" STUDIES="4" TAU2="0.0" TOTAL_1="149" TOTAL_2="143" WEIGHT="12.525180599095261" Z="2.503624144045964">
<NAME>Ramipril 2.5 mg</NAME>
<CONT_DATA CI_END="2.825862640695413" CI_START="-11.225862640695414" EFFECT_SIZE="-4.2" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-5.7" ORDER="341" SD_1="15.0" SD_2="17.0" SE="3.5846896657869842" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.1714937213781185"/>
<CONT_DATA CI_END="0.37998274346115224" CI_START="-11.379982743461152" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="0.5" ORDER="342" SD_1="9.9" SD_2="16.6" SE="3.000046322198625" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="41" WEIGHT="4.528048423893548"/>
<CONT_DATA CI_END="3.4475576893102478" CI_START="-10.247557689310247" EFFECT_SIZE="-3.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-3.7" ORDER="343" SD_1="15.5" SD_2="16.7" SE="3.4937160801539764" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="43" WEIGHT="3.338810465252842"/>
<CONT_DATA CI_END="5.561272452044241" CI_START="-14.96127245204424" EFFECT_SIZE="-4.699999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-5.4" ORDER="344" SD_1="17.6" SD_2="16.6" SE="5.235439290203212" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="19" WEIGHT="1.4868279885707536"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9588583734569788" CI_END="-0.4566475999992381" CI_START="-7.913433074501945" DF="2.0" EFFECT_SIZE="-4.185040337250592" ESTIMABLE="YES" I2="0.0" ID="CMP-016.01.06" NO="6" P_CHI2="0.6191367476645504" P_Z="0.02780567121253472" STUDIES="3" TAU2="0.0" TOTAL_1="109" TOTAL_2="127" WEIGHT="11.262112441224124" Z="2.200017249498665">
<NAME>Trandolapril 0.5 mg</NAME>
<CONT_DATA CI_END="-0.1836083343281505" CI_START="-13.416391665671847" EFFECT_SIZE="-6.799999999999999" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-9.6" ORDER="345" SD_1="15.6" SD_2="15.5" SE="3.3757720641099027" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="41" TOTAL_2="44" WEIGHT="3.576191394859869"/>
<CONT_DATA CI_END="2.6945141837813416" CI_START="-9.894514183781341" EFFECT_SIZE="-3.6" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="0.0" ORDER="346" SD_1="15.7" SD_2="15.1" SE="3.2115458413683444" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="41" TOTAL_2="53" WEIGHT="3.9512884288383145"/>
<CONT_DATA CI_END="4.174520940883619" CI_START="-8.774520940883617" EFFECT_SIZE="-2.299999999999999" ESTIMABLE="YES" MEAN_1="-13.6" MEAN_2="-11.3" ORDER="347" SD_1="12.5" SD_2="12.4" SE="3.3033877111792935" STUDY_ID="STD-Scholze-1998" TOTAL_1="27" TOTAL_2="30" WEIGHT="3.7346326175259406"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.3771097455557" CI_END="-2.507720682991902" CI_START="-3.876512841992774" CI_STUDY="95" CI_TOTAL="95" DF="18.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.192116762492338" ESTIMABLE="YES" I2="0.0" I2_Q="46.308809476705974" ID="CMP-016.02" NO="2" P_CHI2="0.7041978549123006" P_Q="0.09722975671483103" P_Z="6.156942772595731E-20" Q="9.312514681213374" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="19" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1112" TOTAL_2="1064" UNITS="" WEIGHT="100.0" Z="9.141539638126456">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.20864230035396605" CI_END="2.0505682854746548" CI_START="-5.894681687532572" DF="1.0" EFFECT_SIZE="-1.9220567010289582" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.01" NO="1" P_CHI2="0.6478336552050836" P_Z="0.34298680194835973" STUDIES="2" TAU2="0.0" TOTAL_1="50" TOTAL_2="41" WEIGHT="2.967972594321109" Z="0.9482802738891756">
<NAME>Benazepril 5 mg</NAME>
<CONT_DATA CI_END="3.4860462830294825" CI_START="-6.086046283029482" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.7" ORDER="348" SD_1="9.2" SD_2="9.6" SE="2.4419052190658626" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="2.0448489739372353"/>
<CONT_DATA CI_END="3.8232400686959256" CI_START="-10.423240068695927" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-5.0" ORDER="349" SD_1="10.2" SD_2="9.7" SE="3.6343729399535576" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.9231236203838735"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4829490269873233" CI_END="-1.2255304521812174" CI_START="-3.520288178010387" DF="4.0" EFFECT_SIZE="-2.3729093150958023" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.02" NO="2" P_CHI2="0.8296575764086819" P_Z="5.047269181517362E-5" STUDIES="5" TAU2="0.0" TOTAL_1="400" TOTAL_2="358" WEIGHT="35.57962251439491" Z="4.053427291098358">
<NAME>Enalapril 5 mg</NAME>
<CONT_DATA CI_END="0.676225633097292" CI_START="-5.476225633097291" EFFECT_SIZE="-2.3999999999999995" ESTIMABLE="YES" MEAN_1="-5.6" MEAN_2="-3.2" ORDER="350" SD_1="8.9" SD_2="7.8" SE="1.5695317145428012" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" WEIGHT="4.949697441813636"/>
<CONT_DATA CI_END="-0.4697921898483701" CI_START="-4.13020781015163" EFFECT_SIZE="-2.3" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-3.5" ORDER="351" SD_1="8.1" SD_2="7.7" SE="0.9337966537079636" STUDY_ID="STD-Cushman-1998" TOTAL_1="140" TOTAL_2="147" WEIGHT="13.983446253410131"/>
<CONT_DATA CI_END="0.8183038335175081" CI_START="-4.018303833517507" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.4" ORDER="352" SD_1="8.1" SD_2="7.7" SE="1.2338511587931102" STUDY_ID="STD-Gradman-1997" TOTAL_1="85" TOTAL_2="79" WEIGHT="8.009276696222711"/>
<CONT_DATA CI_END="-1.0446979958580411" CI_START="-6.355302004141958" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-5.0" ORDER="353" SD_1="8.1" SD_2="7.7" SE="1.3547708147122302" STUDY_ID="STD-Guitard-1997" TOTAL_1="101" TOTAL_2="50" WEIGHT="6.643350704738641"/>
<CONT_DATA CI_END="3.346867163063842" CI_START="-6.346867163063842" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-5.4" ORDER="354" SD_1="8.1" SD_2="7.7" SE="2.472936850521393" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="18" TOTAL_2="24" WEIGHT="1.9938514182097908"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.6773340013130968" CI_START="-5.722665998686901" DF="0.0" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.03" NO="3" P_CHI2="1.0" P_Z="0.012911069930573739" STUDIES="1" TAU2="0.0" TOTAL_1="74" TOTAL_2="77" WEIGHT="7.360300043555814" Z="2.4862129008726535">
<NAME>Fosinopril 5 mg</NAME>
<CONT_DATA CI_END="-0.6773340013130968" CI_START="-5.722665998686901" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.9" ORDER="355" SD_1="8.1" SD_2="7.7" SE="1.2870981398563288" STUDY_ID="STD-Pool-1990" TOTAL_1="74" TOTAL_2="77" WEIGHT="7.360300043555814"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.809929574020977" CI_END="-3.500646204705929" CI_START="-5.922011933749554" DF="3.0" EFFECT_SIZE="-4.711329069227741" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.04" NO="4" P_CHI2="0.42186804052099713" P_Z="2.4003797028186994E-14" STUDIES="4" TAU2="0.0" TOTAL_1="330" TOTAL_2="318" WEIGHT="31.956134091619052" Z="7.6271297509857705">
<NAME>Lisinopril 10 mg</NAME>
<CONT_DATA CI_END="-2.689910539231597" CI_START="-5.910089460768402" EFFECT_SIZE="-4.3" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-3.2" ORDER="356" SD_1="8.1" SD_2="7.7" SE="0.8214893097365987" STUDY_ID="STD-Black-1997" TOTAL_1="187" TOTAL_2="183" WEIGHT="18.068205094481694"/>
<CONT_DATA CI_END="-3.842144600465568" CI_START="-12.357855399534431" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-1.4" ORDER="357" SD_1="8.1" SD_2="7.7" SE="2.1724151224817656" STUDY_ID="STD-Chan-1997" TOTAL_1="26" TOTAL_2="27" WEIGHT="2.5836471969693844"/>
<CONT_DATA CI_END="-2.4382422531885766" CI_START="-7.161757746811423" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-5.3" ORDER="358" SD_1="6.9" SD_2="7.8" SE="1.2050005844192377" STUDY_ID="STD-Chrysant-1994" TOTAL_1="80" TOTAL_2="71" WEIGHT="8.397390104486572"/>
<CONT_DATA CI_END="0.014145289428536323" CI_START="-8.014145289428537" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-5.1" ORDER="359" SD_1="8.4" SD_2="9.2" SE="2.048070944717149" STUDY_ID="STD-Whelton-1992" TOTAL_1="37" TOTAL_2="37" WEIGHT="2.906891695681402"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.31874981005718195" CI_END="-0.508512282707795" CI_START="-4.495399024363511" DF="3.0" EFFECT_SIZE="-2.5019556535356533" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.05" NO="5" P_CHI2="0.9564644294722097" P_Z="0.013896182094730711" STUDIES="4" TAU2="0.0" TOTAL_1="149" TOTAL_2="143" WEIGHT="11.787106849391211" Z="2.459935929762467">
<NAME>Ramipril 2.5 mg</NAME>
<CONT_DATA CI_END="1.2633733797581526" CI_START="-5.663373379758153" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.8" ORDER="360" SD_1="8.1" SD_2="7.7" SE="1.7670597047072292" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.9049582686235786"/>
<CONT_DATA CI_END="0.6677562477182217" CI_START="-7.667756247718222" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-6.2" MEAN_2="-2.7" ORDER="361" SD_1="9.0" SD_2="10.4" SE="2.126445322767638" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="41" WEIGHT="2.696561959993009"/>
<CONT_DATA CI_END="1.234199723659661" CI_START="-6.034199723659661" EFFECT_SIZE="-2.4" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-2.6" ORDER="362" SD_1="9.3" SD_2="7.7" SE="1.8542176041630174" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="43" WEIGHT="3.5464794205357304"/>
<CONT_DATA CI_END="3.545690786521458" CI_START="-7.145690786521458" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-6.8" ORDER="363" SD_1="10.8" SD_2="7.0" SE="2.727443375841385" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="19" WEIGHT="1.6391072002388947"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.2443243529228778" CI_END="-0.3346669053299953" CI_START="-4.589584670010956" DF="2.0" EFFECT_SIZE="-2.462125787670476" ESTIMABLE="YES" I2="0.0" ID="CMP-016.02.06" NO="6" P_CHI2="0.8850048340697726" P_Z="0.023311990500958456" STUDIES="3" TAU2="0.0" TOTAL_1="109" TOTAL_2="127" WEIGHT="10.34886390671791" Z="2.2682825549759036">
<NAME>Trandolapril 0.5 mg</NAME>
<CONT_DATA CI_END="1.2920919508055344" CI_START="-6.492091950805536" EFFECT_SIZE="-2.6000000000000005" ESTIMABLE="YES" MEAN_1="-9.8" MEAN_2="-7.2" ORDER="364" SD_1="9.1" SD_2="9.2" SE="1.985797688889112" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="41" TOTAL_2="44" WEIGHT="3.092066618719171"/>
<CONT_DATA CI_END="0.33181548183157883" CI_START="-6.1318154818315795" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-1.8" ORDER="365" SD_1="8.1" SD_2="7.7" SE="1.648915749127906" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="41" TOTAL_2="53" WEIGHT="4.484581406426587"/>
<CONT_DATA CI_END="2.510493724108936" CI_START="-5.710493724108935" EFFECT_SIZE="-1.5999999999999996" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-9.4" ORDER="366" SD_1="8.0" SD_2="7.8" SE="2.0972292126447147" STUDY_ID="STD-Scholze-1998" TOTAL_1="27" TOTAL_2="30" WEIGHT="2.7722158815721505"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-017" NO="17">
<NAME>1/4 Max Dose vs Placebo</NAME>
<CONT_OUTCOME CHI2="44.76607806498196" CI_END="-4.218756535977249" CI_START="-6.054071614964744" CI_STUDY="95" CI_TOTAL="95" DF="39.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.136414075470997" ESTIMABLE="YES" I2="12.880462873276468" I2_Q="15.574292942362318" ID="CMP-017.01" NO="1" P_CHI2="0.2426157642045852" P_Q="0.2955824251613911" P_Z="5.296293296560367E-28" Q="11.844733492338975" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="40" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1819" TOTAL_2="1704" UNITS="" WEIGHT="99.99999999999999" Z="10.970526764441566">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.21200201284257095" CI_END="0.1545345471174775" CI_START="-5.920690336848995" DF="2.0" EFFECT_SIZE="-2.883077894865759" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.01" NO="1" P_CHI2="0.8994237446755785" P_Z="0.06284968478688295" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="156" WEIGHT="9.126337982198185" Z="1.8602533886354253">
<NAME>Benazepril 10 mg</NAME>
<CONT_DATA CI_END="2.965223723234434" CI_START="-11.765223723234435" EFFECT_SIZE="-4.4" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-2.5" ORDER="367" SD_1="13.7" SD_2="14.3" SE="3.7578362568549113" STUDY_ID="STD-Moser-1991" TOTAL_1="30" TOTAL_2="26" WEIGHT="1.5523490762763292"/>
<CONT_DATA CI_END="1.0208475480770147" CI_START="-6.020847548077015" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="-5.5" MEAN_2="-3.0" ORDER="368" SD_1="13.9" SD_2="13.4" SE="1.7963837988090652" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" WEIGHT="6.793081624309184"/>
<CONT_DATA CI_END="7.184387862802272" CI_START="-13.584387862802274" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="2.2" ORDER="369" SD_1="13.9" SD_2="13.4" SE="5.298254429526766" STUDY_ID="STD-Weinberger-1990" TOTAL_1="12" TOTAL_2="15" WEIGHT="0.7809072816126724"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.08113161867564" CI_END="-2.1751324287978315" CI_START="-7.340975232303548" DF="8.0" EFFECT_SIZE="-4.75805383055069" ESTIMABLE="YES" I2="27.805207308275623" ID="CMP-017.01.02" NO="2" P_CHI2="0.1971445193726119" P_Z="3.056180577747092E-4" STUDIES="9" TAU2="0.0" TOTAL_1="236" TOTAL_2="226" WEIGHT="12.622311469206908" Z="3.6104908721006836">
<NAME>Cilazapril 2.5 mg</NAME>
<CONT_DATA CI_END="6.996942518114464" CI_START="-20.996942518114466" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="0.0" ORDER="370" SD_1="15.0" SD_2="9.0" SE="7.14142842854285" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" WEIGHT="0.4298282108978458"/>
<CONT_DATA CI_END="-1.467103376036488" CI_START="-16.332896623963514" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-11.3" MEAN_2="-2.4" ORDER="371" SD_1="13.9" SD_2="13.4" SE="3.792363881476013" STUDY_ID="STD-Guntzel-1991" TOTAL_1="28" TOTAL_2="24" WEIGHT="1.524210990477838"/>
<CONT_DATA CI_END="26.402704418317366" CI_START="-32.40270441831737" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-2.0" ORDER="372" SD_1="22.1" SD_2="26.8" SE="15.001655464203498" STUDY_ID="STD-Krum-1992" TOTAL_1="6" TOTAL_2="5" WEIGHT="0.0974062262809697"/>
<CONT_DATA CI_END="8.628806027432919" CI_START="-4.828806027432918" EFFECT_SIZE="1.9" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-5.5" ORDER="373" SD_1="16.4" SD_2="15.8" SE="3.433127384231997" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="44" WEIGHT="1.859881421625079"/>
<CONT_DATA CI_END="-0.36581674084555527" CI_START="-9.834183259154443" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-7.7" MEAN_2="-2.6" ORDER="374" SD_1="12.0" SD_2="12.9" SE="2.4154440063680136" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="51" WEIGHT="3.7572590876132823"/>
<CONT_DATA CI_END="2.3080350917686774" CI_START="-15.908035091768678" EFFECT_SIZE="-6.8" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-2.8" ORDER="375" SD_1="11.2" SD_2="13.3" SE="4.647042069962354" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="1.0151071431252667"/>
<CONT_DATA CI_END="5.253267199721702" CI_START="-6.6532671997217046" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-11.6" ORDER="376" SD_1="16.4" SD_2="15.0" SE="3.037437037966164" STUDY_ID="STD-Prager-1994" TOTAL_1="54" TOTAL_2="53" WEIGHT="2.376022360982946"/>
<CONT_DATA CI_END="-4.388604820771427" CI_START="-21.41139517922857" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-0.3" ORDER="377" SD_1="15.6" SD_2="11.0" SE="4.342628357646044" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" WEIGHT="1.162411142195341"/>
<CONT_DATA CI_END="4.506087605638783" CI_START="-24.506087605638783" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-4.0" ORDER="378" SD_1="18.0" SD_2="13.0" SE="7.401201103724839" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.4001848860083392"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="12.891294708736002" CI_END="-3.869349144543923" CI_START="-6.925009023023772" DF="7.0" EFFECT_SIZE="-5.397179083783848" ESTIMABLE="YES" I2="45.69979076456663" ID="CMP-017.01.03" NO="3" P_CHI2="0.07480173416661307" P_Z="4.399148947072692E-12" STUDIES="8" TAU2="0.0" TOTAL_1="607" TOTAL_2="531" WEIGHT="36.075407202456155" Z="6.923726489868227">
<NAME>Enalapril 10 mg</NAME>
<CONT_DATA CI_END="0.28605417447190007" CI_START="-18.2860541744719" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-1.2" ORDER="379" SD_1="21.8" SD_2="20.3" SE="4.737869801546921" STUDY_ID="STD-Gerritsen-1998" TOTAL_1="40" TOTAL_2="39" WEIGHT="0.9765598127084675"/>
<CONT_DATA CI_END="-7.680909953630103" CI_START="-20.519090046369897" EFFECT_SIZE="-14.1" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-3.9" ORDER="380" SD_1="15.3" SD_2="15.9" SE="3.275106122869022" STUDY_ID="STD-Kuppers-1997" TOTAL_1="47" TOTAL_2="44" WEIGHT="2.0436867927315037"/>
<CONT_DATA CI_END="-0.1779622441004447" CI_START="-15.622037755899555" EFFECT_SIZE="-7.9" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="3.7" ORDER="381" SD_1="17.8" SD_2="12.4" SE="3.939887577940209" STUDY_ID="STD-Levine-1995" TOTAL_1="31" TOTAL_2="29" WEIGHT="1.4122039855087185"/>
<CONT_DATA CI_END="2.837127439759401" CI_START="-9.0371274397594" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-7.5" ORDER="382" SD_1="10.6" SD_2="10.6" SE="3.029202315241864" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="25" TOTAL_2="24" WEIGHT="2.3889580963292336"/>
<CONT_DATA CI_END="-0.8880354783536291" CI_START="-16.11196452164637" EFFECT_SIZE="-8.5" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="1.1" ORDER="383" SD_1="10.0" SD_2="9.0" SE="3.8837267325770144" STUDY_ID="STD-Simon-1983" TOTAL_1="12" TOTAL_2="12" WEIGHT="1.4533417959639867"/>
<CONT_DATA CI_END="-1.84214009992886" CI_START="-5.757859900071139" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-4.8" ORDER="384" SD_1="13.4" SD_2="11.4" SE="0.9989264677894537" STUDY_ID="STD-Waeber-1999" TOTAL_1="318" TOTAL_2="300" WEIGHT="21.96838096702251"/>
<CONT_DATA CI_END="0.6484103815978219" CI_START="-13.44841038159782" EFFECT_SIZE="-6.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-1.2" ORDER="385" SD_1="15.3" SD_2="15.2" SE="3.5961938266186433" STUDY_ID="STD-Whelton-1992" TOTAL_1="35" TOTAL_2="37" WEIGHT="1.6950359355416063"/>
<CONT_DATA CI_END="-3.188455044245875" CI_START="-12.211544955754125" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-0.4" ORDER="386" SD_1="12.9" SD_2="12.9" SE="2.3018509479462965" STUDY_ID="STD-White-2002" TOTAL_1="99" TOTAL_2="46" WEIGHT="4.137239816650122"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7491868036212986" CI_END="-0.46322991139947334" CI_START="-7.393166483951599" DF="2.0" EFFECT_SIZE="-3.928198197675536" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.04" NO="4" P_CHI2="0.6875689342748442" P_Z="0.026283940276801927" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="122" WEIGHT="7.013951301997809" Z="2.2219906087087904">
<NAME>Fosinopril 10 mg</NAME>
<CONT_DATA CI_END="2.415045944774409" CI_START="-16.21504594477441" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-5.6" ORDER="387" SD_1="13.9" SD_2="13.4" SE="4.7526617928953305" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="16" WEIGHT="0.9704904623096345"/>
<CONT_DATA CI_END="0.30587333688651164" CI_START="-8.505873336886511" EFFECT_SIZE="-4.1" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-4.1" ORDER="388" SD_1="13.9" SD_2="13.4" SE="2.2479358659850273" STUDY_ID="STD-Pool-1990" TOTAL_1="71" TOTAL_2="77" WEIGHT="4.338077026833293"/>
<CONT_DATA CI_END="5.226993776686539" CI_START="-8.82699377668654" EFFECT_SIZE="-1.8000000000000003" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-3.4" ORDER="389" SD_1="13.9" SD_2="13.4" SE="3.585266786591269" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="29" WEIGHT="1.7053838128548808"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.5096972752785423" CI_START="-11.309697275278541" DF="0.0" EFFECT_SIZE="-4.8999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.05" NO="5" P_CHI2="1.0" P_Z="0.13404827050033097" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="35" WEIGHT="2.0496808190405478" Z="1.4983271614538016">
<NAME>Imidapril 5 mg</NAME>
<CONT_DATA CI_END="1.5096972752785423" CI_START="-11.309697275278541" EFFECT_SIZE="-4.8999999999999995" ESTIMABLE="YES" MEAN_1="-10.7" MEAN_2="-5.8" ORDER="390" SD_1="12.1" SD_2="14.8" SE="3.2703138046604" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="33" TOTAL_2="35" WEIGHT="2.0496808190405478"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.2227836212912537" CI_START="-14.377216378708745" DF="0.0" EFFECT_SIZE="-7.8" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.06" NO="6" P_CHI2="1.0" P_Z="0.02010701833051894" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.9466013267492517" Z="2.3243448594607043">
<NAME>Lisinopril 20 mg</NAME>
<CONT_DATA CI_END="-1.2227836212912537" CI_START="-14.377216378708745" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-13.5" MEAN_2="-5.7" ORDER="391" SD_1="14.9" SD_2="15.1" SE="3.355784305522443" STUDY_ID="STD-Gomez-1989" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.9466013267492517"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.372608082844401" CI_END="2.138292083464616" CI_START="-5.8585592883544155" DF="2.0" EFFECT_SIZE="-1.8601336024449" ESTIMABLE="YES" I2="40.698712958274314" ID="CMP-017.01.07" NO="7" P_CHI2="0.18520299688401698" P_Z="0.36187002736091567" STUDIES="3" TAU2="0.0" TOTAL_1="112" TOTAL_2="111" WEIGHT="5.26724132888974" Z="0.911807584688284">
<NAME>Moexipril 7.5 mg</NAME>
<CONT_DATA CI_END="0.6625433799382225" CI_START="-10.862543379938222" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-2.9" ORDER="392" SD_1="14.2" SD_2="14.0" SE="2.9401271785565597" STUDY_ID="STD-Mroczek-1996" TOTAL_1="46" TOTAL_2="46" WEIGHT="2.535904292240082"/>
<CONT_DATA CI_END="5.9297986067168" CI_START="-7.9297986067168" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-7.6" ORDER="393" SD_1="17.7" SD_2="17.3" SE="3.5356765029246287" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="48" WEIGHT="1.7535576468130345"/>
<CONT_DATA CI_END="14.280261153561524" CI_START="-4.280261153561524" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="0.6" MEAN_2="-4.4" ORDER="394" SD_1="13.2" SD_2="14.0" SE="4.734914124322201" STUDY_ID="STD-White-1995" TOTAL_1="16" TOTAL_2="17" WEIGHT="0.9777793898366235"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.38961180856360755" CI_END="3.3118694974604086" CI_START="-9.359892484677179" DF="1.0" EFFECT_SIZE="-3.024011493608385" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.08" NO="8" P_CHI2="0.5325038870886976" P_Z="0.3495520811341737" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="65" WEIGHT="2.0977187107263253" Z="0.9354584823582363">
<NAME>Perindopril 2 mg</NAME>
<CONT_DATA CI_END="7.000372720964174" CI_START="-21.000372720964172" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.6" ORDER="395" SD_1="16.8" SD_2="15.1" SE="7.143178564196754" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.4296176140282241"/>
<CONT_DATA CI_END="5.105087868125709" CI_START="-9.10508786812571" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-2.7" MEAN_2="-0.7" ORDER="396" SD_1="19.7" SD_2="19.0" SE="3.6251114429498377" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="55" WEIGHT="1.6681010966981011"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.222106827641662" CI_END="-3.665973364979849" CI_START="-10.70978675155791" DF="3.0" EFFECT_SIZE="-7.187880058268879" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.09" NO="9" P_CHI2="0.7477072841286359" P_Z="6.331518545697172E-5" STUDIES="4" TAU2="0.0" TOTAL_1="148" TOTAL_2="143" WEIGHT="6.788996463260731" Z="4.000102009018363">
<NAME>Ramipril 5 mg</NAME>
<CONT_DATA CI_END="0.33209646318174" CI_START="-12.93209646318174" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-5.7" ORDER="397" SD_1="13.0" SD_2="17.0" SE="3.383784863137726" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.9145186686279596"/>
<CONT_DATA CI_END="0.8061501439779972" CI_START="-12.006150143977997" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-5.1" MEAN_2="0.5" ORDER="398" SD_1="12.9" SD_2="16.6" SE="3.268504010537383" STUDY_ID="STD-Kostis-1991" TOTAL_1="42" TOTAL_2="41" WEIGHT="2.051951293408555"/>
<CONT_DATA CI_END="-0.2419640071348601" CI_START="-14.35803599286514" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-3.7" ORDER="399" SD_1="16.5" SD_2="16.7" SE="3.601104943018355" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.6904157745049657"/>
<CONT_DATA CI_END="-2.7754551603444053" CI_START="-20.024544839655597" EFFECT_SIZE="-11.4" ESTIMABLE="YES" MEAN_1="-16.8" MEAN_2="-5.4" ORDER="400" SD_1="10.8" SD_2="16.6" SE="4.400358837042366" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="19" WEIGHT="1.1321107267192512"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.052068787073854386" CI_END="0.2825938292007528" CI_START="-8.330394885372566" DF="1.0" EFFECT_SIZE="-4.023900528085907" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.10" NO="10" P_CHI2="0.8195017543333724" P_Z="0.06704826126171287" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="80" WEIGHT="4.54060276475059" Z="1.8313503880657955">
<NAME>Spirapril 3 mg</NAME>
<CONT_DATA CI_END="1.4269789119099974" CI_START="-8.826978911909997" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.4" MEAN_2="-6.7" ORDER="401" SD_1="13.9" SD_2="13.4" SE="2.6158536342254006" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="54" TOTAL_2="55" WEIGHT="3.203599461722367"/>
<CONT_DATA CI_END="3.1362327670209353" CI_START="-12.736232767020935" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-2.2" ORDER="402" SD_1="13.9" SD_2="17.7" SE="4.049172755020463" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="25" WEIGHT="1.3370033030282227"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.951333922643951" CI_END="-5.145469083240435" CI_START="-10.342524770600043" DF="3.0" EFFECT_SIZE="-7.743996926920239" ESTIMABLE="YES" I2="0.0" ID="CMP-017.01.11" NO="11" P_CHI2="0.3991897164809266" P_Z="5.189392669231164E-9" STUDIES="4" TAU2="0.0" TOTAL_1="194" TOTAL_2="196" WEIGHT="12.471150630723761" Z="5.8409822738935375">
<NAME>Trandolapril 1 mg</NAME>
<CONT_DATA CI_END="-2.0443203490806665" CI_START="-14.155679650919332" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-9.6" ORDER="403" SD_1="13.1" SD_2="15.5" SE="3.0896892487238343" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="2.29633628855292"/>
<CONT_DATA CI_END="-5.918970626968613" CI_START="-17.081029373031388" EFFECT_SIZE="-11.5" ESTIMABLE="YES" MEAN_1="-21.2" MEAN_2="-9.7" ORDER="404" SD_1="12.3" SD_2="16.1" SE="2.847516289612378" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" WEIGHT="2.703539117862288"/>
<CONT_DATA CI_END="1.9596369487800667" CI_START="-10.759636948780063" EFFECT_SIZE="-4.399999999999999" ESTIMABLE="YES" MEAN_1="-15.7" MEAN_2="-11.3" ORDER="405" SD_1="12.3" SD_2="12.4" SE="3.244772352422835" STUDY_ID="STD-Scholze-1998" TOTAL_1="28" TOTAL_2="30" WEIGHT="2.082076232065621"/>
<CONT_DATA CI_END="-3.0470754300120335" CI_START="-10.952924569987964" EFFECT_SIZE="-6.999999999999999" ESTIMABLE="YES" MEAN_1="-9.7" MEAN_2="-2.7" ORDER="406" SD_1="10.8" SD_2="13.3" SE="2.016835309815961" STUDY_ID="STD-Weir-1995" TOTAL_1="74" TOTAL_2="71" WEIGHT="5.389198992242932"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="81.0451671539351" CI_END="-2.538203884300305" CI_START="-3.5343640678134003" CI_STUDY="95" CI_TOTAL="95" DF="42.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-3.0362839760568527" ESTIMABLE="YES" I2="48.17704562170094" I2_Q="0.0" ID="CMP-017.02" NO="2" P_CHI2="2.800502278108574E-4" P_Q="0.5455258922230237" P_Z="6.659280188933361E-33" Q="8.859099389644442" RANDOM="NO" SCALE="100.0" SORT_BY="USER" STUDIES="43" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="1938" TOTAL_2="1820" UNITS="" WEIGHT="99.99999999999997" Z="11.94789219324239">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6525462678885146" CI_END="0.9339994028785873" CI_START="-2.704672994705779" DF="2.0" EFFECT_SIZE="-0.8853367959135959" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.01" NO="1" P_CHI2="0.721608123596087" P_Z="0.34020010441823023" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="156" WEIGHT="7.495013948608959" Z="0.9537699713393906">
<NAME>Benazepril 10 mg</NAME>
<CONT_DATA CI_END="3.504890270805719" CI_START="-6.104890270805718" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.7" ORDER="407" SD_1="8.6" SD_2="9.6" SE="2.451519675211422" STUDY_ID="STD-Moser-1991" TOTAL_1="30" TOTAL_2="26" WEIGHT="1.0745618514502675"/>
<CONT_DATA CI_END="1.437956061200838" CI_START="-2.637956061200839" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-4.1" ORDER="408" SD_1="8.1" SD_2="7.7" SE="1.0397926070458314" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" WEIGHT="5.97322307476882"/>
<CONT_DATA CI_END="3.747906122794512" CI_START="-11.14790612279451" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-5.0" ORDER="409" SD_1="9.9" SD_2="9.7" SE="3.800021929761283" STUDY_ID="STD-Weinberger-1990" TOTAL_1="12" TOTAL_2="15" WEIGHT="0.447229022389871"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.076147778317015" CI_END="-1.9996159918842127" CI_START="-4.292447869016545" DF="11.0" EFFECT_SIZE="-3.1460319304503788" ESTIMABLE="YES" I2="35.582661014637026" ID="CMP-017.02.02" NO="2" P_CHI2="0.10564330045622261" P_Z="7.50685516206673E-8" STUDIES="12" TAU2="0.0" TOTAL_1="355" TOTAL_2="342" WEIGHT="18.876172429755577" Z="5.378596956361038">
<NAME>Cilazapril 2.5 mg</NAME>
<CONT_DATA CI_END="-0.4777186946497869" CI_START="-5.722281305350214" EFFECT_SIZE="-3.1000000000000005" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-3.3" ORDER="11" SD_1="6.7" SD_2="7.1" SE="1.3379232098316265" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="51" WEIGHT="3.6077780259464367"/>
<CONT_DATA CI_END="3.3376792771020303" CI_START="-3.3376792771020303" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-4.5" ORDER="410" SD_1="7.8" SD_2="7.9" SE="1.7029288820760067" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="43" WEIGHT="2.226943312519929"/>
<CONT_DATA CI_END="6.365538411601468" CI_START="-12.365538411601468" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.0" ORDER="411" SD_1="11.0" SD_2="4.0" SE="4.778423728943817" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" WEIGHT="0.282834815539276"/>
<CONT_DATA CI_END="-2.1218179143766465" CI_START="-9.478182085623352" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.4" ORDER="412" SD_1="6.8" SD_2="6.7" SE="1.876657997104224" STUDY_ID="STD-Guntzel-1991" TOTAL_1="28" TOTAL_2="24" WEIGHT="1.8337153352521893"/>
<CONT_DATA CI_END="-2.7316797747874335" CI_START="-10.468320225212567" EFFECT_SIZE="-6.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-4.3" ORDER="413" SD_1="7.5" SD_2="7.4" SE="1.9736690345972596" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="28" WEIGHT="1.6578816697360357"/>
<CONT_DATA CI_END="3.357263002613596" CI_START="-15.357263002613596" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-2.0" ORDER="414" SD_1="8.1" SD_2="7.7" SE="4.774201503916649" STUDY_ID="STD-Krum-1992" TOTAL_1="6" TOTAL_2="5" WEIGHT="0.2833353056412116"/>
<CONT_DATA CI_END="3.4021969501884666" CI_START="-3.2021969501884664" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-3.1" ORDER="415" SD_1="8.1" SD_2="7.7" SE="1.6848253214017066" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="44" WEIGHT="2.275057736950568"/>
<CONT_DATA CI_END="2.6541694952321704" CI_START="-9.05416949523217" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-4.4" MEAN_2="-1.2" ORDER="417" SD_1="8.1" SD_2="7.7" SE="2.986876055585262" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.7238820072115445"/>
<CONT_DATA CI_END="1.153837549602402" CI_START="-5.553837549602402" EFFECT_SIZE="-2.2" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-7.7" ORDER="418" SD_1="9.0" SD_2="8.7" SE="1.711173050146352" STUDY_ID="STD-Prager-1994" TOTAL_1="54" TOTAL_2="53" WEIGHT="2.2055368640920627"/>
<CONT_DATA CI_END="-2.3772746546627985" CI_START="-12.4227253453372" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-1.7" ORDER="419" SD_1="9.8" SD_2="5.5" SE="2.5626620616275693" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" WEIGHT="0.9833757753450948"/>
<CONT_DATA CI_END="-0.025196872625598665" CI_START="-15.9748031273744" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.0" ORDER="420" SD_1="7.0" SD_2="10.0" SE="4.068851871911234" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="0.39008425901557864"/>
<CONT_DATA CI_END="0.41125044743939654" CI_START="-6.011250447439396" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-3.7" ORDER="421" SD_1="8.1" SD_2="7.7" SE="1.638423191838896" STUDY_ID="STD-Yodfat-1993" TOTAL_1="48" TOTAL_2="45" WEIGHT="2.4057473225056514"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="23.78663307903599" CI_END="-2.227526628917227" CI_START="-3.9989140227564164" DF="7.0" EFFECT_SIZE="-3.1132203258368216" ESTIMABLE="YES" I2="70.57170732511382" ID="CMP-017.02.03" NO="3" P_CHI2="0.0012420120072684782" P_Z="5.607198169727531E-12" STUDIES="8" TAU2="0.0" TOTAL_1="607" TOTAL_2="531" WEIGHT="31.625052756214778" Z="6.889288854374855">
<NAME>Enalapril 10 mg</NAME>
<CONT_DATA CI_END="-2.3363992805054816" CI_START="-8.263600719494518" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-1.5" ORDER="422" SD_1="7.7" SD_2="5.6" SE="1.5120689680376898" STUDY_ID="STD-Gerritsen-1998" TOTAL_1="40" TOTAL_2="39" WEIGHT="2.8246131952160427"/>
<CONT_DATA CI_END="-4.572532860650113" CI_START="-10.627467139349886" EFFECT_SIZE="-7.6" ESTIMABLE="YES" MEAN_1="-12.1" MEAN_2="-4.5" ORDER="423" SD_1="8.1" SD_2="6.6" SE="1.5446544748934987" STUDY_ID="STD-Kuppers-1997" TOTAL_1="47" TOTAL_2="44" WEIGHT="2.7066960603670984"/>
<CONT_DATA CI_END="-3.5335500093847623" CI_START="-13.066449990615236" EFFECT_SIZE="-8.299999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="0.1" ORDER="424" SD_1="11.1" SD_2="7.5" SE="2.431906926970284" STUDY_ID="STD-Levine-1995" TOTAL_1="31" TOTAL_2="29" WEIGHT="1.0919639104638548"/>
<CONT_DATA CI_END="0.5239720188972843" CI_START="-8.323972018897285" EFFECT_SIZE="-3.9000000000000004" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-5.4" ORDER="425" SD_1="8.1" SD_2="7.7" SE="2.2571700570995237" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="25" TOTAL_2="24" WEIGHT="1.2675748793342518"/>
<CONT_DATA CI_END="-0.8880354783536291" CI_START="-16.11196452164637" EFFECT_SIZE="-8.5" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="1.1" ORDER="426" SD_1="10.0" SD_2="9.0" SE="3.8837267325770144" STUDY_ID="STD-Simon-1983" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.42815878153459463"/>
<CONT_DATA CI_END="-0.44802445612516384" CI_START="-2.7519755438748374" EFFECT_SIZE="-1.6000000000000005" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="-5.8" ORDER="427" SD_1="7.8" SD_2="6.8" SE="0.5877534245330387" STUDY_ID="STD-Waeber-1999" TOTAL_1="318" TOTAL_2="300" WEIGHT="18.694413656901165"/>
<CONT_DATA CI_END="0.8280596235304598" CI_START="-7.6280596235304605" EFFECT_SIZE="-3.4000000000000004" ESTIMABLE="YES" MEAN_1="-8.5" MEAN_2="-5.1" ORDER="428" SD_1="9.1" SD_2="9.2" SE="2.157212916605027" STUDY_ID="STD-Whelton-1992" TOTAL_1="35" TOTAL_2="37" WEIGHT="1.3877657362254188"/>
<CONT_DATA CI_END="-0.5259731763340678" CI_START="-6.074026823665932" EFFECT_SIZE="-3.3" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-2.7" ORDER="429" SD_1="8.0" SD_2="7.9" SE="1.4153458153043126" STUDY_ID="STD-White-2002" TOTAL_1="99" TOTAL_2="46" WEIGHT="3.223866536172352"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.20254529573178845" CI_END="-1.4169551406966283" CI_START="-5.4288841294645955" DF="2.0" EFFECT_SIZE="-3.422919635080612" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.04" NO="4" P_CHI2="0.9036866926648847" P_Z="8.24531121581474E-4" STUDIES="3" TAU2="0.0" TOTAL_1="117" TOTAL_2="122" WEIGHT="6.1652669125888995" Z="3.34442569921618">
<NAME>Fosinopril 10 mg</NAME>
<CONT_DATA CI_END="1.8908048757727052" CI_START="-8.890804875772705" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-4.2" MEAN_2="-0.7" ORDER="430" SD_1="8.1" SD_2="7.7" SE="2.750461191274271" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="16" WEIGHT="0.8536722057465393"/>
<CONT_DATA CI_END="-0.5489696449123294" CI_START="-5.65103035508767" EFFECT_SIZE="-3.0999999999999996" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-4.9" ORDER="431" SD_1="8.1" SD_2="7.7" SE="1.3015700161890076" STUDY_ID="STD-Pool-1990" TOTAL_1="71" TOTAL_2="77" WEIGHT="3.8121248347613035"/>
<CONT_DATA CI_END="-0.13247424735407431" CI_START="-8.267525752645927" EFFECT_SIZE="-4.2" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.2" ORDER="432" SD_1="8.1" SD_2="7.7" SE="2.0753063753875325" STUDY_ID="STD-Pool-1997" TOTAL_1="29" TOTAL_2="29" WEIGHT="1.4994698720810562"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.0123802409643057" CI_START="-7.412380240964306" DF="0.0" EFFECT_SIZE="-3.2" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.05" NO="5" P_CHI2="1.0" P_Z="0.13650921391210086" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="35" WEIGHT="1.3981160868833378" Z="1.488917047311095">
<NAME>Imidapril 5 mg</NAME>
<CONT_DATA CI_END="1.0123802409643057" CI_START="-7.412380240964306" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-4.7" ORDER="433" SD_1="7.5" SD_2="10.1" SE="2.149213084623505" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="33" TOTAL_2="35" WEIGHT="1.3981160868833378"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.570361880685744" CI_START="-8.629638119314254" DF="0.0" EFFECT_SIZE="-4.6" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.06" NO="6" P_CHI2="1.0" P_Z="0.025261472534693512" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.5277991860883493" Z="2.2373806436044235">
<NAME>Lisinopril 20 mg</NAME>
<CONT_DATA CI_END="-0.570361880685744" CI_START="-8.629638119314254" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-5.0" ORDER="434" SD_1="10.9" SD_2="7.2" SE="2.0559755950106875" STUDY_ID="STD-Gomez-1989" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.5277991860883493"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.680227071894063" CI_END="-0.2394774494646119" CI_START="-4.1135764097350345" DF="2.0" EFFECT_SIZE="-2.1765269295998233" ESTIMABLE="YES" I2="86.37623253233537" ID="CMP-017.02.07" NO="7" P_CHI2="6.489817654652397E-4" P_Z="0.02764593459510961" STUDIES="3" TAU2="0.0" TOTAL_1="112" TOTAL_2="111" WEIGHT="6.6117578217021915" Z="2.202274354447274">
<NAME>Moexipril 7.5 mg</NAME>
<CONT_DATA CI_END="-0.1801028815155603" CI_START="-5.8198971184844375" EFFECT_SIZE="-2.999999999999999" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-5.2" ORDER="435" SD_1="6.9" SD_2="6.9" SE="1.438749456993816" STUDY_ID="STD-Mroczek-1996" TOTAL_1="46" TOTAL_2="46" WEIGHT="3.119836532116007"/>
<CONT_DATA CI_END="-1.6082010081088018" CI_START="-7.991798991891196" EFFECT_SIZE="-4.799999999999999" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-3.9" ORDER="436" SD_1="7.8" SD_2="8.3" SE="1.6284987974614331" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="48" WEIGHT="2.435158871979463"/>
<CONT_DATA CI_END="11.145186555516677" CI_START="1.4548134444833218" EFFECT_SIZE="6.3" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-7.3" ORDER="437" SD_1="6.8" SD_2="7.4" SE="2.472079381935021" STUDY_ID="STD-White-1995" TOTAL_1="16" TOTAL_2="17" WEIGHT="1.0567624176067214"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7188415685366701" CI_END="0.4476873923971052" CI_START="-5.060543691094052" DF="1.0" EFFECT_SIZE="-2.3064281493484735" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.08" NO="8" P_CHI2="0.39652418285119884" P_Z="0.10072112460447394" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="65" WEIGHT="3.270649871700585" Z="1.6413676322334834">
<NAME>Perindopril 2 mg</NAME>
<CONT_DATA CI_END="10.080113644691036" CI_START="-7.480113644691035" EFFECT_SIZE="1.2999999999999998" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-6.3" ORDER="438" SD_1="12.2" SD_2="7.2" SE="4.479732134849136" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.3218089307095942"/>
<CONT_DATA CI_END="0.20050427275382754" CI_START="-5.6005042727538275" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-1.8" ORDER="439" SD_1="8.1" SD_2="7.7" SE="1.4798763118264597" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="55" WEIGHT="2.948840940990991"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7477243563399947" CI_END="-1.6680609122559733" CI_START="-5.622538849581867" DF="3.0" EFFECT_SIZE="-3.64529988091892" ESTIMABLE="YES" I2="0.0" ID="CMP-017.02.09" NO="9" P_CHI2="0.8619253711910989" P_Z="3.0214827007499847E-4" STUDIES="4" TAU2="0.0" TOTAL_1="148" TOTAL_2="143" WEIGHT="6.34570741901454" Z="3.6134511774672378">
<NAME>Ramipril 5 mg</NAME>
<CONT_DATA CI_END="-0.1366266202418478" CI_START="-7.063373379758153" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.8" ORDER="440" SD_1="8.1" SD_2="7.7" SE="1.7670597047072292" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="2.0682343063186983"/>
<CONT_DATA CI_END="0.49093227944686824" CI_START="-8.290932279446867" EFFECT_SIZE="-3.8999999999999995" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-2.7" ORDER="441" SD_1="10.0" SD_2="10.4" SE="2.2403127374186367" STUDY_ID="STD-Kostis-1991" TOTAL_1="42" TOTAL_2="41" WEIGHT="1.2867224799818568"/>
<CONT_DATA CI_END="1.0341997236596607" CI_START="-6.2341997236596605" EFFECT_SIZE="-2.6" ESTIMABLE="YES" MEAN_1="-5.2" MEAN_2="-2.6" ORDER="442" SD_1="9.3" SD_2="7.7" SE="1.8542176041630174" STUDY_ID="STD-Scholze-1999" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.8783684484266414"/>
<CONT_DATA CI_END="-0.4774977771701012" CI_START="-9.922502222829898" EFFECT_SIZE="-5.2" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-6.8" ORDER="443" SD_1="8.8" SD_2="7.0" SE="2.409484184444405" STUDY_ID="STD-Villamil-1987" TOTAL_1="24" TOTAL_2="19" WEIGHT="1.1123821842873436"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.752405806556843" CI_END="-1.7351492904773593" CI_START="-6.659843369773824" DF="1.0" EFFECT_SIZE="-4.197496330125592" ESTIMABLE="YES" I2="63.66814814814816" ID="CMP-017.02.10" NO="10" P_CHI2="0.09710829443983238" P_Z="8.344790160320224E-4" STUDIES="2" TAU2="0.0" TOTAL_1="104" TOTAL_2="80" WEIGHT="4.091662870939806" Z="3.341097538168502">
<NAME>Spirapril 3 mg</NAME>
<CONT_DATA CI_END="-2.6320941598744025" CI_START="-8.567905840125599" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.3" ORDER="444" SD_1="8.1" SD_2="7.7" SE="1.5142654985173505" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="54" TOTAL_2="55" WEIGHT="2.8164246059660423"/>
<CONT_DATA CI_END="3.3106593339045354" CI_START="-5.510659333904535" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-4.7" ORDER="445" SD_1="8.3" SD_2="9.6" SE="2.2503777460684242" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="25" WEIGHT="1.275238264973764"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.568996539989772" CI_END="-2.1147761747163836" CI_START="-4.92194165062081" DF="3.0" EFFECT_SIZE="-3.518358912668597" ESTIMABLE="YES" I2="74.06862393267988" ID="CMP-017.02.11" NO="11" P_CHI2="0.009015360872551503" P_Z="8.967542304329068E-7" STUDIES="4" TAU2="0.0" TOTAL_1="194" TOTAL_2="196" WEIGHT="12.592800696502973" Z="4.913039015838007">
<NAME>Trandolapril 1 mg</NAME>
<CONT_DATA CI_END="-3.1205546176194527" CI_START="-10.279445382380548" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.9" MEAN_2="-7.2" ORDER="446" SD_1="7.7" SD_2="9.2" SE="1.8262812024173687" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="1.9362743243432925"/>
<CONT_DATA CI_END="-3.757485661436923" CI_START="-10.042514338563077" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-6.1" ORDER="447" SD_1="8.3" SD_2="7.8" SE="1.60335310411356" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" WEIGHT="2.512139954262728"/>
<CONT_DATA CI_END="2.2171407401165952" CI_START="-5.817140740116593" EFFECT_SIZE="-1.799999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-9.4" ORDER="448" SD_1="7.8" SD_2="7.8" SE="2.04959926396775" STUDY_ID="STD-Scholze-1998" TOTAL_1="28" TOTAL_2="30" WEIGHT="1.5373199806284756"/>
<CONT_DATA CI_END="0.23773706450337362" CI_START="-3.637737064503373" EFFECT_SIZE="-1.6999999999999997" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.1" ORDER="449" SD_1="5.9" SD_2="6.0" SE="0.9886595262912972" STUDY_ID="STD-Weir-1995" TOTAL_1="74" TOTAL_2="71" WEIGHT="6.607066437268477"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-018" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="18">
<NAME>1/2 Max Dose vs Placebo</NAME>
<CONT_OUTCOME CHI2="62.30746335769568" CI_END="-6.791487901037751" CI_START="-8.403399497565811" CI_STUDY="95" CI_TOTAL="95" DF="50.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.597443699301781" ESTIMABLE="YES" I2="19.75279155089463" I2_Q="9.103497011248736" ID="CMP-018.01" NO="1" P_CHI2="0.11359448100020852" P_Q="0.35739942412167214" P_Z="3.231161623351219E-76" Q="11.001523349294892" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="51" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2541" TOTAL_2="2439" UNITS="" WEIGHT="99.99999999999997" Z="18.475847009570206">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="8.653767082281503" CI_END="-5.523216637256252" CI_START="-10.414614431203386" DF="5.0" EFFECT_SIZE="-7.968915534229819" ESTIMABLE="YES" I2="42.22169429268038" ID="CMP-018.01.01" NO="1" P_CHI2="0.12369710093767428" P_Z="1.700289561310375E-10" STUDIES="6" TAU2="0.0" TOTAL_1="260" TOTAL_2="244" WEIGHT="10.859666111938164" Z="6.386226637408105">
<NAME>Benazepril 20 mg</NAME>
<CONT_DATA CI_END="2.8946171675547934" CI_START="-8.894617167554793" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-6.5" ORDER="450" SD_1="13.8" SD_2="13.1" SE="3.0075130023055427" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.8694387428870651"/>
<CONT_DATA CI_END="-8.21997203940238" CI_START="-17.380027960597623" EFFECT_SIZE="-12.8" ESTIMABLE="YES" MEAN_1="-14.9" MEAN_2="-2.1" ORDER="451" SD_1="14.8" SD_2="14.1" SE="2.3367918985880842" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="3.0966077006932853"/>
<CONT_DATA CI_END="-2.6080129019826783" CI_START="-13.59198709801732" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-3.9" ORDER="452" SD_1="13.9" SD_2="13.4" SE="2.8020857226650153" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="48" WEIGHT="2.1535920112193883"/>
<CONT_DATA CI_END="0.06748450671776762" CI_START="-15.067484506717769" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.5" ORDER="453" SD_1="15.7" SD_2="14.3" SE="3.8610324303962313" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="1.1342776302207402"/>
<CONT_DATA CI_END="-0.32936165650660953" CI_START="-19.870638343493393" EFFECT_SIZE="-10.100000000000001" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="2.2" ORDER="454" SD_1="13.9" SD_2="13.4" SE="4.985111165594337" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.6804192179767584"/>
<CONT_DATA CI_END="1.4084271112862465" CI_START="-10.208427111286245" EFFECT_SIZE="-4.3999999999999995" ESTIMABLE="YES" MEAN_1="-9.7" MEAN_2="-5.3" ORDER="455" SD_1="13.9" SD_2="13.4" SE="2.963537675744237" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="40" WEIGHT="1.9253308089409273"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.470177485075247" CI_END="-3.1378955460339517" CI_START="-8.699512979828803" DF="4.0" EFFECT_SIZE="-5.918704262931378" ESTIMABLE="YES" I2="52.77548779765074" ID="CMP-018.01.02" NO="2" P_CHI2="0.07579648714526155" P_Z="3.0245606535367002E-5" STUDIES="5" TAU2="0.0" TOTAL_1="193" TOTAL_2="186" WEIGHT="8.400017983915742" Z="4.171609186924556">
<NAME>Cilazapril 5 mg</NAME>
<CONT_DATA CI_END="-3.831183322314997" CI_START="-18.968816677685005" EFFECT_SIZE="-11.4" ESTIMABLE="YES" MEAN_1="-13.8" MEAN_2="-2.4" ORDER="456" SD_1="13.9" SD_2="13.4" SE="3.8617121219506396" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="24" WEIGHT="1.1338783818801756"/>
<CONT_DATA CI_END="3.2306652559757048" CI_START="-9.830665255975706" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-5.5" ORDER="457" SD_1="15.1" SD_2="15.8" SE="3.3320332962690946" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="1.523026994571229"/>
<CONT_DATA CI_END="-4.165816740845556" CI_START="-13.634183259154444" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-2.6" ORDER="458" SD_1="12.0" SD_2="12.9" SE="2.4154440063680136" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="51" WEIGHT="2.898226461981626"/>
<CONT_DATA CI_END="2.3209667192294194" CI_START="-22.320966719229418" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-2.8" ORDER="459" SD_1="19.4" SD_2="13.3" SE="6.286323022471653" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.4278907313020331"/>
<CONT_DATA CI_END="4.484099289588814" CI_START="-5.884099289588816" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-11.6" ORDER="460" SD_1="12.3" SD_2="15.0" SE="2.644997219581752" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="53" WEIGHT="2.416995414180677"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.972973049096257" CI_END="-7.86024644074257" CI_START="-11.221631330092391" DF="7.0" EFFECT_SIZE="-9.54093888541748" ESTIMABLE="YES" I2="61.05263174390626" ID="CMP-018.01.03" NO="3" P_CHI2="0.012092553784886828" P_Z="9.342864294491319E-29" STUDIES="8" TAU2="0.0" TOTAL_1="434" TOTAL_2="533" WEIGHT="22.995663907853142" Z="11.126304906864169">
<NAME>Enalapril 20 mg</NAME>
<CONT_DATA CI_END="-6.988197773693704" CI_START="-14.811802226306293" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-3.8" ORDER="461" SD_1="13.6" SD_2="11.7" SE="1.995854136689292" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="4.244911781519101"/>
<CONT_DATA CI_END="-1.0812636201738322" CI_START="-10.918736379826168" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.0" ORDER="462" SD_1="13.9" SD_2="13.4" SE="2.5096054920521667" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="79" WEIGHT="2.6848211099010113"/>
<CONT_DATA CI_END="-3.4881047514761963" CI_START="-11.311895248523802" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-13.1" MEAN_2="-5.7" ORDER="463" SD_1="13.3" SD_2="14.2" SE="1.9959015978764578" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="4.244709901669525"/>
<CONT_DATA CI_END="-3.3948616190742857" CI_START="-12.805138380925714" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-0.9" ORDER="464" SD_1="11.5" SD_2="11.4" SE="2.4006249186409776" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="2.934118478630299"/>
<CONT_DATA CI_END="-14.485483185481645" CI_START="-26.914516814518354" EFFECT_SIZE="-20.7" ESTIMABLE="YES" MEAN_1="-21.9" MEAN_2="-1.2" ORDER="465" SD_1="17.1" SD_2="14.4" SE="3.170730107051798" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="1.6819292111046107"/>
<CONT_DATA CI_END="-4.80259560939629" CI_START="-16.79740439060371" EFFECT_SIZE="-10.8" ESTIMABLE="YES" MEAN_1="-18.3" MEAN_2="-7.5" ORDER="466" SD_1="10.6" SD_2="10.6" SE="3.0599564267050163" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="24" WEIGHT="1.8059086641879403"/>
<CONT_DATA CI_END="-2.756274958550298" CI_START="-11.643725041449702" EFFECT_SIZE="-7.2" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-1.8" ORDER="467" SD_1="13.5" SD_2="13.8" SE="2.2672483150207032" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="3.2894863642418084"/>
<CONT_DATA CI_END="-5.751280081616442" CI_START="-16.84871991838356" EFFECT_SIZE="-11.3" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="2.5" ORDER="468" SD_1="13.0" SD_2="13.1" SE="2.831031571065159" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="2.109778396598849"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.475926984489138" CI_END="-5.618936595717776" CI_START="-12.35122733182087" DF="4.0" EFFECT_SIZE="-8.985081963769323" ESTIMABLE="YES" I2="38.23278104307494" ID="CMP-018.01.04" NO="4" P_CHI2="0.1663135751984972" P_Z="1.6801911820624656E-7" STUDIES="5" TAU2="0.0" TOTAL_1="138" TOTAL_2="139" WEIGHT="5.732666981662652" Z="5.2316329574684675">
<NAME>Fosinopril 20 mg</NAME>
<CONT_DATA CI_END="3.1400828585161253" CI_START="-14.740082858516123" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="469" SD_1="12.9" SD_2="13.3" SE="4.561350580436353" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="0.8127170300303797"/>
<CONT_DATA CI_END="3.2224384746449424" CI_START="-16.022438474644943" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-5.6" ORDER="470" SD_1="13.9" SD_2="13.4" SE="4.90949759819339" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="16" WEIGHT="0.701539553959566"/>
<CONT_DATA CI_END="7.046251042870823" CI_START="-19.446251042870827" EFFECT_SIZE="-6.200000000000001" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-4.1" ORDER="471" SD_1="14.5" SD_2="24.2" SE="6.758415535874925" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="0.370200060221317"/>
<CONT_DATA CI_END="-4.715945417771892" CI_START="-13.284054582228109" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-13.1" MEAN_2="-4.1" ORDER="472" SD_1="13.9" SD_2="13.4" SE="2.185782298052507" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="77" WEIGHT="3.539259913814554"/>
<CONT_DATA CI_END="-11.900039253544783" CI_START="-40.899960746455214" EFFECT_SIZE="-26.4" ESTIMABLE="YES" MEAN_1="-22.9" MEAN_2="3.5" ORDER="473" SD_1="20.2" SD_2="15.1" SE="7.3980750977207" STUDY_ID="STD-Zamboulis-1996" TOTAL_1="12" TOTAL_2="11" WEIGHT="0.3089504236368342"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.538095505762076" CI_START="-16.26190449423792" DF="0.0" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.05" NO="5" P_CHI2="1.0" P_Z="0.017814466414925397" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="35" WEIGHT="1.1985111811787856" Z="2.3694520183003522">
<NAME>Imidapril 10 mg</NAME>
<CONT_DATA CI_END="-1.538095505762076" CI_START="-16.26190449423792" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-5.8" ORDER="474" SD_1="15.6" SD_2="14.8" SE="3.7561427415542763" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" WEIGHT="1.1985111811787856"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.01.06" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Lisinopril 40 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.6838268096595304" CI_END="-4.880331300005814" CI_START="-11.162869665676045" DF="3.0" EFFECT_SIZE="-8.02160048284093" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.07" NO="7" P_CHI2="0.6405355126534149" P_Z="5.586242018729363E-7" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="159" WEIGHT="6.582822436492306" Z="5.0049986580734815">
<NAME>Moexipril 15 mg</NAME>
<CONT_DATA CI_END="-5.483072463711219" CI_START="-15.71692753628878" EFFECT_SIZE="-10.6" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-1.6" ORDER="475" SD_1="11.8" SD_2="13.6" SE="2.6107252871228512" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="2.480869470283073"/>
<CONT_DATA CI_END="-1.4138175016961254" CI_START="-12.986182498303872" EFFECT_SIZE="-7.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-2.9" ORDER="476" SD_1="14.0" SD_2="14.0" SE="2.9521881748565497" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="46" WEIGHT="1.9401628900061871"/>
<CONT_DATA CI_END="0.9933353224024817" CI_START="-12.593335322402483" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.6" ORDER="477" SD_1="17.5" SD_2="17.3" SE="3.4660510988913287" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" WEIGHT="1.4075257341537741"/>
<CONT_DATA CI_END="3.4800311847926757" CI_START="-15.080031184792674" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="478" SD_1="14.0" SD_2="14.0" SE="4.734796791161662" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="17" WEIGHT="0.7542643420492716"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.930121230046901" CI_END="-4.0242594174407555" CI_START="-9.03756786594694" DF="5.0" EFFECT_SIZE="-6.530913641693848" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.08" NO="8" P_CHI2="0.9680028100805039" P_Z="3.2809355130649367E-7" STUDIES="6" TAU2="0.0" TOTAL_1="472" TOTAL_2="396" WEIGHT="10.3379300163563" Z="5.106550157581224">
<NAME>Perindopril 4 mg</NAME>
<CONT_DATA CI_END="8.132376199755992" CI_START="-17.33237619975599" EFFECT_SIZE="-4.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-3.7" ORDER="479" SD_1="17.1" SD_2="10.8" SE="6.4962296757426925" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.4006854053777496"/>
<CONT_DATA CI_END="-1.1568497204055932" CI_START="-12.843150279594408" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="0.0" ORDER="480" SD_1="18.0" SD_2="19.0" SE="2.9812539034821204" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="1.902516079760848"/>
<CONT_DATA CI_END="8.301941300977354" CI_START="-27.901941300977356" EFFECT_SIZE="-9.8" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-5.6" ORDER="481" SD_1="25.0" SD_2="15.1" SE="9.235854048218822" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.19823126097403798"/>
<CONT_DATA CI_END="2.547623911466262" CI_START="-10.547623911466262" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-0.7" ORDER="482" SD_1="15.9" SD_2="19.0" SE="3.3406858305117257" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="55" WEIGHT="1.5151477877177835"/>
<CONT_DATA CI_END="-3.432635657420326" CI_START="-10.367364342579675" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-5.4" ORDER="483" SD_1="19.1" SD_2="20.0" SE="1.7690959476448556" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="5.402857220289886"/>
<CONT_DATA CI_END="0.7095638646875297" CI_START="-16.10956386468753" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-14.1" MEAN_2="-6.4" ORDER="484" SD_1="10.5" SD_2="19.3" SE="4.290672650630877" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="0.918492262235994"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7985871526218953" CI_END="-2.839234607373326" CI_START="-11.258472870805699" DF="1.0" EFFECT_SIZE="-7.0488537390895125" ESTIMABLE="YES" I2="44.400803789671954" ID="CMP-018.01.09" NO="9" P_CHI2="0.1798835382580608" P_Z="0.0010311447062422514" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="90" WEIGHT="3.6655305134679286" Z="3.2818882251881085">
<NAME>Quinapril 20 mg</NAME>
<CONT_DATA CI_END="-1.0516865160939162" CI_START="-10.348313483906084" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.7" ORDER="485" SD_1="14.1" SD_2="15.9" SE="2.3716320914932045" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="3.006295241622873"/>
<CONT_DATA CI_END="-3.273617500454904" CI_START="-23.126382499545095" EFFECT_SIZE="-13.2" ESTIMABLE="YES" MEAN_1="-19.7" MEAN_2="-6.5" ORDER="486" SD_1="13.7" SD_2="8.7" SE="5.06457392984929" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="0.6592352718450556"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1558566204351286" CI_END="-3.272762880122496" CI_START="-9.071301050313131" DF="3.0" EFFECT_SIZE="-6.172031965217814" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.10" NO="10" P_CHI2="0.7636100430701442" P_Z="3.013850621618216E-5" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="156" WEIGHT="7.72761361110222" Z="4.172417256971918">
<NAME>Ramipril 10 mg</NAME>
<CONT_DATA CI_END="2.5247848464926923" CI_START="-11.124784846492691" EFFECT_SIZE="-4.3" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-5.7" ORDER="487" SD_1="14.0" SD_2="17.0" SE="3.48209706929603" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.3945834880285701"/>
<CONT_DATA CI_END="-2.743410370221225" CI_START="-14.656589629778773" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="0.5" ORDER="488" SD_1="10.4" SD_2="16.6" SE="3.039132186490973" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="41" WEIGHT="1.8307417511629294"/>
<CONT_DATA CI_END="-0.8153776513338435" CI_START="-9.784622348666156" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-1.3" ORDER="489" SD_1="10.3" SD_2="10.7" SE="2.28811467151452" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="32" WEIGHT="3.2297632933720433"/>
<CONT_DATA CI_END="0.3446021353404287" CI_START="-13.944602135340428" EFFECT_SIZE="-6.8" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-3.7" ORDER="490" SD_1="16.7" SD_2="16.7" SE="3.645272153823304" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="43" WEIGHT="1.2725250785386766"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1196792639208124" CI_END="-4.458079361952473" CI_START="-10.406613347735421" DF="2.0" EFFECT_SIZE="-7.432346354843947" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.11" NO="11" P_CHI2="0.5713008206053869" P_Z="9.69543530673129E-7" STUDIES="3" TAU2="0.0" TOTAL_1="164" TOTAL_2="139" WEIGHT="7.342814301133885" Z="4.897721425459541">
<NAME>Spirapril 6 mg</NAME>
<CONT_DATA CI_END="-0.28790299628198834" CI_START="-10.312097003718012" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-6.7" ORDER="491" SD_1="13.9" SD_2="13.4" SE="2.5572393387086665" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="59" TOTAL_2="55" WEIGHT="2.585732015517199"/>
<CONT_DATA CI_END="-4.646205354455403" CI_START="-12.953794645544598" EFFECT_SIZE="-8.8" ESTIMABLE="YES" MEAN_1="-14.8" MEAN_2="-6.0" ORDER="492" SD_1="12.0" SD_2="11.0" SE="2.1193219254584266" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="59" WEIGHT="3.764717595277127"/>
<CONT_DATA CI_END="0.29050391763731387" CI_START="-15.890503917637314" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.2" ORDER="493" SD_1="14.4" SD_2="17.7" SE="4.127883972080189" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="0.9923646903395592"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.0450243307743725" CI_END="-4.097616673455446" CI_START="-8.237975589205963" DF="6.0" EFFECT_SIZE="-6.167796131330705" ESTIMABLE="YES" I2="0.0" ID="CMP-018.01.12" NO="12" P_CHI2="0.8031750420230017" P_Z="5.238119908181049E-9" STUDIES="7" TAU2="0.0" TOTAL_1="407" TOTAL_2="362" WEIGHT="15.156762954898857" Z="5.83942529011515">
<NAME>Trandolapril 2 mg</NAME>
<CONT_DATA CI_END="-4.07400967276598" CI_START="-16.725990327234022" EFFECT_SIZE="-10.4" ESTIMABLE="YES" MEAN_1="-20.0" MEAN_2="-9.6" ORDER="494" SD_1="14.6" SD_2="15.5" SE="3.227605393329992" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="44" WEIGHT="1.6231752092294955"/>
<CONT_DATA CI_END="0.06884077016711476" CI_START="-11.268840770167113" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-5.6" MEAN_2="0.0" ORDER="495" SD_1="16.5" SD_2="15.1" SE="2.892318846102381" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="67" TOTAL_2="53" WEIGHT="2.021314685342926"/>
<CONT_DATA CI_END="-2.7197541822017426" CI_START="-11.680245817798259" EFFECT_SIZE="-7.200000000000001" ESTIMABLE="YES" MEAN_1="-14.3" MEAN_2="-7.1" ORDER="496" SD_1="18.0" SD_2="19.0" SE="2.2858817065710726" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="3.2360763678299227"/>
<CONT_DATA CI_END="1.0378318884243942" CI_START="-14.437831888424395" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-6.3" ORDER="497" SD_1="14.7" SD_2="14.0" SE="3.947945956894833" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="1.0848854084999442"/>
<CONT_DATA CI_END="0.24989870118639956" CI_START="-12.2498987011864" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-17.3" MEAN_2="-11.3" ORDER="498" SD_1="12.3" SD_2="12.4" SE="3.1887824217612173" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.6629396615977459"/>
<CONT_DATA CI_END="4.059658237431083" CI_START="-10.659658237431081" EFFECT_SIZE="-3.299999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-6.9" ORDER="499" SD_1="12.0" SD_2="9.0" SE="3.7549966711037173" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="1.1992428930742138"/>
<CONT_DATA CI_END="-0.9264338756891171" CI_START="-8.673566124310883" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-2.7" ORDER="500" SD_1="10.3" SD_2="13.3" SE="1.976345562910889" STUDY_ID="STD-Weir-1995" TOTAL_1="75" TOTAL_2="71" WEIGHT="4.3291287293246095"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="105.44105395507259" CI_END="-4.253031288352956" CI_START="-5.091926791150888" CI_STUDY="95" CI_TOTAL="95" DF="56.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.672479039751922" ESTIMABLE="YES" I2="46.88975697847154" I2_Q="46.87009500884854" ID="CMP-018.02" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="2" P_CHI2="7.18910774003545E-5" P_Q="0.04258553255847686" P_Z="0.0" Q="18.821791609951973" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="57" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2888" TOTAL_2="2735" UNITS="" WEIGHT="100.0" Z="21.83320951390999">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.278385713821658" CI_END="-2.8955975555154407" CI_START="-5.702862843062091" DF="5.0" EFFECT_SIZE="-4.299230199288766" ESTIMABLE="YES" I2="5.274069174079001" ID="CMP-018.02.01" NO="1" P_CHI2="0.3828586793387416" P_Z="1.934245679957427E-9" STUDIES="6" TAU2="0.0" TOTAL_1="260" TOTAL_2="244" WEIGHT="8.92994576613614" Z="6.003234813063898">
<NAME>Benazepril 20 mg</NAME>
<CONT_DATA CI_END="0.9893751520552083" CI_START="-5.58937515205521" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-7.0" ORDER="501" SD_1="7.4" SD_2="7.6" SE="1.6782834674521472" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.6260313936243609"/>
<CONT_DATA CI_END="-3.9959900988745347" CI_START="-9.004009901125466" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-3.5" ORDER="502" SD_1="8.1" SD_2="7.7" SE="1.2775795478267844" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="2.805974096608926"/>
<CONT_DATA CI_END="-0.6207681753551801" CI_START="-6.9792318246448195" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-5.3" ORDER="503" SD_1="8.1" SD_2="7.7" SE="1.6220868596169085" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="48" WEIGHT="1.7406495685988457"/>
<CONT_DATA CI_END="1.8019107503283864" CI_START="-7.401910750328386" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-4.7" ORDER="504" SD_1="8.3" SD_2="9.6" SE="2.3479567923837736" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="0.8307672308920754"/>
<CONT_DATA CI_END="4.80638209848582" CI_START="-9.006382098485819" EFFECT_SIZE="-2.0999999999999996" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-5.0" ORDER="505" SD_1="9.6" SD_2="9.7" SE="3.5237290853109955" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.36885403329792854"/>
<CONT_DATA CI_END="-0.9392189453125779" CI_START="-7.6607810546874235" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-4.5" ORDER="506" SD_1="8.1" SD_2="7.7" SE="1.7147157198789542" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="40" WEIGHT="1.5576694431140026"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.53932910976932" CI_END="-2.36203831360256" CI_START="-4.4479564977219885" DF="8.0" EFFECT_SIZE="-3.4049974056622743" ESTIMABLE="YES" I2="54.38822118034127" ID="CMP-018.02.02" NO="2" P_CHI2="0.0249582145013848" P_Z="1.5661692192089164E-10" STUDIES="9" TAU2="0.0" TOTAL_1="404" TOTAL_2="396" WEIGHT="16.174139785715873" Z="6.3987862355854315">
<NAME>Cilazapril 5 mg</NAME>
<CONT_DATA CI_END="1.5376792771020305" CI_START="-5.1376792771020305" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-4.5" ORDER="507" SD_1="7.8" SD_2="7.9" SE="1.7029288820760067" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.5793069133738495"/>
<CONT_DATA CI_END="-1.8020003955520747" CI_START="-9.397999604447925" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.4" ORDER="508" SD_1="7.0" SD_2="6.7" SE="1.937790507583844" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="24" WEIGHT="1.2196800233841554"/>
<CONT_DATA CI_END="-4.331679774787432" CI_START="-12.068320225212567" EFFECT_SIZE="-8.2" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.3" ORDER="509" SD_1="7.5" SD_2="7.4" SE="1.9736690345972596" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="28" WEIGHT="1.1757389457781589"/>
<CONT_DATA CI_END="1.4432429194781955" CI_START="-5.243242919478195" EFFECT_SIZE="-1.9" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-3.1" ORDER="510" SD_1="8.1" SD_2="7.7" SE="1.7057675272858424" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="1.5740548943567754"/>
<CONT_DATA CI_END="-3.277718694649786" CI_START="-8.522281305350212" EFFECT_SIZE="-5.8999999999999995" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-3.3" ORDER="511" SD_1="6.7" SD_2="7.1" SE="1.3379232098316265" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="51" WEIGHT="2.5585692937320683"/>
<CONT_DATA CI_END="0.15416949523217038" CI_START="-11.55416949523217" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-1.2" ORDER="512" SD_1="8.1" SD_2="7.7" SE="2.986876055585262" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.5133636999329323"/>
<CONT_DATA CI_END="0.9155869615642485" CI_START="-3.315586961564247" EFFECT_SIZE="-1.1999999999999993" ESTIMABLE="YES" MEAN_1="-6.1" MEAN_2="-4.9" ORDER="513" SD_1="7.4" SD_2="7.4" SE="1.0794009370844198" STUDY_ID="STD-Pordy-1994" TOTAL_1="94" TOTAL_2="94" WEIGHT="3.930917937645168"/>
<CONT_DATA CI_END="0.601151395550148" CI_START="-5.401151395550147" EFFECT_SIZE="-2.3999999999999995" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-7.7" ORDER="514" SD_1="7.1" SD_2="8.7" SE="1.5312278282778902" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="53" WEIGHT="1.9533493954417742"/>
<CONT_DATA CI_END="0.04660204345933705" CI_START="-6.446602043459338" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-3.7" ORDER="515" SD_1="8.1" SD_2="7.7" SE="1.6564600518520338" STUDY_ID="STD-Yodfat-1993" TOTAL_1="46" TOTAL_2="45" WEIGHT="1.6691586820709934"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.953820548680312" CI_END="-4.366040533923236" CI_START="-6.223749860547477" DF="8.0" EFFECT_SIZE="-5.294895197235356" ESTIMABLE="YES" I2="42.66803151086386" ID="CMP-018.02.03" NO="3" P_CHI2="0.08297713640661797" P_Z="5.547583879468738E-29" STUDIES="9" TAU2="0.0" TOTAL_1="470" TOTAL_2="569" WEIGHT="20.392018171558295" Z="11.172688579169233">
<NAME>Enalapril 20 mg</NAME>
<CONT_DATA CI_END="-3.347453568100355" CI_START="-7.852546431899644" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.6" ORDER="516" SD_1="6.7" SD_2="7.8" SE="1.1492795019028121" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="3.4674342711814607"/>
<CONT_DATA CI_END="-0.8480124152623421" CI_START="-6.551987584737656" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.4" ORDER="517" SD_1="8.1" SD_2="7.7" SE="1.4551224447151945" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="79" WEIGHT="2.1630197249507934"/>
<CONT_DATA CI_END="-2.665473531417828" CI_START="-7.3345264685821725" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-4.5" ORDER="518" SD_1="8.4" SD_2="7.5" SE="1.1911068198174144" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="3.228182928713735"/>
<CONT_DATA CI_END="-1.2262714980440963" CI_START="-6.773728501955904" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-1.8" ORDER="519" SD_1="6.8" SD_2="6.7" SE="1.4151936075533633" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="2.286798205106931"/>
<CONT_DATA CI_END="-0.7419618771852332" CI_START="-6.658038122814766" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-3.4" ORDER="520" SD_1="6.6" SD_2="6.2" SE="1.509230856356236" STUDY_ID="STD-Oparil-1999" TOTAL_1="36" TOTAL_2="36" WEIGHT="2.010704303465537"/>
<CONT_DATA CI_END="-6.743710042056022" CI_START="-12.45628995794398" EFFECT_SIZE="-9.600000000000001" ESTIMABLE="YES" MEAN_1="-11.9" MEAN_2="-2.3" ORDER="521" SD_1="7.5" SD_2="7.0" SE="1.457317573421772" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="2.156508404717029"/>
<CONT_DATA CI_END="-1.028804192832859" CI_START="-9.971195807167142" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.4" ORDER="522" SD_1="8.1" SD_2="7.7" SE="2.281264269361765" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.8800520570278838"/>
<CONT_DATA CI_END="-1.80942837700211" CI_START="-6.790571622997891" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="-2.9" ORDER="523" SD_1="7.6" SD_2="7.7" SE="1.2707231574881996" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="2.8363359527394088"/>
<CONT_DATA CI_END="-3.8072023435700277" CI_START="-10.992797656429973" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-1.4" ORDER="524" SD_1="8.4" SD_2="8.5" SE="1.8330937123179314" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.3629823236555167"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="24.697370468546378" CI_END="-5.019374416122745" CI_START="-8.702277213431415" DF="4.0" EFFECT_SIZE="-6.86082581477708" ESTIMABLE="YES" I2="83.8039438040813" ID="CMP-018.02.04" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="4" P_CHI2="5.7872902308298E-5" P_Z="2.8272869324883886E-13" STUDIES="5" TAU2="0.0" TOTAL_1="138" TOTAL_2="139" WEIGHT="5.188421126379934" Z="7.30237654438901">
<NAME>Fosinopril 20 mg</NAME>
<CONT_DATA CI_END="1.3569551483579216" CI_START="-9.356955148357923" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-6.5" ORDER="525" SD_1="7.7" SD_2="8.0" SE="2.7331906048340175" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="0.6130836307311459"/>
<CONT_DATA CI_END="2.8711351378467542" CI_START="-8.271135137846755" EFFECT_SIZE="-2.7" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-0.7" ORDER="526" SD_1="8.1" SD_2="7.7" SE="2.842468117675201" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="16" WEIGHT="0.5668502659610991"/>
<CONT_DATA CI_END="-1.3202189406903013" CI_START="-12.479781059309698" EFFECT_SIZE="-6.8999999999999995" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.7" ORDER="527" SD_1="9.0" SD_2="7.4" SE="2.8468793831531083" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="0.565094947678562"/>
<CONT_DATA CI_END="-3.2204276264743825" CI_START="-8.179572373525616" EFFECT_SIZE="-5.699999999999999" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-4.9" ORDER="528" SD_1="8.1" SD_2="7.7" SE="1.265111192391374" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="77" WEIGHT="2.861555432055992"/>
<CONT_DATA CI_END="-14.101081805389779" CI_START="-25.098918194610224" EFFECT_SIZE="-19.6" ESTIMABLE="YES" MEAN_1="-16.6" MEAN_2="3.0" ORDER="529" SD_1="7.6" SD_2="5.8" SE="2.805622061417958" STUDY_ID="STD-Zamboulis-1996" TOTAL_1="12" TOTAL_2="11" WEIGHT="0.5818368499531346"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.669269822521298" CI_START="-12.1307301774787" DF="0.0" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" I2="0.0" ID="CMP-018.02.05" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="5" P_CHI2="1.0" P_Z="0.0021704843568322455" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="35" WEIGHT="0.786139077057614" Z="3.0658551516303847">
<NAME>Imidapril 10 mg</NAME>
<CONT_DATA CI_END="-2.669269822521298" CI_START="-12.1307301774787" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-12.1" MEAN_2="-4.7" ORDER="530" SD_1="9.5" SD_2="10.1" SE="2.4136821976291896" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" WEIGHT="0.786139077057614"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-018.02.06" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Lisinopril 40 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.716893954604085" CI_END="-2.5972380659076233" CI_START="-5.929877231456718" DF="3.0" EFFECT_SIZE="-4.263557648682171" ESTIMABLE="YES" I2="65.58407139488646" ID="CMP-018.02.07" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="7" P_CHI2="0.03330173496989752" P_Z="5.306215483207542E-7" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="159" WEIGHT="6.336349800676047" Z="5.014896016233132">
<NAME>Moexipril 15 mg</NAME>
<CONT_DATA CI_END="-2.420768175355181" CI_START="-8.779231824644821" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-4.3" ORDER="531" SD_1="8.1" SD_2="7.7" SE="1.6220868596169085" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="1.7406495685988457"/>
<CONT_DATA CI_END="-0.8692873907019822" CI_START="-6.530712609298018" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-5.2" ORDER="532" SD_1="6.8" SD_2="6.9" SE="1.444267665950149" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="46" WEIGHT="2.195655409948808"/>
<CONT_DATA CI_END="-3.013773950503044" CI_START="-9.386226049496955" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-3.9" ORDER="533" SD_1="8.0" SD_2="8.3" SE="1.6256554072572251" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" WEIGHT="1.7330160034351305"/>
<CONT_DATA CI_END="7.535770065665288" CI_START="-2.735770065665289" EFFECT_SIZE="2.3999999999999995" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-7.3" ORDER="534" SD_1="8.1" SD_2="7.4" SE="2.6203389991732435" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="17" WEIGHT="0.6670288186932626"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="3.3073078986209303" CI_END="-3.5836486541780905" CI_START="-6.042166409852563" DF="5.0" EFFECT_SIZE="-4.812907532015327" ESTIMABLE="YES" I2="0.0" ID="CMP-018.02.08" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="8" P_CHI2="0.6527231022673429" P_Z="1.6693341992044127E-14" STUDIES="6" TAU2="0.0" TOTAL_1="472" TOTAL_2="396" WEIGHT="11.643110899843382" Z="7.673831439206918">
<NAME>Perindopril 4 mg</NAME>
<CONT_DATA CI_END="2.384666608330236" CI_START="-11.784666608330237" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-1.7" ORDER="535" SD_1="10.4" SD_2="4.5" SE="3.614692241394833" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.35052331089208216"/>
<CONT_DATA CI_END="-0.5653351193671332" CI_START="-6.434664880632867" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-3.0" ORDER="536" SD_1="8.0" SD_2="10.0" SE="1.4973055136630717" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="2.0428605011333922"/>
<CONT_DATA CI_END="14.946246460034136" CI_START="-9.546246460034137" EFFECT_SIZE="2.6999999999999997" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-6.3" ORDER="537" SD_1="18.4" SD_2="7.2" SE="6.2481997407253225" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.11731397490051092"/>
<CONT_DATA CI_END="-1.1464252577144411" CI_START="-7.05357474228556" EFFECT_SIZE="-4.1000000000000005" ESTIMABLE="YES" MEAN_1="-5.9" MEAN_2="-1.8" ORDER="538" SD_1="8.1" SD_2="7.7" SE="1.506953579546859" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="55" WEIGHT="2.016785964022234"/>
<CONT_DATA CI_END="-3.944033204009827" CI_START="-7.255966795990174" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-5.2" ORDER="539" SD_1="9.5" SD_2="9.2" SE="0.8448965435345895" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="6.415824744787179"/>
<CONT_DATA CI_END="0.21406726094507533" CI_START="-9.814067260945075" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-7.2" ORDER="540" SD_1="9.0" SD_2="9.6" SE="2.5582445904595175" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="0.6998024041079842"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.06325452019835816" CI_END="-0.7238956241379708" CI_START="-5.9802435920439265" DF="1.0" EFFECT_SIZE="-3.352069608090949" ESTIMABLE="YES" I2="0.0" ID="CMP-018.02.09" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="9" P_CHI2="0.801424076539397" P_Z="0.012425991670190026" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="90" WEIGHT="2.547108922688263" Z="2.499810037556136">
<NAME>Quinapril 20 mg</NAME>
<CONT_DATA CI_END="-0.31699911195857844" CI_START="-6.08300088804142" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.9" ORDER="541" SD_1="8.7" SD_2="9.9" SE="1.4709458494044605" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="2.116733527534747"/>
<CONT_DATA CI_END="2.2937279500491288" CI_START="-10.493727950049127" EFFECT_SIZE="-4.1" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-10.1" ORDER="542" SD_1="7.7" SD_2="7.2" SE="3.2621660400303467" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="0.4303753951535158"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.33708683934488803" CI_END="-2.764363384301186" CI_START="-6.171390823010492" DF="3.0" EFFECT_SIZE="-4.467877103655839" ESTIMABLE="YES" I2="0.0" ID="CMP-018.02.10" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="10" P_CHI2="0.9529089902141558" P_Z="2.7403748839276556E-7" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="156" WEIGHT="6.062677544268313" Z="5.140480003785333">
<NAME>Ramipril 10 mg</NAME>
<CONT_DATA CI_END="-0.3366266202418471" CI_START="-7.263373379758153" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-4.8" ORDER="543" SD_1="8.1" SD_2="7.7" SE="1.7670597047072292" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="40" WEIGHT="1.4667534283798065"/>
<CONT_DATA CI_END="-0.7718067617284978" CI_START="-8.628193238271503" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="-2.7" ORDER="544" SD_1="7.7" SD_2="10.4" SE="2.004217051566554" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="41" WEIGHT="1.1401711653646491"/>
<CONT_DATA CI_END="-1.346406783150384" CI_START="-7.253593216849618" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-3.6" ORDER="545" SD_1="7.8" SD_2="6.5" SE="1.5069630055180518" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="32" WEIGHT="2.0167607343293006"/>
<CONT_DATA CI_END="-1.7033783024128009" CI_START="-8.696621697587197" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-2.6" ORDER="546" SD_1="8.6" SD_2="7.7" SE="1.7840234438837164" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="43" WEIGHT="1.4389922161945572"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.208527223954546" CI_END="-4.392360404123115" CI_START="-7.454449938523086" DF="3.0" EFFECT_SIZE="-5.9234051713231" ESTIMABLE="YES" I2="51.679361436557606" ID="CMP-018.02.11" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="11" P_CHI2="0.10189419804547917" P_Z="3.3808307387514173E-14" STUDIES="4" TAU2="0.0" TOTAL_1="264" TOTAL_2="189" WEIGHT="7.50550575153026" Z="7.58283562332644">
<NAME>Spirapril 6 mg</NAME>
<CONT_DATA CI_END="-0.5994957272461732" CI_START="-6.400504272753828" EFFECT_SIZE="-3.500000000000001" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-5.3" ORDER="547" SD_1="8.1" SD_2="7.7" SE="1.4798763118264597" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="59" TOTAL_2="55" WEIGHT="2.091263328691149"/>
<CONT_DATA CI_END="-3.8483034882731904" CI_START="-9.55169651172681" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-4.8" ORDER="548" SD_1="8.1" SD_2="7.7" SE="1.4549739353481124" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="59" WEIGHT="2.163461306860214"/>
<CONT_DATA CI_END="-5.340003195145432" CI_START="-10.659996804854568" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.0" ORDER="549" SD_1="8.1" SD_2="7.7" SE="1.3571661652133833" STUDY_ID="STD-Guitard-1997" TOTAL_1="100" TOTAL_2="50" WEIGHT="2.486528899568894"/>
<CONT_DATA CI_END="1.1979919733955953" CI_START="-8.397991973395596" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-4.7" ORDER="550" SD_1="10.3" SD_2="9.6" SE="2.448000071042909" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="0.7642522164100024"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.517286067580149" CI_END="-3.13989364614298" CI_START="-5.347927576682531" DF="6.0" EFFECT_SIZE="-4.243910611412756" ESTIMABLE="YES" I2="7.937139205126465" ID="CMP-018.02.12" MODIFIED="2008-05-02 14:20:43 -0700" MODIFIED_BY="Ciprian D Jauca" NO="12" P_CHI2="0.36779979205932356" P_Z="4.9124451209987916E-14" STUDIES="7" TAU2="0.0" TOTAL_1="407" TOTAL_2="362" WEIGHT="14.434583154145889" Z="7.534224757084063">
<NAME>Trandolapril 2 mg</NAME>
<CONT_DATA CI_END="-1.9398716638012865" CI_START="-9.260128336198715" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-7.2" ORDER="551" SD_1="8.2" SD_2="9.2" SE="1.8674467311998277" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="44" WEIGHT="1.3132974898120924"/>
<CONT_DATA CI_END="-0.8611405215674743" CI_START="-6.538859478432526" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-5.5" MEAN_2="-1.8" ORDER="552" SD_1="8.1" SD_2="7.7" SE="1.448424308214379" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="67" TOTAL_2="53" WEIGHT="2.183071447535454"/>
<CONT_DATA CI_END="-1.2540421710735012" CI_START="-6.145957828926499" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="553" SD_1="9.8" SD_2="10.4" SE="1.2479605993885103" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="2.940748004663665"/>
<CONT_DATA CI_END="-3.631209535139104" CI_START="-9.168790464860894" EFFECT_SIZE="-6.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-1.2" ORDER="554" SD_1="7.0" SD_2="3.9" SE="1.412674154576697" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="2.2949623216821724"/>
<CONT_DATA CI_END="-1.452727906929221" CI_START="-9.34727209307078" EFFECT_SIZE="-5.4" ESTIMABLE="YES" MEAN_1="-14.8" MEAN_2="-9.4" ORDER="555" SD_1="7.8" SD_2="7.8" SE="2.0139513400278566" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="30" WEIGHT="1.1291759319812489"/>
<CONT_DATA CI_END="4.355344260103939" CI_START="-4.95534426010394" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-8.0" ORDER="556" SD_1="7.0" SD_2="6.0" SE="2.375219288121976" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="0.8118057749097688"/>
<CONT_DATA CI_END="-1.5373011125022757" CI_START="-5.862698887497723" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-3.1" ORDER="557" SD_1="7.3" SD_2="6.0" SE="1.103438075677317" STUDY_ID="STD-Weir-1995" TOTAL_1="75" TOTAL_2="71" WEIGHT="3.761522183561485"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-019" NO="19">
<NAME>Max Dose vs Placebo</NAME>
<CONT_OUTCOME CHI2="8.09307029856357" CI_END="-7.0574679915792" CI_START="-9.906710189973074" CI_STUDY="95" CI_TOTAL="95" DF="15.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.482089090776137" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.01" NO="1" P_CHI2="0.9199971942402958" P_Q="0.8008479290269497" P_Z="1.8253296460738855E-31" Q="4.585218981829392" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="727" TOTAL_2="723" UNITS="" WEIGHT="100.0" Z="11.669481198160444">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.877396707353082E-4" CI_END="-3.6157970168062237" CI_START="-13.732511956586432" DF="1.0" EFFECT_SIZE="-8.674154486696327" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.01" NO="1" P_CHI2="0.9864662202846077" P_Z="7.766688831350191E-4" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="55" WEIGHT="7.931945282409964" Z="3.3609784384476646">
<NAME>Benazepril 40 mg</NAME>
<CONT_DATA CI_END="1.3498592292048226" CI_START="-18.549859229204827" EFFECT_SIZE="-8.600000000000001" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="2.2" ORDER="558" SD_1="13.9" SD_2="13.4" SE="5.0765520732462655" STUDY_ID="STD-Weinberger-1990" TOTAL_1="14" TOTAL_2="15" WEIGHT="2.050051973205405"/>
<CONT_DATA CI_END="-2.8259072337727984" CI_START="-14.5740927662272" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-5.3" ORDER="559" SD_1="13.9" SD_2="13.4" SE="2.997041176552883" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="40" WEIGHT="5.881893309204559"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.007382247001667" CI_START="-11.992617752998333" DF="0.0" EFFECT_SIZE="-7.0" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.02" NO="2" P_CHI2="1.0" P_Z="0.005995875248607229" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="51" WEIGHT="8.14220646760239" Z="2.748006871453546">
<NAME>Cilazapril 10 mg</NAME>
<CONT_DATA CI_END="-2.007382247001667" CI_START="-11.992617752998333" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-2.6" ORDER="560" SD_1="12.7" SD_2="12.9" SE="2.547300762860677" STUDY_ID="STD-Mroczek-1991" TOTAL_1="50" TOTAL_2="51" WEIGHT="8.14220646760239"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Enalapril 40 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.2708896138725565" CI_END="-4.361495172584775" CI_START="-11.199608423294281" DF="2.0" EFFECT_SIZE="-7.780551797939528" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.04" NO="4" P_CHI2="0.5296998480745383" P_Z="8.189159203975873E-6" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="122" WEIGHT="17.361456528912814" Z="4.4601780475711115">
<NAME>Fosinopril 40 mg</NAME>
<CONT_DATA CI_END="-2.6396201034586166" CI_START="-21.560379896541384" EFFECT_SIZE="-12.1" ESTIMABLE="YES" MEAN_1="-17.7" MEAN_2="-5.6" ORDER="561" SD_1="13.9" SD_2="13.4" SE="4.8268131308348785" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="16" WEIGHT="2.267679067463874"/>
<CONT_DATA CI_END="-3.515945417771893" CI_START="-12.08405458222811" EFFECT_SIZE="-7.800000000000001" ESTIMABLE="YES" MEAN_1="-11.9" MEAN_2="-4.1" ORDER="562" SD_1="13.9" SD_2="13.4" SE="2.185782298052507" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="77" WEIGHT="11.058309819555712"/>
<CONT_DATA CI_END="1.791733999335297" CI_START="-12.391733999335294" EFFECT_SIZE="-5.299999999999999" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-3.4" ORDER="563" SD_1="13.9" SD_2="13.4" SE="3.6182981193909627" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="29" WEIGHT="4.03546764189323"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-5.244907233553475" CI_START="-20.55509276644652" DF="0.0" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.05" NO="5" P_CHI2="1.0" P_Z="9.571148020926522E-4" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="35" WEIGHT="3.463361527667319" Z="3.302838537945407">
<NAME>Imidapril 20 mg</NAME>
<CONT_DATA CI_END="-5.244907233553475" CI_START="-20.55509276644652" EFFECT_SIZE="-12.899999999999999" ESTIMABLE="YES" MEAN_1="-18.7" MEAN_2="-5.8" ORDER="564" SD_1="16.7" SD_2="14.8" SE="3.9057313434475933" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" WEIGHT="3.463361527667319"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-6.828294803476471" CI_START="-20.77170519652353" DF="0.0" EFFECT_SIZE="-13.8" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.06" NO="6" P_CHI2="1.0" P_Z="1.0462372226134083E-4" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="39" WEIGHT="4.1756175620767175" Z="3.8796108303805075">
<NAME>Lisinopril 80 mg</NAME>
<CONT_DATA CI_END="-6.828294803476471" CI_START="-20.77170519652353" EFFECT_SIZE="-13.8" ESTIMABLE="YES" MEAN_1="-19.5" MEAN_2="-5.7" ORDER="565" SD_1="16.5" SD_2="15.1" SE="3.5570578089778437" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="39" WEIGHT="4.1756175620767175"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.01.07" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Moexipril 30 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.1157266799186231" CI_END="-4.046781920114019" CI_START="-16.135255319843363" DF="1.0" EFFECT_SIZE="-10.09101861997869" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.08" NO="8" P_CHI2="0.7337163266944358" P_Z="0.0010670895340477648" STUDIES="2" TAU2="0.0" TOTAL_1="64" TOTAL_2="65" WEIGHT="5.555406175169773" Z="3.2722135224989017">
<NAME>Perindopril 8 mg</NAME>
<CONT_DATA CI_END="9.24065981533593" CI_START="-24.04065981533593" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.6" ORDER="566" SD_1="22.2" SD_2="15.1" SE="8.490288569889717" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.7329218335805892"/>
<CONT_DATA CI_END="-4.012700342947171" CI_START="-16.98729965705283" EFFECT_SIZE="-10.5" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-0.7" ORDER="567" SD_1="15.4" SD_2="19.0" SE="3.3099075841310457" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="55" WEIGHT="4.822484341589185"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="8.156197620794291" CI_START="-20.15619762079429" DF="0.0" EFFECT_SIZE="-6.0" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.09" NO="9" P_CHI2="1.0" P_Z="0.4061339320403249" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="1.0127575995169305" Z="0.8307162857041618">
<NAME>Quinapril 40 mg</NAME>
<CONT_DATA CI_END="8.156197620794291" CI_START="-20.15619762079429" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-12.0" ORDER="568" SD_1="15.9" SD_2="10.6" SE="7.222682525014016" STUDY_ID="STD-Saynavalammi-1988" TOTAL_1="7" TOTAL_2="7" WEIGHT="1.0127575995169305"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.01.10" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ramipril 20 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6391780273992929" CI_END="-4.816213626532869" CI_START="-11.649515138923926" DF="1.0" EFFECT_SIZE="-8.232864382728398" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.11" NO="11" P_CHI2="0.42400884633780056" P_Z="2.326331508584444E-6" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="114" WEIGHT="17.385915627587984" Z="4.7227881428882">
<NAME>Spirapril 12 mg</NAME>
<CONT_DATA CI_END="-1.6211187959194202" CI_START="-11.77888120408058" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-6.7" ORDER="569" SD_1="13.9" SD_2="13.4" SE="2.5913135364436015" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="56" TOTAL_2="55" WEIGHT="7.867968903784168"/>
<CONT_DATA CI_END="-4.882278491676955" CI_START="-14.117721508323045" EFFECT_SIZE="-9.5" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-6.0" ORDER="570" SD_1="14.0" SD_2="11.0" SE="2.3560236538768278" STUDY_ID="STD-Guitard-1994" TOTAL_1="56" TOTAL_2="59" WEIGHT="9.517946723803815"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.4817692558729694" CI_END="-5.590539237893551" CI_START="-10.408611097850088" DF="2.0" EFFECT_SIZE="-7.999575167871819" ESTIMABLE="YES" I2="0.0" ID="CMP-019.01.12" NO="12" P_CHI2="0.47669212922476767" P_Z="7.597438124317723E-11" STUDIES="3" TAU2="0.0" TOTAL_1="243" TOTAL_2="235" WEIGHT="34.97133322905611" Z="6.508362546834727">
<NAME>Trandolapril 4 mg</NAME>
<CONT_DATA CI_END="-5.843011424906308" CI_START="-12.156988575093692" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="0.0" ORDER="571" SD_1="14.8" SD_2="13.4" SE="1.61073805437019" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="20.36351401408623"/>
<CONT_DATA CI_END="4.783120214539968" CI_START="-12.183120214539967" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-26.8" MEAN_2="-23.1" ORDER="572" SD_1="10.4" SD_2="10.8" SE="4.328202090167848" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="2.8202493082023183"/>
<CONT_DATA CI_END="-3.1505815711559197" CI_START="-11.44941842884408" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.7" ORDER="573" SD_1="12.3" SD_2="13.3" SE="2.117089120807404" STUDY_ID="STD-Weir-1995" TOTAL_1="76" TOTAL_2="71" WEIGHT="11.787569906767557"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="8.387376618696157" CI_END="-4.196979010498599" CI_START="-5.7085403633698215" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.95275968693421" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-019.02" NO="2" P_CHI2="0.9364887071185457" P_Q="0.8343215717801049" P_Z="9.297124889245151E-38" Q="4.245505740543803" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="819" TOTAL_2="817" UNITS="" WEIGHT="100.0" Z="12.843978303671195">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.24144151412706089" CI_END="-1.6878678463698793" CI_START="-7.838403669151386" DF="1.0" EFFECT_SIZE="-4.763135757760633" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.01" NO="1" P_CHI2="0.6231669384350943" P_Z="0.0023998221525126993" STUDIES="2" TAU2="0.0" TOTAL_1="57" TOTAL_2="55" WEIGHT="6.0398430644069405" Z="3.0356947126807685">
<NAME>Benazepril 40 mg</NAME>
<CONT_DATA CI_END="0.8171120264973482" CI_START="-13.617112026497349" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-11.4" MEAN_2="-5.0" ORDER="574" SD_1="10.1" SD_2="9.7" SE="3.6822676760517066" STUDY_ID="STD-Weinberger-1990" TOTAL_1="14" TOTAL_2="15" WEIGHT="1.096641493974358"/>
<CONT_DATA CI_END="-1.00068333229457" CI_START="-7.799316667705431" EFFECT_SIZE="-4.4" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-4.5" ORDER="575" SD_1="8.1" SD_2="7.7" SE="1.7343771082115826" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="40" WEIGHT="4.943201570432582"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7087949263051276" CI_END="-2.3696043340348267" CI_START="-5.7434594172126605" DF="1.0" EFFECT_SIZE="-4.056531875623744" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.02" NO="2" P_CHI2="0.3998446216684921" P_Z="2.439776805568143E-6" STUDIES="2" TAU2="0.0" TOTAL_1="142" TOTAL_2="145" WEIGHT="20.072372597456255" Z="4.71309892235948">
<NAME>Cilazapril 10 mg</NAME>
<CONT_DATA CI_END="-2.2305276318849026" CI_START="-7.7694723681151" EFFECT_SIZE="-5.000000000000001" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-3.3" ORDER="576" SD_1="7.1" SD_2="7.1" SE="1.4130220707933119" STUDY_ID="STD-Mroczek-1991" TOTAL_1="50" TOTAL_2="51" WEIGHT="7.447276779920626"/>
<CONT_DATA CI_END="-1.3729463584509776" CI_START="-5.627053641549022" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.9" ORDER="577" SD_1="7.4" SD_2="7.4" SE="1.0852513915189004" STUDY_ID="STD-Pordy-1994" TOTAL_1="92" TOTAL_2="94" WEIGHT="12.625095817535628"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.02.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Enalapril 40 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6804941427899163" CI_END="-2.648195518275343" CI_START="-6.606275738694582" DF="2.0" EFFECT_SIZE="-4.6272356284849625" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.04" NO="4" P_CHI2="0.7115945642285857" P_Z="4.591567480728301E-6" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="122" WEIGHT="14.58419205927806" Z="4.58263333472836">
<NAME>Fosinopril 40 mg</NAME>
<CONT_DATA CI_END="-0.12392586618446799" CI_START="-11.076074133815531" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-0.7" ORDER="578" SD_1="8.1" SD_2="7.7" SE="2.793966714189702" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="16" WEIGHT="1.90481555917955"/>
<CONT_DATA CI_END="-1.5204276264743832" CI_START="-6.479572373525617" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-4.9" ORDER="579" SD_1="8.1" SD_2="7.7" SE="1.265111192391374" STUDY_ID="STD-Pool-1990" TOTAL_1="79" TOTAL_2="77" WEIGHT="9.290476512565514"/>
<CONT_DATA CI_END="-1.694496679639129" CI_START="-9.905503320360872" EFFECT_SIZE="-5.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.2" ORDER="580" SD_1="8.1" SD_2="7.7" SE="2.094683041496965" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="29" WEIGHT="3.3888999875329957"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-1.7161421270032093" CI_START="-10.88385787299679" DF="0.0" EFFECT_SIZE="-6.3" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.05" NO="5" P_CHI2="1.0" P_Z="0.0070652861769918964" STUDIES="1" TAU2="0.0" TOTAL_1="31" TOTAL_2="35" WEIGHT="2.718499645783788" Z="2.6937512996077544">
<NAME>Imidapril 20 mg</NAME>
<CONT_DATA CI_END="-1.7161421270032093" CI_START="-10.88385787299679" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-4.7" ORDER="581" SD_1="8.9" SD_2="10.1" SE="2.3387459714329837" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" WEIGHT="2.718499645783788"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9308887981121048E-31" CI_END="-2.038408635694773" CI_START="-9.961591364305228" DF="0.0" EFFECT_SIZE="-6.000000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-019.02.06" NO="6" P_CHI2="0.0" P_Z="0.002993062788042372" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="39" WEIGHT="3.639587920920515" Z="2.968449500672496">
<NAME>Lisinopril 80 mg</NAME>
<CONT_DATA CI_END="-2.038408635694772" CI_START="-9.961591364305228" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.0" ORDER="582" SD_1="10.5" SD_2="7.2" SE="2.0212572249050265" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="39" WEIGHT="3.639587920920515"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.02.07" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Moexipril 30 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.16598466947150023" CI_END="-3.0732402489667834" CI_START="-8.809590711784757" DF="1.0" EFFECT_SIZE="-5.94141548037577" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.08" NO="8" P_CHI2="0.6837055401412628" P_Z="4.9060339564928436E-5" STUDIES="2" TAU2="0.0" TOTAL_1="64" TOTAL_2="65" WEIGHT="6.943528229538891" Z="4.06005889431124">
<NAME>Perindopril 8 mg</NAME>
<CONT_DATA CI_END="7.457859961474509" CI_START="-14.85785996147451" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="583" SD_1="16.5" SD_2="7.2" SE="5.692890302825095" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.4588067036577914"/>
<CONT_DATA CI_END="-3.1320941598744025" CI_START="-9.067905840125599" EFFECT_SIZE="-6.1000000000000005" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-1.8" ORDER="584" SD_1="8.1" SD_2="7.7" SE="1.5142654985173505" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="55" WEIGHT="6.484721525881099"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.22069892656197787" CI_START="-17.77930107343802" DF="0.0" EFFECT_SIZE="-9.0" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.09" NO="9" P_CHI2="1.0" P_Z="0.04451225536081111" STUDIES="1" TAU2="0.0" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.7410912439438772" Z="2.0092346433168506">
<NAME>Quinapril 40 mg</NAME>
<CONT_DATA CI_END="-0.22069892656197787" CI_START="-17.77930107343802" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-2.0" ORDER="585" SD_1="5.3" SD_2="10.6" SE="4.479317550061138" STUDY_ID="STD-Saynavalammi-1988" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.7410912439438772"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-019.02.10" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Ramipril 20 mg</NAME>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.0333792580545365" CI_END="-3.9633270119835005" CI_START="-8.086209323387864" DF="1.0" EFFECT_SIZE="-6.024768167685682" ESTIMABLE="YES" I2="50.82078288942695" ID="CMP-019.02.11" NO="11" P_CHI2="0.1538785469966124" P_Z="1.0150725722204469E-8" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="114" WEIGHT="13.441560250641103" Z="5.728190975136072">
<NAME>Spirapril 12 mg</NAME>
<CONT_DATA CI_END="-1.560310696344752" CI_START="-7.43968930365525" EFFECT_SIZE="-4.500000000000001" ESTIMABLE="YES" MEAN_1="-9.8" MEAN_2="-5.3" ORDER="586" SD_1="8.1" SD_2="7.7" SE="1.4998690419023732" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="56" TOTAL_2="55" WEIGHT="6.6098058525721965"/>
<CONT_DATA CI_END="-4.608456958515623" CI_START="-10.391543041484379" EFFECT_SIZE="-7.500000000000001" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-4.8" ORDER="587" SD_1="8.1" SD_2="7.7" SE="1.4753041710421724" STUDY_ID="STD-Guitard-1994" TOTAL_1="56" TOTAL_2="59" WEIGHT="6.831754398068908"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.3117763674042133" CI_END="-3.3657392605219947" CI_START="-6.045402992502668" DF="2.0" EFFECT_SIZE="-4.705571126512331" ESTIMABLE="YES" I2="0.0" ID="CMP-019.02.12" NO="12" P_CHI2="0.8556548786230765" P_Z="5.8394306885174724E-12" STUDIES="3" TAU2="0.0" TOTAL_1="243" TOTAL_2="235" WEIGHT="31.81932498803057" Z="6.883512900955483">
<NAME>Trandolapril 4 mg</NAME>
<CONT_DATA CI_END="-2.7323818254451604" CI_START="-6.26761817455484" EFFECT_SIZE="-4.5" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="0.0" ORDER="588" SD_1="8.1" SD_2="7.7" SE="0.901862579362471" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="18.281618885593538"/>
<CONT_DATA CI_END="5.083988207138917" CI_START="-11.483988207138916" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-10.0" ORDER="589" SD_1="10.6" SD_2="10.1" SE="4.226602260287413" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.8323627256899023"/>
<CONT_DATA CI_END="-2.9796742852544713" CI_START="-7.2203257147455275" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="-3.1" ORDER="590" SD_1="7.1" SD_2="6.0" SE="1.0818187127265535" STUDY_ID="STD-Weir-1995" TOTAL_1="76" TOTAL_2="71" WEIGHT="12.70534337674713"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-020" NO="20">
<NAME>2 Max and Higher Doses vs Placebo</NAME>
<CONT_OUTCOME CHI2="7.489583640057809" CI_END="-6.703716005773362" CI_START="-10.919754852121038" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-8.8117354289472" ESTIMABLE="YES" I2="19.888737634103137" I2_Q="0.0" ID="CMP-020.01" NO="1" P_CHI2="0.2779308066511482" P_Q="0.5850134082374908" P_Z="2.551149003369595E-16" Q="2.8396186418771796" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="356" UNITS="" WEIGHT="100.0" Z="8.192848648438611">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-5.292300652871394" CI_START="-17.507699347128604" DF="0.0" EFFECT_SIZE="-11.399999999999999" ESTIMABLE="YES" I2="0.0" ID="CMP-020.01.01" NO="1" P_CHI2="1.0" P_Z="2.539273398888882E-4" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="40" WEIGHT="11.912253171422506" Z="3.6582660923316315">
<NAME>Benazepril 80 mg</NAME>
<CONT_DATA CI_END="-5.292300652871394" CI_START="-17.507699347128604" EFFECT_SIZE="-11.399999999999999" ESTIMABLE="YES" MEAN_1="-16.7" MEAN_2="-5.3" ORDER="591" SD_1="13.9" SD_2="13.4" SE="3.116230397754937" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="40" WEIGHT="11.912253171422506"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.799663328688868" CI_START="-17.400336671311127" DF="0.0" EFFECT_SIZE="-10.599999999999998" ESTIMABLE="YES" I2="0.0" ID="CMP-020.01.02" NO="2" P_CHI2="1.0" P_Z="0.0022499545726976694" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="35" WEIGHT="9.60922555603209" Z="3.055086717069694">
<NAME>Imidapril 40 mg</NAME>
<CONT_DATA CI_END="-3.799663328688868" CI_START="-17.400336671311127" EFFECT_SIZE="-10.599999999999998" ESTIMABLE="YES" MEAN_1="-16.4" MEAN_2="-5.8" ORDER="592" SD_1="13.6" SD_2="14.8" SE="3.4696232813211454" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="32" TOTAL_2="35" WEIGHT="9.60922555603209"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.4393355935348113" CI_START="-15.36066440646519" DF="0.0" EFFECT_SIZE="-8.9" ESTIMABLE="YES" I2="0.0" ID="CMP-020.01.03" NO="3" P_CHI2="1.0" P_Z="0.006934316777982832" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="55" WEIGHT="10.646205650360816" Z="2.6999822874177752">
<NAME>Perindopril 16 mg</NAME>
<CONT_DATA CI_END="-2.4393355935348113" CI_START="-15.36066440646519" EFFECT_SIZE="-8.9" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-0.7" ORDER="593" SD_1="15.1" SD_2="19.0" SE="3.296317920852671" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="55" WEIGHT="10.646205650360816"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.61443677464575" CI_END="-6.124514335117709" CI_START="-12.673901856906461" DF="1.0" EFFECT_SIZE="-9.399208096012085" ESTIMABLE="YES" I2="78.32888283366349" ID="CMP-020.01.04" NO="4" P_CHI2="0.03170396923851537" P_Z="1.8486684762270827E-8" STUDIES="2" TAU2="0.0" TOTAL_1="106" TOTAL_2="114" WEIGHT="41.438863075483205" Z="5.625597596750415">
<NAME>Spirapril 24 mg</NAME>
<CONT_DATA CI_END="0.5228733273193376" CI_START="-10.122873327319336" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-6.7" ORDER="594" SD_1="13.9" SD_2="13.4" SE="2.715801601103634" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="47" TOTAL_2="55" WEIGHT="15.68400435301042"/>
<CONT_DATA CI_END="-8.046205354455402" CI_START="-16.353794645544596" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-18.2" MEAN_2="-6.0" ORDER="595" SD_1="12.0" SD_2="11.0" SE="2.1193219254584266" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="59" WEIGHT="25.754858722472786"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0355282235348795" CI_END="-1.9313036487309843" CI_START="-10.137775829818672" DF="1.0" EFFECT_SIZE="-6.034539739274829" ESTIMABLE="YES" I2="0.0" ID="CMP-020.01.05" NO="5" P_CHI2="0.8504931506837425" P_Z="0.0039456288711656904" STUDIES="2" TAU2="0.0" TOTAL_1="154" TOTAL_2="112" WEIGHT="26.39345254670139" Z="2.8824762434488083">
<NAME>Trandolapril 8, 12, 16 mg</NAME>
<CONT_DATA CI_END="-0.15476600373524008" CI_START="-12.84523399626476" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="0.0" ORDER="596" SD_1="16.3" SD_2="15.1" SE="3.2374237722300796" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="43" TOTAL_2="53" WEIGHT="11.03707341692006"/>
<CONT_DATA CI_END="-0.32064512881669316" CI_START="-11.079354871183307" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-0.7" ORDER="597" SD_1="19.6" SD_2="15.5" SE="2.7446192448509112" STUDY_ID="STD-Weir-1995" TOTAL_1="111" TOTAL_2="59" WEIGHT="15.356379129781327"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.26074460649045" CI_END="-4.049959737896275" CI_START="-6.4507405932136255" CI_STUDY="95" CI_TOTAL="95" DF="6.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.25035016555495" ESTIMABLE="YES" I2="51.063331040891356" I2_Q="0.0" ID="CMP-020.02" NO="2" P_CHI2="0.056398418261392025" P_Q="0.8281890203553951" P_Z="1.0115228922077087E-17" Q="1.4912576994103741" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="382" TOTAL_2="356" UNITS="" WEIGHT="99.99999999999999" Z="8.572625200604866">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.263639832402972" CI_START="-10.336360167597029" DF="0.0" EFFECT_SIZE="-6.800000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-020.02.01" NO="1" P_CHI2="1.0" P_Z="1.6404895107306918E-4" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="40" WEIGHT="11.522111318216867" Z="3.768777631020721">
<NAME>Benazepril 80 mg</NAME>
<CONT_DATA CI_END="-3.263639832402972" CI_START="-10.336360167597029" EFFECT_SIZE="-6.800000000000001" ESTIMABLE="YES" MEAN_1="-11.3" MEAN_2="-4.5" ORDER="598" SD_1="8.1" SD_2="7.7" SE="1.8042985460403285" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="40" WEIGHT="11.522111318216867"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.3613792062884185E-31" CI_END="-1.7819911481189576" CI_START="-11.218008851881041" DF="0.0" EFFECT_SIZE="-6.5" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-020.02.02" NO="2" P_CHI2="0.0" P_Z="0.006928904455650808" STUDIES="1" TAU2="0.0" TOTAL_1="32" TOTAL_2="35" WEIGHT="6.473326976245269" Z="2.7002420511422063">
<NAME>Imidapril 40 mg</NAME>
<CONT_DATA CI_END="-1.7819911481189568" CI_START="-11.218008851881041" EFFECT_SIZE="-6.499999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-4.7" ORDER="599" SD_1="9.6" SD_2="10.1" SE="2.407191606119344" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="32" TOTAL_2="35" WEIGHT="6.473326976245269"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.5172950686822597" CI_START="-8.482704931317741" DF="0.0" EFFECT_SIZE="-5.5" ESTIMABLE="YES" I2="0.0" ID="CMP-020.02.03" NO="3" P_CHI2="1.0" P_Z="3.0138959885539686E-4" STUDIES="1" TAU2="0.0" TOTAL_1="53" TOTAL_2="55" WEIGHT="16.196622595406946" Z="3.614102689738019">
<NAME>Perindopril 16 mg</NAME>
<CONT_DATA CI_END="-2.5172950686822597" CI_START="-8.482704931317741" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-7.3" MEAN_2="-1.8" ORDER="600" SD_1="8.1" SD_2="7.7" SE="1.5218161939938366" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="55" WEIGHT="16.196622595406946"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="10.072084674198763" CI_END="-2.471008157321088" CI_START="-6.65778857344947" DF="1.0" EFFECT_SIZE="-4.564398365385279" ESTIMABLE="YES" I2="90.0715687730301" ID="CMP-020.02.04" NO="4" P_CHI2="0.0015053357957943714" P_Z="1.924475250491902E-5" STUDIES="2" TAU2="0.0" TOTAL_1="106" TOTAL_2="114" WEIGHT="32.88097373977014" Z="4.273477717047926">
<NAME>Spirapril 24 mg</NAME>
<CONT_DATA CI_END="2.182791860645877" CI_START="-3.982791860645878" EFFECT_SIZE="-0.9000000000000004" ESTIMABLE="YES" MEAN_1="-6.2" MEAN_2="-5.3" ORDER="601" SD_1="8.1" SD_2="7.7" SE="1.572881892199319" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="47" TOTAL_2="55" WEIGHT="15.162005147962788"/>
<CONT_DATA CI_END="-4.84830348827319" CI_START="-10.55169651172681" EFFECT_SIZE="-7.7" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.8" ORDER="602" SD_1="8.1" SD_2="7.7" SE="1.4549739353481124" STUDY_ID="STD-Guitard-1994" TOTAL_1="59" TOTAL_2="59" WEIGHT="17.718968591807357"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.697402232881313" CI_END="-2.932669781248611" CI_START="-7.116525176154294" DF="1.0" EFFECT_SIZE="-5.024597478701453" ESTIMABLE="YES" I2="0.0" ID="CMP-020.02.05" NO="5" P_CHI2="0.40365838046209257" P_Z="2.5060845628762096E-6" STUDIES="2" TAU2="0.0" TOTAL_1="154" TOTAL_2="112" WEIGHT="32.92696537036076" Z="4.707634067399508">
<NAME>Trandolapril 8, 12, 16 mg</NAME>
<CONT_DATA CI_END="-0.8127266002606577" CI_START="-7.187273399739342" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-1.8" ORDER="603" SD_1="8.1" SD_2="7.7" SE="1.6261897794450042" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="43" TOTAL_2="53" WEIGHT="14.184251092715385"/>
<CONT_DATA CI_END="-3.0272783006808144" CI_START="-8.572721699319185" EFFECT_SIZE="-5.8" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-0.7" ORDER="604" SD_1="11.4" SD_2="7.0" SE="1.4146799232996423" STUDY_ID="STD-Weir-1995" TOTAL_1="111" TOTAL_2="59" WEIGHT="18.74271427764538"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-021" MODIFIED="2008-07-07 22:38:36 -0700" MODIFIED_BY="[Empty name]" NO="21">
<NAME>1/2 Max and Higher Doses vs Placebo</NAME>
<CONT_OUTCOME CHI2="56.30512263500244" CI_END="-7.0914727472521335" CI_START="-8.603249314625748" CI_STUDY="95" CI_TOTAL="95" DF="52.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.8473610309389406" ESTIMABLE="YES" I2="7.646058535224882" I2_Q="5.6483996607194085" ID="CMP-021.01" MODIFIED="2008-07-07 19:30:53 -0700" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3170275022496154" P_Q="0.3898507485886157" P_Z="0.0" Q="11.658519792398756" RANDOM="NO" SCALE="42.68406635502112" SORT_BY="STUDY" STUDIES="53" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="3600" TOTAL_2="2513" UNITS="" WEIGHT="99.99999999999997" Z="20.34764306612296">
<NAME>Change in trough SBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="6.901755863629087" CI_END="-6.207761131981544" CI_START="-10.86805551361856" DF="5.0" EFFECT_SIZE="-8.537908322800051" ESTIMABLE="YES" I2="27.554667264470638" ID="CMP-021.01.01" MODIFIED="2008-07-07 19:30:53 -0700" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22805005879244622" P_Z="6.894186008543143E-13" STUDIES="6" TAU2="0.0" TOTAL_1="354" TOTAL_2="244" WEIGHT="10.523216773593761" Z="7.181517494658676">
<NAME>Benazepril 20, 40, 80 mg</NAME>
<CONT_DATA CI_END="2.8946171675547934" CI_START="-8.894617167554793" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-6.5" ORDER="605" SD_1="13.8" SD_2="13.1" SE="3.0075130023055427" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.6443869381229361"/>
<CONT_DATA CI_END="-8.21997203940238" CI_START="-17.380027960597623" EFFECT_SIZE="-12.8" ESTIMABLE="YES" MEAN_1="-14.9" MEAN_2="-2.1" MODIFIED="2008-07-07 19:30:53 -0700" MODIFIED_BY="[Empty name]" ORDER="606" SD_1="14.8" SD_2="14.1" SE="2.3367918985880842" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="2.7238235405601365"/>
<CONT_DATA CI_END="-2.6080129019826783" CI_START="-13.59198709801732" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-3.9" ORDER="607" SD_1="13.9" SD_2="13.4" SE="2.8020857226650153" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="48" WEIGHT="1.8943325031479792"/>
<CONT_DATA CI_END="0.06748450671776762" CI_START="-15.067484506717769" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.5" ORDER="608" SD_1="15.7" SD_2="14.3" SE="3.8610324303962313" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="0.9977279685877898"/>
<CONT_DATA CI_END="-0.9396092709091004" CI_START="-17.860390729090902" EFFECT_SIZE="-9.4" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="2.2" ORDER="609" SD_1="13.9" SD_2="13.4" SE="4.316605200822761" STUDY_ID="STD-Weinberger-1990" TOTAL_1="29" TOTAL_2="15" WEIGHT="0.7982416536073633"/>
<CONT_DATA CI_END="-3.1852336800145293" CI_START="-12.81476631998547" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-13.3" MEAN_2="-5.3" ORDER="610" SD_1="13.9" SD_2="13.4" SE="2.4565585684041813" STUDY_ID="STD-Whalen-1989" TOTAL_1="125" TOTAL_2="40" WEIGHT="2.464704169567557"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.861958884837639" CI_END="-3.1231816061312982" CI_START="-8.464552731985199" DF="4.0" EFFECT_SIZE="-5.793867169058249" ESTIMABLE="YES" I2="49.12209465106347" ID="CMP-021.01.02" NO="2" P_CHI2="0.09676776023604683" P_Z="2.1186420237497934E-5" STUDIES="5" TAU2="0.0" TOTAL_1="243" TOTAL_2="186" WEIGHT="8.010686025576067" Z="4.2520059793627665">
<NAME>Cilazapril 5, 10 mg</NAME>
<CONT_DATA CI_END="-3.831183322314997" CI_START="-18.968816677685005" EFFECT_SIZE="-11.4" ESTIMABLE="YES" MEAN_1="-13.8" MEAN_2="-2.4" ORDER="611" SD_1="13.9" SD_2="13.4" SE="3.8617121219506396" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="24" WEIGHT="0.9973767836351993"/>
<CONT_DATA CI_END="3.2306652559757048" CI_START="-9.830665255975706" EFFECT_SIZE="-3.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-5.5" ORDER="612" SD_1="15.1" SD_2="15.8" SE="3.3320332962690946" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="1.3396778609679523"/>
<CONT_DATA CI_END="-3.755329149879695" CI_START="-12.244670850120304" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-10.6" MEAN_2="-2.6" ORDER="613" SD_1="12.3" SD_2="12.9" SE="2.16568818794719" STUDY_ID="STD-Mroczek-1991" TOTAL_1="106" TOTAL_2="51" WEIGHT="3.1712259740677036"/>
<CONT_DATA CI_END="2.3209667192294194" CI_START="-22.320966719229418" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-2.8" ORDER="614" SD_1="19.4" SD_2="13.3" SE="6.286323022471653" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.37637923797936423"/>
<CONT_DATA CI_END="4.484099289588814" CI_START="-5.884099289588816" EFFECT_SIZE="-0.7000000000000011" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-11.6" ORDER="615" SD_1="12.3" SD_2="15.0" SE="2.644997219581752" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="53" WEIGHT="2.1260261689258484"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="17.972973049096254" CI_END="-7.86024644074257" CI_START="-11.221631330092391" DF="7.0" EFFECT_SIZE="-9.54093888541748" ESTIMABLE="YES" I2="61.05263174390625" ID="CMP-021.01.03" NO="3" P_CHI2="0.01209255378488705" P_Z="9.342864294491319E-29" STUDIES="8" TAU2="0.0" TOTAL_1="434" TOTAL_2="533" WEIGHT="20.22733802186056" Z="11.126304906864169">
<NAME>Enalapril 20, (40) mg</NAME>
<CONT_DATA CI_END="-6.988197773693704" CI_START="-14.811802226306293" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-3.8" ORDER="616" SD_1="13.6" SD_2="11.7" SE="1.995854136689292" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="3.7338893898358982"/>
<CONT_DATA CI_END="-1.0812636201738322" CI_START="-10.918736379826168" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.0" ORDER="617" SD_1="13.9" SD_2="13.4" SE="2.5096054920521667" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="79" WEIGHT="2.361609751116972"/>
<CONT_DATA CI_END="-3.4881047514761963" CI_START="-11.311895248523802" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-13.1" MEAN_2="-5.7" ORDER="618" SD_1="13.3" SD_2="14.2" SE="1.9959015978764578" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="3.7337118132295637"/>
<CONT_DATA CI_END="-3.3948616190742857" CI_START="-12.805138380925714" EFFECT_SIZE="-8.1" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-0.9" ORDER="619" SD_1="11.5" SD_2="11.4" SE="2.4006249186409776" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="2.580895533230253"/>
<CONT_DATA CI_END="-14.485483185481645" CI_START="-26.914516814518354" EFFECT_SIZE="-20.7" ESTIMABLE="YES" MEAN_1="-21.9" MEAN_2="-1.2" ORDER="623" SD_1="17.1" SD_2="14.4" SE="3.170730107051798" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="1.479450683319297"/>
<CONT_DATA CI_END="-4.80259560939629" CI_START="-16.79740439060371" EFFECT_SIZE="-10.8" ESTIMABLE="YES" MEAN_1="-18.3" MEAN_2="-7.5" ORDER="620" SD_1="10.6" SD_2="10.6" SE="3.0599564267050163" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="24" WEIGHT="1.588504908295402"/>
<CONT_DATA CI_END="-2.756274958550298" CI_START="-11.643725041449702" EFFECT_SIZE="-7.2" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-1.8" ORDER="621" SD_1="13.5" SD_2="13.8" SE="2.2672483150207032" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="2.893482565863091"/>
<CONT_DATA CI_END="-5.751280081616442" CI_START="-16.84871991838356" EFFECT_SIZE="-11.3" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="2.5" ORDER="622" SD_1="13.0" SD_2="13.1" SE="2.831031571065159" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.8557933769700858"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.771987646753925" CI_END="-4.444347343549184" CI_START="-10.438593116804809" DF="3.0" EFFECT_SIZE="-7.441470230176996" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.04" NO="4" P_CHI2="0.8561548479065609" P_Z="1.1368490267703953E-6" STUDIES="4" TAU2="0.0" TOTAL_1="218" TOTAL_2="141" WEIGHT="6.360717791795599" Z="4.866338216643531">
<NAME>Fosinopril 20, 40 mg</NAME>
<CONT_DATA CI_END="3.1400828585161253" CI_START="-14.740082858516123" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="624" SD_1="12.9" SD_2="13.3" SE="4.561350580436353" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="0.7148783417787319"/>
<CONT_DATA CI_END="7.046251042870823" CI_START="-19.446251042870827" EFFECT_SIZE="-6.200000000000001" ESTIMABLE="YES" MEAN_1="-10.3" MEAN_2="-4.1" ORDER="625" SD_1="14.5" SD_2="24.2" SE="6.758415535874925" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="0.32563364049047816"/>
<CONT_DATA CI_END="-4.704651161455391" CI_START="-12.09534883854461" EFFECT_SIZE="-8.4" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.1" ORDER="626" SD_1="13.9" SD_2="13.4" SE="1.8854167054563493" STUDY_ID="STD-Pool-1990" TOTAL_1="158" TOTAL_2="77" WEIGHT="4.184122047211822"/>
<CONT_DATA CI_END="1.791733999335297" CI_START="-12.391733999335294" EFFECT_SIZE="-5.299999999999999" ESTIMABLE="YES" MEAN_1="-8.7" MEAN_2="-3.4" ORDER="627" SD_1="13.9" SD_2="13.4" SE="3.6182981193909627" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="29" WEIGHT="1.1360837623145668"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-5.002810567128996" CI_START="-16.597189432871005" DF="0.0" EFFECT_SIZE="-10.8" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.05" NO="5" P_CHI2="1.0" P_Z="2.608578390160744E-4" STUDIES="1" TAU2="0.0" TOTAL_1="94" TOTAL_2="35" WEIGHT="1.7001226127531774" Z="3.65135748592392">
<NAME>Imidapril 10, 20, 40 mg</NAME>
<CONT_DATA CI_END="-5.002810567128996" CI_START="-16.597189432871005" EFFECT_SIZE="-10.8" ESTIMABLE="YES" MEAN_1="-16.6" MEAN_2="-5.8" ORDER="628" SD_1="15.3" SD_2="14.8" SE="2.957804060992189" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="94" TOTAL_2="35" WEIGHT="1.7001226127531774"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-3.1353372454167054" CI_START="-24.464662754583294" DF="0.0" EFFECT_SIZE="-13.8" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.06" NO="6" P_CHI2="1.0" P_Z="0.011206915579042449" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="10" WEIGHT="0.5023668512950695" Z="2.5361798688879014">
<NAME>Lisinopril (40), 80 mg</NAME>
<CONT_DATA CI_END="-3.1353372454167054" CI_START="-24.464662754583294" EFFECT_SIZE="-13.8" ESTIMABLE="YES" MEAN_1="-19.5" MEAN_2="-5.7" ORDER="629" SD_1="16.5" SD_2="15.1" SE="5.441254450951545" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="10" WEIGHT="0.5023668512950695"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.6838268096595304" CI_END="-4.880331300005814" CI_START="-11.162869665676045" DF="3.0" EFFECT_SIZE="-8.02160048284093" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.07" NO="7" P_CHI2="0.6405355126534149" P_Z="5.586242018729363E-7" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="159" WEIGHT="5.790351393827127" Z="5.0049986580734815">
<NAME>Moexipril 15, (30) mg</NAME>
<CONT_DATA CI_END="-5.483072463711219" CI_START="-15.71692753628878" EFFECT_SIZE="-10.6" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-1.6" ORDER="630" SD_1="11.8" SD_2="13.6" SE="2.6107252871228512" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="2.1822107665433683"/>
<CONT_DATA CI_END="-1.4138175016961254" CI_START="-12.986182498303872" EFFECT_SIZE="-7.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-2.9" ORDER="631" SD_1="14.0" SD_2="14.0" SE="2.9521881748565497" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="46" WEIGHT="1.706596980669163"/>
<CONT_DATA CI_END="0.9933353224024817" CI_START="-12.593335322402483" EFFECT_SIZE="-5.800000000000001" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.6" ORDER="632" SD_1="17.5" SD_2="17.3" SE="3.4660510988913287" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" WEIGHT="1.2380811840563126"/>
<CONT_DATA CI_END="3.4800311847926757" CI_START="-15.080031184792674" EFFECT_SIZE="-5.799999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-4.4" ORDER="633" SD_1="14.0" SD_2="14.0" SE="4.734796791161662" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="17" WEIGHT="0.6634624625582828"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.28654452541635506" CI_END="-4.699165463877509" CI_START="-9.546101959106597" DF="5.0" EFFECT_SIZE="-7.122633711492053" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.08" NO="8" P_CHI2="0.997888515566849" P_Z="8.392323431580666E-9" STUDIES="6" TAU2="0.0" TOTAL_1="589" TOTAL_2="396" WEIGHT="9.728380749949956" Z="5.760383105219727">
<NAME>Perindopril 4, 8, 16 mg</NAME>
<CONT_DATA CI_END="8.132376199755992" CI_START="-17.33237619975599" EFFECT_SIZE="-4.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-3.7" ORDER="634" SD_1="17.1" SD_2="10.8" SE="6.4962296757426925" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.35244901680069063"/>
<CONT_DATA CI_END="-1.1568497204055932" CI_START="-12.843150279594408" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="0.0" ORDER="635" SD_1="18.0" SD_2="19.0" SE="2.9812539034821204" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="1.6734822700294207"/>
<CONT_DATA CI_END="5.348693408679425" CI_START="-22.548693408679426" EFFECT_SIZE="-8.6" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-5.6" ORDER="636" SD_1="23.6" SD_2="15.1" SE="7.116811083624463" STUDY_ID="STD-Luccioni-1988" TOTAL_1="20" TOTAL_2="10" WEIGHT="0.2936622827302799"/>
<CONT_DATA CI_END="-2.240241274403709" CI_START="-13.35975872559629" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-8.5" MEAN_2="-0.7" ORDER="637" SD_1="15.5" SD_2="19.0" SE="2.836663719053492" STUDY_ID="STD-Myers-1996" TOTAL_1="162" TOTAL_2="55" WEIGHT="1.8484313998505209"/>
<CONT_DATA CI_END="-3.432635657420326" CI_START="-10.367364342579675" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-5.4" ORDER="638" SD_1="19.1" SD_2="20.0" SE="1.7690959476448556" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="4.752435925162913"/>
<CONT_DATA CI_END="0.7095638646875297" CI_START="-16.10956386468753" EFFECT_SIZE="-7.699999999999999" ESTIMABLE="YES" MEAN_1="-14.1" MEAN_2="-6.4" ORDER="639" SD_1="10.5" SD_2="19.3" SE="4.290672650630877" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="0.8079198553761316"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7985871526218953" CI_END="-2.839234607373326" CI_START="-11.258472870805699" DF="1.0" EFFECT_SIZE="-7.0488537390895125" ESTIMABLE="YES" I2="44.400803789671954" ID="CMP-021.01.09" NO="9" P_CHI2="0.1798835382580608" P_Z="0.0010311447062422514" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="90" WEIGHT="3.224256756511359" Z="3.2818882251881085">
<NAME>Quinapril 20, (40) mg</NAME>
<CONT_DATA CI_END="-1.0516865160939162" CI_START="-10.348313483906084" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-7.7" ORDER="640" SD_1="14.1" SD_2="15.9" SE="2.3716320914932045" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="2.6443833189373627"/>
<CONT_DATA CI_END="-3.273617500454904" CI_START="-23.126382499545095" EFFECT_SIZE="-13.2" ESTIMABLE="YES" MEAN_1="-19.7" MEAN_2="-6.5" ORDER="641" SD_1="13.7" SD_2="8.7" SE="5.06457392984929" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="0.5798734375739961"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.4468118610712575" CI_END="-2.1561489235107505" CI_START="-9.330419708271936" DF="3.0" EFFECT_SIZE="-5.743284315891343" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.10" NO="10" P_CHI2="0.930411225335295" P_Z="0.0017007259578646842" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="69" WEIGHT="4.440375417994488" Z="3.138055629578666">
<NAME>Ramipril 10, (20) mg</NAME>
<CONT_DATA CI_END="5.908904582459143" CI_START="-14.508904582459142" EFFECT_SIZE="-4.3" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-5.7" ORDER="642" SD_1="14.0" SD_2="17.0" SE="5.208720498430419" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="0.5482226040659974"/>
<CONT_DATA CI_END="2.047922973340837" CI_START="-19.447922973340837" EFFECT_SIZE="-8.7" ESTIMABLE="YES" MEAN_1="-8.2" MEAN_2="0.5" ORDER="643" SD_1="10.4" SD_2="16.6" SE="5.483734934988133" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="10" WEIGHT="0.49461369486697965"/>
<CONT_DATA CI_END="-0.8153776513338435" CI_START="-9.784622348666156" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.6" MEAN_2="-1.3" ORDER="644" SD_1="10.3" SD_2="10.7" SE="2.28811467151452" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="32" WEIGHT="2.8409492384050514"/>
<CONT_DATA CI_END="3.331878209823029" CI_START="-16.93187820982303" EFFECT_SIZE="-6.8" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-3.7" ORDER="645" SD_1="16.7" SD_2="16.7" SE="5.169420606573381" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="14" WEIGHT="0.5565898806564604"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.8683534683136043" CI_END="-5.821685909885612" CI_START="-10.797991606019782" DF="2.0" EFFECT_SIZE="-8.309838757952697" ESTIMABLE="YES" I2="30.273586498533486" ID="CMP-021.01.11" NO="11" P_CHI2="0.23831183450018056" P_Z="5.917235883602054E-11" STUDIES="3" TAU2="0.0" TOTAL_1="382" TOTAL_2="139" WEIGHT="9.229137497041425" Z="6.545813572335334">
<NAME>Spirapril 6, 12, 24 mg</NAME>
<CONT_DATA CI_END="-1.4620237022940978" CI_START="-9.737976297705902" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-6.7" ORDER="646" SD_1="13.9" SD_2="13.4" SE="2.1112511915248096" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="162" TOTAL_2="55" WEIGHT="3.336869560142307"/>
<CONT_DATA CI_END="-6.826093351967181" CI_START="-13.573906648032818" EFFECT_SIZE="-10.2" ESTIMABLE="YES" MEAN_1="-16.2" MEAN_2="-6.0" ORDER="647" SD_1="12.6" SD_2="11.0" SE="1.7214125742338955" STUDY_ID="STD-Guitard-1994" TOTAL_1="174" TOTAL_2="59" WEIGHT="5.01936876282473"/>
<CONT_DATA CI_END="0.29050391763731387" CI_START="-15.890503917637314" EFFECT_SIZE="-7.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.2" ORDER="648" SD_1="14.4" SD_2="17.7" SE="4.127883972080189" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="0.8728991740743891"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.053803581204124" CI_END="-5.338500866475979" CI_START="-8.69692235684775" DF="8.0" EFFECT_SIZE="-7.0177116116618645" ESTIMABLE="YES" I2="0.0" ID="CMP-021.01.12" NO="12" P_CHI2="0.8522367924195544" P_Z="2.5900460136572203E-16" STUDIES="9" TAU2="0.0" TOTAL_1="804" TOTAL_2="511" WEIGHT="20.263050107801394" Z="8.191027869597866">
<NAME>Trandolapril 2, 4, 8, 12, 16 mg</NAME>
<CONT_DATA CI_END="-1.1823488532753412" CI_START="-19.61765114672466" EFFECT_SIZE="-10.4" ESTIMABLE="YES" MEAN_1="-20.0" MEAN_2="-9.6" ORDER="649" SD_1="14.6" SD_2="15.5" SE="4.702969656295888" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="14" WEIGHT="0.6724727526434177"/>
<CONT_DATA CI_END="-0.9089331365446744" CI_START="-11.091066863455325" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="0.0" ORDER="650" SD_1="16.4" SD_2="15.1" SE="2.5975308238380967" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="110" TOTAL_2="53" WEIGHT="2.204436665494915"/>
<CONT_DATA CI_END="-2.7197541822017426" CI_START="-11.680245817798259" EFFECT_SIZE="-7.200000000000001" ESTIMABLE="YES" MEAN_1="-14.3" MEAN_2="-7.1" ORDER="651" SD_1="18.0" SD_2="19.0" SE="2.2858817065710726" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="2.846502315347226"/>
<CONT_DATA CI_END="1.0378318884243942" CI_START="-14.437831888424395" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-6.3" ORDER="652" SD_1="14.7" SD_2="14.0" SE="3.947945956894833" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="0.9542818141996994"/>
<CONT_DATA CI_END="-5.843011424906308" CI_START="-12.156988575093692" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="0.0" ORDER="653" SD_1="14.8" SD_2="13.4" SE="1.61073805437019" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="5.7328318965816125"/>
<CONT_DATA CI_END="4.783120214539968" CI_START="-12.183120214539967" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-26.8" MEAN_2="-23.1" ORDER="654" SD_1="10.4" SD_2="10.8" SE="4.328202090167848" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.7939698020287871"/>
<CONT_DATA CI_END="2.8565652292383295" CI_START="-14.85656522923833" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-17.3" MEAN_2="-11.3" ORDER="655" SD_1="12.3" SD_2="12.4" SE="4.518738762088378" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="10" WEIGHT="0.7284245535043804"/>
<CONT_DATA CI_END="4.059658237431083" CI_START="-10.659658237431081" EFFECT_SIZE="-3.299999999999999" ESTIMABLE="YES" MEAN_1="-10.2" MEAN_2="-6.9" ORDER="656" SD_1="12.0" SD_2="9.0" SE="3.7549966711037173" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="1.054872408369216"/>
<CONT_DATA CI_END="-2.908940261675264" CI_START="-9.491059738324735" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-1.6" ORDER="657" SD_1="14.8" SD_2="14.5" SE="1.67914296603621" STUDY_ID="STD-Weir-1995" TOTAL_1="262" TOTAL_2="106" WEIGHT="5.275257899632139"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="74.75321142051878" CI_END="-4.339049740709211" CI_START="-5.1267003583337765" CI_STUDY="95" CI_TOTAL="95" DF="58.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.7328750495214935" ESTIMABLE="YES" I2="22.41136013043614" I2_Q="12.98125288052406" ID="CMP-021.02" MODIFIED="2008-07-07 22:38:36 -0700" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.06845688143913953" P_Q="0.3174386649791462" P_Z="0.0" Q="12.640954235869543" RANDOM="NO" SCALE="22.718733944303175" SORT_BY="STUDY" STUDIES="59" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="4039" TOTAL_2="2822" UNITS="" WEIGHT="99.99999999999999" Z="23.554262341255182">
<NAME>Change in trough DBP</NAME>
<GROUP_LABEL_1>ACEI</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="5.059562282836835" CI_END="-3.222301038278709" CI_START="-5.9061826748683055" DF="5.0" EFFECT_SIZE="-4.564241856573507" ESTIMABLE="YES" I2="1.1772220501936295" ID="CMP-021.02.01" NO="1" P_CHI2="0.40865469273164057" P_Z="2.6237326246739507E-11" STUDIES="6" TAU2="0.0" TOTAL_1="354" TOTAL_2="244" WEIGHT="8.612723759511194" Z="6.6662773303085405">
<NAME>Benazepril 20, 40, 80 mg</NAME>
<CONT_DATA CI_END="0.9893751520552083" CI_START="-5.58937515205521" EFFECT_SIZE="-2.3000000000000007" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-7.0" ORDER="658" SD_1="7.4" SD_2="7.6" SE="1.6782834674521472" STUDY_ID="STD-Chrysant-1996" TOTAL_1="41" TOTAL_2="39" WEIGHT="1.4334430046476188"/>
<CONT_DATA CI_END="-3.9959900988745347" CI_START="-9.004009901125466" EFFECT_SIZE="-6.5" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-3.5" ORDER="659" SD_1="8.1" SD_2="7.7" SE="1.2775795478267844" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="76" WEIGHT="2.473632400811862"/>
<CONT_DATA CI_END="-0.6207681753551801" CI_START="-6.9792318246448195" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-5.3" ORDER="660" SD_1="8.1" SD_2="7.7" SE="1.6220868596169085" STUDY_ID="STD-McFate_x002d_Smith-1991" TOTAL_1="47" TOTAL_2="48" WEIGHT="1.5344857162255523"/>
<CONT_DATA CI_END="1.8019107503283864" CI_START="-7.401910750328386" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-4.7" ORDER="661" SD_1="8.3" SD_2="9.6" SE="2.3479567923837736" STUDY_ID="STD-Moser-1991" TOTAL_1="35" TOTAL_2="26" WEIGHT="0.7323705312714432"/>
<CONT_DATA CI_END="1.8252868728312102" CI_START="-10.225286872831209" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-5.0" ORDER="662" SD_1="9.6" SD_2="9.7" SE="3.074182444349949" STUDY_ID="STD-Weinberger-1990" TOTAL_1="29" TOTAL_2="15" WEIGHT="0.42722020705188457"/>
<CONT_DATA CI_END="-2.3232559997760323" CI_START="-7.876744000223967" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-9.6" MEAN_2="-4.5" ORDER="663" SD_1="8.1" SD_2="7.7" SE="1.4167321553490624" STUDY_ID="STD-Whalen-1989" TOTAL_1="125" TOTAL_2="40" WEIGHT="2.011571899502833"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="14.211488743481882" CI_END="-2.595070443463218" CI_START="-4.5672767699017305" DF="8.0" EFFECT_SIZE="-3.581173606682474" ESTIMABLE="YES" I2="43.70751619059467" ID="CMP-021.02.02" NO="2" P_CHI2="0.0764169150967533" P_Z="1.095938346569441E-12" STUDIES="9" TAU2="0.0" TOTAL_1="546" TOTAL_2="396" WEIGHT="15.950068060875905" Z="7.117887411058246">
<NAME>Cilazapril 5, 10 mg</NAME>
<CONT_DATA CI_END="1.5376792771020305" CI_START="-5.1376792771020305" EFFECT_SIZE="-1.7999999999999998" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-4.5" ORDER="664" SD_1="7.8" SD_2="7.9" SE="1.7029288820760067" STUDY_ID="STD-Carlsen-1995" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.3922526072029529"/>
<CONT_DATA CI_END="-1.8020003955520747" CI_START="-9.397999604447925" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.4" ORDER="665" SD_1="7.0" SD_2="6.7" SE="1.937790507583844" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="24" WEIGHT="1.0752201982591956"/>
<CONT_DATA CI_END="-4.331679774787432" CI_START="-12.068320225212567" EFFECT_SIZE="-8.2" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="-4.3" ORDER="666" SD_1="7.5" SD_2="7.4" SE="1.9736690345972596" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="28" WEIGHT="1.0364835351431176"/>
<CONT_DATA CI_END="1.4432429194781955" CI_START="-5.243242919478195" EFFECT_SIZE="-1.9" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-3.1" ORDER="667" SD_1="8.1" SD_2="7.7" SE="1.7057675272858424" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="1.3876226412934258"/>
<CONT_DATA CI_END="-3.1500184536763376" CI_START="-7.849981546323664" EFFECT_SIZE="-5.500000000000001" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-3.3" ORDER="668" SD_1="6.9" SD_2="7.1" SE="1.19899220845894" STUDY_ID="STD-Mroczek-1991" TOTAL_1="106" TOTAL_2="51" WEIGHT="2.8085253010325006"/>
<CONT_DATA CI_END="0.15416949523217038" CI_START="-11.55416949523217" EFFECT_SIZE="-5.7" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-1.2" ORDER="669" SD_1="8.1" SD_2="7.7" SE="2.986876055585262" STUDY_ID="STD-Poirier-1991" TOTAL_1="14" TOTAL_2="14" WEIGHT="0.4525605147565068"/>
<CONT_DATA CI_END="-0.4645674576302907" CI_START="-4.135432542369709" EFFECT_SIZE="-2.3" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="-4.9" ORDER="670" SD_1="7.4" SD_2="7.4" SE="0.9364623823944556" STUDY_ID="STD-Pordy-1994" TOTAL_1="186" TOTAL_2="94" WEIGHT="4.603947784191618"/>
<CONT_DATA CI_END="0.601151395550148" CI_START="-5.401151395550147" EFFECT_SIZE="-2.3999999999999995" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-7.7" ORDER="671" SD_1="7.1" SD_2="8.7" SE="1.5312278282778902" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="53" WEIGHT="1.7219932145882753"/>
<CONT_DATA CI_END="0.04660204345933705" CI_START="-6.446602043459338" EFFECT_SIZE="-3.2" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="-3.7" ORDER="672" SD_1="8.1" SD_2="7.7" SE="1.6564600518520338" STUDY_ID="STD-Yodfat-1993" TOTAL_1="46" TOTAL_2="45" WEIGHT="1.471462264408311"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="13.953820548680312" CI_END="-4.366040533923236" CI_START="-6.223749860547477" DF="8.0" EFFECT_SIZE="-5.294895197235356" ESTIMABLE="YES" I2="42.66803151086386" ID="CMP-021.02.03" NO="3" P_CHI2="0.08297713640661797" P_Z="5.547583879468738E-29" STUDIES="9" TAU2="0.0" TOTAL_1="470" TOTAL_2="569" WEIGHT="17.976772104942608" Z="11.172688579169233">
<NAME>Enalapril 20, (40) mg</NAME>
<CONT_DATA CI_END="-3.347453568100355" CI_START="-7.852546431899644" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.6" ORDER="673" SD_1="6.7" SD_2="7.8" SE="1.1492795019028121" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="3.056748731659921"/>
<CONT_DATA CI_END="-0.8480124152623421" CI_START="-6.551987584737656" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.4" ORDER="674" SD_1="8.1" SD_2="7.7" SE="1.4551224447151945" STUDY_ID="STD-Gradman-1997" TOTAL_1="48" TOTAL_2="79" WEIGHT="1.9068300315742928"/>
<CONT_DATA CI_END="-2.665473531417828" CI_START="-7.3345264685821725" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="-9.5" MEAN_2="-4.5" ORDER="675" SD_1="8.4" SD_2="7.5" SE="1.1911068198174144" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" WEIGHT="2.8458344992793987"/>
<CONT_DATA CI_END="-1.2262714980440963" CI_START="-6.773728501955904" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-5.8" MEAN_2="-1.8" ORDER="676" SD_1="6.8" SD_2="6.7" SE="1.4151936075533633" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="2.015948094854883"/>
<CONT_DATA CI_END="-0.7419618771852332" CI_START="-6.658038122814766" EFFECT_SIZE="-3.6999999999999997" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-3.4" ORDER="677" SD_1="6.6" SD_2="6.2" SE="1.509230856356236" STUDY_ID="STD-Oparil-1999" TOTAL_1="36" TOTAL_2="36" WEIGHT="1.7725549638947362"/>
<CONT_DATA CI_END="-6.743710042056022" CI_START="-12.45628995794398" EFFECT_SIZE="-9.600000000000001" ESTIMABLE="YES" MEAN_1="-11.9" MEAN_2="-2.3" ORDER="681" SD_1="7.5" SD_2="7.0" SE="1.457317573421772" STUDY_ID="STD-Prichard-2002" TOTAL_1="51" TOTAL_2="48" WEIGHT="1.9010899170373243"/>
<CONT_DATA CI_END="-1.028804192832859" CI_START="-9.971195807167142" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="-10.9" MEAN_2="-5.4" ORDER="678" SD_1="8.1" SD_2="7.7" SE="2.281264269361765" STUDY_ID="STD-Roca_x002d_Cusachs-2001" TOTAL_1="24" TOTAL_2="24" WEIGHT="0.7758180252968687"/>
<CONT_DATA CI_END="-1.80942837700211" CI_START="-6.790571622997891" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="-2.9" ORDER="679" SD_1="7.6" SD_2="7.7" SE="1.2707231574881996" STUDY_ID="STD-Smith-1998" TOTAL_1="71" TOTAL_2="74" WEIGHT="2.5003981757218714"/>
<CONT_DATA CI_END="-3.8072023435700277" CI_START="-10.992797656429973" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-8.8" MEAN_2="-1.4" ORDER="680" SD_1="8.4" SD_2="8.5" SE="1.8330937123179314" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="1.201549665623311"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.7039226224352899" CI_END="-3.449162373023721" CI_START="-6.84962949852372" DF="3.0" EFFECT_SIZE="-5.149395935773721" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.04" NO="4" P_CHI2="0.8722809438199147" P_Z="2.9201357315681893E-9" STUDIES="4" TAU2="0.0" TOTAL_1="218" TOTAL_2="141" WEIGHT="5.3652513756687465" Z="5.9360259657087076">
<NAME>Fosinopril 20, 40 mg</NAME>
<CONT_DATA CI_END="1.3569551483579216" CI_START="-9.356955148357923" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-6.5" ORDER="682" SD_1="7.7" SD_2="8.0" SE="2.7331906048340175" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" WEIGHT="0.540469541474638"/>
<CONT_DATA CI_END="-1.3202189406903013" CI_START="-12.479781059309698" EFFECT_SIZE="-6.8999999999999995" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.7" ORDER="683" SD_1="9.0" SD_2="7.4" SE="2.8468793831531083" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="0.49816467436463097"/>
<CONT_DATA CI_END="-2.7662002849979177" CI_START="-7.033799715002083" EFFECT_SIZE="-4.9" ESTIMABLE="YES" MEAN_1="-9.8" MEAN_2="-4.9" ORDER="684" SD_1="8.1" SD_2="7.7" SE="1.0886933289760539" STUDY_ID="STD-Pool-1990" TOTAL_1="158" TOTAL_2="77" WEIGHT="3.406433686391633"/>
<CONT_DATA CI_END="-1.694496679639129" CI_START="-9.905503320360872" EFFECT_SIZE="-5.8" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-4.2" ORDER="685" SD_1="8.1" SD_2="7.7" SE="2.094683041496965" STUDY_ID="STD-Pool-1997" TOTAL_1="28" TOTAL_2="29" WEIGHT="0.9201834734378443"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.861933181444156" CI_START="-10.538066818555844" DF="0.0" EFFECT_SIZE="-6.7" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.05" NO="5" P_CHI2="1.0" P_Z="6.228787967777085E-4" STUDIES="1" TAU2="0.0" TOTAL_1="94" TOTAL_2="35" WEIGHT="1.0528880143432404" Z="3.4214512975465796">
<NAME>Imidapril 10, 20, 40 mg</NAME>
<CONT_DATA CI_END="-2.861933181444156" CI_START="-10.538066818555844" EFFECT_SIZE="-6.7" ESTIMABLE="YES" MEAN_1="-11.4" MEAN_2="-4.7" ORDER="686" SD_1="9.3" SD_2="10.1" SE="1.9582333394031854" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="94" TOTAL_2="35" WEIGHT="1.0528880143432404"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.9308887981121048E-31" CI_END="-2.038408635694773" CI_START="-9.961591364305228" DF="0.0" EFFECT_SIZE="-6.000000000000001" ESTIMABLE="YES" I2="100.0" ID="CMP-021.02.06" NO="6" P_CHI2="0.0" P_Z="0.002993062788042372" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="39" WEIGHT="0.9882524321389268" Z="2.968449500672496">
<NAME>Lisinopril (40), 80 mg</NAME>
<CONT_DATA CI_END="-2.038408635694772" CI_START="-9.961591364305228" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-11.0" MEAN_2="-5.0" ORDER="687" SD_1="10.5" SD_2="7.2" SE="2.0212572249050265" STUDY_ID="STD-Gomez-1989" TOTAL_1="40" TOTAL_2="39" WEIGHT="0.9882524321389268"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="8.716893954604087" CI_END="-2.5972380659076233" CI_START="-5.929877231456718" DF="3.0" EFFECT_SIZE="-4.263557648682171" ESTIMABLE="YES" I2="65.58407139488646" ID="CMP-021.02.07" NO="7" P_CHI2="0.03330173496989719" P_Z="5.306215483207542E-7" STUDIES="4" TAU2="0.0" TOTAL_1="162" TOTAL_2="159" WEIGHT="5.5858677344071515" Z="5.014896016233132">
<NAME>Moexipril 15, (30) mg</NAME>
<CONT_DATA CI_END="-2.420768175355181" CI_START="-8.779231824644821" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-9.9" MEAN_2="-4.3" ORDER="688" SD_1="8.1" SD_2="7.7" SE="1.6220868596169085" STUDY_ID="STD-Koch-1999" TOTAL_1="47" TOTAL_2="48" WEIGHT="1.5344857162255523"/>
<CONT_DATA CI_END="-0.8692873907019822" CI_START="-6.530712609298018" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-8.9" MEAN_2="-5.2" ORDER="689" SD_1="6.8" SD_2="6.9" SE="1.444267665950149" STUDY_ID="STD-Mroczek-1996" TOTAL_1="44" TOTAL_2="46" WEIGHT="1.9356003213397401"/>
<CONT_DATA CI_END="-3.013773950503044" CI_START="-9.386226049496955" EFFECT_SIZE="-6.199999999999999" ESTIMABLE="YES" MEAN_1="-10.1" MEAN_2="-3.9" ORDER="690" SD_1="8.0" SD_2="8.3" SE="1.6256554072572251" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" WEIGHT="1.527756276297545"/>
<CONT_DATA CI_END="7.535770065665288" CI_START="-2.735770065665289" EFFECT_SIZE="2.3999999999999995" ESTIMABLE="YES" MEAN_1="-4.9" MEAN_2="-7.3" ORDER="691" SD_1="8.1" SD_2="7.4" SE="2.6203389991732435" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="17" WEIGHT="0.5880254205443141"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.5354611524945843" CI_END="-3.8404301950532442" CI_START="-6.183315877760874" DF="5.0" EFFECT_SIZE="-5.011873036407059" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.08" NO="8" P_CHI2="0.7711453730344665" P_Z="5.0526470537350644E-17" STUDIES="6" TAU2="0.0" TOTAL_1="589" TOTAL_2="396" WEIGHT="11.302253369977752" Z="8.385463037268533">
<NAME>Perindopril 4, 8, 16 mg</NAME>
<CONT_DATA CI_END="2.384666608330236" CI_START="-11.784666608330237" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-1.7" ORDER="692" SD_1="10.4" SD_2="4.5" SE="3.614692241394833" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.3090070646448126"/>
<CONT_DATA CI_END="-0.5653351193671332" CI_START="-6.434664880632867" EFFECT_SIZE="-3.5" ESTIMABLE="YES" MEAN_1="-6.5" MEAN_2="-3.0" ORDER="693" SD_1="8.0" SD_2="10.0" SE="1.4973055136630717" STUDY_ID="STD-Chrysant-1993" TOTAL_1="117" TOTAL_2="59" WEIGHT="1.8009025571723243"/>
<CONT_DATA CI_END="8.37335678975872" CI_START="-9.37335678975872" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-6.3" ORDER="694" SD_1="17.5" SD_2="7.2" SE="4.527306042228646" STUDY_ID="STD-Luccioni-1988" TOTAL_1="20" TOTAL_2="10" WEIGHT="0.19698418298973586"/>
<CONT_DATA CI_END="-2.8131855055138053" CI_START="-7.586814494486195" EFFECT_SIZE="-5.2" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-1.8" ORDER="695" SD_1="8.1" SD_2="7.7" SE="1.2177848742696717" STUDY_ID="STD-Myers-1996" TOTAL_1="162" TOTAL_2="55" WEIGHT="2.72251268148963"/>
<CONT_DATA CI_END="-3.944033204009827" CI_START="-7.255966795990174" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-5.2" ORDER="696" SD_1="9.5" SD_2="9.2" SE="0.8448965435345895" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="5.65592960598451"/>
<CONT_DATA CI_END="0.21406726094507533" CI_START="-9.814067260945075" EFFECT_SIZE="-4.8" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-7.2" ORDER="697" SD_1="9.0" SD_2="9.6" SE="2.5582445904595175" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" WEIGHT="0.6169172776967393"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.06325452019835816" CI_END="-0.7238956241379708" CI_START="-5.9802435920439265" DF="1.0" EFFECT_SIZE="-3.352069608090949" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.09" NO="9" P_CHI2="0.801424076539397" P_Z="0.012425991670190026" STUDIES="2" TAU2="0.0" TOTAL_1="92" TOTAL_2="90" WEIGHT="2.2454274140210684" Z="2.499810037556136">
<NAME>Quinapril 20, (40) mg</NAME>
<CONT_DATA CI_END="-0.31699911195857844" CI_START="-6.08300088804142" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-8.1" MEAN_2="-4.9" ORDER="698" SD_1="8.7" SD_2="9.9" SE="1.4709458494044605" STUDY_ID="STD-MacLean-1989" TOTAL_1="82" TOTAL_2="79" WEIGHT="1.8660260064134486"/>
<CONT_DATA CI_END="2.2937279500491288" CI_START="-10.493727950049127" EFFECT_SIZE="-4.1" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-10.1" ORDER="699" SD_1="7.7" SD_2="7.2" SE="3.2621660400303467" STUDY_ID="STD-Yebes-1993" TOTAL_1="10" TOTAL_2="11" WEIGHT="0.3794014076076196"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.17594748099752955" CI_END="-2.2946727126429494" CI_START="-6.550713092617" DF="3.0" EFFECT_SIZE="-4.422692902629975" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.10" NO="10" P_CHI2="0.9813754881320522" P_Z="4.632788163259757E-5" STUDIES="4" TAU2="0.0" TOTAL_1="188" TOTAL_2="69" WEIGHT="3.4249619914247624" Z="4.073419436818648">
<NAME>Ramipril 10, (20) mg</NAME>
<CONT_DATA CI_END="1.0806720870523936" CI_START="-8.680672087052393" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-8.6" MEAN_2="-4.8" ORDER="700" SD_1="8.1" SD_2="7.7" SE="2.490184577650667" STUDY_ID="STD-Homuth-1993" TOTAL_1="40" TOTAL_2="13" WEIGHT="0.6511004330732054"/>
<CONT_DATA CI_END="1.8626795802685336" CI_START="-11.262679580268534" EFFECT_SIZE="-4.7" ESTIMABLE="YES" MEAN_1="-7.4" MEAN_2="-2.7" ORDER="701" SD_1="7.7" SD_2="10.4" SE="3.348367435337645" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="11" WEIGHT="0.36011801146223493"/>
<CONT_DATA CI_END="-1.3188385803601608" CI_START="-7.28116141963984" EFFECT_SIZE="-4.300000000000001" ESTIMABLE="YES" MEAN_1="-7.9" MEAN_2="-3.6" ORDER="702" SD_1="7.8" SD_2="6.5" SE="1.5210286735648515" STUDY_ID="STD-McCarron-1991" TOTAL_1="64" TOTAL_2="31" WEIGHT="1.7451640579149326"/>
<CONT_DATA CI_END="-0.38354953916252477" CI_START="-10.016450460837474" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-2.6" ORDER="703" SD_1="8.6" SD_2="7.7" SE="2.45741783973023" STUDY_ID="STD-Scholze-1999" TOTAL_1="41" TOTAL_2="14" WEIGHT="0.6685794889743896"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.975153649339054" CI_END="-4.493648785980722" CI_START="-7.193714775754093" DF="3.0" EFFECT_SIZE="-5.843681780867407" ESTIMABLE="YES" I2="69.9252752843684" ID="CMP-021.02.11" NO="11" P_CHI2="0.01877856062866723" P_Z="2.1796194951681806E-17" STUDIES="4" TAU2="0.0" TOTAL_1="482" TOTAL_2="189" WEIGHT="8.50978286566641" Z="8.483796967180302">
<NAME>Spirapril 6, 12, 24 mg</NAME>
<CONT_DATA CI_END="-0.7131855055138057" CI_START="-5.486814494486195" EFFECT_SIZE="-3.1000000000000005" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-5.3" ORDER="704" SD_1="8.1" SD_2="7.7" SE="1.2177848742696717" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="162" TOTAL_2="55" WEIGHT="2.72251268148963"/>
<CONT_DATA CI_END="-4.995908970757421" CI_START="-9.604091029242579" EFFECT_SIZE="-7.3" ESTIMABLE="YES" MEAN_1="-12.1" MEAN_2="-4.8" ORDER="705" SD_1="8.1" SD_2="7.7" SE="1.1755782490989402" STUDY_ID="STD-Guitard-1994" TOTAL_1="174" TOTAL_2="59" WEIGHT="2.9215140440360936"/>
<CONT_DATA CI_END="-5.340003195145432" CI_START="-10.659996804854568" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.0" ORDER="706" SD_1="8.1" SD_2="7.7" SE="1.3571661652133833" STUDY_ID="STD-Guitard-1997" TOTAL_1="100" TOTAL_2="50" WEIGHT="2.19202253469196"/>
<CONT_DATA CI_END="1.1979919733955953" CI_START="-8.397991973395596" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-4.7" ORDER="707" SD_1="10.3" SD_2="9.6" SE="2.448000071042909" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="0.6737336054487252"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.716752229581305" CI_END="-3.7415539674139877" CI_START="-5.54922637473991" DF="8.0" EFFECT_SIZE="-4.645390171076949" ESTIMABLE="YES" I2="0.0" ID="CMP-021.02.12" NO="12" P_CHI2="0.5674784847238203" P_Z="7.23535959496653E-24" STUDIES="9" TAU2="0.0" TOTAL_1="804" TOTAL_2="495" WEIGHT="18.985750877022227" Z="10.073503796980388">
<NAME>Trandolapril 2, 4, 8, 12, 16 mg</NAME>
<CONT_DATA CI_END="-0.3385324101112941" CI_START="-10.861467589888708" EFFECT_SIZE="-5.6000000000000005" ESTIMABLE="YES" MEAN_1="-12.8" MEAN_2="-7.2" ORDER="708" SD_1="8.2" SD_2="9.2" SE="2.684471567534144" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="15" WEIGHT="0.5602649388975938"/>
<CONT_DATA CI_END="-0.8643697715679912" CI_START="-6.735630228432008" EFFECT_SIZE="-3.8" ESTIMABLE="YES" MEAN_1="-5.6" MEAN_2="-1.8" ORDER="709" SD_1="8.1" SD_2="7.7" SE="1.4977980471008066" STUDY_ID="STD-DeQuattro-1997" TOTAL_1="110" TOTAL_2="36" WEIGHT="1.7997183402631876"/>
<CONT_DATA CI_END="-1.2540421710735012" CI_START="-6.145957828926499" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="710" SD_1="9.8" SD_2="10.4" SE="1.2479605993885103" STUDY_ID="STD-Kohlmann-Jr-1999" TOTAL_1="127" TOTAL_2="135" WEIGHT="2.592443585188489"/>
<CONT_DATA CI_END="-3.631209535139104" CI_START="-9.168790464860894" EFFECT_SIZE="-6.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-1.2" ORDER="711" SD_1="7.0" SD_2="3.9" SE="1.412674154576697" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="2.02314524728367"/>
<CONT_DATA CI_END="-2.7323818254451604" CI_START="-6.26761817455484" EFFECT_SIZE="-4.5" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="0.0" ORDER="712" SD_1="8.1" SD_2="7.7" SE="0.901862579362471" STUDY_ID="STD-Messerli-1998" TOTAL_1="155" TOTAL_2="152" WEIGHT="4.963983483755307"/>
<CONT_DATA CI_END="5.083988207138917" CI_START="-11.483988207138916" EFFECT_SIZE="-3.1999999999999993" ESTIMABLE="YES" MEAN_1="-13.2" MEAN_2="-10.0" ORDER="713" SD_1="10.6" SD_2="10.1" SE="4.226602260287413" STUDY_ID="STD-New-2000" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.2260103357736132"/>
<CONT_DATA CI_END="0.1822857283975301" CI_START="-10.982285728397532" EFFECT_SIZE="-5.4" ESTIMABLE="YES" MEAN_1="-14.8" MEAN_2="-9.4" ORDER="714" SD_1="7.8" SD_2="7.8" SE="2.8481572990268638" STUDY_ID="STD-Scholze-1998" TOTAL_1="30" TOTAL_2="10" WEIGHT="0.4977177399715387"/>
<CONT_DATA CI_END="4.355344260103939" CI_START="-4.95534426010394" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-8.0" ORDER="715" SD_1="7.0" SD_2="6.0" SE="2.375219288121976" STUDY_ID="STD-Vaur-1998" TOTAL_1="24" TOTAL_2="10" WEIGHT="0.7156548844872889"/>
<CONT_DATA CI_END="-3.636795648090625" CI_START="-6.963204351909375" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-7.1" MEAN_2="-1.8" ORDER="716" SD_1="9.0" SD_2="6.6" SE="0.8485892419598109" STUDY_ID="STD-Weir-1995" TOTAL_1="262" TOTAL_2="106" WEIGHT="5.60681232140154"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-022" NO="22">
<NAME>ACE Inhibitors vs Placebo</NAME>
<CONT_OUTCOME CHI2="4.792549939677142" CI_END="-9.784074217019448" CI_START="-13.269334689509307" CI_STUDY="95" CI_TOTAL="95" DF="16.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-11.526704453264378" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-022.01" NO="1" P_CHI2="0.9966920261284471" P_Q="0.6121315496723118" P_Z="1.9508353488960905E-38" Q="0.9816163148572286" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="726" TOTAL_2="428" UNITS="" WEIGHT="100.0" Z="12.964268104011195">
<NAME>Change in peak SBP [1/2 Max and Higher Doses Only]</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.6125790577654433" CI_END="-9.020777879271183" CI_START="-13.109046513171435" DF="10.0" EFFECT_SIZE="-11.064912196221309" ESTIMABLE="YES" I2="0.0" ID="CMP-022.01.01" NO="1" P_CHI2="0.9891316482126613" P_Z="2.697692722963447E-26" STUDIES="11" TAU2="0.0" TOTAL_1="461" TOTAL_2="322" WEIGHT="72.67610302375915" Z="10.609297645885025">
<NAME>1/2 Max Dose</NAME>
<CONT_DATA CI_END="6.387320385106872" CI_START="-39.78732038510687" EFFECT_SIZE="-16.7" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="0.8" ORDER="717" SD_1="24.0" SD_2="17.3" SE="11.779461544812408" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.5697225780945769"/>
<CONT_DATA CI_END="-4.177707448249169" CI_START="-15.82229255175083" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-15.0" MEAN_2="-5.0" ORDER="718" SD_1="13.8" SD_2="13.1" SE="2.9706120100554556" STUDY_ID="STD-Chrysant-1996" TOTAL_1="42" TOTAL_2="40" WEIGHT="8.95823483837647"/>
<CONT_DATA CI_END="-6.651585161458876" CI_START="-17.348414838541125" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-2.2" ORDER="727" SD_1="13.9" SD_2="13.4" SE="2.7288332238391813" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="38" WEIGHT="10.615985588267785"/>
<CONT_DATA CI_END="9.148304890787141" CI_START="-24.14830489078714" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-8.0" ORDER="726" SD_1="11.9" SD_2="16.5" SE="8.49418919026413" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="1.0956464824685874"/>
<CONT_DATA CI_END="-6.988197773693704" CI_START="-14.811802226306293" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-3.8" ORDER="719" SD_1="13.6" SD_2="11.7" SE="1.995854136689292" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="19.84525626090456"/>
<CONT_DATA CI_END="-5.769334744024295" CI_START="-18.830665255975706" EFFECT_SIZE="-12.3" ESTIMABLE="YES" MEAN_1="-21.8" MEAN_2="-9.5" ORDER="720" SD_1="15.1" SD_2="15.8" SE="3.3320332962690946" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="7.120256569554657"/>
<CONT_DATA CI_END="10.578159422152837" CI_START="-30.178159422152838" EFFECT_SIZE="-9.8" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-5.6" ORDER="721" SD_1="25.0" SD_2="15.1" SE="10.397211164538307" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="5" WEIGHT="0.7312747522544604"/>
<CONT_DATA CI_END="2.620520770077194" CI_START="-15.220520770077192" EFFECT_SIZE="-6.299999999999999" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-2.9" ORDER="722" SD_1="15.9" SD_2="17.5" SE="4.55136973966926" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="19" WEIGHT="3.8161907353711024"/>
<CONT_DATA CI_END="-4.9161915120327935" CI_START="-20.683808487967205" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="-16.2" MEAN_2="-3.4" ORDER="723" SD_1="12.7" SD_2="17.8" SE="4.022425182377677" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="4.8858300746897205"/>
<CONT_DATA CI_END="-7.1015134687717" CI_START="-17.898486531228304" EFFECT_SIZE="-12.500000000000002" ESTIMABLE="YES" MEAN_1="-17.6" MEAN_2="-5.1" ORDER="724" SD_1="13.8" SD_2="13.7" SE="2.7543804752591754" STUDY_ID="STD-Sassano-1984" TOTAL_1="53" TOTAL_2="47" WEIGHT="10.419969457548465"/>
<CONT_DATA CI_END="-0.8905628965020664" CI_START="-17.109437103497932" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-7.0" ORDER="725" SD_1="13.9" SD_2="13.4" SE="4.137543938288733" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="14" WEIGHT="4.61773568622877"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.29393349717173933" CI_END="-5.601545083581889" CI_START="-17.3667295837298" DF="2.0" EFFECT_SIZE="-11.484137333655845" ESTIMABLE="YES" I2="0.0" ID="CMP-022.01.02" NO="2" P_CHI2="0.8633226959800036" P_Z="1.3008977483088314E-4" STUDIES="3" TAU2="0.0" TOTAL_1="107" TOTAL_2="36" WEIGHT="8.775522770239984" Z="3.8262885834377403">
<NAME>Max Dose</NAME>
<CONT_DATA CI_END="11.691900420345346" CI_START="-26.491900420345345" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.6" ORDER="728" SD_1="22.2" SD_2="15.1" SE="9.740944512725653" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="5" WEIGHT="0.8331288416437796"/>
<CONT_DATA CI_END="-3.8458824965414102" CI_START="-22.15411750345859" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="-2.9" ORDER="729" SD_1="16.1" SD_2="17.5" SE="4.670553936534089" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="18" WEIGHT="3.6239110126688767"/>
<CONT_DATA CI_END="-2.6142938044012354" CI_START="-19.385706195598765" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-7.0" ORDER="730" SD_1="13.9" SD_2="13.4" SE="4.278500146810933" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="4.318482915927329"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.9044210698827305" CI_END="-9.309988281849577" CI_START="-17.402480982092698" DF="2.0" EFFECT_SIZE="-13.356234631971137" ESTIMABLE="YES" I2="0.0" ID="CMP-022.01.03" NO="3" P_CHI2="0.6362202380851725" P_Z="9.82396314797569E-11" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="70" WEIGHT="18.548374206000855" Z="6.469635455326037">
<NAME>2 Max Dose</NAME>
<CONT_DATA CI_END="-6.851981886646527" CI_START="-17.54801811335347" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-14.4" MEAN_2="-2.2" ORDER="733" SD_1="13.9" SD_2="13.4" SE="2.7286308093097404" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="39" WEIGHT="10.617560670849139"/>
<CONT_DATA CI_END="-3.6340823123558614" CI_START="-21.565917687644138" EFFECT_SIZE="-12.6" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-2.9" ORDER="731" SD_1="14.4" SD_2="17.5" SE="4.574531857914815" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="18" WEIGHT="3.777643714770433"/>
<CONT_DATA CI_END="-8.449029652280629" CI_START="-25.55097034771937" EFFECT_SIZE="-17.0" ESTIMABLE="YES" MEAN_1="-24.0" MEAN_2="-7.0" ORDER="732" SD_1="13.9" SD_2="13.4" SE="4.36282014117011" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="13" WEIGHT="4.153169820381283"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="22.285245680173123" CI_END="-5.580236270565538" CI_START="-7.15412690243287" CI_STUDY="95" CI_TOTAL="95" DF="21.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.367181586499204" ESTIMABLE="YES" I2="5.767249321000702" I2_Q="18.812293805343447" ID="CMP-022.02" NO="2" P_CHI2="0.38323533616716254" P_Q="0.2917922213163662" P_Z="1.2360352887168706E-56" Q="2.4634271538658545" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="938" TOTAL_2="547" UNITS="" WEIGHT="99.99999999999999" Z="15.858086120963678">
<NAME>Change in peak DBP [1/2 Max and Higher Doses Only]</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="15.76490805732341" CI_END="-5.083510182249836" CI_START="-6.9528612555378" DF="14.0" EFFECT_SIZE="-6.018185718893818" ESTIMABLE="YES" I2="11.195168731120775" ID="CMP-022.02.01" NO="1" P_CHI2="0.3279410494022812" P_Z="1.6421794722102568E-36" STUDIES="15" TAU2="0.0" TOTAL_1="657" TOTAL_2="446" WEIGHT="70.88712411218961" Z="12.619809547661307">
<NAME>1/2 Max Dose</NAME>
<CONT_DATA CI_END="-4.666141742212261" CI_START="-21.93385825778774" EFFECT_SIZE="-13.3" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="0.8" ORDER="734" SD_1="8.1" SD_2="7.7" SE="4.405110668303352" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.8307670827854283"/>
<CONT_DATA CI_END="-3.7510621531298227" CI_START="-10.248937846870177" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-7.0" ORDER="735" SD_1="7.4" SD_2="7.6" SE="1.6576518101849749" STUDY_ID="STD-Chrysant-1996" TOTAL_1="42" TOTAL_2="40" WEIGHT="5.866867809345557"/>
<CONT_DATA CI_END="-3.310741310420402" CI_START="-9.489258689579598" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-4.1" ORDER="748" SD_1="8.1" SD_2="7.7" SE="1.576181355344933" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="38" WEIGHT="6.489041557659809"/>
<CONT_DATA CI_END="18.340010256156003" CI_START="-23.740010256156" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-6.4" ORDER="747" SD_1="14.0" SD_2="21.3" SE="10.734896366523527" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="0.1398933966352352"/>
<CONT_DATA CI_END="-3.347453568100355" CI_START="-7.852546431899644" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.6" ORDER="736" SD_1="6.7" SD_2="7.8" SE="1.1492795019028121" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="12.20510740710073"/>
<CONT_DATA CI_END="-2.544697995858041" CI_START="-7.855302004141958" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-6.0" ORDER="737" SD_1="8.1" SD_2="7.7" SE="1.3547708147122302" STUDY_ID="STD-Guitard-1997" TOTAL_1="101" TOTAL_2="50" WEIGHT="8.78337172050815"/>
<CONT_DATA CI_END="-4.409495480335747" CI_START="-14.990504519664253" EFFECT_SIZE="-9.7" ESTIMABLE="YES" MEAN_1="-22.2" MEAN_2="-12.5" ORDER="738" SD_1="8.8" SD_2="9.4" SE="2.6992865998534037" STUDY_ID="STD-Guntzel-1991" TOTAL_1="27" TOTAL_2="20" WEIGHT="2.212559354224573"/>
<CONT_DATA CI_END="-4.556757080521805" CI_START="-11.243242919478195" EFFECT_SIZE="-7.9" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-4.1" ORDER="739" SD_1="8.1" SD_2="7.7" SE="1.7057675272858424" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" WEIGHT="5.540554642943841"/>
<CONT_DATA CI_END="15.73398154388662" CI_START="-10.33398154388662" EFFECT_SIZE="2.6999999999999997" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-6.3" ORDER="740" SD_1="18.4" SD_2="7.2" SE="6.65011278099853" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="5" WEIGHT="0.36453136852051465"/>
<CONT_DATA CI_END="-1.164799073756209" CI_START="-6.0352009262437925" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.8" ORDER="741" SD_1="4.5" SD_2="4.6" SE="1.242472282884964" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="18" WEIGHT="10.442861276605854"/>
<CONT_DATA CI_END="-2.8670204304921327" CI_START="-8.932979569507868" EFFECT_SIZE="-5.9" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="-10.0" ORDER="742" SD_1="7.5" SD_2="8.0" SE="1.5474669909404577" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" WEIGHT="6.732093508577141"/>
<CONT_DATA CI_END="0.7485179808076143" CI_START="-9.148517980807613" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-7.0" ORDER="743" SD_1="9.3" SD_2="10.6" SE="2.5248004656416607" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="25" WEIGHT="2.5289416214127667"/>
<CONT_DATA CI_END="-4.131266937297417" CI_START="-11.068733062702583" EFFECT_SIZE="-7.6" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-3.9" ORDER="744" SD_1="8.4" SD_2="9.2" SE="1.7697942870703274" STUDY_ID="STD-Sassano-1984" TOTAL_1="53" TOTAL_2="47" WEIGHT="5.146919190701008"/>
<CONT_DATA CI_END="-3.918412115285914" CI_START="-20.28158788471409" EFFECT_SIZE="-12.100000000000001" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-0.2" ORDER="745" SD_1="9.6" SD_2="9.5" SE="4.174356237792841" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="8" WEIGHT="0.9251537419234295"/>
<CONT_DATA CI_END="-1.1915850687299399" CI_START="-10.808414931270061" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-7.0" ORDER="746" SD_1="8.1" SD_2="7.7" SE="2.4533180044114196" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="13" WEIGHT="2.6784604332455664"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7945953322405546" CI_END="-4.158078373277084" CI_START="-8.813661730955998" DF="3.0" EFFECT_SIZE="-6.485870052116541" ESTIMABLE="YES" I2="0.0" ID="CMP-022.02.02" NO="2" P_CHI2="0.6161118981995868" P_Z="4.734584990408422E-8" STUDIES="4" TAU2="0.0" TOTAL_1="123" TOTAL_2="34" WEIGHT="11.428806680687128" Z="5.461000580985437">
<NAME>Max Dose</NAME>
<CONT_DATA CI_END="9.375325036686167" CI_START="-16.775325036686166" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="749" SD_1="16.5" SD_2="7.2" SE="6.671206787381126" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="0.362229754891613"/>
<CONT_DATA CI_END="-3.492781023728602" CI_START="-9.107218976271398" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-11.1" MEAN_2="-4.8" ORDER="750" SD_1="5.4" SD_2="4.6" SE="1.4322808982279178" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="14" WEIGHT="7.8584433628244215"/>
<CONT_DATA CI_END="-2.6794471499236554" CI_START="-23.720552850076345" EFFECT_SIZE="-13.200000000000001" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-0.2" ORDER="751" SD_1="10.0" SD_2="9.5" SE="5.367727638395972" STUDY_ID="STD-Weinberger-1990" TOTAL_1="16" TOTAL_2="4" WEIGHT="0.559515322913709"/>
<CONT_DATA CI_END="-1.1645725461904703" CI_START="-10.83542745380953" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-7.0" ORDER="752" SD_1="8.1" SD_2="7.7" SE="2.4671001569165374" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="2.6486182400573837"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.262315136743304" CI_END="-5.818093176454528" CI_START="-9.560779648586823" DF="2.0" EFFECT_SIZE="-7.689436412520676" ESTIMABLE="YES" I2="11.594986590635527" ID="CMP-022.02.03" NO="3" P_CHI2="0.3226598792165264" P_Z="8.040470439521954E-16" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="67" WEIGHT="17.684069207123247" Z="8.053583190667366">
<NAME>2 Max Dose</NAME>
<CONT_DATA CI_END="-3.6102677723706713" CI_START="-9.789732227629331" EFFECT_SIZE="-6.700000000000001" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-4.1" ORDER="755" SD_1="8.1" SD_2="7.7" SE="1.576422960830272" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="39" WEIGHT="6.48705266516987"/>
<CONT_DATA CI_END="-4.7029983669843665" CI_START="-10.097001633015633" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-4.8" ORDER="753" SD_1="4.5" SD_2="4.6" SE="1.376046526512343" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="14" WEIGHT="8.513863648704481"/>
<CONT_DATA CI_END="-6.195791532038536" CI_START="-15.804208467961464" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-7.0" ORDER="754" SD_1="8.1" SD_2="7.7" SE="2.451171810225314" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="14" WEIGHT="2.683152893248896"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="11.50394465534782" CI_END="-8.786397702147827" CI_START="-12.136781569062805" CI_STUDY="95" CI_TOTAL="95" DF="23.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-10.461589635605316" ESTIMABLE="YES" I2="0.0" I2_Q="44.13725056480104" ID="CMP-022.03" NO="3" P_CHI2="0.9774331709635525" P_Q="0.12765046091667387" P_Z="1.9004711209469628E-34" Q="7.1604066044762416" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="980" TOTAL_2="428" UNITS="" WEIGHT="500.0" Z="12.239993816412596">
<NAME>Change in peak SBP [All Doses]</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="7.857916916821946" CI_START="-30.457916916821947" DF="0.0" EFFECT_SIZE="-11.3" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.01" NO="1" P_CHI2="1.0" P_Z="0.24765895001076998" STUDIES="1" TAU2="0.0" TOTAL_1="8" TOTAL_2="3" WEIGHT="100.0" Z="1.156054341474648">
<NAME>1/8 Max Dose</NAME>
<CONT_DATA CI_END="7.857916916821946" CI_START="-30.457916916821947" EFFECT_SIZE="-11.3" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="0.8" ORDER="756" SD_1="14.8" SD_2="14.3" SE="9.774627017607033" STUDY_ID="STD-Belz-1986" TOTAL_1="8" TOTAL_2="3" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.1596951166053011" CI_END="-2.1288695664578627" CI_START="-9.92710238324435" DF="5.0" EFFECT_SIZE="-6.027985974851107" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.02" NO="2" P_CHI2="0.9486851361286535" P_Z="0.00244488810785211" STUDIES="6" TAU2="0.0" TOTAL_1="246" TOTAL_2="80" WEIGHT="99.99999999999997" Z="3.0300801957562835">
<NAME>1/4 Max Dose</NAME>
<CONT_DATA CI_END="6.986983644527445" CI_START="-39.186983644527444" EFFECT_SIZE="-16.1" ESTIMABLE="YES" MEAN_1="-15.3" MEAN_2="0.8" ORDER="757" SD_1="14.8" SD_2="14.3" SE="11.779289735237294" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="2" WEIGHT="2.8523184556249546"/>
<CONT_DATA CI_END="0.614048046431372" CI_START="-11.414048046431372" EFFECT_SIZE="-5.3999999999999995" ESTIMABLE="YES" MEAN_1="-7.6" MEAN_2="-2.2" ORDER="762" SD_1="13.9" SD_2="13.4" SE="3.0684482438807117" STUDY_ID="STD-Drayer-1983" TOTAL_1="77" TOTAL_2="26" WEIGHT="42.03379635213487"/>
<CONT_DATA CI_END="3.089741815791232" CI_START="-13.289741815791231" EFFECT_SIZE="-5.1" ESTIMABLE="YES" MEAN_1="-14.6" MEAN_2="-9.5" ORDER="758" SD_1="16.4" SD_2="15.8" SE="4.178516483155236" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="22" WEIGHT="22.666892301377725"/>
<CONT_DATA CI_END="11.094034657363956" CI_START="-25.094034657363956" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-12.6" MEAN_2="-5.6" ORDER="759" SD_1="16.8" SD_2="15.1" SE="9.231819972248159" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="4" WEIGHT="4.643672327058545"/>
<CONT_DATA CI_END="5.4768921383195455" CI_START="-14.676892138319545" EFFECT_SIZE="-4.6" ESTIMABLE="YES" MEAN_1="-7.5" MEAN_2="-2.9" ORDER="760" SD_1="16.4" SD_2="17.5" SE="5.141365972948883" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="14" WEIGHT="14.971978080926176"/>
<CONT_DATA CI_END="2.0850430952158696" CI_START="-19.685043095215867" EFFECT_SIZE="-8.799999999999999" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-3.4" ORDER="761" SD_1="14.9" SD_2="17.8" SE="5.553695466383923" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="12" WEIGHT="12.831342482877721"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.1100822351385364" CI_END="-8.795598975911416" CI_START="-13.140457952811252" DF="10.0" EFFECT_SIZE="-10.968028464361334" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.03" NO="3" P_CHI2="0.9954246879640112" P_Z="4.361011269232519E-23" STUDIES="11" TAU2="0.0" TOTAL_1="461" TOTAL_2="263" WEIGHT="100.00000000000003" Z="9.895345688249227">
<NAME>1/2 Max Dose</NAME>
<CONT_DATA CI_END="14.018645022354235" CI_START="-47.418645022354234" EFFECT_SIZE="-16.7" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="0.8" ORDER="763" SD_1="24.0" SD_2="17.3" SE="15.673066068896667" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="2" WEIGHT="0.5001350227613943"/>
<CONT_DATA CI_END="-4.177707448249169" CI_START="-15.82229255175083" EFFECT_SIZE="-10.0" ESTIMABLE="YES" MEAN_1="-15.0" MEAN_2="-5.0" ORDER="764" SD_1="13.8" SD_2="13.1" SE="2.9706120100554556" STUDY_ID="STD-Chrysant-1996" TOTAL_1="42" TOTAL_2="40" WEIGHT="13.922054558330613"/>
<CONT_DATA CI_END="-5.831975090769765" CI_START="-18.168024909230233" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-2.2" ORDER="773" SD_1="13.9" SD_2="13.4" SE="3.147009311335733" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="25" WEIGHT="12.40506775452914"/>
<CONT_DATA CI_END="9.148304890787141" CI_START="-24.14830489078714" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-8.0" ORDER="772" SD_1="11.9" SD_2="16.5" SE="8.49418919026413" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="1.702751756431423"/>
<CONT_DATA CI_END="-6.988197773693704" CI_START="-14.811802226306293" EFFECT_SIZE="-10.899999999999999" ESTIMABLE="YES" MEAN_1="-14.7" MEAN_2="-3.8" ORDER="765" SD_1="13.6" SD_2="11.7" SE="1.995854136689292" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="30.84164965231452"/>
<CONT_DATA CI_END="-4.272258777208243" CI_START="-20.327741222791758" EFFECT_SIZE="-12.3" ESTIMABLE="YES" MEAN_1="-21.8" MEAN_2="-9.5" ORDER="766" SD_1="15.1" SD_2="15.8" SE="4.0958616005771304" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="22" WEIGHT="7.323263311867532"/>
<CONT_DATA CI_END="13.266314216382124" CI_START="-32.86631421638212" EFFECT_SIZE="-9.8" ESTIMABLE="YES" MEAN_1="-15.4" MEAN_2="-5.6" ORDER="767" SD_1="25.0" SD_2="15.1" SE="11.768743914850614" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="0.8870231835543505"/>
<CONT_DATA CI_END="3.7841138323488384" CI_START="-16.384113832348838" EFFECT_SIZE="-6.299999999999999" ESTIMABLE="YES" MEAN_1="-9.2" MEAN_2="-2.9" ORDER="768" SD_1="15.9" SD_2="17.5" SE="5.14505057842442" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="14" WEIGHT="4.641046284100765"/>
<CONT_DATA CI_END="-2.451350806492597" CI_START="-23.148649193507403" EFFECT_SIZE="-12.799999999999999" ESTIMABLE="YES" MEAN_1="-16.2" MEAN_2="-3.4" ORDER="769" SD_1="12.7" SD_2="17.8" SE="5.280020079519943" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="13" WEIGHT="4.406807178541058"/>
<CONT_DATA CI_END="-7.1015134687717" CI_START="-17.898486531228304" EFFECT_SIZE="-12.500000000000002" ESTIMABLE="YES" MEAN_1="-17.6" MEAN_2="-5.1" ORDER="770" SD_1="13.8" SD_2="13.7" SE="2.7543804752591754" STUDY_ID="STD-Sassano-1984" TOTAL_1="53" TOTAL_2="47" WEIGHT="16.193746413374825"/>
<CONT_DATA CI_END="-0.8905628965020664" CI_START="-17.109437103497932" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="-16.0" MEAN_2="-7.0" ORDER="771" SD_1="13.9" SD_2="13.4" SE="4.137543938288733" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="14" WEIGHT="7.176454884194393"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.22665028037458224" CI_END="-5.162090182722695" CI_START="-17.691935114541074" DF="2.0" EFFECT_SIZE="-11.427012648631884" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.04" NO="4" P_CHI2="0.8928603108180337" P_Z="3.503485489031468E-4" STUDIES="3" TAU2="0.0" TOTAL_1="107" TOTAL_2="29" WEIGHT="99.99999999999999" Z="3.5749098834141564">
<NAME>Max Dose</NAME>
<CONT_DATA CI_END="14.538234472139697" CI_START="-29.338234472139696" EFFECT_SIZE="-7.4" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-5.6" ORDER="774" SD_1="22.2" SD_2="15.1" SE="11.193182448854005" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="8.155076764993508"/>
<CONT_DATA CI_END="-2.5627772548834784" CI_START="-23.43722274511652" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="-2.9" ORDER="775" SD_1="16.1" SD_2="17.5" SE="5.325211497478526" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="13" WEIGHT="36.02977060858258"/>
<CONT_DATA CI_END="-2.6142938044012354" CI_START="-19.385706195598765" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-7.0" ORDER="776" SD_1="13.9" SD_2="13.4" SE="4.278500146810933" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="55.815152626423895"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.8471104187531583" CI_END="-9.129563000423094" CI_START="-18.03145312810214" DF="2.0" EFFECT_SIZE="-13.580508064262617" ESTIMABLE="YES" I2="0.0" ID="CMP-022.03.05" NO="5" P_CHI2="0.654715045905933" P_Z="2.22936058146862E-9" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="53" WEIGHT="100.0" Z="5.980147208276165">
<NAME>2 Max Dose</NAME>
<CONT_DATA CI_END="-6.080806185134928" CI_START="-18.31919381486507" EFFECT_SIZE="-12.2" ESTIMABLE="YES" MEAN_1="-14.4" MEAN_2="-2.2" ORDER="779" SD_1="13.9" SD_2="13.4" SE="3.1220950298742687" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="26" WEIGHT="52.90735496956914"/>
<CONT_DATA CI_END="-2.6470387251952996" CI_START="-22.5529612748047" EFFECT_SIZE="-12.6" ESTIMABLE="YES" MEAN_1="-15.5" MEAN_2="-2.9" ORDER="777" SD_1="14.4" SD_2="17.5" SE="5.078134778655317" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="14" WEIGHT="19.998611299956014"/>
<CONT_DATA CI_END="-8.449029652280629" CI_START="-25.55097034771937" EFFECT_SIZE="-17.0" ESTIMABLE="YES" MEAN_1="-24.0" MEAN_2="-7.0" ORDER="778" SD_1="13.9" SD_2="13.4" SE="4.36282014117011" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="13" WEIGHT="27.094033730474855"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="39.08982791925645" CI_END="-5.235063764446547" CI_START="-6.691648575182205" CI_STUDY="95" CI_TOTAL="95" DF="33.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.963356169814376" ESTIMABLE="YES" I2="15.579060444664877" I2_Q="76.02640390478726" ID="CMP-022.04" NO="4" P_CHI2="0.2150883079923771" P_Q="0.0022251433229619755" P_Z="5.8610747720455256E-58" Q="16.685022906508195" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="1394" TOTAL_2="561" UNITS="" WEIGHT="500.0" Z="16.04844871877775">
<NAME>Change in peak DBP [All Doses]</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.10520296517304885" CI_END="-6.378289577150931" CI_START="-12.643087030540848" DF="2.0" EFFECT_SIZE="-9.510688303845889" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.01" NO="1" P_CHI2="0.9487580369629498" P_Z="2.66664206050991E-9" STUDIES="3" TAU2="0.0" TOTAL_1="123" TOTAL_2="31" WEIGHT="100.0" Z="5.9509047762231315">
<NAME>1/8 Max Dose</NAME>
<CONT_DATA CI_END="4.294475172283318" CI_START="-19.69447517228332" EFFECT_SIZE="-7.7" ESTIMABLE="YES" MEAN_1="-6.9" MEAN_2="0.8" ORDER="780" SD_1="7.5" SD_2="7.8" SE="6.119742641647605" STUDY_ID="STD-Belz-1986" TOTAL_1="8" TOTAL_2="2" WEIGHT="6.8201131175303535"/>
<CONT_DATA CI_END="-6.2896063465612055" CI_START="-13.110393653438793" EFFECT_SIZE="-9.7" ESTIMABLE="YES" MEAN_1="-15.7" MEAN_2="-6.0" ORDER="781" SD_1="8.1" SD_2="7.7" SE="1.7400287353949073" STUDY_ID="STD-Guitard-1997" TOTAL_1="100" TOTAL_2="25" WEIGHT="84.36164791521902"/>
<CONT_DATA CI_END="1.4483882647797" CI_START="-19.648388264779705" EFFECT_SIZE="-9.100000000000001" ESTIMABLE="YES" MEAN_1="-9.3" MEAN_2="-0.2" ORDER="782" SD_1="9.8" SD_2="9.5" SE="5.381929641556703" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="4" WEIGHT="8.818238967250617"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="7.2255708291761955" CI_END="-2.145062752023976" CI_START="-5.242900740781823" DF="8.0" EFFECT_SIZE="-3.6939817464028994" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.02" NO="2" P_CHI2="0.512502569192455" P_Z="2.9499583530652374E-6" STUDIES="9" TAU2="0.0" TOTAL_1="333" TOTAL_2="118" WEIGHT="100.00000000000001" Z="4.674273611965832">
<NAME>1/4 Max Dose</NAME>
<CONT_DATA CI_END="-1.3267408291710492" CI_START="-22.67325917082895" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="0.8" ORDER="783" SD_1="7.5" SD_2="7.8" SE="5.445640458201404" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="3" WEIGHT="2.106023925522226"/>
<CONT_DATA CI_END="0.5750963380661855" CI_START="-6.375096338066186" EFFECT_SIZE="-2.9000000000000004" ESTIMABLE="YES" MEAN_1="-7.0" MEAN_2="-4.1" ORDER="791" SD_1="8.1" SD_2="7.7" SE="1.7730409157909544" STUDY_ID="STD-Drayer-1983" TOTAL_1="76" TOTAL_2="26" WEIGHT="19.866607587767113"/>
<CONT_DATA CI_END="-1.7890194010919211" CI_START="-15.410980598908083" EFFECT_SIZE="-8.600000000000001" ESTIMABLE="YES" MEAN_1="-21.1" MEAN_2="-12.5" ORDER="784" SD_1="9.0" SD_2="9.4" SE="3.4750539564156413" STUDY_ID="STD-Guntzel-1991" TOTAL_1="25" TOTAL_2="10" WEIGHT="5.171757163908711"/>
<CONT_DATA CI_END="-0.8899039339787205" CI_START="-8.91009606602128" EFFECT_SIZE="-4.9" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-4.1" ORDER="785" SD_1="8.1" SD_2="7.7" SE="2.046004976444672" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="22" WEIGHT="14.919279757315328"/>
<CONT_DATA CI_END="11.64222313641546" CI_START="-9.042223136415458" EFFECT_SIZE="1.2999999999999998" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-6.3" ORDER="786" SD_1="12.2" SD_2="7.2" SE="5.276741418716668" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="4" WEIGHT="2.2430017063411007"/>
<CONT_DATA CI_END="0.3732618338370228" CI_START="-5.1732618338370235" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="-7.2" MEAN_2="-4.8" ORDER="787" SD_1="4.7" SD_2="4.6" SE="1.4149555071991926" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="13" WEIGHT="31.194329943940424"/>
<CONT_DATA CI_END="-0.3835184578202706" CI_START="-8.016481542179728" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="-14.2" MEAN_2="-10.0" ORDER="788" SD_1="7.5" SD_2="8.0" SE="1.9472202409246537" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="24" WEIGHT="16.471421409589873"/>
<CONT_DATA CI_END="3.7446908753549826" CI_START="-8.544690875354984" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="-9.4" MEAN_2="-7.0" ORDER="789" SD_1="7.7" SD_2="10.6" SE="3.1351039732482433" STUDY_ID="STD-Pittrow-1997" TOTAL_1="50" TOTAL_2="13" WEIGHT="6.354148088346434"/>
<CONT_DATA CI_END="4.473603599003502" CI_START="-19.473603599003503" EFFECT_SIZE="-7.5" ESTIMABLE="YES" MEAN_1="-7.7" MEAN_2="-0.2" ORDER="790" SD_1="9.7" SD_2="9.5" SE="6.109093684093054" STUDY_ID="STD-Weinberger-1990" TOTAL_1="13" TOTAL_2="3" WEIGHT="1.6734304172688128"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="11.118066370475727" CI_END="-4.935619031700314" CI_START="-7.01959355713012" DF="14.0" EFFECT_SIZE="-5.977606294415217" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.03" NO="3" P_CHI2="0.6767370906932804" P_Z="2.4846137075910045E-29" STUDIES="15" TAU2="0.0" TOTAL_1="657" TOTAL_2="324" WEIGHT="100.0" Z="11.24379680063261">
<NAME>1/2 Max Dose</NAME>
<CONT_DATA CI_END="-0.8145525132749984" CI_START="-25.785447486725005" EFFECT_SIZE="-13.3" ESTIMABLE="YES" MEAN_1="-12.5" MEAN_2="0.8" ORDER="792" SD_1="8.1" SD_2="7.7" SE="6.370243323453195" STUDY_ID="STD-Belz-1986" TOTAL_1="6" TOTAL_2="2" WEIGHT="0.696492742802886"/>
<CONT_DATA CI_END="-3.7510621531298227" CI_START="-10.248937846870177" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-14.0" MEAN_2="-7.0" ORDER="793" SD_1="7.4" SD_2="7.6" SE="1.6576518101849749" STUDY_ID="STD-Chrysant-1996" TOTAL_1="42" TOTAL_2="40" WEIGHT="10.285893275366758"/>
<CONT_DATA CI_END="-2.8418774164171303" CI_START="-9.95812258358287" EFFECT_SIZE="-6.4" ESTIMABLE="YES" MEAN_1="-10.5" MEAN_2="-4.1" ORDER="806" SD_1="8.1" SD_2="7.7" SE="1.815402023531497" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="25" WEIGHT="8.575965157631742"/>
<CONT_DATA CI_END="18.340010256156003" CI_START="-23.740010256156" EFFECT_SIZE="-2.6999999999999993" ESTIMABLE="YES" MEAN_1="-9.1" MEAN_2="-6.4" ORDER="805" SD_1="14.0" SD_2="21.3" SE="10.734896366523527" STUDY_ID="STD-Dupui-1993" TOTAL_1="8" TOTAL_2="5" WEIGHT="0.24526350251601997"/>
<CONT_DATA CI_END="-3.347453568100355" CI_START="-7.852546431899644" EFFECT_SIZE="-5.6" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-5.6" ORDER="794" SD_1="6.7" SD_2="7.8" SE="1.1492795019028121" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" WEIGHT="21.398203655423817"/>
<CONT_DATA CI_END="-1.7932668723864795" CI_START="-8.60673312761352" EFFECT_SIZE="-5.199999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-6.0" ORDER="795" SD_1="8.1" SD_2="7.7" SE="1.738161085859432" STUDY_ID="STD-Guitard-1997" TOTAL_1="101" TOTAL_2="25" WEIGHT="9.35510342017297"/>
<CONT_DATA CI_END="-2.9947033516469572" CI_START="-16.40529664835304" EFFECT_SIZE="-9.7" ESTIMABLE="YES" MEAN_1="-22.2" MEAN_2="-12.5" ORDER="796" SD_1="8.8" SD_2="9.4" SE="3.421132582661501" STUDY_ID="STD-Guntzel-1991" TOTAL_1="27" TOTAL_2="10" WEIGHT="2.4148425964185223"/>
<CONT_DATA CI_END="-3.856036723766347" CI_START="-11.943963276233653" EFFECT_SIZE="-7.9" ESTIMABLE="YES" MEAN_1="-12.0" MEAN_2="-4.1" ORDER="797" SD_1="8.1" SD_2="7.7" SE="2.0632844828435215" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="22" WEIGHT="6.639118406731134"/>
<CONT_DATA CI_END="16.715592682973302" CI_START="-11.315592682973303" EFFECT_SIZE="2.6999999999999997" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-6.3" ORDER="798" SD_1="18.4" SD_2="7.2" SE="7.150943993627694" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="0.5527158069254755"/>
<CONT_DATA CI_END="-0.9129112573945108" CI_START="-6.287088742605491" EFFECT_SIZE="-3.6000000000000005" ESTIMABLE="YES" MEAN_1="-8.4" MEAN_2="-4.8" ORDER="799" SD_1="4.5" SD_2="4.6" SE="1.3709888364280685" STUDY_ID="STD-Myers-1996" TOTAL_1="55" TOTAL_2="14" WEIGHT="15.03698620691264"/>
<CONT_DATA CI_END="-2.1157021571616537" CI_START="-9.684297842838347" EFFECT_SIZE="-5.9" ESTIMABLE="YES" MEAN_1="-15.9" MEAN_2="-10.0" ORDER="800" SD_1="7.5" SD_2="8.0" SE="1.9307996844270634" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="24" WEIGHT="7.5814836018011595"/>
<CONT_DATA CI_END="2.3720344724507703" CI_START="-10.77203447245077" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="-11.2" MEAN_2="-7.0" ORDER="801" SD_1="9.3" SD_2="10.6" SE="3.353140427217101" STUDY_ID="STD-Pittrow-1997" TOTAL_1="46" TOTAL_2="12" WEIGHT="2.513767776313554"/>
<CONT_DATA CI_END="-4.131266937297417" CI_START="-11.068733062702583" EFFECT_SIZE="-7.6" ESTIMABLE="YES" MEAN_1="-11.5" MEAN_2="-3.9" ORDER="802" SD_1="8.4" SD_2="9.2" SE="1.7697942870703274" STUDY_ID="STD-Sassano-1984" TOTAL_1="53" TOTAL_2="47" WEIGHT="9.023667008170259"/>
<CONT_DATA CI_END="-1.5988173220224429" CI_START="-22.60118267797756" EFFECT_SIZE="-12.100000000000001" ESTIMABLE="YES" MEAN_1="-12.3" MEAN_2="-0.2" ORDER="803" SD_1="9.6" SD_2="9.5" SE="5.357844715928224" STUDY_ID="STD-Weinberger-1990" TOTAL_1="15" TOTAL_2="4" WEIGHT="0.9845740686931921"/>
<CONT_DATA CI_END="-1.1915850687299399" CI_START="-10.808414931270061" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-7.0" ORDER="804" SD_1="8.1" SD_2="7.7" SE="2.4533180044114196" STUDY_ID="STD-Whalen-1989" TOTAL_1="45" TOTAL_2="13" WEIGHT="4.695922774119862"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.7945953322405548" CI_END="-4.158078373277083" CI_START="-8.813661730956" DF="3.0" EFFECT_SIZE="-6.485870052116541" ESTIMABLE="YES" I2="0.0" ID="CMP-022.04.04" NO="4" P_CHI2="0.6161118981995868" P_Z="4.734584990408448E-8" STUDIES="4" TAU2="0.0" TOTAL_1="123" TOTAL_2="34" WEIGHT="100.00000000000001" Z="5.461000580985436">
<NAME>Max Dose</NAME>
<CONT_DATA CI_END="9.375325036686167" CI_START="-16.775325036686166" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-6.3" ORDER="807" SD_1="16.5" SD_2="7.2" SE="6.671206787381126" STUDY_ID="STD-Luccioni-1988" TOTAL_1="10" TOTAL_2="3" WEIGHT="3.169445113668113"/>
<CONT_DATA CI_END="-3.492781023728602" CI_START="-9.107218976271398" EFFECT_SIZE="-6.3" ESTIMABLE="YES" MEAN_1="-11.1" MEAN_2="-4.8" ORDER="808" SD_1="5.4" SD_2="4.6" SE="1.4322808982279178" STUDY_ID="STD-Myers-1996" TOTAL_1="54" TOTAL_2="14" WEIGHT="68.7599640311"/>
<CONT_DATA CI_END="-2.6794471499236554" CI_START="-23.720552850076345" EFFECT_SIZE="-13.200000000000001" ESTIMABLE="YES" MEAN_1="-13.4" MEAN_2="-0.2" ORDER="809" SD_1="10.0" SD_2="9.5" SE="5.367727638395972" STUDY_ID="STD-Weinberger-1990" TOTAL_1="16" TOTAL_2="4" WEIGHT="4.895658300522322"/>
<CONT_DATA CI_END="-1.1645725461904703" CI_START="-10.83542745380953" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="-13.0" MEAN_2="-7.0" ORDER="810" SD_1="8.1" SD_2="7.7" SE="2.4671001569165374" STUDY_ID="STD-Whalen-1989" TOTAL_1="43" TOTAL_2="13" WEIGHT="23.174932554709578"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.161369515682731" CI_END="-5.825122066450941" CI_START="-9.739762480315422" DF="2.0" EFFECT_SIZE="-7.7824422733831815" ESTIMABLE="YES" I2="7.466077156721516" ID="CMP-022.04.05" NO="5" P_CHI2="0.3393632896510905" P_Z="6.546039649638963E-15" STUDIES="3" TAU2="0.0" TOTAL_1="158" TOTAL_2="54" WEIGHT="100.0" Z="7.792954118375944">
<NAME>2 Max Dose</NAME>
<CONT_DATA CI_END="-3.1692144731094993" CI_START="-10.230785526890504" EFFECT_SIZE="-6.700000000000001" ESTIMABLE="YES" MEAN_1="-10.8" MEAN_2="-4.1" ORDER="813" SD_1="8.1" SD_2="7.7" SE="1.8014542893343384" STUDY_ID="STD-Drayer-1983" TOTAL_1="68" TOTAL_2="26" WEIGHT="30.73131073764203"/>
<CONT_DATA CI_END="-4.7029983669843665" CI_START="-10.097001633015633" EFFECT_SIZE="-7.3999999999999995" ESTIMABLE="YES" MEAN_1="-12.2" MEAN_2="-4.8" ORDER="811" SD_1="4.5" SD_2="4.6" SE="1.376046526512343" STUDY_ID="STD-Myers-1996" TOTAL_1="53" TOTAL_2="14" WEIGHT="52.669760136061385"/>
<CONT_DATA CI_END="-6.195791532038536" CI_START="-15.804208467961464" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-18.0" MEAN_2="-7.0" ORDER="812" SD_1="8.1" SD_2="7.7" SE="2.451171810225314" STUDY_ID="STD-Whalen-1989" TOTAL_1="37" TOTAL_2="14" WEIGHT="16.59892912629658"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="18.1677552644682" CI_END="0.24403146291134437" CI_START="-1.4604582262836607" CI_STUDY="95" CI_TOTAL="95" DF="21.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6082133816861582" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-022.05" NO="5" P_CHI2="0.638364921897999" P_Q="0.40297580604593486" P_Z="0.16188837072624238" Q="2.9272669869528727" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="966" TOTAL_2="741" UNITS="" WEIGHT="400.0" Z="1.3987486466793193">
<NAME>Change in trough heart rate</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.6162883813132596" CI_START="-6.616288381313259" DF="0.0" EFFECT_SIZE="-3.0" ESTIMABLE="YES" I2="0.0" ID="CMP-022.05.01" NO="1" P_CHI2="1.0" P_Z="0.10396100651435573" STUDIES="1" TAU2="0.0" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0" Z="1.6259466429734435">
<NAME>1/8 Max Dose</NAME>
<CONT_DATA CI_END="0.6162883813132596" CI_START="-6.616288381313259" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-2.9" MEAN_2="0.1" ORDER="814" SD_1="9.7" SD_2="10.0" SE="1.8450789962662992" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="5.668119255165953" CI_END="0.8141975962004908" CI_START="-1.757706168617538" DF="9.0" EFFECT_SIZE="-0.4717542862085235" ESTIMABLE="YES" I2="0.0" ID="CMP-022.05.02" NO="2" P_CHI2="0.772619795682699" P_Z="0.4721303806975645" STUDIES="10" TAU2="0.0" TOTAL_1="331" TOTAL_2="256" WEIGHT="100.0" Z="0.7190171134467211">
<NAME>1/4 Max Dose</NAME>
<CONT_DATA CI_END="6.120994285896459" CI_START="-6.120994285896459" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.0" ORDER="815" SD_1="9.0" SD_2="6.9" SE="3.1230136544232856" STUDY_ID="STD-Boeijinga-1993" TOTAL_1="14" TOTAL_2="12" WEIGHT="4.413727217667476"/>
<CONT_DATA CI_END="-0.5489687730679034" CI_START="-13.451031226932097" EFFECT_SIZE="-7.0" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="4.0" ORDER="816" SD_1="4.0" SD_2="7.0" SE="3.2914029430219163" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" WEIGHT="3.973664063316959"/>
<CONT_DATA CI_END="8.592007860744255" CI_START="-6.9920078607442555" EFFECT_SIZE="0.7999999999999999" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-1.4" ORDER="817" SD_1="8.8" SD_2="7.5" SE="3.975587267014404" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="5" WEIGHT="2.7236460791030797"/>
<CONT_DATA CI_END="2.8570227226814766" CI_START="-7.057022722681477" EFFECT_SIZE="-2.1" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="0.6" ORDER="818" SD_1="7.4" SD_2="7.3" SE="2.5291396993933764" STUDY_ID="STD-Guntzel-1991" TOTAL_1="28" TOTAL_2="12" WEIGHT="6.7298846059415105"/>
<CONT_DATA CI_END="3.9306634900840614" CI_START="-3.3306634900840617" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="-1.3" MEAN_2="-1.6" ORDER="819" SD_1="9.6" SD_2="9.0" SE="1.852413370205918" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" WEIGHT="12.54519571632187"/>
<CONT_DATA CI_END="4.303997380893905" CI_START="-3.3039973808939047" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.0" ORDER="820" SD_1="6.7" SD_2="7.1" SE="1.9408506538382084" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="11.427968076561262"/>
<CONT_DATA CI_END="1.3570535961223598" CI_START="-2.35705359612236" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-0.5" ORDER="821" SD_1="7.3" SD_2="7.1" SE="0.9474937349719492" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" WEIGHT="47.95131934723033"/>
<CONT_DATA CI_END="5.778972720351109" CI_START="-6.778972720351109" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-0.5" ORDER="822" SD_1="10.0" SD_2="10.0" SE="3.2036163775859374" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" WEIGHT="4.194423177945678"/>
<CONT_DATA CI_END="11.186092778806001" CI_START="-5.186092778806001" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-6.0" ORDER="823" SD_1="6.0" SD_2="11.0" SE="4.176654695380556" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" WEIGHT="2.467721313206392"/>
<CONT_DATA CI_END="7.303644522560258" CI_START="-6.303644522560258" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="-1.2" MEAN_2="-1.7" ORDER="824" SD_1="9.2" SD_2="7.8" SE="3.471310991541956" STUDY_ID="STD-White-1995" TOTAL_1="16" TOTAL_2="9" WEIGHT="3.5724504027054267"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="9.394234429180585" CI_END="0.5719564968612034" CI_START="-1.9850259051088033" DF="8.0" EFFECT_SIZE="-0.7065347041237999" ESTIMABLE="YES" I2="14.841384252130036" ID="CMP-022.05.03" NO="3" P_CHI2="0.3101376440825042" P_Z="0.2787471314228763" STUDIES="9" TAU2="0.0" TOTAL_1="513" TOTAL_2="404" WEIGHT="99.99999999999999" Z="1.0831381341095008">
<NAME>1/2 Max Dose</NAME>
<CONT_DATA CI_END="9.840313793407608" CI_START="-6.040313793407607" EFFECT_SIZE="1.9" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="-1.4" ORDER="825" SD_1="8.8" SD_2="7.5" SE="4.051254949601008" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="5" WEIGHT="2.5925083001851776"/>
<CONT_DATA CI_END="1.9404901352410246" CI_START="-8.540490135241026" EFFECT_SIZE="-3.3000000000000003" ESTIMABLE="YES" MEAN_1="-2.7" MEAN_2="0.6" ORDER="826" SD_1="8.0" SD_2="7.5" SE="2.67376858788087" STUDY_ID="STD-Guntzel-1991" TOTAL_1="26" TOTAL_2="12" WEIGHT="5.951845802819928"/>
<CONT_DATA CI_END="2.7105100062379" CI_START="-3.3105100062379007" EFFECT_SIZE="-0.30000000000000004" ESTIMABLE="YES" MEAN_1="-1.1" MEAN_2="-0.8" ORDER="827" SD_1="8.0" SD_2="6.6" SE="1.5360027173889006" STUDY_ID="STD-Krum-1998" TOTAL_1="46" TOTAL_2="45" WEIGHT="18.034966366553082"/>
<CONT_DATA CI_END="5.5630160153297865" CI_START="-2.963016015329787" EFFECT_SIZE="1.2999999999999998" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-1.4" ORDER="828" SD_1="7.7" SD_2="7.9" SE="2.1750481381065736" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" WEIGHT="8.99417965968033"/>
<CONT_DATA CI_END="4.503997380893905" CI_START="-3.1039973808939045" EFFECT_SIZE="0.7" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="0.0" ORDER="829" SD_1="6.7" SD_2="7.1" SE="1.9408506538382084" STUDY_ID="STD-Mroczek-1991" TOTAL_1="56" TOTAL_2="17" WEIGHT="11.295749906598454"/>
<CONT_DATA CI_END="0.8973148106444884" CI_START="-4.097314810644488" EFFECT_SIZE="-1.5999999999999999" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-1.2" ORDER="830" SD_1="14.3" SD_2="13.9" SE="1.2741636225680617" STUDY_ID="STD-Overlack-1994" TOTAL_1="253" TOTAL_2="237" WEIGHT="26.208906481691816"/>
<CONT_DATA CI_END="-1.5945038395418472" CI_START="-12.205496160458154" EFFECT_SIZE="-6.9" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="1.9" ORDER="831" SD_1="8.2" SD_2="7.5" SE="2.7069355367278325" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" WEIGHT="5.806888374139329"/>
<CONT_DATA CI_END="3.440042187719279" CI_START="-2.640042187719279" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.1" ORDER="832" SD_1="7.1" SD_2="7.2" SE="1.551070433793041" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" WEIGHT="17.686270615059854"/>
<CONT_DATA CI_END="8.304527787243245" CI_START="-5.504527787243246" EFFECT_SIZE="1.4" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="-1.7" ORDER="833" SD_1="9.3" SD_2="7.8" SE="3.5227829907617076" STUDY_ID="STD-White-1995" TOTAL_1="18" TOTAL_2="8" WEIGHT="3.428684493272033"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.17813459316879066" CI_END="4.760665913946643" CI_START="-2.1471289785084675" DF="1.0" EFFECT_SIZE="1.306768467719088" ESTIMABLE="YES" I2="0.0" ID="CMP-022.05.04" NO="4" P_CHI2="0.6729812723693319" P_Z="0.45836328248933733" STUDIES="2" TAU2="0.0" TOTAL_1="66" TOTAL_2="23" WEIGHT="100.0" Z="0.7415446384082541">
<NAME>Max Dose</NAME>
<CONT_DATA CI_END="7.289610080117015" CI_START="-7.489610080117016" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="-1.4" ORDER="834" SD_1="8.8" SD_2="7.5" SE="3.7702785043017712" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="6" WEIGHT="21.846196237828437"/>
<CONT_DATA CI_END="5.606918738240087" CI_START="-2.2069187382400877" EFFECT_SIZE="1.7" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="0.0" ORDER="835" SD_1="7.1" SD_2="7.1" SE="1.993362515361182" STUDY_ID="STD-Mroczek-1991" TOTAL_1="50" TOTAL_2="17" WEIGHT="78.15380376217156"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="27.291131092683496" CI_END="1.0695388239168901" CI_START="0.6734989550280898" CI_STUDY="95" CI_TOTAL="95" DF="71.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8487245019851835" ESTIMABLE="YES" EVENTS_1="118" EVENTS_2="136" I2="0.0" I2_Q="0.0" ID="CMP-022.06" LOG_CI_END="0.029196553944333032" LOG_CI_START="-0.1716630737730467" LOG_EFFECT_SIZE="-0.0712332599143568" METHOD="MH" NO="6" P_CHI2="0.9999994048424103" P_Q="0.0" P_Z="0.16447692967173325" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="56" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="4820" TOTAL_2="4664" WEIGHT="600.0" Z="1.3901710913251852">
<NAME>Total withdrawals due to adverse effects</NAME>
<GROUP_LABEL_1>ACE Inhibitor</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ACEI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.0830346469328993" CI_END="2.5727880832529495" CI_START="0.3930777187262117" DF="3.0" EFFECT_SIZE="1.0056369476759752" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" I2="0.0" ID="CMP-022.06.01" LOG_CI_END="0.4104040154897378" LOG_CI_START="-0.40552157309292713" LOG_EFFECT_SIZE="0.00244122119840533" NO="1" P_CHI2="0.7811711133399597" P_Z="0.9906423936635734" STUDIES="4" TAU2="0.0" TOTAL_1="138" TOTAL_2="144" WEIGHT="100.0" Z="0.011728289182550615">
<NAME>1/16 Max Dose</NAME>
<DICH_DATA CI_END="81.92855513062615" CI_START="0.14347991395764387" EFFECT_SIZE="3.4285714285714284" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.9134352958293788" LOG_CI_START="-0.8432088924346804" LOG_EFFECT_SIZE="0.5351132016973491" ORDER="836" O_E="0.0" SE="1.619266441795114" STUDY_ID="STD-Gomez-1989" TOTAL_1="41" TOTAL_2="47" VAR="2.6220238095238093" WEIGHT="6.25096325691117"/>
<DICH_DATA CI_END="7.607417460218821" CI_START="0.013336200776381955" EFFECT_SIZE="0.31851851851851853" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8812372490005013" LOG_CI_START="-1.8749678748313403" LOG_EFFECT_SIZE="-0.4968653129154196" ORDER="837" O_E="0.0" SE="1.6190085331742252" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="42" VAR="2.621188630490956" WEIGHT="20.549026940332986"/>
<DICH_DATA CI_END="13.962365019223395" CI_START="0.059539689568936086" EFFECT_SIZE="0.9117647058823529" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1449589876141004" LOG_CI_START="-1.2251934340300654" LOG_EFFECT_SIZE="-0.04011722320798245" ORDER="838" O_E="0.0" SE="1.3922392649174886" STUDY_ID="STD-Moser-1991" TOTAL_1="34" TOTAL_2="31" VAR="1.9383301707779887" WEIGHT="14.013148400108557"/>
<DICH_DATA CI_END="3.252449064156051" CI_START="0.3139675410006827" EFFECT_SIZE="1.0105263157894737" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.512210503902594" LOG_CI_START="-0.5031152484011528" LOG_EFFECT_SIZE="0.004547627750720661" ORDER="839" O_E="0.0" SE="0.5964073728467522" STUDY_ID="STD-Trevisan-1995" TOTAL_1="19" TOTAL_2="24" VAR="0.3557017543859649" WEIGHT="59.18686140264729"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.4108950602845156" CI_END="1.819527680347865" CI_START="0.4229996762996044" DF="7.0" EFFECT_SIZE="0.8773024676845022" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" I2="0.0" ID="CMP-022.06.02" LOG_CI_END="0.259958666864213" LOG_CI_START="-0.37365996496857323" LOG_EFFECT_SIZE="-0.05685064905218014" NO="2" P_CHI2="0.8445714013874781" P_Z="0.7250552397400944" STUDIES="9" TAU2="0.0" TOTAL_1="419" TOTAL_2="423" WEIGHT="100.0" Z="0.35171069486291456">
<NAME>1/8 Max Dose</NAME>
<DICH_DATA CI_END="4.218640864420126" CI_START="0.010158784509752897" EFFECT_SIZE="0.20701754385964913" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6251725551900479" LOG_CI_START="-1.9931582519227797" LOG_EFFECT_SIZE="-0.683992848366366" ORDER="840" O_E="0.0" SE="1.5380204770446018" STUDY_ID="STD-Applegate-1996" TOTAL_1="56" TOTAL_2="58" VAR="2.365506987808504" WEIGHT="16.46566809225985"/>
<DICH_DATA CI_END="73.08526156114004" CI_START="0.13243453110695871" EFFECT_SIZE="3.111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8638298055758746" LOG_CI_START="-0.8779987617700857" LOG_EFFECT_SIZE="0.49291552190289434" ORDER="841" O_E="0.0" SE="1.6105636727293162" STUDY_ID="STD-Chan-1997" TOTAL_1="26" TOTAL_2="27" VAR="2.5939153439153437" WEIGHT="3.2899822944151738"/>
<DICH_DATA CI_END="2.410110239796336" CI_START="0.20009586219612316" EFFECT_SIZE="0.6944444444444444" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.38203690790278055" LOG_CI_START="-0.69876189209328" LOG_EFFECT_SIZE="-0.15836249209524966" ORDER="842" O_E="0.0" SE="0.6348665651580303" STUDY_ID="STD-Cushman-1998" TOTAL_1="144" TOTAL_2="150" VAR="0.40305555555555556" WEIGHT="39.3902642052429"/>
<DICH_DATA CI_END="108.36816797551899" CI_START="0.2648285020221066" EFFECT_SIZE="5.357142857142857" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.034901731438726" LOG_CI_START="-0.5770352760118023" LOG_EFFECT_SIZE="0.728933227713462" ORDER="843" O_E="0.0" SE="1.5342647274731482" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="41" TOTAL_2="44" VAR="2.353968253968254" WEIGHT="3.2353593444440407"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="844" O_E="0.0" SE="0.0" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="15.111695347702627" CI_START="0.06313184477482867" EFFECT_SIZE="0.9767441860465116" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.179313189610355" LOG_CI_START="-1.1997515199737272" LOG_EFFECT_SIZE="-0.010219165181686082" ORDER="845" O_E="0.0" SE="1.3974743869699322" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="42" VAR="1.9529346622369879" WEIGHT="6.78066067650709"/>
<DICH_DATA CI_END="12.519885440068006" CI_START="0.05315643410314994" EFFECT_SIZE="0.8157894736842105" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0976003549947035" LOG_CI_START="-1.2744441605597783" LOG_EFFECT_SIZE="-0.08842190278253749" ORDER="846" O_E="0.0" SE="1.393350690246424" STUDY_ID="STD-Moser-1991" TOTAL_1="38" TOTAL_2="31" VAR="1.9414261460101867" WEIGHT="7.381710139911662"/>
<DICH_DATA CI_END="6.610561210332914" CI_START="0.15127308683518553" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8202383309235528" LOG_CI_START="-0.8202383309235528" LOG_EFFECT_SIZE="0.0" ORDER="847" O_E="0.0" SE="0.9636241116594315" STUDY_ID="STD-Villamil-1987" TOTAL_1="28" TOTAL_2="28" VAR="0.9285714285714286" WEIGHT="13.403631569839597"/>
<DICH_DATA CI_END="7.926829511929571" CI_START="0.01401709358626841" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8990995176074968" LOG_CI_START="-1.8533420270468215" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="848" O_E="0.0" SE="1.6167977881353308" STUDY_ID="STD-Whelton-1992" TOTAL_1="37" TOTAL_2="37" VAR="2.6140350877192984" WEIGHT="10.052723677379698"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.797315856284945" CI_END="1.0040079660507515" CI_START="0.41957965705609834" DF="18.0" EFFECT_SIZE="0.6490464683496592" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="46" I2="0.0" ID="CMP-022.06.03" LOG_CI_END="0.0017371586239001138" LOG_CI_START="-0.37718557634705235" LOG_EFFECT_SIZE="-0.18772420886157612" NO="3" P_CHI2="0.9991413404825964" P_Z="0.05213792281972167" STUDIES="32" TAU2="0.0" TOTAL_1="1727" TOTAL_2="1658" WEIGHT="100.00000000000003" Z="1.9419932056764508">
<NAME>1/4 Max Dose</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="849" O_E="0.0" SE="0.0" STUDY_ID="STD-Boeijinga-1993" TOTAL_1="14" TOTAL_2="12" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="850" O_E="0.0" SE="0.0" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="42" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.91949256741268" CI_START="0.14451926788815345" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8400742471658783" LOG_CI_START="-0.8400742471658784" LOG_EFFECT_SIZE="0.0" ORDER="877" O_E="0.0" SE="0.9869275424396535" STUDY_ID="STD-Drayer-1983" TOTAL_1="77" TOTAL_2="77" VAR="0.974025974025974" WEIGHT="4.037814609905375"/>
<DICH_DATA CI_END="5.849008089931198" CI_START="0.05086685752225116" EFFECT_SIZE="0.5454545454545454" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7670822220489179" LOG_CI_START="-1.2935650915980808" LOG_EFFECT_SIZE="-0.26324143477458145" ORDER="851" O_E="0.0" SE="1.210434432404959" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="55" TOTAL_2="60" VAR="1.4651515151515153" WEIGHT="3.8622574529529676"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="852" O_E="0.0" SE="0.0" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="853" O_E="0.0" SE="0.0" STUDY_ID="STD-Ford-1993" TOTAL_1="17" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="854" O_E="0.0" SE="0.0" STUDY_ID="STD-Gomez-1989" TOTAL_1="44" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.325009319913585" CI_START="0.013213651919002872" EFFECT_SIZE="0.3111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8648081815974054" LOG_CI_START="-1.878977137791617" LOG_EFFECT_SIZE="-0.5070844780971057" ORDER="855" O_E="0.0" SE="1.6117130785654894" STUDY_ID="STD-Guntzel-1991" TOTAL_1="29" TOTAL_2="27" VAR="2.5976190476190477" WEIGHT="3.1327871973403774"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="878" O_E="0.0" SE="0.0" STUDY_ID="STD-Kayanakis-1987" TOTAL_1="42" TOTAL_2="83" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="856" O_E="0.0" SE="0.0" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="28" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="15.111695347702627" CI_START="0.06313184477482867" EFFECT_SIZE="0.9767441860465116" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.179313189610355" LOG_CI_START="-1.1997515199737272" LOG_EFFECT_SIZE="-0.010219165181686082" ORDER="857" O_E="0.0" SE="1.3974743869699322" STUDY_ID="STD-Kostis-1991" TOTAL_1="43" TOTAL_2="42" VAR="1.9529346622369879" WEIGHT="2.0426591555991895"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="858" O_E="0.0" SE="0.0" STUDY_ID="STD-Kuppers-1997" TOTAL_1="47" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="859" O_E="0.0" SE="0.0" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="44" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="66.3993085345109" CI_START="0.11913009976434784" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8221635567594336" LOG_CI_START="-0.9239784945205962" LOG_EFFECT_SIZE="0.4490925311194189" ORDER="860" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Levine-1995" TOTAL_1="31" TOTAL_2="29" VAR="2.6020833333333333" WEIGHT="1.0420166735239678"/>
<DICH_DATA CI_END="3.8981199813626173" CI_START="0.11862128467332726" EFFECT_SIZE="0.68" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5908552022628226" LOG_CI_START="-0.9258373768503498" LOG_EFFECT_SIZE="-0.16749108729376364" ORDER="861" O_E="0.0" SE="0.8909127287204276" STUDY_ID="STD-Mancia-1997" TOTAL_1="50" TOTAL_2="51" VAR="0.7937254901960783" WEIGHT="5.996754371146596"/>
<DICH_DATA CI_END="13.962365019223395" CI_START="0.059539689568936086" EFFECT_SIZE="0.9117647058823529" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1449589876141004" LOG_CI_START="-1.2251934340300654" LOG_EFFECT_SIZE="-0.04011722320798245" ORDER="862" O_E="0.0" SE="1.3922392649174886" STUDY_ID="STD-Moser-1991" TOTAL_1="34" TOTAL_2="31" VAR="1.9383301707779887" WEIGHT="2.11208764210435"/>
<DICH_DATA CI_END="15.614771657823825" CI_START="0.06404192273275718" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1935356377194557" LOG_CI_START="-1.1935356377194557" LOG_EFFECT_SIZE="0.0" ORDER="863" O_E="0.0" SE="1.402177483386199" STUDY_ID="STD-Mroczek-1991" TOTAL_1="59" TOTAL_2="59" VAR="1.9661016949152543" WEIGHT="2.0189073049526876"/>
<DICH_DATA CI_END="3.911894501982783" CI_START="0.009468070222461135" EFFECT_SIZE="0.19245283018867926" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5923871339927278" LOG_CI_START="-2.0237385296704704" LOG_EFFECT_SIZE="-0.7156756978388714" ORDER="879" O_E="0.0" SE="1.5367251648666533" STUDY_ID="STD-Muiesan-1987" TOTAL_1="52" TOTAL_2="50" VAR="2.361524232334443" WEIGHT="5.144331113581367"/>
<DICH_DATA CI_END="4.450632669395556" CI_START="0.19663048780874626" EFFECT_SIZE="0.9354838709677419" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.648421751497146" LOG_CI_START="-0.7063491433677793" LOG_EFFECT_SIZE="-0.02896369593531662" ORDER="864" O_E="0.0" SE="0.7957991298677433" STUDY_ID="STD-Myers-1996" TOTAL_1="62" TOTAL_2="58" VAR="0.6332962550982573" WEIGHT="6.258612645353332"/>
<DICH_DATA CI_END="14.917636925247036" CI_START="0.061779221777428936" EFFECT_SIZE="0.96" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1737000328145308" LOG_CI_START="-1.209157566735394" LOG_EFFECT_SIZE="-0.017728766960431602" ORDER="865" O_E="0.0" SE="1.3997023493109764" STUDY_ID="STD-Persson-1996" TOTAL_1="50" TOTAL_2="48" VAR="1.9591666666666667" WEIGHT="2.0601094948496814"/>
<DICH_DATA CI_END="7.678236785879494" CI_START="0.03255955852517565" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.885261501010769" LOG_CI_START="-1.4873214923387315" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="866" O_E="0.0" SE="1.3936669947687261" STUDY_ID="STD-Pittrow-1997" TOTAL_1="52" TOTAL_2="26" VAR="1.9423076923076923" WEIGHT="2.6918764066035834"/>
<DICH_DATA CI_END="1.3347403467941887" CI_START="0.06011001342269795" EFFECT_SIZE="0.2832512315270936" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.12539678860529652" LOG_CI_START="-1.2210531750524614" LOG_EFFECT_SIZE="-0.5478281932235824" ORDER="867" O_E="0.0" SE="0.7909113736873794" STUDY_ID="STD-Pool-2001" TOTAL_1="116" TOTAL_2="115" VAR="0.6255408010280574" WEIGHT="14.193530143909804"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="868" O_E="0.0" SE="0.0" STUDY_ID="STD-Prager-1994" TOTAL_1="54" TOTAL_2="53" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="869" O_E="0.0" SE="0.0" STUDY_ID="STD-Uusitupa-1996" TOTAL_1="19" TOTAL_2="20" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.6557887480318043" CI_START="0.09413399321963169" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4241935265646226" LOG_CI_START="-1.0262535178925851" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="880" O_E="0.0" SE="0.8519997737428286" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="83" TOTAL_2="83" VAR="0.7259036144578312" WEIGHT="8.07562921981075"/>
<DICH_DATA CI_END="4.253273056357362" CI_START="0.010543477943512406" EFFECT_SIZE="0.21176470588235294" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6287232649295379" LOG_CI_START="-1.9770161061515112" LOG_EFFECT_SIZE="-0.6741464206109866" ORDER="870" O_E="0.0" SE="1.5306242051909213" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="33" TOTAL_2="35" VAR="2.34281045751634" WEIGHT="4.903060597742241"/>
<DICH_DATA CI_END="4.866701189088486" CI_START="0.04474854101707583" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6872346817861694" LOG_CI_START="-1.349221119869018" LOG_EFFECT_SIZE="-0.3309932190414244" ORDER="871" O_E="0.0" SE="1.1962242185110534" STUDY_ID="STD-Villamil-1987" TOTAL_1="30" TOTAL_2="28" VAR="1.4309523809523808" WEIGHT="4.177049596453837"/>
<DICH_DATA CI_END="1.7998122208818912" CI_START="0.346056821034835" EFFECT_SIZE="0.7892004153686397" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.25522719638725017" LOG_CI_START="-0.4608525860747364" LOG_EFFECT_SIZE="-0.10281269484374313" ORDER="872" O_E="0.0" SE="0.42062880887026155" STUDY_ID="STD-Waeber-1999" TOTAL_1="321" TOTAL_2="304" VAR="0.17692859485161502" WEIGHT="24.885859003768807"/>
<DICH_DATA CI_END="15.815108793485775" CI_START="0.06679227909762638" EFFECT_SIZE="1.0277777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.199072183810896" LOG_CI_START="-1.1752737372114805" LOG_EFFECT_SIZE="0.01189922329970769" ORDER="873" O_E="0.0" SE="1.3947025472104062" STUDY_ID="STD-Whelton-1992" TOTAL_1="36" TOTAL_2="37" VAR="1.9451951951951953" WEIGHT="1.9912510405012807"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="874" O_E="0.0" SE="0.0" STUDY_ID="STD-White-1988" TOTAL_1="9" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="33.96642735829692" CI_START="0.05853132503540649" EFFECT_SIZE="1.41" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.531049869502547" LOG_CI_START="-1.2326116441917871" LOG_EFFECT_SIZE="0.14921911265537988" ORDER="875" O_E="0.0" SE="1.6233884534891783" STUDY_ID="STD-White-2002" TOTAL_1="99" TOTAL_2="46" VAR="2.6353900709219857" WEIGHT="1.3734063298997874"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="876" O_E="0.0" SE="0.0" STUDY_ID="STD-Yodfat-1993" TOTAL_1="48" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.151493360993472" CI_END="1.1944791359573483" CI_START="0.5492833559598402" DF="28.0" EFFECT_SIZE="0.8100046348155439" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="47" I2="0.0" ID="CMP-022.06.04" LOG_CI_END="0.07717856830295061" LOG_CI_START="-0.26020356049859794" LOG_EFFECT_SIZE="-0.09151249609782366" NO="4" P_CHI2="0.9959599224196314" P_Z="0.28766747415027305" STUDIES="38" TAU2="0.0" TOTAL_1="1845" TOTAL_2="1723" WEIGHT="100.00000000000001" Z="1.0632525031733298">
<NAME>1/2 Max Dose</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="881" O_E="0.0" SE="0.0" STUDY_ID="STD-Brown-1990" TOTAL_1="10" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.853594541260966" CI_START="0.009436800535005082" EFFECT_SIZE="0.19069767441860466" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5858660181148891" LOG_CI_START="-2.025175224506629" LOG_EFFECT_SIZE="-0.7196546031958698" ORDER="882" O_E="0.0" SE="1.5337385507784802" STUDY_ID="STD-Chrysant-1996" TOTAL_1="42" TOTAL_2="40" VAR="2.3523539421440725" WEIGHT="4.732165897976894"/>
<DICH_DATA CI_END="73.30314169990443" CI_START="0.12842204919347636" EFFECT_SIZE="3.0681818181818183" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8651225884704998" LOG_CI_START="-0.8913604044528622" LOG_EFFECT_SIZE="0.4868810920088187" ORDER="883" O_E="0.0" SE="1.6191717548540585" STUDY_ID="STD-De-Bruijn-1994" TOTAL_1="43" TOTAL_2="44" VAR="2.6217171717171714" WEIGHT="0.9140363291833081"/>
<DICH_DATA CI_END="9.454427371498973" CI_START="0.27990589240200175" EFFECT_SIZE="1.6267605633802817" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.975635229962736" LOG_CI_START="-0.5529879589445603" LOG_EFFECT_SIZE="0.21132363550908784" ORDER="916" O_E="0.0" SE="0.897920827970967" STUDY_ID="STD-Drayer-1983" TOTAL_1="71" TOTAL_2="77" VAR="0.8062618133040668" WEIGHT="3.547785973040125"/>
<DICH_DATA CI_END="34.65534587289469" CI_START="0.07529768899701761" EFFECT_SIZE="1.6153846153846154" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5397702376208566" LOG_CI_START="-1.1232183527666917" LOG_EFFECT_SIZE="0.2082759424270825" ORDER="917" O_E="0.0" SE="1.564252679999765" STUDY_ID="STD-Dupui-1993" TOTAL_1="12" TOTAL_2="6" VAR="2.4468864468864466" WEIGHT="1.2017500373466903"/>
<DICH_DATA CI_END="6.758250656625501" CI_START="0.14315566392416246" EFFECT_SIZE="0.9836065573770492" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.829834295277077" LOG_CI_START="-0.8441914645313238" LOG_EFFECT_SIZE="-0.007178584627123409" ORDER="884" O_E="0.0" SE="0.9833310178726096" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="61" TOTAL_2="60" VAR="0.9669398907103824" WEIGHT="3.728251864114335"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="885" O_E="0.0" SE="0.0" STUDY_ID="STD-Fernandez-1990" TOTAL_1="6" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.305847014236456" CI_START="0.053191613279225725" EFFECT_SIZE="0.53125" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7247547236276962" LOG_CI_START="-1.2741568375109602" LOG_EFFECT_SIZE="-0.27470105694163205" ORDER="886" O_E="0.0" SE="1.1741705457846552" STUDY_ID="STD-Fernandez-1994" TOTAL_1="16" TOTAL_2="17" VAR="1.3786764705882353" WEIGHT="3.5856411370717103"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="887" O_E="0.0" SE="0.0" STUDY_ID="STD-Ford-1993" TOTAL_1="15" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.509794493265707" CI_START="0.13566435114487724" EFFECT_SIZE="0.9397590361445783" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.813567278606679" LOG_CI_START="-0.8675342579778659" LOG_EFFECT_SIZE="-0.026983489685593488" ORDER="888" O_E="0.0" SE="0.9874873641765766" STUDY_ID="STD-Gradman-1995" TOTAL_1="83" TOTAL_2="78" VAR="0.9751312944084028" WEIGHT="3.812527591009089"/>
<DICH_DATA CI_END="15.174655921154617" CI_START="0.061965966011039465" EFFECT_SIZE="0.9696969696969697" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1811188524169476" LOG_CI_START="-1.2078467755329105" LOG_EFFECT_SIZE="-0.01336396155798149" ORDER="889" O_E="0.0" SE="1.4032902354283254" STUDY_ID="STD-Guitard-1994" TOTAL_1="66" TOTAL_2="64" VAR="1.9692234848484849" WEIGHT="1.8772899991687944"/>
<DICH_DATA CI_END="14.158819821347139" CI_START="0.061221572067659685" EFFECT_SIZE="0.9310344827586207" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1510270551590425" LOG_CI_START="-1.21309552263898" LOG_EFFECT_SIZE="-0.031034233739968786" ORDER="890" O_E="0.0" SE="1.3886973047940554" STUDY_ID="STD-Guntzel-1991" TOTAL_1="29" TOTAL_2="27" VAR="1.9284802043422733" WEIGHT="1.9148764331348365"/>
<DICH_DATA CI_END="6.474871767014122" CI_START="0.07267831101336425" EFFECT_SIZE="0.6859903381642513" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.811231171760296" LOG_CI_START="-1.1385951739080187" LOG_EFFECT_SIZE="-0.16368200107386124" ORDER="891" O_E="0.0" SE="1.1453376472416412" STUDY_ID="STD-Holwerda-1996" TOTAL_1="69" TOTAL_2="142" VAR="1.311798326189018" WEIGHT="3.6275939880534436"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="892" O_E="0.0" SE="0.0" STUDY_ID="STD-Kobrin-1991" TOTAL_1="29" TOTAL_2="28" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.607417460218821" CI_START="0.013336200776381955" EFFECT_SIZE="0.31851851851851853" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8812372490005013" LOG_CI_START="-1.8749678748313403" LOG_EFFECT_SIZE="-0.4968653129154196" ORDER="893" O_E="0.0" SE="1.6190085331742252" STUDY_ID="STD-Kostis-1991" TOTAL_1="44" TOTAL_2="42" VAR="2.621188630490956" WEIGHT="2.8362981650664896"/>
<DICH_DATA CI_END="3.0337474987558988" CI_START="0.03517468449660757" EFFECT_SIZE="0.32666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4819794312758926" LOG_CI_START="-1.4537697893302277" LOG_EFFECT_SIZE="-0.4858951790271676" ORDER="894" O_E="0.0" SE="1.1370686742972156" STUDY_ID="STD-Krum-1998" TOTAL_1="50" TOTAL_2="49" VAR="1.292925170068027" WEIGHT="5.602564276674547"/>
<DICH_DATA CI_END="5.40019320842026" CI_START="0.04629463990476989" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.732409298313654" LOG_CI_START="-1.3344692896416166" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="895" O_E="0.0" SE="1.2140947137789433" STUDY_ID="STD-Kuschnir-1996" TOTAL_1="77" TOTAL_2="77" VAR="1.4740259740259742" WEIGHT="3.697692422605201"/>
<DICH_DATA CI_END="105.88541785315238" CI_START="0.258578237105173" EFFECT_SIZE="5.232558139534884" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.024836154800921" LOG_CI_START="-0.5874080297373694" LOG_EFFECT_SIZE="0.718714062531776" ORDER="896" O_E="0.0" SE="1.534445164815051" STUDY_ID="STD-Lacourciere-1994" TOTAL_1="42" TOTAL_2="44" VAR="2.3545219638242894" WEIGHT="0.9034134896137708"/>
<DICH_DATA CI_END="27.67748496133279" CI_START="0.3110377593004987" EFFECT_SIZE="2.934065934065934" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4421266234638992" LOG_CI_START="-0.507186885376936" LOG_EFFECT_SIZE="0.4674698690434816" ORDER="897" O_E="0.0" SE="1.1450364043505965" STUDY_ID="STD-MacLean-1989" TOTAL_1="91" TOTAL_2="89" VAR="1.3111083672881425" WEIGHT="1.8693889469837404"/>
<DICH_DATA CI_END="3.726439459101925" CI_START="0.006761216321108158" EFFECT_SIZE="0.15873015873015872" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5712940699399335" LOG_CI_START="-2.1699751688470967" LOG_EFFECT_SIZE="-0.7993405494535817" ORDER="898" O_E="0.0" SE="1.6102351203650798" STUDY_ID="STD-Mancia-1992" TOTAL_1="41" TOTAL_2="19" VAR="2.592857142857143" WEIGHT="3.757332622969801"/>
<DICH_DATA CI_END="7.630109995116893" CI_START="0.03179416879689675" EFFECT_SIZE="0.4925373134328358" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8825307987580226" LOG_CI_START="-1.4976525244039007" LOG_EFFECT_SIZE="-0.307560862822939" ORDER="899" O_E="0.0" SE="1.3981314661227826" STUDY_ID="STD-McCarron-1991" TOTAL_1="67" TOTAL_2="33" VAR="1.9547715965626413" WEIGHT="2.4774539231454846"/>
<DICH_DATA CI_END="13.20185019913503" CI_START="0.05616730492272936" EFFECT_SIZE="0.8611111111111112" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1206348005214486" LOG_CI_START="-1.2505164143874776" LOG_EFFECT_SIZE="-0.06494080693301456" ORDER="900" O_E="0.0" SE="1.3928259610253153" STUDY_ID="STD-Moser-1991" TOTAL_1="36" TOTAL_2="31" VAR="1.9399641577060933" WEIGHT="1.9868198091610034"/>
<DICH_DATA CI_END="8.019922762876385" CI_START="0.013854386681307713" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9041701857632025" LOG_CI_START="-1.8584126952025273" LOG_EFFECT_SIZE="-0.4771212547196625" ORDER="901" O_E="0.0" SE="1.622754859285078" STUDY_ID="STD-Mroczek-1991" TOTAL_1="59" TOTAL_2="59" VAR="2.6333333333333333" WEIGHT="2.773269316953901"/>
<DICH_DATA CI_END="3.9093855304869662" CI_START="0.11771051409317983" EFFECT_SIZE="0.6783625730994152" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5921085012091583" LOG_CI_START="-0.929184743539629" LOG_EFFECT_SIZE="-0.16853812116523537" ORDER="902" O_E="0.0" SE="0.8936151824884498" STUDY_ID="STD-Myers-1996" TOTAL_1="57" TOTAL_2="58" VAR="0.7985480943738655" WEIGHT="5.4983078631781686"/>
<DICH_DATA CI_END="10.375684873669314" CI_START="0.3855167199758466" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.016016773050504" LOG_CI_START="-0.4139567817225416" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="903" O_E="0.0" SE="0.8399735445569435" STUDY_ID="STD-Oparil-1999" TOTAL_1="45" TOTAL_2="45" VAR="0.7055555555555555" WEIGHT="3.697692422605201"/>
<DICH_DATA CI_END="14.084399739247377" CI_START="0.058236114729938324" EFFECT_SIZE="0.9056603773584906" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1487383425899753" LOG_CI_START="-1.234807607040379" LOG_EFFECT_SIZE="-0.04303463222520182" ORDER="904" O_E="0.0" SE="1.4001066895556085" STUDY_ID="STD-Persson-1996" TOTAL_1="53" TOTAL_2="48" VAR="1.9602987421383649" WEIGHT="1.9403732514660956"/>
<DICH_DATA CI_END="10.525918116826356" CI_START="0.09500358913123558" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.0222599872327698" LOG_CI_START="-1.0222599872327698" LOG_EFFECT_SIZE="0.0" ORDER="905" O_E="0.0" SE="1.2009611535381535" STUDY_ID="STD-Pittrow-1997" TOTAL_1="52" TOTAL_2="26" VAR="1.4423076923076923" WEIGHT="2.4651282817368005"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="906" O_E="0.0" SE="0.0" STUDY_ID="STD-Pizarro-1996" TOTAL_1="16" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.47367688313985" CI_START="0.12045745704601572" EFFECT_SIZE="2.892857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8418202844479983" LOG_CI_START="-0.9191663093751371" LOG_EFFECT_SIZE="0.46132698753643053" ORDER="907" O_E="0.0" SE="1.6218171923157694" STUDY_ID="STD-Prager-1994" TOTAL_1="55" TOTAL_2="53" VAR="2.630291005291005" WEIGHT="0.9412307984813238"/>
<DICH_DATA CI_END="67.97222226906672" CI_START="0.11810380049073549" EFFECT_SIZE="2.8333333333333335" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8323314688838053" LOG_CI_START="-0.9277361268945442" LOG_EFFECT_SIZE="0.4522976709946303" ORDER="908" O_E="0.0" SE="1.6212773683151482" STUDY_ID="STD-Prichard-2002" TOTAL_1="53" TOTAL_2="50" VAR="2.628540305010893" WEIGHT="0.9508351943841945"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="909" O_E="0.0" SE="0.0" STUDY_ID="STD-Reimann-1995" TOTAL_1="27" TOTAL_2="26" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="910" O_E="0.0" SE="0.0" STUDY_ID="STD-Sassano-1984" TOTAL_1="53" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.973644664227679" CI_START="0.18433895853142787" EFFECT_SIZE="0.6031746031746031" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2952689648198093" LOG_CI_START="-0.7343828704933524" LOG_EFFECT_SIZE="-0.21955695283677154" ORDER="911" O_E="0.0" SE="0.6048225849217371" STUDY_ID="STD-Smith-1998" TOTAL_1="72" TOTAL_2="76" VAR="0.36581035923141186" WEIGHT="12.59214176346636"/>
<DICH_DATA CI_END="8.143906058223955" CI_START="0.014285425381653886" EFFECT_SIZE="0.34108527131782945" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9108327553376903" LOG_CI_START="-1.8451068229638132" LOG_EFFECT_SIZE="-0.46713703381306154" ORDER="912" O_E="0.0" SE="1.6188525504152331" STUDY_ID="STD-Smith-2000" TOTAL_1="42" TOTAL_2="43" VAR="2.620683579985905" WEIGHT="2.7413926581383388"/>
<DICH_DATA CI_END="1.88187685933181" CI_START="0.1237394236911175" EFFECT_SIZE="0.48255813953488375" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.27459120194864256" LOG_CI_START="-0.9074919110115924" LOG_EFFECT_SIZE="-0.31645035453147496" ORDER="918" O_E="0.0" SE="0.6943614719586215" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="172" TOTAL_2="83" VAR="0.4821378537405436" WEIGHT="9.976519163734817"/>
<DICH_DATA CI_END="4.513786041253587" CI_START="0.011215640160458343" EFFECT_SIZE="0.225" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6545409691623963" LOG_CI_START="-1.9501759329396713" LOG_EFFECT_SIZE="-0.6478174818886375" ORDER="913" O_E="0.0" SE="1.5300236018513644" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" VAR="2.3409722222222222" WEIGHT="4.350226379535531"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="914" O_E="0.0" SE="0.0" STUDY_ID="STD-Yodfat-1993" TOTAL_1="46" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="915" O_E="0.0" SE="0.0" STUDY_ID="STD-Zamboulis-1996" TOTAL_1="12" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.689227891154154" CI_END="2.3523223818961063" CI_START="0.5635992656212154" DF="6.0" EFFECT_SIZE="1.1514196311254181" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" I2="0.0" ID="CMP-022.06.05" LOG_CI_END="0.37149684082422296" LOG_CI_START="-0.24902958145491244" LOG_EFFECT_SIZE="0.06123362968465527" NO="5" P_CHI2="0.9459498845912323" P_Z="0.6988902020695642" STUDIES="8" TAU2="0.0" TOTAL_1="418" TOTAL_2="422" WEIGHT="100.0" Z="0.3868190121019525">
<NAME>Max Dose</NAME>
<DICH_DATA CI_END="7.101810115908761" CI_START="0.15068757970397142" EFFECT_SIZE="1.0344827586206897" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8513690562061662" LOG_CI_START="-0.8219225425647535" LOG_EFFECT_SIZE="0.014723256820706378" ORDER="919" O_E="0.0" SE="0.9828997680450374" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="58" TOTAL_2="60" VAR="0.9660919540229884" WEIGHT="14.585562899278752"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="920" O_E="0.0" SE="0.0" STUDY_ID="STD-Ford-1993" TOTAL_1="16" TOTAL_2="16" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="78.2557637637867" CI_START="0.1368684335377907" EFFECT_SIZE="3.272727272727273" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8935163344436925" LOG_CI_START="-0.8636967032255681" LOG_EFFECT_SIZE="0.5149098156090622" ORDER="921" O_E="0.0" SE="1.6196005867515793" STUDY_ID="STD-Gomez-1989" TOTAL_1="43" TOTAL_2="47" VAR="2.62310606060606" WEIGHT="3.5479873769235044"/>
<DICH_DATA CI_END="21.50889698600391" CI_START="0.18596955495220638" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3326181395750694" LOG_CI_START="-0.730558148247107" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="922" O_E="0.0" SE="1.2119199643540823" STUDY_ID="STD-Guitard-1994" TOTAL_1="64" TOTAL_2="64" VAR="1.46875" WEIGHT="7.418519060840055"/>
<DICH_DATA CI_END="15.880747965636855" CI_START="0.06515940093125934" EFFECT_SIZE="1.0172413793103448" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2008709533617878" LOG_CI_START="-1.1860229172033738" LOG_EFFECT_SIZE="0.0074240180792068755" ORDER="923" O_E="0.0" SE="1.4020732748851903" STUDY_ID="STD-Mroczek-1991" TOTAL_1="58" TOTAL_2="59" VAR="1.9658094681472824" WEIGHT="7.355112915020909"/>
<DICH_DATA CI_END="6.543331964594326" CI_START="0.41025181305701997" EFFECT_SIZE="1.6384180790960452" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8157989540343131" LOG_CI_START="-0.38694949096001424" LOG_EFFECT_SIZE="0.21442473153714944" ORDER="924" O_E="0.0" SE="0.7065003902904907" STUDY_ID="STD-Myers-1996" TOTAL_1="59" TOTAL_2="58" VAR="0.4991428014806157" WEIGHT="22.4457756199776"/>
<DICH_DATA CI_END="3.0322027011509056" CI_START="0.16133941130554896" EFFECT_SIZE="0.699438202247191" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.48175823028745723" LOG_CI_START="-0.7922595320417348" LOG_EFFECT_SIZE="-0.15525065087713882" ORDER="926" O_E="0.0" SE="0.7483643400818007" STUDY_ID="STD-VA-Study-Group-1984" TOTAL_1="89" TOTAL_2="83" VAR="0.5600491855060691" WEIGHT="30.70921843789604"/>
<DICH_DATA CI_END="5.926850467224469" CI_START="0.053768601333855075" EFFECT_SIZE="0.5645161290322581" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7728239702492266" LOG_CI_START="-1.2694712605451828" LOG_EFFECT_SIZE="-0.24832364514797822" ORDER="925" O_E="0.0" SE="1.199654328093073" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="31" TOTAL_2="35" VAR="1.4391705069124425" WEIGHT="13.937823690063134"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5198586728333114" CI_END="3.3411072990807034" CI_START="0.6792401959840122" DF="4.0" EFFECT_SIZE="1.5064575588549418" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="10" I2="0.0" ID="CMP-022.06.06" LOG_CI_END="0.5238904231539616" LOG_CI_START="-0.16797662138378847" LOG_EFFECT_SIZE="0.17795690088508653" NO="6" P_CHI2="0.9715391755329585" P_Z="0.3133321944647246" STUDIES="5" TAU2="0.0" TOTAL_1="273" TOTAL_2="294" WEIGHT="100.0" Z="1.0082547486220177">
<NAME>2 Max Dose</NAME>
<DICH_DATA CI_END="9.72413458078874" CI_START="0.28814748025622056" EFFECT_SIZE="1.673913043478261" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.987850960793415" LOG_CI_START="-0.5403851738115992" LOG_EFFECT_SIZE="0.22373289349090783" ORDER="931" O_E="0.0" SE="0.8976934703578565" STUDY_ID="STD-Drayer-1983" TOTAL_1="69" TOTAL_2="77" VAR="0.8058535667231319" WEIGHT="19.715765221640563"/>
<DICH_DATA CI_END="8.37970268699805" CI_START="0.17892941030409548" EFFECT_SIZE="1.2244897959183674" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.9232286100757728" LOG_CI_START="-0.7473182693655128" LOG_EFFECT_SIZE="0.08795517035512998" ORDER="927" O_E="0.0" SE="0.9812875063242307" STUDY_ID="STD-Fairhurst-1994" TOTAL_1="49" TOTAL_2="60" VAR="0.9629251700680271" WEIGHT="18.753700890256162"/>
<DICH_DATA CI_END="27.2414553750772" CI_START="0.3106592434520908" EFFECT_SIZE="2.909090909090909" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.435230306048416" LOG_CI_START="-0.5077157197250538" LOG_EFFECT_SIZE="0.4637572931616809" ORDER="928" O_E="0.0" SE="1.1412961132772765" STUDY_ID="STD-Guitard-1994" TOTAL_1="66" TOTAL_2="64" VAR="1.3025568181818181" WEIGHT="10.589805667543391"/>
<DICH_DATA CI_END="5.7933006065114725" CI_START="0.3177296065492183" EFFECT_SIZE="1.3567251461988303" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7629260640353979" LOG_CI_START="-0.49794231503790615" LOG_EFFECT_SIZE="0.1324918744987458" ORDER="929" O_E="0.0" SE="0.7406403272667952" STUDY_ID="STD-Myers-1996" TOTAL_1="57" TOTAL_2="58" VAR="0.5485480943738655" WEIGHT="31.015992093476893"/>
<DICH_DATA CI_END="7.3158866088366326" CI_START="0.1635193554059517" EFFECT_SIZE="1.09375" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.864266965593584" LOG_CI_START="-0.7864308335328447" LOG_EFFECT_SIZE="0.03891806603036966" ORDER="930" O_E="0.0" SE="0.9696280582927514" STUDY_ID="STD-Vandenburg-1994" TOTAL_1="32" TOTAL_2="35" VAR="0.9401785714285714" WEIGHT="19.924736127082998"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-08-12 14:29:30 -0700" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="ACEI-quorom.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2008-08-12 14:29:30 -0700" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>QUOROM flow diagram</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-02" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Number of included studies according to publication year</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-03" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Number of included studies according to ACE inhibitor studied</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-04" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of benazepril 2 - 80 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-05" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of captopril 37.5 - 200 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a
HBwgJC4nICIsIxwcKDcpLDAxNDQ0Hyc5PTgyPC4zNDL/2wBDAQkJCQwLDBgNDRgyIRwhMjIyMjIy
MjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjL/wAARCAH0A4QDASIA
AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA
AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3
ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm
p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA
AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx
BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK
U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3
uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3+iii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKK5TxJ8Q/DHhMFNU1JPtIGRawjzJT/wABHT8cV5/J+0foSzYi0TUnj7MzIpP4ZP8AOgD2
uivOfDnxk8H+IJVg+3Pp9w3AjvlEYJ9mBK/qK9DVgyhlIIIyCO9AD6KKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPN5/BPgbwPZXviHUdNFyEfzp7m8X7Q4LMB
kKeOrdhmqcfxn+G8aBI5WRAMBRYMAP0rY+LN89j8MNanS3jnJRI9siB1G51G4g5HGcj3xXNeFfBn
wyuvBFnczQ6dP5lsrXNxPc7XV8fPk7hsIOeBjFAEN34u+Dfikrb6hFZo8hx5slm8LD6yKBj88V6d
oWk2eiaBZ6bp7tJZwJthZ33kqeRz3HP5V846faeFZvA/jUT2du8WmzlNJ1LYVll3l/LUkdfuDr2b
0r3f4XSzzfDLw81wSZPsigE/3QSF/wDHQKAOwooooAKKKKACiiigAooooAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooo
oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiig
AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAC
iiigAooooAKKKKACiiigAooooA861b4p/D24ivNK1TVVZCXt7iB7SYjjIYfcryO60D4LzXRlg8Xa
nbwk58oW7sAPQExZ/PJr2Sb4PeB7u4lup9F3zTSGSRvtUwyxOT/H615d8IPAXhrxT/wkP9s6b9p+
x3axwfvpE2L83HysM9B1zQB2nh7QPh14v8Kt4d0C4nm0+xuI7m52B43lchgu9mUE556YxgdK9Ptb
WCytIbS2iWKCFBHHGowFUDAArG8NeCdA8INc/wBhWBtPtO3zf3zvu25x94n+8a6SgAooooAKKKyN
a8R6N4dt0m1fUreyjc4QzPgsfYdTQBr0Vj6L4k0bxFA82kalb3kaHDmJ8lT7jqK2KACiiigAoooo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigDwzUtJ+Nj6ldvY6kq2hncwL5sHCbjt6j0xXP6
H4B+L3h37V/Y8sVp9qcSTbbiE72555z6mvpOigDz/wCHFp47tW1L/hNboTbvL+y4eNsfe3/cA/2a
9AoooAKKKKACvO9f+Gln4k8b2/iLWL03Nlbw+WNOlj/d4APO7d0ycnjmvRK8B+Nvj65XUf8AhE7K
aa3tlCnUZoh87hgCEHTjacnkZzjoDkAb4JOlxfGjWdR8M7bbwzZ2j/apFbEPCjOPbcCR7KSOK7tv
jh4BViv9sSHBxkWkuD/47XM/DjxT4Kv0XwTo2i38MN3BIJ5LpU/f/Idxchickceg6DFa5/Z/8Ekk
/wDEyAPOBcjH/oNAHUeGviD4a8W3c1rot/59xEnmNG0TIdvAyNwGeorrK+ZfgfbpafFvU7aLPlw2
1xGuTzgSIBX01QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByvj3xG/hDwZf6zDEs
s0AVY0b7pZmCjPsM15dZ6l8cdWtYr61ht4reZA8e5LdcqRkcN8w/GvRviff2enfDbWZr61F3C0Qi
8ktjczMApyPQkH8K8r8OXnxrTQrJNOshJZrAv2drgQBjHgbfvEHpjrzigD0z4ef8J9u1H/hN/K/5
Z/ZPL8r/AGt/3P8AgPWu9rg/h5P4+nOo/wDCb28UOPL+yeX5fP3t33Cf9nrXeUAFFFFABTNik5Kg
++KfXC+NviLZ+Dp7Oy+xXGpapef6izt/vEZxk9ep4AAJNAHcBVByFGfpTq4TwR8RbLxjPeWf2K40
3VLM4nsrj7wGcZHToeCCARXd0AfNPwW/5LRrP/XG6/8ARq19LV80/Bb/AJLRrP8A1xuv/Rq19LUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAVFJIkSF3ZURRksxwBUtcp8TP+SZ+Iv+vGT+VAG/8A2rp//P8A2v8A3+X/
ABqSC6trkHyJ4pdvXy3DY/Kvgivf/wBmf/mZv+3b/wBq0AfQFFFFAFHVNTtNH02fUL6ZYbWBC8jn
sK84tvHPjjxGhv8Awz4NiOlNzDNqFyI3nX1VcjAP4j3p/wAc3dvB+nWe4rb3mqwQzkHHyYY/zA/K
vSoYY7eCOGFAkcahUUDAAAwBQBx3hHx0PEd5c6Pf6dLpWvWIBuLGVt2V4+ZG7jkfmOoOas+CPF8v
iyPWGltUt/sGoSWa7HLbwuPmPp1re/sXTP7b/tn7FD/aXleT9p2/Ps9M+leM/D7wtceI7nxUtzrW
pWemR6zPi3sZvJMkhPLOw5IA24HTPNAHvFFeW+BLrW7LUfF/hd9Ql1OTSHT+z5rxyTiRGKq7dcAh
efrj0rFmsNFgsHl8ZfES6j15txmFlqm1bds8BIk6AcdvyoA9sorwqPxZq+ofADVdSbVLg39rcC3j
vo3KSOoljwcjByVbH861tW8JasPBM/iefxXrf9vw2RvQ0dxsgUqm/wAsRgY29vc8n0oA9forx/UP
FeseIdJ8D6Ja3rWOoeIovMu7yAYeONFy+z0Lc/TFZ3xF8Pan4J8K/wBoeH/E2tpC08cV1FPeM5OT
w6twVOeDjgg+1AHuNFeQ+OPEy3Pjy38K3HiFtB0mG1+0311HL5UszH7sSv24IP0z6VmReJNN8K+L
NDTw34ul1jStRuRa3lhcXf2hoSxAWRCeVGTz/wDX4APcawdP1LWJ/FGqWN1pPkaZAqG1vfMz55IG
4Y7YOa3q828Naldz/F7xlYy3lxJaW8NsYYHkYxxkoudq9Bn260Aek0V4j4F0LVfHWl382t+JtZW0
t7+eC2htrooxOclnfktjIAHQY966j4XX+qsfEOianfy3zaPqDW0NxMcuydtx7nj9aAO+mmjt4JJp
nCRxqWdj0UAZJrzS18feMvEwe88J+E4ZdIDFYrq/uRG0+DjKrkYH5/0r0e+tItQsLiynBMVxE0Tg
HB2sMH+deV6ZZ/Eb4eWg0qw0ux8R6Jblvs5SXyp1QknBBPXk8AN9aAOn8HeN5de1K70TVtLk0nXb
JQ81q7b1dD/GjdxyPzHJrDT4ieMNT1zWrHQfCNtqEOmXj2ryNfLGTgkA4bHXFXvCXi3RPEniacXG
jS6T4pt4PLkiu4wJTFkEhW4yM49PpiuQ8Kav4n0zxf44Xw/4ZTWI31iQyu18kHlnc2BhuuaAOx0X
x/qJ8SWnh7xX4ek0W9vQxtJVnEsUxHJXI6H8T26ZFJ4m8deINM8bReGNB8Pw6pcyWYu/nuREQMsD
97jsO/euXutW1XUPiT4cl8a6U2gWlrIx09EYTJPcNgANKpwOgOMfzzU3inW08O/Hi11B9P1C/A0X
Z5NhD5snLvztyOKANK7+IXjTQLc3/iDwEYdNjI86a1vkkaMeu0Z4/Ie9ek6dqFtqum22oWkgktrm
NZY3HdSMivMPEXjvVPFWgXuhaB4L8Qi6voWtzLfWohijVhtLFiSOhPXFd74Q0NvDfhHS9HeQPJaw
KjuOhbq2PbJNAG/RRRQAUUUUAFFFFABRRRQByPxCsbzUvAWr2Wn2Ud9dTRBI7dxw2WHTkcgZIOeo
ryvSdU+NOkWFvYxaEs0VugjR540Z9o4AJDjOK9b8eeJT4R8G3+tJCJpIAojjboWZgoz7c15Vaa/8
btXto72z0y3S3mQPHmOFMqRkHDtn86AO9+HWp+ONROonxlpsdn5fl/ZdkYXdndu6Mf8AZrv64L4e
TePZjqP/AAm9vFFjy/snl+Vz97f9wn/Z613tABRRRQAV4jef6T+1LZrMNywWn7sHt+5Y/wAya9ur
yX4geDfEA8ZaZ408Jwx3Oo2i+XNayOF8xQCMgkjqrFSMg9MUAYFxenRP2jdZvIIHlC6a80kMP3pd
turYHuSo/Gspv2kdV3HHh6zC54BmbP8AKu38AeEfEDeM9T8beK4YrXUbxPLhtY3DCNcKMnBOOFAA
znrmvTTYWZOTawE5znyxQB8eeE/Hlz4S8V3niCCyiuJblZFMUjEKN7Bu30r6k8NeJn17wTF4kbTp
oneB5fswOWbbnhT3Bxx9a8P+DcEUvxh1mOSJHQQ3PysuQP3q19LKoVQAAABgAdqAPnf/AIaN1X7R
/wAi7aeXu+757bsemcdfw/CvYfEHip9C8ETeJBp0szJbpN9lY7WXdjhuOMbufoa3/sNpv3/ZYN2c
7vLGc1YIDKQQCCO/egDwTQPj1qWqa/Y6fPoMJS5nWI/Z5GLjccZAI5x6V6J8S/G03gTQINQg043s
k04iG4lUTgnLEfTiuwSytYnDx20KMOjLGARU0kaSoUkRXU9QwyDQB414G+NF/wCLfFVto1zocca3
Ab97buzGPAJywI6cY/Gtn4nfFC68A3lha2+lLdG5jaQyzOVQYONowOT6+mR616PFa28BLQwRRkjq
iAE06WCGcASxJIAcgOoOKAPNvhl8T7vx7f39pdaUlqbaJZRLC5ZTk42nI4P+BrI8f/Ge+8H+LLjR
LXRI5hAqHzriRl8wsoOVA7c4+oNewRQQwAiKJIwTkhFAzTZbW3nIaaCKQgYy6A4oA474aeNZ/HWg
Tajcad9jeGcwkKSyPwDlSfrzXnuv/HzUtH8QahpsOhQhLWd4QbiRg52nGSAOM9a94jjSJAkaKijo
FGAKheytZXLyW0LserNGCTQBzvhzxS+t+BrfxG9hLC8lu8xtQdzEru4XgZztyPYivIP+Gj9V8/8A
5F608vd9zz23Y9M46/hX0QoCqAAAAOAO1QfYbTdv+ywbs5z5YzQBz3iDxW+ieApvEyafLKyW8cwt
WO1hv28MecY3c/SvLNA+PWpap4gsLCfQITHczrCfs8jFxuIGQCOcele9sAykEAgjkHvUEdlaxOHj
toUYdGWMAigDiviT45n8CaJbX0GnfbHnm8oFmKonGfmI9ew+vpXMfD/4yX3jDxVb6Lc6JHEs6Owm
t5C3l7Vzlge3GPqRXr8saSxlJEV1PZhkGqkRggYmK3jjJHVFAzUyko7kynGO5wXxO+Jd14CvbC1t
tKW6a5jaQyzOVQYONowOT/LI9aT4Y/Ey68fXd/bXWmLatbRrIJYnLIcnG05HB/nz6V38ssM4AlgW
QA5AcA4oimggUiKBYweyAAGp9pHuR7aHc8q+IHxlvvCHim40W20SOVYFQmW4kK+ZuXOVA7c4+oNd
b8NfHE3jnQp7+4sPsbwzmE7WLI/AOQT9a6eVraZg0ttG5Axl1BxT47iOKMJHEEUfwrwBR7WPcPaw
7nh+vfHzUtM169sIdBgCW07xD7RIwc7SRkgdPpXqXh7xY+teAofEzadLGz20k/2RDuZim7heBnO3
j6itl/skrl5LWJ2PUsgJNTrdIqgBMAdAO1HtI9w9tDueAj9o7VDOP+KdtPL3fdE7bsemcdfwr2Tx
J4nfQPBNx4hSwlleOBJhbN8rAtj73pjPP0Nae2z3b/scO7Oc7Bn+VTtdoykFMg9j3o9pHuHtodzx
Hw/8edS1jxDp+mzaDDsu51hJt5GLjccZAI5x1r0H4l+NZ/Augwahb6d9seacQ/MSqJwTliPpxXTx
/Y4nDx2sSMO6oARUklxHLGUkiDqf4W5Bo9pHuHtodzyjwB8ZL7xh4qt9FutDjiWZHImgkLbNozlg
e3GPqRWp8TPibdeAL+xs7bSlujcxGUyzSFUGDjaMDk8ZP1HrXoETW0LForeOMkYyigZpZZYJwBLA
kgB4DgHFHtI9w9tDucD8MfiZdePru/trnTFtWto1kEsTlkOTjacjg/z59KxvHPxnv/Cvim50a20K
ORbfbmW4dlMmQDlQB05616xFNDACIoFjB5wgABpsptpmDS28cjAYy6g4o9pHuHtYdzlvhv42n8d6
FNqM2nGyeGcwnaSyPwDlSR78157r3x91HTNevrCHQoVjtpmiH2iRg52nGSAOM+n617clxHEgSOIK
o6BeAKif7JK5eS1idj1LICTR7SPcPbQ7mR4f8VvrngSHxG2nTRu9s85tUO5mK7uF6Zzt4+oryD/h
o7VPP/5F608vd93z23Y9M46/hXvou1UABMAe/SoNtnu3/Y4d2c52DP8AKj2ke4e1h3MrxN4ok0Dw
TN4jTTpZ3SBJfsxOCu7H3j2Azz9K8s8O/HnU9Y8Q6fp82gQeXdTpCTBIxcbiBkA9cZr29rtHUgpk
Ecg1DH9kicPHaxIw6FUAIo9pHuHtodzlviT47n8C6HbX1vp32x55vK+ZiqJxnkj17Vy/w9+Ml74y
8Uw6Nc6NHCssbsJoJC2zaM5YHsen1Ir1SS4imjKSRB1P8Lcg02JraAkxW0cZPXYoGaPaR7h7aHc4
L4lfE278B3lha22lpdG5jaQyzOVQYONowOT/APW9aX4X/Em58e3F/DdaWtq1squJInLIc8YOeh/n
z6V30ssM4AlgWQA5AcA4pIpoYFIigWME9EAANHtI9w9tDueT+O/jNf8AhPxbc6LbaLFKtuFzLcSM
vmZUNlQO3OO/Suv+G3jibxz4em1GfTzZyQz+UdpLI/AOVJ+vPpXTym2nYNLbxuwGMuoOKtQBBCoj
RUUdFAwBVRnGWxUakZOyZ4RrH7QGpadrd7Zw+HoFS3maICeVg/ykjkAcH2r1TQfFj6x8P08UNps0
TG1kuDaKdzNs3cKcc7tvHsRXRPZWsrF5LaF2PVmjBJqwAFUAAADsO1UWfOy/tHaoZwD4dtDHu+4J
23Y9M46/hXsXiXxQ3h7wTP4iTT5ZnjhSX7MflZd5H3j2xnn6VvfYbQNvFtAGznd5YzmrDAMpBAII
5B70AeD+HPj1qWs+ItP02fQoCl3OkJMEjF13EDIB64613/xK8dT+BNDt7+3077Y80/lfMxCJwT8x
Hr2rso7O2iffHbQow6FYwDUskSSoUkRXU9VYZBoA8f8Ah78Zb7xl4ph0W50aOFZY3YTQSFtm0Zyw
PY9PqRWl8TvifdeAdRsbO10pLo3ERlMszlVHONox1Pc/UetelRWtvAS0MEUZIxlEAzTpYIZwBNEk
gByA6g4oA83+GPxKuvH1xqEF1pS2rWyq4ljcshycbTkcH+fPpWL48+NF94T8XXWjW2iRyLbhf3tw
7KXyAcqB25/HFexRQRQKRFEkYJyQigA0ktpbzsGlgikYDALoDigDkPhv41m8c+HZdSnsDZyRTmEh
WJR8AHKk/XFeb678ftS0zXr2xh0GAJbTvEPPlYOdpIyQOn0r3uONIkCRoqKOiqMAVC9layuXktoX
Y9WaMEmgDn9G8VNqvgOPxO2nzozWj3JtFO5m27uF9c44+orx5f2jdU+0DPh20MZb7onbdj0zjr+H
4V9FAAAADAqr9htA28W0AbOd3ljOaAOc8UeLZPDvgaTxGmmyzusUcn2ZjtKF8fePOMZ5rzDw78eN
S1fxHYafNoMJjup1hP2eRi43EDIB6464r3plDqVYAgjBBHWoI7O2iffHbQo3qsYBFAHF/Evx7ceA
dGtbuDTvtj3ExiBdiqJgZ5IHU9h9fSua+H/xkvfGniuPRbrRY4FkjdxNBIW2bRn5gR0PT6kV6/JF
HMhSRFdT2YZFRxW0EBJhgjjJ6lEAzQBYooooAKKKKACsHxdo8+v+EtU0q2eNJru3aJGkJCgkdTit
6igD5k/4Zw8Uf9BXSP8AvuT/AOIr0v4SfDrVPAB1cajdWk/23ytn2dmONm/Ocgf3hXqFFABRRRQB
zHjzwuvi/wAI3mkh1jnfbJBI3RJFOQf5j8a5Cy+JWtaFZR6d4m8Ja6+pwKEM9lAJorgjjcGz368Z
/pXq1FAHmXhCw8R674zuPFuu29xpditv9m0/TZJCH25zvkX15PXnJ9gTL8K9OvNNi8Ti9sri2M2t
TyxedEU8xDjDDPUe9ekUUAeSR6Jrs3iL4lixguLWe/t4Fsbh1ZFkYRsDsbp3xkdCax/B93pujaFa
abD8OtQm8URIEkebTlAaX++0zdFzzntXudFAHgVtoOuR/ArxPo9zpN5/an9pE+Qlu5Mv72I7kGPm
Xg8jPAr1HWbaaX4a6haxQSPcNpEkSxKpLl/JIC465zxiusooA8YXwzrVr4U8D+IdP02SXVNChxPp
0gMckkTDDqAejDng+v4HL+KHivVPEPg5IYvDOq6ZZLdRfaJ9SjEJLZO1EXJLc859vevTvGPhi58Q
DT7vTdRfTtU02YzW0+zehJ4KuvcHArEm8F+JvE19Y/8ACYaxYy6dZTLcLZafbsgmkXoXZjnHXgfp
QBQ8YaPc6L4+g8XJoTa5plxZi1vrWOETSxEHKyKp69APz9aLDUj4i8R6bF4b8HRWOnwyiS+vtT0x
YsKMYWIdd3Xnscdq9XooAK828NabdwfF7xlfS2dxHaXENsIZ3jYRyEIudrdDj26V6TRQB578KNPv
NN8KXkN5aT2srancOqTxFCVJGDg84PrR4B0+8svEvjWW6tJ4I7jVS8LyRlRKuD8yk9R7ivQqKAMn
XtOk1bQr7TobiS1luIWjjnjYq0bEcMCOeDivONH8da/4N0yHRPFfhfW7q4tB5SX1hF9ojuFH3TuJ
HOMd8+oB4r12igDyzQbfV/FvxHtvGF3o1xo+n2Fo1vbR3a7Z7hmzksvYAMf6Z5xi6BrmqeDfFPjD
zvCfiG+jv9UeaGW0s2ZCu5ucnGc5HSvbaKAPG9cfXvideaNp0XhrUdG0u0vUu7m71FPLf5cjai9e
5/HHTFbM+m3zfHq21JbO4NimimI3IiPlh97fLuxjPPSvS6KACiiigAooooAKKKKACiiigAooooA4
v4pXtjY/DjWZdQtftUDRCPytxXLswCnPbDYP4V5V4d1z4xQ6FZRWGji4tEhX7PLcRJuMeBt6sM8Y
969a+I1hd6j4B1izsdPW/uJYgsdswPzHcORgjkfeHuK8s0nXvjJpWl29hH4aE8dvGI43nt8vtAAA
JDjtQB6L8O9R8c37aifGenRWezy/suxVG7O7d0Y/7Nd7XBfDrWfG2rjUf+Ew0mPT/K8v7NsiKb87
t38R6YX8672gAooooAKKK8r8cal441DxjZ+G/CyzadZtH5k+qvbkxk4J2hyCOBjgckmgD1SivH/B
viXxTpfxEuPBPia8i1RvJMsN0ihWX5Q3OAOCM9ec98V7BQB80/Bb/ktGs/8AXG6/9GrX0tXzT8Fv
+S0az/1xuv8A0atfS1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA1vumsvvWo33TWX3rnr9
DlxPQKKKKwOUKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAq/bf6
lfpVCr9t/qV+lbUdzow/xE9FFFdJ2BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAJRWDfeI7DT9W07TbiYJc6gXEC+pUZOfT0+tblJxlFJtb7BcfRRRTAKK5fx14oj8I
eFbvVmjEsyYjgiJ4kkY4UfzJ9ga5Wy8BeI9esY9Q8TeMdag1CYCQW2mziCK3J5C4A5I6Z/n1oA9S
orzvwgfF2i+KL3w5rj3Oq6WsQmstXePHGf8AVu3duvqePQjGD4L+IljpFr4hk8U6+wKa1PFbLMzS
OI1xwqjJ2jP0FAHsVFY+h6/pXiLTlvtJvoru3J27488H0IPIPsawtQ+KvgjTL5rO51+Dzkba4jje
RVPuyqR+tAHa0VhS+I9Gg0D+35dQhGl7Q32pSWTBO0HjPc4rKu/if4LsdU/s2fxDbLc52nAZkU+h
cDaPxNAHZUVl6jq2n6VpjahfXkNvZooYzSP8uD0+ua5u1+KXgy9tZ7iHX7fy4SA+9HRhkgDCkAkZ
I5GaAO4orG1zxDpHh6w+2avfw2kBOFaQ8sfRQOSfpVPw7448OeK2kj0XVIrmSMZaMqyOB67WAOPe
gDpaKK5TSHtz471xY/EM93OI4vM0pgdlmNowV7fN1/GgDq6K429+JHg/TrSO5uddgWOSR41Co7sS
pw3yqCcA98Yrc0fWtN16xS+0q8iu7ZyQJIzkZHUHuD7GgDWorJ8QSyQ+HNUmhdkkjtJXR1PKsEJB
FeW+B/Cut+K/B2n61ceO/EkE10HLRx3OVXDsvfntQB7RRXlNnqfiPwL4z07Q9e1Z9Y0XV2MVneSo
FlhlGPlb1ByB365GMEVX8SRavrvxlXw/b+I9V0qy/soXOLKYrlwxHTpz/SgD16ivGvFtj4j+HGkp
4js/GOpalDbzRrPZaiRIsyscYB7Hntz3zxWp8UtQ1Er4Ut9O1O80wanqSQSvbSFHCuAO3pn86APU
aK82k+G+uJGzWvxE8RicAmMzTB0z7juKtfCzxNqPibw1cf2syvqGn3b2c0qAASlQDu44zzj8M96A
O/ooooAKKKKACiiigAooooA8f1Txv498FXMq694bj1jTQ5Md/YkrhOcbsAgEe4H1PWq6ftG+HCo8
zR9VVu4URkD/AMeFe0VnvpGmSymWTTrR5Ccl2hUk/jigDym2+MPiLxPMbfwl4LuJy3C3N1IRGvu2
AAP++q9O0IanHotomryQS6iE/wBIeAYQtk/d9hwK1FRY0CIoVQMAAYAqSgAooooA818ZeLvHWj6/
JZ6D4S/tKwWNWW48tzlj1HBxxS+LviRL4Y8M6W0tju8S6lAhj04Z/dyMBncOuAxwB1J49SPSa808
WfB7SvGHiGfWL/VdSSaQKojhZAkaqMADKk+p+pNAGd4I8Aa3p1vq/iPVrxG8X6pbyCJ3wwtWI4z7
525xwAMCuFfwV8bGlLf2lqWS2crrAA/LfXpnhH4P6P4P8Qw61Z6lqM08SOgSdkKkMMdlBr0qgD5i
+BCTxfFK+iuSTMlnMshJySwkTPPfnNfTtfNPwW/5LRrP/XG6/wDRq19LUAFFFFABRRRQAUUUUAQk
+nWvHda8QfFbR7O8v7rT9MjsrcF2ZSrYXPpvya9kPNcn8Sv+Sd63/wBex/mK3wdRRqxi4qSk0tVe
2vQmS0vc4bQvEPxU1q1s9RtbDS5LGf5lZiq5XODxvyOhr2MH161yHwt/5Jxo3/XE/wDobV2AGKMZ
UUqsoqKiotrRWvr1CK0vclooorAoKKKKAGt901l961G+6ay+9c9focuJ6BRRRWByhRRRQAUUUUAF
FFYmvald6Rolxe2WnS6jcRgFbaInc2SB6E8de9XTpuc1GO7KNrvS4ryS7+LmuWDwpeeDbi3aY7Yl
mkdN7ei5TnqK6Hwx4y13XNYWzv8AwneabAULG4k3AKR2O5R16etd1TAVKdNzlbl33X4a6hY7qiii
vOJCiiigAoqpf6hZ6ZbG5v7qG2gUgGSZwoBPuay/+E48Lf8AQwab/wCBC/41tDDVprmjFteSbKN+
isvT/EWjatMYdO1SzupVG4pDKGIHrgVqVE6c6b5Zpp+YBRRRUEhRRRQAUUUUAFX7b/Ur9KoVftv9
Sv0rajudGH+InooorpOwKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACon
kEalmICgZJJ6VLVG+s4tQsZ7Off5U8bRvsYqSCMHBHIoVr67AfL3jbxjca944k1izmKxWcgWxYHo
qHIb8Tk/jivorwl4gg8T+HLPVoiAZkxIgOdrjhh+f9KwP+FN+Cf+gZL/AOBUn/xVdD4c8K6V4WtJ
bXSYZIYZX8xkaVnG7AGRknHSu/FYmhWoRjTi1KOiult16mcIyUm31OjooorgNDy744RuPB2n3m0t
BZarBPOAM/J8y/zIH416TDNHcQpNC4eORQyMDwQeQaqapptrrOlXOmX0QltrlDHImcZB/ke9cDZ+
CfHPhuD+z/Dvi+2bSl4gi1G13yQL6BhnOPwHsKAO0fxJpUXiaLw81yf7UlgNwsQQn5ASMkgYHQ9a
8++EGk2Ul74u1CS3ie6OszQCR1BIQHOB+LGum8G+Bl0C+u9X1G/m1TXr4YuL2VdoC/3UXsOB+Q6d
KseCPCEvhOPWFlukuPt+oSXi7EK7A2PlPr0oA4/wwNO0vxl8TredxZ6TGsMkvlHYIw0blyMdDyen
fpSeGtavP+Edg03wd8Pbi50ZgwjudSuY4VmUk5ZgQS2ea6YfD5J9V8YT3t0HtfEUccflxrhogqlc
57nnNZmleDfG1npUXh//AISuzj0eFPKS4gsyLry/7oJO1TjjPJFAHA2ZI/Zs8RowVNmolQinKr++
i4Ht1r0rVfDukW3wcvbGOwtxDFpDSKPLGd4iLB8/3s859aoQ/C24tfhtrXhCLVIzHeXfn287xkmN
NyNtbnk/J146122o6M974QudEEyo81i1r5pXIBKbc4oA8etidXf4TaPf/vdOlt3mkR+VkdE+UH1x
gD8a6L46aXYP4GivmgiW5trqJYXC4bBOCv0xzj2p+v8AhzR9K8LeEvDmqaxLYatbuE0zVIYjtjnX
HXPAByOCRnHXiua+KOh68+iafBrniiPUr2a9iisbC2tlhV2PBkYAksccdgM+9AF/xJdarcfG1VtP
D4146bpiyW1m90kKxliMy5fIJ5x+XpU2rWfjfXvFXh7WF8ELpNzp92rTXSanDIZICQGQgYJGM+vU
4HNdZ4q8E3Gr6xY6/o2p/wBma7ZRmJZmj3xzRnPyOvpyfz6dMU7fwT4g1jxFp2r+LdatrldNfzLW
y0+IxxeZx8zknJ6Dj+mQQD0evMPCf/JdfHP/AF72v/oC16fXIaR4Tl0zx5r/AIka6R49UjhRYQhD
JsUDk984oA5X4KaNYDQdX1BreJ7qfU543kZATtXGF+nJOPerfwthiste8cWVsgjtodYYRxKMBAQe
APwFdF4F8LS+EtFuLCW5S4eW8luQ6IVADkcfpS+F/Csvh7WPEV9JdJMurXv2pFVCDGOeD69aANbx
L/yKur/9eU3/AKAa5j4M/wDJJ9D/AN2X/wBGvXW6rZnUNIvbJXCG4geIMRnbuUjP615tovgPx/4d
0a30nTPGtlDZ24YRodOViMkseTk9SaAE+LoN14g8D6bbkG8k1VZVAPzBVK5P0/wrO8T6Jc6/8eFs
7XWLzSpBoof7RaNhyA5+X6HP6V1fhnwA2l643iLXNXuNb1wp5aXEqBEgU5yEQE46n8zwMmofEngj
X73x0vijQtet9NuBZi1xLaiXjJJ6nHpQBynjLwNqvh7SR4lk8S3evf2Qy3IsdXBkhfBweN3UZqX4
janceItH+Hmp6ey2tzfahBLAZBuEUjBcZ9QD+dbV98P/ABb4kjFh4n8afaNKLBpbezsUhaXBBwW7
dPf6Vt+I/Aq6t/wjMVjNHZ22h3kU6xlC25ExhR6dKAMubw58TbuJoJfGmnwRuMNJBp43ge3+RXSe
DPCdl4O8PppVm7yfOZZpn4aVzjLH8gPwrpqKACiiigAooooAKKKKACiiigDwvUv2hX07VLyyPhcy
fZp3h3/bcbtrEZx5ftVb/hpR/wDoUm/8Dv8A7XXYX3xPt4/iRaeEtM057xzOIry4XpEe+ABzjjJO
AOfrW/488R3PhPwpNq1jppvp43QeUEJCqT8zMV6AAHn1xQBl/Df4kH4gnUv+JQdP+xeX1n8zfv3f
7K4xt9+tehVx3gXxpp/jXQvt9nEYZo32XFuxyY26jnuD2P8AhXY0AFFFFABRRXBfErxbN4b0qGw0
pDNruqP9nsYl6hjwXx7ZGPfHbNAHWW+p2F7cTwWt7bTzW52zRxShmjPowB46HrWjXgvwMtn0nXPG
dtezqZLR445pS3ykq0oZsn6HmvSj8UfBCkqfEtgCPRyf6UAeM/Bb/ktGs/8AXG6/9GrX0tXzR8FJ
Y5/i/qs0TB45Le5dWHcGVMGvpegAooooAKKKKACiiigBh61ynxL/AOSc63/17H+YrrD1rk/iX/yT
nW/+vY/zFa4f+LH1X5ky+FkXwu/5Jtov/XE/+htXY96474Xf8k30b/rif/Q2rse9LEfxZer/ADCH
wodRRRWZQVWm8zyX8kKZAp2BjwT2z7VZooA8T1zxN8VNA0y41PULLS4rOEje6hWxlgo4356kVJoe
s/E3VFsL0WOmGwuNkhc7RmM47bs9PxrqPi//AMkw1f8A7Y/+jkq34I/5EXQ/+vKL/wBBFdc6kFhu
flXM21t0sn95yVlZ2ub9FFFeKcwUUUUAFFFFABRRRQB5d8W/+Q34Q/6/j/6FHXqR615d8W/+Qz4Q
/wCv4/8AoUdeod69jEN/Voej/MoKKKK8ckKKKKBmZrGh6d4gsDZapbC4tywfYWK4IzzkYPc15F4y
8GaBpXjTwzp1lY+Va30wS4TznbeN6jqSSOCemK9w/hry74h/8lJ8E/8AXwP/AEYtexga1RT5VJqP
K3a+l7dijsNF8D+HfDt6bzStOEFwVKbzK7kA9R8xNdDRRXm1qsqkrybb7t3/ADEFFFFYkhRRRQAU
UUUAFX7b/Ur9KoVetv8AUj6VtR3OjD/EWKKKK6TsCiiigBtcD4x1rxnpt/DH4d0OC+tWizJK75If
J4xuHbHr19q76jqKqjNU580oqS7PYTV0eIWnxM+IF/q11plt4dspL21GZ4Ruyn1+fHcV6T4RvvEG
o6S03iPTY9PuxKVWKNsgpgYPU45z3riPBP8AyWvxb/uf+zLXrWMmurGypxahGCV0ndXvqr23Jhd6
tktFFFcZYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU
UAY+s6FpviHT3sdVsoru3Yg+XIDwR3B6g+4rJ0T4deE/Dt+t7p2jxx3S/clkleVk4/h3k4/Cuuoo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDwb4SXllo3xC8XaXq
zx2+rz3RERmYAyAO5ZVJ6k5U47jntXtt7fWmnWcl1fXMNvbRgl5JXCqo9ya4Xxz8KtH8bXH295Zb
DUAmz7TEAwkA6b1OM4+oPvxXF237OjvcINR8Uyy2ynlI7chj9CzED8jQBZ+B6x3PizxpqGnxGPSJ
rkC3wMDG9yoH0Uj8xXuNYvh3w5p3hjSIdL02DyraPJ5OWdj1Zj3JraoAKKKKAPM/GXw68QeJPEUm
o6d4yu9Lt2jRBbReZtBHU8OBz9K5W7+H/wARLPxjFremXmnXktrbR2ttc3rbmCqgUnaQcEncc5J+
Y8817tRQB80fDbTvEuq+MfE+nyvatZzzvDry8AyBjKp8s4453dMdq6//AIZv8OZ/5DOq4z0/d/8A
xNerW2l2FjPPNaWNtbyzndM8USo0h9WIHJ5PX1rSoA+ZPgZbLZ/FnUrVGLJDaXEYJ6kCRB/Svpuv
mn4Lf8lo1n/rjdf+jVr6WoAKKKKACiiigAooooAaetcn8S/+Sc63/wBex/mK6xq5L4l/8k51v/r2
P8xWuH/ix9V+ZMvhZH8Lv+Sb6N/1xP8A6G1dj3rjvhd/yTbRf+uJ/wDQ2rse9LEfxZer/MIfCh1F
FFZlBRRRQB538YriKH4b6hHI6q0zxJGD/EfMVsD8Afyq34Dnin8B6I8Lq6raohIOcMowR+BBFeVf
GXxDPrPiJdItUke007Icqpw0x+9+QwPruq98F9flt7m58P3ayLHNma2LKQAwHzL+IwfwPrXXOklh
lK+qd7eTVjirSvI9qooorxTAKKKKACiiigAooooA8v8Ai3/yGPCH/X8f/Qo69Q715f8AFv8A5DHh
D/r+P/oUdeod69ev/u0PR/mMKKKK8gQUUUUAHavLviH/AMlJ8Ff9fA/9GLXqPavLviH/AMlK8Ff9
fA/9GLXpYD436P8AIaPUaKKK4avxCCiiiswCiiigAooooA5PxZpPivUpLY+Htbh0+NFYSpIvLHPB
ztP5cV59p0/xFv8Axhe+GIfE6rdWcXmvIw+Qj5enyZ/jFe215l4Y/wCTgPEf/Xn/APGa9vA137Gc
XFPlV1dJu91u7am1PWSR2vg7TvEmnWU8XiTVYtQnaTMbouNi46ZwM811nakp1cc6jqTc2kr9lZfc
dqVlYWiiigYUUUUAeQeCf+S1eLv9z/2Za9eryHwT/wAlq8Xf7n/sy169W+K+Nei/JCjsLRRRWAwo
oooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACii
igAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKo3up2OmQia/vLe0iJwH
nlVFJ+pNcJZ/FOGw1Q6V4y0u40C6LlYp5Rut5gDwQ/b9R71y3xJsorvxpYa5qGhXvibw4+n+XbjT
5mKxy7iS3ydcjHcA++MUAezWV/aalbCeyuoLmEnAkhkDqfxFXK8b+FGlTQ+JdX1LT9Av9D8PzW6R
xWt47EvMCMsN3OMAjv169h7JQAUUUUAFcd408e6T4Kt4H1Hzpri4JEFtbqDI+Op5IwOR/wDXq1rP
j/wv4fv2sNW1mC1ulUMY3ViQD0PArxjxZrd5efHLS7vRrWPVpRaRHTopGKxtvjLK56cDeW7dKAPU
vB/xK0rxle3OnQ291YajANzW10oVivcjB7ZGRwa7yvGNI8aSWHjXUoPGPhjT7bxFBZPcxXljHuae
NIyxQEknJVTjnsQQKwm/aWn3nb4Xj254zenP/oFAGb8Fv+S0az/1xuv/AEatfS1fMPwLuftvxX1C
727fPtJ5NoPTMiHFfT1ABRRRQAUUUUAFFFFAEfavL/jL4lj0jwodKQg3WpExgf3YwQWP8h+PtXqN
eWeMvhRdeMPEEmqXHiDyU2rHDB9k3CNR2zvGcnJ7da6cFKlCvGdWVox12bu1stCKl+W0R3wZ8RRa
r4TXS2IW501jGVHeNiWVv5j8PevT/avMPBvwouvB3iCPVIPEAmj2NHNAbXaJFI6Z3nGCAe/SvUTx
U450p15VKTvGWvVWb33CndRtIfRRRWBYUUUUARNGvJxWdgZ6VqN901l96xqzascuJ6BRRRXMcoUU
UUAFFFFABRRRQB5d8Wv+Qz4Q/wCv4/8AoUdeo968E+Lnig3Hi60srMoRpLbt/XMpIJ/LAH1zXsvh
zW4fEPh+z1WHAFxGCyg52MOGX8CDXu4rD1KWFhOS0s/xd196HY1qKKK8IQUUUUAHavLviH/yUrwX
/wBfA/8ARi16j2ry74h/8lK8F/8AXwP/AEYtengPifo/yGj1GiiivPq/EIKKKKgAooooAKKKKACv
MvC//JwPiL/r0/8AjNem15l4X/5OB8Rf9en/AMZr1MF/Cn6fqa0vjR7HRRRWR3hRRRQAUUUUAeQe
Cf8AktXi3/c/9mWvXq8h8Ef8lq8W/wC5/wCzLXr1b4n416L8iY7C0UUVgUFFFFABRRRQAUUUUAFF
FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU
UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHj/iD4jHWZr/TLLwDfeI9JglaCafadhdeG2jY
3T6g9+Ko+HvDt1caKniD4YavcadG7ETaPqJMkPmKfmXnJB9+c+oqRfBtzdeI9Ws/B3xCazhFw8t1
p0eWNtIzYfow7g+np71taR4l8EfDXT4/DNz4kWS8ikZ7hzG8hMrHLFtoIU+xPHegDa8I+MNU1bUZ
9F1/QZ9J1a3i81iPmgmXIXKN9SOOfrXbVS07ULPVbKO8sLmK5tpRlJYm3Kwq7QAUUUUAcxrPgDwv
4gv2v9W0aC6umUKZHZgSB0HBrhfHPgfWNL8UaJ4o8GWUU02mQrbtZFgMxqCq4yRkbSVPOenWvYaK
APHfDHhzxR4h+I6+N/Eth/ZUdrCYbW0D7mJ2leeenzMcnHOOMV6X/wAI3oJYk6LppJOcm1Tn9K16
KAPmn4Lqo+MusIqhUWC5AAGMDzVr6Wr5p+C3/JaNZ/643X/o1a+lqACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigBrfdNZfetRvumsvvXPX6HLiegUUUVgcoUUUUAFFFFABUcokaJxEwRypCsVyAe
xxUlFEXYZ5FP8DluZ5J5vEcrzSMXdzajLMeSfvV2PgjwfJ4Ns7mzGqNeW0riRUaHZsboSOT14/Ku
spM+1enWzCrVpeznK8e1l0C4tFFFeYIKKKKACvnL4g+MJNR8dpeafIPJ0qQJbOOQWVss34t+YAr6
GuoPtNpNB5jxeYjJvQ4ZcjGR715//wAKT8L/APPbUv8Av8v/AMTXt5biMLQlKVe7drJJX33KOx8P
a1B4h0G01S34SeMEr12N0ZfwORWtWB4Y8L2fhOwksbCe6kgeTzAs7htrYGcYA68Vv15eK5XUl7P4
b6X3sAUUUVgSFFFFABRRRQAV5n4X/wCTgPEX/Xp/8Zr0yvK/DN3Afj9rwEq5ktmjXnqy+VkfUbT+
Rr1cGm6U7dv1RpS+NHtVFFFYnoBRRRQAlNYgAmjtXGfEXVb/AErwfdHTLe6nv7keRCLaJnZN3VuM
4wM8+uKKcXOcYLq7CbsrnD+BNXsp/jR4l8udSLsOsDdnKsM4/In8K9oA7V8i6TpnibR9UtdQtdG1
JZ7aQSIfssmDjt079K+q9LvP7R0y1vfJkhM0ayGORSrISOQQe46V6GY0adOcZU5XTSXzSsRSldNM
1aKKK880CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD5q8P8Aiex8
NePfiI11qCWd1ctdJZu4PMokcryBxzjrir/wv8AeDPEfgiXWddH2m786QXEkl00Yt8HjOCOowcnP
Wut+INx8LdLvnj8R6XbTalKPMeO0iImbP8TMpXk+5ya5DRfHvwz0vQdS8OWthrlpp2p7xO0qK5Xc
u3g7yRgex5oA3PgiY7bxF4s03S7t7rQbedDaynlScsMg+4A+uAa9srivANh4asfDMP8AwiMiTadI
xZpQSXkfvvJAO7oMHGB2rtaACiiigArynxx4t8Snx7pvg3wzNb2V3dQ+e93cKGwPmOACCOAhPQk9
OKt+MvHnirw/4gksNI8G3eq2qxowuo45CCx6j5VI4ri/FEl38QfiR4d0CSIaLeQ2SXc90qkXETNH
5jRqeDxwPY7j7UAdV4E8W+In8can4M8UyW95eWcPnpeQqFBX5eCAAOQ4PQEcg5r1WvAvC1vqPgr4
j6/4TtJYb/UdQsnmtdTnX98JPLLIHJJ+XPX1OD7VitpHxzMjHztVyTzi9iA/9CxQAvwW/wCS0az/
ANcbr/0atfS1fMHwIE6/FK+W6ybgWc4lyed3mJn8c5r6foAKKKKACiiigAooooAKKK4/UfiX4P0j
UJ9Ov9dhgu7dtksbRuSp9OFxQB2FFcdYfE7wdqt9BY2OuQzXVw4jijWNwWY9uVrsaACiiigAoooo
AY33aze9fLXi7xv4qs/G2vW1t4i1KKCLUJ4440uWCqokYAAZ6CrHw/8AGPiW/wDHejWl5ruoT28t
wFeOS4ZlYYPBGayqwcjGtTclfsfTlFFFcpwhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU
UAFFFFABRRRQAUUUUAc94x8QL4Y8L3mpKAZlXZAp/ikbhfy6/QV8z6fq17pmtwavC7m8hm87c3O5
s5Ofrzn619ckA9QD9at28aeSuVHT0r28FjadClKm4czlu7207WsbUo8zsUtB1WDXNGtNTtmzDcxi
RfbPUH3ByPwrX7U0KAMAYFOridnJtKyO4WiiimAUUUUAN2L/AHRTqKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA+bdJufCmn/EzxYfiDGr3pu2Ns11E0kWzc
3YA9V2YyMYq1oCeENZ+JOsPo+lW0/hSLTWmvN9rmNXXnegYZU+gGP4uK9l17wV4c8USpJrOkwXci
DCyHKuB6blIOPaptI8L6Hoemy6dpumW9tazAiVEX/WAjB3HqeOOaAPK/ggYX1zxY+jpMmgGdDapL
2OWx687ce/Svcao6dpljpNmlpp1pDa26fdihQKoP0FXqACiiigArz3xr8N7fxPq9rrNpqVzpOs2w
CpeWwySB0yMjpk85HBxzXctcwJMsDTRiZhlYywDH6CnzSxwRmSV1RB1Z2wBQBwfgv4c2/hjVrrWr
3U7nVtWuQVe8uBjCnrgZPXA5yeB2r0KoopY5oxJE6uh6MrZBqWgD5p+C3/JaNZ/643X/AKNWvpav
mn4Lf8lo1n/rjdf+jVr6WoAKKKKACiiigAooooAK+MPip/yVHxD/ANfZ/kK+z68K+KXwlsPsviHx
j/adz9owbn7PsXZngYz1xQB5B8Mv+SmeHf8Ar+j/AJ19qV4J8LfhLYT2Hh/xidTuRcBhc/Zwi7cq
xGM9e1e90AFFFFABRRRQB8ifELwR4lsfEHiHXbnSZY9La/mkFyWXBV5TtPXPOR+dXfhr4J8Rx+Kt
B1p9JmGmmVZvtGVxsIOD1zivbfjV/wAko1r/ALYf+jkqz4B/5J94f/68Iv8A0Gs6kuVGVWbijoqK
KK5DhCiiigQUUUUAFV7m4htLWW5uHCQwo0kjn+FQMk1OayPFf/Ina1/14T/+izQtxrVmP/wtDwR/
0MNt/wB8P/8AE1qaJ4w8P+JLiS30fU4ruWJN7rGrDAzjPIFfGlex/s9/8jJq3/XkP/QxXRKkkrnT
OjGMW0fQlFFFc5yhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABV62/1I+lUav23+pX6VtR3OjD/ET0
UUV0nYFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRRRQAVz1l4gF54s1bQvs5U2EMEpm358zzN3GMcY20zxJY+I71bYeHtYttNZWYzGe2E28cYxz
xjmvOtL0nxy/xB8Qww+KLBL9La0NxObAFZFIfaAueMc/XNAHo8viIR+N4PDhtsmawe98/f0CuF27
ce+c5roq8y0y31W1+KumRazeRXl8NBuDJPFF5asPtC4+X2GK9NoAKwvFF/faX4cvL3S7FtQvolHk
2q5zIxYDtzxnP4VD4w0vWdY8PSWehap/Zt8zoy3OSMAHkcc81keBPDXizQJL4+JfEX9rrMqCAb2P
lkbt33h3yPyoA8t0AeIT+0Bo83ilohqU9u8phjOVgQwybYx9PYnk9TzW148jfxp8Y9J8H3U8sekw
Q+bMkbYLtsZyfyCj2yfWptU/5On0f/ryP/oqWq/iu5h8KftC6Vr2pMYdNu7babgj5VOxozn6HaT6
A5o7AO8C58D/ABd1nwdBcO2jywfaIlmfPlsEV85/3SwPrgHtXpJ+I3g1WKnxPpWQcf8AHyp/rXlW
iwWnj/43+Ib+1ZptHWxe2eeM43BohF8p9/nx7DNX/wDhm3R8/wDIfv8AGenlJR0A5f4KSJN8YNWl
jYPG9vcsrA8EGVMGvpevmP4GWy2fxa1G0ViywWlxGGPfEiCvpygAooooAKKKKACiiigArj/ip/yS
/wAQ/wDXqf5iuwrj/ip/yS/xD/16n+YoAi+En/JKtA/64N/6G1drXFfCT/klWgf9cG/9Dau1oAKK
KKACiiigDz741f8AJKNa/wC2H/o5Ks+Af+SfeH/+vCL/ANBqt8av+SUa1/2w/wDRyVZ8A/8AJPvD
/wD14Rf+g1jW2Rz4jZHRUUUVzHGFFFFABRRRQAVS1SxXU9JvNPZyi3UDwlwMlQykZ/WrtFBR80eN
/hfbeFNQ0K2i1OW5Gp3JgZmiClOUGRyc/er1rwJ8NLbwJqN1eQapLdmeHyirxBNoyDngn0rC+MP/
ACG/BX/X+f8A0KKvWm6n61tKbcUbTqScEFFFFYnOFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFX7b
/Ur9KoVftv8AUr9K2o7nRh/iJ6KKK6TsCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKyrbRLS012+1eJXF3exxxzEtkER524Hb7xrkfFvxa
8NeE9QOnXjXN1dp/rIrRFfy89mLEDPtW94X8XaN4z09rzSJ2fYdssUi7ZIz6MP8A9YoA0H0SyfxJ
FrpD/bY7VrVTu+XyywY8fUCtWiigAooooAyX0LSpNZj1h9Otm1JF2pdGMGRRgjAbrjBP50ur6Fpe
v2otdVsLe8hByEnjDbT6j0NYb+P9FHjqDwjE0s+oyqxLxBTFGQpYqxzkHC9MHqKXxf8AELQ/BJhj
1SWaS6mG6O2tk3yEdM8kADPqaANzSNC0vQLQ2ul2FvZwE7ikKBdx9T6mtSuN8IfEfQPGzyxaa08V
3CNz21ygSQD1GCQR+NdlQB80/Bb/AJLRrP8A1xuv/Rq19LV80/Bb/ktGs/8AXG6/9GrX0tQAUUUU
AFFFFABRRRQAVx/xU/5Jf4h/69T/ADFdhXH/ABU/5Jf4h/69T/MUARfCT/klWgf9cG/9Dau1rivh
J/ySrQP+uDf+htXa0AFFFFABRRVaZpEgkaJPMkVSVTONxxwM0AcP8af+ST61/wBsP/RyVZ8A/wDJ
PvD/AP14Rf8AoNeb+Ltf+JHivw7eaFceBpIIbgqGkjVmI2uG9cfw1Y8L+I/iDpdjpWjN4MY2tukd
uZnDKdowNxOcDisqqujGvG6PYqKWkrlOEKKKKACiiigAooooA8l+Mv8AyG/BX/YQP/oUVetnqfrX
knxl/wCQ34K/7CB/9Cir1s9T9auXwo2l8CEoooqDEKKKKACiiloGJRS0lAgooooAKKKKACiiigAq
/bf6lfpVCr9v/ql+lbUdzow+5PRRRXSdgUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgHw40XRde+IHje+1u2trxob1liW7VWUb5JMnaeM/
KB7Va+GkNnoXxk8X6XZskFgkRMabvlGHXAH03Gl1b4BWV3q1zdzeKTA95O8ixm2HVmJwPnGetYur
/BHw34f8v+1vHcNkZPuCaBVLfQb80AfREc0U2fLkR8ddrA4qavOfhf4BsvBdvfXNhrS6rb6ksbJK
kYCgLu6EMc53fpXo1AGdqur6foli17qd3FaWqsFMsrbVBPSufvNU0/xzoOpaZ4Z8SwpdlFVrq1fc
0ALDngg8gEda2de8P6Z4n0t9M1e2+0WbsrNH5jJkg5HKkGqfhrwP4f8ACD3L6FYfZGuQol/fO+7b
nH3ifU0AeN6N4Ys/B/7QGh6VZyTSqLRpJJZWy0jtDJub8cdK9X1Pw54cs9dPjbVB5d3ZRczzSny4
1AxnaeM8nHfJ9a5bUdA1eT9ofS9aSwuG0yO0KvdBD5anypBjPrkj86wPi9B4x8ReJIdMstB1G60K
z2OyxIQly55JJHoDtHocmgBvhS9TW/iT4h+I8VrJb6Bp9tIC4TDTlYwCcdzgFj6fLVw/tJaMGONA
vyPXzUra8C694nm1G10K+8Bro2jCNxvCNsTAOBzxyePxrqz8OfBjHcfDGlZzni2UUAeG/Ay5W8+L
Wo3aqVWe0uJAp7ZkQ19OV80fBSNIfjBq0UahI0t7lVUDgASpgV9L0AFFFFABRRRQAUUUUAFcf8VP
+SX+If8Ar1P8xXYVx/xU/wCSX+If+vU/zFAEXwk/5JVoH/XBv/Q2rta4r4Sf8kq0D/rg3/obV2tA
BRRRQAUUUUANb7prL71qN901l9656/Q5cT0CiiisDlCiiigAooooAKKKKAPJfjL/AMhvwV/2ED/6
FFXrZ6n615J8Zf8AkN+Cv+wgf/Qoq9bPU/Wrl8KNpfAhKKKKgxCiiigDnvHLtH4C190Yqy2EpBBw
R8pr5E/tO/8A+f25/wC/rf419h+JbCfV/C2q6ba7PPurSSGPecLkggZNfMes/DjXtC1zS9JvPsv2
rU3CQeXLuXO4L8xxxyRXRRasdeHasz0L4AXVxc3ev+fPLLtjgxvctjl/Wvc68u+FHgPWfBUmqvq3
2bF0sQj8mTfypbOePcV6jWVRpy0MazTm2goooqDIKKKKACiiigDyz48TTW/geyeCV42OooCUYg/6
uT0r52Gq6gOl/df9/m/xr6i+KHhTU/GPhm20/S/J8+O7WZvOfaNoRx6f7QrwbT/hpr2peLb7wxb/
AGX+0bKLzZd0uE2/L0OOfviuqi1y2O2g1y2PoH4Hzy3Hwys5JpHkfz5gWdsn75r0iuJ+GfhvUPCX
ge20jUvK+1RyyO3lPuXDMSOeK7atTcKKKKACvOviv491HwFpmnXWnW1rO1zO0bC4DEABc8YIr0Wv
EP2k/wDkXdD/AOvt/wD0CgDlf+Gj/E3/AECdJ/75k/8Ai69x8DeILnxT4M0/WrqKKKe6VmZIgQow
7LxnJ7V8UV9i/Bz/AJJPoP8A1zk/9GvQB3VFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQ
AUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQB82w+Err4r+P/Ftxe6u9smnXBhtwE3gDc6oBzwBs5x1JqP4feB0+Il5q
kvinUb6d9MEdlFskwRgMOpByBj9eah0jUfHvgrxN4im0bwndXMd9eM7NPp8zqVV32lduOu4881B4
S1v4keD5NTfT/BtzKdQn8+Xz9NnOG5+7gjjk+tAHdfAg3Fhc+LPD8lw0tvpt6qxZ6A5kViB2zsBr
2mvF/gxYa3BqXizUNa0q60+W/mimCzwPErMTKzbdw6DcPXFe0UAFFFUtQ1G00mwlvb+4jt7WEbpJ
XOFUUAXaK8a0X4uXHiX4oWWiaUqf2JIJF8x4z5kxVHbeD2GQOMdvfA9O1zWbLw/o11qt/KsdrbR7
2J6n0A9ycAUAa9FeVfCT4g6t471DXP7RSBILby2t0jTBUMX4J78AV6rQB80/Bb/ktGs/9cbr/wBG
rX0tXzT8Fv8AktGs/wDXG6/9GrX0tQAUUUUAFFFFABRRRQAVx/xU/wCSX+If+vU/zFdhXH/FT/kl
/iH/AK9T/MUARfCT/klWgf8AXBv/AENq7WuK+En/ACSrQP8Arg3/AKG1drQAUUUUAFFFFADW+6ay
+9ajfdNZfeuev0OXE9AooorA5QooooAKKKKACiiigDyX4y/8hvwV/wBhA/8AoUVetnqfrXknxl/5
Dfgr/sIH/wBCir1s9T9auXwo2l8CEoooqDEKKKKACvJviX/yU7wJ/wBfI/8ARqV6zXkvxL/5Kd4E
/wCvkf8Ao1Kunua0viPW6SlpKggKKKKCQooooAKKKKBh3ryvwb/ycf4p/wCvD/4xXqnevLPBv/Jx
/in/AK8P/jFb0dzfD/Ez2miiiug7AooooAKrXFrb3SqLiCKYKcgSIGA/OrNFAHifgWytJPjj42he
2haNE+VGjBA+Zeg7V7NDDHBGI4Y0jQdFVcAV5D4B/wCS9+Of9z/2Za9koAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooo
oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAorm/GniJfCXhW/1tovPa3UBI843MzBV
BPpk15LaeOvjHq1sl1YeG7f7PMu+NhbFQVPQjc9AHv1FcB8OtT8caidRPjLTY7Py/L+y7Iwu7O7d
0Y/7Nd/QBzfjPxMfCPh+TVvsEt9skRPIhOGO44z0Nc74X8WWXxTtNU0rUfD1zbWkaxmSO5c4lySc
cAdCor0aigDw25tLew/aW0K0tII4LeKw2xxRqFVQIZeABVL4k+MtL1X4iW3h3XLia28PaVIJbtVj
Lm6lwCFwP4ecf99e1eh3fgSS4+Ktl41/tFVS3gMX2XySS3yOud2f9r07V08+gaPcTvPcaTYzTOct
JJbozH6kigDwH4Z+KrO18WeL4dNYfb9Zkc6PG0ZCO4MrIG/ujleuKjbV/jospHk6rkH+GyiI/wDQ
cV6r4M+Glv4V8R63q0ktrdfbp/NtkFqFNqNznCnJ7MBxjpXoVAHzB8CDO3xSvmusi4NnOZcjnd5i
Z/HOa+n6+afgt/yWjWf+uN1/6NWvpagAooooAKKKKACiiigArj/ip/yS/wAQ/wDXqf5iuwrj/ip/
yS/xD/16n+YoAi+En/JKtA/64N/6G1drXFfCT/klWgf9cG/9Dau1oAKKKKACiiigBrfdNZfetRvu
msvvXPX6HLiegUUUVgcoUUUUAFFFFABRRRQB5L8Zf+Q34K/7CB/9Cir1s9T9a8k+Mf8AyG/BX/X+
f/Qoq9bPU/Wrl8KNpfAhKKKKgxCiiigAryX4l/8AJTvAn/XyP/RqV61XkvxL/wCSneBP+vkf+jUq
6e5rS+I9bpKWkqCAooooJCiiigAooooGHevLPBv/ACcf4p/68P8A4xXqfevLPBv/ACcf4p/68P8A
4xW9Lc3w/wATPaaKKK6DsCiiigAooooA8b8A/wDJe/HP+5/7MteyV434B/5L345/3P8A2Za9koAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDjPihCtx8ONZiax
lvt0ShYIs7y29cEYB5BwenavLND+LHjPStHtNPn8F3F09tGsQm8qVCyqMDI2nnH/AOqu2g+I2vSa
f4ouG8LSq+kOq2qYk/0oGQpx8vYDPGa5n/hd3i//AKJ/cf8AfM3/AMRQB3Pw68b6x4w/tH+1fD8m
k/ZfL8veHHmbt2fvAdNo/Ou9rgvh1431jxh/aP8Aavh+TSfsvl+XvDjzN27P3gOm0fnXe0AFFFYf
iXV59C8P3epW1hLqE8Cgx2sOd0rFgoAwCe/oaANvIzjIzS1876Fc+JLv4+aLP4mVYL6W3kkjtUbI
gjMUm1Pbvnqc9a1PilrUms/EDT/CE+rNpeiRw/aNRmWUJkYLHJ7/ACgAD1boeKAPcwQRkHNLXkHw
v0K20zX7658MeLIdS8NMm1rJ5C0sb44YjAA5B5wMj6V6SfEuggkHWtOBBxg3SD+tAHz/APBb/ktG
s/8AXG6/9GrX0tXzT8F2U/GXWHVgyNBckEHOR5q19LUAFFFFABRRRQAUUUUAIeleNXnwS1C/My3H
jzVZIpiS8cqM4YE9D+8wa9mooA8asPglqGmtbi38d6rFDAwKxwoUAwc8fvMD8q9kFLRQAUUUUAFF
FFADW+6ay+9ajfdNZfeuev0OXE9AooorA5QooooAKKKKACsjxJNrUGg3Mnh+3huNTG3yY5jhW5Ge
45xnuK16Kadhp2dzwbxHo/xW8T3Wm3GoaDah9Ol86HypYlBbKnn94c/dFdx4X1D4j3OtrH4m0ixt
tOKsXkjZdwbHy42u3f2/GvQeaKp1Lq1jV1Lq1goooqDEKKKKACvJfiX/AMlO8Cf9fI/9GpXrVeS/
Ev8A5Kd4E/6+R/6NSrp7mtL4j1ukpaSoICiiigkKKKKACiiigYd68s8G/wDJx/in/rw/+MV6n3ry
zwb/AMnH+Kf+vD/4xW9Lc3w/xM9poooroOwKKKKACiiigDxvwD/yXvxz/uf+zLXsleN+Af8Akvfj
n/c/9mWvZKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAC
iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK
wfFviKDwt4XvtanTzFto8qmcb2JAVfxJFeUeHfG3xBvPHHh3+3FitNL1hZpbeziiQeYqxlhycuOS
vUjNAHutFecfDrxtqniNNT0vXbNbXW9NlCToqlQwOcHHODwfboe9ej0Ac34xsvEGoaBJbeGb+Gw1
MyIUnlOFCg/MPut29qyfAWjeN9Kkvj4v1q31JJFQW4hYnyyN27PyL1yPXpXdUUAeJ6p/ydPo/wD1
5H/0VLWR4/0/TbL476TfeI40/sW8SNmaYfuyVUrhvYMEJzxg817TJ4b0aXxBF4gewjbVYk2Jcknc
q4Ix1x0Jo17w9pPiSwFnrFhDeQg7lEgIKnHVSOQfpQB4tFZ6TqPxxuNN8KvFHpV5pssGoNpzARru
iYErt44Pl9ON3vQf2a5dx2+KE254zY8/+h17B4d8IaD4UheLRNNjtBJjewJZ2x6sxJ/CujoA+Yvg
VbfYvivqFru3eRaTx7sdcSIK+na+afgt/wAlo1n/AK43X/o1a+lqACiiigAooooAKKKKACiiigAo
oooAKKKKACiiigBrfdNZfetRvumsvvXPX6HLiegUUUVgcoUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAV5L8S/+SneBP8Ar5H/AKNSvWq8l+Jf/JTvAn/XyP8A0alXT3NaXxHrdJS0lQQFFFFBIUUUUAFF
FFAw715Z4N/5OP8AFP8A14f/ABivU+9eV+Df+Tj/ABT/ANeH/wAYrejub4f4me1UUUV0HYFFFFAB
RRRQB434B/5L345/3P8A2Za9krxvwD/yXvxz/uf+zLXslABRRRQAUUUUAFFFFABRRRQAUUUUAFFF
FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAct4/wDDjeK/BWo6PE6pPMgaFmOBvVgyg+xIx+NeGXGq
fEOw17w3Je+E7qe98PxyQwlLZ2WYMuwZKZBwAOQea9t+IV1c2XgLWLm11EafPFEHW6JPyYYdMZOT
0Hua8j0nQvjFq+ixarBrc8aTRiSGGa82yOp5HGMDI9SPwoA7n4X+Htbs7nWvEniePyNU1eRW+z8D
y0GeoHTr06gDnrXqVfMmmap8To9A1DxDbeIhOulyOt9YzvulhKn5gyMuMYyeD69xXv3hXWx4j8K6
Zq4QIbuBZGQdm6MPzzQBu0VRvb+0023Nxe3MFtACAZJ5Aign3PFYWq3Y8S6BqFj4X1+zTUGVQtzB
MJPJyw5O0nGQCBQA6XxroieNYfCv2hn1WVC+xEyqYUthm7HAzj6etN8VePdA8GrD/a94Y5Z8mOFI
y7sB3wOg9zXkGheGU8K/HzRNOF5PeTNbPNPcTH5pJGik3H/JJ9zWv8TZY9C+LXh3W0gTWLow+V/Z
IUtKQN4DqMEdWJHfK/iAD0rwr470Hxkkx0e8MkkOPMidCjqD0OD1HuK6mvAvAerWdz8QvFniq+Rd
FltrR2k0nYRKEUKXcjAyfk5HXLduCdX/AIaP8ObiBo+qkZ64j/8AiqAOR+C3/JaNZ/643X/o1a+l
q+ZPgZcrefFnUrpFKpNaXEgB6gGRD/WvpugAooooAKKKKACiiigAooooAKKKKACiiigAooooAa33
TWX3rUb7prL71z1+hy4noFFFFYHKFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeS/Ev8A5Kd4E/6+
R/6NSvWq8m+Jf/JTvAn/AF8j/wBGpV09zWl8R61SUppKggKKKKCQooooAKKKKACvLPB//Jxnij/r
w/8AjFd9qXiTRdCaNNV1O2s3lBKCZ9pYDvXk/hjxZoFp8d/Eer3Gr2kenT2eyK5Z8I7fueAf+An8
q3op3udOHTvc+g6KydJ13Sdet3n0jULe9ijbY7QuGCnrg+la1dB1hRRRQAUUUUAeN+Af+S9+Of8A
c/8AZlr2SvG/AP8AyXvxz/uf+zLXslABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU
UAFFFFABRRRQAUUUUAcr8QvDs3izwRqOkW7hLiVVaEscAurBgD7HGPxryzT/AB18UNA0yPRpfBU9
1cW0YgjuDbSMMAYXOz5W6dQRmvUPiJ4iuPCngjUtYtEVrmJVWLcMgMzBQSO+M5ry2y0/4261YQX6
a3HBFcRiVA7xIcHkcKnHFAEEXg7xrp/gDXbj7NJLrvia9Rbi2RVLRxHzCxbsu4t+Ax0PT2bwboj+
HPB+laRKwaW1t1WQjpv6tj8SawPh1pnjjTjqI8ZalHeeZ5f2XZIG243buij/AGa7+gDF8TeGtO8W
aLJpWqLI1q7q5Eb7TlTkc1m+Efh/oXgqS7k0aOdGugok82UvkLnH8zXWUUAeQ6hpGpv+0VpWqJp9
21hHZlWuhC3lKfKkGC+MZyQPxqp4wsdb8K/FK28aWujXGr6a9v5UqW6lnhO3aeADjsQenUcV7TRQ
B4n4T0/V/GXxVufGV7olxpelJbGBIrtNrT5TYAQRyMEk9uAOa7w/C7wO2WPhqwyf9gj+tdhRQB80
fBSKOD4v6rDEoSOO3uUVR2AlTAr6Xr5p+C3/ACWjWf8Arjdf+jVr6WoAKKKKACiiigAooooAKKKK
ACiiigAooooAKKKKAGt901l961G+6ay+9c9focuJ6BRRRWByhRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFAGB4p8NxeK9EOmS3tzaKZFk823bByM8H1HP8AKvP3+AdhI6u/iPUWZfusyKSP1r1+iqU2tEaR
qSirI4Twj8NLfwhq0moR6zf3jPEYvLmICc45I79K7uiik23qyZScndhRRRSJCiiigAooooAw9b8I
6B4mkhfWdOjunhG2NizKQD2ypFUofhB4CaNS3h6Ik/8ATeX/AOKrqau2/EC/St6Ld7HTh227GboX
hvR/DFtJbaLYJaQyPvcIS24+pJJNbdFFdB1hRRRQAV5/4yb4ipqVt/wiCae9l5X737Rjf5mf9o9M
Y6e/tXoFFAHz5pnhT4u6T4n1LxBaWmmC/wBRGJy0sZU8g8DPHQV614LPiptEc+LVs11DzTsFr/zz
wMbscZznp2xXU0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQByXxCtLzUPAer2enWCX91PCES3cZDZYZPUcgZIOeoFeU6Pqfxo0fTYNPi0JZ4bdAiNPGjPtHQE
hxnH516v8RfEU/hTwJqWrWoU3MSqkO4ZAZmCg474zn8K8SW4+K91rumabJ4iaC71Wz+2WytKqqy4
zt4XAbA6frQB618OtT8caidRPjLTY7Py/L+y7Iwu7O7d0Y/7Nd/Xk3wgudfluvEkPibVZ7rVLWaK
CS1mfcYAAx3Dths9uu36V6zQAVznjPxRD4Q8N3WsTRGbytqxxA43uxwBntR4z8UR+EPDsmry2c12
qSInlQnDHccVg+DviNYeN49SV9KmsYLGNZJGvCpQg7vwwNtAHGS/FHx7ounWPiTW/Dun/wBgXrLs
ELESKrDKnJY4JHPI59q6LxZ8SL2z1DR9D8JWMV9q2rRLcRfaMhI42GVJGRzgE9QAB3rl9e1K9+MO
vR+GfD6GDwxYzh7rUCvEhHA2/gTtXqepwBxMtrHY/tNadaAbYIbAR24PZRbsAP0NAHT+A/Hupa1r
t94b8SWMVlrtgCzCE/JIoIzjk88g9SCDnivTa8GupLyP9o3V5dLiWa8j012SMnAeQWy7QfYttrBf
xv8AGpZGH9makMHoNGyB+OygBfgt/wAlo1n/AK43X/o1a+lq+QNCtPiL4d1yfWNM0DV4b6dXV5Dp
rtkMQx4K46gV03/CcfGz/oHap/4Jv/sKAPpmivmb/hOPjZ/0DtU/8E3/ANhR/wAJx8bP+gdqn/gm
/wDsKAPpmivmb/hOPjZ/0DtU/wDBN/8AYUf8Jx8bP+gdqn/gm/8AsKAPpmivmb/hOPjZ/wBA7VP/
AATf/YUf8Jx8bP8AoHap/wCCb/7CgD6Zor5m/wCE4+Nn/QO1T/wTf/YVXvviN8XNLtTdahDeWlup
AMtxpSogJ6clAKAPqGivl2w+Inxd1S1F1p0V5d25YqJYNKV0yOoyExVn/hOPjZ/0DtU/8E3/ANhQ
B9M0V8zf8Jx8bP8AoHap/wCCb/7Cj/hOPjZ/0DtU/wDBN/8AYUAfTNFfM3/CcfGz/oHap/4Jv/sK
P+E4+Nn/AEDtU/8ABN/9hQB9LkblqkbR/UV816j8SfizpNsLnUku7OAsFElzpaxqSe2Sg96ksviD
8Xb+1S6sYL26tpPuTQaSro2Dg4ITHXNTKCluROnGe59IfZH9RR9kf1FfOv8AwnHxr/6B2qf+Cb/7
Cj/hOPjX/wBA7VP/AATf/YVHsYkewgfRX2R/UUfZH9RXzr/wnHxr/wCgdqn/AIJv/sKP+E4+Nf8A
0DtU/wDBN/8AYUexiHsIH0V9kf1FH2R/UV86/wDCcfGv/oHap/4Jv/sKP+E4+Nf/AEDtU/8ABN/9
hR7GIewgfRX2R/UUfZH9RXzr/wAJx8a/+gdqn/gm/wDsKP8AhOPjX/0DtU/8E3/2FHsYh7CB9FfZ
H9RR9kf1FfMuofFf4n6RMkWqSy2Uki7kW505Iyw9RuUcVoDxz8aWAYafqZBAIxo3X/xyj2MQ9hA+
ivsj+oo+yP6ivnX/AITj41/9A7VP/BN/9hR/wnHxr/6B2qf+Cb/7Cj2MQ9hA+ivsj+oo+yP6ivnX
/hOPjX/0DtU/8E3/ANhR/wAJx8a/+gdqn/gm/wDsKPYxD2ED6K+yP6ij7I/qK+df+E4+Nf8A0DtU
/wDBN/8AYVQvvin8TdNuI7XUZpbS4kAZIp9PRHYE4BAKg9c0exiHsIH0z9kf1FH2R/UV86/8Jx8b
P+gbqn/gm/8AsKP+E4+Nf/QO1T/wTf8A2FHsYh7CB9FfZH9RR9kf1FfOv/CcfGv/AKB2qf8Agm/+
wo/4Tj41/wDQO1T/AME3/wBhR7GIewgfRX2R/UUfZH9RXzr/AMJx8a/+gdqn/gm/+wo/4Tj41/8A
QO1T/wAE3/2FHsYh7CB9FfZH9RR9kf1FfOv/AAnHxr/6B2qf+Cb/AOwo/wCE4+Nf/QO1T/wTf/YU
exiHsIH0T9kf1FWok2RhT1FfNn/Cb/Gv/oG6p/4Jv/sKoRfFH4oT6o2mQzSSX6sytbJpyGUFc5G3
bnjBqowUdUVClGDuj6oor5m/4Tj42f8AQO1T/wAE3/2FH/CcfGz/AKB2qf8Agm/+wqzQ+maK+Zv+
E4+Nn/QO1T/wTf8A2FH/AAnHxs/6B2qf+Cb/AOwoA+maK+Zv+E4+Nn/QO1T/AME3/wBhQPHHxsJw
NO1TP/YG/wDsKAPpmivlSz+K3xO1DUHsbSaW5vE3boIdOR5BjrlQueP0rS/4Tj42f9A7VP8AwTf/
AGFAH0zRXzN/wnHxs/6B2qf+Cb/7Cj/hOPjZ/wBA7VP/AATf/YUAfTNFfM3/AAnHxs/6B2qf+Cb/
AOwo/wCE4+Nn/QO1T/wTf/YUAfTNFfM3/CcfGz/oHap/4Jv/ALCj/hOPjZ/0DtU/8E3/ANhQB9M0
V8zf8Jx8bP8AoHap/wCCb/7Cj/hOPjZ/0DtU/wDBN/8AYUAfTNFfM3/CcfGz/oHap/4Jv/sK7D4c
eI/iXqnitbfxLp90mlGJ2lkubDyNhwdu07Rkk4GOeKAPaaKKKACiiigAooooAKKKKACiiigAoooo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooA5vxd4cj8W+EdQ0V5fKNwg2SEZCOpDKcemQPwrz7UfAnjCPwl4au7O8hn8VaA8io25dskRJU
KCwAOFC/exnJyc12HxP1XUdE+H2rX+lu0d3GiKsidYwzqrMPoCfp1rzPS/gxruuaXaalfeN7hXuo
Vn2hXlxuAP3jIM9etAHZ/DHwv4j0rUdb8QeKXUanqrpuiVlbaFzydvHcAAdhXp1cF8PPAFz4F/tH
z9dl1T7Z5ePMjKeXt3erN13fpXe0AFcl8QPDeoeK/C8ujabfRWTTyL50kikhoxklePU4/WutooA8
O0v4R+PNEsRZaX45W0tlJYRQq6rk9TXR+J/hvqerzaJrel6ytp4m02BImu5E3LMVHU9ccluxyGwa
9OooA838CfD288PaxqHiHXtSXUddvxtklRcIi5BIHA64HYAAAYr0iiigAooooAKKKKACiiigAoor
F13xJo/h21W41fUYbKNyVQyHlz6ADk/hQBtV5v8AHCKSX4Yah5aM2yWF2wM4Acc10+k+LNC16ymv
9L1S3ubeAFpmQkGMAZ+ZTgjv1FZrfFDwJIhV/ElgysMEEnn9KAMX4FwyQ/C+1MiFQ9xK65HVd2M/
oa9NrI0LW9J16xNzo13DdWsbmLfD90MAOPyIo1vxFpHh2CO41e+hs4ZH8tHlOAWxnH5ZoA16K5jS
vHfhfXL9LHS9atbq6cErFGTuIAye1dPQAUUVnatrFhodg99qd1Ha2qEBpZDgAk4FAHnH7QMUknw4
RkRmWO/idyB91drjJ/EgfjW18G4pIfhZoiyxsjFZWAI6gyuQfxBBq/b/ABB8HapPFYQa7Y3M1y4i
SHOfMJOAMYqbXfG/hnwxcRWuravBaTOAViILHHYkKDgflQB1NFU7C/tdTsoryxuI7i2lG6OWJtys
PrVygAooooAKKKKACiiuX1Hx74V0XUJbDUtbtLa7iwHidjuXIBHb0IoA8Z/aItp5PFOiMkTsslqY
0IXO5954HvyPzr6GtQVtIVYYYRqCD2OK5/S/GnhTxHfx2WnatZ3t2AZEjXJYY6kZFRTfEjwdZ3c1
rc+ILKOeFzHIjMcqwOCOnrQB1tFZ2l6pZazp8V/p9wlzaSgmOVPutgkH9Qa0aACiiigAr5w+OFtP
P8V/D6xQu5ltoEjwM7m85+B69R+de46L4n0jxE10NIvlu/sknlTbFYBW/EDPQ9M1T1zxz4R0PUor
TVtXs4LxeVRwWaPPc4B2/jigDqqKof2jZf2d/aP2uD7F5fm/aPMHl7MZ3bumPesXR/H/AIW8QX7W
Ol63b3N0BkRDcpbHXbkDd+GaAOpooooAKKKKACiis/UtSs9I06a/v51gtYF3ySNkhR+FAGhXzh4Q
tph+0tqeYXAS6vJG+XopDYJ9juH5ivetK1a01vS4NS06cTWc4LRyhSoYA46HB7GsD/hZXgNJnk/4
SHThKflZgeTj3xQB2lFYN74l0Sw0WLWbzUoItPmVXindsLIGGRt7nI7U7QfFei+KYHl0XUoLtUOH
CEhl+qnBFAG5RRRQAUVzWu+OvDfhqVIdZ1e3tZmG4RHLPj1KqCRWhpWs6drenrqGm3kNzZnOJYnB
UY6g+hFAHgnwstLiH4662skUimI3e8Ffu5kGM/WvpCuPsvH/AINvdcbTrPWbGTUJGCYXjzGHQB8Y
b2wTWxrev6V4esvtmr38NnAThWlP3jjoB1J+lAGxRWLonibRvE1q8+jahFeRIdrmMkFD7g4IraoA
KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAo
oooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPD9a+H3xS1O61BV8V2x
0+5kkC28tzJt8ticKR5eOhxVHT/hj8V9Lsks7HxhawW8YxHEt5NtUeg/d8fSreh3/iP4hfFq4voL
9rXQ/D91hIcna/JXG0YyzAMcnoOK9G8b+Gb3xX4Vn0qw1D7DcM6SCRgSG2ncFJByOQOecY6GgCh8
PfD/AIy0L+0f+Er1tNT87y/s22d5PLxu3feUYzlfXpXeV5T8IPFWr6pDqvh/X3Mmo6NKIzJIcuVy
ykMe5BU8+hFerUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFee+MvCOg32rL4t1wXd7HpVszHT8K
8UiqGP3COTk+uCQAeK9CrzHxx4213wV4nsZ7rT1n8KyriWaCImWN+RgnOOuCBxkZGaAOP+FEFhrX
xE8T6lZQRabpc0DQf2UzBZCGK5JQdBwenALYFWPih4Y8I+HtNstJ0Tw5bHXdWmFva8uTGMgFuvXk
AfXPameE55/HXxqfxXpVlcWui28Bjed02+cdhQA9skkHHPCjNaoR/EP7SDmZHa20WyzFkHbu2j9d
0p/75oA7zwT4UtPBvhi20i2O9l/eTy/89JDjc36AD2ArzL45Xgl8SeFNLaymvYlka5ltYgS0w3KN
ox3IVvzr0rxz4xi8EaLFqc1jPepJOsHlwkAgkMc/+O1zXjfxvrvhTVNG1QaWtx4YnjVrmSOItNEx
zxuzgcEY4GeRmgDD+HWreDJPGRsY/B8nhzX40byVndmLDB3D5sYO3PbpnmvbK8E027f4nfGfTvEO
j2VxDpGlQqJLqaPbvI3EDuMkvjHoCa97oAK8f/aFvWi8EWNhGGL3d8vAHVVVj/MrXsFcB8S/EPiT
wvpllqeh6fBe2iTYvleJndE4IIweBwQTg44oA888J6l4JtfFelafqXgS40PUGaNrK6umcF5BjaxB
xjJ78jNSfDzRtP8AHXjfxvqWvWkV4wm8mNZ13CNWZx8uehCoAD2qv4h19fi94q8NWfhywuxDYS+d
dXU0YUQglSckEjgL+J6UaXrX/Cn/AB14qj1mwu3s9RYz2MsaZEmGZlGeB0fB9COlAG7+z9dyLpmv
6OzM0VjeAx57bgwP/oH617TXknwO0K+07w9qOqajA8E2p3IkRHUqxjA4bB9Szf5Net0AFFFFABRR
RQAVwHjLwn4Lhs9T8Ta7okFzNFEZZpC7BpNowo64ycAV39eR/Hq5uJfDOlaLbBs6lfqjkDPyr2/7
6Kn8KAKPwi8M2tjpV546urVLea7WWS1t4wdtvACfu59cfkB6mvMfDWp6TBp2oatr/gi71tJrtpZb
4F1jhB7ZAxnJPUjtX0+1nNpvh37Fo6xCa2tfKtFlHyblXCBsY44HpXjVz8XrlvDGsaD4k0O4j8ST
JLbJbwwbY23gqMgknjJ9c8Y60AereDbnRbvwhYS+HY1h0xkJhiGf3ZydynOeQ2c109cB8IfD974d
+H1paagjR3UsjztE3BjDEYU++AD+Nd/QAtcP400HxN4k+x6Zo2qppulyB/7Qm6ysPl2quOefmzyP
r2ruKKAPDv2flWy03xSoJZYbpAM98BqyPhn4f07xn4c8XatrVrFeX9zI6rPKu5oiULZQnockcj0F
b/wEhYReK0lRlD3qjkYyPnrk9A8RyfCuDxR4Z1ixuzc3DM1g6x/LMSCoOfQ/KcjPcdaQGH/wkV3/
AMM+/wBm732/219m+9/yy2ebt+m6uo+Jnh/TvBnh3wjq2i2kVnf20iK00S7WlIQNlyOpyDyfU1WP
w71b/hQoH2C4/tD+0f7S+zbD5nl7fL+71+782OtN1zxG/wAU4vC/hjSrC7Fzbsrag7x/LCQArHPP
A+Y5OOw60wPo+GQSwxyAcMob86lqNECIqKMBQAPpUlABRRRQAV4p8XdB8TapYa1qV5q6weHbCJJL
WxiGTM/ygl+nRicZz06DrXtdcV8WFLfC7X1VSSYBgAZJ+daAMPwjqJ0n9nuHUFzvg02d1x/ey+P1
xXjvhi+8N6P4Ytp/EHgK81CB5mEmqEsqcnhV6A4HuOa9j8FvrFp8D9Pk0W2jl1KK0d4IZ1JDsJGO
MZHUZxz1xXDa98U38S+Abjwtc6JeHxLckW8lvHbkICHB3BeWzx0x1o6gWPGbaX4h+IngLQbRFk8P
G1imhhBOxo2Y8Yz/AHYwPXqKtm3tvCv7RdhaaRBHaWeoWuJYIFCoco/RRx95AfrWNrnh3VPAn/CD
+Iri0muI9LhVNQEQ3eV+8ZyCfpIy56ZXrzWxoM7/ABF+NEfirT7O5j0XTYPLE0y7d7BSAO/OXJx6
DnGaAPd6KKKAPMpPAHhvR9Z17xX4lnh1GK5DSsL+FSluMnheuTjAHGeOOteUaDPdab8LPHmq2HnW
2k31zFb2SE9AZCG/8cYKfX8Kf4+8bjxV41FpqcF+fDVhOyC3tFw9wVyNxJ45PHsOnJJrtX1qy+JH
w317w34c0C6sWsLeJ7eCRVUMQ+4KuD1+Q/XNIDlvEnhTSbD4EaHrNtZRRaluima6RcSNvJyC3Ujk
YHbFXdVuP+E2+JngHTtTzPaPpdvdSxOch3aMyNn67VBrH1DxXJ4g+Hej/D6x0q+fXYZkimiMWAoQ
nHv3GcgYwc10fjTSrrwH4u8IeKDazXOnadZQ2V08K52FFKE+2VbjOOVp9QLOmwQ+F/2j/wCzdNiF
rY6jakvbxDagPll+FHH3k/U17pXhng+SXxz8Yrnxja2k0Wj2UHlQyzJje+zZj0z8zH2GPWvc6ACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD55/ta9+DPjzVftthLc+H
9Yl86OSP7w5JGCeCy7iCpxng59ehv/2hvDiWjnT9N1Ke6wdiTIiJn3IYn8ga9bu7K2v7dre7t4ri
FuscyB1P4Gsu28H+GbSdZ7bw9pUMynIkjs41YfiBQBwPwc8P6rDHq/izWozFd61L5iRsu0hMsxbH
bJbgeg969coooAKKKKACiiigAooooAKKKKACiiigAooooAKjZVZSrAEEYIIzmpKKAI1VUUKqhVHQ
AYFSYoooAMUwgMpBAIPr3p9FAEaIsahUUKo7AYAqSiigAooooAiSNIwQiqgJyQBjNK8aSY3orYOR
kZxUlFABRRRQAUUUUAFFFFABRiiigAqMxozhyilx0YjkVJRQAUUUUAFFFFABiomjRypZVYqcgkZI
qWigAqJI0QsVVVLHJIGM1LRQAUUUUAFFFFABRRRQAVH5aeZv2rvxjdjmpKKAGkBgQRx701EWNQqK
FUdgMAVJRQAUUUUAGPajFFFAEYjQOXCqHIwWxyacQGUggEHse9OooAjVFjUKihVHQAcCpKKKACii
igAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKK
ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA
KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArwTVtd8SfE/xxe+G/D+qvpei2BYTTwkgu
FO0sSME5bgLkDHJr3uvn34GONM8e+KdIvDsvW4Ct1JSRg3/oQoAkvfCvj/4canZ3vh/Vb/xDazPt
mtTG7DjnDLlgAefmBBB/X1/VPEml6Bo0Op65cpp0UgX5Zj8wYjO3AySRzwM9Ko+LfG+jeCoLSXWZ
JVW5kKRiJN7DAySRnoOPXqK4/wCKOr+E5F0FtX0i71i+uMS6dZwu0e4Nt++Pc4GME+3WgDp9F+Kn
g/xBqMdhY6upuZDiOOWJ4959AWABPtV/UPG3hvSdZ/snUNUhtr7yvOMcoKgIATktjb0B714B44/t
c+KfDV3qHhSx8OF7gCCO2dTJIA6ff2+mRjgdTXQ+O9NstW/aL0iwvwr2k0cAkRjw+AxCn6kAfjQB
6ronxM8I+ItSOn6bq6SXROER0ePzP93cBmuE8f8AxUfSviBpWiWepRwaZBcRnVJFjJcYf5kJx02g
H5eeevasf44aNp3h+bw5qmj2kFlfeewH2aMR7tm0qcDuD/Om/EjTLN/jZ4Vjawtgl4bdrqPyVxMx
mYNvGPmJAxznigD2xfEGkvoCa2b6JNLeMSrcyEou09DzjFc9Z/F3wPf6gLODXYg5O0NLE8aE/wC8
wArgPjwfsVp4Y0S3RbPSZZXLpEoRF27ABgccBjWz8TfBfhrT/hddyW2m2lq+npGbaWNAHzuC4LdW
zk5znJ5o8wPRfEHijRvDFpDdazerawTSeXG5Rmy2CcfKD2BrEuvir4Ks9TGnTa9AJ84LKrNGp9C4
G0fnx3xXi3jK+u9R+APhCa9LNKt48QdupRBIq/oAPwrvPE3gzw5b/BiSS20+0V4LCO5hulQeYZMK
d27qd2env9KAPRNb8UaL4e0uLUtVv0t7KVlSOYKXDEgkY2g9QDVLTviB4Z1fxF/YWn6otxqGwuES
NipAGT82MZA968L127nuv2bvD5uGZjHqhiQn+4olA/Lp+Fez/D3wboejeHtG1C10+BNRewQyXIX9
45dVZsn60Acbp8kNn4f+INxp/ja71i4S1lbyiksZsmHmY2lmP0yMfdrf+CV7eaj8Pkub66nupjdS
jzJ5C7Y44yTXmPgn/kE/Fn/r0k/nNXpHwB/5JhH/ANfk39KEAfHG9vdN8BR3FjeT2k326NfMglZG
xtfjII9BXLaN8NPF+reGdP1qy+IWpJcXVslwkEjyhVLKDt3iQ+vXb+FdH+0N/wAk3i/7CEX/AKC9
dp8P/wDknnhz/sHQf+gCkgOH+EnjjWNau9S8MeIW36pphOJTw7hW2sG9SDjnvnn36/xD8R/Cnhe6
+y6rq8UdyMZgjRpHX6hQcfjivJ/hy733xv8AF2rWI320aXTBl5DEyDb+eCal+COkad4km13WtYt4
r/UjOoJuVEm0NkscHuTnn2+tMD2XQvE+i+J7X7VouoxXcSnD7MhkP+0pwR+IrB1n4q+DdD1B7G91
lPtEbFXSKJ5NhB5BKgjPtXnehW0Hhr9oufSNFXybC4ibzoIzhFzD5mMezAY9M4rMtvDnjj4eapqj
ad4fsfEOnXEp8x2hE7svPBAO9Tg8jBGfWgD3nQ9f0rxHYC90m+ivLf7peM9D6EHkH2Nc7ffFrwVp
2pGwn1yIyq20tHG7op93UEV5z4c8T6G3w28YJ4c0R9D1SC1LXMIlaTOcruUscjGW44xx1rD8Cabq
l14Bngs/h/Zaxb3ZkV9Rlvoo5AeRxu5Xb+Hr3oA+j7O8ttQs4ruznjuLaVQ0csbBlYeoI61V13VL
fQtDvtWuf9TaQtMw7nA6fjwK4z4N6P4g8P8AhSfTdethBsuWe2AlSQFGAJwUJH3sn8aX43yvD8K9
SEZIEksKPj08xf8AAUMEVfhA19ceGdS8Wa1dSvNqtw8/zklY4kJHyjsM7unYCtqX4s+CIdNGoHXo
WgZzGoWNy5YYz8mN2ORzjHvSeEI0i+DGmrHjB0fcfqYyT+pNeb/Ajw1pGreHdZu9R023u5Wm+zhp
ow+1NgJAz0znt7UAemXHxQ8GW+kw6q+uwG1mJEe1WZ2IxkbMbgRkdQOtauheKtG8SaW+o6VqMVxa
xkiR/u+XgZ+YHBXjnmvFfgH4c0rVH8QXOoWNvdvC0cMYnQOFVt+7g+uBXJ6TPPpng/4j29kWSIS2
8JVT91DO6n9OPxoA98tvir4Ku9SOnRa9B52cBirCNj6ByNp/Pmn31/pnxH8D6vBoGpNMSjRpNEHj
KTABlHIB64/A1x/hLwh4bufgsJ5tPtJGuLGWea6aMGRZBu53dRtxjj09zSfs4f8AIn6r/wBhD/2m
tAHS/CHxZJ4o8FRreOW1DT3+y3Bb7zYHysfqOPqDXodeHfBYtD4/8dWsR/0ZbkkAdARLIB+ma9xo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvLfGvwlt/Eesr
ruj6lLo+sggtPEDtkI4zwQVbHcHn0716lRQB41pfwTuLrWotT8Y+I7jWjCQUhYsQ2D0ZmJO32GPr
XQ/EH4dN4yn0+/sdSOnanp/+plC5XGQw6EEEEcGvRKKAPGtT+D2sa81pqGr+L5brV7eQMskluPKR
ByFVARg55J7+neua8f6MmvfH/TNLluJYPPtox50Bw8bBXYMv0IBr6KrEl8MaLca/Frk2nQPqcQAj
uiPnXAI/qaAPO7D4P6leeJbbVPFfieXWo7JgbeFkIzg5G7JOBnBIHX1rT+IHw0uvGGsabrOmasNP
1CxUKjFCRgNuUgg5BBz/APWr0yigDgtU8AReIfA9roXiDUJbu+t1DLqIX5xJz82DnIxwQeo9OMcj
/wAKd8QajHBpeveNbm70S3YFLdEYMwHQckgcf72K9rooA8N+Pen22k/D7QbCziWG2t7tY44x/CBG
1PPwj1rVtLsNOj8YXaeG3jjlNjKpdkGA20c4Iz0z09DivWNb8P6T4it4rbV7CG9hjfeiSjIDYxn8
ia0IoY4IUhjQKiKFVR0AHQUAcD4s+GVtrvgTTvC+l3S6fb2MyyRu8ZkJwrA55HJLkk+tdrpFidM0
ax08yeYbW3jhL4xu2qFz+laFFAHl2h/CeXR7TxdAdYSU6/E0akQEeRnfyfm+b7/t0ro/h74Pk8D+
GBo8l4t4wmeXzVj2D5scYyfSuuooA434i+C38deG00iO9WzK3CT+Y0e8cBhjGR/erhY/gt4lFmli
/wAQ78WKoI/IRZNgQfwhfMxj2r2yigDkPBXgjSfA+nNaacrySykGe5lxvlI6fQDnA/n1rk9V+FF9
Z67c6r4K16TRZLsnz4ApKcnJxjtnsQcdiOlet0UAeeeC/hla+FLi71LUL6TV9avAyzXcy9m6gAkn
nuSefasGP4U+IPD1/eS+CvFb6Za3bbntpod4Xr0JznHQHAOO5r2GigDz3wZ8MLHwvpupxX1y2qXe
rArezSLtDqc5UDJPO45OefauVf4Na9p6Xem6F4yntNFu2PmWzxkkKeCOCAeOO2a9sooA5rwf4Ssv
Bvh+LSbJnkVWMkkr/ekc9T7dB+VL450E+JvBOraSgBlngJiB/wCei/Mv/jwFdJRQB5j8I77+3fhT
HpjNsubQS2MoI5Q87cj/AHWH5Vq/DbwHJ4B0a90+TUVvTcT+cHWLZt+ULjGT6Vv6b4e0rR7u/utN
s1t5r+QS3JRjiRuecZwDyemK2qAPP/ht8PJPAEeqJJqSXv26RHBWEps27vc5+9XP2/gSx8B6N4u1
TXbh9V0zUkDT29vb7XRN5ORluSN+e2Nua9gqKRFlRo5FDIwIZSMgigD5n0nTPDH/AAjOoPH8RrtN
CCyP/Y0p8iWRwMhSu87gTj7q8+1df8DbhdC+F2t6zefLbR3Ms2T3VI1z+uRXcy/CjwNNcGdvDdoH
znCllX/vkHH6Vt3fh7SL/QH0KWxiGlsoQ20WY02g5wNuMcjtQB598C9Knh8N6h4huxifWboyjjqi
k8/izP8ApXrdVLS0t9PsobO1iWG3gQRxxoMBVAwAKt0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQB//9k=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-06" NO="6" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of cilazapril 0.5 - 10 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-07" NO="7" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of enalapril 5 - 40 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-08" NO="8" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Lose dose-response curve of fosinopril 2.5 - 40 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-09" NO="9" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of imidapril 5 - 40 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-10" NO="10" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Lose dose-response curve of lisinopril 1.25 - 80 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-11" NO="11" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of moexipril 7.5 - 30 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-12" NO="12" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of perindopril 2 - 16 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-13" NO="13" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of quinapril 10 - 40 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)<BR/>
</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-14" NO="14" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of ramipril 1.25 - 20 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-15" NO="15" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of spirapril 3 - 24 mg/day<BR/>
</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-16" NO="16" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of temocapril 1 - 20 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)<BR/>
</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-17" NO="17" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of trandolapril 0.5 - 16 mg/day<BR/>(Shaded area represents manufacturer's recommended dose range)</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-18" NO="18" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-19" NO="19" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-20" NO="20" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-21" NO="21" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-22" NO="22" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a
HBwgJC4nICIsIxwcKDcpLDAxNDQ0Hyc5PTgyPC4zNDL/2wBDAQkJCQwLDBgNDRgyIRwhMjIyMjIy
MjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjL/wAARCAJEA4QDASIA
AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA
AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3
ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm
p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA
AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx
BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK
U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3
uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3+iii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACisPxB4j0rwtpjajq92ltbA7QSMl
25O1QOSeDXzP8QviZf8Ai/Wg9lLc2Gm2ylLeJJSrPnq747njjsPxyAfWlITiqmnEnTLUkkkwoST9
BXjHjqWTxB8e/DWhRs5hshHJMgYgHkytn/gKrQB7nRXzf4x8U+KfHvxHk8JeH72SxtIp3gURyGMO
UB3u7LyRwcD0xxk1l6/pvjj4U39hqA8QyXNvMxCkTO0bEYJR0b1H/wCsGgD6korI8OaxH4g8O6dq
8abFu4Em2f3SRyPwORVHxzJJD4B1+WJ2jkTT52V0Ygqdh5BoYI6WiviPTPFev6ff2mof2nfyJbzo
+1rhyrYIbaee+K+vta1+303wbeeII2DRRWbXMZ/vZXK/mcUAb1FfDJ8Q+ICFlfWNS2yE4b7U/J79
6+4IObaInn5B/KgCaism58RaHZzmC61jT4JgcGOW5RWH4E1diuIZ4BPDNG8JGRIjAqR9aALNFU4b
60uH2Q3UEr4ztSQMf0p891b22PtE8UW77vmOFz+dAFmioopY5oxJE6uh6MpyDUtABRRRQAUUUUAF
FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUU
UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFAHLeL/B2neNtOtbDU3nFvBcC4KwsFLkKy4JwePm7V4V8dtIsdC1fQtP0y1itr
WOybbHGMD755Pqfc19PV82ftJf8AI06N/wBeTf8AoZoA+h9N/wCQTaf9cE/9BFeLfC4f8JP8YvFf
ihstDAWihb/ebav/AI5Gfzr0zxBqg0T4cX2pbtrwaaWQ/wC3swv/AI8RXHfADSTY+AJL5wQ1/dPI
p9UXCD9Q1HUOh6ZOLO1V72cQRCNSzzuAu0dyW7V83/EHxRdfFTxdY+HfDcLTWlvIywvj/WseGkP9
1AB+WT3wJfjN8RbjWdWuPDGnTiPS7SQJcup/18g65/2VPGO5GfSuj+H3ib4a+BdKEcOrPNqUyj7V
dm0lyx/ur8vCg9vxNAHsGgaTFoXh+w0mJt0dnAkIY/xYGM/jVHx9/wAk+8R/9g2f/wBFtWlpOqWu
s6VbalZSGS1uUEkTlSuQfY81m+Pv+SfeI/8AsGz/APotqTBHyzoukjUfhf4mvAuZNPvLSYEDkK3m
I3/oQP4V2uveMftX7Oej2Sv+/muBYSjP8EPzfyEf51N8EtJGveDvG2lsP+PuKOJfZismD+BxXlGm
2l9qmo2Ph8O4828EaRHosjlVJ+vA/KmBveM9H/sTQPB8LLtln003UmR1MkjMM/8AAcD8K+nfF2m6
1rHg6fTtBvIbW+uI1QTSuyhV/iwVBIJHH414n+0LAlt4j0GCIYji08Io9AHIFegfGjWdS0XwBbHT
XeH7XOkE80ZIKpsZsA9s4Az6ZHegDiIfhJ4U0rSHfxb4uhs9WJYNHBcx7Izk4+Vhubse39aj/Z+1
K4i8XapowuWlsXtHlC5+UsrqAwB9QxqTwL4c+GP/AAhkOu+ItQgnvQGNxBNdFdjAnCiNSC3GPXOa
ofAWWFvibqDxqER7GYxp6DzEIH5UAJ8Q/DF58L/G1n4n0FSmnzTeZEoHyxP1aE/7JGce2R2qCMan
8bfiQryRyWulQKNwU7hbwjtnpvY/5wK3PjJ4vm8Sa3b+B9B/0hVnVbjYM+bPnCxg+i9/f6VieEtY
1P4Q+P5tJ1sBLG4KpdFcsu0/clX1Ayfw3DqKEDPpiwsbbTLCCxs4VhtoECRxoOFA7VcqvFKk8SSx
OrxuAyspyCD0IqxQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRVF9U0+KbyZb61SX+40yhvyzVwEMoIIIPcUAOooooAKKKKACiiigAooooAKKKKACiiigAooo
oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiig
ArkPFfw78O+MryC71q2mllgjMaFJmQBc57V19FAGD4i8L2Pibw6+hXclxFZOEDeQ4ViFIIGSD6Cp
tC0a00DRLTSbNWFvax+Wm85Yj1Puea2KKAPN5vgh4InmkmlsrtpJGLMxu35J696j/wCFD+A/+fC6
/wDAt/8AGvTKKAM3R9JtdC0m10uyRltbaMRxqzFiAPc0up6fb6tpd1p12pa2uomhlAYglWGDz2rR
ooA5jwn4H0PwUl0miwSxLdFTKJJS+SucYz9TWbZfC3wtp/iYa9BZyrfidrgEzMUDsT/D07mu5ooA
5DxV8O/DvjG8gu9Zt5pZYIzGhjmZAFzntWvq+h6dr2kyaZqdqk9nKArRtnt0IPUEetbFFAHmVj8C
vBVlffamtru5AORDcTbox+AAJ/EmtXS/hl4b0bXX1rTrae1vZPMyYpmCAPnIC9AOeB249K7iigDi
NB+GHhfw3rK6tp9nKb5QwWWeZpMFup5PXrz7mrXif4f+H/GE1vPrFq0s1upRHjkKNtJzgkdf/rn1
rraKAMfRNGtdD0m30ux8z7PbqViEshdlXnAyecDOB7VsUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABXnvirwb4l8VarJAfE7aXoIChLezQ+bKcDdvbI4znA5GO1e
hVzvjaW3h8Ea49zNLDALKUPJF99QVIyvvQBwcX7PHhIRkTX2ryyHq/nIP/ZKlsfhTrXhN/tHg/xb
dRbTkWeoJ5kEns23GPqFzXH+Gfg5qOv+F7bVn8WXEE93CJoYkDOiAjKhm3DJ9cdPesDT9P1LRPB1
54v0vxNdpqWjXwtbq0d90bneF+U5+ZTuBwR/eoA+pE3bF34345x0zUlVLG4N5YW1yV2+dEsm30yA
aLy+tLCISXd1BboTjdNIEB/E0AW6Krw3EVxCssEiSowyro25T+IqA6rp4vPsRv7X7VnHkecu/wD7
5zmgC/RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU
UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc5rupeHJra70fWd
U0+JZ4jHNBPdJG21h6E5HB610defeJPhH4a8V67PrGpfbftUwUN5UwVflAUcYPYCgDzk+CfsCvp+
kfFy0ttIcn9wb0KVB6jCyAH9M+ldRZ/Crw3qvhzTdJ07XVu9Ps703V60DJI1xIVAwSpwnAx34P41
x3w/+F3hzxJrniyzv/tnlaXfm3t/Lm2nZucfNxyflFe0eD/BOl+CLK4tdI8/yriUSP50m85xj0FA
HSIixoqIAqKMADsK8z1f4aL4l8b3Ot+KL1bzSI4NttZBmjEOMdSCOPvE9MkjsK9Qr54+Lvj432un
whBeSWemQsE1K4iXcznqUAGMgenGT14FAFn4X297dXPjbR/DWoyxaP8AMmn3MmWWJ2LBWX328+vC
mqPjT4baJ4K+HT32oXRl8TtODDdpMw81zJnAUnsmST1zzmuu8FeOvA+j+GL+28PQ3aW+lWpu7gzR
BXmPAyTnlicD8scCvMbDxtoXiHxjJ4k8ezXU6Qn/AEPTYIt8SDtnJHA9P4jyeOCAe8eGPEEFn4M0
KTxJqltb381lHI32udY3fgc/MRk9M+9dBp+uaVqzSppup2d40WPMW3nWQpnpnaTiuUvvB/hD4nWe
neIruynkEtuBA4kaJvLySAQDjqT+dcR8K9NttE+KPjPTLFWS2tVEcSs2SAJPWnuxbI92orN3t/eP
50b2/vH86v2ZPOaVFZu9v7x/Oje394/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j
+dHsw5zSorN3t/eP50b2/vH86PZhzmlRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHOa
VFZu9v7x/Oje394/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j+dHsw5zSorN3t/e
P50b2/vH86PZhzmlRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHOaVFZu9v7x/Oje394
/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j+dHsw5zSorN3t/eP50b2/vH86PZhzm
lRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHOaVFZu9v7x/Oje394/nR7MOc0qKzd7f3
j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j+dHsw5zSorN3t/eP50b2/vH86PZhzmlRWbvb+8fzo3t/e
P50ezDnNKis3e394/nRvb+8fzo9mHOaVFZu9v7x/Oje394/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5
pUVm72/vH86N7f3j+dHsw5zSorN3t/eP50b2/vH86PZhzmlRWbvb+8fzo3t/eP50ezDnNKis3e39
4/nRvb+8fzo9mHOaVFZu9v7x/Oje394/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3
j+dHsw5zSorN3t/eP50b2/vH86PZhzmlRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHO
aVFZu9v7x/Oje394/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j+dHsw5zSorN3t/
eP50b2/vH86PZhzmlRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHOaVFZu9v7x/Oje39
4/nR7MOc0qKzd7f3j+dG9v7x/Oj2Yc5pUVm72/vH86N7f3j+dHsw5zSorN3t/eP50b2/vH86PZhz
mlRWbvb+8fzo3t/eP50ezDnNKis3e394/nRvb+8fzo9mHOaNLWbvb+8fzq9ESYlJ9KmUbDUrklFF
FSUFFFFABXl/jDwh8QtV8TXN7oHitLDTnCCO2MzrtIUBuApHJya9QooA8C0/4SfEjS57uew8X2tt
LdyebcPHNKDK/PLfJyeT+del+A9E8T6Hpt1D4n1hdVuJJg0UgkZti4HHzAd67KigArJl8PaLPM80
2kWEsrtuZ3tkZifUkitaql5fWlhEJLu6gt0JxumkCA/iaAKceg6PEkkcelWKJKAsirboA464IxzS
/wDCM6D/ANATTf8AwET/AAq9DcRXEKywSJKjDKujblP4iof7Ssftn2L7bbfa8Z8jzR5n/fOc0AS2
8EVtCsMESRRIMKkahVUewFeO+AP+S0+Pv98/+jK9rrxTwB/yWnx9/vn/ANGU47iex6xRRRW5kFFF
FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA
UUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABR
RRQAUUUUAFFFFABRRRQAUUUUAFX4v9Uv0qhV+L/VL9KzmVDckooorM0CiiigAqpe3lvp1jPe3Uqx
W8EbSSyN0VQMk1brnfGNvZ3Xg3WYdRuDbWb2cglmAyYxtPOO+PTvQBw7ftB+Do3KiDVXAOAywLg/
m9dh4O8caZ45sbm80qO5SO3k8p/tCBSTgHjBNeK+F/i14Z0fw3ZabeeE1lntoxEZoo4yJccbzkZy
ep68969e+Hni7SvGOl3l1pWktp0cE4jdGRV3NgHPy0AdtXl+r/DRfEvje51vxRereaRHBttrIM0Y
hxjqQRx94npkkdhXqFfPHxd8fG+10+EILySz0yFgmpXES7mc9SgAxkD04yevAoAj8C6vP4e0/wCI
U+gXMkmhWEbvYO53KshLBCM+2CfXC5rIHg+z/wCFJf8ACdeZc/2/9p8/7X57bsef5fr17565712+
iX/hXXvh7rnhDwZb3Qmj095D50W1pn9Sc8sSAP5cCuK/4S/S/wDhQX/CJec39t/aPJ+ybG3f6/zM
9MYxx9aAPcfDni6xuPB2h6hrGqWdrcXdmkjGeZY97YAYjJHfNef/AA5uIbv4ueObi3mjmhkO5JI2
DKw8zqCOtdFYfCbRNZ8LaBH4jspW1Cz0+OBtkzIV6sVODzhmNcr8K9LtdF+J/jLTLJWS1tVEcQZt
xCiT171S3Jex7JRRRWxmFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRR
RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFF
ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFLgnsaAMsB718leL
PFviL/hLtYC67qSKl7KipHcuqqocgAAHAwAKmUrDSufWuD6GjB9DXxb/AMJd4l/6GHVf/AyT/Gj/
AIS7xL/0MOq/+Bkn+NLnHyH2lg+hpCCOtfF3/CXeJf8AoYdV/wDAyT/GvdfgdrWqapomt/bL25vn
gmTyRcTFyCVbgE9M4FCncHGx65RXkej6ld67aNcf8J7cWPirLZ0qYxxQQyAnERiZckdBkEnvXo1l
rPmawuh3kJi1RbGO7k28xPk7W2Hqdrew4IpqVyWjWorl5PHemrpEeow2t9ci4vHsrSCCINJdOhIJ
QZxt+U8kjgVg+JPiHcQeHzNp+lara6hFqENtc289svmRKxB9SPnXhSM8+nWjmQ7M9GorkLv4hWkF
xLFbaHrd69tGsl6La2DfZCQG2P8AN98DqBnFZeueKkfU0vLXVLtdGl8OXF9vs8b9wkQB1DcbwCRz
070cyCx6HRXM6n4xtdKuLTToLHUtW1Ca3W4+zWcIeRY/77kkAZP5mtbQ9atPEGkxajZeaInLIyTJ
seN1JDKy9iCDTuI0KK8rv9TFz4/8SWWp+ObnQbaza3+ywpcxRKwaIF8bxzz/ADpJPEOuSfC/Vbwa
tLI0OqJa2WrxoI3uYDNGvmendhnpxS5h2PVaK8119dS8IwW2p2njO/1OU3kMI0+9eKQXKu4Uqu0A
g4Ocj0r0sjDEehpp3E0JRRRTAKKKKACiiigAq/F/ql+lUKvxf6pfpWcyobklFFFZmgUUUUAFc74z
iS48Ga3HLayXSNYy5giOHk+U8LwefTg810VYvibV/wDhHvDOpav5Xmmzt3lEfTcQOB9KAPFPDPxR
17w94dsdKk8B3dx9kiWJZIw8e4AYBI8s8+vqea9U8DeL7vxfpt1dXegz6Q0E3liKZiS4wDkZVa88
07X/AIy63YQ6nZadpotblBLDkRrlCMg4L5x9a9F8Cy+MX066/wCEygt4rsSjyRAVIKYH90nvmgDr
6yZfD2izzPNNpFhLK7bmd7ZGYn1JIrWqN3WNGd2CqoySTgAUAU7XSNN092ey0+0tmYYZoYVQkfgK
j/sDRv7R/tH+ybH7dnP2n7OnmZ/3sZq3b3EN1EJreWOWNvuujBgfxFN+3Wf2r7L9qg+0f88vMG/8
utAFuvFPAH/JafH3++f/AEZXtdeKeAP+S0+Pv98/+jKcdxPY9YooorcyCiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKAFH3h9a+MvF8EsXjLXFkidG+3zkgqR/G1fZlIVUnJUE+4zUyjcadj4W8t
/wC435UeW/8Acb8q+6Ni/wBxfyo2L/cX8qn2ZXOfDGx/7rflXv8A8A4Lk+G/EPksYJJJUWKZkyof
Y3OO+DjivaNi/wBxfypwAAwAB7DimoWE5XPMtRudS1XRm0nxD8P7jVNYEZi+1RpEbeRsYEglyCnr
0yKTxTper6B4S8M3lvdCbXLFBpbSFj++89PLwD1O1tjD/dzXp1Zd14e0y91u01i5tzLe2ikQM0jb
UPPOzOM8nnGRT5RXOc8SeG4bPwdpWjw6E+sWViyJJHbyeXcIFUjzYjkfNnORnnJrl00bxK/hzUhD
Za3LpkV7Z3FhYanKsl3iOQNLjngdMAnt+fr9FHKFzzrTb7XPC91rHl+FdT1CLV7ptRtGh2Bo3lUZ
inBPyFSOvNYUvgjW7DQY9PW0aeZfDd7buYeVE8s4kEQ/MgfSvYqKOULnCTrqvhnxM2rx6JearZ32
nW9vKtltaaCSLPBUkZU7uvbFdRoM+qXWlLcavZxWV3K7sLaM5MaEnaGPOWxjOOM1p0U0hM80lju9
J8f+Jr258H3+sWt8bY200MEcijZEFb75Hfj8KpXHhjV7vwd4kC6G1lFqmpW01to6srGKNXj8wkDg
bsEkDpXrFFLlHcxLDwb4Z0m9F3p2hafb3CE7JY4huX6HtW3RRTSsIKKKKYBRRRQAUUUUAFX4v9Uv
0qhV+L/VL9KzmVDckooorM0CiiigArn/ABfe/wBneDtavDaJdiKzlYwOMrINp4Yenr7V0FYWsMNV
0zVdJ07UIItTa2eMfOC0LMvysy8kDkHpQB4r4W8PfFs+GbCTRdctLbTZYVktoZZFYrGwyo5RsDB6
Zr1fwNZeMLLTbpfGGoQXt002YWhxgJgcHCr3zXnWnfCr4k6TZpZ6f43it7ZPuRJLLtUew28V6B4O
07XPC2jXreL/ABFDfEyh0uJJSFjTHQlsY5oA7WvHfixeeML6DVtN0u2Wz0G0s/PvL5sgzjGTEp/n
j8SOh9fVg6BlIIIyCO9cv8S/+SaeIv8Arxk/lQBy3w3XUD8BIBpJxqJtbv7MR/z08yTb+OcV415H
hceAg4kvv+FhfbduzMvm7/MxjHT7vf726vV/Bpvx+zjnSzIL0Wd0YjFnfnzZM7cd8Zx7154L3wN/
wpMxMlr/AMJTuPzFP9J83zc53ddu38McdaHuCPoDTtYh0nw9pUfiPVLO01NrSPzxc3CIWk2jeeSM
85rzX4c3EN38XPHNxbzRzQyHckkbBlYeZ1BHWt3TPh9pPjDwp4evvFlpcS6rFp8cbSGZ0cryVDc9
efrkmua+Fel2ui/E/wAZaZZKyWtqojiDNuIUSeveqW5L2PZKKKK2MwooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigApcH0NA5YfWvn/wx4Nl+IfjLxcb3Xr+2NjfEJ5T7shnkHc8Y2DFTKVhpXPo
DB9DRg+hryz/AIZ/t/8AobtX/T/Gj/hn+3/6G7V/0/xqfaFch6ng+hoII6jFeWf8M/2//Q3av+n+
NUfg3JcRab4stJLuedbS5KRtI5OMK4z7ZwKancTjY9hwfQ0mDXmnhHwdHrfgrStSk1zX4NRurYSG
ePUpTtck87ScfhU/h/xM+pxeF01Xz5NTa+u7JpYJvLjMkStl3QcMCoHHY80+YVj0SiuL1PxxqWm2
95qX/CJXzaLZSMst1JOkUhVTgukTclfTpkc0+78cTtrF1p+i6FLqhso45Lki6jifDoHAjRuXO0j0
5460cyCx2NFeezeMNStvHkjXOn3UGiRaMt5IJZVUwrks0rJ13D7m3rkZ6Gr9v47u0l06bVvDN5pu
majKkVvdvOjlWf7nmoOU3ceuO9HMhWO0x7UleZ+G9XB12ztLt724uZ9W1ZIJDcsI41jK8On8Qx0/
u9q108fXM8X9pWnhi+udA88wi/ilVnYbtvmLD94pnv1xzihSG0drSkEdQap6qWXRtQdWIZbWUhgc
EHYa8Nt9c8PReCrW6tPFOur4qa3j8tTeTmM3Bxw2/wDd7c9cnGKHKwJXPfgCegzSEEdeK8x8TXFn
L8QtLs/EOtPp1mdFMzmHUGtY2n8wDhgRn+LH/wBarPhK8hTx9d6boWt3Wr6EuniWZprk3KQXG8BQ
khJ6rnjJo5gsei0UUVQgooooAKKKKACr8X+qX6VQq/F/ql+lZzKhuSUUUVmaBRRRQAVwfiz4Z6J4
tuvt7NcafqqjC3to+1yBjG4d/wBD713lef8AiT4u+GPCmuz6PqX237VCFL+VCGX5lDDnI7EUAcuf
hR49gYw2nxKvvs/Qb3lDAfTef51qaR8F9PS8S88S6tfeIJ0OQl0xEWfdSST+ePaj/hoLwT/1Ev8A
wGH/AMVXWeD/ABtpfjeyuLrSPP8AKt5RG/nR7DnGfU0AdKAFUAAAAY47VBcW8N5bvb3MMc0Mi7Xj
kUMrD0INWqjd1jRndgqqMkk4AFAFW0tLawt1trS3ht4EztihQIq554A4HeqJ8J+Hm1H+0joemm9z
u882yb8+ucdfetO3uIbqITW8scsbfddGDA/iKa17ax3K2z3MKzv92IyAMfoOtAFuvFPAH/JafH3+
+f8A0ZXtdeKeAP8AktPj7/fP/oynHcT2PWKKKK3MgooooAKKKKACiiigAooooAKKKKACiiigAooo
oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiig
AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAC
iiigBQcMD714F4f8Uat8PPGHi0yeF9Rvxf3xZWjVlACvIQc7TnIcV75ShmAwGIH1qZRuNOx5V/wv
XUv+if6r/wB9t/8AG6P+F66l/wBE/wBV/wC+2/8Ajdeq72/vH86N7f3j+dT7MrnPKv8Aheupf9E/
1X/vtv8A43Vf4OWl+dO8VXN1YXFp9tud0SzIVySH4GcZxuHNeu72/vH86Cc8kk/WmoWE5XPOfDx8
faH4ZsNEh8L6cJLWHylu59UBTP8AeKBc/hmrNj4KutKn8HRxSLcrptzc3F/cEhd7yxtlgP8AeNd5
RT5RXPFdS8AeJNSstStb3QrXUNUmaVk1q51RirKSSoSHopxgDoBW34i8K6rqM0YuPCGnar/o0SW9
3He/ZZ7VggBV2HLgNkgjtxivT6KOVBzHml34N12We2srgrfRXegDSL2+84BoJAxbzNp5cdB6nHNW
prDxj4ih03RtX0qxsLO1uIJrq+juxL54iIYCNMAruIHXpXoNFHKFzzrR/CGr2fiXTL24gjFvBqOq
XEpEoJCT7fL/ADwfp3p2l6f420HSIfC2mWdkltbvsg1t5wdkJfdzCRkvg4x0r0OijlC5W1GB7jSr
y3j5klgkjTPGSVIFed2tn42HgqLwo/hXTVT7F9ia7n1JXQDbt3lAuffGetem0U2rgmcNYeC5bbxL
pElzFDfadYaCNPMsyqxaUOpB2HPYH+VdpBbwW0fl28EUKZztjQKM/QVLRQlYQUUUUwCiiigAoooo
AKvxf6pfpVCr8X+qX6VnMqG5JRRRWZoFFFFABXlvjjxR4W03xbYaPN4ctdY1i9kjExNsjtFGSBkk
qSx25IHoOo4r1KvD7vU7LwV8eL/UvEA8qz1SzUWt265WM4RT9PuEH0yOxoA6rx5H4f8ABug/2rF4
M07UNsyq8aWaAInJZiQhwAB34yRWz4F1bQdc8Opqfh2yhs7eZyJYY4VjKSADIYLxnpz6Yqvq3xJ8
GWGmTTy67p10nlk+RDMsryDH3doz16c1zfwFsp4fBt/evCYba+1B5baPsEAVcj2yCP8AgNCA9Zrx
34sXni++t9W03S7ZbPQLSz8+8vmyDcDGTEp/nj8SOh9irlPiX/yTTxF/14yfyoA47wHqz6B+zwmq
Qgeba2t1JHkcb/Nk25/HFeWaavgfVtBE/iHxDeQeK7+cytflXlW2w+BuAwDkDPqMjpivTvBmmTa1
+zf/AGdaruuJ7S6WJR/E3myED8SMV59peseEYPgtqWjXscEev+Y48qSD960m/wCVgccYHHUYwR35
b3BH0Fpk9tpej2EGoa1BdSiBQLuaRUNxgD5+vfg9TXmXw8kjm+MHjuWKRZI2OVZGyCPM7Gruh/Cr
SfFXgnw3P4jju1v7exWIeXLsKxlmZFIIPQNWN8J9LttD+J/jLS7Pf9mtF8qPe2TgSdzTW5L2PZqK
KK2MwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigBGLBGKgFgCVBOATXm/iHxj498NaLcatqHhvRhaQFQ5jvWZvmYKOP
qRXpNcL8Yv8Aklmr/wC9B/6OSplsNbmlo1/42n1KJNZ0PS7WwYEvLb3hdxwcYXvziuopqfcX/dFO
ppWEFFFFMAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAq/F/ql+lUKvxf6pfpWcyobklFFFZmgUUUUAFYniHw3pHiex+x6vYRXcQJK78hkOOqsOQfpW3UK
Sxyl1R1YodrAHOD6GgDz60+CHge0uRcDTpZ9pyI5p2ZPy7/jmu9ggitoEhhjSONAFVEXCqPQDsK4
3xd401fSdct9B0DQTq2py2xu3VphGkcW7bk568/SrngvxZfeIJdR0/V9JbStW04x/aLfzA4KuCVY
EeuDQB2FVbm3hu7d7e5hjmhkUq8cihlYehB61apjMEUsxAAGSSelAFS0s7WwtktrO3ht4UztihQI
q554A4FUpPC+gT6iNSm0bT5L4HP2hrdC+fXOOvvWpFNHPEJInSRD0ZGyD+NTEgDJIAoAWvFPAH/J
afH3++f/AEZXtdeKeAP+S0+Pv98/+jKcdxPY9YooorcyCiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuF+MX/JLNX/
AN6D/wBHJXdVwvxi/wCSWav/AL0H/o5KT2GtzuE+4v8AuinU1PuL/uinUxBRRRQAUUUUAFFFFABR
RRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFF
FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVfi/1S/SqFX4v9Uv0rOZ
UNySiiiszQKKKKACvNfGPhvS7LV5NasPFK+GNcusFpJblRDc4GAHjc4PQDj8jXpVeKeMPDOpwePN
T1e58Fr4ssr1IhbE3OxrXauGTbzwTznH49aAKOvyC8FlP8QbC7tWjTZb+I/D826F0J/ixnaOp6fQ
V6L4A0Hw5pGlSz+G7w30d2wea8efzXlYDADHtjnjA61U+HPh2+0PwdLZatbR2/2i6lnjsN/mrbRO
RiLJznHPr19c1v6L4T0fw7fXt1pFilm17s86OIkRkrnBC9B949MUAdBXjnxX1HxfeWuraXpNr9k0
O0sjPe6gxIMwIJMSn9CBn3I6H2OuU+Jf/JNPEX/XjJ/KgDJ+CnHwl0XsP3//AKOevIvi74sv/Fjy
Saczf8I3pt2toswOFuLkqxJHqAAce3Peu68I2Gr6l+zlb2GhSKmo3CSxxsz7MKbht/Pb5d1eb+N9
C8ZeGvAOmaVrNrpcOkQ3Y8n7MQZGlKucse+Ru/Sh7gj6am1TT9PhhF7fWtsXUbRNMqbuO2TXkfw7
niuPi/46nglSWJzlXjbcCPM6giugPw5g8a6Zp9/44t1/tyKJoXNjMVTZvYoO46H9a5X4U6Xa6J8T
/Gel2asLa1URRh2yQok7mmtyXsey0UUVuZhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXC/GL/klmr/70H/o5K7qu
F+MX/JLNX/3oP/RyUnsNbncJ9xf90U6mp9xf90U6mIKKKKACiiigAooooAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooo
oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACr8X+qX6VQq/F/ql+lZzKhuSUUUVmaBRRRQAV
4xfeIF0r9oGdL3VBbWA04bY57jZEXKDA5OMmvZ68u+JkXw3tZFufF1qr38yYj8jcJ2A4z8pHH+9x
QBwfhbwJc/FayvPEus+JbiO7a5eNY4huEOMY6ngc8AY4+td78IdW1K6sNY0fULz7cNHvmtobwNu8
xORjPcDGR7MPSuC0Lxt8NdI0HV/D9iniC0s9VUrLNKiOY8qVyuCT+hr134fad4c03wpAnhScXGny
OzmctuaR+AS3AweAMYGPSgDsKp3VrBe20trdQxzwSqVkilQMrA9iD1FXKYzBFLMQABkknpQBSsbC
00y0S0sbaG1t0ztihjCIuTk4A4HOajv9I0/V4Vg1OwtryFWDiO4iWRQ3rgjryeauxTRzxCSJ0kQ9
GRsg/jR9pg8/yPOj87GfL3jd+VAEoAAwBgV4t4A/5LT4+/3z/wCjK9rrxTwB/wAlp8ff75/9GU47
iex6xRRRW5kFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcL8Yv+SWav8A70H/AKOSu6rhfjF/ySzV/wDeg/8ARyUn
sNbncJ9xf90U6mp9xf8AdFOpiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACii
igAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKK
ACiiigAooooAKKKKACiiigAq/F/ql+lUKvxf6pfpWcyobklFFFZmgUUUUAFeD+Op18JfFGbxPrmh
Nquj3Vokds5UMsDgKD14zweuPv8AB617xUbqrKQ4BUjkEcUAeCeHNRj8UeMNT8Wad4TS28P2ulSr
cQPGu29kUFlGMbd3QcZwByecV0/wT06/tdI1m8udPfTrO/vjPaWbAgRL7A846AHvtr1KFomjHksh
QcDYcgUqSxygmN1fBwdpzigCWvHfirqfjG8h1XStIszaaJaWZnvb9jjzlKkmNT/MDn1IHX2KuU+J
f/JNPEX/AF4yfyoA5f4Z2+oXXwMsrfS7hLa+lhuUgmfpGxlkw3Q9K4Txf8NbHwd8Pn1rUtSmbxSJ
1KXMdy2JHL9FyASdmTnrkeld38MtWttC+B1lqt5kW9pFcSvjqcSvwPc9K8rtPGGheMfGDa7471CV
bK2f/Q9JiheRAOwJHGOBnux9BxR1A938K+IFHgnQrnX9Qt4L24s45HNzKsbScD5uccng/jXA/Due
K4+L/jqeCVJYnOVeNtwI8zqCK67U/BfhL4nW+n6/cQ3Do9uFgkjkMR8vJIBX6k1w/wAKdLtdE+J3
jPS7JWFtaqIow7ZIUSdzTW4nsey0UUVuZBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUA
FFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFKAT0BP0oASil2N/dP5UlABRRRQAUUUUAFcL8Yv+SW
av8A70H/AKOSu6rhfjF/ySzV/wDeg/8ARyUnsNbncJ9xf90U4DNNT7i/7op1MRws/wAYfA9vNJDJ
qsoaNirYtJSAR/wGrWj/ABQ8I69qtvpun6lJLd3DFY0a2kXJwT1IxUvxLVf+Fa+IDtGfsh5xz95a
3tGVRoWmkKAfskXOOfuLUq97D0sXaKKKoQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFABRRRQAUUUUAFFFFABV+L/VL9KoVfi/1S/Ss5lQ3JKKKKzNAooooAK8++IHje98LSJZW3hm+1
VLm3Zmnt87Y+owcKfr2r0Gq9xF9otpYSxXzEK5HbIoA+d/g543vtE0qHRYfDN9fQXWo/NfQ7vLi3
7FOflI4xnqK6/wCAPGleJBnONUb/ANBFdr4D8GQ+BdBk0qG8ku43uGn8x0CkEhRjA/3aZ4G8Dw+C
bXUIIb6S6F5cm4JdAu0kYxxQB19U7q1gvbaW1uoY54JVKyRSoGVgexB6irlISACScCgDJGiaWukn
SRptmNOPH2QQL5WM7vuYx15+tVf+EE8Jf9Cxo3/gDH/hW6jrIoZGDKe4OQaPMTzNm5d+M7c80AQW
tpb2NrHbWkEVvBGNqRRIFVR6ADgV4/4A/wCS0+Pv98/+jK9rrxTwB/yWnx9/vn/0ZTjuJ7HrFFFF
bmQUUUUAFFFFABRRRQAUVz/iLxhZeGp4Ibqw1S5aZSwaztDMoGcckd/asCL4u6DO0iw6Zr8jRNtk
CaeSUPoeeD7UroLM7+iq9hex6jp1vexJLHHPGJFSaPY4B/vKehqxTAKKKKACiiigAooooAKKKKAC
iiigAooooAKKKKACiiigAooooAK5jxD4Gs/E2pR3dxqus2jLGIvLs7vy0IBJzjB55rp6VPvj60mg
PGvBHgWDxFpV9c3uv+IFkg1Ge1UR35A2oQAeh5r160tls7K3tVkllWGNYw8zlnbAAyx7n+Zri/hV
/wAi9q3/AGGrv/0IV3VEVoN7hRRRTEFFFFABXC/GL/klmr/70H/o5K7quF+MX/JLNX/3oP8A0clJ
7DW53CfcX/dFOpqfcX/dFOpiOV+Jn/JNPEH/AF6H/wBCWt3R/wDkA6b/ANekX/oC1hfEz/kmniD/
AK9D/wChLW7o/wDyAdN/69Iv/QFqV8QdC7RRRVAFFFFABRRRQAUUUUAFFFFAHK654+03QNUewudP
1ieVArF7axaSPkZ4bv1rKtvi/wCH7yMSW+na7LGTjfHYFl49wa9ADMAQGIGDwDXA/BxmHw6hwxH+
mXHf/poal3uPSx3iOHjVwCAwBAIwcGlooqhBRRRQAUUUUAFFFFABRRRQAUUUUAFYviO/1+wt4G0H
RYdUlZiJUkuhD5a8YPPX+lbVFAHmkPjvxxPrlzo0fguzN9bQpNLH/aQwEb7pz0rutCutUvdKSbWd
Nj069LMGt45hKAvY7h6+lczpf/JafEX/AGCbX+ddvUxGwoooqhBRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABV+L/VL9KoVfi/1S/Ss5lQ3JKKKKzNAooooAK8
28efFKy8G6nDpUOnT6pqciCQwxPtCA9MnByTg8AdK9JrwXVvFWj+Ev2gNY1PWzIIRYRxRNHHvYOU
j7duN3+TQB33gH4iWPj2C6WK3lsr+2I862kbdgHuDxkZyOgNd5XzfofxJ8MaZ8X9f8RlrhNLv7VU
jKwncZP3e7K545Vuf8a9s8J+NNI8Z2VxdaO8zxQSeW5ljKHOM0AdJXjvxV1nxdcRato+j6e1tpFr
Z+ff6i5I8xCMmND69jjJ+g6+xVynxL/5Jp4i/wCvGT+VAHHeBNXfQf2dU1SHHnWtrdSR7uRv82Tb
+uK87/4RmX/hU3/CyP7U1D/hIftPnfaPMP3fO8v/AOv+nSu88JafNqn7N72VsheeWzuvLQclmErk
D8cYriP+Es0n/hnP/hH/ALbH/avneT9lz8/+v8zOPTb39eOtDBHu3hfxFHqnhDR9UvbiGKe7tUkf
c4UFsDdj8c15x8PXST4xePHjdXVmyGU5B/eVo2nwk0fxJ4T8OnXRfQ31pp0cLLDKExnLYIIPILH0
rA+E+k22hfEzxhpVo0ht7RRFGZDliBJ36VS3Jex7PRRRWxmFFFFABRRRQAUUUUAKCR0JH0rhvh+z
DXfHGGP/ACG27/7IruK4b4f/APId8cf9htv/AEEVL3Q+h3JJPJ60UUVQgooooAKKKKACiiigAooo
oAKKKKACs/WdPudT0x7W01O502ZmUi5tgC4A7c+taFFAHkt/pXiW08eaR4eXx3rLQ31rLO0xVAyl
M8AfhXoPh/Rr7RoZ0vdfvtYMhBVrtVBjxngY9a5vWv8Aktfhf/sGXP8AWu9qIobYUUUVYgooooAK
VPvj60lKn3x9aAOE+FX/ACL2rf8AYau//QhXdVwvwq/5F7Vv+w1d/wDoQruqS2G9wooopiCiiigA
rhfjF/ySzV/96D/0cld1XC/GL/klmr/70H/o5KT2GtzuE+4v+6KdTU+4v+6KdTEcr8TP+SaeIP8A
r0P/AKEtbuj/APIB03/r0i/9AWsL4mf8k08Qf9eh/wDQlrd0f/kA6b/16Rf+gLUr4g6F2iiiqAKK
KKACiiigAooooAKKKKAA9D9DXA/Bz/knUP8A1+XH/ow13x6H6GuB+Dn/ACTqH/r8uP8A0YaT3Q+h
31FFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBxGl/8lp8Rf9gm1/nXb1xGl/8AJafEX/YJtf51
29THYbCiiiqEFFFFABRRRQAUUUUAFFFFABRRRQBBewSXVjPbw3UlrJLGVS4iALxk/wAQzxkV5Z4o
0vxLoF9oEEPjnWpV1PUFs5C6oCgPce9etVwPxJ/5DHgf/sOx/wAqmSGjf0Dw/qWjXM0t94n1HV0d
NoiukUBDkfMMc5rfpT1NJTSsIKKKKYBRRRQAUUUUAFFFFABRRRQAVfi/1S/SqFX4v9Uv0rOZUNyS
iiiszQKKKKACvJ/iJ4q8C+GNYih1fw7aatq0qB5P9Fid0ToNzMPQcD0HbivWK8SfVdH0j9ovW7zW
7u1toF0yNYpLk4AcrF0z3xu/DNAGbq/jzwDELUeHvAOn6y7wCecCyjT7OvdWwjcjv26cnNelfDvW
dB13w0dR8PaZBp0TSlLi3ihRNsgAznbgHgjB9K84+F3ibwpoPibxpNc6pY2kFzqGbRmcKrxBpCNv
tyP0rd+AzxNpniQwFTAdVcxlehBAxj2xigD1+ql5aW9/aS2l3DHPbyqUkikXcrA9iKt0UAUNO06z
0qyjsrC1htbaPOyGFAqrk5OAOnJNZv8Awhnhk6x/av8AYNj9v3b/AD/JGd3970z79a6Go/MTzPL3
LvxnbnmgCSvFPAH/ACWnx9/vn/0ZXtdeKeAP+S0+Pv8AfP8A6Mpx3E9j1iiiitzIKKKKACiiigAo
oooAK4b4f/8AId8cf9htv/QRXc1w3w//AOQ744/7Dbf+gik90PodzRRRTEFFFFABRRQBk4oAKK4L
UPilb6WLl7rwp4oSC3Yh7g2AEYAOM7i3Srmi/EGPW7+1tYvDHiS3jueVurixCwqCMhi248e9K6HZ
nY0UUUxBRRRQAUVU1PULfSNKu9Suywt7WJpZCq5O1QScCvM/+GgvCn/QP1f/AL9R/wDxdJtIErm1
rX/JbPC//YMuf613teB6h8XtAu/iFo3iCO01EWtlaTQSIyIHLPnGBuxj8RXSf8NBeFP+fDWP+/Uf
/wAXUpoppnrFFZXhzX7LxRodvq+n+aLafcAsqhWBBIIPXuK1askKKKKAClT74+tJSp98fWgDhPhV
/wAi9q3/AGGrv/0IV3VcL8Kv+Re1b/sNXf8A6EK7qkthvcKKKKYgoooHUUAGDXC/GIH/AIVZq/1g
/wDRyV4h4x8eeKY/GetQw6/fwxQ3s0UccUxRVVXKgAD2Fc7f+MPEWo2b2d/rl/c20mN8Us7MrYOR
kH3ANZua2LUT7KQHYvH8Ipa+Nx4+8XAYHiXVMD/p5b/GvWfgd4m1zWta1S21XVLq8ijtlkRZ5C+1
twGRn2NNTuJxsei/Ez/kmniD/r0P/oS1u6P/AMgHTf8Ar0i/9AWsL4mf8k08Qf8AXof/AEJa3dH/
AOQDpv8A16Rf+gLTXxE9C7RRRVAFFFFABRRRQAUUUUAFFFFAAeh+hrgfg5/yTqH/AK/Lj/0Ya749
D9DXA/Bz/knUP/X5cf8Aow0nuh9DvqKKKYgooooAKRmVVZmYKoBJJOAKWo54IrmCWCZFkhlUpIjD
IZTkEGgCn/b+i/8AQZ07/wACk/xqa21TTr2UxWmoWlxIATshmV2x9Aa8x+Ivgfwvpei6bNY6HawS
SarbQuyA5KMx3L1713ul+DPDeg3pu9K0a0tLkAoJY1O4A9Ryam7vYeht0UUVQgooooAKKKKAOI0v
/ktPiL/sE2v867euI0v/AJLT4i/7BNr/ADrt6mOw2FFFFUIKKKKACsu58S6DZXL213renQTxnDxy
3SKy/UE1qVzPiLwj4cvLLVL+50LT5rxreSRp3gUuzBDg59eBSYF5PFnhx3CJ4g0pmYgBReRkk/nW
xXm3w18JeHbzwDod/daHp0140RdppIFZywc4OT9BXpNCGwooopiCiiigArgfiT/yGPA//Ydj/lXf
VwPxJ/5DHgf/ALDsf8qmQ1ud+eppKU9TSVQgooooAKKKKACiiigAooooAKKKKACr8X+qX6VQq/F/
ql+lZzKhuSUUUVmaBRRRQAVxGvfC3wp4n1ibVtVspZbyUKHdbh0BCgAcA46AV29UdT1C20nS7rUb
x9ltbRNLK2MkKBk0AcJ/wonwF/0DLj/wLk/xrp/DHg7RvB9nPbaLC8MU8nmOHkZ8tjHc15x/w0Pp
chYweHNSlQHAbcvP5ZruvAvjeLxxp11eRadc2It5REUnIJbjORQB19FFFAGT4ja/j8N6m+lKW1Bb
WQ2wAyTJtO39cV8xfZ9BHgMasNXv/wDhYH2zHk+a/nb/ADMY29fu856549q+jvHE9/beCNbm00yC
8SzkaJo/vA46j3Aya8BVvBB+CpujLbf8JX5hbeZP9K87zc59du3nPT8aAPoPR9RktfDmlNrtzBba
i9rGbgTSKhMm0b+vvXmXw8kjm+L/AI7likWSNjlWRsgjzOxrXsfh7p3jzwp4e1PxOL5tTGnxxs6z
bWZeWBYEHnnr15rzrwlrelfDf4o69pItb2e2lnFlB5eHdcOOW6Z/CmtxPY991PU7LRtOn1DUJxBa
QANJIQTgcDtk+lcr/wALb8C/9DBF/wB+JP8A4mk8bfEfSvBV7BYahpt5dm4i8zMKKUxkjHzHnp/K
uT8d+ItI0298C+KDpbfYX8+drYQIsjBo1ABHTjNacxmkejaB4v8AD/iiSePRtRS7eBQ0ihGXaD0+
8BW5XG6H440fUPBV94ns9Kura1tS4khWBVkcqB93bwfvde3PpTPBfxJ03xxfXVpY6ffWz28QlZp1
BUjOMZBPP8/wpqQWO1orzrRfjDo2ueKIdBg0rVIpppTCskiKACO7DOR0/Cn+Jvi7pHhbxHLolzpe
pzzRbN0kKrtO4A/KCQT1/OnzILM9CpQCxwASfQVxvjP4jad4I+w/bbC+uTeoXTyUA2geu7HPPTtX
BfFfxXLqvgTw9q2mSX1jBfXEjGMsY2O0Y+bB55Bx270nJIEj3DY/91vyrhvACk6743wpP/E7bt/s
Cvlr+29V/wCgnef9/wBv8aWPVNQiLtFfXSNI25yszDc3qeeTUOZXKfbmxh/C35UlfFMWv6xHKjx6
rfK6kFWFwwIP519L+Kvivpfg/VINNvtP1G5meBJTJCqhTuHbJGf8iqUhOJ39Fcj4t+IWneEdJ07U
Luxv5478ZjWKMAoNobD5PB56fX0pU+IOnv4APjAWN+LNePI2Dzfv7c9cYz3qroVmdbRXIeDPiHp3
ja31Caysb63FkoZxMgO7OThcE5PB4+lZvhb4saR4r8RR6Na6XqUE0gcrJKq7RtBPzYJx06+vFHMg
szX+Jh/4tn4h/wCvQ/8AoS1seHSf+EX0jn/lyg/9AWvLvib8UdLWw1/wn/Z1/wDayht/OZVWPOQc
9c4/nWzqXxO0zwPpWg2N7p1/cSTaZBKHhUBANuMZJGTx+HFTdXHZ2PSqK4/XviJp3h/wppviGexv
5INQCmOJEAdMru+bJwP60ujfEDT9b8GX/iaGxv47ay3h4XjBkbaAflxwevXtz6VV0KzOvorjPBPx
J03xzd3VtY2F7bPbxiRmnUFSCcdQeD/OqOifFnSNc8VJoMGm6lFcPI0QeSMAArn7wzkdPw70cyCz
N/x9/wAk88Rf9g+b/wBBNfGtfSfxO+Jmm6db634TksL5rqW1aETAKIwXXg8nJHPWvmys5vUuK0Ci
iioKPqz4K/8AJLNM/wCus/8A6MavQK8h+Bviu1vNDh8MJbXC3Vokk7TlQYipk6Z7H5h+tbUPxf0m
bxevh0aZqYuGuvsolKLtDbtucZzj/wDXW0WrGTTueiUVwXi74p6V4O106Td6bqNxMI1kMkKqEO7s
MkZ/x4q74r+ImneEtJ0zUbqwv5o9RXdGkcYDJ8obD5PB5HHXr6U7oLM693SNcyOqDplmwM0xLq23
j/SYeo/5aCvnn4v+J4fFHh7wtqtpFc29vO11+6nGGypjGeOD7GvHsn1qHMaifVvwsnhTw/qwaaJS
dZuyAzgZG4c13SzwuwVJomY9AHBJr4YyfWtPQZXh8Q6bJG7I63UZDKcEfMKSmNxPtiiuK8b/ABK0
zwRq0Nje6ffXEk8XmhoFUIBkjGSRk8fhx61Y8QfEHTvD3hTT/ENxY38lvfbPLiSMB03KW+bJwP8A
GtOZE2Z1tKOorkNM+IOnap4Gu/FcdhfpaWpcPAYwZDtx93nBHI57c+lR+CPiPpvjm5uoLGwvrZrZ
BIzTqCCCcYBBPNF0FmfMfjb/AJHvxB/2Ebj/ANGNWDW54oukvvFer3caOiT3s0irIMMAXJwR2NYd
Ys1QGvZv2dv+Rl1n/ryH/oYrxk16R8K/FNp4OudY1S8tri4j+zpFst0BOS46k8AcfniiO4nse9fE
z/kmfiH/AK9D/wChLW7o/wDyAdN/69Iv/QFrzvV/G1l44+FHii8srS6tkgg8thcKOckHgg4rQ+Hv
xH03xXJDotrp97DPa2iFpJVBjO0Kp5B49q0TVzOzseg0V59D8W9In8YDw0NL1MXBujaiUxrt3Zxn
GcgfyHNSeLvippfg/XBpV5puoXEvlrJ5kKqF57DJ5/x4quZBZne0VyHi74g6d4P07Tr28sb+dL9S
Y1ijAKDAOHzjB+YcdevpSr8QNObwC3jAWF+LNTgwGMeafmC+uMZ70XQWZ11Fcj4O+IWneM7HULqz
sb63WxAMgmjB35BOFxnJ+U8fT1rP8JfFXSfF+vf2RaaZqEE3ls4kmVdo2+uCcf48UcyCzO+orz27
+LekWfjB/Db6ZqjXC3QtTKEXaWJxkDOcfz61a8a/E7TPBGrRafe6ffXMskQl3wKoQDJHUkZPH4Uc
yCzO4qpfarp2mBDqF/a2gfOzz5lTdj0ziua174iadoHhPTfEU9hfyW9/t8uJEAdMru+bJwP614X8
U/Fdp4wv9J1Oytrq3iW3eLZcqAchzyMZBHI5/DtScrAo3Poz/hK/DmD/AMVBpXQ/8vkf+NcR8JvE
Gi2HgOGC81ewt5hdTny5bhFYAvwcE18xUVHOXyn21a+IdEvbhbe01jT552ztjiuUZj9ADWlXxl4T
1CPS/F2k6hKkrx213HIyRDLsAw4A7mvp3xt8RdO8DvZLe2N9cm7VmUwKoAA9S2OeelUpEuJ2FFcj
qPxB0/TvAtr4qksL97W5KhYBGBIM5+92A4PPQ8Y60vh34g2HiLwtqOv29jfRW9huMkTxgu+1d3yY
OD/SquhWZ1tFcP4L+KGmeN9Wl06y06/t5I4jNvnVShAIHUE4PP41VtPi3pF54wXw4ml6mtw10bUS
lF2hgcZIznH8hzS5kFmWPir/AMi9pP8A2GrT/wBCNd2/3z9a8f8AjB41sbK7svDz2l21xb3ltetK
FGxlBJwvOSf0zXY+MfiHp3g6z0+7vLG+uFvwWjWGMAoAAfm3YwfmHH19KLq4W0Ouorj/APhYOnf8
IF/wl32C/wDsZbb5Hljzc7tueuMe/wDWjwf8RNO8ZWeo3NnY39uLBQ8izIDvBBOFweT8p4+lO6Cz
OworgPCnxV0nxfr8ekWmm6hBKyMwkmVSo2884Jx9fXio7v4uaPZ+L28PPpeqNOt19mMojXBbOMgZ
zj+Y5o5kFmeh0VxHjb4m6Z4I1OCwvdPvrmSWISh4FAUDJGMk8nj8OKs+IviDYeHPDGna9PY38tvf
hTHGiAOm5d3z54B9u9HMgsytpf8AyWbxF/2CbX+ddvXjfhrx7Yal4t8U+LI7K7S0g0mEtAVHmttb
HGDjH9K7PwV8RtO8czXkVjY31s1qiuxnVSpBOMAgnmpi0DTOxorz7w/8WtJ8SeJY9DttM1KGeRnU
STRgBSoJ+YA5HT8O9Jr3xY0fw/4ok0K407UpZ45EjLxxqVJbH3QTk9fx7VXMgsz0KiuM8bfEjTfA
tzawX1hfXLXKF1aBVCgA46kjmpdS+IWnaZ4GtPFclhfvaXRUJAIwJAWz97nAHB578etF0FmddVLW
P+QDqX/XpL/6A1c54f8AiFp3iDwxqWu29hfxW+nhjJE8YLvhd3y4OCfbtWTonxQ0zxvbaxp9lp1/
byRafNKXmVShAXHUE4PP40m1YLM1vhX/AMkw0D/rg3/obV2FeLfDL4naXHpugeEzp1+bvPkecqq0
eSxOeucc/h1rqfFXxY0nwl4gfR7vTNSnmRVYyQqoU7gD8uSM9evrxQpKwNO56BRXI+L/AIhad4O0
7Tr27sb6dL8ExrFGAU4B+fOMHkcdevpS/wDCwdP/AOEC/wCEw+w3/wBj6eR5Y837231xjPendBZn
W0VyPhH4haf4x03Ub60sb+BLAAyLLGCXGCcJjOTweOvT1qh4S+KuleMNdOkWmm6hby+W0m+ZV24X
scHj/Hii6CzO9rgfiT/yGPA//Ydj/lTLj4t6Tb+LW8OnSNWa4W6+y+aIhgtnGQM5x/Mc1ifGDxVa
6L4j8MW0tpdO9jeJqMjIgCugJG1SercH2FS2gS1PXT1NJXJ+JPH9j4a8N6drlxp+oSwX+0xxxxgO
m5d3z5PBx2pLP4gafe+BLjxYthfraQbg0BjBlbBAyOcEc9e3PpVcyCzOtorjfBPxG0/xxLepZaff
W5tI1kYzKpBBz0wetZugfF/SPEfiSDRLbStUhmmZkWSWNcDAJ+YA5HT8KOZBZnolFeea98XdI8P+
JpdEuNM1OWaJ1RpIo1IOQOVGckc/j2rQ8bfEjTfA91a299YXty1zGZFaBAFABx1JHP8AKjmQWZse
Idc1DRvs/wBh8OX+sCXdu+yMo8vGOufX+lcvb/EzUbvULzT4PA2syXdns+0wiVN0e8ZXP1HNaup/
EHTtK8EWfiqSzv3tLvYEhWMCRd2fvZ4A4PPfjHWuQ8BeLrTVNe8feKo7W5W0ENrMYCoaXCRuCMDj
J2mob13C2h6hpN7PqOmQXdzp8+nzSAlrWcgvHgkc4456/Q1driPBXxN0vxxqk9hZaff20kUXml51
BQjIHUE4PP481UsPi1pN/wCLl8PJpepJcNcm3ErIuAQSMkZyBx+HU1Skgsz0KiuB8V/FXSvCWvnR
7vTdRnlVUYyQqoU7vTJ5/wAeKv8AjP4h6d4KttPnvLG+uBfKWQQoBtAAOG3YweRx160+ZBZnX1fi
/wBUv0rgpPiDp0fgFfF5sb/7Gxx5GwCX7xX1xjPetfwX4ptPGXh9dWs7a6t4vMaLZcKASRjkY4I5
6+ufSom0VFHVUUUVmWFFFFABXO+M4rebwRraXMMk0BspS8cR+dgFJwvvxxXRVwd9e+OI/EWtQWOm
W8mkxac8mnynbukutqlVPzDjdu7Ae9AHm/hX4wTaB4csdIn8K3khsohEskOUDgDgldvBPfrzzXqv
gPxp/wAJvp11d/2Vcad9nlEWyc5LcA56CuB/4SD46f8AQtaf+Sf/AB2u98B3vjC9026bxfp8FndL
NiFYcYKYHPDN3zQB2FFFFABXNHwJ4VOp/wBpHw/p5u927zPIH3vXHTPvXS0mRnGRmgBa8N8H3Btf
ix8R7kKGaCOSUA9yrZ/pXuVeEeGf+Sl/FH/r3m/maFuJ7HGN8ffFzE/6NpOM8A27HH/j1Zuo/F7x
HqesaTqlxFp/n6Y8jwBYSFJddp3Ddzx9K88op3YWR6r/AML+8XAYFvpIHoLdv/iq9j+GHiy98Z+E
21K/gt4rhLl4W8hdqkAKQcEn+9ivkevpr4Bf8k9n/wCwhJ/6ClVBu5MkrHqOBnIAz645oIBOSASO
hI5paK1IAgHqAfqM141+0V/yLmh/9fcn/oAr2WvGv2iv+Rd0P/r7k/8AQBUz2HHc+eKKKKxNRR1H
1r7mgANrBkA4jXqM9hXwyOo+tfc9v/x6w/8AXNf5CtKZEyQgHggEeh5owMYwMdMdqKK0IAADhQAP
YYpAADkAAnuBilooA5T4mAH4a+ICQM/ZDzjn7y1seHgD4Y0jIBxZQ9Rn+BayPiZ/yTPxD/16H/0J
a2PDv/IsaR/15Qf+gLU9R9DSIBGCAfY80AADAGB6DpRRVCEAA6AD6DFGBnOBk98c0tFAHO+PwD8P
fEJIBI0+Xkjn7pr41r7K8ff8k88Rf9g+b/0E18a1lPcuGwUUUVBZ9WfBUD/hVmmHHJln5/7aNXf4
Gc4GfXHNcB8Ff+SWaZ/11n/9GNXoFbx2MnuIQD1UHHTIzSkA/eAI9+aKKYjwn9ozp4bA4AFxx/37
rwmvd/2jf+Zc/wC3j/2nXhFYy3NI7BWhof8AyH9O/wCvqP8A9CFZ9aGh/wDIf07/AK+o/wD0IUkU
fXXirxY/h28ihHhzWdVEqlvMsLfzFTnGD71zNv8AFuK9adLbwd4mnMEhimWO0DeW4/hbB4Psea9K
YnzT9TXAfDcn+0/G3P8AzH5v5CtdTJHaafdG+023uzbTWpmjDm3nXbJHn+Fh61ZUAHgAc9hiilHU
VQj4x8bf8j34g/7CNx/6MasCt7xt/wAj14g/7CNx/wCjGrBrBmqCvQvhX4f1rxJrN9a6Jr0mkSx2
3mSSJu/eLuA28EdyDXnte0/s3f8AI4av/wBeH/tRaQzp7n4QeNr60ltLr4gzTW0q7ZInWQqw9CN1
Sx/Cfx5DGscXxFuERVCqqiQAAdB96vaqKLgeF/Dq68Rad8VNb8Mavrs+qR2loXLysSC+Y8EbskcO
RXsBAPUA49RmvJPDf/JyPiz/AK8z/wC0a9craGxnLcCARggH2PNGBjGBjpjtiiiqJAADgAAdeOKQ
ADkAAnqQMUtFACYGc4GfXHNBAPUA46ZGaWigAIBGCAfY8187/tD4HifRwBgCyPT/AK6NX0RXzv8A
tEf8jRpH/Xkf/Q2qZ7FR3PG6KKKxNDpPAP8AyUHw/wD9f8P/AKEK+yCATyAee4zXxv4B/wCSg+H/
APr/AIf/AEIV9knqa1hsZz3EIBGCAR6dqBgDAGB6DiiirJEAA6ADPXAxRgZzgZ9cc0tZc3iXQbeZ
4Z9b02KWNiro90gZT6EZoA5n4qgf8I/pJxyNatOf+BGu7cAswIB5PB5rzP4leIdEvdD0yO11jT53
XV7V2WK5Riqhjk8HoK7R/Fnhzcf+Kg0rqf8Al8j/AMalbjtoa+BjGBjpjtQABwoAHsMVVstSsNTj
aSwvra7RThmglDgH3xmrVUIQADooBPXAxRgZzgZ9cDNLRQBBd3drY2r3N7cQwW8Yy0s7hUUe5PFZ
J8a+FCMHxLo5Hob2M/1rmfjd/wAkuvf+viD/ANDr5XqJSsyoxufTum+KfD0fxZ128bXNNW0l0y3j
jmNygRmB5AOcEj0rsR418KDgeJNHGewvIx/WvjCipUrFcp91RPHLGs0TI6SAMrochge+aUgE5IBI
6Ejmuf8AAf8AyT7w7/2Dof8A0EV0NamYhAPUA/UZpSARggEenaiigAAAGAAPYcVR1cAaDqWABm0l
zgY/gar1UtY/5AOpf9ekv/oDUnsBznwrA/4VjoBwM+Q3OOfvtXXkAnJAJHcjNch8K/8AkmGgf9cG
/wDQ2rsKFsN7gQD94Aj35o4xjHHTHbFFFMQAAcAAD24pCAqswAB2k5Apaa/3G/3TQB8WT+JddluZ
JX1nUDIzElvtL5J/OoptZ1S5aJp9SvJTE26MyTs2w+oyeDWe/wB9vqabWFzY1D4j1wjB1nUT9bp/
8a95+CV5f654Q1y0vNRvHAnEccvmkyRB0OSrHOD39jzXzlX0P+zr/wAi7rn/AF9x/wDoBpx3JlsJ
418JX/hfT9OuLTxn4lka61GG0YSXpwqvnLDGOeK77w74Kbw5qcl23iTXNS3RmPyr653xjJHOMdeO
tY/xa/5Auhf9hy1/9mr0F/vn61olqQ3oNwCQSASOhxzQQD1AP1GaWiqEBAIwQCPTtXCeFBj4q+PQ
Bgf6DwOP+WJru64Twr/yVbx7/wBuP/ok0mNHdAAdABnrgYowM5wM+uOaWimIQgEgkAkdyM0pAIwQ
CPQjNFFABgYxgY6Y7VehAESgDHFUavxf6pfpWdQqG5JRRRWZoFFFFABRRWD4ubUo/COsPpG7+0Vt
JDblPvB9pxt9/T3oA3s+9Ga+fPCvwftvFHhyy1q48W30k93GJJBFhtjHqpJJOR0PvXqngTwPD4H0
66s4dQuLwXEolLzgAqcAY4+lAHX0UUUAYnirV20DwpquqooaS0tXlRT0LAHaPzxXzhYQ6H4h0ePV
da8ay2fi68mLwySyN5cCh8AMVHy5AJHIx8vavoXx5p0+reBtcsbZC88tnJ5aDqzAZA/HGK8A0qTw
UPgfqEd2LEeIldwA4H2gyb/k2/xbdvXHHXNAH0Xpkr6foljDqupW812IVWS43BBMwHLDPr1rx7ws
6SfEb4mvG6urW0xDKcg8nvWtofwz07xn4F8NXXiFr5LyCwWFDFKFzFuZkBDA/wAJHp+grnfAGlW2
heMPiBpdo0ht7SylijMhyxAJ69KfUl7Hg1FFFIoK+mvgF/yT2f8A7CEn/oKV8y19NfAL/kns/wD2
EJP/AEFKuG5Mtj1KiiitTMK8a/aK/wCRd0P/AK+5P/QBXsteNftFf8i7of8A19yf+gCpnsOO588U
UUViajh1H1r7ntlJtYcAn92vQZ7V8MDqPrX2RrPhHTvE8Fi1/PfxmCIBRa3TRA5A646n3q4+REzp
Nj/3W/KmkYOCMH0rx3w94E0vUfGXivTLi+1hrbTZYFtwt+4IDoWbJ7816tpemwaPpkFhbvO8MIKq
08hkc8k8seT/AIVabZD0LlGDRXzL8S/GXiOy+Ies2lprl/bW0EoSOKGdkVRtXjApuVhpXPcPiYP+
LaeIf+vQ/wDoS1seHQf+EY0nj/lyg/8AQFr5GuvGXiW8tZbW713UZ7eUbZIpLhmVh6EZp0XjfxTB
CkMXiHU0jjUIqrcsAoHQDms+fW5XKfZODRXgPwU8Va9q/jWez1LV7y8tzZSP5c8xcBgy4PP1Ne/V
onclqwUUUUxHO+Pv+SeeIv8AsHzf+gmvjWvsrx9/yTzxF/2D5v8A0E18a1lPcuGwUUUVBZ9WfBX/
AJJZpn/XWf8A9GNXoFeZ/C25vbP4N2dxp2nnULtHmMVqJRH5h80/xHgdz+FLefETxbp+qWGmXPgH
ZeagXFrH/asZ8zYAW5C4GB64rZOyMmtT0uisLw5quv6l9o/tvw3/AGN5e3yv9MSfzM5z93pjj65r
dqhHhX7Rv/Muf9vH/tOvCK93/aN/5lz/ALeP/adeEVjLc0jsFaGh/wDIf07/AK+o/wD0IVn1oaH/
AMh/Tv8Ar6j/APQhUoo+3m/1p/3jXA/Db/kJ+Nv+w9L/ACFd83+tP+8a4H4bf8hPxt/2Hpf5Ctux
l0O8pR1FJSjqKoR8YeNv+R78Qf8AYRuP/RjVg1veNv8Ake/EH/YRuP8A0Y1YNYM2QV7T+zd/yOGr
/wDXh/7UWvFq9p/Zu/5HDV/+vD/2otID6WooooA8Q8N/8nI+LP8ArzP/ALRr1yvI/Df/ACcj4s/6
8z/7Rr1ytYbGctwoooqyQooooAKKKKACvnf9oj/kaNI/68j/AOhtX0RXzv8AtEf8jRpH/Xkf/Q2q
Z7FR3PG6KKKxNDpPAP8AyUHw/wD9f8P/AKEK+yT1NfG3gH/koPh//r/h/wDQhX1Hr3hjU9Z1Bbi0
8WappUewJ9ntQu0nn5uecmtIuyIludLRXkHgrRPEfijSLq9n8c65A0N7LbBYyCCEIwee5zXrVtE8
FrDDJM87xoqtLJw0hAHzHHGTVp3IaJk++v1FfE3iH/kZNV/6/Jv/AEM19sp99fqK+JfEP/Iy6r/1
+S/+hmomXAzKKKKzLPdv2cuviP6W/wD7Ur2k6vpYJB1SxB6YNygP868X/Z1VXTxKjAFWW3BB6EHz
K3Pih4I8L6R4Du73TtEtLa5SaFVkjBBAMgB7+ma1TaiZvVnqEGo2NzJ5dvfWs0mCdkcys35A1ZrA
0vwT4Y0W9ivtN0S0trqMEJLGp3DIIPU+ma36pEnnfxv/AOSXXv8A18Qf+hV8r19UfG//AJJde/8A
XxB/6FXyvWc9zSOwUUUVBR9meAgT8PvDoAJP9nQ9P90V0Wx/7rflXD6F4es/Enww8NWl7LdxxJZQ
SA2s5iYnZjkjqOa5OLwJpb/E640Fr7WPsEekrdqv2993mGTb19MVrdmVj2MgqcEEH3pKy9A0C08O
ae1lZSXckTSGTNzOZWBIA4J7cdPWtSrQjiPF3xR0LwZqyaZqEN9NctEJSLeNSFBzjJZh6Vy1/wDH
jwvdabd20dhqweaB41LRR4BZSP7/AL1wnx6/5KN/24w/+zV5dWTky1Fbnu/gz40eHfDng/TNIu7L
U3uLWMo7RRoVPzE8ZcHvXaeGvi94e8U67b6RaWuow3NxuEbTxqFJAJxwx7A18qV2/wAI/wDkqWhf
9dX/APRb0KT2G4o+i9a+IGj6FqMun3dvqrzxBdzQWTyJyAeG6Hr/AErNt/i34Yu0EkEOryxscB00
92X9M13u5gpAYgYPQ1wfwcZh8NbEBiB59x0P/TVqt3uRpY7oEMoIzggEZGDSP9xv9006mv8Acb/d
NUI+F3++31NNpz/fb6mm1zmwV9D/ALOo/wCKd1z/AK+4/wD0A188V6p8KvCXiPxNYak+ieJ5tHjg
lQSpGX/eEg4PykdMU07MTV0es/FsH+xdC/7Dlr/7NXoDg7247mvH7v4OeMtRjijvfHktwkUiyosq
yMFcdGGW6irR+FHj4nJ+JV5n6y//ABdXz63J5T1WsLxb4s0/wZoo1TUkneEyrEqQIGYsQT3IHQGu
I+EGp6xd3fiaw1fVLjUDYXSxRvO5YggupIzzztHFHx//AOSfW/8A2EI//QHqr6XRNtbEf/DQXhT/
AJ8NY/79R/8Axdc7o3xd0DTvG3ifWJbPUjb6r9m8lUjTevloVbd82OvTGa8NorPnZfKj6VH7QXhQ
kA2GrgHqfKj4/wDH69StrmK8tILqFiYZ41kQkYJVgCK+Ga+2fDv/ACLGkf8AXlB/6AtXGTZMlY0q
KKKskKvxf6pfpVCr8X+qX6VnMqG5JRRRWZoFFFFABWZrWmLrOiX+mNM8K3cDwGRPvJuBGR+dadc9
42vbvTvBGt3lhuF1DZSvGVHKkKfm/Dr+FAHiV38L/AekagbK6+IRt7ndhoy6Aqf9rB4/HFeteAPB
9n4Q0i4hstVl1GC7kE6zSEEdAOCOCK8/8C/DXwHrvgS21TUJPtd3NEXurg3RQwP3GAQBj/aBz171
tfBOYpYa/ptvctdaVY6m8djOejIc9P0P/AvegD1qiiigArl5/AnhW61Y6pPoFlJeFg5kaP7zepXo
T7kV1FFADQAAABgV4V4Z/wCSlfFH/r3m/ma92r5307X9K0T4l/EUalexWv2uOaGHzM/O+TxTQnse
E0UUUhhX018Av+Sez/8AYQk/9BSvmWvof4I3lvd+BdR0S21RbTVDNJKpUAvEpVFEgDcHmqjuTLY9
lorw2+129OtaRpujfE271Ga8vVtp9tug8lT/ABDjB5rr7LXtO8I65c2fiH4htqE4RVNrcwhRExwQ
cqDzjt71pzEWPQ68a/aK/wCRd0P/AK+5P/QBXpeteLvD/h7yP7W1W3tTcKWi3EtvUY5G3PFeVfHf
UrLVvCHh++0+5jubWa6kMcqHIOFAP65pSeg47ngVFFFZGg4dR9a+5rf/AI9Yf+ua/wAhXwyvUfWv
sfUPG3hrw/LBZarrFva3Pko/lvuJAI46A1cHYiRj+D/+SkePv+vi1/8ARRru68t0bxVoWhePPGl1
qeqW9tBdT2hgdiT5g8nORjPYj867oeKtCPh46+NUgOkg4N1k7Qc7ceuc/jVxasS0bFfI/wAVv+Sp
a/8A9fA/9BWvp/RfFmg+IY7iTSdUgultlDTFSR5YOeTnHHB/Kvlj4jajaat491i/sZ1ntZpw0cqd
GG0D+lTMqO5ydFFFZlnqnwB/5KFN/wBg+X/0JK+mK+Wfg1rml+HvGc15q14lpbmykjEjgkFiyYHH
0NfR1l4r0HUNFuNXtNUt5dOtsia4BIWPGCc557j65rWD0M5LU2KKxND8X+H/ABLPLDo+qwXcsS73
RMggdM8getQWPjzwrqeqppdlrdrPeuxRIlz8zDsDjHr9e1VdE2Dx9/yTzxF/2D5v/QTXxrX1d8Rf
GHh628Na/oc2qwJqb2UkYtuS25l4HAxk5FfKNZz3NI7BRRRUFH1Z8Ff+SWaZ/wBdZ/8A0Y1HjH/k
qnw+/wCul5/6LWvO/AOv/Eez8H2tt4c8O2l7piPJ5c8iZYksS3/LQdDntV/U5fixqmu6PrM/hOBb
nSmkaBUX5G3gA7h5hJ6eorTmVrEcrue60V49N4u+MMEMk0vhCwWNFLMxjOFA6n/W+1bvhP4oWF94
Qt9Z8TXVnps01xJAqoG2ybdpyByR94Z7fnVKSZLi0cb+0b/zLn/bx/7Trwmva/jvq+n63Y+Gr/TL
qO6tGNyolj6Egx5FeKVnLcuOwVdsJXt9QtZ0QyPHKrqn94gg4/GqVXNL/wCQvZf9fCf+hCpKPoQ/
FPxyWJ/4VlqPJz/q5v8A43WF4d8W+NvD1zrMyfD7U5zqd894waCZfLLfwj5OR719GUU+Zi5UeD3n
xl8R6QIZdX8CXVjbPIE8ycyR59huQAnGeK9lBB2kdDg15d+0YceDdKJ6DUVP/kN67bQPF2geJHeL
R9Ugu5IUDSImQVHTPIFaQlfciStsfJnjb/ke/EH/AGEbj/0Y1YNb/i6aK58Za3cQSLJDLfzujqeG
UuxBFYFZs0QV7T+zd/yOGr/9eH/tRa8Wr2n9m7/kcNX/AOvD/wBqLSA+lqKKKAPEPDf/ACcj4s/6
8z/7Rr1yvGdH1Ky0/wDaR8Ri7uY4PtMIt4d5+/IfJwo9zg16NrHjfwz4fvzY6rrNva3W0MYmDEgH
pnANawasZy3OgorG1fxXoGg29rcarqlvbRXSloGYk+YMA5GM8cjn3FA8V6CfD514apbnSgcG6ydo
OQuPXOfxqromxs0VjaN4s0HxBDczaVqkF1HbAGcqSPLHJyc444PPtUGkeOPDWvX4sNK1i3urogsI
k3AkDrjIFF0FjoKK52bx74Vg1c6TLrlql8svkmI54fONucY61LrfjPw54cvFtNX1aC0uGQSCNwSd
vIB4B9DRdBY3a+eP2h/+Ro0j/ryP/obV7df+LNA0vSbXVb3VbeKxu8eRMSSsmRnjGT0/KvA/jTr2
l+INb0q90m9iu7cWrIXjzwwcnBzg9wfxqZvQqO55RRRRWRodJ4B/5KD4f/6/4f8A0IV9lL/rR/vC
vjPwXdQWXjfRbq5lWG3hvYnkkc4CqGGSa+stZ8XaB4bltxrGqQWhnBaMPklgCOeAfzrSL0Ilucz8
Iv8AkVdR/wCwvdfzFd9Xl/w18QaTpHgK+1PUb6K3sn1e4CSyZwxYgjHfkV3GneKtB1XSrrVLHVLe
axtcmeYEhYwBk7s47VUXoS1qbKffX6ivibxD/wAjLqv/AF+S/wDoZr680Pxn4c8Q35tNJ1aC7uFX
zDGmQdoI55A9RXyH4h/5GXVf+vyX/wBDNTN3KiZdFFFZlnu/7OX/ADMf/bv/AO1K7r4xf8k1vv8A
r4t//Rq14z8LdR8a2Lamvg7Sre/LiI3PnAfIBu24yy9ct6113iJfjB4o0aXSr/wvaLBI6OTCUVsq
24cmQ9xV8ytYhxd7nuQ+6PoKWvIhrvxtwB/wimn8ey//AB2pPBvxVvbjxHf6J40Nhpl1CyxxKisu
Zd2ChOWHp6Cr50Tys1fjf/yS+9/6+IP/AEKvlevpn4561p0PgqfRZL2IalLJFKlt/EUDnn9D+VfM
1Zy3LjsFFFFSUfZfgP8A5J94d/7B0P8A6CKx7f8A5Lnef9i/H/6OqL4eeMvDt14c0DRIdWt21NbK
OM23IbeqcjkYzwazrrxRoek/G28e/wBSggQaPHalmJIEvmbthI6HBBrW+xlbU9PorF1zxd4f8NSx
RazqkFpJKCyI+SSPXgGnXPivQbPQodbuNUt002cgRXJJKuTngd+x+mDVXQrHz58ev+Sjf9uMP/s1
eXV6F8YNc03xB44F9pV4l3bfZY08xAQNwzkc157WL3NVsFdx8I/+SpaF/wBdX/8ARb1w9dh8NNSs
tI+IWk3+oXCW9pDI5klfOFBRgOnuRQtwZ9dn7p+hrhfg7/yTWx/6+Lj/ANGtXRax4q0LQLW2uNU1
OC2hu1JgZiT5gwDkYzxyPzrkPhhq9ho/wltdQ1G7jgtI5590rngEytj88itW1cz6HpFNf7jf7prJ
0jxXoOvW91c6XqkFzDaDM7qSPLGM5OcccHn2NVtK8ceGdfvGsdK1m3uroxswiQMCQBz1Ap3QrHxs
/wB9vqabTn++31NNrA2Cvov9mr/kEa//ANd4f/QWr50r6L/Zq/5BGv8A/XeH/wBBagD3SiiigDxH
4Mf8h/xz/wBhEf8AoctT/H//AJJ9b/8AYQj/APQHrB+GninQ/DviTxhFq+pQ2bXGonyhLnDYeTPQ
e4rV+P8AqNmvhKz003Ef217tJ1hz8xQK4LfTJrRP3SH8R84UUUVmWFfYS23iG48IaEPD2oWNlKLS
IytdwGUMPLXGMdK+Pa+uPC/jvwvc2Gj6RDrdq9+beGEQjOS4QDbnGM5q4kyMKzv/AIi3ni7UvD66
/oyzWEEUzSmxyrh+w78V6Do0WqwaYketXdtd3wZi0ttF5aFe3B/nXAf8JLovhz4xeJH1jUYrNJrK
1SMyAkMQASOAa7bWfFmgeHo7eTVtUgtVuVLQliT5gGORjPHI596pEM2avxf6pfpXLnxXoI0Aa6dU
txpROBdZO0nO3HrnNaWh67pniCxF5pF3Hd24YoZI84DADI5x6ilNlRNqiiisywooooAK5LUPHHh6
11fVdEu5JDc6fZNeXUZhLL5IUMfY8MOK62vKfiV4t0XwbNcm48OrLqmpWUkcN8bWJ0k427JCSCVH
y5XnjFAHmGo2nwZu9R+0W+r61ZwMctbQwEqP90spI/Wva/hnqHha68NvbeEllFjaS7H81CrM5AJJ
J6k8V5PpHxM+H0ekWq6x4JtZdQCYne3023WMtz90ZHFehfB7Wzr1jrl1BpNpp+nC+ItFtrRINy46
Nt4ZgNoJoA9QooooAK+aPi/421LxDcSRaO8qeH9NultnuYnIWe5IY8EdQADj8+4r27x3ba3e+DtQ
tPDy/wDEzmQRxHeEwCwDYYkYO3NfPXi/S/GPh74f6Zour6Jp1lpUF4GjlgcNLLMVfl8Oeoz2HQD2
oA+pFmjigi82REyoxubGa8B0nRtK1v4lfEZ9Qs7e8FtFNNAZBuCNk8iu0uvh0PH+m6dqHjMXFhrM
cLQvFp8y+UEDsV4O8ZwQev8AKuL+H+kW+g+LviDpNq0jwWljLEjSkFiAT1xin1E9jwiiiikMK9h+
F3wr0jx14ZudTvr++t5YrtoAtuVCkBEbPIPPzGvHq+n/ANnP/kn99/2E3/8ARcdAEQ/Zx8Mjkatq
3/fUf/xFB/Zx8MnJOr6tn/ej/wDiK9loPSgD59+DfhrRtf8ADmqQ6zYQ362l+UgMwyUBUZxz3wKd
8e7G003wh4fs7G3jt7aK6kWOKMYVRtrT+Av/ACAtf/7CR/8AQaqftFf8i7of/X3J/wCgCr+yR9o+
eKKKKgsK9/m+Amra15V9f+MGuZniXDz27OwGOBkv2rwCvvXT/wDkG2n/AFxT+QoA8LuP2fdRu5S1
z4v81mxkyWrMTgYHV+wwPpXP+PPhxrPgbwOZH8WT3enGdYjYKjJHliWzjeR1GelfT1eV/tBf8k0/
7fov5NQB0XhXw/o+j6Hbtp2m21qbu2iacxpzISnf8z7c18v/ABIsLXS/iBrNlYwR29rFOBHFGMKo
2g8fnX1lo/8AyAdN/wCvSL/0Ba+VPit/yVLX/wDr4H/oK1ctkRHc4uiiioLPSfgvoum6941ms9Vs
4ry3+xSP5co4DBkwf1Nel+I/hfZ6J4V8Qz6Zr2sWtn9nnuv7PjmUQE7SdpXHI4A+g615/wDAD/ko
c3/YPl/9CSve/G4P/CBeIuP+Ybcf+i2rSKViJPU4b4d/DSy02w0fxFZa3q0E91bQXE8MbqscmQGK
N8uSueK7qz8G+GtP1QapaaJZQXwZnEyR4IY5yR2HU0nggH/hAvDvH/MNt/8A0WtbuDVJIls4X4ie
FdBufC2vaxNpNq+pR2UjrdFCHDKvB47jA5r5Nr7K8ff8k88Rf9g+b/0E18a1E9y4bBRRRUFH1n8B
/wDkldl/13m/9DNemV5n8B/+SV2X/Xeb/wBDNemUAZ+u/wDIvan/ANesv/oBrx/4QaBpHiH4ZxR6
vp1veJFfzNGJlztJC5xXsGu/8i9qf/XrL/6Aa8w+A3/JNx/1+y/yWqhuTLY4z48aZY6PZeGbHTrS
K0tY/tJWKJcKCTHk+5rxKvdv2jf+Zc/7eP8A2nXhNEtwjsFXNL/5C9l/18J/6EKp1c0v/kL2X/Xw
n/oQqSj7zooooA8b/aLGfBulA9DqK/8Aot67rRfC+h+H98mkaVbWbzKokaJSCw9MnNcL+0Z/yJ2k
/wDYSX/0W9eoJ91PoP6VpEiZ8Z+MI0h8aa7FEixxx6hOqoowFAkbAFYFb3jb/ke/EH/YRuP/AEY1
YNQy0Fe0/s3f8jhq/wD14f8AtRa8Wr2n9m7/AJHDV/8Arw/9qLSA+lqKKKAPCdFsbW9/aP8AEbXM
EcxtoBNCZFz5bgQgMPcZNekar4P8Oa5ei81XRrS7uQAvmyISxA6A+tefeG/+TkfFn/Xmf/aNeuVr
BaGctzL1Xw3out20Fvqml211DB/qkkT/AFY4GFxjHQUDw3og0M6INKtRpR/5dPL+Q85/PPOeua1K
KqyJuZekeG9E0KGeHStLtrSOfHmrGn+sHPBz1HJ9uag0rwf4b0S9N7pei2dpclSvmxJ8wB649K26
KLILmHL4M8Mz6v8A2rNolk+oGQSmcx/MXB+96Z4/On6x4U0DX7hJ9X0i1vZ1Xaskq5YDk4yMe9bN
FFkFzKvvDOh6npcGmXulWs1jb48mBo8LHgYG3GMccV4D8cdH03Q9b0mz0uxhs7b7Iz+XCuASXPPv
0FfSdfPH7Q//ACNGkf8AXkf/AENqma0KjueNUUUVkaGvoMjJ4g090sl1B1uEK2jDInORhMe/SvZt
Z8Q+JfEJhOr/AAjkvDDkRmWOUlQeoHy+1eR+BP8AkoHhz/sJ2/8A6MWvt6i4HzRok/inTPDk+g3X
w1uNQsZLl7kRzQyAIT0A47evWtLTvGt14cls9Ev/AIcxaPpmq3AhkRg6iXdhW4YfNgEV9C14z8c/
+Q34G/7CLf8AoUVNN3FZHeaR4R8P6BdtPpWk2tnO42NJEvJGRxzn2r4+8Qf8jLqv/X5L/wChmvtv
/lv/AMCr4k8Qf8jLqv8A1+S/+hmrl0JiZdFFFZlnvP7NH/H74j/652/85K+hq+ef2aP+P3xH/wBc
7f8AnJX0NQAV4N4R0fTtW+NXjN9QsoblrWfzYDKu7y38wcivea8U8Af8lp8ff75/9GU47iexZ+OW
k6fL4Gn1WSzhbUIZYo47gr86qX5GfTrXzFX1R8b/APkl97/18Qf+hV8r05bijsFFFFSUfWXw88Ke
H7XwxoGswaRapqT2UTm5CEuWZPmP1OTWbP4e0fVPjddrfabbXAGjR3OJFyDKJdu8jucAD6V1fgP/
AJJ94d/7B0P/AKCKxrf/AJLnef8AYvx/+jq1tsZHSax4X0LxC8T6xpVtevECEaVclQT0yMU+58Oa
Ld6RHo9xplrJpsWNlsY/kXGcY9O9adFVZCufK/xk0bTtD8dCy0uzitLb7JE/lxDAyc5Ned16j8ev
+Sjf9uMP/s1eXVi9zVbBXQ+C9Ci8T+LdP0Wed4Y7uQoZEAJX5Se/0rnq7X4Sf8lU8P8A/Xdv/QGp
DPX5f2eNOmVVl8SalIEGFDopA+npR/wzvp3keR/wkupeVnPl7F2/lXtdFAHzdceBofh78TvC2n2W
pXNzDqEv75ZAFDLnaVIHBBBPWvYtN8H+HNDuZLzStGtLS5KMvmxphgCOR7Vw/wAS/wDktXgP/fH/
AKMr1N/9W3+6f5VpBaESPhZ/vt9TTac/32+pptZlhX0X+zV/yCNf/wCu8P8A6C1fOlfRf7NX/II1
/wD67w/+gtQB7pRRRQB8/fC7w7ouueJfGE2qabb3kltqOYWmXdsy8n4dhWn8f7G1bwdZ37W8Zu0v
EhWbb84Qq5K59MgHFHwY/wCQ/wCOf+wiP/Q5an+P/wDyT63/AOwhH/6A9aJe6Q/iPmeiiisywr2n
Q9Zu9PWx1Cy+EEslzHGjR3scUvznaP3g/dkc9cj1rxavuXwh/wAiVoX/AGDrf/0WtAHz7d32t6p4
qvtd1b4W3t/9piijS3mgm2xFBjIOznPpWn4m8e315YRzeJPhW5tLbhJLwSIsecDG4xjGeOPpX0TX
nPxy/wCSUap/10g/9GrTuxWRpaTpmha14I0+3XR7ZNIureOdbJkyiBgH/PJ69e9dBo2jadodgtpp
dlDaW4O7y4VwMnqaw/BX/Ih+Hv8AsG2//ota6yL/AFS/SrmtETHckooorMsKKKKACsDxa+mQ+FtT
udXtluLGG1keWMjll2nIB7E9K36yNe0iHX9BvtKuCUiu4GiLDquR1/CgDhfBF5fah8Lrm+s/DNrZ
3MaS/wBl2mzcsibQYzlzlssTySM4rX+HfjGTxdo919ssFsNR0+c211bqMBW9QDyO4x6g1wlna/GL
wtZw6Fp1lp99ZwL5VvdZQ4QdPvMpGPcfnXb/AA28IX3hXSr2fVrjz9Y1G5NzduhyoY9s9zyST0yf
agDvqKKKACsnV9C0rxBbpbatYQXsEbiRUmQMA2CM/qa1qTIzjIz6UANACqABgAYxXhfhn/kpfxR/
695v5mvd68I8M/8AJS/ij/17zfzNNbiex870UUUhhX0/+zn/AMk/vv8AsJv/AOi46+YK+n/2c/8A
kn99/wBhN/8A0XHQB7BQelFB6UAeJfAb/kBa/wD9hI/+g1U/aK/5F3Q/+vuT/wBAFW/gN/yAtf8A
+wkf/QaqftFf8i7of/X3J/6AK06EfaPniiiisywr710//kG2n/XFP5CvgqvvXT/+Qbaf9cU/kKAL
VeV/tBf8k0/7fov5NXqleV/tBf8AJNP+36L+TUAdpo//ACAdN/69Iv8A0Ba+Vfit/wAlR1//AK+B
/wCgrX1Vo/8AyAdN/wCvSL/0Ba+Vfit/yVHX/wDr4H/oK1ctkZx3OKoooqDQ7X4aaHqXiPxQdP0r
WZtIuDbu/wBph3btoIyvykHnjv2r16b4O+LrmCSCf4j38sMqlHjkErKynqCDJyK4H9n3/kpf/bjL
/Na+qqAPE4fg74utoI4IPiNfxQxKESOMSqqqOgAEnAql4Pj1/wAPfGSTwzqfiO81W3Fk0rGeRipJ
UMPlYnGK95rxdv8Ak5+4/wCwZ/7SFNN3E9js/H3/ACTzxF/2D5v/AEE18a19lePv+SeeIv8AsHzf
+gmvjWqnuTDYKKKKgs+s/gP/AMkrsv8ArvN/6Ga9MrzP4D/8krsv+u83/oZr0ygDP13/AJF7U/8A
r1l/9ANeX/Ab/km4/wCv2X+S16hrv/Ivan/16y/+gGvL/gN/yTcf9fsv8lq4bky2OX/aN/5lz/t4
/wDadeEV7v8AtG/8y5/28f8AtOvCKUtwjsFXNL/5C9l/18J/6EKp1c0v/kL2X/Xwn/oQqSj7zooo
oA8b/aM/5E7Sf+wkv/ot69QT7qfQf0ry/wDaM/5E7Sf+wkv/AKLevUE+6n0H9K0pkTPjLxt/yPfi
D/sI3H/oxqwa3vG3/I9+IP8AsI3H/oxqwahloK9p/Zu/5HDV/wDrw/8Aai14tXtP7N3/ACOGr/8A
Xh/7UWkB9LUUUUAeIeG/+TkfFn/Xmf8A2jXrleR+G/8Ak5HxZ/15n/2jXrlaw2M5bhRRRVkhRRRQ
AUUUUAFfO/7RH/I0aR/15H/0Nq+iK+d/2iP+Ro0j/ryP/obVM9io7njdFFFYmh0PgX/koHhz/sJ2
/wD6MWvt6viHwL/yUDw5/wBhO3/9GLX29QAV4z8c/wDkN+Bv+wi3/oUVezV4z8c/+Q34G/7CLf8A
oUVCA9W/5b/8Cr4k8Qf8jLqv/X5L/wChmvtv/lv/AMCr4k8Qf8jLqv8A1+S/+hmtJ9CIGXRRRWZZ
7z+zR/x++I/+udv/ADkr6Gr55/Zo/wCP3xH/ANc7f+clfQ1ABXingD/ktPj7/fP/AKMr2uvFPAH/
ACWnx9/vn/0ZTjuJ7Gp8b/8Akl17/wBfEH/oVfK9fVHxv/5Jde/9fEH/AKFXyvVT3FDYKKKKgo9/
8LWHxbufC+ly6PqWmRaabZBbrIE3BAOAfkNTr4R+Ly6++uDUNKGoPbC1aXcuDGDuxjZjrXpnwx/5
Jl4d/wCvJK62ndisjwXXH+Mfh3RLvVr7VtN+y2qb5PLSNmxkDgbPevSPBGs3PiDwVpWq3mz7Tcw7
pCgwCQSM4/Cm/Ff/AJJZ4g/69x/6EtUPhX/yTDQP+uDf+htVwbuTJKx4p8ev+Sjf9uMP/s1eXV6j
8ev+Sjf9uMP/ALNXl1Q9ylsFdr8JP+SqeH/+u7f+gNXFV2vwk/5Kp4f/AOu7f+gNSGfZVFFFAHjH
xM/5LT4D/wB8f+jK9Tf/AFbf7p/lXlnxM/5LT4D/AN8f+jK9Tf8A1bf7p/lWsNjOZ8LP99vqabTn
++31NNrI0Cvov9mr/kEa/wD9d4f/AEFq+dK+i/2av+QRr/8A13h/9BagD3SiiigDxH4Mf8h/xz/2
ER/6HLU/x+/5J9b/APYQj/8AQHqD4Mf8h/xz/wBhEf8AoctT/H7/AJJ9b/8AYQj/APQHrVfCZv4j
5nooorI0CvuXwh/yJWhf9g63/wDRa18NV9y+EP8AkStC/wCwdb/+i1oA2q85+Of/ACSfVP8ArpB/
6NWvRq85+Of/ACSfVP8ArpB/6NWgDW8Ff8iH4e/7Btv/AOi1rrIv9Uv0rk/BX/Ih+Hv+wbb/APot
a6yL/VL9K0nsiI7klFFFZlhRRRQAVl61a3V/od/aWN0bW7mgeOGcZ/dOQQG454PNalZetWtzqGh3
9nY3JtbueB44ZwSDG5BAbjng80AeUN8MviWFJX4jTk44BmmA/nXQfCKXV20vWbXXdXmv9Rs79reZ
JZGcwlRjAY9Qeorn/wDhVvxJIIPxIucH/ptN/jXZ/D3wQPBWlXUMt899e3c3nXFwQRuOOBySfXnv
mgDuKKKKAMjXI9Tl0S9j0eSKLUXhZbeSU4VXI4J4PSvCPFPw8fwp4Ck8Uaprl6PFqTqRMl0WV2Mm
AqnAYnbls+oPavfNX1S20XSLvVLxittaxNLIQMnAGeB6184w+LtC8eeLG1fxzrAs9JtH/wBE0pYp
XDD/AGiqkY6ZPU9OBQB734N1W51DwVot/qsirdXFpHJIz4XcSOv48H8a8r8Lsr/En4nsrAqbaYgq
c55NdjrvgHwz8S4NN1v7bfLb/ZhHb/ZWEaGPJI+R1OOpHbt6CvP/AIf6Rb6D4u+IOk2rSPBaWMsS
NKQWIBPXGKa3E9jwiiiikMK+n/2c/wDkn99/2E3/APRcdfMFfT/7Of8AyT++/wCwm/8A6LjoA9go
PSig9KAPEvgN/wAgLX/+wkf/AEGqn7RX/Iu6H/19yf8AoAq38Bv+QFr/AP2Ej/6DVT9or/kXdD/6
+5P/AEAVp0I+0fPFFFFZlhX3rp//ACDbT/rin8hXwVX3rp//ACDbT/rin8hQBaryv9oL/kmn/b9F
/Jq9Uryv9oL/AJJp/wBv0X8moA7TR/8AkA6b/wBekX/oC18q/Fb/AJKjr/8A18D/ANBWvqrR/wDk
A6b/ANekX/oC18q/Fb/kqOv/APXwP/QVq5bIzjucVRRRUGh6r+z7/wAlL/7cZf5rX1VXyr+z7/yU
v/txl/mtfVVABXi7f8nPXH/YM/8AaQr2ivF2/wCTnrj/ALBn/tIU1uJ7HZ+Pv+SeeIv+wfN/6Ca+
Na+yvH3/ACTzxF/2D5v/AEE18a1U9yYbBRRRUFn1n8B/+SV2X/Xeb/0M16ZXmfwH/wCSV2X/AF3m
/wDQzXplAGfrv/Ivan/16y/+gGvL/gN/yTcf9fsv8lr1DXf+Re1P/r1l/wDQDXl/wG/5JuP+v2X+
S1cNyZbHL/tG/wDMuf8Abx/7Trwivd/2jf8AmXP+3j/2nXhFKW4R2Crml/8AIXsv+vhP/QhVOrml
/wDIXsv+vhP/AEIVJR950UUUAeN/tGf8idpP/YSX/wBFvXqCfdT6D+leX/tGf8idpP8A2El/9FvX
qCfdT6D+laUyJnxl42/5HvxB/wBhG4/9GNWDW942/wCR78Qf9hG4/wDRjVg1DLQV7T+zd/yOGr/9
eH/tRa8Wr2n9m7/kcNX/AOvD/wBqLSA+lqKKKAPEPDf/ACcj4s/68z/7Rr1yvI/Df/JyPiz/AK8z
/wC0a9crWGxnLcKKKKskKKKKACiiigAr53/aI/5GjSP+vI/+htX0RXzv+0R/yNGkf9eR/wDQ2qZ7
FR3PG6KKKxNDofAv/JQPDn/YTt//AEYtfb1fEPgX/koHhz/sJ2//AKMWvt6gArxn45/8hvwN/wBh
Fv8A0KKvZq8Z+Of/ACG/A3/YRb/0KKhAerf8t/8AgVfEniD/AJGXVf8Ar8l/9DNfbf8Ay3/4FXxJ
4g/5GXVf+vyX/wBDNaT6EQMuiiisyz3n9mj/AI/fEf8A1zt/5yV9DV88/s0f8fviP/rnb/zkr6Go
AK8U8Af8lp8ff75/9GV7XXingD/ktPj7/fP/AKMpx3E9jU+N/wDyS69/6+IP/Qq+V6+qPjf/AMku
vf8Ar4g/9Cr5Xqp7ihsFFFFQUfaXwx/5Jl4d/wCvJK62uS+GP/JMvDv/AF5JXW0AcX8WP+SW+IP+
vcf+hLVD4V/8kw0D/rg3/obVf+LH/JLfEH/XuP8A0JaofCv/AJJhoH/XBv8A0NquG5M9jxT49/8A
JRv+3GH/ANmry6vUfj3/AMlG/wC3GH/2avLql7jjsFdr8JP+SqeH/wDru3/oDVxVdr8JP+SqeH/+
u7f+gNSGfZVFFFAHjHxM/wCS0+A/98f+jK9Tf/Vt/un+VeWfEz/ktPgP/fH/AKMr1N/9W3+6f5Vr
DYzmfCz/AH2+pptOf77fU02sjQK+i/2av+QRr/8A13h/9BavnSvov9mr/kEa/wD9d4f/AEFqAPdK
KKKAPEfgx/yH/HP/AGER/wChy1P8fv8Akn1v/wBhCP8A9AeoPgx/yH/HP/YRH/octT/H7/kn1v8A
9hCP/wBAetV8Jm/iPmeiiisjQK+5fCH/ACJWhf8AYOt//Ra18NV9y+EP+RK0L/sHW/8A6LWgDarz
n45/8kn1T/rpB/6NWvRq85+Of/JJ9U/66Qf+jVoA1vBX/Ih+Hv8AsG2//ota6yL/AFS/SuT8Ff8A
Ih+Hv+wbb/8Aota6yL/VL9K0nsiI7klFFFZlhRRRQAV4/wDEv4c217Lq/i+51+/to4rfzGtoFBHy
IAADkdcfrXsFUdSsrbU9NubC8QPa3ETRSqTjKkEGgDwbwr8HJ/EHhay1WbxPdQy3sImSOJS6oD0B
O7k+vSuv+Cduthpmv6bJeSXV5Z6k0M7FtyHA2gofQ4P5V57b+G9LGvjwz4a+KF2lvMz4too5Si4B
ZssrBG4B54r134X6H4f0bwup8OX/APaNvcOZJbs8NI4AGCP4ceh5H40Ad7RRRQBQ1DTrPVbGaxv7
eO4tZRiSKQZVuc8/pWH/AMKz8E/9Cxpv/fkV1dFAFOxsbXTbKGysoEgtoV2RxRjCqPQV4p4Z/wCS
l/FH/r3m/ma93rwjwz/yUv4o/wDXvN/M01uJ7HzvRRRSGFfT/wCzn/yT++/7Cb/+i46+YK+n/wBn
P/kn99/2E3/9Fx0AewUHpRQelAHiXwG/5AWv/wDYSP8A6DVT9or/AJF3Q/8Ar7k/9AFW/gN/yAtf
/wCwkf8A0Gqn7RX/ACLuh/8AX3J/6AK06EfaPniiiisywr710/8A5Btp/wBcU/kK+Cq+9dP/AOQb
af8AXFP5CgC1Xlf7QX/JNP8At+i/k1eqV5X+0F/yTT/t+i/k1AHaaP8A8gHTf+vSL/0Ba+Vfit/y
VHX/APr4H/oK19VaP/yAdN/69Iv/AEBa+Vfit/yVHX/+vgf+grVy2RnHc4qiiioND1X9n3/kpf8A
24y/zWvqqvlX9n3/AJKX/wBuMv8ANa+qqACvF2/5OeuP+wZ/7SFe0V4u3/Jz1x/2DP8A2kKa3E9j
s/H3/JPPEX/YPm/9BNfGtfZXj7/knniL/sHzf+gmvjWqnuTDYKKKKgs+s/gP/wAkrsv+u83/AKGa
9MrzP4D/APJK7L/rvN/6Ga9MoAz9d/5F7U/+vWX/ANANeX/Ab/km4/6/Zf5LXqGu/wDIvan/ANes
v/oBry/4Df8AJNx/1+y/yWrhuTLY5f8AaN/5lz/t4/8AadeEV7v+0b/zLn/bx/7TrwilLcI7BVzS
/wDkL2X/AF8J/wChCqdXNL/5C9l/18J/6EKko+86KKKAPG/2jP8AkTtJ/wCwkv8A6LevUE+6n0H9
K8v/AGjP+RO0n/sJL/6LevUE+6n0H9K0pkTPjLxt/wAj34g/7CNx/wCjGrBre8bf8j34g/7CNx/6
MasGoZaCvaf2bv8AkcNX/wCvD/2oteLV7T+zd/yOGr/9eH/tRaQH0tRRRQB4h4b/AOTkfFn/AF5n
/wBo165Xkfhv/k5HxZ/15n/2jXrlaw2M5bhRRRVkhRRRQAUUUUAFfO/7RH/I0aR/15H/ANDavoiv
nf8AaI/5GjSP+vI/+htUz2KjueN0UUViaHQ+Bf8AkoHhz/sJ2/8A6MWvt6viHwL/AMlA8Of9hO3/
APRi19vUAFeM/HP/AJDfgb/sIt/6FFXs1eM/HP8A5Dfgb/sIt/6FFQgPVv8Alv8A8Cr4k8Qf8jLq
v/X5L/6Ga+2/+W//AAKviTxB/wAjLqv/AF+S/wDoZrSfQiBl0UUVmWe8/s0f8fviP/rnb/zkr6Gr
55/Zo/4/fEf/AFzt/wCclfQ1ABXingD/AJLT4+/3z/6Mr2uvFPAH/JafH3++f/RlOO4nsanxv/5J
de/9fEH/AKFXyvX1R8b/APkl17/18Qf+hV8r1U9xQ2CiiioKPtL4Y/8AJMvDv/XkldbXJfDH/kmX
h3/rySutoA4v4sf8kt8Qf9e4/wDQlqh8K/8AkmGgf9cG/wDQ2q/8WP8AklviD/r3H/oS1Q+Ff/JM
NA/64N/6G1XDcmex4p8e/wDko3/bjD/7NXl1epfHr/kov/bjD/7NXltS9xx2Cu1+En/JVPD/AP13
b/0Bq4qu1+En/JVPD/8A13b/ANAakM+yqKKKAPGPiZ/yWnwH/vj/ANGV6m/+rb/dP8q8s+Jn/Jaf
Af8Avj/0ZXqb/wCrb/dP8q1hsZzPhZ/vt9TTac/32+pptZGgV9F/s1f8gjX/APrvD/6C1fOlfRf7
NX/II1//AK7w/wDoLUAe6UUUUAeI/Bj/AJD/AI5/7CI/9Dlqf4/f8k+t/wDsIR/+gPUHwY/5D/jn
/sIj/wBDlqf4/f8AJPrf/sIR/wDoD1qvhM38R8z0UUVkaBX3L4Q/5ErQv+wdb/8Aota+Gq+5fCH/
ACJWhf8AYOt//Ra0AbVec/HP/kk+qf8AXSD/ANGrXo1ec/HP/kk+qf8AXSD/ANGrQBreCv8AkQ/D
3/YNt/8A0WtdZF/ql+lcn4K/5EPw9/2Dbf8A9FrXWRf6pfpWk9kRHckooorMsKKKKACuc8aW99ee
CtattM3G9ls5FiVT8xJU8D3PIro68y8b/FB/C+ux6FpWlyatqbRiV40JARTyBgAknHP0oA8l0XxJ
4N0u+8ETRWptJbBLlNZLW5LyM0YXJP8AECd2B/CD2r074KRI2n+IL6wtpbXR7vUmawhkJ4QDBP8A
If8AAcdqyW8c/D3VPD03iTXfDdnHqqTmCS0kt0eaSUAHqQMj1LYx09M9j8MvEep+KdDu9QudLTTb
ITBLCCOPC+SFHQ9+c8gAegoA76iiigDC8W6s+geEtW1aNQ0tpavJGD0LAfLn8cV8/f2Lqn/Crv8A
hZf/AAkGp/279q8zd53ybPN8vGPrz6Y4xXu3xCsptR+H2vWsCF5XspCiDqxAzj9K8R/4SfSf+GaP
7H+2wf2j53k/Zt48z/j48zO3Ocbe9AHu3hbXF1nwnpGrXDxxyXlqkjgkAbyBux+Oa8l8NTRD4kfE
5jKgVrebaS2AeTW3a/CPSvE/hLw2+sTajb3drpscRS3kVQAfnwQynkFj6fpTf+GdPCX/AEENZ/7/
AEf/AMbp9RWuj5hor6f/AOGc/CP/AEENZ/7/AEf/AMbo/wCGc/CP/QQ1n/v9H/8AG6Qz5gr6b/Z6
nhi8BXwkmjQnUnOGcA/6uOif9nnwnFbSyDUNYJVCwzNH2H/XOuJ+Ffwt0Px14YudS1K7v4ZYrxoA
ttIiqVCI2TlTz8xoA+kvtlt/z8w/9/BQby2wf9Jh/wC/gryf/hnTwl/0ENZ/7/R//G6P+GdPCX/Q
Q1n/AL/R/wDxugDP+A80Ueh68HljQnUsgM4GRtqp+0LNFJ4e0QRyo5F1ISFYHHyCtv8A4Zz8Jf8A
QQ1n/v8AR/8Axuj/AIZz8Jf9BDWf+/0f/wAbqubSxPLrc+YKK+n/APhnPwj/ANBDWf8Av9H/APG6
P+Gc/CP/AEENZ/7/AEf/AMbqSj5gr7t0+8tRptqDcw5EKf8ALQegr52+Kfwt0PwN4XttT025v5Zp
bxYCtzIjLtKO2eFHPyiu2tf2ffCc9rBM2oayGeNWIE0fUj/rnQB679stv+fmH/v4K8u+PdxBL8Nt
sc0bt9ti4VwT0aoP+GdPCX/QQ1n/AL/R/wDxul/4Z08I/wDQQ1n/AL/R/wDxugDutHubcaFpwNxC
CLWIEGQf3Fr5Z+KjK/xO15lYMpuBgg5B+Va9r/4Z08Jf9BDWf+/0f/xul/4Z08I/9BDWf+/0f/xu
qcrkqNj5for6f/4Zz8I/9BDWf+/0f/xuj/hnPwj/ANBDWf8Av9H/APG6ko8z+AciRfEjdIyov2KX
ljgdVr6k+2W3/PzD/wB/BXzVa/C7Q5fjHeeD2ur/APs+C0E6yCRPNLbUbk7cY+Y9q73/AIZ08Jf9
BDWf+/0f/wAboA9Y+2W3/PzD/wB/BXjZnhP7TM8nmx7P7Nxu3jH+qFXP+GdPCX/QQ1n/AL/R/wDx
ul/4Z08I/wDQQ1n/AL/R/wDxugGdN49uYG+H3iFVniJOnygASAknaa+Oa+n/APhnTwl/0ENZ/wC/
0f8A8bo/4Zz8I/8AQQ1n/v8AR/8Axum3cSVj5gor6f8A+Gc/CP8A0ENZ/wC/0f8A8brP134E+F9K
8PajqEN9qzSWtrLMivNGVJVSwz8g9KQzoPgdcQRfC6yWSaNG8+Y4LgH75r0j7Zbf8/MP/fwV88/D
X4Q+H/GPgy31m/u9SiuJJJEKwSIqfK2B1Qn9a67/AIZ08Jf9BDWf+/0f/wAboA9I1y7tz4f1IC4h
ybWX/loP7hrzT4Fzwx/Dna80an7bKcM4HZaf/wAM6eEv+ghrP/f6P/43S/8ADOnhH/oIaz/3+j/+
N007MTVzlP2iJY5B4d8uRHx9oztYHH+rrwqvp/8A4Z08JH/mI6z/AN/o/wD43R/wzp4R/wCghrP/
AH+j/wDjdDd2CVkfMFXdK41eyJ4xOn/oQr6S/wCGc/CP/QQ1n/v9H/8AG64H4mfC3RfB0OjPp91f
yG+u/Il+0SI2F45GFHP50hn0t9stv+fmH/v4KPtlt/z8w/8AfwV5P/wzp4S/6CGs/wDf6P8A+N0f
8M6eEv8AoIaz/wB/o/8A43QBX/aGnhl8H6UI5Y3I1FSQrAn/AFb16el1bbU/0mH7o/5aCvOP+GdP
CX/QQ1n/AL/R/wDxuj/hnTwl/wBBDWf+/wBH/wDG6qMrEtXPn/xoQ3jrXyCCDqNwQQcg/vGrAr6g
/wCGdPCP/QQ1n/v9H/8AG6T/AIZz8I/9BDWf+/0f/wAbqSj5gr2b9nSWOLxdqxkkVAbD+JsZ/eLX
c/8ADOfhH/oIaz/3+j/+N1wHh34YaJrPxO8Q+Gri6v1s9OQtC8ciiQ/Mo+YlSP4j2FAH0v8AbLb/
AJ+Yf+/go+2W3/PzD/38FeT/APDOnhL/AKCGs/8Af6P/AON0f8M6eEv+ghrP/f6P/wCN0AZvhuaI
ftGeK5DLGENmcMXAB/1PevWvtVv/AM/EP/fwV5v/AMM6eEv+ghrP/f6P/wCN0f8ADOnhL/oIaz/3
+j/+N1cZWRLjc9I+1W//AD8Q/wDfwUfarf8A5+If+/grzf8A4Z08Jf8AQQ1n/v8AR/8Axuj/AIZ0
8Jf9BDWf+/0f/wAbp+0FyHpH2q3/AOfiH/v4KPtVv/z8Q/8AfwV474v+B3hrQPCOq6ta3uqPNaW7
SossqFSR64QVW8CfBfw54p8F6brV7e6olxcq5dYZUCAh2XgFCew70e0DkPa/tVv/AM/EP/fwUfar
f/n4h/7+CvN/+GdPCX/QQ1n/AL/R/wDxuj/hnTwl/wBBDWf+/wBH/wDG6PaByHpH2q3/AOfiH/v4
K+e/2g5Ek8TaQUkRwLIg7WyB87V3n/DOnhL/AKCGs/8Af6P/AON0f8M6eEv+ghrP/f6P/wCN0nO6
Go2PmCivp/8A4Zz8I/8AQQ1n/v8AR/8Axuj/AIZz8I/9BDWf+/0f/wAbqCjwLwMQPH3h1iQANSty
STgD94tfav2y2/5+Yf8Av4K+avHHww0Xwx4u8KaRZ3V+8Gr3IhnaaRCyjei/LhR/fPXNd7/wzp4S
/wCghrP/AH+j/wDjdAHrH2y2/wCfmH/v4K8d+N88MmteB9ksb7dQYnDA4+aKrX/DOnhL/oIaz/3+
j/8AjdH/AAzn4S/6CGs/9/o//jdAHpf2q283/j5h+9/z0FfFPiAg+JNUOePtkp4/3zX0X/wzp4S/
6CGs/wDf6P8A+N0v/DOnhH/oIaz/AN/o/wD43VOVyVGx8v0V9P8A/DOfhH/oIaz/AN/o/wD43R/w
zn4R/wCghrP/AH+j/wDjdSUct+zfLHFeeIjJIiZjgxuYDPL19A/bLb/n5h/7+CvmrwN8MNF8T+Lf
FekXl1fpBpFyYYGhkQMw3uvzZU/3B0xXe/8ADOnhL/oIaz/3+j/+N0AesfbLb/n5h/7+CvGfAU8K
/GTx27SxhWY7WLgA/vKvf8M6eEv+ghrP/f6P/wCN0n/DOnhL/oIaz/3+j/8AjdNaCauTfGqeGT4Z
3ipNGzGeHhXBP3q+W+9fT/8Awzp4S/6CGs/9/o//AI3R/wAM5+Ef+ghrP/f6P/43Q3dglY+YKK+n
/wDhnPwj/wBBDWf+/wBH/wDG65zx58F/DfhbwTqWtWd7qb3FsqFFmkQocuq8gID3PekM9Q+Gl1An
w28PK08QYWSZBcDFdX9stv8An5h/7+CvDPCPwP8ADXiDwfpWrXV7qiTXdusrrFKgUE+gKGtv/hnT
wl/0ENZ/7/R//G6AOm+Kl1bv8MNfVJ4mY24wA4JPzLVL4XXECfDPQVaeJWEDZBkAx87Vjf8ADOnh
L/oIaz/3+j/+N0f8M6eEv+ghrP8A3+j/APjdNOwmrnmPx2dJPiHuRlcfYoRlTkfxV5dX1B/wzp4R
/wCghrP/AH+j/wDjdJ/wzn4R/wCghrP/AH+j/wDjdDdwSsfMFdp8JmVPiloLOwVRO2STjHyNXtf/
AAzn4R/6CGs/9/o//jdcHr/wt0PSfinoHhaC6v2stQh8yWR5EMgOX+6doA+6OxpDPpT7Zbf8/MP/
AH8FH2y2/wCfmH/v4K8n/wCGdPCX/QQ1n/v9H/8AG6P+GdPCX/QQ1n/v9H/8boAqfEeeF/jJ4GdZ
YyquMsHGB89epPdW2xv9Jh+6f+Wgrzj/AIZz8Jf9BDWf+/0f/wAbo/4Z08Jf9BDWf+/0f/xuqjKx
Ljc+Yn++31NNr6f/AOGc/CP/AEENZ/7/AEf/AMbo/wCGc/CP/QQ1n/v9H/8AG6ko+YK+h/2cZ4od
I1/zJUTM8WNzAZ+Vq2P+Gc/CP/QQ1n/v9H/8brgfhx8LNE8Xy68uoXV/ENPuxBCYJEXcvzfeyp54
HpQB9LfbLb/n5h/7+Cj7Zbf8/MP/AH8FeT/8M6eEv+ghrP8A3+j/APjdH/DOnhL/AKCGs/8Af6P/
AON0AZ3wcmij1/xwXljUHUQQWcDPzy1P8ep4ZPAFuqSxsf7QjOFcE/cerX/DOfhL/oIaz/3+j/8A
jdL/AMM6eEf+ghrP/f6P/wCN1XNpYnl1ufL9FfT/APwzn4R/6CGs/wDf6P8A+N0f8M5+Ef8AoIaz
/wB/o/8A43UlHzBX294RurceC9CBuIgRp9uMFx/zzWvEfiV8ItB8G+DZ9Y0+81KW4jljQLcSIVwx
weiA/rW/oXwH8Lap4f03UJr/AFZZLm1imcJLHtBZAxxlDxzQB7R9stv+fmH/AL+CvPPjbcQSfCvU
1SaNm8yDhXBP+tWsr/hnTwl/0ENZ/wC/0f8A8bo/4Zz8Jf8AQQ1n/v8AR/8AxugDq/BVzAvgXw+D
cRAjTrcEGQAg+WtdfAyvAjKwYFeCDkGvJf8AhnTwl/0ENZ/7/R//ABuu98J+EtP8H6MNL06S5kg8
wyFp3DMScegAHQdAKpyuSlY6OiiipKCiiigArw278TaP4V/aD1zUNcu/s1s2mxxI5iZ/nKxHGFBP
QGvcq5jUvAfhfXNQkv8AU9Gtbq7kADyyKcnAAHf0AoA8I0jV/AV58R9e17XrtHszcedYK8EjJKxy
SzKFJ4wOG4Oa998OeK9C8VWcs+g3YuYIHETkROm04zjDAdqof8Kr8Df9CzY/98n/ABrZ0TQNH8Ow
SwaRYQ2cUrb3WIYDHpmgDXooooAK5T/hXfhM6t/a39gWX23d5m/bxuznO37uffFdXRQAUUUUAFFF
FABWdpuk6fo9ubfTbOC0hZy5jhQIpY9Tgd6wvGHiw+HFtLa0s1vdSvC/kQPMsKKqDLyO54VVGOfe
l8LeNdG8UtJa2WoW8+oW8StcxQFmRScZ2MQN6g8ZH9aAOtooooAKKKKACiiigDO1LSdP1m2W21Ky
t7yEOHEc8YdQw6HBrQAAGAMV5lr/AMR9Qt7yefQNDuNT0nSbp4NXuAoGCoG4RfNklc5J246cgc12
+ja1YeINLh1LS7lLi1mGVdT0PcH0I7igDXooooAKKKKACiisfxBrlj4a0S61fUXKWtsoLlRkkkgA
AdySQKAJhpWnrqr6otnAL94xE1yEHmFBzjd1xWlXmmk/EHUrfxH/AGb4r0ltGttRbdpNxLgKw4/d
yEMQH5HccnGBxXpdABRRRQAUUUUAFQSRpNG0ciq6MMMrDIIPap64vxd4ru9LmXRNBsm1DxHcW7Tw
W+BsjQHG+Qll4zwOeTQB0un6bZaTZR2en2sNrbR52wwoFUZOTgCr9cb4J8ZW3iu3lhmiNlrVm3l3
9hJw8Tg4JHqpPf8ACuyoAKKKKACiiigArO1DSdP1XyP7Qsre6+zyiaLzow3luOjDPQ1o15XqfxRv
re7TVrHQri68JW0zwXt+FG7cDt3xjdkoDnkqM+ooA9Uoqlp+oWmq2MN7ZXEc9tOoeORDkMKu0AFF
FFABRRRQAVmW+k6da6lcajBZW8d7cgCadIwHkA6ZPU1X8SeIrPwtoz6jeLK6B1jSKFd0krscKqju
Sa5Lw94+1BvET+H/ABdpo0e/uGMmnMxGyeMnhMgkbxx0PPTg9QD0iiiigAooooAKKKKAKlzawXtr
JbXMSTQSqUkjdcqynqCKSzsrbTrOK0s7eO3toVCRxRrtVR6ACuP8X+L9SsLp9D8Mac2peIhALoxF
R5UUW4AliWXk8gAZNX/B/i6w8X2BliJt9Qtv3d7YycSW8gOCCPTIOD/LkUAdbRRRQAUUUUAFFFQS
SJDE0kjBUQFmY9ABQBVu9K0++uba5u7OCee1ffBJIgZomPdSelaNeUz/ABUuoNQtdaOjXA8E3H7n
+0mQBxJuI8zaGJ8vjHIB/QH0y2uoby2jubeVJYJVDpIhyrKehBoAtUUUUAFFFFABRRXNeI/Edp4Y
sYZrmK4mluJlt7a3t03STSt0VRke/oKANO00nT7C6urq0sreCe7bfcSRoFaVvViOvetKvPvBvju5
1TVJtC8S6eNI8QR5kS3Jwk8Z6FDk5I6EZPTI7geg0AFFFFABRRRQAVTvLG11Kzls723juLaZdskU
q7lYehBq5Xn3ibxzqGn3VxpvhjR59Y1GwMct+qp8kUbZO3OQd5AyAAfp2oA7a1tYLK1itraFIYIl
CRxxrhVUdABVusDwx4m0/wAVaPHqWnTb0biSM8PE/dGHYj9a36ACiiigAooooAKzJtK0+61G31Ga
zgkvbYMsM7RgvGD1APUVPfXtvptjcXt1II7e3jaWVz/CqjJP5V5tH8Tb231a21DVdHmsfCOoqi2O
oyqAysQcNIAxwrckZxxg880Aeq0VBHIk0ayRsrIw3KynIIPep6ACiiigAooooAKzrDStP0vz/wCz
7K3tftEpmm8mML5jnqxx1NZfifxNH4dgtYkt5rvUb6Qw2VpCAWlfGeckAKOpORgVi+C/HE+rXMuh
eJLUaZ4mthmS2PCzJ13x8nIx15Pr06AHf0UUUAFFFFABRRRQBn6jpllq9m9nqNrDdW0mN8UyBlOD
kcGrEcaQxrHGqpGoCqqjAAHYCvPfE/xEvrC+uI/D2h3GrQaVMF1aVUwsa4yVQ5yXHU8EDv7dloeu
6d4l0eDVNMuFntZlyrDqD3Vh2I7igDYooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACii
ql5e22nWc13dzJDbwoZJZHOAqjqTQBbrmvEPiSw02KTT4tZ0y01maM/ZIryYAFz90sM5xmuc8RfF
G28PeIdJszaLdadq1vHLaXsc6qpLPg7s8BQpBz/kcVqkWnWV74p0nxR4Xu9T1LU7mWfT9Qt7XzWm
RgPKVH6pt4GBx/UAu+G9I0rxZYah4e8U2u/xhZXU928V7M4VnfoyFTzFgJlR6Z7g12vhDwXcaFfS
6pqk9nJqDWy2kUVjbiGC3hU7tqr1OW5JNXPB3hz7Foeh3GrW0T65aWK273LqGkQf3N3t0/P1rr6A
CiiigAoorm9f8XaF4Z8n+2dTgszOSI1kyS2OpwBnHI5oA6EkKpJIAAzz2ry7UPiBq+v61cWfgKTS
9RTToBcXQmLbrg7iPLj6dAM7umWUZ9et8RWE3i3wjcW+i6z9me6jzBd27hlcehIz8p6HH/1q830D
Qn114LeCE+G/Gfhry4JpoYcw3EPTJA4cMoP/AOo8AFe2S81DTdc17wfrcmn2V8ztrOky2Znntbg8
P5agZJOT6D34wOo+FugT6ZJrF/b6fdaVo18YfsVhdnEo2qQ0rLzsLHBx/TFeg29nb2rSvBBFG8z7
5WRApkbGNxx1NXqACiiigAoornLHxXpmo+J7zw/aSST3dnGJLiSOMmKMk42F+m72+voQAC3rWvaZ
4c019Q1e8S1tVIUu+TyegAGST9K8k1jxTqmt+HGvfFFnBJ4G1rMaTWWWnsMPiN39eVBPXnj2PSfE
TStZt9T07xXaodVsNMy11osi7lZcMrSIMcsFY9fQH2qTwd4WsvNm1XRbs/8ACJazbeadHuYMqkjH
kgHgLgHjkH3GKAOO17QdauLXTtM1ue48V2zWkg0ZNPtCqszKFSWebgLtBB6n1Pv7B4as7zTvDWm2
WoT/AGi7t7ZI5pc53MAM89/r3rWRFiQIihUUAKoGABU1ABRRRQAUVS1PVLHR7GW91G5jt7WMZeWR
sAVn6N4h0fxTZyT6NqUV1EPlZ4ThoyR3B5B+ooAwPGHjiPS7yDw9o97Z/wDCSXkscUUdyW2Qhv43
wPToOpJHBFcaX1rxB4qt7a5u49C+IGlxskb7C1rqNseTjr7n8+OPlY3hoWer3fg7xfBLfprdwZ9M
19EzMJQoAV26hlCj2xnsePT/AA7ol3p+k2Kazcw6jq1tG0X28xAOVJ6ZPPQDPrigDzLwz4e1S98f
WuqCK+GoWl1NJrGrTQG3iuQVCrBCh5ZRtHJAx17ivb6KKACiiigAqvLKkETyyuqRoNzOxwAB1JrD
13xl4e8MzwQaxq1vaSz8xo5JJHrwDge5wKo+N9FvfFvg2ez0fVjbSTpujeNgY7hSPuMR/CwPb9RQ
BzF78QNd13Ur2XwGunanp2kIj3UT7hNdli24RjA4AHXuemelczDZzXHhLU77w9r1wPCd/I32/SUs
TPd2rv8A6yJAOmc9SQADnnqdvw5pP/CTanb6rp8DeGPFGiypa6nCkH7mePuMDAYEDj046jaa9Wtr
S2tRILa3jhEkjSP5ahdznqxx1J9aAOJ+F2iXmjafqcslpNp2n3t2Z7DTZny9tHj+Lngt129sV6JR
RQAUUUUAFc/4l8UaT4T0w3ur3aW8ZJWMHJaRsE7VA57VFp/jfw1q2ryaXYa1aT30ZIMKvySOu09G
/DNcd8QtN1DSvEtt4vmgOtaDbwtDeaZKgf7MjAB5YweOgGe/XnB4AOf1bWdX1bQbZPHEdrB4d1tY
57HVNNJb+zpvvRiT19z9eeuIfE3h/wASancQ6TrTz+ItUNqU0me0tjDBbFmX/SJZuBuwnQZ/UV3H
g7wdbWEd2bS6+1+E9RRLiz0y7g3CBmIY/f7dCBj68jJ9DAwMCgClYxTW+nW0FxMZp44kSSU9XYAA
t+J5q9RRQAUUVk6xrWm6DYSX+q3kdpapgGSQ4GT0A7k+woA1q888WeOPJ1a28LeGtQ0//hJLmYRk
XW7y7ddjOS2BgscABeuWHFdNp2s6b4p0iWfRNUSaKRTH59uwLRMR6HoRnOCK8mtfDITUbjwJ4qik
bU7yeS+0nxHBGTJJJ94lm6hhjkZ6cZHykgFi1k1fxF4r863u4vD3xA06DyLyCWMvbX1vnIdevHIP
ft6AiXwNoF7N43h1uGPUIGg+0/2vqF3AbddRlkPypHEedqnnPHQDANelaDpdxZ2Fk2rSwX2rxW4g
lvxEFdxnOM9cdPqea36ACiiigAoormtR8VabpniHTtDmeWXUb9j5cMCbzGoB+d8fdX3/AKAmgDau
7qCxtJru6lSG3hQySSOcKqgZJNeW33j3WdZlv9X8MwWWreF9OkWG7tgGFzcKUBd1BxgDOB67W4Ir
p/iF4c1XxF4eMGlXvk3ETeYbV8eVeAYPlv7HH09fUc34W02LxJrdr4t0RZfD2o285tNc04wkRzlR
yMcDPI5/qOQDnE02SLwfEdM1q61TwDdXKsNNt7Ez3ijeGMGf4RuHJJHtnPPovw00O/0LwvJb3sbW
yTXctxa2TvvNnCxBWInuRyT7muqtbS3sYRBaQRQRAkhIkCqCTknA9Tmr1ABRRRQAUUVz+heKNJ8S
terpl0JZLKdoJ0IKsjA4zg9jg4NAFPxd400nwVpMl1e3CLcPG5tbYk7p3A4UYBwM4GegzXmuu3+u
ajHYaX40ntNPe6ljvdD17TgTDDPjKxv7c9fx5HI1fGem3Ph7xTL4j1m1bXvDV7CbS6ilTe+nqxHK
D+7kDpz75wT1fhLweuh2c9hJdjUdF85LjTLa6h3Paj73VvQnjgYx6k0AebeIPD/ibW9eFlqTy33i
uEQrZXtjbtBa2MYfe0ryEDcxHYA4PTnivekDLGodtzAAFsdTUtFABRRRQAUVj65r2l+HtPa+1e+i
tLbO3fITyfQAck9elQQ39j4r8PTS6LqwMVxG0cd3aMC0TEYyM9GHoaAOZ8U+NJ5tbh8KeEr3Tn15
2fzjdE7IQi7tvAwWPTHOOciuP06417UvEmp6ppF9BofiuOEJrek3cTSRTKgws0QAJPGMYz164PLN
P8MPcSv4I163a08TWzy3+k6/bIcz5YsXZxznceQfboQCfX9J017S3glvmgudVECRXN6kIRpsfTtn
PFAHmvww0KaLxHPqllbX9tpb2IhupbyPyjqF1v3NKsR+6o5H449a9joooAKKKKACqWo6jZ6RYT31
9cJb20K7pJXPCise98beG9N1pNIvdatYL9sDyXfGCegJ6An3NYnxE8Pa1q+n2d3o0/nGwmW4k0qT
mK+CsrBT7/LwDx9KAOZ1DxtrOs2eo63BY2eo+BPMksbqCHd9q8rGGm5xgfNnHXHUDqMqTSbmDw1p
cEmo3XiXwVJOHsbGysS9zKADtikfgIoPU5zxgAdB0/g/SbXWdWh8X+GpZdJsrzfFq2kSQYR5V44H
ABB6kdfYkivSbW1t7K2S3tYY4IIxtSONAqqPQAdKAOf+H+j6hoXgyw0/UyRcxhj5Rff5KFiVj3d9
owM11dFFABRRVS4uIraGSaeRY4o1Lu7nAVR1JPYUAW64zxr4503wdpriW6hGqTRn7HbSE/vG6Atj
ouepOOhrT8O+LtF8WR3Mmi3jXMdvJ5cj+U6DPsWAz+Fec+I9Lfw/4uvrjxNbSa/4b17Za/aXj3za
e24lU4HCZc4245x3HIBX1ebV9T1ew0DxZcwaXr8cwuNB1yyUm3kc4zGQe54HbPHHTdTvPDfiHWPF
8cV8Lq78TW9zbsdXhtmt7Syt0LMQjHHmM248Yxnvwa9D8KeFrjw/pY0/Ur4avBa3Jk017iIGS2jx
hRuPcZPI6DpxwO3oAKKKKACiisLxD4p0Xwrapda3fJaxO21AVLM59Aqgk0AbteYa7481DVPEB8P+
A7vS7m/to5Z7prknaShAESdAWJJyc4AHUV1d06eK/C0kmha08CXkOba+tjyp9efpgjgjnoa8t0jw
y+oxR+Frm2OieM/D6Cay1W1iPl3EW7AcsB8wOeQeSc/7QoAZp9xrF7Nrus+GtTTSbxwTr2j3ds8z
28wGDJEoBLZwSP19uh+E/h6fTLy/vbG2vbHQJ7eGOGC9G2S4mUYefZk7M88d8+gFeh2dmttmZkha
8lRBc3KRBGmZRjJ/oOcdK1aACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqvLNHCm+R1Rc
gZY4GScCgBs0qwxPI+7ailjtBY4+g5rg7r4m6Ve6TbnRtLvNdnuxIr6fDGDJGqYD+apzt+8BznOa
0PF9xZ3d3Y2EWtw2uuQSfabGza88oXEgBCrIByUJ7d+nrXm9pPqVxrVzrvhywj0/xvYgxazoUoxH
eocZkjGe5weD6cngsAKmoR34ub2GzvNb8I6tP9m1HTpo911pM5wPkA5Cj5cY4GAOCBn0nwX4TuPC
sM6Ta9qOpwsix28V02FgjUnAAz1568cAcCpPBvhu60V9U1DUZ4pNT1adbm5jgTZHEQMBVGTnHOT3
NdhQAUUUUAFFFYHiXxHbeFdEk1a9guZbaJ1WT7Om9kUnG489B3oAg8V+K4fC9rbYs7i+v7yXybSy
thl5nxk/QAck15lqfiGXVdWTxvb6FLcx2Eb6Rr2j3MYeWCPdu3oD16nPTpg8ZI9RfT9E8UnR9dUr
dC0Y3FlPE525YYJ46/T1FeZ2Fz4mX4l+K9F8P2ot5LnUYp7rUZk3JbwhARhTwWbPHt+YALfw4v7C
18dXmk+FL177wvd2YvxGQ2LCYtjy8npkduvT0JPsIABJAGT+tVbaytrMMLa3ihDnc4iQLuPqcVco
AKKKKACiiua8W3UlroT+TrkOizSTRxx3csYcAlh8oDcZIyP1oA1LLVNP1M3KWV5DcG3kMM4icMY3
HVTjoa8guPAieHrrULXWPE8mkeEjM01nJDcCGWSeT+F26sE2nGevX1xFHe3Fx4g1DxD4RsZLHxPZ
uV1rw7cED7ZGD/rFA4Lcg5Hc98/P6lpM+neLNAs7+Sx321wokEF3DkqwOOVYdjnnv1oAyPhZqGoa
l4PEmoXEt2IrqWG1vJVIa5gU4STnnnn8q7gAKoAAAHYdqaiLGioihVUYAAwAKkoAKKKKACqOqala
6PpdzqN7II7a2jMkj4zhRU8sgiidyrNtBOFGScegrk9N1jQ/iX4ZvbTbL5Uga3vLOUbJoDnGGHY8
ZB/wIoA4nXPENz8Q7NNDi0e80jVV2atpC34BjvRHztPYZBzg5Hqaxv8AhItPfxFpWvaFC+k+K2vI
7HVdCMZX7SrHDHbjt1z+J5HPRePZ7vw34p8Ez6VpT3s1vBdWtnbKxOXMaIoY9cAHJ9gee9d94d0+
/g061m197W71sIRNdRQKhGTnaCOw6ds46UAdAVBIJAJB49qdRRQAUUUUAFcn4s8Xp4cks7O20651
TVL0sbextsBmVRlmJ7AetWPE/imw8JWUF5qCXP2WSdYXlij3LDn+J/Rf8ipTpGlavq+meI0xNcW0
Li1njkO0pIBnpwwx0+tAHlV/rUV1f/8ACeJosl/ot3D/AGZrmnzwh5rFkPXHpzz098E8bHwtu7a0
8R6vomg6g+p+GFhS8tpTuP2SRjgwZPtzj29SayvB0/ieXxR4g0LSLdbS1j8Q3F3qN/NHvUxkjEKK
epYA/gQeO/s1tZ21nGUtbeKBCSxWJAoJ9eKALIABJAGTTqKKACiiigArjbnxro7+MrjwhePJbXUk
CmKV2CrMXH3VPZsdPXn2zYh8Y6a/jCfwvK01vqKRrJF56bUuQRk+Wf4sf49cGqOv/DPQvEU+rXN4
J/teoiIifdlrZowQrR+nXkdDQB5hc6fp2k6W3gzxei6Te6dvm0LxBFGVWQA7hlhznpkfyIBPr3gH
VNQ13wJpN/q8JjvJ4f3oYYL4JAbH+0AG/GofC1hrTaM+n+LorO9ltZtlvcEBzcIPuyMp6N+v8z1w
GBgUALRRRQAUUVRvLoWdnNcGOWURIX8uJdztgZwo7n2oAuMcKSBk46eteLX3iYfEzw9HJokSW/iT
Qb0Xy6VckMJghIx2ByD+B44yDXpnhbxTpnizSVvtOkOAds0L8SQv3Vx2NePaj8N/EHiDV9U02Czh
0u2sLm6ltdScENcpMxdYRtx8gy2TzjOMdQQB9jr+l/8ACa6LrHhiGSw1fULxbHWtBMZU4P3pCuMD
byc8e+PmB97IBIJAyP0rJ0zT/s9tbyXUFqNRECxzTQp1IAyAx+bH1NbFABRRRQAUUVzWveLNL8MX
GnRaq0kMV/KYkuRGfJjIHG9+i57f4AmgCLxh410/wXBp9xqSS/Z7u5FuZUGRFwTuI6kcdq43XvCM
zeIpvEGma0lloOsQK+sXkcwV440G4GKTqA4wDjj8MCu+1rw1pniK60+fUYvPjs3d0iYgxyb0KHcO
/B4rmfDPhLV/CWs3WkRSRXvg64RpIorl90lq5P8AqwD95Tn/ACeoBT+GN6w1nX9M07VrjWfD1sYm
s7yZy5R2BLRBz94Dj6fjXpoAGcADJzx3qC1s7aygEFrbxQRL0jiQIo/AVaoAKKKKACo3dY0Z3YKq
jJJPAFSVx/jDUriwl05bO/RLlpZHGm7FaTUlVCTEu7p25/8ArAgHQadqVlq1ml3p91DdW0mdksLh
lbHB5FfP9/pmsab8QdatPCNvex+Jl1Ce482MAQtZyoHw+7gkMSF/xArZ0XWf+Ee83xZ4Ugmm8PzS
Y1rQc/vdOl/idF9OD6fl932a1khuoYryKPBnjVgzJtcr1AOeR1PHbmgCj4Zub288M6bLqcE8V69u
n2iO4UB9+OSwHAz1xx16DpW/RRQAUUUUAFYnibxDaeF9Fm1O9WSREKokUS7nldjhUUdyTVjWdUi0
XSbrUpoppY7aNpWSBN7sB6Cskp4f+Ivhm1uFf7Zp0kqToUYoyuhyAccgg8EUAee65rep+MZoZrHQ
57XxF4ZnF42kXoDi5gdcHb6nGPz4yap+Hda0tPiFpV94OaSEa07RaxoZQr9mZRzLjouDn+nUgaHi
m+8Qaf8AGG5h8Pad9o1HUdHjggmk/wBXAPMO6VvULj88deh9R03ThZwxvOIJb8xKtzdRwiNpmA5J
x6nnFAGpgbgcDI4p1FFABRRRQAVyPibxtp3hHVtIttVWSOHUndBdcbISuPvd8EsPpVjXPGOneHdY
07T9TE0K35ZY7tlxAjDorP2Jo1rwfpHiS/tbvVIWuBbwywLCzfuysgAY49eBgjFAHnGv2Wn+Gte1
dPE2npe+EPEkwuF1GNNzWczDuw5A7gj8M8ium+E2o3c+j6jYPetqWnaddm30/UGBHnxYzjJ67emf
w7VY8JeG9c8N3t7oF1JDf+FhHusJJm3Sx5P+pYd1HPP09cDt4IIreFYoI0iiUYVEUKoHsBQBMqhR
gADmnUUUAFFFFAFW5uIbS2kuJ5UihiUs8kjYVQOpJrD1qytvGfgy9s7K+jMGo2zLDcxtuU56HjqM
9fxFZPjTVJtNu7f7NdR3bC3nll0ERK0mopjGAT0C8k8EkAjnpXGeHtcHhdYtb8OmbUPBF9Li4slB
efSZmIyAvJ25PT/6xIBzV1rGoW8N/Br+van4f8S6PFHHplnbBhb3ARAvCgYcuw69MEdQCK+gdHmu
rvQrCfUYBDeS28ck8WPuSFQWH4HNWGgt7iSKZ4EeRPmjd0G5fpnkVboAKKKKACiiigDOutUsbK6t
bW5u4YZ7pylvG7hWlIGcKO9ZF74XjvvGNj4ikuCfslpJa/ZWjDK2453ZPQ/hzxXn/i/UtI1Rns9e
vzfaTdX8iWuuWsaqukTrt2xEjJPI5JwCCD6kdL4F8R619vl8L+JIXl1K1h82DUY1LQ3kGQBJu6Z6
fX65oA5X4eeKprC6fwvpGmNfXB1i6e5APlx2VtvxknGM5zgfh3Fe14G7OBnHWsfS9C0zSZLyTT7O
OB7ydp7hl6yOSck/rx0raoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiijNABXnXxI1rwe
lgPDnim9kiN4BIvkqxaHB+WQlRwAfXrg8Gp/HN/4o8PXdp4i0nbe6PaIV1HTFQb2TPMit6gdu2O4
Jxx1rcra61N4giSXxL4R8T7La4Dr51xaPk4jZeu0FiMduPQZAM/TtB0251O68M+NP32o6qyTaP4j
Q5a4VUVYwr9iAAdvQ555wT6f4Z8My2aWV94iNnf+ILSN7dNRjjKu0WeNxPVsdT7n1JK+F/Blv4Xt
ZLOO6lvLRLgzWUVyob7ECD8qE5Pc8+/1z19ABRRRQAUUUUAMJCqSSAAM89q8m1PWJ5dQ1zxB4RsX
1eCCSKHVFlkMkN5CEO5LfkjKhgW45zxnkHR1Txjruuazf6d4Gj0m/TTEBvzesw3uWZfJQDHPyHk8
c9axfANnepqcWt+F7dLTQ7+Z4tX0aZ8fYrhBhmiP5ce+OONoBb8FQz2eqW994NmS98HamzNc2Mso
V9Mlxk7Qef8AgP8A9Y16qqIrs6qoZsbiB1qnYaTp+lCcafZQWwuJWmmESBd7nqxx1NaNABRRRQAU
UVla3q9toOjXmq3m4W9pE0r7RkkDsPc0AJresWfh/SLjU79ylvApZtoyzeyjuT6V4/4n1y88Va/p
xtLDU9O8Q6YftdtouqpiG/jGSSo6eYBn8iByKTxD4jh8aXKeHfFVmmhXMgjudKvop/MW2ldSUSY8
AMVxx79uDVzw7d6v4j+IunWHjC4tLXVfDweW3jhhYNf7lx5gfONuMHAAz6dQADsdP0vSvGsmh+Mn
sb7TdSt/mHJhkIGQY3/vJnPpkexIruqKKACiiigAoorifGHjB9Hv7PQtI+zTeIdRdVtoblmWONTn
MjkdhtPA5NAFLxnfW174i0vRtMklfxJF5tzaiOU+TbsE4e4UH7pyAOD19Mg8XbSajq2tS6rokMel
fEPTQE1TS5CFi1GMYyw5wc8HOfTnoadNa6/q/jGZvs1ppXj3SoRcpJbMRa6pbEhcHPOe3P0OMceu
Wmmwy3Fvq97p1rHrIthFJLGNxQHlkD4yRmgCzbB5ba2murdIrnYCyBt/lsQNwDd/TPetCiigAooo
oAKqyzRwQvLK6xxoCzMxwAB1JPpVkkAEngV5ZqXjPXfEx1R/BljpOraLp6+Xdpd7/Mu2K5ZI14GA
OOep6ZoAz9Q1o+Xq3iHQtPk1bw3LePFrUU7GT7SgUL5lvkkbF59M49MY0fAUOoaffxDRLqPU/A18
jzW7PL+9sH7x4PJGcjHbrxg5rfDe0vI7iDUfDhVvBuqrJLJY3Mn7zT5xwyp/eBYY+nPXr6Xp2l2G
kWv2XT7SG1g3M/lwoFXJOScCgC4sSRliiqpY7mwOpqWiigAooooAK5TxxrGlaV4XvF1WSXZcxtAk
FvJsnnLcbY+c55q/4i8Q6d4Y0aXVNTnEVvHxnGSzHoox615T4ku9Y1+z0pPGWkafFpGrug0/UNOd
mm02aQAxlyeueM4wDzzwKAF12BZLy18NeKYjpcR2v4b11Cwe2IA2xSsTncMDOTyeeOCPTPB8niNt
DEfieCFNQhkaLzYXDLcKOkmB93Pp+PGcCj4e0bVbzw4mmeNrey1Ga2nxHKcOJ1QjZIwI4b9fXqa7
IDAwKAFooooAKKKKACvNvF16t/4stNO8PtJP4nsbaaeBhNm3tiQBiZQerDgZ7kE8VoeLPF1za6xZ
+GNA+xTeIbzLBLtmEcMYVmLtt5P3eAOe9cJb2+vaj4wvNRsLK20vxzpWz7baxsRa6pbt/Fk9D05P
t3HAA7Tpb3U9Yl8R+FLcWHjC2cRa74fnfYl0MgFxk4Hrn+v3va4y7RKZFCOQCyg5wfTNUINKsxqR
1ZrG3j1OSERSzooLFR/DuxkjP8hWtQAUUUUAFFFZ51Ox+3zWYu4ftUEYllh3jeiHOGI644NAE1zc
w2lvJcXE0cMMa7nkkYKqj1JNeNalqET6Lc63Bo91qHgnUrqY6rHdFmuAd20XEWScRjAxjBGDnsRo
ax4v1nxZpur3nh/SdK1jwpZkwXUVw7ie7AVWcoONoAPGecjIz0q78NLTUbazFvaSC98G3lubixku
XHnWxY4aBl/iAOfb88UAWvh2NZsCNNjuI9W8KmATaXqvmjzFUn/UuOpI59MYx7D0is/TNNstJsY7
LTrWK1tYs7Iol2quTk8fXNaFABRRRQAUVGzLGhd2CqoySTwKwPEnii28N6LFfmN72S5lSC0hhYZu
JH+4oPTn1oAXxL4ltvDWnLcTQz3M0sqw29rbrulnkboqj+teUXfiC4ufGreMdPs9QkvtJj8vVfD1
+n763hIAMsHbHQnHPc8GrWujVvE/imygutKPh/xtp8ZutKl88TW92i8tGT0z1/XPFafw/nn8TeMN
S8R63JDa6/ZW406XTIoTG0K7s73JJ3Zxweg/KgDrtO8OaRLr6eMLKG6tLu9tgs0XMayhgCDIn94D
/Oa66iigAooooAKKK8/8ReLtQk8Rp4V8InTptbVGmujelxHboApGdvJZtw6dO9AGf4lvpNR8UXT+
FVe78R6VY8s0ha0CtJ80LANgSkKcZ9PUAjn/AApPc/20uueCbYRx3E6xa74cnkEZtpM4MqZ6Ac/y
x2DfDMGuyeLrzWND06DTtXguktvEOjGTbBMGORPGeccZPf1GckH2G30rT7bULrULezgjvboKJ50Q
B5NvAye+KALnlp5nmbV3427sc49KloooAKKKKACqOo6jaaXYS3t9cR29tENzySMAAPrVeXWdMiN/
uvrfdYJvu1DgtAuN2WA5HGTXl+ueLda8R6BqOsxaFpeq+B0keGaFnb7VJGhw0y9lx1HcYz70AZ91
fQ2/huC4vtFu5vh9q5d7g3RZ7q0ldyVnzknaflIx6+p+buPh9Br2nQzaZd3MOqaBGivpeqrKC8kZ
6Iw74Hf8Oe1bwDo2oW2lT6Xcywar4QubZZtNmmOZfKkGfKde4AP+eg7uysrXTbKGzsoI7e2hXbHF
Gu1VA7AUAXKKKKACiiigArmvFHimDw1Bbj7HdahfXUnl21laJukkOCSfYAA5NR+LPE7eHLO0W2tD
e6jf3C2tnb79geQg/eY9FGOTXlH9rT+MdcTWtKMGmeO9I3qkBffb6nCpZSIyev8AEPx69wAT2mvz
ReNrnxtY2uoXtupFlq+lXUe6707ceDGv9zI6D/aB9R6jpXhDS9L8R3uvaek9tNqEYE9uG2xM2c7y
n97/AOv6muT+GM48RalrHiu7mhTVrgpaXNhFEY/suzPD7jlmPr7Y9QPVKACiiigAooqjPf2ltc29
tPcxRTXLFYI3cBpCBkhR34oAvV5r4x8fWUEeqaStlrUlnDGIr/VdMUYtC65GG9QCCcdM1D4u+JN1
o9/fW2l6VHe22lyQxag8kuxmeX7sUKjlmxk+2K4lb+Twtotxqfg2e2uvB2snF1HcxNK+lyONrF1U
5Ix2Oc4A54JAOl+HsYawm8Davp6ajpk8DXVnqUERMF5A7Zy5/hcE9+QeOwJ9D8OaJb+GtGt9ItJr
iW3twRG1w+9gCScZ9B2HpVfwRpVpong3StPsLsXltHAGjuR0kDEtuHsdxxXTUAFFFFABRRRQAUUU
UAFFFFABRRRQAUUUUAFFFFABRRRQAV4bq/iu01rxLqDeIrubS9L8OzK0OkKStzqE2flY4xkZAwBn
rknHNbl0uq+OfHGuaMviC90Ww0QxJHDYPslmdhu8xj12jHA6dPxTxnoGm+JPENtpOmXU1r4w0m0W
9s72ROJFVgAHYj5vm5zzg59xQB2Oj6/NPpmnNrtvb6TqWoM3lWLzhnI5IHIGW24yO36UzQvB2neH
tW1O/wBLWWD+0GV5bZX/AHKMOpVOgz/+rA4rM8MeEr5NRPijxXJHdeIJUCxxoMxWKf3Ixzz6t/8A
XJ7ygAooooAKKKjZlRSzMAoGSScYoAeSACScCvLvHPjOa2vdLsdM1xdPs7y2luFv7aBbp7h1YKsM
Q6FiT/Tip9S1zR/iLMfDWh+KY4okkJ1FIEYS3EIHKxOeCM8EjPHt14XwWtn4p8P6Z4KbQhfx2N3P
Je3UjtGLGMyNt2OOd5546HHPcgAttoniLWDeajp149n490mCIamLJBHHdrICyxk/dMoUDJxtzgds
j0r4f2lraeDLFrTT72y87dNLFfEmYyMTuZyepJ78cY4HStTw/wCGdK8L6ebLSrbyo3cySMzFnkc/
xMx5JrcoAKKKKACiiuF8T+Lbuytrqfw1b2+ry6XcKuqWis3mpGQSdmOrfnjB4PNAHXXF1DaIGnlj
Tcdq73C7j2AyeteRvrOuwfETSr7xdJFp2kX9nd40yRw0cEUahsy9mY4B9uB7VmeNptH8UJb+IrvV
IJtH1WSCwsHkLAaXwWnkdRx5ny4H4ZOBWt4W8ITeN7DS73xQ/wBu0/SpZP7KnYkPewbsAzKR0+RC
O5B5z1IBP4a8IDxS76rdXxu/C15qEupxWF3ZbJZZGBRd5PVAOVx1GOnSvUBaWwnjnEEQmjTy0kCD
cq/3QfTpxVtVVFCqoCgYAA6U+gAooooAKp3NwlraS3EgcpEhdgilmwBngDkmrlcT4x8W3Wg3Ftpu
l2tvc6pcRSXH+lS+XDDDGMvI7en+e1AFXUPG8mteELS/8Gr9puL67S03yR7vsOc7pJU7bQM88dDy
Ovnf2u68StaaH4kku7r7ZNJL4c8RQQBZ1KPt3MichCcHPoQfQiXTL99YuZvEvhKzWDW5UCa74alb
at2jD/WRg4PIOc+/13el+DvAmmeEi81rJfSzyxiNReT+YbePO7ykwAAufzxQBh/DjS9UtdY1iXxJ
aX0viG3C2zalcPvimg+8ohOBgdyPXGTnIHqFFFABRRRQAUVia3rMeirZtLaXc6XFwsBa3i3CEHne
5/hUY5NcD4813+0/EGk6BeXd1pXhzUD5iazZ3AC3L7Ttj3gEKM469eO3NAGjrGreJNe8aah4a8O6
rbaQ2l28c8k01uJnuGfkKAeAg4BPJya4RNN17WtI1HxXoXnadrtncyWOuWGnPsS+MeC7x9QHwfQ5
OSOeu3YeAdT1XxA+meJP7TWfT4f9B8SafN5T3EBOBFKecsPzxnnGCfTtB0HT/Dmkx6ZpkHlW0eSA
TlmJ6sxPUn1oAh8H2Nlp3hLTLfTrGextvJDrb3AxKhb5jv8A9rJOfeugoooAKKKKACuWTxppcviD
UNAjMx1Syi837O6FDOMZ/d5+96f40+/8URaV4gWw1G2a0sJI08vUZpVWKSZmwIh33Yyfw/GvKNYW
18ReIPEc+v8AiWTRvEGh3UjaUhdIo44FwUYZGX3dTznkcc4oANS8R+J4XuL/AFhP7W0426Sa3ock
KoljHM22KNCeTJjk9+nrkWtG8LXen+JdAtZxrWreDriRbrTInJUWUoBZROhGcDtyB7HkVt+DvCcX
ik2fjHxHp9xZ6tKY3kgWf/R7soB5c7RjoenGcZGcc16xQAUUUUAFFFUby6FnZz3JjllESFykS7nb
AzhR3PtQBerivHviPUNHTR7DSXt4b7VrwWsdzcLujgGMlsdz0wO9Z/izxvfQ+A5dV0LT7hrkxgXE
b4E2nBlJDvHycjg49OelcbN4Vln0+xe1utR8Y+EtXkRnDzbrqzmPHnxt2xkgg4A5DetAFy90bXNb
8Tv4Y16+STXLW1/tHRtetovJkQBgpSRV7bvT8zmug+GOnX8J1W616zvl8QiVbe7vLp96zqoyvlHA
GzB7fme294W8E6d4Veee3nvby9nULJeX03mylB0XPGAPSutoAKKKKACiiigCKR0iQySMqooyWY4A
rzHUXu/Fmpa9L4VddL1/RbmJDMQpF+oUlUkOPuHnAyR0J7Yo6340HiKRLG68NRX/AIbu7x7Uf6bs
nkEWd82wYxGpBySRjgkjIrO0n4YWEvjS8Oj3OradoMthBdWd7p92VUsx+7uOd2Rk+34igDMnsb/V
NOv/ABF4atdR0yUSmDxLoNsTG0jD77REgjJBPAGefXr7d4esrbTfD2n2llaSWttHAojglGHjGM4b
/a55981bt4Ft4I4UZ2CKF3SMWZsDGSTyT71coAKKKKACiiuWl8Z2I0vVr+1tL65bTJJI5LdISssh
TG4orY3KNw5oAXxzq+n6L4M1S+1S1N3ZiLy5LfOPN3kKFz2BLDntXjt9pupeHtF0/wAPeLLn7Pol
7cLcaRqNrKZm0uYcqjEgFlw2OPcg+mnJf+IdW8KnxVJdjxFoGoB11TQ4kwbWLPHlkchkAGe/fkcj
sfDvgOC1fTNQn1rU9RsLWIvp1jfoALbev8QxkkKcDONtAFjQvBusjxDba/4n1uLU72ygaCzWC3ES
IG+859WI/CuyS1gjuJZ0hjWaXHmSBAGfHTJ74q5RQAUUUUAFFUrqRre1llSF53jQssceNzkDoM8Z
NedeJvG+q3Pgm7l0ayaLVoowNSs1nDXOnIyn59o6nGD2x3wQcAGv4+1fVbFbK102c6dBOs0t7qxh
81bKGNQx46bmJAGe9eb2w1bxhdW2m6iLrTPG1nbrdabq0SbftELAsqzhMhDjjnocj1B07PwuRp8L
+FJ7rXfB+vhYL6yluAJbZjjMysejAj5ge/BBGMek+F/CVj4Qs54rSe7upp2DTXN3L5ksm0YUE8cA
cAUAYnwztLhNFu7q906/tdZluiuoy3zbmnkQY3KeBs7DAwOcZ616FRRQAUUUUAFU728g06wuL66k
EdvbxtLK56KqjJP5Ci+v7TTrSS7vbqG2t4xl5ZnCKv1J6V494xuh4w8YR+HtX1CfS9FubZjo95aT
hoL2U4wXboe42+/XkZAJZ/EQ8SX8994L87TPEVo32q40y9t1iOrQ7cAt3b5emTxu7cEYEulTXelH
X/DFrq8fh3UJzDrvh62YxyRyfdcRgjlecEDHpwMhe00nw3qXiIW8HiuyuLLWPD9wi2usWbhPtkY9
D1wR1HqexyK9SAAGAMUAU7G2gs7C3traEQwQxrHHEBjYoAAH4VdoooAKKKqXN1BZ2slzdTRwwRKW
eSRgqqB3JPSgC3XH614rl8P63s1kWtlo1xsgs71nZmads5DqBhVGOpI7c8nCar490q28J33iDSn/
ALYgtDtZbEiQqeOW54Azkn0rzi9u9Zbw5o+t61rEHiPQdeljt77TjEqCFpOnkkc5Q5HY5H4gA0PD
+/8A4SfxJ4e8Tzm38RauGax1JT+6ljMZRTADwrAEnjk5IzxXUeEPAM2kz2t5r9zZ6leWFvHaae0V
sEW2iQEZH+2c8n2q34V8Ft4fso7O/u49VisLhn0qSeEGW1jIxt3dz16Y/kB2tAFOO3gt3leKGNHm
bdIyqAXPTJ9T0q5RRQAUUUUAFeQ+OfEngXxIx0TULu7t5be42Qa1FATFa3A7CX69e3HUYBEOseNN
S0Dx1qWpae+o6z4ciIg1eNYSY7B1AB8pvUZyw/M9CM7TdK8Uz+CpvB+kabp2r+Hb7cbLWzOFWOJ3
3ZdPvF1JPoQR3xQBLbQ+JNd12y0i4uLfTfFGiO10l41r5tvqUTIIxOccbwMYz68YIIHpXh3wnpfh
vw+NLt4IpRIv+lyvGM3LkYZnHfPPH4VsaXZLpulWdkHMn2aBId5HLbVAz+lXqAIURYkVEUKqgBVA
wAKmoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKp319a6bZS3l7PHBbQqXklkbCqB3JoAuV5
T4p8X+MtL+Jdvo+j2ljd2k1n58FrOdjXBXO8K/Zxg8dMds1tJ49htvGaaHqlstrZ3yK+k6gsu+K7
BA4z0U5PA+nqM1vi54Xudd8Krd6ZFM2q6fJ5tuICRI6t8siAjnkHP/AaAOHTxHo/izxPBqmg6pN4
a8Yk/ZZI7mPzYLvBC7CRkHtzx0HHAI9G8L+Eb3TdYuvEHiDUxqWuXUawebHEI44Ygc7EX68k/wD1
87ei6Hpul6Tp0FtpcNqtrGDHEVDNCSPm+b15OT3rcoAKKKKACiimkgEAkZPT3oAUnAya8x8WePdL
nS/0a8stSTQJ92n3GuW+PKikZeg65Azgn14waPFnxBu7W81XT9P0W21CzsGjtbxZrjY9xJKOIYUA
JZsH+fHFUPCOhXWn3j6NZWsWqeCtUEnnW8squ2mzAfPExBIYbvl4zyM5yCSAYB8LajrXiiKzsrHU
rC4sLiJNM1qID7NBp0cZ2FCCBI7sckd93YAivatJ0ay0W2aGytoofMcyzGNAvmSH7znHc03QtEs/
Duj2+lWCyLa24Kxq7lyAST1P1rVoAKKKKACiiigDzzxF4j8S3fif/hFvCaWcV7FbC6u729yUhUnC
qqjOSfxqt4m0vV5IdHmstdtIPG1vG0620ThIb44AkBjJ5GBgMfTt2s+LfDWvw+I7bxV4SeF9SjhF
vd2U7bUu4gcgZ6A/l0HPGDDpGj+IPEHjqw8VeIdLi0WPTbeSG2s0nE0sjOCGZ2XjbgnA65oAg8Ie
F7fVLlvEJsJtLt9QVl1TQbu2DQyXCnHmKG6DOe3PtzXpqqqKFUAKBgADpT6KACiiigArI1fV7HQt
Pn1HUbhILWBdzu38vcnsK168d+JcmoaR4n07XdZsn1bwlaglbKE7RDcY+V5QeGGeh6DpjP3gDf8A
GXjlNF8KWd/ZtMj6rsS0vJID5Nvux88oOMYBJwRzjp1rkNZtfEsvmeEvEl99uh1hVi0zxBb2gJD7
g/kyqvRG2/lzyM41F1t4vDTS+LJBrl34mZBZaDZMHjWPsEPsOS2cZA5zzXceEvDLeFtLGnLqN1d2
6OzW63OCYIz0jBHUD/8AVgcUAVPCnhF9HuLnV9Xnt77xBdkCa8SARhECqqxoB0UBR9TXY0UUAFFF
FABRXOax4r03R9W0zS7gyvf6jJ5cMEEe9gO7sOyDuf8AA45fxHqGua948l8KaVrv9hrbWIuvNWIP
LcsxIwuf4V4zjnr+ABn698SbYa9eaZcGwOi28z2F1aSRtNeXz7fmWKJcALkgbm4POM9KoeE/Dv8A
bVg2l2sR1L4f6ksjxR3bbLnTJlJBQZyfvZxjPrnruteHtI1LxZa3s0l5aaX4i03UZbG91iysY2ku
1VQMq5xtODgkc8Dp0r0rQ9Is/D2kW2l2CstvADgu25mJOWZj3JJJJ9TQBNpthFpemW1hA0jQ20Sx
IZHLsVAwMk9TWhRRQAUUUUAFYHiPxRpHhLThfavdi3gZtifKWZ264AHJ71B4xsdfvtEf/hGr9bLU
43WVC6ArNtOfLJPQH1/DoTXllzrV/ruqweKre1lm1HQlaLWPDVyc+WpBV5YVPsT2z9e4A++8Rarq
3h+31PxnbWV/4L1hcl7FD5mmOSQpJ6kjoTzzkex6rw14GM9oI/EsGm65b2bKNIv5I900lvjKiTjk
DjHXv7GrPgzwnZWklxqml3E8fhzV4FnXRrmDCRSNyWw3QYxwPzIAr0OgBiqFUKoAAGAB2p9FFABR
RWdq2p2+j6Vc6ld7/s9tGZZPLUs20dcAdaADVdX0/Q7Fr7U7uK1tlYKZZWwoJOBXH+O/HL+GJrPT
rOWwhvryN5hc6hIVggjTqTjl2PQKvJP69Jp99pHi/QIby2aG90+4Addyg4IOeQejA/kRXm02h6lo
+uReG9dt21zTL6R/7H1a5thdS2MzZO2QN1A656cZ6ZAAKFpqK674hk17wMZG11YY21SwuITBb6pE
cKZEDE457nn9c+n+GfCumeF47v8AsyB7Zb2UTy2/mFo42I5CDoB/noABD4X8Jf2BLcX17qE2qavc
qsc17MgTCL91EQcKo9B1PNdZQAUUUUAFFFch478R3/hLwvcaxYaY1/NGQCv8MS93fHJA9vXsMmgC
/deK9GsvEtr4fuNQij1K6UtFATyR2yegJ5wOpxXIahq/irxF4s13S/DOsWelDRRGoimtxI91Iylu
c/dTtkA+teZeMdf0DxXdaX4gvLWbStQCLHdxg5M0Rxtnt5Bw7Rt24J6djXcaJ4Sl8RalKPEkV+mo
2kKLHr+mXBhj1O2YfJuI6tgc+3U9MgGf4X8ES+KLG416x1Z9HTVxLbavZw2ySBiHIkELkkorkE4G
cZ74Fe0WFlBpmn21japst7aJYYlz0VQAB+QpmmaZZ6Np8Gn2ECw2sC7Y416Af5zV+gAooooAKKYz
KilmYBQMkk9K81n+MOlR6gBHp2ovopuPsp1lY/8AR/Mz2Pce/wChoA7vV7+TTNIur6K0mvHt42kW
3hxvkx2Ga8n0qy1Xx54btPGml6vEvi2zlkWPYuxBHuJ+zSL06HOf9rnPWue1+/d/GerQa/qd3pOp
2d691BfNeNEgsl5jit0HDO/PJB79TkV6d4N8PwSzxeMPstxpV7qlqDdafG+ISxORIy4Hz4xzx1PH
JoATwR4WNleSeJTa3OkXOpwA3ujq4MCzZ5kA7E46dtxrvqKKACiiigAqNnVACzBQTgEnrUleK6Bo
Wn/E3UfEF/4nubmeWyv5LS3s0naNbONfusAD9488nOSpoA7vWtagu7688LabrA0/xFJa+bbO8WQM
91yMN05Azgc9jXm9sNS13X5JrQQ6P8SdIAW7hbi31GHjk44OQQfy9iMjTJ9H1bUp/B+o6/c6hc2d
1GfD+u2aNJNDuI+VmH8KnGcnHXBGBj2jwt4aTw7aS+deS6jqNw5kub64UeZKcAY9lAUAD2oAl8P+
G9P8OQ3P2C0jtZLyXz7lImPl+YQAdoPQeg4roaKKACiiigArhvEvja4sdWGg+HtLOta5t8yWBJAk
dunrI54BPYdf0z3NeLeNvC+teD59U8Q+E7q5j07UsHWLaAB5YxnLSxZ74LfTJPToAO1/VR4z8Ewe
M5bMtbaTFcebos6eZHJdcIrN/eVMlunT05ql4E8IQa/ZXemR3P8AangYFDE11E8Uv2kKpdoDgFV3
E57dQM8mtrwn4C0+aw07VPCvjLX00dyH+zeeCjDPzLjA2nOc8HnNeqxxpEgSNVRFGAqjAFADYo1h
iSJBhEAUAnOAKnoooAKKKKACvPPiho2r6xpmlrp2n/2paW14s17pomEf2lB0GT2B7f4V6HRQB4Lq
d7408L6FJrPmaHodv9qWOHw3aW8b/aGYhWViv8WOTjsO3SuhtPhu2heP7HXdG0uzl0u4YvcWlw3N
hIRnzIe34dugxwR1Vn8O/C+n+IZNeg0sf2g0hl8ySRnCuerKGJAPv27Yrr6ACiiigAooooAK858R
eNdYn1mfR/BFtY6lfWCNLfieQjZggCNRxljzznAqv438XanJEYvDmpxWdjFayXNxq6RC4Uur+Wtu
nbzGfjHX0rmdOXVPFOvebAi6D8Q9H2rekoTbX0Jx/rNuR0xx+XbaAL4e/t7V5NYuPBN1YRWmpyud
U0nVQ3mafcvxIwAHIODjPHGMccemeE/C1h4O0CHS9PB2qA8rknMkmAGfBPGcdOgrTtdNtLS7uLuK
1giu7kq1xLHGFaUgYGT1NalABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeVp8XPDG
pXmpaPrVhc2Vss72bS3cO+GQgkEPj7p9j+deqV4f410O7tfiEumW18tjo3jEpHeSGPeVlTOQnYM4
IGfVj6UAQXehW+jwJohWTXfAerzBbS4tm86bS52+7sIzlckf/ryG9R8JaZq2jaDFp+r6muo3EDMk
dxsKsY8/KGz1bHf+fU0vDPw/8P8AhK+nutGhuYXmjWNka4Zk474Pc8c/ljmuzoAKKKKACiiigDL1
q6u7HRry60+yN7eRRForYPt8xh0Ge1fPkMj+LJtO1DT7i/1Hx7Ne+dKrM0EOmRxtyjDoE6D1P14P
0vXnHiz4fXt9ria94X1P+xtXlHk3kiD5Z4jwSR/fHUH2HIIBoA5fR9G1Dxl4w1HWBcx+H/E2kz/Z
Lua1iW5gnypAZQ/RwuRnnjHA5r1Tw5oFr4a0G30m0eR0i3M0khy8jsSWY+5JJpPDHhvT/Cujx6dp
6NsBLySucvM56ux7k1uUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFVbm1hvLaS2uIklglUo8brl
WU9QRVqigDiPCXw80Hwbf3d5YRyS3EzERNMdxt4ic+WnoM5Pqa7eiigAooooAKKKKAPB/Eg8Q/Dn
xRqeoGW3uIvEEiww67dKS2nZPKsACMAHgcA7QexFd3c/D/Q9c0bSodTnutRuLOICLVPPKzyA8/fX
qDnjrx37nsNR0601bT57G+hSa1nQpJG4yCKg0TR7PQNIttLsEZLW2TZGrMWOOvU0AR6JoenaDpMW
m6ZbLbWsWcICSST1JJ5JPqea2KKKACiiigAooooAK5q88JaXe+J7HxG0Ukep2qsoliOzzVIxh8fe
x2/qOK6WigAooooAKKKKACkIBBBGRS0UAeU6p4V8QeCddl1bwHAlxZ6i+y70uQ4jikPCyr6AHr6D
26dV4P8ADUvhy3uZr6/lv9Wv5BNe3Tn5WfHCovZQOB/kDrKKACiiigAooooAKYyq6lWAKkYII60+
igDyz/hWEVvrc1pbw2lz4Tv973Wn3Od1nLjh7cjlc59sD14x6Jpum2uj6bb6dZRiK1t4xHEgJOAK
v0UAFFFFABRRRQBm6zpNtrmkXWmXvmfZrmMxybHKsAfQivEZ9Mv9J17RPA/i7UwvheKYyWFykW0X
hBGyKVs/LjJ/Mc8gj6ArOvdPstRSNL21huEikWVFlQMFdejDPcUAOutMsL2WKW8sba4kiOY3liVy
n0JHFX6KKACiiigAooooAK4HW/hyt3r767oWs3Wh6pMu25ktkDJP7shIGff+vNd9RQBy3hHwfaeE
rS4EU013e3Unm3d5PgyTN/QDsK6miigAooooAKKKKACkIBBBGRS0UAVra1gs7dLe1hjhhQYWONQq
qPYCrNFFABRRRQAUUUUAFFFFABRRRQAUUUUAct4r8UW3hTTxcSxyXV7cN5VnZRAmSeU9FA9PU/8A
1hXJeDb6/wDG3hjW45/El3a63czsJbeNPLbTCDhURTztIAye/PQ5NelyQRSyRvJEjPExaNmAJQ4x
kenBNcZ4k8C3E3iK18T+GLqPTtcjdUnZwTFcxZAYSKOpx39vXBABzHhjSBq2gXfwz8RWE+nX2mhZ
oruzBVJ1DfJMrYxuz1z1+oIHpHhrw3aeGdMNnbzT3DySGae5uX3yzyHqzt3PA/KtpQcDON2OSBT6
ACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACqctrBPLC80EbvA2+JmUEo2MZHp
wSKuUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUU
UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUU
UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH//Z
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-23" NO="23" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-24" NO="24" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-25" NO="25" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-26" NO="26" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Near maximal blood pressure lowering efficacy of ACE inhibitors</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-27" NO="27" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot of near maximal change in trough SBP for ACE inhibitors at 1/2 Max and higher doses</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-28" NO="28" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Funnel plot of near maximal change in trough DBP for ACE inhibitors at 1/2 Max and higher doses</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-29" NO="29" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Post-hoc tertile analysis of the effect of trial size on reported trough BP lowering</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a
HBwgJC4nICIsIxwcKDcpLDAxNDQ0Hyc5PTgyPC4zNDL/2wBDAQkJCQwLDBgNDRgyIRwhMjIyMjIy
MjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjIyMjL/wAARCAF1A4QDASIA
AhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQA
AAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3
ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWm
p6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEA
AwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSEx
BhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElK
U1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3
uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3+iii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK53VfGvhjQ7z7Jqeu2Nt
cd4nlG4fUDp+NXv7b0r+yDq39o2p08LvN0JQYwOmd3SgDUormo/iB4PldUTxPpJdjgD7Wgz+tXtS
1zS9Hs47zUtQtrS2kYKks0gVGJGRgn2BoA16K5+x8Z+GdTuVtbDXtNubhzhYorlCzfQZ5roKACii
igAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiisLUvF/h3R7s2mp63YWdyAGMU86ow
B6HBNAG7RWZpmu6VrcTSaVqVpeov3jbzK+364PFZ11458K2NzLa3XiHTILiJikkUlyqsrDqCM8UA
dJRWZYa3pmq2bXen6ha3Vsud0sEodR9SOlZY+Ifg1iAPFGk5J73aD+tAHT0VVt7iG7gSe2mjmhcb
kkjYMrD1BHWrVABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFF
FABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAVgeIfFei+F7MXOs6hFao2dgbJZ/91Rya3657V/D2jXd3/bd7
pEF7f20BWEypvIAy2FB4ByTzjNAHBP8AHvQzJ/oeh63dW4P+uSFQD9Bn/Cuk8NfFXwp4pnS1tb5r
e9c4W1u08tyfQdQT7AmuNt/jpdSW0r23gPUHt7clZGilJSMjqCRHgYqsPiN4c8UXdg/ifwLNa2dz
KqwanKm5Q2eCH2qcZ9CfpQB7rRRRQAUUV57418cX+ja9YeHPD+lpqWvXsZlEckuxI4xnknjrtPcd
PpQB6FRXF+BPGZ8X2F59osTY6nYXBt722Lbgjj0PpwfxB+tdpQAUUUUAFFFFABRRRQAUUUUAFFFF
AHzpe6Xe+DPEniC68Q+Bh4i0/ULp5kvxH5jRoxJ9Dt6/7JyOuMVpWzeGT8EvFB8LXd+9sw3zW18w
L27krxwMYIA9c465zWzFovxK8I6rqcegPZaxpt3M00P9oTMXhJ6DlgeBgdSDjPHNR6d8N9dsvh/4
ntbmW2k1vXnErxxttijO7OM4x3b26D3oDqedve+Hz8N1g/4V7ffbzZBf7XNsVj34/wBbvHUd/et7
xskMX7PXhVFvo75I7uMGaMkqfllyozg/L93t0rds9G+Llr4Yj8OQ2+gx2a232USFyXCY25zkjOD6
fhTta+Fmrj4S6R4a02SC5vbe/F1cM77EOQ+dpPYbgPfrQBx3ihvDXiyTTLHwD4XvbbV1uVc3EdsY
VRMHrgnvg54xjrX0xGGWNQ5ywABPqacowoHoKdQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAV4pquj6drn7RhstUsobu2OlBzFMu5cgcHFe115F4o8L+No/ic3irw1Bp8o+xrbr9
rkwOnzccUAZuo6PY+BPjZ4ZOgRfZLbVY2hubaMnYRyM49Pun6rmuVtrjSLX4k+NTqvhC78Rhr9vL
W3t/N8n53yT6Z4/KvRvD3g/xRqXjC38VeNrqyNxZxmOzs7QErHnPJ/MnuenIxisiDwv8SPDvjLxH
qvh210h4NVu2kzdSEnYGYrwCMfeNCAofCw2UmseMp7SL+y45Yv3eiuT5kSgH5yDjjnHtuxxxnivB
eq+B7bwVdWeueH59Q1aSSTypIrfJwVG0B88c5r1bwp4L8Rf8JPrHifxRNZnVLy0NrDBafcUEAZP/
AHyB375NbPwm8Kan4Q8HyabqyRLcm7eUCNw42kKBz+BoArfBXStS0j4dwwapDLC7zySwxSjDJG2M
cHpk7j+NekUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU
UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQ
AUUUUAFFFFABRRRQAUUUUAFFFFABWfqdvNd6VeW9vL5U0sDxxyf3GKkA/gea0K888c6H4/1XVreX
wnrttp1okIWWOViCz7jz9xu2KAOJ8N+Otd8BeH4vC+oeCNRlvbPckUlup2TZJOchTnr1Gc1nv4a8
XTeAbLw6+kOk+u6vJePGEO2whGw89kycnB7cYyTTdHX4s654h1jRrbxfAlzpDqk7SNhGLZxtxGSe
h6gV654E0zxVpel3MPivVIdRvGn3RSRHIVNo4+6vfNAHWgYUDrgU6iigArx7UCLX9pfTpLhgiT6W
RCWOATtfj9DXsNcz4o8FaJ4vhij1i1MphJMUsblJEz1AI7GgDyXw9Z+ItX1T4jzeEL6K3uJtUjEc
5bCuA8pYK2CM8jn0+tYnilvi54N0tdT1fxBKtu0qwgxXCudxBI4x7GvoDw/4d03wxpSafpFqILdW
3EZJLMerMTyTXAftD/8AJOIf+wjF/wCgPQBx2laR8ZtZ0q01O015jbXUSzRlrpQSrDIyMe9XP+EW
+OX/AEHf/Jxf8K9Z+Hf/ACTjw5/2Dof/AEAV01AHgH/CLfHL/oO/+Ti/4Uf8It8cv+g7/wCTi/4V
7/RQB8s6FqnxT8R+Ib/QtP8AEU7Xthv84POqqNr7Dg455NdP/wAIt8cv+g7/AOTi/wCFJ8H/APkt
XjH/ALef/SgV9AUAeAf8It8cv+g7/wCTi/4Uf8It8cv+g7/5OL/hXv8ARQB4B/wi3xy/6Dv/AJOL
/hR/wi3xy/6Dv/k4v+Fe/wBFAHgH/CLfHL/oO/8Ak4v+Fcz4r1T4qeDJ7KLVvEM6velhD5U6vnaR
nPHH3hX1LXgX7Rf/ACF/Cn1m/wDQo6AGf8It8cv+g7/5OL/hXms/xL8dW88kL+Jb3fGxVsODyOPS
vsodK+DNU/5C97/18P8A+hGgDpP+FqeOv+hmvv8Avof4Uf8AC1PHX/QzX3/fQ/wrj6KAOw/4Wp46
/wChmvv++h/hR/wtTx1/0M19/wB9D/CuPooA7D/hanjr/oZr7/vof4Uf8LU8df8AQzX3/fQ/wrj6
KAO5s/iP49vr23tYfEl75s8ixIC4A3McDtXo/wDwi3xy/wCg7/5OL/hXi3hn/katH/6/YP8A0MV9
0UAeAf8ACLfHL/oO/wDk4v8AhR/wi3xy/wCg7/5OL/hXv9FAHgH/AAi3xy/6Dv8A5OL/AIUf8It8
cv8AoO/+Ti/4V7/RQB4B/wAIt8cv+g7/AOTi/wCFH/CLfHL/AKDv/k4v+Fe/0UAeAf8ACLfHL/oO
/wDk4v8AhXMa7qnxT8OeIbDQtQ8RTre3+zyQk6sp3PsGTjjkV9TV8/8Axg/5LV4O/wC3b/0oNAC/
8It8cv8AoO/+Ti/4Uf8ACLfHL/oO/wDk4v8AhXv9FAHgH/CLfHL/AKDv/k4v+FH/AAi3xy/6Dv8A
5OL/AIV7/RQB4B/wi3xy/wCg7/5OL/hR/wAIt8cv+g7/AOTi/wCFe/0UAfN2vWfxi8N6Lc6xqGvu
trbAGQpdKxGSF6Y9SKZ4dt/jD4q0WHV9M16RrSYsFMlyqnKkqeMeoNetfGP/AJJPr3/XOP8A9GpV
P4Gf8kn0v/rpP/6NagDxHxR4o+Jfg/V/7L1XxFcrc+WsuI5Q42nOOcexrE/4Wp46/wChmvv++h/h
XS/tBf8AJS/+3GL+bV5VQB2H/C1PHX/QzX3/AH0P8KP+FqeOv+hmvv8Avof4Vx9FAHYf8LU8df8A
QzX3/fQ/wo/4Wp46/wChmvv++h/hXH0UAdh/wtTx1/0M19/30P8ACj/hanjr/oZr7/vof4Vx9FAH
uGi6f8Y/EOj2urWHiB2tblS8Ze6VWIyR0x7Vof8ACLfHL/oO/wDk4v8AhXpXwk/5JVoH/XBv/Q2r
taAPAP8AhFvjl/0Hf/Jxf8KP+EW+OX/Qd/8AJxf8K9/ooA8q+H+h/Eiw19p/FWsRz6b5TKYWlEjM
3GCMDjHrmvVaKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooo
oAK898d+LPGGgarb2/h3ws2rWzwB5JgjttfcRt+X2AP416FRQB846FrHxF0PxJretxeBbmSbVXR5
Y3hkCx7c/d/OvYvA2veINd0q5uPEWiHSLmOfZHEVZd6bQd3ze5I/CusooAKKKKACql5e22nWU15d
zJDbwoZJZHOAqjqTVHWfEmjeHjC2sajbWSzEiMzvt3EYzj8xXAfEnSG8Y+FrnWbTXy3h6206a4W2
tTlbmZNxUs390EDjnkdutAHo2lapZazpsOoadcLcWkwJjlXOGAJHf3Brzf8AaH/5JxD/ANhGL/0B
6Twx4rh8FfA3RdYuLWa6jRNgjiIBJaR+ST0FebfEX4uWnjnwzHpMOkT2rrcpP5jzBgcBhjAA/vUA
e/fDv/knHhz/ALB0P/oArpq5n4d/8k48Of8AYOh/9AFdNQAUUUUAfP8A8H/+S1eMf+3n/wBKBX0B
Xz/8H/8AktXjH/t5/wDSgV9AUAFFFFABRRRQAV4F+0X/AMhfwp9Zv/Qo699rwL9ov/kL+FPrN/6F
HQB76OlfBmqf8he9/wCvh/8A0I195jpXwZqn/IXvf+vh/wD0I0AU6KKKACiiigAooooA1/DP/I1a
P/1+wf8AoYr7or4X8M/8jVo//X7B/wChivuigAooooAKKKKACiiigAr5/wDjB/yWrwd/27f+lBr6
Ar5/+MH/ACWrwd/27f8ApQaAPoCiiigAooooAKKKKAOF+Mf/ACSfXv8ArnH/AOjUqn8DP+ST6X/1
0n/9GtVz4x/8kn17/rnH/wCjUqn8DP8Akk+l/wDXSf8A9GtQB43+0F/yUv8A7cYv5tXlVeq/tBf8
lL/7cYv5tXlVABRRRQAUUUUAFFFFAH2V8JP+SVaB/wBcG/8AQ2rta4r4Sf8AJKtA/wCuDf8AobV2
tABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUU
AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA
VQ1KWe30u8ntY/NuI4HaJMfeYKSB+JxV+szVTP8A2TefZpVin8h/Kkc4VG2nBP0OKAPGfC+hfELx
nocOuJ8QHt/tBYmGME+WQSNpAwAfbtXqHgrQ9b0HTLi313Xn1m4ebekzgjYuANvJPcE/jXhnhLwb
4I1nRVv9Z8cyWmqyyObuE3kUZD7iP4s7s9d2SDmvZvhxoeh6Bot1b6FrR1a3kuC7zGdJdjbQNuU4
HAB/GgDtqKKKAMbWfDejeITCusadbXqwkmMTpu2k4zj8hVXVPDsLeCdR0DSYILVJrOaC3jA2xozq
3p2yc10dFAHK+CvD8/h/wNp2h6iIJZreNkl2fMjZYnuOeo7Vw/x8srS3+HkLw2sEbnUIxuSMKfuv
6V7FXkv7Q/8AyTiH/sIxf+gPQB2nw7/5Jx4c/wCwdD/6AK6auZ+Hf/JOPDn/AGDof/QBXTUAFFFF
AHz/APB//ktXjH/t5/8ASgV9AV8//B//AJLV4x/7ef8A0oFfQFABRRRQAUUUUAFeBftF/wDIX8Kf
Wb/0KOvfa8C/aL/5C/hT6zf+hR0Ae+jpXwZqn/IXvf8Ar4f/ANCNfeY6V8Gap/yF73/r4f8A9CNA
FOiiigAooooAKKKKANfwz/yNWj/9fsH/AKGK+6K+F/DP/I1aP/1+wf8AoYr7ooAKKKKACiiigAoo
ooAK+f8A4wf8lq8Hf9u3/pQa+gK+f/jB/wAlq8Hf9u3/AKUGgD6AooooAKKKKACiiigDhfjH/wAk
n17/AK5x/wDo1Kp/Az/kk+l/9dJ//RrVc+Mf/JJ9e/65x/8Ao1Kp/Az/AJJPpf8A10n/APRrUAeN
/tBf8lL/AO3GL+bV5VXqv7QX/JS/+3GL+bV5VQAUUUUAFFFFABRRRQB9lfCT/klWgf8AXBv/AENq
7WuK+En/ACSrQP8Arg3/AKG1drQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA
UUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABR
RRQAUUUUAFFFFABRRRQAUUUUAFU7tYXs51uSBA0bCXJwNuOefpVys7WVtn0PUFvHKWrW0gmYdQm0
7j+WaAPAJ9R+BUE7xro19MFOBJG0+0/TMgNeo/C648I3eg3jeDbOe1shckSpMWJMm1efmZu2K8x8
EePZ9H8Mw2Ft4AuNWtYGdYb6C3K+cu48t8jDdzzzXr3gXxBL4i0q5uZfDs+hGOfYIJk2l/lB3fdX
1x+FAHX0UUUAFec+LrDxvrviaz0vRr99G0QRGS41KLa0jSc/KFyGx09ByeTjFbnjDR/EmrR2g8O+
IV0d4yxmJgEnmA4x16Y5/OvLfiD411jQrCw8Fz6y0moSRbtU1aKLDrGzHARARg7evTjHIycAHUfD
PxPqlxceI9K17VIb2LRblYU1JyEEgJYYJzg/d69eeSeKzPjxrOl3/gCGG01KzuJBfxtshnV2xtfn
ANR+FdJ8FeO/Atx4S0V9Rht7SSO4uLh4wkkkhz8x6g5weOwxjpXHfEz4S6V4G8KJq1lqF7cStdJB
sn27cEMc8Af3RQB7t8O/+SceHP8AsHQ/+gCumrmfh3/yTjw5/wBg6H/0AV01ABRRRQB8/wDwf/5L
V4x/7ef/AEoFfQFfP/wf/wCS1eMf+3n/ANKBX0BQAUUUUAFFFFABXgX7Rf8AyF/Cn1m/9Cjr32vA
v2i/+Qv4U+s3/oUdAHvo6V8Gap/yF73/AK+H/wDQjX3mOlfBmqf8he9/6+H/APQjQBTooooAKKKK
ACiiigDX8M/8jVo//X7B/wChivuivhfwz/yNWj/9fsH/AKGK+6KACiiigAooooAKKKKACvn/AOMH
/JavB3/bt/6UGvoCvn/4wf8AJavB3/bt/wClBoA+gKKKKACiiigAooooA4X4x/8AJJ9e/wCucf8A
6NSqfwM/5JPpf/XSf/0a1XPjH/ySfXv+ucf/AKNSqfwM/wCST6X/ANdJ/wD0a1AHjf7QX/JS/wDt
xi/m1eVV6r+0F/yUv/txi/m1eVUAFFFFABRRRQAUUUUAfZXwk/5JVoH/AFwb/wBDau1rivhJ/wAk
q0D/AK4N/wChtXa0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQA
UUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABR
RRQAUUUUAFFFFABVDUYmm026iWJZmeF1Eb9HyDwfY9Kv1xPivQ/E97cQ6j4X8RPp95FHsa1nQPbz
jJOSMHa3PXB7DigDz/w43xi8M6RFpVn4a02W0hJEKzzITGpJO0ESjIGe+T716Z4LvPFl9pc8ni3T
bWwvVmxFHbMGVo9o5OHbnOe9cWde+NFm32eTwvpF43QTxyAA/wDkQfyFXdO0X4ma9dRyeJNcttGs
FYM9ppajzX9t/O38GP0oA9RooooAKge2gkYs8MbN6sgJqeuE8X/EG38Napa6TbaZfatq9xH5qWdo
uWCc/Mevoex6dqAO1jhihz5caJnrtUDNeV/tD/8AJOIf+wjF/wCgPXY+DvGdj4z0yW7s4p7eWCTy
ri2nXDxP6H/P5Vx37Q//ACTiH/sIxf8AoD0Adp8O/wDknHhz/sHQ/wDoArpq5n4d/wDJOPDn/YOh
/wDQBXTUAFFFFAHz/wDB/wD5LV4x/wC3n/0oFfQFfP8A8H/+S1eMf+3n/wBKBX0BQAUUUUAFFFFA
BXgX7Rf/ACF/Cn1m/wDQo699rwL9ov8A5C/hT6zf+hR0Ae+jpXwZqn/IXvf+vh//AEI195jpXwZq
n/IXvf8Ar4f/ANCNAFOiiigAooooAKKKKANfwz/yNWj/APX7B/6GK+6K+F/DP/I1aP8A9fsH/oYr
7ooAKKKKACiiigAooooAK+f/AIwf8lq8Hf8Abt/6UGvoCvn/AOMH/JavB3/bt/6UGgD6AooooAKK
KKACiiigDhfjH/ySfXv+ucf/AKNSqfwM/wCST6X/ANdJ/wD0a1XPjH/ySfXv+ucf/o1Kp/Az/kk+
l/8AXSf/ANGtQB43+0F/yUv/ALcYv5tXlVeq/tBf8lL/AO3GL+bV5VQAUUUUAFFFFABRRRQB9lfC
T/klWgf9cG/9Dau1rivhJ/ySrQP+uDf+htXa0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWe+oWcd9HYyXcC3Ui7kgMgEjAdwvUjg81oV5P4il
ig/aG8MSTSJGg0uXLOwAHEtAHqiyRszKrqWXggHkVR07V9O1ZJn069gulhkMUphkDbHHVTjvXmnw
9vbSL4nfECSS5hRHuYtjGQAN9/pU3wOIOl+JiCCDrcxBHfhaAPV6KKKAOR8YeM/+EQjtH/sXUdT+
0Fxiyj3mPbj731z+lUk1y18WaUi6bdQ6J4mu7ctAl1Ej3VugYgkoecEA/nXd1xHi74e6f4svrbUf
td5p2qW6lI72zfa5Xn5T+Z9OpoA868LXviHSdC8VaF4asobrxNp+ohrq8Zt/2sMzAuAxwGG3p05J
65rj/iFqXxLvPDyJ4vsvI00XClWMMa/vMNjleema+gvCPgrTPB2nTW1kZZZp5PMuLqdt0kzep/M8
e59a4/8AaH/5JxD/ANhGL/0B6AO0+Hf/ACTjw5/2Dof/AEAV01cz8O/+SceHP+wdD/6AK6agAooo
oA+f/g//AMlq8Y/9vP8A6UCvoCvn/wCD/wDyWrxj/wBvP/pQK+gKACiiigAooooAK8C/aL/5C/hT
6zf+hR177XgX7Rf/ACF/Cn1m/wDQo6APfR0r4M1T/kL3v/Xw/wD6Ea+8x0r4M1T/AJC97/18P/6E
aAKdFFFABRRRQAUUUUAa/hn/AJGrR/8Ar9g/9DFfdFfC/hn/AJGrR/8Ar9g/9DFfdFABRRRQAUUU
UAFFFFABXz/8YP8AktXg7/t2/wDSg19AV8//ABg/5LV4O/7dv/Sg0AfQFFFFABRRRQAUUUUAcL8Y
/wDkk+vf9c4//RqVT+Bn/JJ9L/66T/8Ao1qufGP/AJJPr3/XOP8A9GpVP4Gf8kn0v/rpP/6NagDx
v9oL/kpf/bjF/Nq8qr1X9oL/AJKX/wBuMX82ryqgAooooAKKKKACiiigD7K+En/JKtA/64N/6G1d
rXFfCT/klWgf9cG/9Dau1oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKA
CiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACvMfiT4N8H63e2eq+JtauNPZYxbQiOZEEnJbABUkn5u3avTq8S8fto5+
MmhDxYyroaaczxGUkRebubrj6L/47mgDD8TfDn4W+ErmO21fxBrMVzIAwijZJGC+pAjOB9a9Q+Ge
g+HND8NufDOpTahp93MZvNldWIbAUjhVx06EZrzbwPb6N418ZeLfGXiKK3k0iN/Kga9x5aqeBnPA
IRV/76rpfgSEGj+IhZ7zpQ1V/sZb+7tHr/s7KAPXaKKKACiq891b2wBnniiz08xwufzrhPHniK5m
S08LeGrhDrmsgqkqHItoOd8pI6cAge+ccigDuILmC6QvbzRyqCVLRuGAPpxXmH7Q/wDyTiH/ALCM
X/oD1k/CfxJpvg74UXmo6pLItumqyRAxpuZmKpgAfga5/wCK3xS8OeM/CMem6ULz7St2kx86EKNo
Vgecn1FAHtXw7/5Jx4c/7B0P/oArpq5n4d/8k48Of9g6H/0AV01ABRRRQB8//B//AJLV4x/7ef8A
0oFfQFfP/wAH/wDktXjH/t5/9KBX0BQAUUUUAFFFFABXgX7Rf/IX8KfWb/0KOvfa8C/aL/5C/hT6
zf8AoUdAHvo6V8Gap/yF73/r4f8A9CNfeY6V8Gap/wAhe9/6+H/9CNAFOiiigAooooAKKKKANfwz
/wAjVo//AF+wf+hivuivhfwz/wAjVo//AF+wf+hivuigAooooAKKKKACiiigAr5/+MH/ACWrwd/2
7f8ApQa+gK8A+MHPxq8Hf9u3/pQaAPf6KKKACiiigAooooA4X4x/8kn17/rnH/6NSqfwM/5JPpf/
AF0n/wDRrVd+Mf8AySfXv+ucf/o1KpfAz/kk+l/9dJ//AEa1AHjf7QX/ACUv/txi/m1eVV6r+0F/
yUv/ALcYv5tXlVABRRRQAUUUUAFFFFAH2V8JP+SVaB/1wb/0Nq7WuK+En/JKtA/64N/6G1drQAUU
UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFc/4i
8J6F4qgji1vTortYiTGWJVkJxnDKQRnA710FFAHJT+CPDs/hR/DS2CwaY7K7RQEqSQwbO7qTwOeu
K1tH0fTdBsItP0u1S1tYgdscY79ye5PuarrrMreM5dD8lfJTT0u/NzySZGTbj/gOadZaxJc+KtV0
hokWOyt7eZZATljIZMg/TYPzoA3aKKKAOZ8UeCNB8Yx2ya5avcC2LGILKybd2M/dIz0FcnJ8FdFX
UPtel6vrOlERCFEtLnG1R23EFsE89a9SooA8e+GXwym0vSNQi8SwSyi4lZf7NuJElg2gqVl2jI3n
BGfasz43eEvD2h+BorvStGsrO4N9GhkgiCkqVfI4+gr3SvJf2h/+ScQ/9hGL/wBAegDtPh3/AMk4
8Of9g6H/ANAFdNXM/Dv/AJJx4c/7B0P/AKAK6agAooooA+f/AIP/APJavGP/AG8/+lAr6Ar5/wDg
/wD8lq8Y/wDbz/6UCvoCgAooooAKKKKACvAv2i/+Qv4U+s3/AKFHXvteBftF/wDIX8KfWb/0KOgD
30dK+DNU/wCQve/9fD/+hGvvMdK+DNU/5C97/wBfD/8AoRoAp0UUUAFFFFABRRRQBr+Gf+Rq0f8A
6/YP/QxX3RXwv4Z/5GrR/wDr9g/9DFfdFABRRRQAUUUUAFFFFABXlXxN+GGo+NtesNV07VIbOW1h
EWJQ3BDFgykd+f0r1WigD5//AOFJ+Pv+h4/8mZ6P+FJ+Pv8AoeP/ACZnr6AooA+f/wDhSfj7/oeP
/Jmeud0PwN4y1vxLrehw+LJo5tIdFlke5m2ybs/d/LvX1FXlPw8/5K78RP8ArvB/7PQByv8AwpPx
9/0PH/kzPR/wpPx9/wBDx/5Mz19AUUAfPc/wP8bXUDQ3PjCOaJ+GjkmmZSPcGvWvAfhh/B/g+y0W
W4W4lh3s8irgEsxbj2Ga6qigDw/4q/CvX/F/i5NW0hrRoTbJEyzS7CrKT7HPUVwf/DP3jf8Au6d/
4E//AFq+rKKAPlP/AIZ+8b/3dO/8Cf8A61H/AAz943/u6d/4E/8A1q+rKKAPjrQPhb4j8Rz6lDp4
tC2nXLWs/mTbfnGc445HFbP/AAz943/u6d/4E/8A1q9W+Dn/ACFPHX/Ybk/m1erUAfKf/DP3jf8A
u6d/4E//AFqP+GfvG/8Ad07/AMCf/rV9WUUAc34G0S48OeC9K0e6dGuLWHbIUOVySTwfxrpKKKAC
iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKK
KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArK1
fSrXWtNl0+983yJdu7ypWjbggj5lII5ArVooA8nX4a6KfH0tubfUxYjTEkEn26fmTzWBG/dnoAcZ
98V0XhrR10bxfrdvbQzrZrYWSQyTMz7iGnJG9skkbh3PUV21FABRRRQAV5p8SvF2uaJrGg6N4cns
ob3UDK0j3gHlqqgYyT07/lW/4uXxk8Vp/wAIjJpiOC32j7cDgjjbtxn3rzfxLDoNx4p8Pw/E2OZd
QazcNc283l2B+dyBx8+eRk5A6dqAPQfAsviy4trqbxTc6ZcI5Q2j6ewKkfNuyR17frXMftDf8k6g
5/5iEf8A6A9cd4T8MnxYfGfh/QdWurTw39qjezuAGdd4J+XkgsCOvOeFJ9+f+IfwnvPBPhxNVuNe
+3o1wsIj8krgkMc5LH0oA+hfh3/yTjw5/wBg6H/0AV01cz8O/wDknHhz/sHQ/wDoArpqACiiigD5
/wDg/wD8lq8Y/wDbz/6UCvoCvn/4P/8AJavGP/bz/wClAr6AoAKKKKACiiigArwL9ov/AJC/hT6z
f+hR177XgX7Rf/IX8KfWb/0KOgD30dK+DNU/5C97/wBfD/8AoRr7zHSvgzVP+Qve/wDXw/8A6EaA
KdFFFABRRRQAUUUUAa/hn/katH/6/YP/AEMV90V8L+Gf+Rq0f/r9g/8AQxX3RQAUUUUAFFFFABRR
RQAUUUUAFcX4qT4gtqSf8IvJoiWHljd9tD+YXyc9OMYxXaUUAeXeV8af+fjwv+T/AOFYWk+Dviro
2u6trFpceHfteqMr3G9nK5XONo28dTXt1FAHl3lfGn/n48L/AJP/AIV2PhgeI10kDxO1i2oeYebH
ds2ds7u/Xp7V0FFABRRRQAUUUUAcF4l8Ban4g1iS/tfGmtaXEyqotbWQqi4GMjDDr1rI/wCFS63/
ANFL8Sf9/m/+Lr1SigDyGz+DF5p7ztZePNctmuJPMmMJKGRv7zYbk+9Wv+FS63/0UvxJ/wB/m/8A
i69UooAxvDmlz6Lo0NhcaldalIhbN1cnLtkk8/TpWzRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXj3xPOq+IPH/h/wXY6nNp9tdwPc
XEkRILAbjzgjOAhwPU17DXl3xC8B+IfEHiux1/QNbt9MltLUwCR2ZXBLNnBAPBDYoAzPh4mreE/i
Pqngq91WXUbFbQXdu8pJK8r0BJx945HsDXslfPl38N/G2l6v/bd94+060vpYxB9rmuGRnX+7kgZ6
CvU/AOk+INI0eePxFrKatPLN5kM6OzARlQMZIHcE/jQB2FFFFABWZq2h6XrlqLfVtPtryEHcEnjD
AH1Geladcn4o8daN4Ot4JNUeVprjIhtrdN8smMZwOOORycUAdBp2m2WlWaWlhaQWtun3YoYwij8B
XmP7Q/8AyTiH/sIxf+gPXX+FfGeleMdOkvNKMuYn8uaGZNskTf7QyfzGf0rkP2h/+ScQ/wDYRi/9
AegDtPh3/wAk48Of9g6H/wBAFdNXM/Dv/knHhz/sHQ/+gCumoAKKKKAPn/4P/wDJavGP/bz/AOlA
r6Ar5/8Ag/8A8lq8Y/8Abz/6UCvoCgAooooAKKKKACvAv2i/+Qv4U+s3/oUde+14F+0X/wAhfwp9
Zv8A0KOgD30dK+DNU/5C97/18P8A+hGvvMdK+DNU/wCQve/9fD/+hGgCnRRRQAUUUUAFFFFAGv4Z
/wCRq0f/AK/YP/QxX3RXwv4Z/wCRq0f/AK/YP/QxX3RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQ
AUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAB
RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFF
FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXjPxJ0yfxf8AEnw74QuL6a206a1kuZRCeWI3dun8
AxnOMmvZq8u8e+AfEviDxhp+veHNXttOmtLUwB5GYOCS2cYU8YbFAHCeGPh7beJvF+t+Htf1O+vb
Lw8ot7L95tZVdmI9emOn9ABXb/AyWdfCuqadNM8qafqctvEWPRQF4/PJ/Gubs/hR8SdP1G81C18X
2cV3elTczLJJulx0z8nua7z4YeDdT8GaRqFrqt5b3dzd3jXJkhLEHKqDnIHOQaAO9ooooA5bxb45
0bwVHavrD3CrdFhH5MRf7uM59Oorx/V9e1HxT8YNGvvCiQSyzaafsLaghVIh+83OV9Rhsde1fQ5U
HqAfqK4bxn4CPibUbHWNO1WbSNasVKQ3cSbsqTnawyPU/wDfR4NAHF6V4213SrTxRbw+FbC48Vaf
cxi7awgIF0rFv3jBfmYj/wBnzxzXCeP/AB14w8TeHI7HXvDf9nWYuFkE/wBmljy4DALlzjuePavd
PBngceEWvrqbUJtT1XUZBJd3kq7SxGeAOcDk9/5AVzf7Q3/JOIP+wjF/6A9AHafDv/knHhz/ALB0
P/oArpq5n4d/8k48Of8AYOh/9AFdNQAUUUUAfP8A8H/+S1eMf+3n/wBKBX0BXz/8H/8AktXjH/t5
/wDSgV9AUAFFFFABRRRQAV4F+0X/AMhfwp9Zv/Qo699rwL9ov/kL+FPrN/6FHQB76OlfBmqf8he9
/wCvh/8A0I195jpXwZqn/IXvf+vh/wD0I0AU6KKKACiiigAooooA1/DP/I1aP/1+wf8AoYr7or4X
8M/8jVo//X7B/wChivuigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK
KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoo
ooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiii
gAooooAKKKKACmkhQSTx706svWY0l0PUIpJTEj20itIBkoCpGfwoA52f4reCLeZ4pPEdrvU4OxXY
fmARW5oHiXR/E1rLdaLfJeQRP5buikYbAOOQOxFeBeC/EPwpsfDdvba7pKSalEWWad7VpRN8xwwP
YYxwQPpXsfw91Hwnqek3UvhC2S3slnKyqkBiBk2r2PXjFAHaUUUUAFFFeZfEPwLo2otd+KNV1vVr
GG1tgZEtJFVcLnoCPvHOPrigD02vJf2h/wDknEP/AGEYv/QHqr8NbO28EeDbjxV4g1SaCHUijxJc
uz+XFk+WOBkuwOeB0xx1rA+MPxD8K+K/BcWn6Lqn2m6W9SUp5EifKFcE5ZQO4oA9d+Hf/JOPDn/Y
Oh/9AFdNXM/Dv/knHhz/ALB0P/oArpqACiiigD5/+D//ACWrxj/28/8ApQK+gK+f/g//AMlq8Y/9
vP8A6UCvoCgAooooAKKKKACvAv2i/wDkL+FPrN/6FHXvteBftF/8hfwp9Zv/AEKOgD30dK+DNU/5
C97/ANfD/wDoRr7zHSvgzVP+Qve/9fD/APoRoAp0UUUAFFFFABRRRQBr+Gf+Rq0f/r9g/wDQxX3R
Xwv4Z/5GrR/+v2D/ANDFfdFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAF
FFFABRRRQAUUUUAFcnrPixdO8UWvh5tJu7lbq0knNyi5iUKrnY3udmP+BCusooA8G/4WN4Z/6JRN
/wCC+P8A+Ir0X4ea3Ya7pF1caf4efQ40uCjQNAse87VO7AA9cfhXaUUAFFFFAHK+LfBNr4ujtUud
R1OyFsWKmxnEZbdjO7IOelcj4/8AC1/D4C0fwnpCahqEEt/HHczyEyyLDuLEuQOgYjnsBXrFFAGL
q3hvSdc0ZdJ1GxSbT124hyVC7fu4IIIxXi3xh+HnhXwp4Li1DRdL+zXTXqRF/Pkf5SrkjDMR2FfQ
deS/tD/8k4h/7CMX/oD0Adp8O/8AknHhz/sHQ/8AoArpq5n4d/8AJOPDn/YOh/8AQBXTUAFFFFAH
z/8AB/8A5LV4x/7ef/SgV9AV8/8Awf8A+S1eMf8At5/9KBX0BQAUUUUAFFFFABXgX7Rf/IX8KfWb
/wBCjr32vAv2i/8AkL+FPrN/6FHQB76OlfBmqf8AIXvf+vh//QjX3mOlfBmqf8he9/6+H/8AQjQB
TooooAKKKKACiiigDX8M/wDI1aP/ANfsH/oYr7or4X8M/wDI1aP/ANfsH/oYr7ooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArP1W7aw0i9vI4/Mkt4Hl
VP7xVSQP0rQqrdzx29nNPKCY442dgBnIAyaAPnzw7bXt/rvg/wAU33iK4vr3V7qdZY948u22o2FA
zwR1xwB/P0P4T6jez6ZrGl3OotqUOk6g9tbXZYsZIwBjnvj8ev0rx3U7j4RX2pNdRJ4nskZtzQWy
RBBnrjcSRXpPgb4keANNhtfDmjJeWEcsmEa7j4kkbHLMCeTwOcDp0FAHsdFFFABXnvjDxhrll4u0
/wAK+GrCym1O7t2uWlvmYRIgJ/ukHPyn9K1vGGpeLNOjtT4V0S21R3LeeJ5hHsAxtxlhnPP5V5hr
kmo+L/iN4d0TxOi+HLuKye4eezlVZixL4RJcnjAHHPO6gD0LwL4tvfE9vq1rq1jFaappd0bW5WBi
0bNzyuc+h45/Wue/aG/5JxB/2EYv/QHrmPCOma3qGjeLvCPhrVo7aWw1BXh1RCUa5BLhleRMnPyj
kZ9Olcr8QPBnjrw94bS88SeJP7RsTcLGsP22aXDkNhtrgDoDz15oA+hfh3/yTjw5/wBg6H/0AV01
cz8O/wDknHhz/sHQ/wDoArpqACiiigD57+E9xBbfGbxi080cSk3IBkcLk/aB617x/aun/wDP/a/9
/l/xrybW/gFpur61e6kmuXcBu53maPyVcKzEk85HcmqH/DNWnf8AQyXX/gMv/wAVQB7R/aun/wDP
/a/9/l/xo/tXT/8An/tf+/y/414v/wAM1ad/0Ml1/wCAy/8AxVUtX/Z8sNM0a+v18QXLm2t5Jght
1G7apbHX2oA91/tXT/8An/tf+/y/40f2rp//AD/2v/f5f8a+ePBvwQsvFfhHT9bk1u4t3u1ZjEkA
YLh2Xrn2rf8A+GatO/6GS6/8Bl/+KoA9o/tXT/8An/tf+/y/414R+0Fc29zqvhUwTxShTNu8tw2P
mj9Kv/8ADNWnf9DJdf8AgMv/AMVUtp+zxpdvdQyy6/dyxo6syCBV3AHpnJxQB7eOlfBmqf8AIXvf
+vh//QjX3nXI3Xw48H3t1LdXPh6xkmlYu7bMZYnk8UAfF1FfZ/8AwqvwN/0LNj/3yf8AGj/hVfgb
/oWbH/vk/wCNAHxhRX1Z48+HfhDTPAet31l4fs4bmC0d45FUgqQOo5o8B/DvwhqfgPRL698P2c1z
PaI8kjKSWJHU80AfKdFfZ/8AwqvwN/0LNj/3yf8AGj/hVfgb/oWbH/vk/wCNAHyP4Z/5GrR/+v2D
/wBDFfdFcpZfDrwhYXcN1aeH7KK4hYPG4TJUjoea6ugAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArxLxT8a9U0Xxjf6Dpfh+O8No/l7i
zF3IAycKOle214B4V/5Og1v/ALb/APoK0AH/AAvXxf8A9CX/AOOTf4Uf8L18X/8AQl/+OTf4V7/R
QB4B/wAL18X/APQl/wDjk3+FH/C9fF//AEJf/jk3+Fe/0UAeVfDX4p3njPxBd6PfaRHZTQW7TBo3
JxtZVKsDyD8w/Kuv0zxLHqPi/XPD62zpJpSws0xbIk8xdwwO2OleTfC45/aA8YE9T9s/9KErcjj8
VSfF7xl/wi8+lRMEs/tB1BHbP7r5du38c/hQB6Br/iaPQdT0Sxe2eY6rd/ZVdWA8s4zk+tXNF1G6
1OykmvNMm0+VZnjEUzAllB4bjsa8w16LxlH4y8GHxNc6NLB/ao8oaekisG2n727tiq8XiTWbfwBH
Ha6hMuoap4ik0yO7kYu0KtI3Iz6AYHp2oA9urndI8RJq3iPXdHW3eN9IkiR5CwIk8xNwwO2K4HxP
4Xu/CL6Bc6Z4k1p4J9YtILyG7uzJ52X+8D1B65A4OenFLY+Gm8Q/E/xvBLqt9aWMctp5kNlL5LTO
YeCzjnAGeO5Oe1AHr9FeGTeK9c8N+AvENjHf3N1d2WunSbO8lHmzLGcHP+0wGce5HpVQ6pc6PJaX
/hseOrnUklT7TFqdrLJDdIT8+4HO04yQR0/WgD36sTW9fs9BFibsSE317FZQrGuSZJCcZ9Bwefav
MPGNzJa+MtSfxbJ4og0j5P7NudIdlt4l2jcX28792eufpjFU9es4Nd8MeCro+KLzWA2uQ2QvIZGh
JRmY5ZeolUADdwfzoA9wkcpGzKpZgCQo6k+lea6l8Udb0ZLd9R8A6jbrczrbwlruM75WztUYHU4N
egWFolhp9vaJJLKkMaxq8z73YAAZZu5964f4wf8AIP8ACv8A2Mdp/wCz0AdB4b17WNZnnj1Lwxd6
QkahkknmRxIc9Bt6V1FeYfFLxHd2F3oWi202oQRanLIbmXTYy9z5SAErGBzk56joBmsXw5qdzp3j
LSbfQo/F0mlXZaK+h1i3kaOPj5JEdvunPXsaAPaa5QeL1utL1W80fTbrUpdOvzYSW6AIzyKVDlc9
hu/Q1x/gTQrjxHLqWqalr2rubTVbmC2hiu2REQNzn+9nP4AAVxltpkmieB/GepWGpapHcwa+1kp+
1tgqJ4vmOMZc9C3fpQB7WfE0Q8djwt9lfzTp32/z9w248zZtx69810dePeMNZfw98UdV1eBQ01p4
RaSMMMjf9oAXPtkiuZTUbj+xU1W2uvHkvigxiZZ2tJDbSSYzs8v7vlnp9OfagD6Hrn9Q19NO1nS9
Lit3ub3UZGxGjACKJRl5WPoOB7kgCrOhXlxqGg6fe3du1vc3FtHJLC6lTG5UFlweRg5rl/Dch1L4
seL7ubk6fDa2Nvn+FGUyP+bYP4UATa749aw16XRdJ0G+1q/t41kultiFWBWGVDMe5HOKdbfELRJ/
Cd14kuPPtIbKRobu2mT99FMCB5ZX+9kjH17c45kw+INX+JHiG78G3EGnRwiO11Ge8HmJczovy7Ux
kbQcE559Ku/D3T7G8sNd0LXbFJ9YtNS+0aoZmEqTTN8yTLwMAgcDAxigC1b/ABLeK7tBrXhnVdGs
b2QRW97chSm5vuhwOUz/AJ9a9GrzLXpj8SNUt9D0oF9CsrpJtS1ED5HZDkQxH+I56sOB79K3J/iR
4ct9ZOkSzXYvFn8gqLOUrvzj723GM96AIdc8eNYa7No2j6Ffa5e26K90tqVVIAwyoZj/ABEc49Kf
YePdPvvC+q601vc20ulLJ9tsp1CyxOq52n69jU+t6rovg2O4v2t1+3ahIAsFtHme9lAwoAHJPbPQ
CuWk8FeINU8EeIvNNta674jmSaeN3Pl28YK7Y8gHJCAgnuT+NAGlp3xE1jUZLQp4E1tLe5KFbhiu
1VbHzfTBzV3XPHZ0/XZdG0fQ77W763jWS7S1KqtuG5UMx/iI5x6VzetSeMPAGn2+tXPiOLVdNhli
hvLBrJIVRGIXMTLzxkcH8c13etWeomyuH8N/2da6pKyl57mIkMB/e28k+maAF8L+J7PxXpLX1pHN
A0UrQXFvOm2SGVcbkYdiMit+vOPhe72sev6RqEbLr9tqBn1OQuGWZ5RuWRcAYUqPu9se9S/EqbU/
L8N22k6hLYXN3rMUBmjPRWR85HRsdcHuBQB6FRXld5Y3Xw+8SeHp7DWNUvLLVb1bC8tr+4M4ZnB2
yKT90g5Jx16ViareaJd65qqa14u1y+1Fbhxb2ugiYJaoOFXCAqXHOSTQB6xruvWfh2yhubzeUmuI
7aMRrkl3OFFMtdSu7jXb2xl0yeG1t0Ror1mGycsOQo68V4pevdeK/hl4bv8AVdQ1BrqHWksi4lKF
1MuNzj++ABg9Qc11dlqVx4X8VeNoxd3l5a6NpEEsEd1cNISRGW5z3J6mgD1qivni31Oa+0RNWN54
8bxHNEJ0uLe1kNqHIyEVB8pj6D3HPtXRXt3rvinxN4Ms59Q1DRjqOlSvqEUDGJ8rywAP3SSMZ6gG
gD2NmCqWbgAZNZPh7XbTxLoltq9h5n2a43GPzF2kgMVzj8K85tdJn03x7qvg1dY1aXR7zRftq+Zd
s0sDiQL8jnkA4P51zWh6Vqtj8J9BvtLm16eyvJy2qQ6fOTMkSmQAQj+EE/ex14oA9+csI2KLufGQ
CcZNY3hrXYfEWki8iieGVJGgubaQ/PBKpwyN7j9QQe9cL8O9U0mbxJc2+i+JdSlha3Jk0bWA7TRy
A/fRmPTHBAz6ntW1oDGw+LXifTo+ILu0t7/aOiycxsfxwPyoA76iiigAooooAKKKKACqOqLcvpV4
lkQLpoHEJPQPtO39cVeqjqV5/Z+l3d75Zk+zwvLsXq20E4/SkwPCvCHxH8KeFvCp0LxDod1Hq0Jk
W8je1VzcOSTlixySc45/lWNOuo3fw407R30iQXOsa076MjJ89tApU8d9uWIHbGT0xXS6ZcfFTxjZ
Qa9aQ+H47a4y1uJ4ELBQccZDHt3Oa9M8Fw+LE06c+MJLKW+879y1sBgR4HBwB3zTA6lRgAE5IFOo
ooAK53xF4N8P+KkiXW9PiuvKz5bEsrrnsGUg49q6Kuc8Q+MfD/haOJ9b1KK0Ev8Aq1ILO3uFUE49
6ALOieHtJ8NWH2HR7GO0tydxVMksfUk5JP1rz/8AaH/5JxD/ANhGL/0B69G0rWdP1zT4r7TLuO6t
ZM7ZIjkZHb2Psa85/aH/AOScQ/8AYRi/9AegDtPh3/yTjw5/2Dof/QBXTVzPw7/5Jx4c/wCwdD/6
AK6agAooooAKKKKAPLr7R/i1JqFw9n4m0WK1aVjCjW3Kpngf6s84x3P1qteeGPi1fWc9rceKtEaG
eNopALfGVYYP/LPjivWqKAPGtE8E/FTw9pFvpWm+KNFis7cERoYdxGST1MZPUmtIaF8YwQT4s0Mj
0+zf/a69TooAqQLKtvGs7q8wQB2UYBbHJA7VboooAKKKKACikIJBwcGvK38D/EpnYr8RsAngfYlF
AHVfEz/kmfiL/rxk/lR8M/8Akmfh3/rxj/lXF3/w4+IOqWM1lfeP1mtZ0McsbWgAZT24osPhx8Qd
LsYbKx8frDawII4o1tAQqjtzQB6/RXlSeCfiUsilviNkAjI+xKf0r1JQQoBOSByfWgB9FFFABRRR
QAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFA
BXzpr+gePtE+KmreI/DmjPcee7eTMEWRCjAZ4z1r6LooA8A/4Sn45f8AQC/8k1/xo/4Sn45f9AL/
AMk1/wAa9/ooA8A/4Sn45f8AQC/8k1/xo/4Sn45f9AL/AMk1/wAa9/ooA8K+EnhbxVaePNY8Q6/p
b2f2uCXezgLulkkVztUHpwfavS9I8Mz6d448Ra/JcxvDqqW6xxKpDR+Um05PvXVUUAcr4m8Mza5r
Hh29iuY4l0q9+1SKykmQYxge9cjrXhax8PfDm6stfvpFiOqNdxX1pESbSR5Mo5HoCcH616xVeaGK
5geGeNJI3G1kZcgj3FAHhesTalq+u+FLS78a2GvXA1W3kitNNjUKEU5eaUqTyAMAcDkkd69U0Tw5
NpXivxHq8lxHJHq0kDxxqpDR+XHtOfrWlp3h7RdIkaXTtIsLKR+Ge2t0jJ+pUCtagDzw/DdLvTfE
tjf3ny6rqbahbywAh7duNp56kEfjTI/CvjbUJ7O213xbGdNtpFkb+z4TBPc7TwHbPAPfH/169Goo
A4HUvDni+21y9vfDfiOBLW9YPJaalE0qwtjBMZHQHrjpmqEnw0vIPCdtYWGqR/2xDqy6w11LDiKS
47/IOi9OPb3r02igDN05bxNNtl1GSKS9Eaid4VKoz45Kg9BmsTxt4Zn8UW+jxQ3McH2HU4b5zIpO
4Ju+UY7nNdbRQByHjHwxJr62F1ZXrWGr6bKZrK7CbwhIwysvdSAM/wCQaOl+HPFcuvW2qeJfEKTJ
aKwistPRoonYjG6Tn5voeP697RQBy/hDw3N4c06+tprhJmudQnuwyKRtEhyBz3Fcde/DrXZbbxDp
VvrFkNI1W+/tCNXhbzY5TKjnJHUYQj8jxXrNFAHD6p4HXWPGV1qt5Oj6fdaM2ly24BDnMm7cD0H+
NZEfgnxxHpqaAnjGJNGQCJbhLYreCIdE3Zx043df5V6fRQBRs7VbO0htkeR1iRUDSuXdgBjLMeSf
euPijHh/4qXErnbaeJLVNjnoLmAY2+2Yzkeu0131Urm0t7ny/tEEUvlOJI96BtjDowz0I9aAOM1H
wn4hsdfvtW8Jata2Q1Jg95aXkBkjMgGPMUjkEjqP8ijc/DzWT4V1OxtdfH9t6zOsupai8W3zFAI2
Kq/dGMD6bvXA9OooA8z03wr8RdKtLaytPEuiwWduoRIY9OwAor0yiigDy/U/BnjObxpeeIrHX9Oj
dx5VqtxaGQ20X91c8AnuR1NaMng7X9f8O6hpPirW4Ll5WjktLiyg8prd1JOffnH6139FAHmp8FeK
tcmtLXxd4htbzSbWRZTb2lsY2umU5XzD6eoH/wBerWp+EPEFn4jvtb8J6zbWb6iF+2215CZI2dRg
OuOQcdq9AooA5Lwd4Zk0BL64vr5r/VtRmE17dsmwOwGFVV7KB0/yBh/Fi1kvIfCtrBdSWksuvQJH
cRgFomKvhhn0Nek1QubK1u2ha4t4pjDIJYjIgYo46Mueh96AON07wjr974gstS8W61BfLpzF7K2t
LfykMhGPMf1OO3QH9c7TfAfi7QPtWnaH4mtLbRZ7h5t72e+5i3HJAPQn3P5dq9SooA8wh+Gd7a/D
/wD4R2HVYjd2+pfbrS5eMkZD7lDjueucVqaJ4L1Bdb1vUvEFzZ3Z1ixitbiK3jZVO1SrdexBru6K
APLk8D+NbCx/sHT/ABdDHoqr5UUr2ubqGL+4rDjgcA8H0xW8PB0sPi/QNWjvmkt9KsZLQrcEvLKW
GAxc9T612dFAHJyeGJn+I58Tm4j+znSTp5g2ndkyb92emO1crp3w88WaXottptp4pht/7Lm8zTJI
omAZGLb0nTOGB3DHXGD616tRQBwGh+EdabxTD4k8VarZ3V5aQPDaw2UHlogb7zMTyxxxjoKPBanW
PFHiPxaAWtLuVLKxbs8MIIZx6hnzj6V3bKsisrAFSMEHvUFvbw2lulvbxJFDGu1I41CqoHYAUAW6
KKKACiiigAooooAKqXayS2s0cDhJmQqjEZCsRwTVus3W5Z4dB1GW0z9pS1kaLHXeFOP1xQB41pvg
z4jeHrZrCw8c6NaQhmbyC/yoSSThWjO0ZJ4GB7V6P4Bi1yHS7uPXtfstZuhP8stowIjXaPlOAOc5
P418+6f4Y8L3GneFtZ1HVLlrPU5p7bVpvNC/ZpwNyckHHUE5zkc1638FotOtNJ1/TtMk+0W1rqjr
Heg5FwhUbT6ZAHb2pger0UUUgMXXPE+ieG1hbWdQgshOWEZlON2MZx+YryPxDqNna/FGy8Z3Ony6
94au7AwW81tAJlRwSpGDxnIPp94+hr2DU9D0rWRGuqabZ3wjyUFzCsgXPXG4HHauR8QeFfFFvqVh
e+CtTtbC3t4jC2lyqUtTkk7wijGfmPbsOetAHmngTxpJ4UtfG99b6Fcm1S+ikh00ZQ2/mNIMNwdu
AFB47AVifEP4sXfjbw6mlT6AbBVuFmEhmL5IBGMFR/er3PwB4On8KWV9PqF4LzVdSn+0Xs6jClue
F9uSc8degrnP2hv+SdQcf8xCP/0B6AO0+Hf/ACTjw5/2Dof/AEAV01cz8O/+SceHP+wdD/6AK6ag
AooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAC
iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK+efHfxn8TaD401PSd
OjsEtrSXylMkJdm4HJOa+hq+MPip/wAlR8Q/9fZ/kKAOl/4aC8bf9Q3/AMBj/wDFUf8ADQXjb/qG
/wDgMf8A4qvKqKAPVf8AhoLxt/1Df/AY/wDxVH/DQXjb/qG/+Ax/+KryqigD6X+EvxR13xp4ju9N
1eK02R2puEkgjKEEMq46nOd36V3eheJbnVfGXifRpIIkh0hrdYpFJ3SeYhY7vpivDf2c/wDkoF9/
2DH/APRkdet+DP8Akq3xC/662X/oo0AeiVTgvLW4kdILqGV0++scgYr9QOlcZ8Vrq4i8M2NlBdSW
qanqdvYzzxttKROTuIPbpXOeNvB2ieA9Cs/EXhq2bTtSsLmFEaKRibhWcKyPkndkUAesJPC8bSJK
jRrncwYEDHXmnG5gWDzzNGISMiQuNv5147qjNoUXjnwpASj6reW72K/3lvCI32+ykPVbTFN3pGhf
DuVvMa116aG5DdWtrdjMMj0YNGBQB7RNe2tvIkc11DE8n3FeQKW+metTSSJFGXkZURRksxwBXzvo
dpd+KrO91rUvh9c+Irm/nlzetqaxeWAxURop5QLjHr+GK27jQvFereA9Ds7+yW+l0++kL6TcXyhr
2BQdgLqcMV6fhk0AextqNoLCW9S4ilgjUsXSQFeB69Ky/B/iSPxZ4ZtdXjiEH2gMTD5gcoAxAz7k
DNeZeH7Xw2+r6lpVz4e1Tw7dX+muH0ic5tbkId3mKepYY9hjPvXT/BnSbGx+HGnXtvbJHc3yF7mR
ScyFXcKT9BQBta9deOLe+kbQ7HRJtPSMMGvJpFkJxzwoxWD4T8T+PvFWmafrEOm6DHpt02STPKJQ
gcq3GCM8HFejXn/HlP8A9c2/lXlngvUbjSP2dU1G0/4+LaxupIzjoweTB/DrQB6f9ttRdfZTcw/a
MZ8rzBv/AC60st1bwZ82eJMLuO9wML6/Svnu18OXt14Ving+Ht4+pTQC5TXjrKCUyldwmzngZ5x6
e/NdJdaQ/ibx54PtfE8AklfQne9gD/LK6nuVOCN2GxnGQKAO/u/FtrZ+K9K0P90/2+KWX7R5wCxh
AMD3JyPT8aztd8V614f8GXWr3dtp73cV6kEccEpeMxtIqgk9d2CeK53WfBHhqP4peF7JNIgFtJZz
l4gWwTGF8vv2rnD/AMkT1z38SH/0ojoA93uLu3tFD3M8UCk4DSOFB/Op1YOoZSCCMgjvXg96l54l
8feI7i98Fz+J47G5Nlbob9YY7ZFHZD1Ldc12nwvtdZ06HVtPv9Ml03TobhXsLWa7W4eFGB3R7gSc
AgEZwfm70Adb4k1618OaBd6tdgtHbpkIv3pGPCoPckgfjUDaumj+GY9U8SzWtg6RK9yVY7Ec/wAK
55J7eprnviUPP1TwZZSH/Rp9ciaQdm2AsoPtmu0urO2vVVLqCKdUcSKsiBgGHQjPcUAcx4I8ZP4z
k1eT7C9pBZ3QhhWVSsjLtzlgehOenpWZJ4z8Uavdam/hfQbS903Tpmgaa4uSj3UifeEQAxgHjJ4P
6VZ+H/8AyM/jr1/tj/2mtN+EA2/D6OJv9fFeXSTA9Q/mt198EUAdN4Z1+38UeHbPWLZWjS4UlomP
zRsDhlPuCCK12ZUUszAKBkknGK8l8FeIbvQ/CTz2Wgajq8N3qt68ZsVB8tBJwTkjg84+hqXxj4wu
bzTNJ0660vV9MtdV8w6ji3Mk8UCkgxgLnBk6Z7Kc0Ab/AIW8ex+K/Feq6ZZ2uNPs4lkguySDcZYq
WA/u5Bwe+KqeN/iTZeGLmLTrBVv9UaeOOaIZKWysRzIR0J7Dr3+vN+EvFejP8VLuOwsr+C2ubC2s
raI2bJ5WzPDD+FcY5re+K1pbWvhGKSC3ijefVrV5WRApdt45bHU0Ael1VeeKNiskiKQpYgkA7R1P
0q1XlvjHRLTX/iloNjqDy/ZG064eWFJConUOp2NjkrnBI/2aAPSre4guohLbzRzRno8bBgfxFRtf
Wa3Atmu4FnPSIyAOfwzmvLksbDwJ8SZLDSJjp2j6ho811dxqxKWzR5xMAc444rjNR0zQ5/Bd7Ppf
g/XNQkEElwPEF83ksxALedktkgdcY5HuaAPadX8V2+keKNC0SREL6mZt0rTBRCI03cj3OAPxq5ot
zqV0t6dSSzQx3bxwfZZS+YhjaW9H65FeW32haXr3iD4Z3Op2SXU2p6fIbx5GOZtlujLnnsST/Os4
6pe6X8OPHMmnM8c8/iee38xG2squyKcHsccZ7ZzQB7lFfWs87ww3MUksf30SQFl+ookvLaESGW4i
QRAeYWcDZnpn0rwa68N6tp1pbXGgfDq40bVLN0eHUW1eNiSCNwkyQGDDIxxyfwro4vDGm+KPjN4l
Gs25nhgtLST7KzkRlzGBlgDzgZA/3jQB6Nr2vW2h+G73WiVnht4WlVUkA8zAzgHpzUmn6xbXeh2u
pyTQxRzRJIxMo2oWAO3d7ZrxqbRLCDwz8TNDEO7TtJmFzYwuxIgcxMcrzVnVfBLW9r4autK8N2+t
aXFp4muNHF0Y285wu6cAn5iRgd+nSgD13VLq7/sO5u9HSC6uljLwIzZSUj+HI9eR9aTw/rFt4h0K
y1a0yIrmMPsb7yHoyn3ByD7iuH+GU2jw32tafp9lquj3IaOabRr77lvkY3Rd8N3/AA4xitD4ZO0d
x4vsF/49rXXrgQjsobDFR9CT+dAHoFFFFABRRRQAUUUUAFFFFABVS8uorKznup22wwxtJIcdFUZN
W68/8d6x4ysrxbHQPDEOsWFxbETvI+MElgV+8P4cfnQB563i5vEOh3VrpfwnmvdCu7hp8oXVZJOh
cbE4bjqp46Zr0b4YM6+HpoP+EUfw5HFOQls7MxkBVTvywBPp36da4LwzqnxT8L6THpFt4NjuLW33
CDzXG5FJztJD84zXp/grVvEer6ZcTeJtGTSrpJtkcSNkMmB83U9yR+FAHVUUUUAFFeEeKvFHi+78
b+HPOt7jRtEbWVtoYhKVku9sihnccfIQeB0579a2vGl7qviH4n6Z4Is9XudLsjaNdXc1o22RzhiA
D6fKP++jnOBQB67Xkv7Q/wDyTiH/ALCMX/oD0/4ceJrm1i8SaN4l1dJRoF55K313IF3Rkso3MT6r
35+bFY/xv8S6FqvgKG30zV9PvJxfRuY7e5SRgoVxnAJ46UAek/Dv/knHhz/sHQ/+gCumrmfh3/yT
jw5/2Dof/QBXTUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUU
UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXzp
47+DXinXfGep6tpq2ctrdy+ahabYwyBwQRX0XRQB8of8KD8c/wDPvY/+BQo/4UH45/597H/wKFfV
9FAHyh/woPxz/wA+9j/4FCj/AIUH45/597H/AMChX1fRQB4r8Ifhj4g8HeJbzUtZ+zJE9oYESKTe
SS6tn2xt/Wuuvfh9NN4k1PWtP8T6rpkuotG08dts2tsXavUH3/Ou8ooA4seBIrvRb7SNc1fUNZt7
soQbplDQlc4KFQMHp+X1qpa/DhHvbOfW/EOra1BYuJLW2u3Xy1YdGbAG8j1Nd/RQByes+CNP1rxj
pHiOeWZbnTRhY1xtk5JXd9CSaLLwTptl49v/ABZG8pvLyERGM42JwoLDvk7B+tdZRQBwFz8NQt7e
TaN4k1bRre9kMtza2jL5Zc/eZMj5CfUVLdfDfRX0HTdLsZbzT5NNkM1pe28uJkkb7zEnru7/ANK7
qigDjdG8DR2WrNq2qaxf61qAha3iluiFWGNvvBVXABPc9aseDvCn/CIWUunwapd3dhn/AEaC4C/6
OuSSAQATkt39K6qigCGWMSxPGTgMpXI7ZrC8OeF7Pw94Rg8OK73VpFG8ZMwGXV2YkHHH8RFdHRQB
5t/wqeIWR0pfE+tpoJPOmCUFdvXZvxu2+1dDH4O0+38S6XrNs7wjTbJrKC2QDywh/XiuoooA5PxJ
4QOvanpuq2+qXWmahp+9YprcK2UfG5SGGO1Uf+FcWH/CJ3fh37dc+Rc3325pcLvDbw+BxjGVruqK
AOL1fwGl1rs2t6VrWo6NfXKqt01oVKTgDALKwIyB3rS8L+FLHwrZzw201xc3FzL511dXL75Z3Pdj
XRUUAcb8QdDutX8OR3Gmpv1TS7mPULNP77xnOz8VyPrit/StSt9Y0u11G1LGC5jWRNwwQD2I7EdD
WnRQBg6J4bg0TUNYvIZ5ZG1S6+1SK4GEbAGB+Vc7qPw0iudS1C503xBqukQaixe+tbN1EcrH7zDI
+Vj3Ir0CigDI0XSbTQ9ItNL0+LyrS2jEca5ycepPcnkn3rXoooAwbbw7BbeLb7XlnlM95bR27RHG
1QhJBHfvTPFXhi38VaVFp9xcSwJHcx3AaMAklDkDntXQ0UAFeW+MNF/t34p6HB9pu7Rk064kiurV
yrxSAjBz09eDwRXqVFAHFaZ8P7C1Gpzape3mr32pQG1ubq7f5vJP/LNQuAo+nestfhVHJpX9j3fi
jXLnRVQxxWRlVVVf4QWAywHGB04HFek0UAcPfeAUutO8PQ22s3tne6FEYrW8iVS5UoEIYEY5UCpr
LwJpVvoWuaPdPLeWmsXkt3OJMAqz7eFx6FQQfWuyooA86T4XpMbW21bxJrGq6Vaurxafcuuw7fuh
yBlwK6Sw8MQWHizVPECTytPqMUUTxEDYgjGBjvXQ0UAcf/wgtgzeJxJcTuniHAuFyB5eEK/Lx755
rIT4XtGLKaPxPqiatZIYLfUI9gcQdomXGGUHJ57mvR6KAOIs9DsPBFnq3iC+v73U9QkiBuLq4O6R
wv3Y0VRgckAADqRVvwBolzo3hoPqCbNT1CeS/vR6SyHJX8BgfhXWYooAKKKKACiiigAooooAKKKK
ACvKPH2q6/qPjjR/Bfh7UG06SeE3dzdDghAWwOOf4TwMZyBkc16vXl/xD8M67J4g03xb4U2yaxp0
Ziktn/5bRcnHJGfvMMZGc8cigDqPGOj6zrnhuWz0PVjp1+HWRZl3Ddt525ByuTjnnjsaxvhX4ov/
ABP4Vkl1YY1GyuXtJ3xjeVAO4gcZ5wfpXJXHj74n6mj6fY+B5bS7f5PtMkThUJ7gthfzJH1rtfhp
4Ol8I+ExYXU6zX1xM1zdOvI3sAMA98ADn1zQB3NcDeeBtdufFbatF431OC0Nws39noD5e0EZT7/Q
49O9d9RQB5T8V4JZvEvgExRSOE1dS5VSdo3R9fSs/wAbyyeDfixpfjK6tLibSZLNraeWCPcY3wwG
fzXrjPPpXs1IQCMEZoA8O8G+C4vHmn+KtS1q1ubSx13UFuLQA7JVVGchhnI/5aY6EHB9jWkP2dPC
IOTqGskennR//G69gooAoaZp9vpGmWunWqFLe1iWGJSckKoAFX6KKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooo
AKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigA
ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACi
iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK
KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoooo
AKKKKACiiigAooooA//Z
</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-30" NO="30" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Post-hoc tertile analysis of the effect of publication year on reported trough BP lowering</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-31" NO="31" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve of peak blood pressure lowering efficacy of ACE inhibitors according to proportions of Max</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-32" NO="32" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve assessing the effect of ACE inhibitors on heart rate</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-33" NO="33" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Log dose-response curve assessing the effect of ACE inhibitors on withdrawals due to adverse effects</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>